RESULT_COUNT: 2186,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
CELG,CELG:UW,BBG000BFCMR2,Celgene dives 10% after ditching key drug,2017-10-21 15:11:37 +0000,http://finance.yahoo.com/r/90377313-c584-3260-92b4-a811713a6277/Story.aspx?guid=673FF8A2-B592-11E7-87BC-C03F0B2DEBB2&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The once high-profile drug was expected to bring in as much as $2.4 billion in peak revenue.
CELG,CELG:UW,BBG000BFCMR2,Celgene Down on Discontinued Crohn's Disease Drug Study,2017-10-21 00:00:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D2f5qbTCiFg/celgene-down-on-discontinued-crohns-disease-drug-study-cm863006,Shares of Celgene Corporation CELG declined after the company announced that a phase III trial REVOLVE CD 002 on pipeline candidate GED 0301 in Crohn s disease and the extension trial SUSTAIN CD 004 will be discontinued Celgene s stock has moved up 84 2 year to date
CELG,CELG:UW,BBG000BFCMR2,Gilead (GILD) CAR-T Therapy Yescarta Clinches FDA Approval,2017-10-20 23:59:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jwCW8zJfQ9Y/gilead-gild-car-t-therapy-yescarta-clinches-fda-approval-cm863004,Gilead Sciences Inc GILD announced that the FDA has approved its chimeric antigen receptor T cell CAR T therapy Yescarta axicabtagene ciloleucel for treatment of refractory aggressive non Hodgkin lymphoma which includes DLBCL transformed follicular lymphoma TFL and primary
CELG,CELG:UW,BBG000BFCMR2,Celgene Stock: Performance in 3Q17,2017-10-20 22:06:47 +0000,http://finance.yahoo.com/r/e41f1474-9ca4-347e-808e-0417a3969c8c/celgene-stock-performance-in-3q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Celgene stock has risen ~12.3% in 3Q17. It has risen ~17.5% year-to-date as of October 20, 2017."
CELG,CELG:UW,BBG000BFCMR2,Celgene Abandons Crohn's Drug; Could Others Take Its Spot?,2017-10-20 22:00:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ytckz20-0Dc/celgene-abandons-crohns-drug-could-others-take-its-spot-cm862804,Celgene CELG toppled to a four month low Friday after it scrapped trials in Crohn s disease 160 a late stage failure that throws some cold water on the biotech s efforts in treating inflammatory bowel disease ibd display video id 2386617 width 50 float
CELG,CELG:UW,BBG000BFCMR2,Celgene Down on Discontinued Crohn&apos;s Disease Drug Study,2017-10-20 21:43:09 +0000,https://finance.yahoo.com/news/celgene-down-discontinued-crohn-apos-214309397.html?.tsrc=rss,"Shares of Celgene Corporation (CELG) declined after the company announced that a phase III trial, REVOLVE, (CD-002) on pipeline candidate GED-0301 in Crohn&apos;s disease and the extension trial, SUSTAIN (CD-004) will be discontinued."
CELG,CELG:UW,BBG000BFCMR2,Here are 4 home run stocks to kick off the World Series: ...,2017-10-20 21:25:00 +0000,https://finance.yahoo.com/video/4-home-run-stocks-kick-212500104.html?.tsrc=rss,"The “Fast Money” traders share their final trades for the day including Harsco Corp, Celgene, Walmart, and Alibaba."
CELG,CELG:UW,BBG000BFCMR2,Celgene Abandons Crohn&apos;s Drug; Could Others Take Its Spot?,2017-10-20 21:11:13 +0000,http://finance.yahoo.com/r/05bec9c9-2e29-33f2-a7e1-f260715ea65f/celgene-abandons-crohns-drug-could-others-take-its-spot?src=A00220&yptr=yahoo&.tsrc=rss,Celgene toppled to a four-month low Friday after it scrapped trials in Crohn&apos;s disease after a late-stage failure.
CELG,CELG:UW,BBG000BFCMR2,What Happened in the Stock Market Today,2017-10-20 21:06:00 +0000,https://finance.yahoo.com/news/happened-stock-market-today-210600048.html?.tsrc=rss,"On another record day for the major benchmarks, shares of Skechers skyrocketed on earnings and Celgene tumbled after discontinuing a drug trial."
CELG,CELG:UW,BBG000BFCMR2,How Big of a Deal Is Celgene's Flop?,2017-10-20 21:02:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QgqPElzO_wE/how-big-of-a-deal-is-celgenes-flop-cm862917,Celgene NASDAQ CELG 160 shuttered two GED 301 Crohn s disease trials this week after an interim look at data by independent monitors 160 proved disappointing The late stage failure dings Celgene s pipeline and it will result in a writedown but investors might not want to
CELG,CELG:UW,BBG000BFCMR2,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,629.05.",2017-10-20 20:49:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BfP0f8rjNfg/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-662905-cm862948,Friday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 6 629 05 up 23 98 for the day The index had a previous high 6624 22002 on 10 18 2017 The total shares traded for the NASDAQ was over 1 88 billion Friday s session closes with the
CELG,CELG:UW,BBG000BFCMR2,The Biggest Loser: Does Celgene Need to Pipe Up?,2017-10-20 20:47:00 +0000,http://finance.yahoo.com/r/46df7816-09e4-3646-803e-e88c049a7607/the-biggest-loser-does-celgene-neet-to-pipe-up-1508532437?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Celgene (CELG) plunged to the bottom of the S&P 500 today after the drug maker abandoned clinical trials testing its experimental drug Mongersen as a treatment for Crohn’s disease.  The stock fell almost 10.8% to close at $121.33 on a day when the S&P 500 posted a 0.5% gain, making Celgene the worst-performing stock in the index.  Mongersen was a high-profile drug in Celgene’s pipeline."
CELG,CELG:UW,BBG000BFCMR2,PayPal and Skechers jump while Celgene tumbles,2017-10-20 20:30:55 +0000,https://finance.yahoo.com/news/paypal-skechers-jump-while-celgene-203055652.html?.tsrc=rss,"Stocks that moved substantially or traded heavily Friday: Celgene Corp., down $14.63 to $121.33 The drugmaker ended late-stage testing of a potential treatment for Crohn's disease. General Electric Co., ..."
CELG,CELG:UW,BBG000BFCMR2,"Health Care Sector Update for 10/20/2017: CELG,ACRX,DRRX",2017-10-20 20:19:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b8G2yGIjxP4/health-care-sector-update-for-10202017-celgacrxdrrx-cm862906,Top Health Care StocksTop Health Care Stocks JNJ 0 14 JNJ 0 14 PFE 0 31 PFE 0 31 ABT 0 74 ABT 0 74 MRK 0 28 MRK 0 28 AMGN 0 51 AMGN 0 51 Health care stocks climbed a short way past their starting marks today with the NYSE Health Care Index rising almost 0 3 while shares of
CELG,CELG:UW,BBG000BFCMR2,"GLOBAL MARKETS-U.S. tax plan hopes lift stocks, dollar strengthens",2017-10-20 20:19:11 +0000,https://finance.yahoo.com/news/global-markets-u-tax-plan-201911296.html?.tsrc=rss,"World stocks advanced, bond  yields rose and the U.S. dollar strengthened on Friday on  increased hopes President Donald Trump could make progress on  his fiscal plans after the U.S. Senate approved a budget  blueprint that paves the way for tax cuts.  U.S. Republican Senator Rand Paul appeared to back the  administration's sweeping tax cut plan, saying he was ""all in""  for massive tax cuts, even as the Senate passed a key budget  measure without his support one day earlier."
CELG,CELG:UW,BBG000BFCMR2,Tax Cut Progress Gives Wall Street Enough Fuel to End With More Records,2017-10-20 20:15:00 +0000,http://finance.yahoo.com/r/64d2b41d-b475-3176-b7cd-db1f2e73cac8/tax-progress-cut-reform-wall-street-major-indexes-trade-records.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Congress makes progress toward tax reform and Wall Street cheers. All major indexes secure new records heading into the weekend.
CELG,CELG:UW,BBG000BFCMR2,Stocks close near session highs,2017-10-20 20:00:00 +0000,https://finance.yahoo.com/video/stocks-close-near-session-highs-200000058.html?.tsrc=rss,Discussing the winners and losers of the market at the closing bell with CNBC Contributor Evan Newmark and Cathie Wood of ARK Invest.
CELG,CELG:UW,BBG000BFCMR2,"Tax Progress Boosts Wall Street, Major Indexes Trade Above Records",2017-10-20 19:09:00 +0000,http://finance.yahoo.com/r/faaafd9a-423e-36bc-88e0-0196712ba709/tax-progress-reform-cuts-wall-street-indexes-records.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks are rising after the Senate votes for a budget blueprint that paves the way for major tax cuts.
CELG,CELG:UW,BBG000BFCMR2,Catch This Falling Knife — Go Long Celgene Corporation,2017-10-20 19:04:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cTcoL4F-8n0/catch-this-falling-knife-go-long-celgene-corporation-cm862894,InvestorPlace Stock Market News Stock Advice amp Trading Tips Last night Celgene Corporation NASDAQ CELG released a headline that they canceled phase three for their potential solution to Crohn s disease The stock is now trading down 10 This means that it would now be
CELG,CELG:UW,BBG000BFCMR2,How Big of a Deal Is Celgene&apos;s Flop?,2017-10-20 19:01:00 +0000,https://finance.yahoo.com/news/big-deal-celgene-apos-flop-190100369.html?.tsrc=rss,"A disappointing late-stage trial failure is causing shares to tumble, but there&apos;s a lot going on at this company that could pan out for investors."
CELG,CELG:UW,BBG000BFCMR2,Mid-Day Market Update: Dow Surges Over 100 Points; DURECT Shares Plummet,2017-10-20 18:49:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pigyWerhnJI/mid-day-market-update-dow-surges-over-100-points-durect-shares-plummet-cm862826,Midway through trading Friday the Dow traded up 0 46 percent to 23 269 14 while the NASDAQ climbed 0 41 percent to 6 632 30 The S amp P also rose gaining 0 33 percent to 2 570 62 Leading and Lagging Sectors On Friday the technology shares surged 0 56 percent Meanwhile top
CELG,CELG:UW,BBG000BFCMR2,Biotech Earnings: Good News on the Way,2017-10-20 18:32:00 +0000,http://finance.yahoo.com/r/b37ccf3f-62ca-30e4-86cb-862b90e3ff9e/biotech-earnings-good-news-on-the-way-1508524374?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"BMO Capital Markets’ M. Ian Somaiya takes a look at the biotech sector on Friday, writing that another strong quarter could help the stocks keep climbing. Somaiya writes that he expects solid results from ..."
CELG,CELG:UW,BBG000BFCMR2,"GLOBAL MARKETS-U.S. tax plan hopes lift stocks, strengthen dollar",2017-10-20 17:34:54 +0000,https://finance.yahoo.com/news/global-markets-u-tax-plan-173454748.html?.tsrc=rss,"World stocks and bond yields  rose and the U.S. dollar strengthened on Friday, as investors  anticipated President Donald Trump could make progress on his  fiscal plans after the U.S. Senate approved a budget blueprint  that paves the way for tax cuts.  U.S. Republican Senator Rand Paul appeared to back the  administration's sweeping tax cut plan, saying he was ""all in""  for massive tax cuts, even as the Senate passed a key budget  measure without his support one day earlier."
CELG,CELG:UW,BBG000BFCMR2,Why Celgene Corporation Dropped Today,2017-10-20 17:11:00 +0000,https://finance.yahoo.com/news/why-celgene-corporation-dropped-today-171100063.html?.tsrc=rss,A phase 3 failure sent shares down.
CELG,CELG:UW,BBG000BFCMR2,Is a Beat in the Cards for Vertex (VRTX) in Q3 Earnings?,2017-10-20 17:05:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D5gzbKs51c0/is-a-beat-in-the-cards-for-vertex-vrtx-in-q3-earnings-cm862675,We expect Vertex Pharmaceuticals Inc VRTX to beat expectations when it reports its third quarter 2017 results on Oct 25 after the market closes Year to date Vertex s shares have soared 109 9 while the industry has recorded an increase of 12 1 Vertex s track record has
CELG,CELG:UW,BBG000BFCMR2,What's in the Cards for Amgen (AMGN) this Earnings Season?,2017-10-20 17:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RKiVsbKWKYU/whats-in-the-cards-for-amgen-amgn-this-earnings-season-cm862668,Biotech major Amgen Inc AMGN will report third quarter 2017 results on Oct 25 after the market closes Amgen delivered a positive earnings surprise of 5 83 in the last quarter Amgen shares are up 25 9 so far this year This compares favorably with the 12 1 increase registered by
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Friday Option Activity: CELG, CBS, MAC",2017-10-20 17:02:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T3hEUXZOpRI/noteworthy-friday-option-activity-celg-cbs-mac-cm862677,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Celgene Corp Symbol CELG where a total volume of 77 205 contracts has been traded thus far today a contract volume which is representative of approximately 7 7
CELG,CELG:UW,BBG000BFCMR2,Celgene's Whiff Isn't the End of the World,2017-10-20 16:33:02 +0000,http://finance.yahoo.com/r/58b38139-3715-3b18-b8a0-ef1ff7f0604e/celgene-stops-mongersen-trial-not-the-end-of-the-world?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"The drugmaker has a full pipeline, so investors should expect some misses."
CELG,CELG:UW,BBG000BFCMR2,Stocks Reach New Record Highs Amid Optimism About Tax Reform - U.S. Commentary,2017-10-20 16:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cglAoZQxCwQ/stocks-reach-new-record-highs-amid-optimism-about-tax-reform--us-commentary-20171020-00881,Stocks Reach New Record Highs Amid Optimism About Tax Reform - U.S. Commentary
CELG,CELG:UW,BBG000BFCMR2,"S&P 500 Movers: CELG, PYPL",2017-10-20 16:03:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/09B7lh_kx5k/sp-500-movers-celg-pypl-cm862616,In early trading on Friday shares of PayPal Holdings PYPL topped the list of the day s best performing components of the S amp P 500 index trading up 6 1 Year to date PayPal Holdings registers a 80 8 gain And the worst performing S amp P 500 component thus far on the day
CELG,CELG:UW,BBG000BFCMR2,"Nasdaq 100 Movers: CELG, PYPL",2017-10-20 16:03:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kOD_TyQS0rI/nasdaq-100-movers-celg-pypl-cm862613,In early trading on Friday shares of PayPal Holdings PYPL topped the list of the day s best performing components of the Nasdaq 100 index trading up 6 4 Year to date PayPal Holdings registers a 81 3 gain And the worst performing Nasdaq 100 component thus far on the day is
CELG,CELG:UW,BBG000BFCMR2,Celgene Remains Firmly Negative After Initial Sell-Off,2017-10-20 15:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F8ry2PMIENk/celgene-remains-firmly-negative-after-initial-selloff-20171020-00841,Celgene Remains Firmly Negative After Initial Sell-Off
CELG,CELG:UW,BBG000BFCMR2,Celgene's Sharp Sell-Off Is Likely Overdone,2017-10-20 15:12:00 +0000,http://finance.yahoo.com/r/3724edf1-858d-3aa6-907b-a8aa169514ca/celgenes-sharp-selloff-likely-overdone?partner=YahooSA&yptr=yahoo&.tsrc=rss,Celgene's stock tanked after it terminated a clinical trial for its ulcerative colitis drug GED-0301.
CELG,CELG:UW,BBG000BFCMR2,Modest Gains Drive Wall Street to Trade at Records as Tax Progress Buoys Spirits,2017-10-20 14:59:00 +0000,http://finance.yahoo.com/r/6bcbb8dc-c4a4-31dc-8dff-c1e31112385e/tax-reform-progress-stocks-records-ge-general-electric.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks are rising after the Senate votes for a budget blueprint that paves the way for major tax cuts.
CELG,CELG:UW,BBG000BFCMR2,Celgene: No Surprise? Its 10% Drop Says Different.,2017-10-20 14:55:00 +0000,http://finance.yahoo.com/r/03c3cd57-69d0-340e-bc73-7669bef7b2d6/celgene-no-surprise-its-10-drop-says-different-1508511320?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Celgene’s (CELG) efforts to reduce its dependence on the blood cancer drug Revlimid suffered a setback today when the drug maker Celgene said it would abandon testing mongersen, a big treatment for Crohn’s disease.  The drug maker announced that it would stop two trials, and would not initiate a third study following a risk-benefit analysis by a data monitoring committee.  Celgene says there were “no meaningful safety imbalances” identified in the committee’s analysis."
CELG,CELG:UW,BBG000BFCMR2,"US STOCKS-Bank, tech stocks lift Wall Street",2017-10-20 14:14:02 +0000,https://finance.yahoo.com/news/us-stocks-bank-tech-stocks-141402140.html?.tsrc=rss,"U.S. stocks inched higher on Friday as  bank stocks rose and tech stocks recovered, with investor  optimism back as Trump administration cleared a hurdle to lower  taxes.  Bank of America's 2 percent gain was the biggest  boost to the S&P. Apple led the gains in the technology  index as it rose 0.60 percent after falling 2.5 percent on  Thursday."
CELG,CELG:UW,BBG000BFCMR2,"Stocks Open Higher As Skechers, Atlassian, PayPal Soar; GE Slides",2017-10-20 13:39:22 +0000,http://finance.yahoo.com/r/7ffe47fa-8a31-3a3e-b062-7e4cefc09913/futures-shift-higher-dow-financials-rally-as-this-biotech-dives?src=A00220&yptr=yahoo&.tsrc=rss,"Stocks jumped at the starting bell Friday, as global markets rebounded and earnings news rolled in."
CELG,CELG:UW,BBG000BFCMR2,Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers,2017-10-20 13:26:00 +0000,http://finance.yahoo.com/r/7255af24-7057-37fb-b18b-b03d858c25cf/celgene-down-after-pulling-plug-crohns-disease-drug-study-biotech-movers?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial."
CELG,CELG:UW,BBG000BFCMR2,US STOCKS-Wall St set to open higher fueled by tax-cut optimism,2017-10-20 13:09:57 +0000,https://finance.yahoo.com/news/us-stocks-wall-st-set-130957564.html?.tsrc=rss,"Wall Street was poised to open higher on  Friday on growth optimism as the Trump administration inched a  step closer to implementing its tax-cut plan.  Hopes of tax cuts have helped the market rally, as companies  expect the move to lift economic growth and inflation.  ""The good thing is we're seeing incremental positives as we  move toward tax cuts,"" said Art Hogan, chief market strategist  at Wunderlich Securities in New York."
CELG,CELG:UW,BBG000BFCMR2,Stocks Set to Open With More Records as Trump Tax Reform Makes Progress,2017-10-20 12:50:00 +0000,http://finance.yahoo.com/r/7bc715ea-53f0-30c9-95ab-8dd4b389cfc0/stock-futures-records-trump-talks-tax-reform.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stock futures set up for more records after the Senate voted for a budget blueprint that paves the way for major tax cuts.
CELG,CELG:UW,BBG000BFCMR2,"Morning Movers: GE Slumps, Procter & Gamble Slips, Celgene Sinks",2017-10-20 12:32:00 +0000,http://finance.yahoo.com/r/d47a6ace-34bd-34c6-bb90-947d9cb2cd7b/morning-movers-ge-slumps-procter-gamble-slips-celgene-sinks-1508502752?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a higher open this morning after the Senate passed a budget resolution that could clear the way for tax cuts. S&P 500 futures have, while Dow Jones Industrial futures have. Nasdaq Composite ..."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Could Be the Best CAR-T Stock to Buy, Not Gilead Sciences",2017-10-20 11:31:00 +0000,https://finance.yahoo.com/news/celgene-could-best-car-t-113100536.html?.tsrc=rss,Celgene&apos;s partnership strategy gives it exposure to multiple companies&apos; research on next-generation cell therapy.
CELG,CELG:UW,BBG000BFCMR2,Celgene downgraded to neutral at Baird for 'increasing risks to long-term goals',2017-10-20 11:29:35 +0000,http://finance.yahoo.com/r/15a063f7-089c-35b1-9a9e-368a85008be8/Story.aspx?guid=69B93474-A90D-448A-A04B-E14FC875CA6B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Celgene Corp. was downgraded to neutral at Baird Equity Research on Friday after the drugmaker abandoned three Crohn's disease drug trials late Thursday. Baird analyst Brian Skorney also lowered the company's ...
CELG,CELG:UW,BBG000BFCMR2,"3 Stocks to Watch on Friday: Celgene Corporation (CELG), Intuitive Surgical, Inc. (ISRG) and Skechers USA Inc (SKX)",2017-10-20 11:05:29 +0000,https://finance.yahoo.com/news/3-stocks-watch-friday-celgene-110529388.html?.tsrc=rss,"Several companies made headlines late yesterday, including Celgene Corporation (NASDAQ:CELG), Intuitive Surgical, Inc. (NASDAQ:ISRG) and Skechers USA Inc (NYSE:SKX).  Celgene stock took a hit on the company’s latest decision for one of its drugs.  The pharmaceutical company will not move ahead with the phase 3 trial for a Crohn’s disease drug."
CELG,CELG:UW,BBG000BFCMR2,Celgene's $710 Million Bad Bet Drags Shares Lower,2017-10-20 09:54:00 +0000,http://finance.yahoo.com/r/d82b7842-c75d-3941-9c21-48619b4f3ab3/celgenes-710-million-bad-bet-drags-shares-lower?partner=YahooSA&yptr=yahoo&.tsrc=rss,"In a statement released Thursday, Celgene Corporation revealed it will be abandoning its Crohn's disease therapy GED-0301."
CELG,CELG:UW,BBG000BFCMR2,"Covenant Asset Management, LLC Buys Albemarle Corp, FedEx Corp, State Street Corporation, Sells ...",2017-10-20 09:44:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3HTC54zVzj4/covenant-asset-management-llc-buys-albemarle-corp-fedex-corp-state-street-corporation-sells-cm862385,Covenant Asset Management LLC New Purchases ALB FDX STT SUM USCR DWDP BTT BTT ITW INTC Added Positions VWO STLD SPY AAPL ABBV DGS QCOM HON EPD RF Reduced Positions DIS CVS CMG GE CEF PANW FRC BAC FB AGN Sold Out PXD
CELG,CELG:UW,BBG000BFCMR2,S&P 500 Futures Rise After Senate OKs Budget Resolution Paving Way For Tax Cuts,2017-10-20 09:43:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7S62DnbuVYE/sp-500-futures-rise-after-senate-oks-budget-resolution-paving-way-for-tax-cuts-cm862359,Futures for the S amp P 500 index Nasdaq 100 and Dow industrials rose Friday morning after the Senate approved a budget resolution 160 late Thursday paving the way for up to 1 5 trillion in tax cuts over the next 10 years ibd display video id 2326958 width 50 float
CELG,CELG:UW,BBG000BFCMR2,S&P 500 Futures Rise After Senate OKs Budget Resolution Paving Way For Tax Cuts,2017-10-20 09:40:38 +0000,http://finance.yahoo.com/r/829f77d4-cb4f-3447-9129-418c1b0edf30/facebook-google-lose-buy-points-paypal-celgene-active-late-sp-500-futures?src=A00220&yptr=yahoo&.tsrc=rss,Stock futures rose Friday morning after the Senate approved a budget resolution that paves the way for tax cuts. Several top-rated stocks already were moving late.
CELG,CELG:UW,BBG000BFCMR2,Celgene Corp. (CELG) Is Sinking After Phase 3 Study Discontinued,2017-10-20 09:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mRzMpM2gBts/celgene-corp-celg-is-sinking-after-phase-3-study-discontinued-20171020-00585,Celgene Corp. (CELG) Is Sinking After Phase 3 Study Discontinued
CELG,CELG:UW,BBG000BFCMR2,"Final Trades: HAIN, CELG & PHM",2017-10-19 21:59:00 +0000,https://finance.yahoo.com/video/final-trades-hain-celg-phm-215900850.html?.tsrc=rss,"The “Fast Money” traders share their final trades for the day including PulteGroup, Hain Celestial Group, VanEck Vectors Semiconductor ETF, and Celgene."
CELG,CELG:UW,BBG000BFCMR2,Drug That Celgene Bought For $710 Million Fails,2017-10-19 21:49:00 +0000,http://finance.yahoo.com/r/7594e4ae-7224-33a7-bd72-99c4581b7347/drug-celgene-bought-for-710-million-fails?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Celgene announced that after consulting the data safety and monitoring committee that was overseeing the main mongersen study, called REVOLVE, it had decided to stop developing the drug. It cited a futility analysis, implying the medicine was not effective, but said there were no safety problems."
CELG,CELG:UW,BBG000BFCMR2,Celgene Falls After Scrapping Crohn's Disease Drug Trials,2017-10-19 21:44:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m0b7O5sqj-w/celgene-falls-after-scrapping-crohns-disease-drug-trials-cm862311,Celgene CELG stock fell late late Thursday after the biotech discontinued a pair of trials and won t begin a third for a late stage drug being investigated to treat Crohn s disease ibd display video id 2382612 width 50 float left autostart true A Phase 3 trial dubbed
CELG,CELG:UW,BBG000BFCMR2,Celgene Falls After Scrapping Crohn&apos;s Disease Drug Trials,2017-10-19 21:26:03 +0000,http://finance.yahoo.com/r/29e80e1e-5583-373b-bd9b-466ff1e8d33b/celgene-shares-halted-as-it-scraps-trials-in-crohns-treatment?src=A00220&yptr=yahoo&.tsrc=rss,Celgene stock fell late Thursday after the biotech discontinued a pair of trials for a late-stage drug to treat Crohn&apos;s disease.
CELG,CELG:UW,BBG000BFCMR2,Celgene shares drop after Crohn's disease drug trials halted,2017-10-19 21:13:11 +0000,http://finance.yahoo.com/r/96f07acb-7637-3d61-91b3-fff291dd0daf/Story.aspx?guid=746AE3AF-6D07-43D3-92F4-4C04220D57D3&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Celgene Corp. shares dropped in the extended session Thursday after the biotech company said it would discontinue two clinical trials for a Crohn's disease treatment and not start a third. Celgene shares ...
CELG,CELG:UW,BBG000BFCMR2,"Celgene reopens, shares plunge",2017-10-19 21:10:00 +0000,https://finance.yahoo.com/video/celgene-reopens-shares-plunge-211000390.html?.tsrc=rss,CNBC's Meg Tirrell reports on Celgene stock reopening after being halted on news the company is discontinuing its Crohn's disease drug trial.
CELG,CELG:UW,BBG000BFCMR2,Does Gilead Now Have A New Multi-Billion-Dollar Franchise?,2017-10-19 20:48:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p7Athhyn3y0/does-gilead-now-have-a-new-multi-billion-dollar-franchise-cm861865,Gilead Sciences GILD jumped early Thursday after the Food and Drug Administration approved what is known as a CAR T drug dubbed Yescarta to treat an aggressive form of non Hodgkin lymphoma ibd display video id 2381354 width 50 float left autostart true The late
CELG,CELG:UW,BBG000BFCMR2,Celgene abandons Crohn's disease drug trials,2017-10-19 20:44:46 +0000,https://finance.yahoo.com/news/celgene-abandons-crohns-disease-drug-204446752.html?.tsrc=rss,"Celgene Corp said on Thursday it would stop two studies of its drug for an inflammatory bowel disease and would not begin a third, following a recommendation by a data monitoring committee. The drug, mongersen, ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene won&apos;t initiate phase 3 trial for Crohn&apos;s disease drug,2017-10-19 20:35:29 +0000,https://finance.yahoo.com/news/celgene-won-apos-t-initiate-203529643.html?.tsrc=rss,Celgene said Thursday that it won&apos;t initiate a phase 3 trial for a Crohn&apos;s disease drug.
CELG,CELG:UW,BBG000BFCMR2,Celgene won't initiate phase 3 trial for Crohn's disease drug,2017-10-19 20:35:29 +0000,http://finance.yahoo.com/r/21101528-92a8-3fed-9376-65cfe0d22d35/104784292?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104784292&yptr=yahoo&.tsrc=rss,Celgene said Thursday that it won't initiate a phase 3 trial for a Crohn's disease drug.
CELG,CELG:UW,BBG000BFCMR2,Celgene discontinues trial of Crohn's disease drug,2017-10-19 20:34:00 +0000,https://finance.yahoo.com/video/celgene-discontinues-trial-crohns-disease-203400876.html?.tsrc=rss,CNBC's Meg Tirrell reports on Celgene stock halted on news the company will discontinue Crohn's disease drug trial.
CELG,CELG:UW,BBG000BFCMR2,Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program,2017-10-19 20:30:00 +0000,https://finance.yahoo.com/news/celgene-provides-ged-0301-mongersen-203000098.html?.tsrc=rss,Celgene Corporation today announced that the GED-0301 phase III REVOLVE trial in Crohn’s disease and the extension trial will discontinue.
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: IBM, Celgene, Procter & Gamble, Valero and Sprint",2017-10-19 14:52:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M8slVUJ5a8w/the-zacks-analyst-blog-highlights-ibm-celgene-procter-gamble-valero-and-sprint-cm861890,For Immediate Release Chicago IL October 19 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the
CELG,CELG:UW,BBG000BFCMR2,Celgene: Look Beyond Any Short-Term Weakness,2017-10-19 13:46:00 +0000,http://finance.yahoo.com/r/a95f2c77-b73d-305a-aa7b-e034b53c5021/celgene-look-beyond-any-short-term-weakness?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,CELG could dip and then post longer-term gains.
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: IBM, Celgene, Procter & Gamble, Valero and Sprint",2017-10-19 13:08:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-ibm-130801334.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: IBM, Celgene, Procter & Gamble, Valero and Sprint"
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-10-19 12:03:09 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120309427.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,Phase III Efficacy and Safety Data for Oral Ozanimod in Relapsing Multiple Sclerosis to Be Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting,2017-10-19 11:30:00 +0000,https://finance.yahoo.com/news/phase-iii-efficacy-safety-data-113000523.html?.tsrc=rss,"Celgene Corporation today announced that new data on the efficacy and safety of ozanimod, a novel, oral, selective, sphingosine 1-phosphate 1 and 5 receptor modulator, in relapsing multiple sclerosis were accepted for the MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting, which is being held in Paris, October 25-28, 2017."
CELG,CELG:UW,BBG000BFCMR2,"Top Stock Reports for IBM, Celgene and Procter & Gamble",2017-10-18 19:13:07 +0000,https://finance.yahoo.com/news/top-stock-reports-ibm-celgene-191307378.html?.tsrc=rss,"Top Stock Reports for IBM, Celgene and Procter & Gamble"
CELG,CELG:UW,BBG000BFCMR2,"Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals",2017-10-18 15:54:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/La5VxIdwgl0/zacks-industry-outlook-highlights-novo-vertex-pharmaceuticals-celgene-and-ligand-pharmaceuticals-cm861311,For Immediate Release Chicago IL October 18 2017 Today Zacks Equity Research discusses the Industry Pharmaceuticals Part 2 including Novo Nordisk NYSE 160 NVO 160 Free Report Vertex Pharmaceuticals Nasdaq 160 VRTX 160 Free Report Celgene Corp Nasdaq
CELG,CELG:UW,BBG000BFCMR2,"Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals",2017-10-18 13:55:01 +0000,https://finance.yahoo.com/news/zacks-industry-outlook-highlights-novo-135501090.html?.tsrc=rss,"Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals"
CELG,CELG:UW,BBG000BFCMR2,Biogen Could Rise 20% on Healthy Outlook,2017-10-18 10:00:00 +0000,http://finance.yahoo.com/r/cddc9372-25d9-3ca2-8c7b-9da50ac8b4be/biogen-could-rise-20-healthy-outlook?partner=YahooSA&yptr=yahoo&.tsrc=rss,Biogen shares were buoyed by strong revenue and earnings forecasts.
CELG,CELG:UW,BBG000BFCMR2,Celgene Blood Cancer Treatment: Just The Tip Of Its Disruptive Science?,2017-10-17 21:51:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CEItNXh7o0I/celgene-blood-cancer-treatment-just-the-tip-of-its-disruptive-science-cm859983,Celgene CELG a pioneer and leading player in blood cancer treatment has become a biotech juggernaut thanks largely to a drug that proved key in fighting the tricky disease multiple myeloma ibd display video id 2326965 width 50 float left autostart true In multiple
CELG,CELG:UW,BBG000BFCMR2,Celgene Blood Cancer Treatment: Just The Tip Of Its Disruptive Science?,2017-10-17 20:47:14 +0000,http://finance.yahoo.com/r/8b3803fa-dab5-3c62-bd97-6909c96c288a/celgene-blood-cancer-treatment-leads-stocks-disruptive-science?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene became a biotech juggernaut thanks to a treatment for tricky blood cancers. Now drugs battling lupus, MS and more are on the stock’s potential hit list."
CELG,CELG:UW,BBG000BFCMR2,Top 3 Healthcare Stocks for 2017,2017-10-17 20:25:00 +0000,http://finance.yahoo.com/r/1f1ae4ef-ff63-3542-9371-e42a6abc21f8/top-healthcare-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss,"These three healthcare stocks have been strong in 2017, and the upward trend may continue for the rest of the year."
CELG,CELG:UW,BBG000BFCMR2,Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks,2017-10-17 19:55:07 +0000,https://finance.yahoo.com/news/innovative-pipelines-regulatory-catalysts-drive-195507406.html?.tsrc=rss,Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks
CELG,CELG:UW,BBG000BFCMR2,"Notable ETF Outflow Detected - XLV, JNJ, PFE, CELG",2017-10-17 16:52:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RRLKbaw6vLA/notable-etf-outflow-detected-xlv-jnj-pfe-celg-cm860795,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 155 9 million dollar outflow that s a 0 9 decrease week over week
CELG,CELG:UW,BBG000BFCMR2,"Atwood & Palmer Inc Buys iShares 1-3 Year Credit Bond ETF, DowDuPont Inc, Marsh & ...",2017-10-17 16:50:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RhqW26Bu4H8/atwood-palmer-inc-buys-ishares-1-3-year-credit-bond-etf-dowdupont-inc-marsh-cm860850,Atwood Palmer Inc New Purchases CSJ DWDP ESLT GAB GAB AMX TYG TYG SQ POL Added Positions EBIX UNM PNC ON AMP MMC URI BRK B FXU FXR Reduced Positions AMLP MA CDW CSCO INTC FITB GOOGL BSCH CELG AAPL Sold Out MDT AGG
CELG,CELG:UW,BBG000BFCMR2,Immune Design's Sarcoma Candidate to Enter Phase III in 2018,2017-10-17 15:55:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7UX6hKlq69k/immune-designs-sarcoma-candidate-to-enter-phase-iii-in-2018-cm860614,Immune Design IMDZ announced that it plans to initiate a pivotal phase III study to support a regulatory application for CMB305 in patients with synovial sarcoma The company plans to start the study in mid 2018 and enroll 248 patients aged 12 years and older The decision was based
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene",2017-10-17 14:56:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SPwZ1-io-rI/the-zacks-analyst-blog-highlights-bayer-aktiengesellschaft-monsanto-adaptimmune-therapeutics-and-celgene-cm860509,For Immediate Release Chicago IL October 17 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the
CELG,CELG:UW,BBG000BFCMR2,Stocks Showing Market Leadership: PTC Therapeutics Earns 92 RS Rating,2017-10-17 14:54:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8GvxdIyFhQ4/stocks-showing-market-leadership-ptc-therapeutics-earns-92-rs-rating-cm860690,PTC Therapeutics PTCT saw a welcome improvement to its Relative Strength RS Rating on Tuesday with an increase from 81 to 92 ibd display video id 449419 width 50 float left autostart true This proprietary rating measures market leadership by showing how
CELG,CELG:UW,BBG000BFCMR2,Exelixis Earns Relative Strength Rating Upgrade,2017-10-17 14:53:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JE_WDkUmyVw/exelixis-earns-relative-strength-rating-upgrade-cm860672,Exelixis EXEL saw a positive improvement to its Relative Strength RS Rating on Tuesday rising from 89 to 95 ibd display video id 2102289 width 50 float left autostart true IBD s proprietary RS Rating identifies market leadership by showing how a stock s
CELG,CELG:UW,BBG000BFCMR2,Immune Design&apos;s Sarcoma Candidate to Enter Phase III in 2018,2017-10-17 14:04:02 +0000,https://finance.yahoo.com/news/immune-design-apos-sarcoma-candidate-140402183.html?.tsrc=rss,Immune Design (IMDZ) plans to initiate a pivotal phase III study to support a Biologics License Application (BLA) for CMB305.
CELG,CELG:UW,BBG000BFCMR2,Bayer to Sell Select Business Lines to Close Monsanto Buyout,2017-10-17 13:54:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9RMA81SXnkE/bayer-to-sell-select-business-lines-to-close-monsanto-buyout-cm860578,Bayer Aktiengesellschaft BAYRY has inked a deal to sell selected Crop Science businesses to BASF for EUR 5 9 billion Notably the company intends to divest these assets as a part of its strategy to complete the planned acquisition of Monsanto Co MON The divestiture is subject to the
CELG,CELG:UW,BBG000BFCMR2,Glaxo's Shingles Vaccine Shingrix Gets Approval in Canada,2017-10-17 13:54:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-1s7lmZvA2E/glaxos-shingles-vaccine-shingrix-gets-approval-in-canada-cm860573,GlaxoSmithKline plc GSK announced that its vaccine Shingrix has been approved in Canada for the prevention of shingles herpes zoster in older patients aged 50 years or older This is the first regulatory approval for this key pipeline product of Glaxo which has blockbuster potential So
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene",2017-10-17 12:57:12 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-bayer-125712359.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene"
CELG,CELG:UW,BBG000BFCMR2,Glaxo&apos;s Shingles Vaccine Shingrix Gets Approval in Canada,2017-10-16 22:07:10 +0000,https://finance.yahoo.com/news/glaxo-apos-shingles-vaccine-shingrix-220710696.html?.tsrc=rss,GlaxoSmithKline plc (GSK) announced that its vaccine Shingrix has been approved in Canada for the prevention of shingles (herpes zoster) in people aged between 50 years or more.
CELG,CELG:UW,BBG000BFCMR2,Bayer to Sell Select Business Lines to Close Monsanto Buyout,2017-10-16 21:43:09 +0000,https://finance.yahoo.com/news/bayer-sell-select-business-lines-214309785.html?.tsrc=rss,Bayer Aktiengesellschaft (BAYRY) inked a deal to sell selected Crop Science businesses to BASF for EUR 5.9 billion to as a part of its strategy to complete the planned acquisition of Monsanto Co.
CELG,CELG:UW,BBG000BFCMR2,Stocks Showing Improving Market Leadership: Five Prime Therapeutics Earns 83 RS Rating,2017-10-16 15:21:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HR9yLMIVH3Y/stocks-showing-improving-market-leadership-five-prime-therapeutics-earns-83-rs-rating-cm860172,Five Prime Therapeutics FPRX had its Relative Strength RS Rating upgraded from 80 to 83 Monday ibd display video id 2102289 width 50 float left autostart true This unique rating tracks market leadership by showing how a stock s price movement over the last
CELG,CELG:UW,BBG000BFCMR2,"ETFs with exposure to Celgene Corp. : October 16, 2017",2017-10-16 13:49:43 +0000,http://finance.yahoo.com/r/5ed35c86-34dd-3575-a22d-1bbeb3d3bef3/etfs-with-exposure-to-celgene-corp-october-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celgene Corp. Here are 5 ETFs with the largest exposure to CELG-US. Comparing the performance and risk of Celgene Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,Kite Pharma Cancer Treatment Stands Out In Hot CAR-T Field,2017-10-16 13:18:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I9RrLF1kayM/kite-pharma-cancer-treatment-stands-out-in-hot-car-t-field-cm859985,Kite Pharma is edging closer to approval for a cutting edge cancer treatment that fights the disease by rebuilding a patient s own cells 160 a technology that could benefit thousands of people and pave the way for blockbuster drugs ibd display video id 2326965 width 50 float
CELG,CELG:UW,BBG000BFCMR2,6 Top Biotech Companies In Innovation Earn Recognition In New Awards,2017-10-16 13:17:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MuKXg8YZMu8/6-top-biotech-companies-in-innovation-earn-recognition-in-new-awards-cm859974,Cure is a strong word when it comes to treating cancer and other deadly diseases but Brad Loncar is among the biotech stock analysts and investors ready to employ the term ibd display video id 2326965 width 50 float left autostart true For the first time biotech companies are
CELG,CELG:UW,BBG000BFCMR2,IBD Biotech Innovator Awards,2017-10-16 13:17:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kHgIl9n9Ak8/ibd-biotech-innovator-awards-cm859972,Investor s Business Daily has created the IBD Biotech Innovator Awards to recognize leading companies with groundbreaking treatments already on the market or close to final approvals Recipients of the inaugural awards are Celgene CELG Biogen BIIB
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bearish Manner : CELG-US : October 16, 2017",2017-10-16 12:36:03 +0000,http://finance.yahoo.com/r/c8bc7bc3-d48c-361f-b8ad-916191433f6b/celgene-corp-breached-its-50-day-moving-average-in-a-bearish-manner-celg-us-october-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Celgene Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,Today's Research Reports on Stocks to Watch: Celgene Corporation and Valeant Pharmaceuticals,2017-10-16 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000313.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 16, 2017 / Shares of Celgene Corporation saw a small gain on Friday despite any news, while Valeant Pharmaceuticals saw a loss of roughly 3% despite not having any significant ..."
CELG,CELG:UW,BBG000BFCMR2,6 Top Biotech Companies In Innovation Earn Recognition In New Awards,2017-10-16 12:01:09 +0000,http://finance.yahoo.com/r/6c7c83e3-cdcb-3b9b-a44f-7114dc6f5297/top-biotech-companies-innovation-6-biotech-stocks-recognized?src=A00220&yptr=yahoo&.tsrc=rss,Cancer. Alzheimer’s. MS. Treatments from the fast-growing U.S. biotech industry provide new hope for patients. What are the top biotech companies in innovation?
CELG,CELG:UW,BBG000BFCMR2,Results from Phase 2 Studies of Oral Ozanimod in Crohn’s Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017,2017-10-16 12:01:00 +0000,https://finance.yahoo.com/news/results-phase-2-studies-oral-120100722.html?.tsrc=rss,Celgene Corporation  today announced that phase 2 data of investigational compound ozanimod in Crohn’s disease and ulcerative colitis will be presented at the World Congress of Gastroenterology at ACG2017 in Orlando.
CELG,CELG:UW,BBG000BFCMR2,[$$] Nimbus Therapeutics Strikes Immunology Deal With Celgene,2017-10-16 03:05:16 +0000,http://finance.yahoo.com/r/afe6e1ee-369a-365f-ba26-b8828a062365/nimbus-therapeutics-strikes-immunology-deal-with-celgene-1508123113?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Nimbus Therapeutics, which struck a $1.2 billion deal to sell a drug program focused on liver diseases to Gilead Sciences Inc. last year, has formed a new immunology collaboration with Celgene Corp."
CELG,CELG:UW,BBG000BFCMR2,This No. 1-Ranked Medical Stock Is Breaking Out With Q3 Earnings Due,2017-10-13 22:18:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qvoNs6oKnLM/this-no-1-ranked-medical-stock-is-breaking-out-with-q3-earnings-due-cm858615,When biotech companies like Celgene CELG Biogen BIIB and Gilead Sciences GILD 160 put their drugs through extensive trials to gain FDA approval they turn to clinical research firms like PRA Health Sciences PRAH ibd display
CELG,CELG:UW,BBG000BFCMR2,Valeant Reports Positive Results on Psoriasis Drug Siliq,2017-10-13 19:01:07 +0000,https://finance.yahoo.com/news/valeant-reports-positive-results-psoriasis-190107852.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc. (VRX) announced encouraging results from the long-term phase III extension study, AMAGINE-2 on psoriasis drug Siliq."
CELG,CELG:UW,BBG000BFCMR2,Here's Why Intercept (ICPT) Stock Lost 37% So Far in 2017,2017-10-13 01:11:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UI6rrP0GYao/heres-why-intercept-icpt-stock-lost-37-so-far-in-2017-cm859143,Shares of Intercept Pharmaceuticals Inc ICPT declined 37 4 year to date against the industry s gain of 15 4 160 In particular shares have plunged 40 4 over a month due to safety issues regarding approved drug Ocaliva Per a recent news article prescriptions of the drug
CELG,CELG:UW,BBG000BFCMR2,Here&apos;s Why Intercept (ICPT) Stock Lost 37% So Far in 2017,2017-10-12 22:56:10 +0000,https://finance.yahoo.com/news/apos-why-intercept-icpt-stock-225610908.html?.tsrc=rss,Shares of Intercept Pharmaceuticals (ICPT) have plunged 37% in the year so far due to safety issues regarding approved drug Ocaliva.
CELG,CELG:UW,BBG000BFCMR2,Breakout Watch: No. 1-Ranked Medical Research Stock Tests Buy Zone,2017-10-12 21:13:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Xd_oTTuuOw/breakout-watch-no-1-ranked-medical-research-stock-tests-buy-zone-cm858615,When biotech and Big Pharma companies like Celgene CELG Biogen BIIB Gilead Sciences GILD and Pfizer PFE put their drugs through extensive and costly trials to gain FDA approval they turn to clinical research firms like PRA
CELG,CELG:UW,BBG000BFCMR2,"Notable Thursday Option Activity: GE, CELG, LMT",2017-10-12 21:10:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HYWRz1HUFI4/notable-thursday-option-activity-ge-celg-lmt-cm859042,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in General Electric Co Symbol GE where a total volume of 245 818 contracts has been traded thus far today a contract volume which is representative of approximately 24 6
CELG,CELG:UW,BBG000BFCMR2,Top 5 Biotech Stocks for 2017,2017-10-12 18:35:00 +0000,http://finance.yahoo.com/r/26ddb200-f2e8-37d5-8acd-b9613f65a9c4/biotech-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Biotech can be risky, but these top biotech stocks have stable track records."
CELG,CELG:UW,BBG000BFCMR2,Intra-Cellular Therapies Shows Rising Price Performance With Jump To 83 RS Rating,2017-10-12 15:17:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NwExEYVWiwg/intra-cellular-therapies-shows-rising-price-performance-with-jump-to-83-rs-rating-cm858868,On Thursday Intra Cellular Therapies ITCI reached an important technical milestone with its Relative Strength RS Rating jumping into the 80 plus percentile with an upgrade to 83 a rise from 80 the day before ibd display video id 449433 width 50 float
CELG,CELG:UW,BBG000BFCMR2,Stocks With Rising Relative Price Strength: Ionis Pharmaceuticals,2017-10-12 15:17:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HTGBb3nrq3c/stocks-with-rising-relative-price-strength-ionis-pharmaceuticals-cm858866,On Thursday Ionis Pharmaceuticals IONS hit an important performance benchmark with its Relative Strength RS Rating moving into the 90 plus percentile with an improvement to 91 an increase from 88 the day before ibd display video id 449419 width 50 float
CELG,CELG:UW,BBG000BFCMR2,Aerie Pharmaceuticals Scores Relative Strength Rating Upgrade,2017-10-12 15:16:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FC964KSpffo/aerie-pharmaceuticals-scores-relative-strength-rating-upgrade-cm858864,On Thursday Aerie Pharmaceuticals AERI hit an important technical milestone with its Relative Strength RS Rating jumping into the 90 plus percentile with an improvement to 93 a rise from 82 the day before ibd display video id 449423 width 50 float
CELG,CELG:UW,BBG000BFCMR2,"Lgt Capital Partners Ltd. Buys Akamai Technologies Inc, Urban Outfitters Inc, Tupperware Brands ...",2017-10-12 11:10:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hJXN4MtGwxQ/lgt-capital-partners-ltd-buys-akamai-technologies-inc-urban-outfitters-inc-tupperware-brands-cm858564,Lgt Capital Partners Ltd New Purchases URBN TMUS ABEV Added Positions AKAM TUP DPS CL MRK SRCL MS MDLZ COF C Reduced Positions BIIB ISRG AAPL ORCL CTSH HCP AMG HCN COP EL Sold Out MD MAS ECL PCAR SPG New Purchases
CELG,CELG:UW,BBG000BFCMR2,7 Essential Rules for Investing in Biotech Stocks,2017-10-12 10:04:00 +0000,https://finance.yahoo.com/news/7-essential-rules-investing-biotech-100400466.html?.tsrc=rss,"If you only master one of these rules, definitely focus on the last one."
CELG,CELG:UW,BBG000BFCMR2,"Celgene, Biogen Are Poised to Break Out: A Technical View",2017-10-12 10:00:00 +0000,http://finance.yahoo.com/r/36734f30-43ee-3d77-a985-4c6700482d52/celgene-biogen-are-poised-break-out-technical-view?partner=YahooSA&yptr=yahoo&.tsrc=rss,"After a period of consolidation, the biotech sector is set to rise again based on technical analysis."
CELG,CELG:UW,BBG000BFCMR2,Stocks Showing Rising Market Leadership: Aerie Pharmaceuticals Earns 82 RS Rating,2017-10-11 15:16:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/04zCniEIB4k/stocks-showing-rising-market-leadership-aerie-pharmaceuticals-earns-82-rs-rating-cm858237,When considering what names to put on your watch list focus on stocks with an 80 or higher RS Rating Aerie Pharmaceuticals AERI now meets that criteria with a jump from 74 to 82 Wednesday ibd display video id 2102289 width 50 float left autostart true IBD
CELG,CELG:UW,BBG000BFCMR2,Alexion Pharmaceuticals Trying To Close In On Key Technical Measure,2017-10-11 15:15:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rrtjC6Pj8f8/alexion-pharmaceuticals-trying-to-close-in-on-key-technical-measure-cm858225,In a welcome move Alexion Pharmaceuticals ALXN saw its Relative Strength Rating rise from 68 to 73 on Wednesday ibd display video id 449433 width 50 float left autostart true This proprietary rating tracks technical performance by showing how a stock s price
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Amgen's Imlygic Data Promising, Regeneron Scores Win in PCSK9 Lawsuit",2017-10-11 14:17:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p4s3Nz7jdEo/biotech-stock-roundup-amgens-imlygic-data-promising-regeneron-scores-win-in-pcsk9-lawsuit-cm858027,Companies like Amgen AMGN and Regeneron REGN were in the news with Amgen providing pipeline and regulatory updates while Regeneron and partner Sanofi got some good news with an appeals court ruling in their favor in the PCSK9 inhibitor lawsuit against Amgen Recap of the Week s Most
CELG,CELG:UW,BBG000BFCMR2,Mallinckrodt to Begin Sarcoidosis Study on Acthar Gel,2017-10-10 20:50:08 +0000,https://finance.yahoo.com/news/mallinckrodt-begin-sarcoidosis-study-acthar-205008189.html?.tsrc=rss,Mallinckrodt plc (MNK) announced that it will initiate a new phase IV study on H.P. Acthar Gel as a therapy option in patients with symptomatic sarcoidosis.
CELG,CELG:UW,BBG000BFCMR2,MannKind Tripled In The Past 3 Weeks; Vindicating Nate Pile,2017-10-10 19:15:00 +0000,http://finance.yahoo.com/r/1a1d76cd-5c9b-3f3a-b247-562ec2c09754/mannkind-tripled-in-the-past-3-weeks-vindicating-nate-pile?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"In the past 3 weeks, MannKind has tripled to $6.75, bringing the year-to-date return on Nate Pile's fund to 34.82%. Here's what's behind MannKind's strong gains and what Nate is doing about it."
CELG,CELG:UW,BBG000BFCMR2,Amgen Label Expansion Application for Prolia Accepted by FDA,2017-10-10 15:00:03 +0000,https://finance.yahoo.com/news/amgen-label-expansion-application-prolia-150003122.html?.tsrc=rss,Amgen (AMGN) announced that the FDA has accepted its regulatory application in the U.S. seeking label expansion for Prolia for treating patients with glucocorticoid-induced osteoporosis (GIOP).
CELG,CELG:UW,BBG000BFCMR2,"Strategic Research Analysis ­ Positioning to Benefit on  Abbott, Rite Aid, Kroger, Celgene, Twitter, and NIKE ­ Effects of Key Drivers of Growth and Emerging Market Trends",2017-10-10 13:45:00 +0000,https://finance.yahoo.com/news/strategic-research-analysis-positioning-benefit-134500414.html?.tsrc=rss,"NEW YORK, Oct. 10, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Abbott ..."
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Biogen Inc. vs. Celgene,2017-10-10 11:37:00 +0000,https://finance.yahoo.com/news/better-buy-biogen-inc-vs-113700187.html?.tsrc=rss,Which one of these large-cap biotech stocks looks like a better pick right now?
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Biogen Inc. vs. Celgene,2017-10-10 11:37:00 +0000,http://finance.yahoo.com/r/794f27e7-d74b-327e-a833-c638d152b421/better-buy-biogen-inc-vs-celgene.aspx?yptr=yahoo&.tsrc=rss,Which one of these large-cap biotech stocks looks like a better pick right now?
CELG,CELG:UW,BBG000BFCMR2,3 Stocks at 52-Week Highs Still Worth Buying,2017-10-10 10:04:00 +0000,http://finance.yahoo.com/r/07658508-a866-3b8c-a74e-2e75d1b50bd0/3-stocks-at-52-week-highs-still-worth-buying.aspx?yptr=yahoo&.tsrc=rss,"Sometimes, the stocks making new highs are just beginning to take off."
CELG,CELG:UW,BBG000BFCMR2,"$50,000 Per Year in Prescription Drugs? You Likely Know Someone Who Used at Least That Much",2017-10-10 10:02:00 +0000,http://finance.yahoo.com/r/04f58ad0-461a-393a-96d0-2bc2813cfd9c/50000-per-year-in-prescription-drugs-you-likely-kn.aspx?yptr=yahoo&.tsrc=rss,"Only one-third of 1% of Americans had such high prescription costs last year, but they account for more than a fifth of the spending in the category."
CELG,CELG:UW,BBG000BFCMR2,"Flexion Therapeutics Clears Technical Benchmark, Hitting 90-Plus RS Rating",2017-10-09 14:54:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JuT9Y_XEL74/flexion-therapeutics-clears-technical-benchmark-hitting-90-plus-rs-rating-cm857013,On Monday Flexion Therapeutics FLXN received an upgrade to its Relative Strength RS Rating from 85 to 92 ibd display video id 449419 width 50 float left autostart true This proprietary rating measures technical performance by using a 1 worst to 99
CELG,CELG:UW,BBG000BFCMR2,"Forget Teva (TEVA), Buy These 5 Drug Stocks Instead",2017-10-09 14:20:02 +0000,https://finance.yahoo.com/news/forget-teva-teva-buy-5-142002954.html?.tsrc=rss,"With another challenge cropping up for Teva (TEVA) in the form of earlier-than-expected generic competition for the 40 mg dose of Copaxone, here is a look at 5 drug stocks that look better-positioned."
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-10-09 12:02:46 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120246657.html?.tsrc=rss,"This could indicate that investors who seek to profit from falling equity prices are not currently targeting CELG.  Over the last one-month, outflows of investor capital in ETFs holding CELG totaled $7.31 billion."
CELG,CELG:UW,BBG000BFCMR2,Navient: The S&P 500’s Worst Performer on October 5,2017-10-09 11:41:36 +0000,http://finance.yahoo.com/r/c9047b5c-81d1-34d4-a8e6-5d556ae6db11/navient-sp-500s-top-loser-october-5?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Navient (NAVI) was the biggest loser amid the S&P 500 on October 5. Navient started the week on a weaker note and traded weakly for the first three trading days.
CELG,CELG:UW,BBG000BFCMR2,Roundtable: 1 Stock Retirees Should Consider,2017-10-08 14:48:00 +0000,http://finance.yahoo.com/r/7cb020ed-f1b2-30cf-87f5-77b264f92012/roundtable-1-stock-retirees-should-consider.aspx?yptr=yahoo&.tsrc=rss,Retirement is a time for quiet contemplation -- of profitable stock investments.
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Bristol-Myers Squibb,2017-10-07 14:34:00 +0000,http://finance.yahoo.com/r/3be6f34a-2d78-3bd2-9fc2-1c63fce47401/better-buy-celgene-corporation-vs-bristol-myers-sq.aspx?yptr=yahoo&.tsrc=rss,Two of the biggest pharma stocks with two of the most successful cancer drugs. But which is the better pick for investors?
CELG,CELG:UW,BBG000BFCMR2,This Dirt-Cheap Biotech Stock Is a Bargain to Buy,2017-10-07 14:29:00 +0000,http://finance.yahoo.com/r/c48e8c07-dd98-331b-b959-b3b6818c48ff/this-dirt-cheap-biotech-stock-is-a-bargain-to-buy.aspx?yptr=yahoo&.tsrc=rss,"A splashy acquisition puts this company on the cutting edge of cancer treatment, but that&apos;s not the only reason to buy shares."
CELG,CELG:UW,BBG000BFCMR2,Cramer Remix: Don’t ignore the oldest rule in the game wh...,2017-10-06 23:34:00 +0000,https://finance.yahoo.com/video/cramer-remix-don-t-ignore-233400835.html?.tsrc=rss,Jim Cramer explains why Celgene’s recent sell-off is a perfect buying opportunity.
CELG,CELG:UW,BBG000BFCMR2,Cramer Remix: Don’t ignore the oldest rule in the game when it comes to Celgene,2017-10-06 22:59:51 +0000,http://finance.yahoo.com/r/494ba09e-d4b2-3e98-871c-37c4d8050357/104757424?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104757424&yptr=yahoo&.tsrc=rss,Jim Cramer explains why Celgene’s recent sell-off is a perfect buying opportunity.
CELG,CELG:UW,BBG000BFCMR2,Cramer Remix: Don’t ignore the oldest rule in the game when it comes to Celgene,2017-10-06 22:59:51 +0000,https://finance.yahoo.com/news/cramer-remix-don-t-ignore-225951725.html?.tsrc=rss,Jim Cramer explains why Celgene’s recent sell-off is a perfect buying opportunity.
CELG,CELG:UW,BBG000BFCMR2,"Apple Inc. (AAPL) Bulls, Watch Out!",2017-10-06 22:55:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m80mCUQ2sXM/apple-inc-aapl-bulls-watch-out-cm856571,InvestorPlace Stock Market News Stock Advice amp Trading Tips Sometimes you have step back and smell the roses or in the case of Apple Inc NASDAQ AAPL acknowledge a stock which looks ripe for a corrective pullback Let me explain Source via Apple I haven t always
CELG,CELG:UW,BBG000BFCMR2,iShares S&P 100 ETF Experiences Big Outflow,2017-10-06 16:44:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-dGwR_fToQk/ishares-sp-100-etf-experiences-big-outflow-cm856309,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 100 ETF Symbol OEF where we have detected an approximate 45 1 million dollar outflow that s a 0 9 decrease week over week from 43 900 000
CELG,CELG:UW,BBG000BFCMR2,Flexion Therapeutics Hits 80-Plus Relative Strength Rating Benchmark,2017-10-06 15:48:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Ny2LFc5T3k/flexion-therapeutics-hits-80-plus-relative-strength-rating-benchmark-cm856356,When considering what names to put on your watch list look for stocks with an 80 or higher RS Rating Flexion Therapeutics FLXN now meets that criteria with an increase from 80 to 85 Friday ibd display video id 2102289 width 50 float left autostart true IBD
CELG,CELG:UW,BBG000BFCMR2,Stocks Showing Improving Market Leadership: Intra-Cellular Therapies Earns 83 RS Rating,2017-10-06 15:48:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mdIP0PdveBU/stocks-showing-improving-market-leadership-intra-cellular-therapies-earns-83-rs-rating-cm856355,When building your watch list look for stocks with an 80 or higher RS Rating Intra Cellular Therapies ITCI just cleared that benchmark with an upgrade from 78 to 83 ibd display video id 449433 width 50 float left autostart true This exclusive rating from Investor
CELG,CELG:UW,BBG000BFCMR2,Stocks With Rising Relative Price Strength: Innoviva,2017-10-06 15:47:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H8WvCVQQrrM/stocks-with-rising-relative-price-strength-innoviva-cm856348,Innoviva INVA saw a positive improvement to its Relative Strength RS Rating on Friday rising from 78 to 82 ibd display video id 449423 width 50 float left autostart true This exclusive rating from Investor s Business Daily identifies market leadership with a
CELG,CELG:UW,BBG000BFCMR2,Stocks To Watch: Adamas Pharmaceuticals Sees Relative Strength Rating Jump To 92,2017-10-06 15:47:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/guIrSNRJUhs/stocks-to-watch-adamas-pharmaceuticals-sees-relative-strength-rating-jump-to-92-cm856341,Adamas Pharmaceuticals ADMS saw a positive improvement to its Relative Strength RS Rating on Friday with an upgrade from 87 to 92 ibd display video id 449419 width 50 float left autostart true IBD s unique rating identifies market leadership with a 1 worst
CELG,CELG:UW,BBG000BFCMR2,No Side Effects to This Bullish Trade on Celgene Corporation (CELG) Stock,2017-10-06 13:37:37 +0000,https://finance.yahoo.com/news/no-side-effects-bullish-trade-133737087.html?.tsrc=rss,"Yesterday, Celgene Corporation (NASDAQ:CELG) caught a downgrade and the stock fell 4% on the headline.  To do this, I use CELG options instead of trading its underlying equity.  Click to Enlarge Fundamentally, Celgene is not cheap."
CELG,CELG:UW,BBG000BFCMR2,Everything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now?,2017-10-06 11:18:00 +0000,http://finance.yahoo.com/r/ba6ad26f-af4a-3d27-98be-ea0488d07804/everything-is-going-right-for-abbvie-is-it-the-bes.aspx?yptr=yahoo&.tsrc=rss,"A streak of good news, the world&apos;s top-selling drug, and a strong pipeline. Is AbbVie simply the best biotech around?"
CELG,CELG:UW,BBG000BFCMR2,Should You Sell Celgene Stock Following an Analyst Downgrade?,2017-10-06 01:00:00 +0000,http://finance.yahoo.com/r/d463cffb-78f1-3850-93f8-a37d4799be11/should-you-sell-celgene-stock-following-an-analyst.aspx?yptr=yahoo&.tsrc=rss,"Morgan Stanley has downgraded Celgene to a sell, but label expansions, collaborations, and internally developed drugs could catapult Celgene&apos;s sales and profit higher."
CELG,CELG:UW,BBG000BFCMR2,Big biotech trades: 5 plays,2017-10-05 21:00:00 +0000,https://finance.yahoo.com/video/big-biotech-trades-5-plays-210000226.html?.tsrc=rss,The &quot;Fast Money&quot; traders give you 5 ways to play biotech stocks.
CELG,CELG:UW,BBG000BFCMR2,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,585.36.",2017-10-05 20:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nNwIsTw1X_M/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-658536-cm855990,Thursday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 6 585 36 up 50 73 for the day The index had a previous high 6534 62735 on 10 04 2017 The total shares traded for the NASDAQ was over 1 88 billion Thursday s session closes with the
CELG,CELG:UW,BBG000BFCMR2,"As Celgene Outperforms, Are Challenges To Its Pipeline Being Overlooked?",2017-10-05 18:32:12 +0000,https://finance.yahoo.com/news/celgene-outperforms-challenges-pipeline-being-183212338.html?.tsrc=rss,"Celgene Corporation (NASDAQ: CELG ) has gained about 15 percent from its mid-August lows. Against this backdrop of share price appreciation, Morgan Stanley said in a note Thursday that the consensus expectations ..."
CELG,CELG:UW,BBG000BFCMR2,"Biotech: Buy Biogen, Sell Celgene",2017-10-05 17:29:00 +0000,http://finance.yahoo.com/r/7a026254-dd84-3bd8-ac9e-d2d6c01899e0/biotech-buy-biogen-sell-celgene-1507224573?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Morgan Stanley's Matthew Harrison and his team take a look at biotech today, writing that investors should buy Biogen (BIIB) rather than Celgene (CELG).  Harrison upgraded Biogen to Overweight from Equal Weight, and raised his price target from $311 to $375, writing that the company's base business is more durable than he anticipated, as its multiple sclerosis treatment, Ocrevus, is losing market share more slowly than expected.  In addition, he sees Spinraza, Biogen's spinal muscular atrophy drug, as worth potentially $4 billion, a fact that's under-appreciated by the market, and writes that the company's Alzheimer's business ""remains the key, must-own catalyst."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Is Not a Sell, Jim Cramer Rebuts Analysts' Call",2017-10-05 17:06:00 +0000,http://finance.yahoo.com/r/10e6e443-ac1f-3f99-b979-5eecd34833b7/celgene-not-a-sell-jim-cramer-rebuts-analysts.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Morgan Stanley analysts downgraded shares of Celgene over concerns of generic drug pressures. Those concerns are not warranted just yet and Celgene is not a sell, Jim Cramer reasoned."
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Thursday Option Activity: DYN, CELG, TWX",2017-10-05 16:47:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TKT_mwxNxnI/noteworthy-thursday-option-activity-dyn-celg-twx-cm855827,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Dynegy Inc Symbol DYN where a total of 37 262 contracts have traded so far representing approximately 3 7 million underlying shares That amounts to about 150 7 of DYN s
CELG,CELG:UW,BBG000BFCMR2,"Celgene and Biogen Analyst Moves Are 'Useless,' Jim Cramer Says",2017-10-05 15:59:00 +0000,http://finance.yahoo.com/r/d7e75893-54a5-3119-928d-09542c59ad2c/celgene-and-biogen-analyst-moves-are-useless-jim-cramer-says.html?puc=yahoov&cm_ven=YAHOOV&yptr=yahoo&.tsrc=rss,"Morgan Stanley analysts upgraded shares of Biogen and downgraded shares of Celgene over concerns of generic drug pressures. TheStreet's Jim Cramer called these moves ""useless."""
CELG,CELG:UW,BBG000BFCMR2,"S&P 500 Movers: NAVI, FCX",2017-10-05 15:50:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wv0tMgH9GSQ/sp-500-movers-navi-fcx-cm855767,In early trading on Thursday shares of Freeport McMoran Copper amp Gold topped the list of the day s best performing components of the S amp P 500 index trading up 4 8 Year to date Freeport McMoran Copper amp Gold registers a 15 4 gain And the worst performing S amp P 500
CELG,CELG:UW,BBG000BFCMR2,"Nasdaq 100 Movers: CELG, NCLH",2017-10-05 15:50:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-_3ZIh9IOWw/nasdaq-100-movers-celg-nclh-cm855762,In early trading on Thursday shares of Norwegian Cruise Line Holdings topped the list of the day s best performing components of the Nasdaq 100 index trading up 3 8 Year to date Norwegian Cruise Line Holdings registers a 36 6 gain And the worst performing Nasdaq 100 component thus
CELG,CELG:UW,BBG000BFCMR2,Stocks With Rising Relative Strength: Amgen,2017-10-05 14:53:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JGTD2v0qZew/stocks-with-rising-relative-strength-amgen-cm855785,In a welcome move Amgen AMGN saw its Relative Strength Rating improve from 70 to 73 on Thursday ibd display video id 449433 width 50 float left autostart true This proprietary rating identifies market leadership by using a 1 worst to 99 best score that
CELG,CELG:UW,BBG000BFCMR2,Global Blood Therapeutic Earns Relative Strength Rating Upgrade,2017-10-05 14:53:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dC2Ibj7Y5CY/global-blood-therapeutic-earns-relative-strength-rating-upgrade-cm855784,Global Blood Therapeutic GBT saw a positive improvement to its Relative Strength RS Rating on Thursday rising from 87 to 92 ibd display video id 2102289 width 50 float left autostart true This unique rating tracks technical performance by using a 1 worst to
CELG,CELG:UW,BBG000BFCMR2,Aerie Pharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold,2017-10-05 14:52:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kc8537qcLgg/aerie-pharmaceuticals-earns-relative-strength-rating-upgrade-hits-key-threshold-cm855781,On Thursday Aerie Pharmaceuticals AERI cleared a key technical benchmark with its Relative Strength RS Rating jumping into the 80 plus percentile with an improvement to 81 a rise from 74 the day before ibd display video id 2102289 width 50 float
CELG,CELG:UW,BBG000BFCMR2,Stocks With Rising Relative Strength: Intra-Cellular Therapies,2017-10-05 14:50:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GhiDt7LxnUU/stocks-with-rising-relative-strength-intra-cellular-therapies-cm855750,Intra Cellular Therapies ITCI saw a welcome improvement to its Relative Strength RS Rating on Thursday rising from 70 to 78 ibd display video id 449433 width 50 float left autostart true IBD s unique rating tracks share price performance with a 1 worst to
CELG,CELG:UW,BBG000BFCMR2,Cramer's Stop Trading: Celgene is not a sell,2017-10-05 13:55:00 +0000,https://finance.yahoo.com/video/cramers-stop-trading-celgene-not-135500674.html?.tsrc=rss,CNBC's Jim Cramer explains why he is watching shares of Celgene after Morgan Stanley downgraded the stock.
CELG,CELG:UW,BBG000BFCMR2,"Morning Movers: Constellation Brands Jumps, Biogen Bounces, Celgene Slips",2017-10-05 12:16:00 +0000,http://finance.yahoo.com/r/8c213a63-a44b-3998-b23b-c230d233d8f6/morning-movers-constellation-brands-jumps-biogen-bounces-celgene-slips-1507205791?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a higher open today ahead of U.S. jobless claims data this morning. S&P 500 futures have ticked up 0.1%, while Dow Jones Industrial Average futures are little changed. Nasdaq Composite ..."
CELG,CELG:UW,BBG000BFCMR2,Which Stocks May Outperform in the Next Market Crash,2017-10-05 12:00:00 +0000,http://finance.yahoo.com/r/a725d77e-fdca-3ffe-b638-fe98b4e3081e/which-stocks-may-outperform-next-market-crash-0?partner=YahooSA&yptr=yahoo&.tsrc=rss,Investors looking for stocks likely to rise in the next market crash may find the answer in 2008.
CELG,CELG:UW,BBG000BFCMR2,3 Big Pharma Stocks Set to Succeed,2017-10-05 10:03:00 +0000,http://finance.yahoo.com/r/95c39b07-5929-34ce-ba00-36385b5d02f4/3-big-pharma-stocks-set-to-succeed.aspx?yptr=yahoo&.tsrc=rss,Solid current franchises and strong pipelines could make these three big pharma stocks big winners in coming years.
CELG,CELG:UW,BBG000BFCMR2,Celgene Corp. (CELG) Is Losing Ground Following Downgrade,2017-10-05 09:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8A3tvJZ3MGk/celgene-corp-celg-is-losing-ground-following-downgrade-20171005-00740,Celgene Corp. (CELG) Is Losing Ground Following Downgrade
CELG,CELG:UW,BBG000BFCMR2,Amgen Enters Into an Immuno-Oncology Partnership With CytomX,2017-10-04 13:11:01 +0000,https://finance.yahoo.com/news/amgen-enters-immuno-oncology-partnership-131101519.html?.tsrc=rss,Amgen (AMGN) has entered into a strategic immuno-oncology collaboration with CytomX to jointly develop a T-cell engaging bispecific probody.
CELG,CELG:UW,BBG000BFCMR2,Aerie Pharmaceuticals Sees IBD RS Rating Climb To 73,2017-10-03 15:02:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rRZKsx0GOPc/aerie-pharmaceuticals-sees-ibd-rs-rating-climb-to-73-cm854621,The Relative Strength RS Rating for Aerie Pharmaceuticals AERI moved into a new percentile Tuesday as it got a lift from 65 to 73 ibd display video id 449433 width 50 float left autostart true IBD s unique RS Rating identifies market leadership by
CELG,CELG:UW,BBG000BFCMR2,Stocks Showing Rising Market Leadership: Flexion Therapeutics Earns 85 RS Rating,2017-10-03 15:01:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zIwj4I-3Cmk/stocks-showing-rising-market-leadership-flexion-therapeutics-earns-85-rs-rating-cm854615,Flexion Therapeutics FLXN saw a positive improvement to its Relative Strength RS Rating on Tuesday rising from 78 to 85 ibd display video id 449419 width 50 float left autostart true This exclusive rating from Investor s Business Daily measures share
CELG,CELG:UW,BBG000BFCMR2,Acorda Therapeutics Shows Market Leadership With Jump To 91 RS Rating,2017-10-03 15:01:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6volWQtxWYY/acorda-therapeutics-shows-market-leadership-with-jump-to-91-rs-rating-cm854609,Acorda Therapeutics ACOR saw a welcome improvement to its Relative Strength RS Rating on Tuesday rising from 80 to 91 ibd display video id 449433 width 50 float left autostart true This exclusive rating from Investor s Business Daily tracks share price
CELG,CELG:UW,BBG000BFCMR2,Stocks With Rising Relative Price Strength: Innoviva,2017-10-03 15:01:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zi_sYHT9lXU/stocks-with-rising-relative-price-strength-innoviva-cm854608,The Relative Strength RS Rating for Innoviva INVA jumped into a new percentile Tuesday with an increase from 79 to 82 ibd display video id 449423 width 50 float left autostart true This exclusive rating from Investor s Business Daily tracks market
CELG,CELG:UW,BBG000BFCMR2,"Ionis Pharmaceuticals Clears Technical Benchmark, Hitting 80-Plus RS Rating",2017-10-03 15:00:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lV3llHuggT0/ionis-pharmaceuticals-clears-technical-benchmark-hitting-80-plus-rs-rating-cm854602,One important metric to look for in a stock is an 80 or higher Relative Strength Rating Ionis Pharmaceuticals IONS cleared that benchmark Tuesday with a jump from 74 to 82 Tuesday ibd display video id 449419 width 50 float left autostart true IBD s unique RS
CELG,CELG:UW,BBG000BFCMR2,"Why bluebird bio, Inc. Stock Gained 10% in September",2017-10-03 14:42:00 +0000,http://finance.yahoo.com/r/ac489f4c-ad0c-3b68-b4f6-1d2695b54d3a/why-bluebird-bio-inc-stock-gained-10-in-september.aspx?yptr=yahoo&.tsrc=rss,Another licensing deal with an important partner bodes well for the clinical-stage biotech.
CELG,CELG:UW,BBG000BFCMR2,3 Top-Ranked Big Biotech Stocks to Buy Now,2017-10-03 13:30:01 +0000,https://finance.yahoo.com/news/3-top-ranked-big-biotech-133001290.html?.tsrc=rss,"With biotech stocks on a tear, here we have picked three of the biggest biotech companies which look well poised for growth and can be added to one&apos;s portfolio"
CELG,CELG:UW,BBG000BFCMR2,Nimbus Therapeutics Reaches Summit In Deal With Celgene,2017-10-03 11:42:00 +0000,http://finance.yahoo.com/r/3ee0bc37-725f-33fe-897e-e2a327896dea/nimbus-therapeutics-reaches-summit-for-deal-with-celgene?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Nimbus and Celgene announced a significant partnership focused on autoimmune and inflammatory diseases. Here are the three unique elements of the Nimbus model.
CELG,CELG:UW,BBG000BFCMR2,[$$] Stock market winners of 2008's crash had one thing in common,2017-10-03 03:00:52 +0000,"http://finance.yahoo.com/r/d8fafa6c-b1f1-3671-b0f3-fecdce59320e/1d6ec1a2-a77f-11e7-93c5-648314d2c72c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss",When people ponder how certain investors made double-digit annual returns in 2008 - a year when US stocks tumbled almost 40 per cent - they think back to daring and contrarian hedge funds betting against ...
CELG,CELG:UW,BBG000BFCMR2,Why Bluebird's Downgrade Sent These Two Rivals Skyrocketing,2017-10-02 20:48:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qCaFqfJamf0/why-bluebirds-downgrade-sent-these-two-rivals-skyrocketing-cm854190,Bluebird Bio BLUE toppled to a four week low Monday 160 as an analyst downgraded the stock on doubts regarding its sickle cell disease drug 160 sending shares of rivals Crispr Therapeutics CRSP and Editas Medicine EDIT
CELG,CELG:UW,BBG000BFCMR2,Why Bluebird&apos;s Downgrade Sent These Two Rivals Skyrocketing,2017-10-02 20:10:03 +0000,http://finance.yahoo.com/r/eda14fae-3cce-3a4d-a18f-dbd74a86cec2/bluebird-downgrade-sent-crispr-editas-stock-skyrocketing?src=A00220&yptr=yahoo&.tsrc=rss,Bluebird toppled to a four-week low Monday as an analyst downgraded the stock on doubts regarding its sickle cell disease drug.
CELG,CELG:UW,BBG000BFCMR2,Here's Why Bluebird Bio (BLUE) Stock Is Falling Today,2017-10-02 17:46:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yT5eEkQXjNs/heres-why-bluebird-bio-blue-stock-is-falling-today-cm854044,Shares of Bluebird Bio BLUE a major player in the emerging gene therapy and CAR T research markets slumped more than 6 in morning trading Monday after receiving a key analyst downgrade In a note to clients Morgan Stanley downgraded the biotech firm from Equal weight to Underweight
CELG,CELG:UW,BBG000BFCMR2,Today's Research Reports on Stocks to Watch: Celgene Corporation and Acceleron Pharma,2017-10-02 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000851.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 2, 2017 / Celgene and Acceleron both saw their share prices head higher this past Friday after it was learned that Celgene has purchased 750,000 more shares of Acceleron ..."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corporation to Announce Third Quarter 2017 Results on October 26, 2017; Will Host an Investor Webcast Event from the MSParis2017–7th Joint ECTRIMS – ACTRIMS Meeting on October 28, 2017",2017-10-02 11:30:00 +0000,https://finance.yahoo.com/news/celgene-corporation-announce-third-quarter-113000317.html?.tsrc=rss,"Celgene Corporation will host a conference call and live audio webcast on Thursday, October 26, 2017 at 9 a.m. ET to discuss third quarter 2017 financial and operational results."
CELG,CELG:UW,BBG000BFCMR2,Who Wants Tax Reform Less?; Trend: Buy if Up -- Jim Cramer's Top Thoughts,2017-10-02 05:00:00 +0000,http://finance.yahoo.com/r/5361bed1-7b86-33ad-a082-259293a32d0a/who-wants-tax-reform-less-no-downside-conviction-jim-cramer-s-top-thoughts.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Cramer reflects on who wants tax reform less and also explores a strange new trend.
CELG,CELG:UW,BBG000BFCMR2,All You Need To Know About Celgene Corporation’s (CELG) Risks,2017-09-30 01:07:11 +0000,https://finance.yahoo.com/news/know-celgene-corporation-celg-risks-010711981.html?.tsrc=rss,"If you are looking to invest in Celgene Corporation’s (NASDAQ:CELG), or currently own the stock, then you need to understand its beta in order to understand how it can affectRead More..."
CELG,CELG:UW,BBG000BFCMR2,Big Dose Of Healthy News Sends Biotech Stocks To New Heights,2017-09-29 20:35:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3FWQwxHomzs/big-dose-of-healthy-news-sends-biotech-stocks-to-new-heights-cm853272,Biotech news aplenty has breathed renewed life into the sector driving 160 those stocks to new highs ibd display video id 2324623 width 50 float left autostart true Zogenix ZGNX on Friday spiked more than 140 nearing a four year high after reporting positive Phase
CELG,CELG:UW,BBG000BFCMR2,1 Great Biotech Stock You Have Never Heard Of,2017-09-29 15:34:00 +0000,http://finance.yahoo.com/r/83f334cc-d023-39f1-b406-6a4792d540fa/1-great-biotech-stock-you-have-never-heard-of.aspx?yptr=yahoo&.tsrc=rss,Big pharma companies have thrown hundreds of millions of dollars at this small biotech. Should retail investors follow suit?
CELG,CELG:UW,BBG000BFCMR2,"Big Caps Lose Their Lead, But A Few Beat The Trend",2017-09-29 15:09:47 +0000,http://finance.yahoo.com/r/165bbd45-2207-3d90-8bc6-9f4b157e4666/big-caps-fade-from-leadership-but-a-few-resist-the-trend?src=A00220&yptr=yahoo&.tsrc=rss,"Beginning with the short-term lows of Aug. 21, the small cap S&P 600 has risen 10% vs. 1% for the Big Cap 20."
CELG,CELG:UW,BBG000BFCMR2,Flexion Therapeutics Sees Relative Strength Rating Improve To 75,2017-09-29 14:38:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KrGJhZAgoEQ/flexion-therapeutics-sees-relative-strength-rating-improve-to-75-cm853122,The Relative Strength RS Rating for Flexion Therapeutics FLXN entered a higher percentile Friday as it got a lift from 69 to 75 ibd display video id 2102289 width 50 float left autostart true This proprietary rating tracks technical performance by using a
CELG,CELG:UW,BBG000BFCMR2,Ionis Pharmaceuticals Hits 80-Plus Relative Strength Rating Benchmark,2017-09-29 14:38:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HnMtzplTfU0/ionis-pharmaceuticals-hits-80-plus-relative-strength-rating-benchmark-cm853118,When building your watch list focus on stocks with an 80 or higher RS Rating Ionis Pharmaceuticals IONS now meets that criteria with an increase from 75 to 81 Friday ibd display video id 2102289 width 50 float left autostart true This proprietary rating
CELG,CELG:UW,BBG000BFCMR2,Adamas Pharmaceuticals Hits 80-Plus Relative Strength Rating Benchmark,2017-09-29 14:36:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DLRGQQPPx1A/adamas-pharmaceuticals-hits-80-plus-relative-strength-rating-benchmark-cm853090,One important metric to look for in a stock is an 80 or higher Relative Strength Rating Adamas Pharmaceuticals ADMS just hit that mark with a jump from 79 to 84 Friday ibd display video id 449433 width 50 float left autostart true IBD s proprietary RS Rating
CELG,CELG:UW,BBG000BFCMR2,Stocks Flashing Renewed Technical Strength: Acceleron Pharma,2017-09-29 14:35:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W8XKA7lNm1E/stocks-flashing-renewed-technical-strength-acceleron-pharma-cm853086,The Relative Strength RS Rating for Acceleron Pharma XLRN climbed into a new percentile Friday with an increase from 79 to 84 ibd display video id 449423 width 50 float left autostart true This exclusive rating from Investor s Business Daily identifies
CELG,CELG:UW,BBG000BFCMR2,"Morning Movers: Conn's Climbs, JB Hunt Soars, Goldcorp Gains",2017-09-29 14:33:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E_DFPxYL9Vc/morning-movers-conns-climbs-jb-hunt-soars-goldcorp-gains-cm853029,Stocks looks set for a mixed open this morning as September normally the market s worst month looks set to close with solid gains Stocks looks set for a mixed open this morning as September normally the market s worst month looks set toclose with solid gains
CELG,CELG:UW,BBG000BFCMR2,"[$$] Celgene Invests in Acceleron, BeiGene",2017-09-29 09:50:00 +0000,http://finance.yahoo.com/r/b007c187-ee13-3f28-8486-27ab1e401ec2/celgene-investments-in-acceleron-beigene-1506678656?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Celgene doesn’t let a partner down.  The biotech on Monday bought 750,000 more shares of Acceleron (XLRN) for $28 million in a public stock offering.  Celgene (CELG) remains Acceleron’s largest holder and is a partner for the latter’s lead program, Luspatercept, and for sotatercept."
CELG,CELG:UW,BBG000BFCMR2,"Why BlackBerry, AbbVie, and bluebird bio Jumped Today",2017-09-28 22:35:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tf9GqBj_mGY/why-blackberry-abbvie-and-bluebird-bio-jumped-today-cm852882,Thursday was a quiet day on Wall Street with major benchmarks remaining close to the unchanged level Sentiment among market participants remained relatively favorable in the aftermath of the release of the Trump administration s tax reform proposal although a closer look at the
CELG,CELG:UW,BBG000BFCMR2,Bluebird Hits High On Bullish Report Highlighting Blood Drugs,2017-09-28 21:33:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5o9fy8Hv5g8/bluebird-hits-high-on-bullish-report-highlighting-blood-drugs-cm852795,Bluebird Bio BLUE rocketed to a two year high Thursday on an analyst s bullish report outlining the biotech s blood disease pipeline that includes a tie up with No 2 biotech Celgene CELG ibd display video id 2323827 width 50 float left autostart true By
CELG,CELG:UW,BBG000BFCMR2,Bluebird Hits High On Bullish Report Highlighting Blood Drugs,2017-09-28 20:57:42 +0000,http://finance.yahoo.com/r/ca925682-2d5b-39e2-aa4d-e12ace212fa7/bluebird-hits-high-on-bullish-report-highlighting-blood-drugs?src=A00220&yptr=yahoo&.tsrc=rss,Bluebird rocketed to a two-year high Thursday on an analyst&apos;s bullish report outlining the biotech&apos;s blood-disease pipeline.
CELG,CELG:UW,BBG000BFCMR2,"Biotechs Beating The Market, But Are They In Buy Range?",2017-09-28 19:42:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_heWsI7EUBo/biotechs-beating-the-market-but-are-they-in-buy-range-cm852774,Biotechs continue to outmuscle the broader stock market as both nonleveraged and leveraged exchange traded 160 funds are showing healthy gains ibd display video id 2323711 width 50 float left autostart true Despite 160 a recent pullback iShares Nasdaq Biotechnology
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Outflows: IVW, CELG, UPS, TWX",2017-09-28 16:44:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R3G0crxZq90/noteworthy-etf-outflows-ivw-celg-ups-twx-cm852666,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Growth ETF Symbol IVW where we have detected an approximate 121 2 million dollar outflow that s a 0 6 decrease week over week
CELG,CELG:UW,BBG000BFCMR2,Clovis Oncology Scores Relative Strength Rating Upgrade,2017-09-28 14:44:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ExXVg4f2oQA/clovis-oncology-scores-relative-strength-rating-upgrade-cm852533,Clovis Oncology CLVS saw a positive improvement to its Relative Strength RS Rating on Thursday with an upgrade from 88 to 92 ibd display video id 449419 width 50 float left autostart true IBD s unique RS Rating identifies market leadership by showing how
CELG,CELG:UW,BBG000BFCMR2,First Week of CELG November 17th Options Trading,2017-09-28 14:41:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dpv_wq-2OJ4/first-week-of-celg-november-17th-options-trading-cm852492,Investors in Celgene Corp Symbol CELG saw new options begin trading this week for the November 17th expiration At Stock Options Channel our YieldBoost formula has looked up and down the CELG options chain for the new November 17th contracts and identified one put and one call contract
CELG,CELG:UW,BBG000BFCMR2,Acceleron Pharma Reaches 80-Plus Relative Strength Rating Benchmark,2017-09-27 14:57:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xj7b6r-WRPM/acceleron-pharma-reaches-80-plus-relative-strength-rating-benchmark-cm851895,Acceleron Pharma XLRN saw a positive improvement to its Relative Strength RS Rating on Wednesday rising from 77 to 81 ibd display video id 449419 width 50 float left autostart true IBD s proprietary rating tracks market leadership with a 1 worst to 99
CELG,CELG:UW,BBG000BFCMR2,Stocks Flashing Renewed Technical Strength: Innoviva,2017-09-27 14:57:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xmHlGvhHS0Q/stocks-flashing-renewed-technical-strength-innoviva-cm851883,When considering what names to put on your watch list look for stocks with an 80 or higher RS Rating Innoviva INVA just cleared that benchmark with an upgrade from 77 to 81 ibd display video id 449423 width 50 float left autostart true IBD s proprietary RS
CELG,CELG:UW,BBG000BFCMR2,Stocks To Watch: Prothena Sees Relative Strength Rating Jump To 81,2017-09-27 14:56:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ucZemWcA9k4/stocks-to-watch-prothena-sees-relative-strength-rating-jump-to-81-cm851877,One important metric to look for in a stock is an 80 or higher Relative Strength Rating Prothena PRTA now clears that threshold with a jump from 78 to 81 Wednesday ibd display video id 449419 width 50 float left autostart true IBD s proprietary RS Rating
CELG,CELG:UW,BBG000BFCMR2,Stocks Showing Market Leadership: Sarepta Therapeutics Earns 91 RS Rating,2017-09-27 14:56:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o6gKLKDVRVA/stocks-showing-market-leadership-sarepta-therapeutics-earns-91-rs-rating-cm851869,Sarepta Therapeutics SRPT had its Relative Strength RS Rating upgraded from 87 to 91 Wednesday ibd display video id 449433 width 50 float left autostart true IBD s unique RS Rating measures technical performance by showing how a stock s price action over the
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Hike Bets in Major Biotechs,2017-09-27 14:25:20 +0000,https://finance.yahoo.com/news/short-sellers-hike-bets-major-142520224.html?.tsrc=rss,"The September 15 short interest data have been compared with the previous report, and short interest in all the selected biotech stocks increased."
CELG,CELG:UW,BBG000BFCMR2,5 Drugs That Could Make Celgene the Best Biotech Stock of the Next Decade,2017-09-27 13:54:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T6QJqtT-kJ0/5-drugs-that-could-make-celgene-the-best-biotech-stock-of-the-next-decade-cm851567,Over the past five years Celgene NASDAQ CELG stock has soared 280 That s better than any other biotech with a market cap of 50 billion or more Celgene s past success stemmed primarily from four drugs Revlimid Pomalyst Otezla and Abraxane These drugs should continue
CELG,CELG:UW,BBG000BFCMR2,5 Drugs That Could Make Celgene the Best Biotech Stock of the Next Decade,2017-09-27 12:33:00 +0000,http://finance.yahoo.com/r/f475e6f9-d69f-327e-8b1e-8544c05f6a72/5-drugs-that-could-make-celgene-the-best-biotech-s.aspx?yptr=yahoo&.tsrc=rss,Celgene&apos;s pipeline is loaded with candidates with blockbuster potential. Here are the best of the bunch.
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-09-27 12:03:43 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120343142.html?.tsrc=rss,"This could indicate that investors who seek to profit from falling equity prices are not currently targeting CELG.  Over the last one-month, outflows of investor capital in ETFs holding CELG totaled $9.17 billion."
CELG,CELG:UW,BBG000BFCMR2,Stocks Flashing Renewed Technical Strength: Innoviva,2017-09-27 07:00:00 +0000,http://finance.yahoo.com/r/4fded98e-5403-3b86-8586-cb5d810a390b/stocks-flashing-renewed-technical-strength-innoviva?src=A00220&yptr=yahoo&.tsrc=rss,"Innoviva shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81."
CELG,CELG:UW,BBG000BFCMR2,Acceleron Pharma Reaches 80-Plus Relative Strength Rating Benchmark,2017-09-27 07:00:00 +0000,http://finance.yahoo.com/r/3fb34c9f-68cf-3bb4-ab3f-d69df8e9cc87/acceleron-pharma-reaches-80-plus-relative-strength-rating-benchmark?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Acceleron Pharma shows improving technical performance.
CELG,CELG:UW,BBG000BFCMR2,Stocks Showing Market Leadership: Sarepta Therapeutics Earns 91 RS Rating,2017-09-27 07:00:00 +0000,http://finance.yahoo.com/r/f208b781-1549-3880-ab1c-6238b7e693cf/stocks-showing-market-leadership-sarepta-therapeutics-earns-91-rs-rating?src=A00220&yptr=yahoo&.tsrc=rss,"Sarepta Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating."
CELG,CELG:UW,BBG000BFCMR2,Acceleron Pharma Trying To Close In On Key Technical Measure,2017-09-26 14:58:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fQCHZu6bTPo/acceleron-pharma-trying-to-close-in-on-key-technical-measure-cm851113,Acceleron Pharma XLRN had its Relative Strength RS Rating upgraded from 67 to 77 Tuesday a welcome improvement but still below the 80 or higher score you prefer to see ibd display video id 449419 width 50 float left autostart true IBD s unique RS
CELG,CELG:UW,BBG000BFCMR2,Acorda Therapeutics Getting Closer To Key Technical Measure,2017-09-26 14:57:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5V-QSgc-zpU/acorda-therapeutics-getting-closer-to-key-technical-measure-cm851105,Acorda Therapeutics ACOR saw a welcome improvement to its Relative Strength RS Rating on Tuesday rising from 67 to 78 ibd display video id 449433 width 50 float left autostart true IBD s unique rating measures market leadership with a 1 worst to 99
CELG,CELG:UW,BBG000BFCMR2,"Global Blood Therapeutic Clears Technical Benchmark, Hitting 80-Plus RS Rating",2017-09-26 14:55:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-b79O5RoKjM/global-blood-therapeutic-clears-technical-benchmark-hitting-80-plus-rs-rating-cm851071,The Relative Strength RS Rating for Global Blood Therapeutic GBT climbed into a new percentile Tuesday with an increase from 78 to 82 ibd display video id 449433 width 50 float left autostart true IBD s unique rating tracks market leadership with a 1
CELG,CELG:UW,BBG000BFCMR2,"Morning Movers: Chesapeake Energy Falls, Darden Drops, Tesla Gains",2017-09-26 13:51:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XE4kCsgKX7w/morning-movers-chesapeake-energy-falls-darden-drops-tesla-gains-cm850932,Stocks look set for a higher open as they bounce back from yesterday s losses Stocks look set for a higher open as they bounce back fromyesterday s losses Agence France Presse Getty Images Agence France Presse Getty Images S amp P 500 futures are little changed while
CELG,CELG:UW,BBG000BFCMR2,3 Bargain Biotech Stocks You Can Buy Today,2017-09-26 12:52:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rBf9Fang0KY/3-bargain-biotech-stocks-you-can-buy-today-cm850823,You might have heard that the stock market is overpriced after years of solid gains And it is That doesn t mean every stock is overpriced though Actually several biotech stocks look attractively valued right now Here s why AbbVie NYSE ABBV Celgene NASDAQ
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-09-26 12:02:32 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120232352.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,3 Bargain Biotech Stocks You Can Buy Today,2017-09-26 11:17:00 +0000,http://finance.yahoo.com/r/6e0a8259-1098-31d5-9281-b594c45df4bd/3-bargain-biotech-stocks-you-can-buy-today.aspx?yptr=yahoo&.tsrc=rss,Spectacular growth prospects make these three biotech stocks look like steals right now.
CELG,CELG:UW,BBG000BFCMR2,Acorda Therapeutics Getting Closer To Key Technical Measure,2017-09-26 07:00:00 +0000,http://finance.yahoo.com/r/1a84de45-b9ae-39ea-8707-4a3f7d8596e1/acorda-therapeutics-getting-closer-to-key-technical-measure?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Acorda Therapeutics shows improving technical performance. Will it continue?
CELG,CELG:UW,BBG000BFCMR2,Roche (RHHBY) Gets Approval for Label Expansion of Tecentriq,2017-09-25 16:48:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-yo4a4Ps4HE/roche-rhhby-gets-approval-for-label-expansion-of-tecentriq-cm850405,Roche Holding AG RHHBY announced that the European Commission EC has approved immunotherapy drug Tecentriq as a monotherapy for the treatment of patients with locally advanced or metastatic non small cell lung cancer after they have been previously treated with chemotherapy regardless of PD
CELG,CELG:UW,BBG000BFCMR2,"Oddly, Juno Therapeutics Is Jumping 11.3% Today",2017-09-22 21:48:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D6AIkN0MWtQ/oddly-juno-therapeutics-is-jumping-113-today-cm849862,What happened Despite a 6 1 million share follow on public stock offering shares of Juno Therapeutics NASDAQ JUNO are rallying 11 3 higher at 3 p m EDT So what Juno Therapeutics shares have been rallying since competitor Gilead Sciences NASDAQ GILD acquired
CELG,CELG:UW,BBG000BFCMR2,Juno Tenders $250M Follow-on Public Offering of Common Stock,2017-09-22 21:47:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WLljq_3wHY0/juno-tenders-250m-follow-on-public-offering-of-common-stock-cm849852,Juno Therapeutics Inc s JUNO shares dropped more than 7 after the company announced that it has launched a proposed 250 million follow on public offering of 6 1 million shares of common stock at 41 per share The offering subject to customary closing conditions is expected to close on
CELG,CELG:UW,BBG000BFCMR2,"Oddly, Juno Therapeutics Is Jumping 11.3% Today",2017-09-22 20:00:00 +0000,http://finance.yahoo.com/r/03bfbe08-3495-39a0-b0df-4566490b66cf/oddly-juno-therapeutics-is-jumping-113-today.aspx?yptr=yahoo&.tsrc=rss,Optimism that it can develop CAR-T cancer drugs that are better than its competitors&apos; is trumping news that the company is diluting investors by selling more shares.
CELG,CELG:UW,BBG000BFCMR2,3 Big Biotech Stocks to Buy This Fall,2017-09-22 19:26:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p84p2dZ3FqQ/3-big-biotech-stocks-to-buy-this-fall-cm849475,A change in season presents a good time to look for great stocks to buy And one of the best places to look is in the biotech industry Biotech stocks in general are trouncing the S amp P 500 index so far in 2017 I expect that trend to continue well into the future Which biotech
CELG,CELG:UW,BBG000BFCMR2,Juno Tenders $250M Follow-on Public Offering of Common Stock,2017-09-22 19:11:07 +0000,https://finance.yahoo.com/news/juno-tenders-250m-public-offering-191107333.html?.tsrc=rss,Juno Therapeutics (JUNO) launches a proposed follow-on public offering of shares. The company plans to utilize net proceeds from the offering for general corporate purposes.
CELG,CELG:UW,BBG000BFCMR2,3 Big Biotech Stocks to Buy This Fall,2017-09-22 11:43:00 +0000,http://finance.yahoo.com/r/85e23292-2c6e-3efb-ba49-5215f6cda7fb/3-big-biotech-stocks-to-buy-this-fall.aspx?yptr=yahoo&.tsrc=rss,"Leaves might fall in autumn, but these big biotech stocks should rise."
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Celgene Corporation vs. Merck & Co., Inc.",2017-09-22 11:37:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RJCrtc7lefw/better-buy-celgene-corporation-vs-merck-co-inc-cm849424,Based on recent history Celgene Corporation NASDAQ CELG and Merck amp Co NYSE MRK stocks don t even belong in the same league Celgene stock is up more than 270 over the past five years while Merck stock has increased in price less than 50 But the past is the
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Celgene Corporation vs. Merck & Co., Inc.",2017-09-22 10:04:00 +0000,http://finance.yahoo.com/r/03ad810b-7573-3122-b54c-81422fb46eae/better-buy-celgene-corporation-vs-merck-co-inc-2.aspx?yptr=yahoo&.tsrc=rss,Which stock wins in a head-to-head matchup between cancer juggernauts Celgene and Merck?
CELG,CELG:UW,BBG000BFCMR2,Immunize Juno Therapeutics Inc (JUNO) Stock With This Trade,2017-09-21 20:39:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-ehlFKBmeH0/immunize-juno-therapeutics-inc-juno-stock-with-this-trade-cm849309,InvestorPlace Stock Market News Stock Advice amp Trading Tips Juno Therapeutics Inc NASDAQ JUNO has a lot going for it off and on the price chart That doesn t mean you shouldn t immunize JUNO stock against the always real bearish threats To do that we
CELG,CELG:UW,BBG000BFCMR2,3 Small-Cap Biotech Stocks to Buy This Fall,2017-09-21 13:38:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oCubhAT53go/3-small-cap-biotech-stocks-to-buy-this-fall-cm848876,Hundreds of small cap biotech stocks are available for investors All of them come with relatively high levels of risk With that high risk though also comes the potential for high returns But which small cap biotech stocks have the best risk reward profiles Celldex
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-09-21 12:04:05 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120329784.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for Northrop Grumman, BNY Mellon & Celgene",2017-09-20 23:35:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/prpPQs_x458/top-research-reports-for-northrop-grumman-bny-mellon-celgene-cm848756,Wednesday September 20 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 16 major stocks including Northrop Grumman NOC Bank of New York Mellon BK and Celgene CELG These research reports
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for Northrop Grumman, BNY Mellon & Celgene",2017-09-20 20:47:08 +0000,https://finance.yahoo.com/news/top-research-reports-northrop-grumman-204708893.html?.tsrc=rss,"Top Research Reports for Northrop Grumman, BNY Mellon & Celgene"
CELG,CELG:UW,BBG000BFCMR2,3 Stocks That Put Coca-Cola's Returns to Shame,2017-09-20 13:36:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RrTMeEAcph4/3-stocks-that-put-coca-colas-returns-to-shame-cm848204,Warren Buffett famously invested in soda giant Coca Cola NYSE KO 160 in 1988 buying in right before the stock began an epic run Over the past 30 years shares of Coca Cola have gained about 1 450 Recent performance hasn t been quite as good Shares of Coca Cola are
CELG,CELG:UW,BBG000BFCMR2,3 Stocks That Put Coca-Cola&apos;s Returns to Shame,2017-09-20 12:25:00 +0000,http://finance.yahoo.com/r/8ba065bb-ccf7-305f-9baa-f473f882a27d/3-stocks-that-put-coca-colas-returns-to-shame.aspx?yptr=yahoo&.tsrc=rss,Coca-Cola has been a great investment over the decades. But these stocks are leaving the soda giant in the dust.
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-09-20 12:04:17 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120417063.html?.tsrc=rss,"This could indicate that investors who seek to profit from falling equity prices are not currently targeting CELG.  Over the last one-month, outflows of investor capital in ETFs holding CELG totaled $1.24 billion."
CELG,CELG:UW,BBG000BFCMR2,Roche (RHHBY) Announces Positive Data on Leukemia Drug,2017-09-19 21:37:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6J-Kx1ZABGE/roche-rhhby-announces-positive-data-on-leukemia-drug-cm848038,Roche Holdings AG RHHBY announced positive results from the phase III study MURANO The study evaluated Venclexta in combination with Rituxan in patients suffering from relapsed or refractory chronic lymphocytic leukemia CLL Data showed that the study met its primary endpoint as the
CELG,CELG:UW,BBG000BFCMR2,These 3 Biotech Stocks Just Hit 52-Week Highs: Are They Buys?,2017-09-19 13:38:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k_oVn29DKgI/these-3-biotech-stocks-just-hit-52-week-highs-are-they-buys-cm847598,These are the best times in a long time for three small biotechs For two of them these are the best times ever Abeona Therapeutics NASDAQ ABEO BeiGene NASDAQ BGNE and Vanda Pharmaceuticals NASDAQ VNDA stocks recently hit 52 week highs Abeona and BeiGene
CELG,CELG:UW,BBG000BFCMR2,These 3 Biotech Stocks Just Hit 52-Week Highs: Are They Buys?,2017-09-19 11:31:00 +0000,http://finance.yahoo.com/r/1f246f85-650d-334f-a43a-90fc13ec017d/these-3-biotech-stocks-just-hit-52-week-highs-ar-2.aspx?yptr=yahoo&.tsrc=rss,"Will the good times keep rolling for Abeona Therapeutics, BeiGene, and Vanda Pharmaceuticals?"
CELG,CELG:UW,BBG000BFCMR2,"Yes, Juno Therapeutics (JUNO) Just Became a Great CAR-T Trade",2017-09-19 11:09:37 +0000,https://finance.yahoo.com/news/yes-juno-therapeutics-juno-just-110937168.html?.tsrc=rss,"Juno Therapeutics Inc (NASDAQ:JUNO) is poised to benefit from a rising acquisition trend.  Three weeks ago when Gilead Sciences, Inc. (NASDAQ:GILD) announced it would be acquiring smaller rival biopharma name Kite Pharma Inc (NASDAQ:KITE), traders clearly took notice.  If Gilead wanted Kite for its CAR-T cancer therapy and Novartis AG (ADR) (NYSE:NVS) recently won the first-ever FDA approval for its CAR-T based oncology drug, there had to be something to it."
CELG,CELG:UW,BBG000BFCMR2,Apple Leads 7 Top Stocks Holding In Buy Range,2017-09-19 11:01:21 +0000,http://finance.yahoo.com/r/352304b8-fbd3-38e1-8748-2b15e4a79c56/apple-microsoft-lead-7-top-stocks-holding-in-buy-range-sp-500-futures?src=A00220&yptr=yahoo&.tsrc=rss,"With the market grinding higher, some breakouts struggle. But Apple, Microsoft, Biogen, Alexion Pharmaceuticals, Wynn Resorts and Electronic Arts are holding in buy zones after breaking out several days or weeks ago."
CELG,CELG:UW,BBG000BFCMR2,Roche's (RHHBY) Tecentriq Studies Put on Partial Hold by FDA,2017-09-18 23:35:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dzquLKTQSBE/roches-rhhby-tecentriq-studies-put-on-partial-hold-by-fda-cm847443,Roche Holdings AG RHHBY announced that the FDA has put a partial clinical hold on a phase Ib and phase I II b trials evaluating Tecentriq due to safety issues A partial hold was put due to emerging safety data from clinical trials evaluating Merck amp Co MRK Keytruda in combination
CELG,CELG:UW,BBG000BFCMR2,Roche&apos;s (RHHBY) Tecentriq Studies Put on Partial Hold by FDA,2017-09-18 21:59:09 +0000,https://finance.yahoo.com/news/roche-apos-rhhby-tecentriq-studies-215909928.html?.tsrc=rss,Roche Holdings AG (RHHBY) announced that the FDA has put a partial clinical hold on a phase Ib and phase I/II b trials evaluating immunotherapy drug Tecentriq.
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks That Are Just Getting Started,2017-09-18 20:36:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dDIJ6m50J6w/3-biotech-stocks-that-are-just-getting-started-cm847411,InvestorPlace Stock Market News Stock Advice amp Trading Tips The bull market beat rolls on this week with stocks hot right out of the gate Monday morning While some sectors are pushing into overbought territory others are just starting to run Like biotech stocks for instance They
CELG,CELG:UW,BBG000BFCMR2,5 of the Toughest Stocks to Withstand a Downturn,2017-09-18 19:35:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HGpgoyhmHaI/5-of-the-toughest-stocks-to-withstand-a-downturn-cm847364,InvestorPlace Stock Market News Stock Advice amp Trading Tips According to leading banks the evidence of an upcoming downturn is growing 160 HSBC Citigroup and Morgan Stanley have all noted a trading pattern breakdown a signal to get out soon according to Bloomberg
CELG,CELG:UW,BBG000BFCMR2,What Analysts Recommend for Novartis in September 2017,2017-09-18 18:19:40 +0000,http://finance.yahoo.com/r/b2abd793-25e1-39d4-b8dc-faf8e4a167ef/what-analysts-recommend-for-novartis-in-september-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Three analysts were analyzing Novartis in September 2017. One analyst recommended a “strong buy,” while the other two recommended a “hold.”"
CELG,CELG:UW,BBG000BFCMR2,RBC Capital's Marc Harris breaks down his best biotech pi...,2017-09-18 18:16:00 +0000,https://finance.yahoo.com/video/rbc-capitals-marc-harris-breaks-181600703.html?.tsrc=rss,"Marc Harris, RBC Capital, discusses the run in the biotech sector and gives his stock picks."
CELG,CELG:UW,BBG000BFCMR2,"Notable ETF Outflow Detected - ITOT, DWDP, CELG, HON",2017-09-18 16:36:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3n67RlQejJA/notable-etf-outflow-detected-itot-dwdp-celg-hon-cm847137,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core S amp P Total U S Stock Market ETF Symbol ITOT where we have detected an approximate 60 1 million dollar outflow that s a 0 6 decrease week
CELG,CELG:UW,BBG000BFCMR2,"Gilead Sciences: Is The Kite Deal Too Little, Too Late?",2017-09-18 15:35:00 +0000,http://finance.yahoo.com/r/f671e14c-d4a0-3468-acf7-c08c5badbf8d/gilead-sciences-is-the-kite-deal-too-little-too-late-1505748947?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last month, Gilead Sciences (GILD) made big news when it announced the acquisition of Kite Pharma (KITE).  For the most part, analysts were bullish on the deal, with the noted exception being Leerink's Geoffrey Porges and Bradley Canino.  The pair penned a note late last month explaining why they were not excited by Gilead’s latest purchase."
CELG,CELG:UW,BBG000BFCMR2,Don't Make This Huge Mistake With Celgene,2017-09-17 14:35:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YH99_I8g0xc/dont-make-this-huge-mistake-with-celgene-cm846801,Several years ago I started to look seriously at investing in Celgene NASDAQ CELG stock Someone I knew told me that I probably shouldn t get too excited about the biotech I m glad I didn t listen to the person s advice Celgene is a much bigger and much more successful company
CELG,CELG:UW,BBG000BFCMR2,Don&apos;t Make This Huge Mistake With Celgene,2017-09-17 13:18:00 +0000,http://finance.yahoo.com/r/6c65b735-998c-3c29-90cc-d5f568d73ca4/dont-make-this-huge-mistake-with-celgene.aspx?yptr=yahoo&.tsrc=rss,You can do a lot of things about Celgene. But don&apos;t do this.
CELG,CELG:UW,BBG000BFCMR2,Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?,2017-09-16 12:03:00 +0000,http://finance.yahoo.com/r/29feae24-c8ef-371c-86aa-b23e5176bdff/which-of-these-5-will-be-the-best-selling-drug-wor.aspx?yptr=yahoo&.tsrc=rss,All five of these drugs have a genuine shot at $10 billion or more in annual sales in 2020.
CELG,CELG:UW,BBG000BFCMR2,Traders give their award-winning stock picks ahead of thi...,2017-09-15 21:25:00 +0000,https://finance.yahoo.com/video/traders-award-winning-stock-picks-212500900.html?.tsrc=rss,"The “Fast Money” traders share their final trades for the day including Lions Gate Entertainment, Netflix, Square and Celgene."
CELG,CELG:UW,BBG000BFCMR2,3 Reasons Why Gilead Sciences Stock Is a Buy Now,2017-09-15 13:37:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bSprk9REnJA/3-reasons-why-gilead-sciences-stock-is-a-buy-now-cm846175,Gilead Sciences NASDAQ GILD is a biotech behemoth but its shares have fallen on tough times because hepatitis C sales are slipping While headwinds in hepatitis C remain the company s recent push into cancer treatment best in class operating metrics and cheap valuation make it
CELG,CELG:UW,BBG000BFCMR2,RBC Launches Biotech Sector Coverage Amid 'An Innovation Revolution',2017-09-14 20:52:00 +0000,http://finance.yahoo.com/r/0f7f86bb-fddc-3516-921a-b7d578b017c8/rbc-launches-biotech-sector-coverage-amid-an-innovation-revolution-1505422378?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"RBC Capital Markets just launched coverage of the biotech sector, covered by Brian Abrahams, Kennen MacKay, and Matthew Eckler, and they spoke with Barrons.com about the industry, which they say is seeing a number of exciting innovations as we enter a new era of personalized medicine.  Of course, biotech has been on a wild ride in recent years, but after being shunned by a number of investors previously, the sector is seeing new life in 2017, with the Nasdaq Biotechnology Index (NBI) up more than 25% this year, and SPDR S&P Biotech ETF (XBI) up more than 40%."
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Thursday Option Activity: EQT, ESRX, CELG",2017-09-14 18:38:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bm9ErhWwj7E/noteworthy-thursday-option-activity-eqt-esrx-celg-cm845892,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in EQT Corp Symbol EQT where a total volume of 10 973 contracts has been traded thus far today a contract volume which is representative of approximately 1 1 million
CELG,CELG:UW,BBG000BFCMR2,Celgene To Present At BOA Merrill Lynch Conference; Webcast At 11:10 AM ET,2017-09-14 10:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1-f4CkDVNgM/celgene-to-present-at-boa-merrill-lynch-conference-webcast-at-1110-am-et-20170914-00793,Celgene To Present At BOA Merrill Lynch Conference; Webcast At 11:10 AM ET
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Hike Bets in Major Biotechs,2017-09-13 12:55:07 +0000,https://finance.yahoo.com/news/short-sellers-hike-bets-major-125507850.html?.tsrc=rss,"The August 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased."
CELG,CELG:UW,BBG000BFCMR2,Celgene To Present At Morgan Stanley Conference; Webcast At 9:20 AM ET,2017-09-13 08:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5COVH-UDOes/celgene-to-present-at-morgan-stanley-conference-webcast-at-920-am-et-20170913-00472,Celgene To Present At Morgan Stanley Conference; Webcast At 9:20 AM ET
CELG,CELG:UW,BBG000BFCMR2,[$$] Celgene Launch to Lift BeiGene,2017-09-12 17:34:00 +0000,http://finance.yahoo.com/r/e25e1396-0569-3a15-82cf-e5c3e01a576c/celgene-launch-to-lift-beigene-1505237681?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"BeiGene (BGNE: Nasdaq) By Maxim Group ($72.64, Sept. 8, 2017) We have updated our BeiGene model to include the launch of BGB-A317 in the U.S. by Celgene, following the close of the transaction. Our model ..."
CELG,CELG:UW,BBG000BFCMR2,"Checkpoint Inhibitors Are Hot, and CKPT Has Something in the Oven",2017-09-12 15:00:00 +0000,https://finance.yahoo.com/news/checkpoint-inhibitors-hot-ckpt-something-150000001.html?.tsrc=rss,NASDAQ:CKPT Checkpoint Therapeutics Inc. (NASDAQ:CKPT) holds a portfolio of targeted anti-cancer and immuno-oncology agents which it is developing for both mono- and combination therapies in solid tumors. ...
CELG,CELG:UW,BBG000BFCMR2,Who Joins Apple On This List Of New Buys By Top Mutual Funds?,2017-09-12 13:39:29 +0000,http://finance.yahoo.com/r/58c8c97d-fb69-3971-a14d-60e157f15fbb/apple-celgene-boeing-unitedhealth-mutual-funds-new-buys?src=A00220&yptr=yahoo&.tsrc=rss,"Apple, Celgene, Boeing and UnitedHealth are among the top stocks on this month&apos;s list of new buys by top mutual funds."
CELG,CELG:UW,BBG000BFCMR2,3 Growth Stocks to Hold for 50 Years,2017-09-12 12:37:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NFp7ME5tDsA/3-growth-stocks-to-hold-for-50-years-cm844146,Today s growth stocks aren t the same growth stocks that were around in 1967 However some of the companies from back then are still solid picks today And some of today s will still be winners 50 years from now We asked three Motley Fool investors which growth stocks they would
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-09-12 12:02:21 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120221068.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,3 Growth Stocks to Hold for 50 Years,2017-09-12 10:04:00 +0000,http://finance.yahoo.com/r/4d5a82cc-08c6-3eae-9a8b-0da9c0c12b21/3-growth-stocks-to-hold-for-50-years.aspx?yptr=yahoo&.tsrc=rss,"Why Baidu, Paycom, and Celgene look like growth stocks you can buy and hold for decades."
CELG,CELG:UW,BBG000BFCMR2,5 Ways To Play The Biotech Bull Market,2017-09-11 23:30:00 +0000,https://finance.yahoo.com/news/5-ways-play-biotech-bull-233000371.html?.tsrc=rss,"After a tough couple of years biotech is making a spectacular comeback, with important breakthroughs in cancer and stroke treatment jolting the market"
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-09-11 14:07:22 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-140722818.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,What’s Gilead Sciences’ Valuation?,2017-09-11 12:36:46 +0000,http://finance.yahoo.com/r/47c215a5-9292-3017-a7cb-0781a98329b0/whats-gilead-sciences-valuation?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Gilead’s stock price has risen ~8.9% in the last 12 months. Wall Street analysts estimate that the stock price will fall ~4.5% over the next 12 months.
CELG,CELG:UW,BBG000BFCMR2,3 Reasons to Buy Allergan plc Stock Right Now,2017-09-10 13:49:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4BM1mBJiGts/3-reasons-to-buy-allergan-plc-stock-right-now-cm843382,Allergan NYSE AGN is one of the most underappreciated big pharma stocks on the market right now That s the thought that occurred to me as I listened to Brent Saunders Allergan s CEO speak at the Wells Fargo Healthcare Conference on Thursday One thing s for sure
CELG,CELG:UW,BBG000BFCMR2,CAR-T Mania: Could Juno Therapeutics Get Acquired Next?,2017-09-10 09:00:00 +0000,http://finance.yahoo.com/r/6fb824cb-4a74-3b0a-aed7-214824617990/car-t-mania-could-juno-therapeutics-get-acquired-n.aspx?yptr=yahoo&.tsrc=rss,Juno Therapeutics is developing next-generation CAR-Ts that it believes could be better than what its competitors offer.
CELG,CELG:UW,BBG000BFCMR2,Why The Biotech &apos;Catch-Up Rally&apos; Could Add Another 15%-20%,2017-09-08 20:32:23 +0000,http://finance.yahoo.com/r/3d487276-a862-3de8-ba40-1e7247ff72d7/why-the-biotech-catch-up-rally-could-add-another-15-20?src=A00220&yptr=yahoo&.tsrc=rss,"A rally in the biotech sector could tack on another 15%-20% with Celgene, Alexion and Regeneron leading the charge, an analyst says."
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Fusion Program Studies Put on Hold by FDA,2017-09-08 15:56:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p82BPo9NP9U/celgene-celg-fusion-program-studies-put-on-hold-by-fda-cm842970,Celgene Corporation CELG announced that the FDA put a hold on several trials in the FUSION program Partial clinical hold has been put on five trials and a full clinical hold on one trial The trials are evaluating Imfinzi durvalumab an anti PD L1 antibody in combination
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-09-08 14:24:06 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-142406667.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Fusion Program Studies Put on Hold by FDA,2017-09-08 13:15:01 +0000,https://finance.yahoo.com/news/celgene-celg-fusion-program-studies-131501430.html?.tsrc=rss,"Celgene Corporation (CELG) announced that the FDA put a hold on several trials in the FUSION program evaluating Imfinzi, an anti-PD-L1 antibody, in combination with immunomodulatory and chemotherapy agents in blood cancers."
CELG,CELG:UW,BBG000BFCMR2,Data Presented at ESMO 2017 Further Evaluate Role of ABRAXANE® for Patients with Historically Challenging Cancers,2017-09-08 11:30:00 +0000,https://finance.yahoo.com/news/data-presented-esmo-2017-further-113000821.html?.tsrc=rss,"Celgene Corporation today announced that data from multiple studies evaluating investigational uses of ABRAXANE® will be presented during the European Society of Medical Oncology 2017 Annual Meeting between September 8-12 in Madrid, Spain."
CELG,CELG:UW,BBG000BFCMR2,"Kymriah, First CAR-T Therapy Approved: 4 Pharma Stocks in Focus",2017-09-07 23:51:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CQa0ae-zpw0/kymriah-first-car-t-therapy-approved-4-pharma-stocks-in-focus-cm842662,Of late biotechnology and pharmaceutical companies are investing in immuno oncology research therapies as it remains a key area of focus thanks to its vast growth potential Last week the immuno oncology space grabbed investors attention with the FDA approving Novartis AG s NVS
CELG,CELG:UW,BBG000BFCMR2,"Despite biotech's epic run, these names are still a barga...",2017-09-07 21:52:00 +0000,https://finance.yahoo.com/video/despite-biotechs-epic-run-names-215200237.html?.tsrc=rss,CNBC's Meg Tirrell reports on what's driving the biotech sector to a possible breakout. The “Fast Money” traders weigh in.
CELG,CELG:UW,BBG000BFCMR2,Top Biotech Stock Near Buy Zone After FDA Drug Approval,2017-09-07 20:10:05 +0000,http://finance.yahoo.com/r/fa1baa96-d0e4-394d-a998-75965e57c481/top-biotech-stock-vertex-pharmaceuticals-fda-approval-cystic-fibrosis-drug?src=A00220&yptr=yahoo&.tsrc=rss,"Boosted by a biotech boom, promising cystic fibrosis drug trial results and a new FDA approval, Vertex Pharmaceuticals may be ready to climb."
CELG,CELG:UW,BBG000BFCMR2,Jazz Pharmaceuticals on the Street: Analysts’ Recommendations after 1H17,2017-09-07 17:29:23 +0000,http://finance.yahoo.com/r/97b0e62f-b5ab-3f00-9307-f03e998962e9/jazz-pharmaceuticals-on-the-street-analysts-recommendations-after-1h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In July 2017, Jazz Pharmaceuticals entered into a license agreement with XL-Protein GmbH involving products using XL-Protein’s PASylation technology."
CELG,CELG:UW,BBG000BFCMR2,FDA widens holds on immunotherapy combination blood cancer trials,2017-09-07 17:07:26 +0000,https://finance.yahoo.com/news/fda-puts-celgenes-multiple-cancer-122706745.html?.tsrc=rss,"U.S. health regulators stopped five blood  cancer trials testing AstraZeneca Plc's immunotherapy  Imfinzi in combination with Celgene Corp medicines from  accepting new patients  and halted another study entirely, the  companies said on Thursday.  The Food and Drug Administration's decisions stem from  safety concerns uncovered in similar blood cancer trials of  Merck & Co Inc's rival Keytruda medicine in combination  with widely used multiple myeloma drugs that Celgene sells."
CELG,CELG:UW,BBG000BFCMR2,Celgene Faces Multiple Clinical Holds From FDA,2017-09-07 15:25:12 +0000,https://finance.yahoo.com/news/celgene-faces-multiple-clinical-holds-152512496.html?.tsrc=rss,"Celgene received an update from the FDA early on Thursday. Although shares did not dip initially, this action could prove to be problematic for the biotech giant going forward."
CELG,CELG:UW,BBG000BFCMR2,5 Things You'll Want to Know From Celgene Corporation's Latest Presentation,2017-09-07 13:53:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oBJnE0iBScM/5-things-youll-want-to-know-from-celgene-corporations-latest-presentation-cm842109,It s been a busy week for biotech and healthcare conferences Drugmakers big and small have been making the rounds answering questions about their current status and future prospects Celgene Corporation NASDAQ CELG is no exception Bob Kellogg Celgene s CFO fielded questions
CELG,CELG:UW,BBG000BFCMR2,"Opening Bell, September 7, 2017",2017-09-07 13:29:00 +0000,https://finance.yahoo.com/video/opening-bell-september-7-2017-132900575.html?.tsrc=rss,"Roland Ormand, Lilis Energy executive chairman, at the NYSE, and Mark Alles, Celgene CEO, at the Nasdaq, ring today's opening bells."
CELG,CELG:UW,BBG000BFCMR2,Celgene CEO: FDA places 'FUSION' trials on hold in 'cauti...,2017-09-07 12:50:00 +0000,https://finance.yahoo.com/video/celgene-ceo-fda-places-fusion-125000554.html?.tsrc=rss,"We're stopping now to understand what's happening, says Mark Alles, Celgene CEO, talking about the company's latest cancer drug trials."
CELG,CELG:UW,BBG000BFCMR2,FDA puts Celgene's multiple cancer trials on hold,2017-09-07 12:01:20 +0000,https://finance.yahoo.com/news/fda-puts-celgenes-multiple-cancer-120120216.html?.tsrc=rss,Celgene Corp said on Thursday the U.S. Food and Drug Administration had placed a partial clinical hold on the company's five trials and a full clinical hold on one trial. The trials are testing AstraZeneca ...
CELG,CELG:UW,BBG000BFCMR2,Celgene shares drop 1% on news that FDA has placed six trials on partial or full clinical hold,2017-09-07 11:52:26 +0000,http://finance.yahoo.com/r/11fd4490-7009-3c36-8cc3-bf3652211f03/Story.aspx?guid=11A3944A-A109-46F2-9D60-D6B5D270B58B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Celgene Corp. shares dropped 1% in premarket trade Thursday after the company said that the Food and Drug Administration has placed a partial clinical hold on five clinical trials and a full clinical hold ...
CELG,CELG:UW,BBG000BFCMR2,5 Things You&apos;ll Want to Know From Celgene Corporation&apos;s Latest Presentation,2017-09-07 11:47:00 +0000,http://finance.yahoo.com/r/6db966e4-076b-3d8a-af84-527b22f9af29/5-things-youll-want-to-know-from-celgene-corporati.aspx?yptr=yahoo&.tsrc=rss,Celgene CFO Bob Kellogg discusses what&apos;s in store for the big biotech.
CELG,CELG:UW,BBG000BFCMR2,Celgene Provides Update on the Fusion™ Clinical Program,2017-09-07 11:30:00 +0000,https://finance.yahoo.com/news/celgene-provides-fusion-clinical-program-113000371.html?.tsrc=rss,Celgene Corporation today announced that the U.S. Food and Drug Administration has placed a partial clinical hold on five trials and a full clinical hold on one trial in the Celgene FUSION™ program.
CELG,CELG:UW,BBG000BFCMR2,Celgene Says FDA Places Clinical Hold On FUSION Program,2017-09-07 07:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xrJtJwOdkew/celgene-says-fda-places-clinical-hold-on-fusion-program-20170907-00456,Celgene Says FDA Places Clinical Hold On FUSION Program
CELG,CELG:UW,BBG000BFCMR2,New Drugs Approved In August,2017-09-07 05:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZoP1iaTzo4w/new-drugs-approved-in-august-20170907-00189,New Drugs Approved In August
CELG,CELG:UW,BBG000BFCMR2,Celgene To Present At Baird Global Healthcare Conference; Webcast At 3:45 PM ET,2017-09-06 14:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rw1siMZdQW4/celgene-to-present-at-baird-global-healthcare-conference-webcast-at-345-pm-et-20170906-01229,Celgene To Present At Baird Global Healthcare Conference; Webcast At 3:45 PM ET
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation (Nasdaq: CELG) to Ring The Nasdaq Stock Market Opening Bell,2017-09-06 14:00:00 +0000,https://finance.yahoo.com/news/celgene-corporation-nasdaq-celg-ring-140000499.html?.tsrc=rss,"What: Celgene Corporation, a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related ..."
CELG,CELG:UW,BBG000BFCMR2,7 Medical Conditions That Will Be Lining Big Pharma's Pockets by 2020,2017-09-06 11:50:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_PMPntqAH_g/7-medical-conditions-that-will-be-lining-big-pharmas-pockets-by-2020-cm841383,Image source Getty Images Imagine a stack of dollar bills reaching from the ground to more than 95 000 miles into the sky nearly four tenths of the way to the moon That stack would total 1 4 trillion 160 It s a staggering number It s also how much will be spent worldwide
CELG,CELG:UW,BBG000BFCMR2,7 Medical Conditions That Will Be Lining Big Pharma&apos;s Pockets by 2020,2017-09-06 10:00:00 +0000,http://finance.yahoo.com/r/f6031dfe-f15c-3962-b7f5-e6b45193a2de/7-medical-conditions-that-will-be-lining-big-pharm.aspx?yptr=yahoo&.tsrc=rss,Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions.
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. – Value Analysis (NASDAQ:CELG) : September 6, 2017",2017-09-06 03:00:43 +0000,http://finance.yahoo.com/r/b575e72e-d6e7-34a9-8d0e-a154a820bb44/celgene-corp-value-analysis-nasdaqcelg-september-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Celgene Corp. a score of 66. Our analysis is based on comparing Celgene Corp. with the following peers – Amgen Inc., Biogen Inc., Gilead Sciences, Inc., OncoMed Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., Eli Lilly and Company, Epizyme, Inc., Illumina, Inc., Johnson & Johnson and Shire PLC Sponsored ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,Pfizer's Acute Leukemia Drug Mylotarg Approved by the FDA,2017-09-04 15:49:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dUP9K9NnRcE/pfizers-acute-leukemia-drug-mylotarg-approved-by-the-fda-cm840773,Pfizer Inc PFE announced that the FDA has granted approval to Mylotarg for adult patients with newly diagnosed CD33 positive acute myeloid leukemia AML The drug also received approval to treat relapsed or refractory CD33 positive AML in adults as well as children 2 years and older
CELG,CELG:UW,BBG000BFCMR2,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,2017-09-01 18:03:23 +0000,https://finance.yahoo.com/news/attention-biotech-investors-september-ushers-180323046.html?.tsrc=rss,"Biotech stocks had a somber performance in August, as they reacted to earnings news flow, FDA decisions and M&A news, among other catalysts. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB ) ..."
CELG,CELG:UW,BBG000BFCMR2,Stocks Higher As Top-10 Group Continues To Add Breakouts,2017-09-01 17:31:48 +0000,http://finance.yahoo.com/r/2e1167e3-7b84-3592-948a-477e983d8ddf/stocks-higher-as-celgene-adds-to-biotech-rally?src=A00220&yptr=yahoo&.tsrc=rss,"Stocks were near session highs in afternoon trading Friday, as the market looked to cap a solid week with the indexes in reach of all-time highs."
CELG,CELG:UW,BBG000BFCMR2,These 4 Biotechs Just Moved Into Buy Zones; Is This Giant Next?,2017-09-01 11:45:46 +0000,http://finance.yahoo.com/r/3177b128-03e5-3556-8021-991ed8c0fd9f/these-4-biotechs-just-moved-into-buy-zones-sp-500-futures?src=A00220&yptr=yahoo&.tsrc=rss,Several biotech stocks broke out Thursday as the Nasdaq composite and other major averages approached all-time highs. Celgene could be next.
CELG,CELG:UW,BBG000BFCMR2,"Thursday Sector Leaders: Healthcare, Energy",2017-08-31 19:48:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i1t9oVX6pk4/thursday-sector-leaders-healthcare-energy-cm839908,Looking at the sectors faring best as of midday Thursday shares of Healthcare companies are outperforming other sectors higher by 1 4 Within that group Biogen Inc Symbol BIIB and Celgene Corp Symbol CELG are two large stocks leading the way showing a gain of 3 8 and 3
CELG,CELG:UW,BBG000BFCMR2,Thursday's ETF with Unusual Volume: BBH,2017-08-31 17:48:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jsRmZudX38o/thursdays-etf-with-unusual-volume-bbh-cm839844,The Biotech ETF is seeing unusually high volume in afternoon trading Thursday with over 127 000 shares traded versus three month average volume of about 31 000 Shares of BBH were up about 1 6 on the day Components of that ETF with the highest volume on Thursday were Gilead
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : August 31, 2017",2017-08-31 12:56:10 +0000,http://finance.yahoo.com/r/0ca9efb3-b6af-3824-bd8e-b4f051ff89fc/celgene-corp-breached-its-50-day-moving-average-in-a-bullish-manner-celg-us-august-31-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Celgene Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,1 Stock I'm Never Selling,2017-08-31 12:51:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y4eR3zCFN_U/1-stock-im-never-selling-cm839528,Sure never is a long time but we re long term investors around here and our Motley Fool investors are happy to play the long game when it comes to investing in Vanguard Information Technology ETF NYSEMKT VGT Celgene NASDAQ CELG and Walt 160 Disney NYSE
CELG,CELG:UW,BBG000BFCMR2,1 Stock I&apos;m Never Selling,2017-08-31 11:31:00 +0000,http://finance.yahoo.com/r/49989a86-0ab2-3b89-9fc0-c9c9e8c6d57d/1-stock-im-never-selling.aspx?yptr=yahoo&.tsrc=rss,"Vanguard Information Technology ETF, Celgene Corp., and Walt Disney are top stocks that investors can include in forever portfolios."
CELG,CELG:UW,BBG000BFCMR2,5 Biotech Stocks That Are Breaking Higher,2017-08-31 00:48:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p9gpEQanX48/5-biotech-stocks-that-are-breaking-higher-cm839469,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities are continuing to melt higher on Wednesday as fears over the North Korean missile strike earlier in the week are fading amid a fresh focus on possible tax reform legislation Source Shutterstock Also we
CELG,CELG:UW,BBG000BFCMR2,Cramer pinpoints the trend that could lead to a surge in ...,2017-08-30 22:46:00 +0000,https://finance.yahoo.com/video/cramer-pinpoints-trend-could-lead-224600977.html?.tsrc=rss,Jim Cramer says the market's response to some recent takeovers bodes well for the acquisition market going forward.
CELG,CELG:UW,BBG000BFCMR2,Cramer: This trend could lead to surge in takeovers,2017-08-30 22:33:00 +0000,https://finance.yahoo.com/video/cramer-trend-could-lead-surge-223300183.html?.tsrc=rss,Jim Cramer says the market's response to some recent takeovers bodes well for the acquisition market going forward.
CELG,CELG:UW,BBG000BFCMR2,Why bluebird bio Inc Jumped Higher Today,2017-08-30 21:50:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wJ4WvnQYe38/why-bluebird-bio-inc-jumped-higher-today-cm839403,What happened bluebird bio NASDAQ BLUE is up 10 1 at 3 40 p m EDT after Novartis NYSE NVS got its chimeric antigen receptor T cell CAR T therapy Kymriah 160 approved by the Food and Drug Administration FDA today Bluebird is developing CAR T therapies of its
CELG,CELG:UW,BBG000BFCMR2,Juno/Bluebird Hot Acquisition Targets After Kite/Gilead Deal,2017-08-30 14:53:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nq-rcq0Sdzk/junobluebird-hot-acquisition-targets-after-kitegilead-deal-cm839092,Biotech giant Gilead Sciences Inc s GILD 11 8 billion deal to buy CAR T cancer therapy designer Kite Pharma Inc KITE has made two other leading independent CAR T developers Juno Therapeutics Inc JUNO and Bluebird Bio Inc BLUE hot takeover targets Terms of the Gilead
CELG,CELG:UW,BBG000BFCMR2,Juno/Bluebird Hot Acquisition Targets After Kite/Gilead Deal,2017-08-30 12:49:12 +0000,https://finance.yahoo.com/news/juno-bluebird-hot-acquisition-targets-124912268.html?.tsrc=rss,"Gilead&apos;s (GILD) $11.8 billion deal to buy Kite Pharma KITE) has made two other leading independent CAR-T developers, Juno and Bluebird Bio hot takeover targets."
CELG,CELG:UW,BBG000BFCMR2,"Indecision Won't Kill You, But It Will Take Your Money",2017-08-30 00:49:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/490sbc5vNyU/indecision-wont-kill-you-but-it-will-take-your-money-cm838900,Welcome back to Mind Over Money I m Kevin Cook your field guide and story teller for the fascinating arena of Behavioral Economics This episode is all about the risk reward 160 mechanics 160 of decision making Sometimes we avoid making decisions and often we never learn from our bad ones
CELG,CELG:UW,BBG000BFCMR2,3 Reasons to Be Cautious on Vertex Pharmaceuticals Incorporated (VRTX) Stock,2017-08-29 22:48:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/olltIQ64dt0/3-reasons-to-be-cautious-on-vertex-pharmaceuticals-incorporated-vrtx-stock-cm838888,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotech companies are a great source for finding huge gainers And yes a clear example of this is Vertex Pharmaceuticals Incorporated NASDAQ VRTX For the year so far the shares are up a sizzling 109 to 153
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics (JUNO) Continues Gains After Gilead-Kite Acquisition,2017-08-29 21:50:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nk3tL-k5Ur8/juno-therapeutics-juno-continues-gains-after-gilead-kite-acquisition-cm838832,Shares of Juno Therapeutics JUNO continued to soar on Tuesday The stock has now gained nearly 40 since the announcement that fellow CAR T cancer therapy designer Kite Pharma KITE is being acquired by biotech behemoth Gilead Sciences GILD Along with Kite and Bluebird Bio BLUE Juno is
CELG,CELG:UW,BBG000BFCMR2,Why Juno Therapeutics Stock Is Blasting Off Today,2017-08-29 19:51:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/noIWs005k_s/why-juno-therapeutics-stock-is-blasting-off-today-cm838800,What happened Shares of Juno Therapeutics NASDAQ JUNO 160 are up by double digits for the second day in a row on extremely heavy volume The catalyst behind this continued surge higher is the nearly 12 billion buyout of rival adoptive cell therapy company Kite
CELG,CELG:UW,BBG000BFCMR2,3 Reasons to Be Cautious on Vertex Pharmaceuticals Incorporated (VRTX) Stock,2017-08-29 18:15:27 +0000,https://finance.yahoo.com/news/3-reasons-cautious-vertex-pharmaceuticals-181527876.html?.tsrc=rss,"Biotech companies are a great source for finding huge gainers.  Founded in the late 1980s, Vertex Pharmaceuticals pioneered groundbreaking therapies for cystic fibrosis.  It was back in early 2012 that Vertex Pharmaceuticals received FDA approval for its drug, Kalydeco."
CELG,CELG:UW,BBG000BFCMR2,Why Juno Therapeutics Stock Is Blasting Off Today,2017-08-29 17:50:49 +0000,http://finance.yahoo.com/r/60959532-a62b-3896-9899-4494be661d8c/why-juno-therapeutics-stock-is-blasting-off-today.aspx?yptr=yahoo&.tsrc=rss,Gilead&apos;s buyout of Kite Pharma sparks yet another rally in fellow CAR-T developer Juno Therapeutics.
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Outflows: IWV, HON, CELG, UNP",2017-08-29 16:50:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZJSyYTtVoNk/noteworthy-etf-outflows-iwv-hon-celg-unp-cm838673,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 3000 ETF Symbol IWV where we have detected an approximate 28 9 million dollar outflow that s a 0 4 decrease week over week from 53 050 000
CELG,CELG:UW,BBG000BFCMR2,September Could be Kind to Biotechnology ETFs,2017-08-29 15:04:43 +0000,https://finance.yahoo.com/news/september-could-kind-biotechnology-etfs-150443283.html?.tsrc=rss,"The iShares Nasdaq Biotechnology ETF (NASDAQGM:  IBB ) , the largest biotechnology exchange traded fund by assets, is up nearly 18% and the behemoth biotech fund could add to those gains in September. ..."
CELG,CELG:UW,BBG000BFCMR2,Here's What Else Gilead Sciences Gets by Buying Kite Pharma,2017-08-29 12:50:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BdXLCWNSpPw/heres-what-else-gilead-sciences-gets-by-buying-kite-pharma-cm838305,Gilead Sciences NASDAQ GILD planned 11 9 billion acquisition of Kite Pharma NASDAQ KITE nets it axi cel a CAR T therapy that s already under FDA review However axi cel isn t the only intriguing therapy in development at Kite Pharma Gilead Sciences also gets its
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-08-29 12:03:06 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120306272.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,Biotech Stocks Facing FDA Decision In September,2017-08-29 08:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eLoYmPQkXWM/biotech-stocks-facing-fda-decision-in-september-20170829-00502,Biotech Stocks Facing FDA Decision In September
CELG,CELG:UW,BBG000BFCMR2,Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today,2017-08-28 19:02:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uLI9r9YemOs/why-bluebird-bio-inc-and-juno-therapeutics-inc-shot-higher-today-cm838108,What happened bluebird bio NASDAQ BLUE is up 9 5 and Juno Therapeutics NASDAQ JUNO is up 17 at 12 40 p m EDT Monday Both appear to be riding the coattails of fellow immuno oncology drug developer Kite Pharma NASDAQ KITE which is being acquired by
CELG,CELG:UW,BBG000BFCMR2,Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today,2017-08-28 17:40:00 +0000,http://finance.yahoo.com/r/de897895-c983-3d25-a84a-15080e096c7e/why-bluebird-bio-inc-and-juno-therapeutics-inc-sho.aspx?yptr=yahoo&.tsrc=rss,The biotechs&apos; surge is related to a big move for fellow immuno-oncology drug developer Kite Pharma.
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics: Celgene's Next Target?,2017-08-28 15:09:00 +0000,http://finance.yahoo.com/r/39ba05ae-4932-36e0-b959-172c830ea6b8/juno-therapeutics-celgenes-next-target-1503932949?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"As is typical following announcements of an acquisition, companies conducting research similar to Kite Pharma (KITE) have popped after Gilead Sciences' (GILD) announcement that it had agreed to the CAR-T ..."
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-08-28 12:01:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120304423.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,Why You Can Back Up the Truck and Load Up on This Biotech Stock,2017-08-27 13:09:00 +0000,http://finance.yahoo.com/r/f5b2d60e-dad5-3c94-a8fb-50eaa60a77db/why-you-can-back-up-the-truck-and-load-up-on-this.aspx?yptr=yahoo&.tsrc=rss,Celgene&apos;s bright prospects make the biotech stock a bargain right now that investors shouldn&apos;t pass up.
CELG,CELG:UW,BBG000BFCMR2,Consider This Before You Buy Biogen,2017-08-27 12:01:00 +0000,http://finance.yahoo.com/r/56dc560a-f1bc-34e4-a5ad-15262c996ca5/consider-this-before-you-buy-biogen.aspx?yptr=yahoo&.tsrc=rss,New drugs that compete against Biogen&apos;s franchise of top-selling multiple sclerosis medicine pose a threat to Biogen&apos;s revenue.
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Can’t Make Up Their Minds on Major Biotechs,2017-08-25 14:10:26 +0000,https://finance.yahoo.com/news/short-sellers-t-minds-major-141026173.html?.tsrc=rss,"The August 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed."
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Webcast at Upcoming Investor Conferences,2017-08-24 11:30:00 +0000,https://finance.yahoo.com/news/celgene-corporation-webcast-upcoming-investor-113000461.html?.tsrc=rss,Celgene Corporation plans to present at four upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com.
CELG,CELG:UW,BBG000BFCMR2,3 Biopharma Picks for Big Rewards with Less Risk,2017-08-23 23:38:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mYt6GBw1neM/3-biopharma-picks-for-big-rewards-with-less-risk-cm836271,InvestorPlace Stock Market News Stock Advice amp Trading Tips Investors may initially shy away from biopharma companies given the complexity of the science behind the treatments After all a company s stock will only do as well as their treatments pass FDA hurdles and are
CELG,CELG:UW,BBG000BFCMR2,"Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells Centene ...",2017-08-23 22:37:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8srIcgQhMh4/orbimed-advisors-llc-buys-cigna-corp-clovis-oncology-inc-gilead-sciences-inc-sells-centene-cm836259,Orbimed Advisors Llc New Purchases CI CLVS EVHC JUNO IOVA IART CTIC NVUS ARGX VRNA Added Positions GILD MYL BIIB ALNY REGN CELG IMMU JNJ GBT NVRO Reduced Positions HCA PFE SHPG BMY AET INCY IRWD BMRN AGN BSX Sold Out CNC
CELG,CELG:UW,BBG000BFCMR2,"3 Stocks to Watch on Wednesday: Intuit Inc. (INTU), Salesforce.com, Inc. (CRM) and Wells Fargo & Co (WFC)",2017-08-23 16:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3piSlvKe__4/3-stocks-to-watch-on-wednesday-intuit-inc-intu-salesforcecom-inc-crm-and-wells-fargo-co-wfc-cm836046,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock markets roared ahead Tuesday on a day of light trading that saw tech stocks post a 1 5 bid The 160 S amp P 500 Index 160 gained 1 1 the 160 Dow Jones Industrial Average grew 0 9
CELG,CELG:UW,BBG000BFCMR2,Key Developments for Allergan in 2Q17,2017-08-23 13:07:03 +0000,http://finance.yahoo.com/r/4218f96d-aa02-3a03-87ef-cc660c3ad5eb/key-developments-for-allergan-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Allergan (AGN) is a leading pharmaceuticals company involved with pharmaceuticals, over-the-counter products, eye care, and aesthetics products."
CELG,CELG:UW,BBG000BFCMR2,Trade of the Day: Celgene Corporation (CELG) Stock Flashing Buy Signals,2017-08-23 11:45:54 +0000,https://finance.yahoo.com/news/trade-day-celgene-corporation-celg-114554771.html?.tsrc=rss,"From a trend perspective, the IBB and thus many large cap biotech firms including CELG stock remain both long-term and medium-term bullish.  On the multiyear chart, we see that CELG stock remains trending higher but in recent months has struggled to overcome its previous all-time highs from July 2015.  In other words, what I am looking for in CELG stock in coming weeks or months is a strong bullish reversal on a weekly closing basis, possibly followed by another week of follow-through buying to confirm that the stock may be ready for a renewed leg higher to new all-time highs."
CELG,CELG:UW,BBG000BFCMR2,ETF Topper: Biotechnology Isn't Totally on the Outs,2017-08-22 21:29:00 +0000,http://finance.yahoo.com/r/3e7342d6-43f8-3f07-8edb-cf07ee16b19c/etf-topper-biotechnology-isnt-totally-on-the-outs-1503437394?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Technology stocks led the S&P 500 on Tuesday, but in exchange-traded fund land, those tracking biotech stocks were the real winners. The SPDR S&P Biotech ETF (XBI) and First Trust NYSE Arca Biotechnology ..."
CELG,CELG:UW,BBG000BFCMR2,What&apos;s the Most Important Drug in Regeneron Pharmaceuticals&apos; Pipeline?,2017-08-22 19:20:00 +0000,http://finance.yahoo.com/r/f55cea7a-9b9a-3d55-976d-aac7a1741ae3/whats-the-most-important-drug-in-regeneron-pharmac.aspx?yptr=yahoo&.tsrc=rss,"Regeneron Pharmaceuticals has a slew of clinical trials going on, and studies evaluating REGN-2810 could be the most important."
CELG,CELG:UW,BBG000BFCMR2,3 Growth Stocks for Retirees,2017-08-22 12:10:00 +0000,http://finance.yahoo.com/r/3d8188b3-6326-386c-ba89-ea24aa0df2ed/3-growth-stocks-for-retirees.aspx?yptr=yahoo&.tsrc=rss,You don&apos;t need to take on a ton of risk to be a growth investor.
CELG,CELG:UW,BBG000BFCMR2,3 Large-Cap Biotech Stocks to Scrape From the Selloff,2017-08-21 19:40:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UUlOW0nOoMs/3-large-cap-biotech-stocks-to-scrape-from-the-selloff-cm834953,InvestorPlace Stock Market News Stock Advice amp Trading Tips The broader markets finished lower for a second straight week and are showing sure signs of their age after a raging eight year bull run With large cap biotech stocks 160 just emerging from bear market corrections
CELG,CELG:UW,BBG000BFCMR2,Monday's ETF with Unusual Volume: BBH,2017-08-21 18:38:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R-oiXcoVdjI/mondays-etf-with-unusual-volume-bbh-cm834883,The Biotech ETF BBH is seeing unusually high volume in afternoon trading Monday with over 115 000 shares traded versus three month average volume of about 32 000 Shares of BBH were up about 0 4 on the day Components of that ETF with the highest volume on Monday were Gilead
CELG,CELG:UW,BBG000BFCMR2,iShares Russell 1000 Growth ETF Experiences Big Outflow,2017-08-21 16:41:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tJjDwB7nqyg/ishares-russell-1000-growth-etf-experiences-big-outflow-cm834747,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Growth ETF Symbol IWF where we have detected an approximate 48 2 million dollar outflow that s a 0 1 decrease week over week
CELG,CELG:UW,BBG000BFCMR2,"Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells Centene ...",2017-08-18 19:37:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/quy__G9HnE0/orbimed-advisors-llc-buys-cigna-corp-clovis-oncology-inc-gilead-sciences-inc-sells-centene-cm834160,Orbimed Advisors Llc New Purchases CI CLVS EVHC JUNO IOVA IART CTIC NVUS ARGX VRNA Added Positions GILD MYL BIIB ALNY REGN CELG IMMU JNJ GBT NVRO Reduced Positions HCA PFE SHPG BMY AET INCY IRWD BMRN AGN BSX Sold Out CNC
CELG,CELG:UW,BBG000BFCMR2,Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?,2017-08-18 04:36:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cw1WH4bohLE/is-regeneron-pharmaceuticals-the-best-biotech-stock-to-buy-cm833693,It may not get the attention as often as larger cap biotech stocks like Celgene Corp NASDAQ CELG and Gilead Sciences NASDAQ GILD but a bunch of recent drug approvals could soon change that for Regeneron Pharmaceuticals NASDAQ REGN Is Regeneron Pharmaceuticals
CELG,CELG:UW,BBG000BFCMR2,Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?,2017-08-18 02:36:00 +0000,http://finance.yahoo.com/r/93bffcb7-4356-36dd-81f2-59ea67bd56ad/is-regeneron-pharmaceuticals-the-best-biotech-stoc.aspx?yptr=yahoo&.tsrc=rss,"With a slate of promising drugs hitting the market and in its development pipeline, Regeneron Pharmaceuticals is becoming one of biotechs most important players."
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Thursday Option Activity: ALGN, CELG, CB",2017-08-17 19:41:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BIk6gUNq3Q4/noteworthy-thursday-option-activity-algn-celg-cb-cm833501,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Align Technology Inc Symbol ALGN where a total volume of 4 688 contracts has been traded thus far today a contract volume which is representative of approximately 468
CELG,CELG:UW,BBG000BFCMR2,Stock Losses Top 1%; These Stocks Hit Sell Signals,2017-08-17 17:36:32 +0000,http://finance.yahoo.com/r/c4e8d884-88b7-396b-8ef5-b85b2bc3572a/stock-losses-top-1-these-stocks-hit-sell-signals?src=A00220&yptr=yahoo&.tsrc=rss,"The major indexes traded at session lows Thursday afternoon, as the stock market&apos;s complexion worsened."
CELG,CELG:UW,BBG000BFCMR2,The 3 Best Stocks in Healthcare,2017-08-17 13:03:00 +0000,http://finance.yahoo.com/r/6d995e84-ff4d-395d-95ed-734247228a48/the-3-best-stocks-in-healthcare.aspx?yptr=yahoo&.tsrc=rss,"Why Align Technology, Celgene, and Vertex stand at the top of all healthcare stocks."
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-08-17 12:03:07 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120507455.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,Biogen: Goldman Has Conviction!,2017-08-16 14:08:00 +0000,http://finance.yahoo.com/r/7b7787d2-935f-3328-9c2a-a0daa604d2bf/biogen-goldman-has-conviction-1502892539?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Biogen (BIIB) has had a good, though not great year. Is it time to add it to your portfolio? Shares of Biogen have gained 11.5% so far this year, and while that's better than the S&P 500's 10.3% rise during ..."
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Regeneron Drops RSV Antibody, Gilead HIV Drug Gets Priority Review",2017-08-16 13:39:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FDwjiDI9TQI/biotech-stock-roundup-regeneron-drops-rsv-antibody-gilead-hiv-drug-gets-priority-review-cm832739,With earnings season drawing to a close focus is back on pipeline and regulatory updates While Regeneron Pharmaceuticals REGN which has several pipeline catalysts lined up for the second half of the year reported data on one of its late stage pipeline candidates Gilead Sciences GILD
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-08-16 12:02:47 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120451725.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,Why I Love Celgene Corporation,2017-08-15 12:04:00 +0000,http://finance.yahoo.com/r/3e9e58f3-546d-3031-877c-9550f6ba8f97/why-i-love-celgene-corporation.aspx?yptr=yahoo&.tsrc=rss,"How do I love thee, Celgene? Let me count the ways."
CELG,CELG:UW,BBG000BFCMR2,Pfizer’s Declining-Revenue Products in 2Q17,2017-08-15 11:36:43 +0000,http://finance.yahoo.com/r/6a6eb8be-826d-366f-89b1-e22fdcc5e854/pfizers-declining-revenue-products-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,We discussed the products that contribute to the growth of Pfizer’s (PFE) revenues in 2Q17. Let's now take a look at the products that have impacted revenue growth in 2Q17.
CELG,CELG:UW,BBG000BFCMR2,3 Stocks for Retirees to Grow Their Nest Egg,2017-08-15 00:41:00 +0000,http://finance.yahoo.com/r/397ceae0-5e1a-3e3a-996e-0a80c792e19f/3-stocks-for-retirees-to-grow-their-nest-egg.aspx?yptr=yahoo&.tsrc=rss,Don&apos;t let retirement stop you from putting your money to work.
CELG,CELG:UW,BBG000BFCMR2,"ETFs with exposure to Celgene Corp. : August 14, 2017",2017-08-14 20:18:44 +0000,http://finance.yahoo.com/r/198d8a44-2f00-3c63-ba91-f486af0fe705/etfs-with-exposure-to-celgene-corp-august-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celgene Corp. Here are 5 ETFs with the largest exposure to CELG-US. Comparing the performance and risk of Celgene Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,3 'Strong Buy' Biotech Stocks You Should Watch,2017-08-14 12:55:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J21ybI75RXE/3-strong-buy-biotech-stocks-you-should-watch-cm831519,"The volatile biotech sector is rebounding with attractive stock valuations and renewed political confidence. Investors believe that President Trump is unlikely to introduce tough controls on drug prices, and could even streamline the lengthy drug-approval process by the Food & Drug Administration (FDA). We can see"
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-08-14 12:05:04 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120504995.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,"Bb Biotech Ag Buys AveXis Inc, Sells Regeneron Pharmaceuticals Inc, Puma Biotechnology Inc, PTC ...",2017-08-12 15:34:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UVUjaV_SnhA/bb-biotech-ag-buys-avexis-inc-sells-regeneron-pharmaceuticals-inc-puma-biotechnology-inc-ptc-cm831321,Bb Biotech Ag Added Positions RDUS ALXN NBIX TSRO HALO AVXS ESPR ALDR ITCI VRTX Reduced Positions REGN CELG KITE SAGE IONS ALNY Sold Out PBYI PTCT Added Positions RDUS ALXN NBIX TSRO HALO AVXS ESPR ALDR
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-08-12 12:03:57 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120357903.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,Edited Transcript of CELG earnings conference call or presentation 27-Jul-17 1:00pm GMT,2017-08-12 01:06:07 +0000,https://finance.yahoo.com/news/edited-transcript-celg-earnings-conference-123049346.html?.tsrc=rss,Q2 2017 Celgene Corp Earnings Call
CELG,CELG:UW,BBG000BFCMR2,"Green Valley Investors Llc Buys The Kraft Heinz Co, Exact Sciences Corp, O'Reilly Automotive ...",2017-08-11 15:34:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0e1gP5hXpxk/green-valley-investors-llc-buys-the-kraft-heinz-co-exact-sciences-corp-oreilly-automotive-cm830970,Green Valley Investors Llc New Purchases EXAS Added Positions KHC ORLY UNH NKE MD Reduced Positions GILD ESRX IFF CELG AMZN DHR LKQ JNJ DIS ABT Sold Out AGN New Purchases EXAS New Purchases EXAS Added Positions
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bearish Manner : CELG-US : August 11, 2017",2017-08-11 14:17:20 +0000,http://finance.yahoo.com/r/1c796507-44c9-3364-82ca-335ba6c3fded/celgene-corp-breached-its-50-day-moving-average-in-a-bearish-manner-celg-us-august-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Celgene Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,Luspatercept: Opportunity for Celgene’s Long-Term Growth?,2017-08-11 13:06:04 +0000,http://finance.yahoo.com/r/1273d6bf-e79c-3769-aaf6-35adf89dc808/luspatercept-opportunity-celgenes-long-term-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Celgene and Acceleron are conducting the Phase 3 MEDALIST trial to evaluate the safety and efficacy of luspatercept in individuals with ring sideroblasts.
CELG,CELG:UW,BBG000BFCMR2,"Fcg Advisors, Llc Buys Celgene Corp, Guggenheim BulletShares 2019 Corporate Bond, PowerShares ...",2017-08-11 12:34:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ls0_4Mw8irQ/fcg-advisors-llc-buys-celgene-corp-guggenheim-bulletshares-2019-corporate-bond-powershares-cm830751,Fcg Advisors Llc New Purchases BSCJ SPLV VTI SDY VB CSJ VEU HYG LQD DPLO Added Positions CELG XOM AAPL QQQ VGK BSCK MSFT FRME VWO VTV Reduced Positions IVE ADP IWD VOE IWP IDXX KO MMM VZ IWO Sold Out MKL DVMT IYF
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-08-11 12:03:55 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120300189.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,Ozanimod Could Drive Celgene’s Long-Term Growth,2017-08-11 11:36:04 +0000,http://finance.yahoo.com/r/9d40c045-5dc0-3d38-8b13-e04e23d5554f/ozanimod-drive-celgenes-long-term-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"The Phase 3 RADIANCE trial enrolled 1,313 RMS patients and conducted the trial in 21 countries."
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Abraxane Continued Steady Growth in 2Q17,2017-08-10 14:36:47 +0000,http://finance.yahoo.com/r/448fd9d5-26f8-3ac4-9c3d-fd38266bf2bb/celgenes-abraxane-continued-steady-growth-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Celgene’s (CELG) Abraxane generated revenues of around $254 million, which reflected ~2% growth on a year-over-year basis."
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Otezla Witnessed High Revenue Growth in 2Q17,2017-08-10 13:07:27 +0000,http://finance.yahoo.com/r/8fcb1437-8b38-34a4-b963-f6c506b0a45d/celgenes-otezla-witnessed-high-revenue-growth-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Celgene’s (CELG) Otezla generated revenues of around $358 million, which reflected ~49% growth on a year-over-year basis."
CELG,CELG:UW,BBG000BFCMR2,Major Biotechs Send Short Sellers Running for Cover,2017-08-10 12:50:59 +0000,https://finance.yahoo.com/news/major-biotechs-send-short-sellers-125059580.html?.tsrc=rss,"The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased."
CELG,CELG:UW,BBG000BFCMR2,How 2 biotech partners reimagined cancer pact — and made it work again for both,2017-08-10 12:20:13 +0000,http://finance.yahoo.com/r/2fecfbca-e0b1-34a5-9662-a2bfaccf13fe/sutro-biopharma-celgene-celg-cancer-immunotherapy.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Biotech giant Celgene Corp. and Sutro Biopharma Inc. reworked a three-year-old cancer drug development deal, the companies said Thursday, that gives a little more cash and a lot more flexibility.  Under the rejiggered plan, Celgene (CELG) won't have an option to buy 130-employee, South San Francisco-based Sutro — like it did in the 2014 pact — but will pay for an option for the second of four ongoing programs within the collaboration.  Celgene already has an option for one program that it hasn't yet exercised."
CELG,CELG:UW,BBG000BFCMR2,"IHS Markit Score downgrades Celgene Corp to 60 out of 100, ranking positively in only one out of three available IHS Markit categories.",2017-08-10 12:04:04 +0000,https://finance.yahoo.com/news/ihs-markit-score-downgrades-celgene-120301561.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,How Celgene’s Pomalyst Is Positioned after 2Q17,2017-08-10 11:37:33 +0000,http://finance.yahoo.com/r/b2f9a0f6-f27a-3127-82e7-ffe47cfa044f/celgenes-pomalyst-positioned-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Celgene’s (CELG) Pomalyst generated revenues of ~$391 million, which reflected ~23% growth on a year-over-year basis."
CELG,CELG:UW,BBG000BFCMR2,[$$] Sutro Biopharma Reworks Immuno-Oncology Alliance With Celgene,2017-08-10 11:30:04 +0000,http://finance.yahoo.com/r/5887e720-86d9-3e80-b049-85b9f9c30813/sutro-biopharma-reworks-immuno-oncology-alliance-with-celgene-1502364601?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Sutro Biopharma has reworked an immuno-oncology alliance with Celgene Corp. that originally gave Celgene an option to acquire the company.
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Revlimid Witnessed High Growth in 2Q17,2017-08-09 20:05:43 +0000,http://finance.yahoo.com/r/cf5d3eed-98ac-345f-a2f3-01f2b5606788/celgenes-revlimid-witnessed-high-growth-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Celgene’s (CELG) Revlimid generated revenues of ~$2.0 billion, which reflected ~20% growth year-over-year and ~8% growth quarter-over-quarter."
CELG,CELG:UW,BBG000BFCMR2,How Celgene Performed in 2Q17,2017-08-09 18:36:00 +0000,http://finance.yahoo.com/r/4590d37d-74d8-37e8-96cf-f78c29b8283f/celgene-performed-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Celgene updated its adjusted diluted EPS from $7.15–$7.30 to $7.25–$7.35 and its adjusted operating margin from about 57.0%–57.5%.
CELG,CELG:UW,BBG000BFCMR2,"Agios (AGIO) Q2 Loss Wider than Expected, Revenues Up Y/Y",2017-08-09 17:36:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mb1FATF_nWg/agios-agio-q2-loss-wider-than-expected-revenues-up-yy-cm829621,Agios Pharmaceuticals Inc AGIO posted second quarter 2017 loss of 1 78 per share wider than both the Zacks Consensus Estimate of a loss of 1 52 and the year ago loss of 1 47 Agios shares have significantly outperformed the industry so far this year The company s shares have
CELG,CELG:UW,BBG000BFCMR2,Analysts’ Recommendations for Celgene in August 2017,2017-08-09 17:02:23 +0000,http://finance.yahoo.com/r/2d54cc01-3307-30c2-94bb-d9937bd485a9/analysts-recommendations-celgene-august-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 27 analysts covering Celgene (CELG) in August 2017, 12 analysts recommended a “strong buy,” and ten analysts recommended a “buy.”"
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Q2 Earnings from Regeneron, Kite & More, FibroGen Up on IPF Data",2017-08-09 14:40:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/--rt8-jvMo4/biotech-stock-roundup-q2-earnings-from-regeneron-kite-more-fibrogen-up-on-ipf-data-cm829359,Regeneron REGN and several mid and small cap biotech stocks reported earnings results while companies like Dynavax DVAX and AbbVie ABBV provided regulatory updates Recap of the Week s Most Important Stories A Look at Earnings Results Regeneron reported a strong quarter with
CELG,CELG:UW,BBG000BFCMR2,"Ray Gerald L & Associates Ltd Buys Norfolk Southern Corp, Splunk Inc, ONEOK Inc, Sells ...",2017-08-09 14:34:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u2Ds6fZrzbE/ray-gerald-l-associates-ltd-buys-norfolk-southern-corp-splunk-inc-oneok-inc-sells-cm829415,Ray Gerald L Associates Ltd New Purchases OKE AABA XBI CSJ DXCM TWLO ALB CNI DDS XLRN Added Positions NSC SPLK TXN HEDJ HHC QCOM USB GILD PANW VGK Reduced Positions GE CSCO MDT DVN PFE KMI AMGN CL EEP CVS Sold Out OKS
CELG,CELG:UW,BBG000BFCMR2,Why BeiGene Soared 56.6% In July,2017-08-09 13:37:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7u-8spsdnHo/why-beigene-soared-566-in-july-cm829254,What happened After inking a collaboration agreement with biotech powerhouse Celgene NASDAQ CELG shares in BeiGene Ltd NASDAQ BGNE rocketed 56 6 higher last month 160 according to S amp P Global Market Intelligence So what Celgene
CELG,CELG:UW,BBG000BFCMR2,Is This Why bluebird bio Dipped 10.5% in July?,2017-08-09 13:37:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sMHrFaHItLw/is-this-why-bluebird-bio-dipped-105-in-july-cm829239,What happened bluebird bio NASDAQ BLUE a clinical stage biotech focused on gene 160 therapy fell more than 10 in July according to S amp P Global Market Intelligence However there wasn t any news released during the month that can help to explain the double digit
CELG,CELG:UW,BBG000BFCMR2,Is This Why bluebird bio Dipped 10.5% in July?,2017-08-09 12:18:00 +0000,http://finance.yahoo.com/r/14933c1b-ed73-352e-b4a6-1b7709a49301/is-this-why-bluebird-bio-dipped-105-in-july.aspx?yptr=yahoo&.tsrc=rss,"It was a quiet month for the clinical-stage biotech, but that didn&apos;t stop its share price from dropping by double digits."
CELG,CELG:UW,BBG000BFCMR2,Biotech Breakouts Suggest It Is Time to Buy,2017-08-09 12:08:00 +0000,http://finance.yahoo.com/r/9eedf4cb-1823-3f31-8eb3-9c7f6693bafe/biotech-breakouts-suggest-it-time-buy?partner=YahooSA&yptr=yahoo&.tsrc=rss,Bullish chart patterns on key biotech names are presenting traders with the best risk/reward setup of 2017.
CELG,CELG:UW,BBG000BFCMR2,See what the IHS Markit Score report has to say about Celgene Corp.,2017-08-09 12:03:00 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120300461.html?.tsrc=rss,Celgene Corp NASDAQ/NGS:CELG
CELG,CELG:UW,BBG000BFCMR2,Why BeiGene Soared 56.6% In July,2017-08-09 12:01:00 +0000,http://finance.yahoo.com/r/fda31e6c-d12c-3c17-82a0-5dd7e141510a/why-beigene-soared-566-in-july.aspx?yptr=yahoo&.tsrc=rss,The company inked a trans-formative deal with biotech behemoth Celgene last month.
CELG,CELG:UW,BBG000BFCMR2,Agios (AGIO) Q2 Loss Wider than Expected; Sales Miss,2017-08-08 13:12:01 +0000,https://finance.yahoo.com/news/agios-agio-q2-loss-wider-131201799.html?.tsrc=rss,"Agios (AGIO) posted wider-than-expected loss in the second quarter of 2017. Revenues also came below expectations. However, revenues increased significantly year-over-year."
CELG,CELG:UW,BBG000BFCMR2,Here's Why Array BioPharma Inc. Fell 13.7% in July,2017-08-07 21:36:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s9STc1HU2IA/heres-why-array-biopharma-inc-fell-137-in-july-cm828363,What happened Shares of Array BioPharma NASDAQ ARRY a cancer focused clinical stage biotech dropped nearly 14 in July according to data from S amp P Global Market Intelligence So what Here s a review of the two company announcements made during the
CELG,CELG:UW,BBG000BFCMR2,bluebird bio Pauses During 2017 Data Blitz,2017-08-07 20:37:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U8of2spDxMI/bluebird-bio-pauses-during-2017-data-blitz-cm828320,Clinical stage gene therapy specialist bluebird bio NASDAQ BLUE reported 160 second quarter earnings last week which mostly just served as a reminder of its pipeline progress because revenue and earnings are essentially meaningless at this point for the biotech company For
CELG,CELG:UW,BBG000BFCMR2,bluebird bio Pauses During 2017 Data Blitz,2017-08-07 19:20:00 +0000,http://finance.yahoo.com/r/e101ee51-ee70-3bb3-81b5-a5a7057fa0ac/bluebird-bio-inc-pauses-during-2017-data-blitz.aspx?yptr=yahoo&.tsrc=rss,"With the ASCO and EHA conferences behind it, the biotech looks to ASH to end the year with a bang."
CELG,CELG:UW,BBG000BFCMR2,"Benzinga's Bulls & Bears For The Past Week: Apple, Tesla, Twitter And More",2017-08-06 19:50:37 +0000,https://finance.yahoo.com/news/benzingas-bulls-bears-past-week-195037225.html?.tsrc=rss,Benzinga has featured a look at many investor favorite stocks over the past week. Bullish calls included a look at the iPhone maker and at a top biotech. Bearish calls featured the leading electric vehicle ...
CELG,CELG:UW,BBG000BFCMR2,Celgene vs. Gilead Sciences: Who Reported Better Earnings?,2017-08-04 23:00:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FeKwT2zbOYg/celgene-vs-gilead-sciences-who-reported-better-earnings-cm827602,Celgene Corp NASDAQ CELG and Gilead Sciences NASDAQ GILD reported second quarter earnings that were better than industry watchers forecasts but these two giants circumstances are very different While Celgene is racking up substantial growth for its top selling
CELG,CELG:UW,BBG000BFCMR2,Celgene vs. Gilead Sciences: Who Reported Better Earnings?,2017-08-04 21:04:00 +0000,http://finance.yahoo.com/r/63e27f27-edf6-3fa1-8145-f35be590aa20/celgene-vs-gilead-sciences-who-reported-better-ear.aspx?yptr=yahoo&.tsrc=rss,"Celgene&apos;s and Gilead Sciences’ Q2 2017 results are fueling gains in their stock prices, but is one of these stocks doing better than the other?"
CELG,CELG:UW,BBG000BFCMR2,3 Value Stocks for Every Investor,2017-08-04 19:01:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5tGXYBpDt14/3-value-stocks-for-every-investor-cm827456,Think fast Which type of stock offers you the best long term appreciation prospects If you said value stocks give yourself a pat on the back According to a 2016 analysis from Bank of America Merrill Lynch that examined growth stocks versus value stocks between 1926 and
CELG,CELG:UW,BBG000BFCMR2,3 Value Stocks for Every Investor,2017-08-04 17:21:00 +0000,http://finance.yahoo.com/r/8e523456-3def-3274-aff9-2ca42933d3e9/3-value-stocks-for-every-investor.aspx?yptr=yahoo&.tsrc=rss,Buying-and-holding cheap stocks over the long-term is a proven method to grow your wealth.
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics' Cash Position and Potential Cash Cow JCAR017 Are Still What's Important,2017-08-04 00:00:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l16rarK2VpU/juno-therapeutics-cash-position-and-potential-cash-cow-jcar017-are-still-whats-important-cm826942,It s been a pretty good year for Juno Therapeutics NASDAQ JUNO so far The clinical stage biotech s share price is up more than 50 year to date Its financial position in the first quarter looked great thanks to its collaboration with Celgene NASDAQ CELG And at
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics&apos; Cash Position and Potential Cash Cow JCAR017 Are Still What&apos;s Important,2017-08-03 22:34:00 +0000,http://finance.yahoo.com/r/559936ee-2565-324c-8825-79da8d385cd7/premium-juno-therapeutics-cash-position-and-potent.aspx?yptr=yahoo&.tsrc=rss,The clinical-stage biotech is sitting on a sizeable pile of cash to fund development of its promising cancer treatment.
CELG,CELG:UW,BBG000BFCMR2,"440 Investment Group, Llc Buys Procter & Gamble Co, UnitedHealth Group Inc, 3M Co, Sells ...",2017-08-03 13:58:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kixYCMA8vwk/440-investment-group-llc-buys-procter-gamble-co-unitedhealth-group-inc-3m-co-sells-cm826367,440 Investment Group Llc New Purchases FB AMZN NOW GIS TTC GOOG AGN QCOM AOBC PCLN Added Positions PG UNH MMM GE WFC PFE JPM GOOGL XOM DIS Reduced Positions SPY CVX KSU UTX SBUX TMO KEY CELG PNC CTSH Sold Out CBI NEM
CELG,CELG:UW,BBG000BFCMR2,Looking to Buy Some Celgene? Now's a Good Time,2017-08-03 13:25:00 +0000,http://finance.yahoo.com/r/ea49706f-1706-3af3-9082-011a3c51885f/looking-buy-some-celgene-nows-good-time?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"CELG looks like it has a promising future, according to the charts."
CELG,CELG:UW,BBG000BFCMR2,Celgene CEO: Time to think about health care in a differe...,2017-08-03 12:24:00 +0000,https://finance.yahoo.com/video/celgene-ceo-time-think-health-122400547.html?.tsrc=rss,"Mark Alles, Celgene CEO, talks about the importance of forming a partnership between innovators and insurance companies in order to provide patients with access to precision medicines."
CELG,CELG:UW,BBG000BFCMR2,Celgene CEO: Precision medicine targeting metabolic drive...,2017-08-03 12:15:00 +0000,https://finance.yahoo.com/video/celgene-ceo-precision-medicine-targeting-121500066.html?.tsrc=rss,"Mark Alles, Celgene CEO, talks about gaining FDA approval for a drug that targets a lethal form of leukemia and discusses the importance of getting patients access to precision medicines."
CELG,CELG:UW,BBG000BFCMR2,Op-Ed: Getting patients access to &apos;precision&apos; medicines is crucial,2017-08-03 10:00:00 +0000,https://finance.yahoo.com/news/op-ed-getting-patients-access-100000677.html?.tsrc=rss,"&quot;Precision&quot; medicines can be highly effective in treating serious diseases like cancer, explains Celgene CEO Mark Alles."
CELG,CELG:UW,BBG000BFCMR2,Op-Ed: Getting patients access to 'precision' medicines is crucial,2017-08-03 10:00:00 +0000,http://finance.yahoo.com/r/cfdd6b55-ea28-36d4-8960-7b8577f97756/104627486?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104627486&yptr=yahoo&.tsrc=rss,"""Precision"" medicines can be highly effective in treating serious diseases like cancer, explains Celgene CEO Mark Alles."
CELG,CELG:UW,BBG000BFCMR2,"Davis-Rea Ltd. Buys Goldman Sachs Group Inc, Apple Inc, Manulife Financial Corp",2017-08-03 09:54:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1a3CQOKpmV8/davis-rea-ltd-buys-goldman-sachs-group-inc-apple-inc-manulife-financial-corp-cm826215,Davis Rea Ltd New Purchases GS MFC Added Positions AAPL AMZN FB COT CERN BIP SWK BMO BHP SU Reduced Positions GOOGL C MSFT New Purchases GS MFC New Purchases GS MFC Added Positions AAPL AMZN FB COT
CELG,CELG:UW,BBG000BFCMR2,3 Reasons the Best Is Yet to Come for Celgene,2017-08-03 02:54:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T88UgkLb6BU/3-reasons-the-best-is-yet-to-come-for-celgene-cm826180,Celgene Corp s NASDAQ CELG second quarter revenue and sales came in nearly 50 higher than they were two short years ago yet the company doesn t appear to be anywhere near peaking A flurry of R amp D activity should provide it with a steady stream of label expansion and new
CELG,CELG:UW,BBG000BFCMR2,"Gainers & Losers Of Aug.2: ONCE, ILMN, XENT, NOVN, FLKS...",2017-08-02 22:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9F0Ot6PnVn8/gainers--losers-of-aug2-once-ilmn-xent-novn-flks-20170802-02061,"Gainers & Losers Of Aug.2: ONCE, ILMN, XENT, NOVN, FLKS..."
CELG,CELG:UW,BBG000BFCMR2,This Small Biotech Launched To A 9-Month High Today — Here&apos;s Why,2017-08-02 20:07:58 +0000,http://finance.yahoo.com/r/697b0ec3-080c-3fcd-8d0c-1dccfaf17062/this-small-biotech-launched-to-a-9-month-high-today-heres-why?src=A00220&yptr=yahoo&.tsrc=rss,Agios launched to a nine-month high Wednesday after the FDA approved its blood cancer drug — a development that bodes well for a similar medicine in its pipeline.
CELG,CELG:UW,BBG000BFCMR2,"Corcept (CORT) Q2 Earnings Beat Estimates, Guidance Raised",2017-08-02 17:00:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Li-Pjlf1kMM/corcept-cort-q2-earnings-beat-estimates-guidance-raised-cm825879,Corcept Therapeutics Incorporated s CORT adjusted second quarter 2017 earnings including stock based compensation expense of 10 cents per share surpassed the Zacks Consensus Estimate of 8 cents 160 The reported figure also topped the year ago adjusted earnings of 1 cent Revenues
CELG,CELG:UW,BBG000BFCMR2,iShares S&P 500 Growth ETF Experiences Big Outflow,2017-08-02 16:53:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zKFSvQQDwj4/ishares-sp-500-growth-etf-experiences-big-outflow-cm825790,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Growth ETF Symbol IVW where we have detected an approximate 105 5 million dollar outflow that s a 0 6 decrease week over week
CELG,CELG:UW,BBG000BFCMR2,"Kelly Lawrence W & Associates Inc Buys Under Armour Inc, Allergan PLC, Alkermes PLC, Sells ...",2017-08-02 14:54:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F8h2nrPhYps/kelly-lawrence-w-associates-inc-buys-under-armour-inc-allergan-plc-alkermes-plc-sells-cm825727,Kelly Lawrence W Associates Inc New Purchases UAA ETP Added Positions AGN ALKS DLPH BR CHKP CFG REGN COF ROP BFAM Reduced Positions IBM GILD SLB CFX AMAT MMM PEP AAPL JNJ CVX Sold Out 4ETA AIG MET WEC GIS PCG PXD GLD DD
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Q2 Earnings from Gilead, CELG & More, Dynavax Up on Panel Vote",2017-08-02 12:32:12 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-q2-earnings-123212689.html?.tsrc=rss,Companies like Gilead (GILD) topped expectations in the second quarter while Dynavax shot up on a positive FDA advisory panel vote.
CELG,CELG:UW,BBG000BFCMR2,Earnings Preview: What To Expect From Regeneron Pharmaceuticals On Thursday,2017-08-02 12:00:00 +0000,http://finance.yahoo.com/r/07e95ea8-26c0-3f0f-aba6-0b9dacd72023/earnings-preview-what-to-expect-from-regeneron-pharmaceuticals-on-thursday?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Regeneron is expected to report earnings of $3.15 per share on $1.36 billion in revenue. Meanwhile, the so-called Whisper number is $3.29."
CELG,CELG:UW,BBG000BFCMR2,"FDA Nod For AGIO's IDHIFA, BMY Expands Opdivo Use, OCUL Reduces Headcount",2017-08-02 02:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NKjz_8xnheE/fda-nod-for-agios-idhifa-bmy-expands-opdivo-use-ocul-reduces-headcount-20170802-00079,"FDA Nod For AGIO's IDHIFA, BMY Expands Opdivo Use, OCUL Reduces Headcount"
CELG,CELG:UW,BBG000BFCMR2,FDA Oks New Targeted Treatment For Relapsed Or Refractory Acute Myeloid Leukemia,2017-08-01 21:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WzVhhWRVLzk/fda-oks-new-targeted-treatment-for-relapsed-or-refractory-acute-myeloid-leukemia-20170801-01942,FDA Oks New Targeted Treatment For Relapsed Or Refractory Acute Myeloid Leukemia
CELG,CELG:UW,BBG000BFCMR2,"FDA approves leukemia treatment developed by Celgene, Agios",2017-08-01 19:06:41 +0000,https://finance.yahoo.com/news/fda-approves-leukemia-treatment-developed-160624424.html?.tsrc=rss,"The U.S. Food and Drug Administration  (FDA) on Tuesday approved Celgene Corp and Agios  Pharmaceuticals Inc's oral treatment for acute myeloid  leukemia (AML) patients with a rare genetic mutation.  The drug, Idhifa, will have a monthly list price of $24,872,  Celgene said in an email, noting that the median time on therapy  for patients was 4.3 months in the trial to secure the FDA's  approval."
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Bank of America, UnitedHealth, Intel, UPS and Celgene",2017-08-01 16:59:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UXqM0rDEDlY/the-zacks-analyst-blog-highlights-bank-of-america-unitedhealth-intel-ups-and-celgene-cm825060,For Immediate Release Chicago IL August 01 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,Trade of the Day: Celgene Corporation (CELG),2017-08-01 16:53:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FGYF8bdHmK4/trade-of-the-day-celgene-corporation-celg-cm825095,InvestorPlace Stock Market News Stock Advice amp Trading Tips To receive further updates on this Celgene Corporation NASDAQ CELG trade as well as an alert when it s time to take profits 160 sign up for a risk free
CELG,CELG:UW,BBG000BFCMR2,"FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation",2017-08-01 15:30:00 +0000,https://finance.yahoo.com/news/fda-grants-approval-idhifa-first-153000126.html?.tsrc=rss,"Celgene Corporation and Agios Pharmaceuticals, Inc. today announced that IDHIFA® was granted approval from the U.S. Food and Drug Administr"
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Bank of America, UnitedHealth, Intel, UPS and Celgene",2017-08-01 15:09:03 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-bank-150903648.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Bank of America, UnitedHealth, Intel, UPS and Celgene"
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation -- Moody's assigns Baa2 to Celgene's notes; stable outlook,2017-08-01 13:35:07 +0000,http://finance.yahoo.com/r/a0e766ae-19c8-36be-aec0-bfab739c264f/viewresearchdoc.aspx?docid=PR_370675&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170801_PR_370675&yptr=yahoo&.tsrc=rss,"Rating Action: Moody's assigns Baa2 to Celgene's notes; stable outlook. Global Credit Research- 01 Aug 2017. New York, August 01, 2017-- Moody's Investors Service assigned a Baa2 rating to the new senior ..."
CELG,CELG:UW,BBG000BFCMR2,Trade of the Day: Celgene Corporation (CELG),2017-08-01 12:52:34 +0000,https://finance.yahoo.com/news/trade-day-celgene-corporation-celg-125234156.html?.tsrc=rss,"Celgene Corporation (NASDAQ:CELG) experienced a slight pullback last week after the company reported its quarterly earnings, but we expect the pullback to be only temporary.  Celgene beat its revenue estimates by $40 million and its earnings estimates by $0.04 per share — coming in at $3.27 billion and $1.82 per share, respectively."
CELG,CELG:UW,BBG000BFCMR2,3 Stocks With Disney-Like Return Potential,2017-08-01 11:56:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7kuRXCsQWDw/3-stocks-with-disney-like-return-potential-cm824697,Few large caps have performed as well as Disney NYSE DIS over the past decade The House of Mouse has appreciated more than 220 over that time frame which blows past the 68 return of the S amp P 500 in general So which stocks do we think can go on a Disney like run
CELG,CELG:UW,BBG000BFCMR2,Featured Company News – Dynavax Announces FDA Advisory Committee Vote in Favor of HEPLISAV-B(TM),2017-08-01 11:00:00 +0000,https://finance.yahoo.com/news/featured-company-news-dynavax-announces-110000710.html?.tsrc=rss,"Research Desk Line-up: Celgene Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 1, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Dynavax Technologies ..."
CELG,CELG:UW,BBG000BFCMR2,3 Stocks With Disney-Like Return Potential,2017-08-01 10:00:00 +0000,http://finance.yahoo.com/r/62d1ac8c-3c24-3131-b13d-ea13377dfb7b/3-stocks-with-disney-like-return-potential.aspx?yptr=yahoo&.tsrc=rss,The entertainment giant has generated strong returns for its long-term investors. Here&apos;s why a team of Fools thinks these three stocks can do the same for you.
CELG,CELG:UW,BBG000BFCMR2,"Top Analyst Reports for Bank of America, UnitedHealth, Intel & Celgene",2017-07-31 22:30:10 +0000,https://finance.yahoo.com/news/top-analyst-reports-bank-america-223010529.html?.tsrc=rss,"Top Analyst Reports for Bank of America, UnitedHealth, Intel & Celgene"
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. :CELG-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017",2017-07-31 17:40:18 +0000,http://finance.yahoo.com/r/dc38c599-943e-3346-ab12-4593b9fd85c2/celgene-corp-celg-us-earnings-analysis-q2-2017-by-the-numbers-july-31-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Celgene Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Celgene Corp. – Amgen Inc., Gilead Sciences, Inc., Biogen Inc., Johnson & Johnson, Alexion Pharmaceuticals, Inc., Eli Lilly and Company and Novartis AG Sponsored ADR (AMGN-US, GILD-US, BIIB-US, JNJ-US, ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,The Celgene Story Is Bigger Than Revlimid Now; Argus Upgrades,2017-07-31 16:35:27 +0000,https://finance.yahoo.com/news/celgene-story-bigger-revlimid-now-163527657.html?.tsrc=rss,Argus upgraded Celgene Corporation (NASDAQ: CELG ) Monday on the strength of a diversified drug portfolio and a “robust development pipeline” that’s expected to result in several drugs going under regulatory ...
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Continues to Get It Done,2017-07-28 21:59:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qRx3HKb94VE/celgene-corporation-continues-to-get-it-done-cm823675,Celgene NASDAQ CELG continues to grow revenue 160 with its top three drugs all experiencing sales growth of at least 20 year over year in the second quarter The solid quarter allowed management to increase its 2017 earnings guidance Celgene results The raw
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Continues to Get It Done,2017-07-28 20:30:00 +0000,http://finance.yahoo.com/r/9b087723-3b4d-3ec7-be88-681d7e79010b/celgene-corporation-continues-to-get-it-done.aspx?yptr=yahoo&.tsrc=rss,Double-digit revenue growth and increased efficiency leads to an increase in earnings guidance.
CELG,CELG:UW,BBG000BFCMR2,"Notable Friday Option Activity: NFLX, IP, CELG",2017-07-28 19:59:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OQSdzjATfEY/notable-friday-option-activity-nflx-ip-celg-cm823569,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Netflix Inc Symbol NFLX where a total of 74 357 contracts have traded so far representing approximately 7 4 million underlying shares That amounts to about 79 9 of NFLX s
CELG,CELG:UW,BBG000BFCMR2,"Commit To Purchase Celgene Corp. At $105, Earn 3.7% Using Options",2017-07-28 17:02:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rRpwLDYiH_I/commit-to-purchase-celgene-corp-at-105-earn-37-using-options-cm823435,Investors eyeing a purchase of Celgene Corp Symbol CELG shares but tentative about paying the going market price of 134 12 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the September
CELG,CELG:UW,BBG000BFCMR2,"Mcrae Capital Management Inc Buys Investors Bancorp Inc, Sells iShares Core U.S. ...",2017-07-28 14:56:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5ID_RabOWVQ/mcrae-capital-management-inc-buys-investors-bancorp-inc-sells-ishares-core-us-cm823216,Mcrae Capital Management Inc Added Positions ISBC BBT MDT LH CBS KMI GE IBM PNR DNKN Reduced Positions AAPL OMC XOM PWR WFC DD COP CVX WMGI ISRG Sold Out AGG VTV IJK VNQ VTI IWP ICF SHY IYH IVW Added Positions
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Webcast at Upcoming Investor Conference,2017-07-28 11:30:00 +0000,https://finance.yahoo.com/news/celgene-corporation-webcast-upcoming-investor-113000031.html?.tsrc=rss,Celgene Corporation plans to present at an upcoming investor conference where Celgene management will provide an overview of the Company. The conference will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com.
CELG,CELG:UW,BBG000BFCMR2,Celgene beats Street 2Q forecasts,2017-07-28 05:24:54 +0000,https://finance.yahoo.com/news/celgene-beats-street-2q-forecasts-114317455.html?.tsrc=rss,"The Summit, New Jersey-based company said it had profit of $1.31 per share. Earnings, adjusted for one-time gains and costs, came to $1.82 per share. The results surpassed Wall Street expectations. The ..."
CELG,CELG:UW,BBG000BFCMR2,Biotech Fever Cools As These Players Dip On Longer-Term Views,2017-07-27 20:29:27 +0000,http://finance.yahoo.com/r/e0e84444-b923-3d34-8f46-b359808f2173/biotech-fever-cools-as-these-players-dip-on-longer-term-views?src=A00220&yptr=yahoo&.tsrc=rss,"Biotech stocks toppled midday Thursday, in-line with broader indexes, and included pitfalls from large players like Vertex, United and Spark."
CELG,CELG:UW,BBG000BFCMR2,Benzinga's Option Alert Recap From July 27,2017-07-27 20:05:03 +0000,https://finance.yahoo.com/news/benzingas-option-alert-recap-july-200503562.html?.tsrc=rss,"Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity. Here's a recap of the option alerts from Thursday, July 27, 2017. All timestamps are in Eastern ..."
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Beats Q2 Earnings & Sales Estimates, Ups View",2017-07-27 17:58:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EWmGOLf8H4g/celgene-celg-beats-q2-earnings-sales-estimates-ups-view-cm822690,Celgene Corporation CELG reported second quarter 2017 earnings of 1 68 per share including share based compensation expense and tax adjustments beating the Zacks Consensus Estimate of 1 61 and up from 1 28 per share in the year ago quarter Celgene s share price movement shows
CELG,CELG:UW,BBG000BFCMR2,"Biotech’s Sell-Side Roundup: Cowen’s Take on Gilead Sciences, Inc. (GILD) and Celgene Corporation (CELG)",2017-07-27 16:39:18 +0000,https://finance.yahoo.com/news/biotech-sell-side-roundup-cowen-163918065.html?.tsrc=rss,"Gilead Sciences, Inc."
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Beats Q2 Earnings & Sales Estimates, Ups View",2017-07-27 16:04:04 +0000,https://finance.yahoo.com/news/celgene-celg-beats-q2-earnings-160404446.html?.tsrc=rss,Celgene Corporation (CELG) beat earnings and revenue estimates in the second quarter and upped view.
CELG,CELG:UW,BBG000BFCMR2,Revlimid drives Celgene profit beat; raises EPS forecast,2017-07-27 15:37:51 +0000,https://finance.yahoo.com/news/celgene-beats-profit-estimates-raises-121040339.html?.tsrc=rss,Celgene Corp rode its flagship  multiple myeloma drug Revlimid and a rebound in sales of Otezla  for psoriasis to a modestly higher-than-expected second-quarter  profit and raised its full-year earnings forecast on Thursday.  Analysts said the results may have come up short of  investors' lofty expectations for Celgene.  Revlimid sales rose 19.6 percent to $2.03 billion on  increases in duration of use and new reimbursement agreements in  Europe.
CELG,CELG:UW,BBG000BFCMR2,"AstraZeneca Beats, But Stock Dives On Drug Failure; 4 More Report",2017-07-27 14:27:26 +0000,http://finance.yahoo.com/r/fbf729ae-b2bc-30e8-b2c0-0076ed74d9bd/astrazeneca-beats-but-stock-dives-on-mystic-failure-3-more-drug-giants-report?src=A00220&yptr=yahoo&.tsrc=rss,"AstraZeneca topped profit views, but shares crashed on an immuno-oncology setback. Roche also beat."
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Beats on Q2 Earnings & Sales,2017-07-27 12:22:12 +0000,https://finance.yahoo.com/news/celgene-celg-beats-q2-earnings-122212518.html?.tsrc=rss,Celgene beat on second-quarter 2017 earnings and sales.
CELG,CELG:UW,BBG000BFCMR2,"Celgene shares surge 1.6% on second-quarter profit, revenue beats",2017-07-27 11:47:27 +0000,http://finance.yahoo.com/r/99a35231-57f0-374f-9196-ad54c1d0cd12/Story.aspx?guid=B07237FF-E51E-4D05-BF96-019AE1A8B4F3&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Celgene Corp. shares surged 1.6% in premarket trade Thursday after the company reported second-quarter profit and revenue beats. Earnings for the latest quarter rose to $1.06 billion, or $1.31 per share, ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene's profit rises 77.4 pct on Revlimid demand,2017-07-27 11:41:15 +0000,https://finance.yahoo.com/news/celgenes-profit-rises-77-4-114115722.html?.tsrc=rss,"Celgene Corp reported a 77.4 percent rise in quarterly profit on Thursday, helped by higher sales of its flagship cancer drug, Revlimid. The company's net income rose to $1.06 billion, or $1.31 per share, ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Reports Second Quarter 2017 Operating and Financial Results,2017-07-27 11:30:00 +0000,https://finance.yahoo.com/news/celgene-reports-second-quarter-2017-113000048.html?.tsrc=rss,"Celgene Corporation reported net product sales of $3,256 million for the second quarter of 2017, a 19 percent increase from the same period in 2016. Celgene reported second quarter of 2017 total revenue of $3,268 million, a 19 percent increase compared to $2,754 million in the second quarter of 2016."
CELG,CELG:UW,BBG000BFCMR2,"Earnings Reaction History: Celgene Corporation, 54.5% Follow-Through Indicator, 2.4% Sensitive",2017-07-27 10:57:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3sQ32M0eGtI/earnings-reaction-history-celgene-corporation-545-follow-through-indicator-24-sensitive-cm822172,Expected Earnings Release 07 27 2017 PremarketExpected Earnings Release 07 27 2017 Premarket Avg Extended Hours Dollar Volume 9 708 571Avg Extended Hours Dollar Volume 9 708 571 Celgene Corporation CELG is due to issue its quarterly earnings report in the upcoming extended
CELG,CELG:UW,BBG000BFCMR2,Celgene Q2 17 Earnings Conference Call At 9:00 AM ET,2017-07-27 08:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n0BNZOqEQJk/celgene-q2-17-earnings-conference-call-at-900-am-et-20170727-00997,Celgene Q2 17 Earnings Conference Call At 9:00 AM ET
CELG,CELG:UW,BBG000BFCMR2,Celgene Updates 2017 EPS Guidance - Quick Facts,2017-07-27 07:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YFdAAEvUAss/celgene-updates-2017-eps-guidance--quick-facts-20170727-00852,Celgene Updates 2017 EPS Guidance - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Reports 28% Gain In Q2 Bottom Line,2017-07-27 07:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l2ZnApZ5XhE/celgene-corporation-reports-28-gain-in-q2-bottom-line-20170727-00836,Celgene Corporation Reports 28% Gain In Q2 Bottom Line
CELG,CELG:UW,BBG000BFCMR2,"Pre-Market Earnings Report for July 27, 2017 :  PG, CMCSA, VZ, MO, MA, CELG, CHTR, BMY, DOW, UPS, AMT, COP",2017-07-26 20:16:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p7T0mmWMir0/pre-market-earnings-report-for-july-27-2017-pg-cmcsa-vz-mo-ma-celg-chtr-bmy-dow-ups-amt-cop-cm822036,The following companies are expected to report earnings prior to market open on 07 27 2017 Visit our Earnings Calendar for a full list of expected earnings releases Procter amp Gamble Company PG is reporting for the quarter ending June 30 2017 The
CELG,CELG:UW,BBG000BFCMR2,What's in Store for Agios Pharma (AGIO) in Q2 Earnings?,2017-07-26 16:59:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7TpzKkKYO34/whats-in-store-for-agios-pharma-agio-in-q2-earnings-cm821810,Agios Pharmaceuticals Inc AGIO is expected to report second quarter results on Aug 3 Shares have surged 38 9 so far this year comparing favorably with the 160 industry s increase of 22 3 Agios performance has been mixed with the company missing estimates twice in the
CELG,CELG:UW,BBG000BFCMR2,"Celgene 2Q Preview: Rising Earnings, Revenue",2017-07-26 16:15:00 +0000,http://finance.yahoo.com/r/3f36e54b-3531-3763-bd3e-6ab13bc82a1f/celgene-2q-preview-rising-earnings-revenue?partner=YahooSA&yptr=yahoo&.tsrc=rss,Celgene is expected to report healthy 2Q earnings thanks to its blockbuster cancer drug Revlimid.
CELG,CELG:UW,BBG000BFCMR2,"A Drug Program That Keeps Patients Safe (And Profits, Too)",2017-07-26 16:09:48 +0000,http://finance.yahoo.com/r/c74fc979-0096-3919-9ab8-fe7779871dc3/a-drug-program-that-keeps-patients-safe-and-profits-too?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"For generic drug companies, manufacturing low-cost alternatives to brand-name medicines is the easy part. The hard part: getting their hands on the drugs they want to copy."
CELG,CELG:UW,BBG000BFCMR2,Amgen (AMGN) Stock Falls Despite Q2 Earnings & Sales Beat,2017-07-26 16:05:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZsrQxOYmcEI/amgen-amgn-stock-falls-despite-q2-earnings-sales-beat-cm821718,Biotech major Amgen Inc AMGN reported second quarter 2017 earnings of 3 27 per share which beat the Zacks Consensus Estimate of 3 09 by 5 8 and increased 15 from the year ago period Better revenues and lower operating costs drove the bottom line A lower tax rate and share count
CELG,CELG:UW,BBG000BFCMR2,Is a Beat in the Cards for Pfizer (PFE) in Q2 Earnings?,2017-07-26 16:04:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eUPDY9U0AQs/is-a-beat-in-the-cards-for-pfizer-pfe-in-q2-earnings-cm821692,We expect Pfizer Inc PFE to beat expectations when it reports second quarter 2017 results on Aug 1 before the market opens Last quarter the company delivered a positive earnings surprise of 2 99 The pharma giant has a mixed record of earnings surprises The company s earnings
CELG,CELG:UW,BBG000BFCMR2,What&apos;s in Store for Agios Pharma (AGIO) in Q2 Earnings?,2017-07-26 14:55:02 +0000,https://finance.yahoo.com/news/apos-store-agios-pharma-agio-145502644.html?.tsrc=rss,"Encouraging performance of Agios&apos; (AGIO) lead candidate Idhifa, which is under review in the U.S. for treatment of AML might drive the stock in Q2."
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Run for Cover From Major Biotech Stocks,2017-07-26 13:35:07 +0000,https://finance.yahoo.com/news/short-sellers-run-cover-major-133507673.html?.tsrc=rss,"The July 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased."
CELG,CELG:UW,BBG000BFCMR2,"Early movers: KO, BA, F, DHI, HLT, ANTM, NOC, T, APRN, AMGN & more",2017-07-26 12:07:05 +0000,http://finance.yahoo.com/r/a4f324eb-1759-3399-87a1-289f270d0637/104610305?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104610305&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
CELG,CELG:UW,BBG000BFCMR2,"Lgt Capital Partners Ltd. Buys Dr Pepper Snapple Group Inc, UnitedHealth Group Inc, Starbucks ...",2017-07-26 10:56:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uWY7Q_948jI/lgt-capital-partners-ltd-buys-dr-pepper-snapple-group-inc-unitedhealth-group-inc-starbucks-cm821357,Lgt Capital Partners Ltd New Purchases DPS C Added Positions UNH SBUX AKAM BIIB CL MS CELG AMG VZ NDAQ Reduced Positions AWK MRK CERN AQN MCD ISRG DVMT AAPL MAS Sold Out INDA TGNA WFM CARS New Purchases DPS C
CELG,CELG:UW,BBG000BFCMR2,Pharmaceutical company Celgene settles suit for $280 million,2017-07-26 05:11:42 +0000,https://finance.yahoo.com/news/pharmaceutical-company-celgene-settles-suit-050824481.html?.tsrc=rss,Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat ...
CELG,CELG:UW,BBG000BFCMR2,Pharmaceutical company Celgene settles suit for $280 million,2017-07-26 05:11:42 +0000,http://finance.yahoo.com/r/9e9c62fa-5904-3a7a-9587-3c27632451cb/pharmaceutical-company-celgene-settles-suit-050824481.html?.tsrc=rss,"LOS ANGELES (AP) — Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat leprosy and another therapy for unapproved cancer treatments, federal prosecutors announced Tuesday."
CELG,CELG:UW,BBG000BFCMR2,Celgene Corp. to pay $280M to settle cancer drug fraud suit,2017-07-26 02:59:50 +0000,https://finance.yahoo.com/news/celgene-corp-pay-280m-settle-cancer-drug-fraud-210142902--finance.html?.tsrc=rss,Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat ...
CELG,CELG:UW,BBG000BFCMR2,[$$] Celgene Settles Lawsuit Over Improper Promotion of Cancer Drugs,2017-07-25 22:58:04 +0000,http://finance.yahoo.com/r/1c39278f-2a3c-3f69-ad8c-fc43dbf83d8b/celgene-settles-lawsuit-over-improper-promotion-of-cancer-drugs-1501021308?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Drugmaker Celgene Corp. agreed to pay $280 million to the U.S. and many state governments to settle a former sales manager’s lawsuit accusing the company of improperly promoting two cancer drugs and causing ...
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Settlement Of Civil Litigation,2017-07-25 22:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7-VhIfXZBSQ/celgene-announces-settlement-of-civil-litigation-20170725-01757,Celgene Announces Settlement Of Civil Litigation
CELG,CELG:UW,BBG000BFCMR2,Business Highlights,2017-07-25 21:48:48 +0000,https://finance.yahoo.com/news/business-highlights-214744863.html?.tsrc=rss,"___ As McDonald's works on transforming, $1 sodas boost US sales McDonald's is trying to modernize its image by rolling out delivery and promising fresh beef in Quarter Pounders. But for now, $1 sodas ..."
CELG,CELG:UW,BBG000BFCMR2,Business Highlights,2017-07-25 21:48:48 +0000,https://www.yahoo.com/news/business-highlights-214744863.html?.tsrc=rss,"___ As McDonald's works on transforming, $1 sodas boost US sales McDonald's is trying to modernize its image by rolling out delivery and promising fresh beef in Quarter Pounders. But for now, $1 sodas ..."
CELG,CELG:UW,BBG000BFCMR2,Biotech still has more room to run: Technician,2017-07-25 21:30:00 +0000,https://finance.yahoo.com/video/biotech-still-more-room-run-213000114.html?.tsrc=rss,"Rich Ross, Evercore ISI, discusses Amgen earnings and where else in biotech you can put your money to work. The “Fast Money” traders weigh in."
CELG,CELG:UW,BBG000BFCMR2,Celgene Corp. to pay $280M to settle cancer drug fraud suit,2017-07-25 21:02:02 +0000,http://finance.yahoo.com/r/ccf25953-3fee-34cb-9b0c-6d0bc86f8a26/celgene-corp-pay-280m-settle-cancer-drug-fraud-210142902--finance.html?.tsrc=rss,LOS ANGELES (AP) — A New Jersey pharmaceutical company has agreed to pay $280 million to settle a federal lawsuit alleging it committed fraud promoting two cancer drugs for unapproved purposes.
CELG,CELG:UW,BBG000BFCMR2,Celgene Corp. to pay $280 million to settle lawsuit alleging it promoted cancer drugs for unapproved uses,2017-07-25 20:57:44 +0000,https://finance.yahoo.com/news/celgene-corp-pay-280-million-settle-lawsuit-alleging-205737513.html?.tsrc=rss,Celgene Corp. to pay $280 million to settle lawsuit alleging it promoted cancer drugs for unapproved uses.
CELG,CELG:UW,BBG000BFCMR2,Celgene to pay $280 mln to settle off-label marketing case,2017-07-25 20:48:21 +0000,https://finance.yahoo.com/news/celgene-pay-280-mln-settle-204821942.html?.tsrc=rss,"The U.S. Justice Department said on  Tuesday that Celgene Corp had agreed to pay $280  million to settle a lawsuit that accused the company of  promoting its cancer drugs Revlimid and Thalomid for off-label  uses.  In a statement, Celgene said it has agreed to resolve a  ""whistleblower"" lawsuit that alleged it had violated the federal  False Claims Act by submitting false claims to Medicare.  The lawsuit alleged that Celgene violated the laws of 28  states and the District of Columbia by submitting fraudulent  claims to state healthcare programs, including California's  Medi-Cal program."
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Announces Settlement of Civil Litigation,2017-07-25 20:00:00 +0000,https://finance.yahoo.com/news/celgene-corporation-announces-settlement-civil-200000977.html?.tsrc=rss,"Celgene Corporation today announced that it has reached a civil settlement with Relator Brown, the Department of Justice, 28 States, the District of Columbia, and the City of Chicago to resolve the previously disclosed False Claims Act litigation pending in the United States District Court for the Central District of California."
CELG,CELG:UW,BBG000BFCMR2,Celgene Settles 'Whistle Blower' Lawsuit for $280 Million,2017-07-25 19:28:00 +0000,http://finance.yahoo.com/r/0eabc990-24a9-3f30-8702-70b1491ee61b/celgene-settles-whistle-blower-lawsuit-for-280-million.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Celgene had been accused of marketing off-label uses for two of its cancer treatments.
CELG,CELG:UW,BBG000BFCMR2,Celgene Settles Whistle-Blower Fraud Suit for $280 Million,2017-07-25 18:54:36 +0000,http://finance.yahoo.com/r/caa8f3ef-f33e-3bb5-978c-80a0ef353060/celgene-agrees-to-pay-280-million-to-settle-whistle-blower-suit?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Celgene Corp. agreed to pay $280 million to resolve a whistle-blower’s claims the drugmaker used illegal marketing tactics to turn its Thalomid and Revlimid cancer drugs into blockbuster sellers, the U.S. ..."
CELG,CELG:UW,BBG000BFCMR2,3 Stocks You Can Safely Own Until 2030,2017-07-25 17:02:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_K5f5GycY-4/3-stocks-you-can-safely-own-until-2030-cm820981,Although buying and holding stocks is a proven method of producing life changing returns on capital the reality of the matter is that not all equities are great long term investing vehicles Many companies after all lack the type of rock solid competitive moat necessary to create
CELG,CELG:UW,BBG000BFCMR2,Celgene To Pay $280 Mln To Resolve False Claims Act Litigation - Quick Facts,2017-07-25 16:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IHvaL7d3T-s/celgene-to-pay-280-mln-to-resolve-false-claims-act-litigation--quick-facts-20170725-01555,Celgene To Pay $280 Mln To Resolve False Claims Act Litigation - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Outflows: TQQQ, CSCO, CELG, KHC",2017-07-25 15:58:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qfg-yaiF9JY/noteworthy-etf-outflows-tqqq-csco-celg-khc-cm820849,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the ProShares UltraPro QQQ Symbol TQQQ where we have detected an approximate 130 3 million dollar outflow that s a 6 2 decrease week over week from 18 500 000
CELG,CELG:UW,BBG000BFCMR2,"Jag Capital Management, Llc Buys Monster Beverage Corp, Cognex Corp, WestRock Co, Sells Post ...",2017-07-25 15:57:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eE5XjgxPVGw/jag-capital-management-llc-buys-monster-beverage-corp-cognex-corp-westrock-co-sells-post-cm820969,Jag Capital Management Llc New Purchases MNST CGNX WRK CRM WMT NVDA LYV AVGO TTWO VMW Added Positions ISRG FB CELG LNG VEEV ALB GOOGL USB ALK GILD Reduced Positions AMAT AGN OC BRK B MSFT SBUX AMZN EA ETN TSRO Sold Out
CELG,CELG:UW,BBG000BFCMR2,3 Stocks You Can Safely Own Until 2030,2017-07-25 15:00:00 +0000,http://finance.yahoo.com/r/8940839b-fa38-3bcd-a2ef-2f4cd131718c/3-stocks-you-can-safely-own-until-2030.aspx?yptr=yahoo&.tsrc=rss,"This biotech titan, entertainment giant, and top beverage company all have what it takes to be great long-term buys."
CELG,CELG:UW,BBG000BFCMR2,Risk-On Attitude Drive Stocks and Biotech Higher,2017-07-25 10:00:00 +0000,http://finance.yahoo.com/r/3dfb3767-8880-3405-a3b7-74f6b76b5d25/riskon-attitude-drive-stocks-and-biotech-higher?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Investors have had an appetite for risk recently, sending certain market sectors soaring."
CELG,CELG:UW,BBG000BFCMR2,Biotechs Find Strength In Numbers In Treating Multiple Sclerosis,2017-07-24 20:45:02 +0000,http://finance.yahoo.com/r/06e1cfaf-3d8c-3f7d-9983-b0d05eb22cd0/new-ms-drugs-threaten-biogen-novartis-dominance?src=A00220&yptr=yahoo&.tsrc=rss,"Roche, Celgene and Novartis could change the multiple sclerosis landscape, a sector now dominated by Biogen."
CELG,CELG:UW,BBG000BFCMR2,3 Large-Cap Biotech Stocks to Buy Now,2017-07-24 19:06:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IyTu-2bqDkQ/3-large-cap-biotech-stocks-to-buy-now-cm820463,InvestorPlace Stock Market News Stock Advice amp Trading Tips Last week was a swell one for the broader market which saw multiple major indices hit all time highs The S amp P 500 gained 0 52 while the Nasdaq 100 tacked on 1 4 and hit uncharted territory However the party to
CELG,CELG:UW,BBG000BFCMR2,Is Celgene (CELG) Poised For a Beat This Earnings Season?,2017-07-24 16:09:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xNhWO-IuSHA/is-celgene-celg-poised-for-a-beat-this-earnings-season-cm820167,Celgene Corporation CELG is scheduled to report second quarter 2017 results on Jul 27 before the opening bell Last quarter the company beat expectations by 4 08 Celgene has outperformed the Zacksclassified industry in the year so far The stock has gained 19 during this
CELG,CELG:UW,BBG000BFCMR2,2 Ways To Trade This Week's Healthcare Earnings,2017-07-24 15:51:55 +0000,https://finance.yahoo.com/news/2-ways-trade-weeks-healthcare-155155577.html?.tsrc=rss,View more earnings on CURE See more from Benzinga Focusing On An Alternative To S&P 500 ETFs A New ETF For Low Vol ETFs © 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved....
CELG,CELG:UW,BBG000BFCMR2,Is Celgene (CELG) Poised For a Beat This Earnings Season?,2017-07-24 14:25:02 +0000,https://finance.yahoo.com/news/celgene-celg-poised-beat-earnings-142502526.html?.tsrc=rss,Celgene Corporation (CELG) is likely to beat on earnings estimates when it reports results on July 27 on the back of growth in Revlimid driven by share gains in important markets.
CELG,CELG:UW,BBG000BFCMR2,These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet,2017-07-23 13:04:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HIqLPfhEpfU/these-5-drugs-could-be-worth-45-billion-and-theyre-not-even-on-the-market-yet-cm819829,45 billion for five experimental drugs That s how much market research firm EvaluatePharma projects the five most valuable pipeline candidates are worth right now The firm calculated the net present value the current value of potential future sales of all the experimental drugs
CELG,CELG:UW,BBG000BFCMR2,These 5 Drugs Could Be Worth $45 Billion -- and They&apos;re Not Even on the Market Yet,2017-07-23 11:27:00 +0000,http://finance.yahoo.com/r/cd7be451-95ee-3e17-9e89-8b2c3babf417/these-5-drugs-could-be-worth-45-billion-and-theyre.aspx?yptr=yahoo&.tsrc=rss,"Biogen, Johnson & Johnson, Lilly, AbbVie, and Celgene could have huge winners on their hands in the near future."
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Celgene Corporation vs. Gilead Sciences, Inc.",2017-07-22 17:03:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S1oYO5ol_Cc/better-buy-celgene-corporation-vs-gilead-sciences-inc-cm819776,Celgene NASDAQ CELG and Gilead Sciences NASDAQ GILD are two big biotechs facing dramatically different outlooks for the future Their stock prices reflect that reality Celgene s share price is up more than 30 over the last 12 months while Gilead stock is down by
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Celgene Corporation vs. Gilead Sciences, Inc.",2017-07-22 15:43:00 +0000,http://finance.yahoo.com/r/3cfdffa3-bc47-3d20-932c-fe471ab27d55/better-buy-celgene-corporation-vs-gilead-sciences.aspx?yptr=yahoo&.tsrc=rss,"With big biotechs Celgene and Gilead Sciences, it&apos;s a battle of growth stock versus income/value stock."
CELG,CELG:UW,BBG000BFCMR2,Is a Beat in the Cards for Vertex (VRTX) in Q2 Earnings?,2017-07-21 21:04:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NMnxuY57gYw/is-a-beat-in-the-cards-for-vertex-vrtx-in-q2-earnings-cm819573,We expect Vertex Pharmaceuticals Inc VRTX to beat expectations when it reports its second quarter 2017 results on Jul 26 after the market closes Year to date Vertex s shares have soared 116 3 while the industry has recorded an increase of 11 2 Vertex s track record has
CELG,CELG:UW,BBG000BFCMR2,"Biotechs On A Hot Streak, And Could Be &apos;Cooking With Gas&apos;",2017-07-21 20:14:03 +0000,http://finance.yahoo.com/r/a8195dfd-eb98-3013-9614-baa8c81e7481/biotechs-on-a-hot-streak-and-could-be-cooking-with-gas?src=A00220&yptr=yahoo&.tsrc=rss,IBD&apos;s 439-company Biotech industry group is now ranked fourth out of 197. How far can the rally go?
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Friday Option Activity: NFLX, SPGI, CELG",2017-07-21 20:04:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8bDMydRnMxs/noteworthy-friday-option-activity-nflx-spgi-celg-cm819546,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Netflix Inc Symbol NFLX where a total of 125 789 contracts have traded so far representing approximately 12 6 million underlying shares That amounts to about 142 8 of NFLX s
CELG,CELG:UW,BBG000BFCMR2,Nothing Can Keep Celgene Down,2017-07-21 19:06:00 +0000,http://finance.yahoo.com/r/5b2e73f9-072a-3a85-96e9-3820f95ff2b2/nothing-can-keep-celgene-down-1500664008?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"When it comes to Celgene (CELG), what goes might must keep going up.  Shares of Celgene started rallying on June 1, and after taking a break through the first couple of weeks of July, its shares are on the move again.  In fact Celgene is trading a new 52-week high today."
CELG,CELG:UW,BBG000BFCMR2,Will Gilead Beat 2Q Earnings? Perhaps…But Does It Matter?,2017-07-21 17:38:00 +0000,http://finance.yahoo.com/r/160bc290-317e-38d7-a838-bece487a56a4/will-gilead-beat-2q-earnings-perhapsbut-does-it-matter-1500658730?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Is Gilead Sciences (GILD) poised for a beat next week?  Guggenheim analyst Tony Butler sees Gilead earning $2.15 a share, a penny above the consensus forecast compiled by sell-side analyst, with operating revenue of $6.54 billion beating the $6.31 billion expected by the Street.  Butler’s estimates for the full 2017 calendar year are also above consensus, with per-share earnings of $8.28 on operating revenue of $25.4 billion."
CELG,CELG:UW,BBG000BFCMR2,US STOCKS-Wall Street pares losses but GE-led industrials weigh,2017-07-21 17:11:30 +0000,https://finance.yahoo.com/news/us-stocks-wall-street-pares-171130812.html?.tsrc=rss,"U.S. stock indexes pared losses, helped  by a rise in Visa in early afternoon trading on Friday, but weak  earnings from industrial heavyweight General Electric weighed.  Shares of GE fell as much as 5.4 percent to their  lowest level since Oct 2015, as the company reported a nearly 60  percent slump in profit and its 2017 profit forecast came in at  the low end."
CELG,CELG:UW,BBG000BFCMR2,HCA Healthcare (HCA) Q2 Earnings: Will it Beat Estimates?,2017-07-21 17:11:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8IpWoM422tk/hca-healthcare-hca-q2-earnings-will-it-beat-estimates-cm819444,HCA Healthcare Inc HCA is scheduled to report second quarter 2017 results on Jul 25 before the market opens Last quarter this hospital company posted in line results It has however surpassed earnings estimates in three out of the last four quarters with an average positive surprise
CELG,CELG:UW,BBG000BFCMR2,HCA Healthcare (HCA) Q2 Earnings: Will it Beat Estimates?,2017-07-21 14:46:02 +0000,https://finance.yahoo.com/news/hca-healthcare-hca-q2-earnings-144602122.html?.tsrc=rss,"HCA Healthcare&apos;s (HCA) second-quarter earnings are likely to witness equivalent, admission growth and accretion from a number of acquisitions. Commercial business will likely be a dampener."
CELG,CELG:UW,BBG000BFCMR2,Amgen (AMGN) to Report Q2 Earnings: What's in the Cards?,2017-07-21 14:11:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Uvnop-IL6zQ/amgen-amgn-to-report-q2-earnings-whats-in-the-cards-cm819288,Biotech major Amgen Inc AMGN will report second quarter 2017 results on Jul 25 after the market closes Amgen delivered a positive earnings surprise of 5 0 in the last quarter Amgen shares are up 22 6 so far this year This compares favorably with the 10 5 increase registered by
CELG,CELG:UW,BBG000BFCMR2,The Best Stock in New Jersey: Celgene,2017-07-21 12:03:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tvld7dI4lTE/the-best-stock-in-new-jersey-celgene-cm819111,We scoured the nation to identify the best stock in every state Celgene symbol CELG is the publicly traded company we picked in New Jersey The company headquarters is located in Summit We scoured the nation to identify thebest stock in every state Celgene symbolCELG is the
CELG,CELG:UW,BBG000BFCMR2,The Best Stock in New Jersey: Celgene,2017-07-20 12:50:03 +0000,https://finance.yahoo.com/news/best-stock-jersey-celgene-201005471.html?.tsrc=rss,We analyzed publicly traded companies based in the Garden State to identify the best stock in New Jersey to buy now.
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals",2017-07-19 17:05:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yrM-fJX4YQ8/the-zacks-analyst-blog-highlights-apple-jpmorgan-celgene-paypal-and-vertex-pharmaceuticals-cm818188,For Immediate Release Chicago IL July 19 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog include
CELG,CELG:UW,BBG000BFCMR2,3 Big Pharma Companies With the Best Projected Return on Investment,2017-07-19 15:05:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SqeXztQDCUc/3-big-pharma-companies-with-the-best-projected-return-on-investment-cm818005,Some projections are easier than others Research firm EvaluatePharma recently published its report of where the pharmaceutical industry could be in 2022 One of the firm s projections was which big pharma companies would have the best return on investment ROI in the coming years
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals",2017-07-19 14:54:02 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-apple-145402612.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals"
CELG,CELG:UW,BBG000BFCMR2,We Did The Math FBT Can Go To $127,2017-07-19 14:03:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wzCGG7VT1Y8/we-did-the-math-fbt-can-go-to-127-cm817944,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
CELG,CELG:UW,BBG000BFCMR2,3 Big Pharma Companies With the Best Projected Return on Investment,2017-07-19 13:23:00 +0000,http://finance.yahoo.com/r/822aab45-4c3d-382c-ab75-c497e6f9c474/3-big-pharma-companies-with-the-best-projected-ret.aspx?yptr=yahoo&.tsrc=rss,"Novo Nordisk, Celgene, and Bayer should get the biggest bang for the buck on their R&D and acquisitions."
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics",2017-07-19 12:03:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DAq2yLLqSiI/better-buy-celldex-therapeutics-inc-vs-juno-therapeutics-cm817864,Celldex Therapeutics NASDAQ CLDX and Juno Therapeutics NASDAQ JUNO are both once promising clinical stage biotechs that have fallen on extremely hard times of late Over the past two and half years for example these former stars have each lost a staggering amount of
CELG,CELG:UW,BBG000BFCMR2,"Top Stock Reports for Apple, JPMorgan & Celgene",2017-07-19 06:02:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2w6oD7_m9KU/top-stock-reports-for-apple-jpmorgan-celgene-cm817845,Tuesday July 18 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 16 major stocks including Apple AAPL JPMorgan JPM and Celgene CELG These research reports have been hand picked from the
CELG,CELG:UW,BBG000BFCMR2,Does Puma Biotechnology's Approval Make It Worth More?,2017-07-19 03:02:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ykZb6YCCgws/does-puma-biotechnologys-approval-make-it-worth-more-cm817834,Puma Biotechnology s NASDAQ PBYI roller coaster ride to approval is finally over After fits and starts in clinical trials 160 the FDA gave the company s breast cancer drug Nerlynx a green light clearing the way to its commercialization later this year The decision is
CELG,CELG:UW,BBG000BFCMR2,"Top Stock Reports for Apple, JPMorgan & Celgene",2017-07-18 22:09:10 +0000,https://finance.yahoo.com/news/top-stock-reports-apple-jpmorgan-220910656.html?.tsrc=rss,"Top Stock Reports for Apple, JPMorgan & Celgene"
CELG,CELG:UW,BBG000BFCMR2,"Nasdaq Leads, Apple Firm; Is This Industry Group Set To Recover?",2017-07-18 19:25:15 +0000,http://finance.yahoo.com/r/c7c28ccb-0d71-37c8-bf05-eb20368bf61f/nasdaq-leads-apple-firm-is-this-industry-group-set-to-recover?src=A00220&yptr=yahoo&.tsrc=rss,"Solar stocks are helping the indexes gain more strength lately. Yet for now the Nasdaq still rules as tech, internet and software firms climb."
CELG,CELG:UW,BBG000BFCMR2,"J&J (JNJ) Beats on Q2 Earnings, Lags Sales, Ups 2017 View",2017-07-18 16:08:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4dSHrIxehAw/jj-jnj-beats-on-q2-earnings-lags-sales-ups-2017-view-cm817557,Johnson amp Johnson JNJ reported mixed second quarter 2017 results While earnings beat expectations sales missed the same However the drug and consumer products giant raised its 2017 sales and profit outlook which sent shares up more than 1 in pre market trading This year so
CELG,CELG:UW,BBG000BFCMR2,5 CAR-T Stocks in Focus as NVS Drug Wins FDA Advisory Panel Vote,2017-07-18 14:08:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pKNcNeEiq00/5-car-t-stocks-in-focus-as-nvs-drug-wins-fda-advisory-panel-vote-cm817351,The CAR T chimeric antigen receptor T cells space got a significant boost recently with an FDA advisory panel issuing a positive recommendation for an experimental treatment in this corner of the immune oncology market Last week Swiss pharma giant Novartis NVS experimental CAR T
CELG,CELG:UW,BBG000BFCMR2,Wall Street’s 5 Hottest Biotech Stocks Right Now,2017-07-17 23:45:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pr9S-b3dxaE/wall-streets-5-hottest-biotech-stocks-right-now-cm817217,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotech stocks recently experienced their best week since the start of 2017 The biotechnology sector spiked following news that President Donald Trump plans to address drug prices with an executive order rather than
CELG,CELG:UW,BBG000BFCMR2,David Rolfe's Wedgewood Partners 2nd Quarter Client Letter,2017-07-17 16:55:26 +0000,https://finance.yahoo.com/news/david-rolfes-wedgewood-partners-2nd-165526941.html?.tsrc=rss,'The Fab Five'
CELG,CELG:UW,BBG000BFCMR2,"TQQQ, CELG, KHC, AVGO: Large Outflows Detected at ETF",2017-07-17 16:50:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ySVyh_MNJVw/tqqq-celg-khc-avgo-large-outflows-detected-at-etf-cm817008,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the ProShares UltraPro QQQ Symbol TQQQ where we have detected an approximate 75 3 million dollar outflow that s a 3 6 decrease week over week from 19 200 000
CELG,CELG:UW,BBG000BFCMR2,Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA,2017-07-17 16:49:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nrxfqv9KYSU/amgen-amgn-gets-crl-for-osteoporosis-drug-evenitys-bla-cm816989,Amgen Inc AMGN and partner UCB SA UCBJF announced that the FDA has issued a complete response letter CRL for the biologics license application BLA for Evenity romosozumab Amgen is looking to get Evenity approved for the treatment of postmenopausal women with osteoporosis The
CELG,CELG:UW,BBG000BFCMR2,3 Stocks to Buy if the Bull Market Fizzles,2017-07-17 12:23:00 +0000,http://finance.yahoo.com/r/ad30c3d7-3d12-3528-ba6d-d5fe5eee8c97/3-stocks-to-buy-if-the-bull-market-fizzles.aspx?yptr=yahoo&.tsrc=rss,"Don&apos;t panic if the current bull market ends. Look at buying Celgene, Facebook, and Wal-Mart stocks instead."
CELG,CELG:UW,BBG000BFCMR2,These 3 Stocks Have Doubled Investors' Money in 2017,2017-07-17 11:48:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zlHkZEQmGn0/these-3-stocks-have-doubled-investors-money-in-2017-cm816670,The stock market has done well so far in 2017 with gains of almost 10 for the S amp P 500 and even greater rises for some other major market benchmarks A small number of top performing stocks have done a lot better than that with a select handful having managed to double
CELG,CELG:UW,BBG000BFCMR2,These 3 Stocks Have Doubled Investors&apos; Money in 2017,2017-07-17 10:06:00 +0000,http://finance.yahoo.com/r/d9ddf51e-4ac4-3bfd-a8a6-c2cc28c2a666/these-3-stocks-have-doubled-investors-money-in-201.aspx?yptr=yahoo&.tsrc=rss,Find out how these stocks have jumped so much this year.
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Biogen Inc. vs. Celgene Corporation,2017-07-16 15:42:00 +0000,http://finance.yahoo.com/r/224aa79f-c4a4-30f8-ab8c-4fcdbb4c497e/better-buy-biogen-inc-vs-celgene-corporation-2.aspx?yptr=yahoo&.tsrc=rss,Which big biotech stock wins in a head-to-head matchup between Biogen and Celgene?
CELG,CELG:UW,BBG000BFCMR2,These Are the Best Growth Stocks Right Now in Biotech,2017-07-14 20:11:00 +0000,http://finance.yahoo.com/r/ff21db70-042b-37f6-be12-270c76816cda/celgene-vertex-and-spark-among-jefferies-top-biotech-picks.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Top names.
CELG,CELG:UW,BBG000BFCMR2,Risk Happens Fast: Doug Kass,2017-07-14 13:43:00 +0000,http://finance.yahoo.com/r/91032b85-c571-3c25-9a95-69bdafed08ef/risk-happens-fast-doug-kass.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,What you need to know.
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Merck, Celgene, Gilead Sciences, Seattle Genetics and Vanda Pharmaceuticals",2017-07-14 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-merck-133001779.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Merck, Celgene, Gilead Sciences, Seattle Genetics and Vanda Pharmaceuticals"
CELG,CELG:UW,BBG000BFCMR2,Corcept Therapeutics Focuses on Korlym's Label Expansion,2017-07-13 23:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c6fMnVA1mE0/corcept-therapeutics-focuses-on-korlyms-label-expansion-cm815921,We issued an updated research report on Corcept Therapeutics Inc CORT on Jul 12 Corcept s shares have surged 71 2 year to date comparing favorably with the Zacks classified Medical Drugs industry s gain of 6 3 Currently the company is striving to commercialize
CELG,CELG:UW,BBG000BFCMR2,Novartis CAR-T Therapy Drug Recommended by FDA Panel,2017-07-13 22:47:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X9FqoH3jG_I/novartis-car-t-therapy-drug-recommended-by-fda-panel-cm815892,Novartis AG NVS announced that the FDA Oncologic Drugs Advisory Committee ODAC has unanimously 10 0 recommended the approval of immunocellular therapy candidate CTL019 tisagenlecleucel CTL019 an investigational chimeric antigen receptor T cell CAR T therapy is being evaluated for
CELG,CELG:UW,BBG000BFCMR2,"MainStay Mutual Fund Enjoying Big Rally, With Stocks Like Alibaba",2017-07-13 22:03:39 +0000,http://finance.yahoo.com/r/3beeae14-a2a2-3737-90e6-1dda586a7fae/mainstay-mutual-fund-enjoying-big-rally-with-stocks-like-alibaba?src=A00220&yptr=yahoo&.tsrc=rss,"After a ho-hum 2016, $12.1 billion MainStay Large Cap Growth Fund is having a hi-ho 2017."
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Thursday Option Activity: CELG, LITE, ULTA",2017-07-13 20:49:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UouAT0Wpkgo/noteworthy-thursday-option-activity-celg-lite-ulta-cm815836,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Celgene Corp Symbol CELG where a total volume of 29 530 contracts has been traded thus far today a contract volume which is representative of approximately 3 0
CELG,CELG:UW,BBG000BFCMR2,5 Drug Stocks Well Poised to Beat Q2 Earnings Estimates,2017-07-13 18:31:06 +0000,https://finance.yahoo.com/news/5-drug-stocks-well-poised-183106599.html?.tsrc=rss,The NYSE ARCA Pharmaceutical Index has risen almost 9.8% year to date.
CELG,CELG:UW,BBG000BFCMR2,Amgen's Myeloma Drug Improves Overall Survival in Phase III,2017-07-13 16:51:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4Z0zy0db-nA/amgens-myeloma-drug-improves-overall-survival-in-phase-iii-cm815681,Biotech major Amgen Inc AMGN has announced final data from the phase III ASPIRE study which showed that a combination regimen of its drug Kyprolis significantly improved overall survival OS in patients with relapsed multiple myeloma Overall survival data from the study showed
CELG,CELG:UW,BBG000BFCMR2,"Nasdaq 100 Movers: STX, LILA",2017-07-13 15:51:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CdUL9468KPs/nasdaq-100-movers-stx-lila-cm815610,In early trading on Thursday shares of Liberty Global LILA topped the list of the day s best performing components of the Nasdaq 100 index trading up 3 4 Year to date Liberty Global registers a 16 3 gain And the worst performing Nasdaq 100 component thus far on the day is
CELG,CELG:UW,BBG000BFCMR2,Amgen&apos;s Myeloma Drug Improves Overall Survival in Phase III,2017-07-13 14:30:02 +0000,https://finance.yahoo.com/news/amgen-apos-myeloma-drug-improves-143002942.html?.tsrc=rss,"Biotech major, Amgen, Inc. (AMGN) announced final data from the phase III ASPIRE study, which showed that a combination regimen of its drug, Kyprolis, significantly improved overall survival (OS) in patients with relapsed multiple myeloma."
CELG,CELG:UW,BBG000BFCMR2,5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings,2017-07-13 13:52:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/36s15LHvYVU/5-pharma-biotech-stocks-that-could-be-big-winners-in-q2-earnings-cm815547,Drug stocks have bounced back this year with the NASDAQ Biotechnology Index and the NYSE ARCA Pharmaceutical Index gaining 18 6 and 10 8 respectively year to date YTD There are several reasons for this improved performance Investors are now more comfortable with the drug
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Hike Bets in Major Biotechs,2017-07-13 13:40:16 +0000,https://finance.yahoo.com/news/short-sellers-hike-bets-major-134016321.html?.tsrc=rss,"The June 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased."
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Merck, Eli Lilly, Celgene, Gilead Sciences and Shire",2017-07-13 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-merck-133001965.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Merck, Eli Lilly, Celgene, Gilead Sciences and Shire"
CELG,CELG:UW,BBG000BFCMR2,Novartis Grabs Key FDA Panel Approval Of Experimental Cancer Drug,2017-07-12 21:08:24 +0000,http://finance.yahoo.com/r/8f5f1893-2747-3ba9-8de9-374ebf7633bc/novartis-grabs-key-fda-panel-approval-of-experimental-cancer-drug?src=A00220&yptr=yahoo&.tsrc=rss,An FDA panel voted to recommended an experimental immuno-oncology treatment from Novartis Wednesday.
CELG,CELG:UW,BBG000BFCMR2,Celgene Price Increases Could Add 3 Cents In EPS This Year,2017-07-12 19:31:00 +0000,http://finance.yahoo.com/r/1fe30027-cf74-3db9-98a1-f61395659a75/celgene-price-increases-could-add-3-cents-in-eps-this-year-1499887866?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Celgene (CELG) is higher Wednesday, helped in part by reports that it increased the price of its cancer drugs Revlimid and Abraxane.  According to third-party reports, the firm upped the price of Revlimid by 1.8%, from $16,722.10 to $17,014.74 per (28 count) bottle, and Abraxane by 1.7% from $1,214.36 to $1235.61 per vial.  SunTrust Robinson Humphrey’s Yatin Suneja and his team write that the price increases should add some $33 million to sales and as much as three cents to the company’s earnings per share this year."
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Arena Shoots Up on Study Data, CELG Inks Immuno-Oncology Deal",2017-07-12 13:39:01 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-arena-shoots-133901394.html?.tsrc=rss,Arena (ARNA) saw it shares shoot up on mid-stage data on its pulmonary arterial hypertension drug while quite a few companies provided regulatory updates.
CELG,CELG:UW,BBG000BFCMR2,"&quot;Fast Money&quot; final trades: AAL, BAC and more",2017-07-11 21:59:00 +0000,https://finance.yahoo.com/video/fast-money-final-trades-aal-215900042.html?.tsrc=rss,"The “Fast Money” traders discuss their final trades for the day, including American Airlines, Bank of America, Netflix and Celgene."
CELG,CELG:UW,BBG000BFCMR2,3 Top Healthcare Stocks to Buy Today,2017-07-11 21:15:00 +0000,http://finance.yahoo.com/r/3b847fe7-9095-3865-bc7c-3fa1e1dd5fcf/3-top-healthcare-stocks-to-buy-today.aspx?yptr=yahoo&.tsrc=rss,"Here&apos;s why our healthcare experts think that Bristol-Myers Squibb, Celgene, and Mazor Robotics are all great buys right now."
CELG,CELG:UW,BBG000BFCMR2,5 Top Multibagger Biotech Stocks to Buy in the 2nd Half,2017-07-11 15:51:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YuwPUF1jU7Q/5-top-multibagger-biotech-stocks-to-buy-in-the-2nd-half-cm814468,After a dreadful 2016 biotech stocks have sprung back to life this year as possibilities of a draconian crackdown on drug prices ease out The unveiling of a health care refurbish plan by Senate Republicans in the meanwhile has reinstated investors confidence in the Republicans ability
CELG,CELG:UW,BBG000BFCMR2,3 Red-Hot Biotech Stocks That Could Get Even Hotter,2017-07-11 14:23:00 +0000,https://finance.yahoo.com/news/video-3-biotech-stocks-double-135500082.html?.tsrc=rss,An analyst weighs in.
CELG,CELG:UW,BBG000BFCMR2,How Celgene Stock Performed in 2Q17,2017-07-11 11:37:36 +0000,http://finance.yahoo.com/r/51f5b089-5c25-3298-95f6-d05096b6afbb/how-celgene-stock-performed-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Celgene (CELG) stock has risen ~6.1% in 2Q17, while it has risen ~14.0% year-to-date as of July 7, 2017."
CELG,CELG:UW,BBG000BFCMR2,Why Celgene Corporation Stock Bolted Higher in June,2017-07-11 11:09:00 +0000,http://finance.yahoo.com/r/88892baa-02db-3c85-b4d1-62a386a5922f/why-celgene-corporation-stock-bolted-higher-in-jun.aspx?yptr=yahoo&.tsrc=rss,Celgene&apos;s shareholders can rest easy thanks to President Trump.
CELG,CELG:UW,BBG000BFCMR2,3 Growth Stocks for Buy-and-Hold Investors,2017-07-11 00:21:00 +0000,http://finance.yahoo.com/r/e52c389b-9eb5-3a82-8df2-00bf6b4d4d77/3-growth-stocks-for-buy-and-hold-investors.aspx?yptr=yahoo&.tsrc=rss,Win big by placing long-term bets on these three great businesses.
CELG,CELG:UW,BBG000BFCMR2,These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now,2017-07-10 20:22:00 +0000,http://finance.yahoo.com/r/0ca6ce6f-5816-30f6-be9e-60b7a94bc2be/these-5-cancer-drugs-will-be-the-biggest-winners-5.aspx?yptr=yahoo&.tsrc=rss,Five cancer drugs that are already successful will become even bigger winners by 2022.
CELG,CELG:UW,BBG000BFCMR2,Prima Biomed's Intra-Tumor Study on Lead Candidate Approved,2017-07-10 15:51:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RnANm0hGYM0/prima-biomeds-intra-tumor-study-on-lead-candidate-approved-cm813802,Prima Biomed Ltd PBMD announced that a new clinical study INSIGHT on its lead candidate IMP321 has received regulatory approval for initiation The approval was granted to its German partner the Institute of Clinical Cancer Research by Paul Ehrlich Institut PEI the Federal Institute
CELG,CELG:UW,BBG000BFCMR2,[$$] BeiGene Boosted by Celgene Deal,2017-07-10 15:32:00 +0000,http://finance.yahoo.com/r/9ddff3a1-7d43-3151-86c3-fdba74bd2d26/beigene-boosted-by-celgene-deal-1499700771?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Maxim Group  We believe BeiGene has landed a solid deal with an excellent oncology partner in Celgene.  On the global front, it is strategic for BeiGene (BGNE) to expand the development of BGB-A317 in multiple indications with a partner, it also mitigates the risk of developing and commercializing its PD-1 inhibitor by itself in a highly competitive space.  The acquisition of Celgene’s (CELG) China business brings immediate revenues to BeiGene and more importantly, the existing commercial infrastructure sets the stage for commercial launches following the approvals on pivotal studies of BGB-A317 and BGB-3111 in China."
CELG,CELG:UW,BBG000BFCMR2,"Amgen, Inc. (AMGN) Stock Is the Cure for Ailing Portfolios",2017-07-10 15:31:46 +0000,https://finance.yahoo.com/news/amgen-inc-amgn-stock-cure-153146609.html?.tsrc=rss,"As violent as the biotech sector has been for the past twelve months, stocks like Amgen, Inc. (NASDAQ:AMGN) have been resilient in setting new highs.  While the range is flat overall, AMGN stock has had several +/- 25% moves in recent months.  Most of the headlines are not specific to AMGN stock, but rather caused by politicians."
CELG,CELG:UW,BBG000BFCMR2,What the FDA's Hold on 3 Merck Studies Means for Other Drug Makers,2017-07-10 01:20:00 +0000,http://finance.yahoo.com/r/c3ad822f-a27c-3c09-a37d-7c3fbfe96835/fda-puts-three-merck-studies-on-hold-what-it-means-for-other-drug-makers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The FDA has placed a clinical hold on three combination studies of Merck's Keytruda in multiple myeloma.
CELG,CELG:UW,BBG000BFCMR2,Billions of Dollars on the Line for Celgene With These 3 Small Biotechs,2017-07-09 11:28:00 +0000,http://finance.yahoo.com/r/d5b4c444-20a8-3696-9d0c-60e4f32908e3/billions-of-dollars-on-the-line-for-celgene-with-t.aspx?yptr=yahoo&.tsrc=rss,"Celgene&apos;s future fortunes depend heavily on Acceleron Pharma, bluebird bio, and Juno Therapeutics."
CELG,CELG:UW,BBG000BFCMR2,Investing in These Stocks Now Could Make You a Millionaire Retiree,2017-07-08 15:41:00 +0000,http://finance.yahoo.com/r/5e3d88e2-83ce-3a14-9655-406b3ec5ca1f/investing-in-these-stocks-now-could-make-you-a-mil.aspx?yptr=yahoo&.tsrc=rss,"How Celgene, Criteo, and Facebook stocks could turbocharge your retirement account."
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Amgen Inc. vs. Celgene Corporation,2017-07-08 12:44:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yYb7nN3iXak/better-buy-amgen-inc-vs-celgene-corporation-cm813403,Biotechs don t get to be big biotechs without racking up major successes along the way That s certainly the case for two of the biggest biotechs around Amgen NASDAQ AMGN and Celgene NASDAQ CELG Both companies stocks have also been successful Over the last 10
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Amgen Inc. vs. Celgene Corporation,2017-07-08 11:27:00 +0000,http://finance.yahoo.com/r/b0ca70e8-a40a-3bed-9e09-48c084539238/better-buy-amgen-inc-vs-celgene.aspx?yptr=yahoo&.tsrc=rss,Which big biotech stock wins in a head-to-head matchup between Amgen and Celgene?
CELG,CELG:UW,BBG000BFCMR2,Why Celgene&apos;s $413 Million Gamble Helps This Small Biotech More,2017-07-07 20:42:28 +0000,http://finance.yahoo.com/r/904f729d-e57e-3367-b8fe-76eb17a7ebc5/why-celgenes-413-million-gamble-helps-this-small-biotech-more?src=A00220&yptr=yahoo&.tsrc=rss,"Chinese biotech BeiGene is the strongest beneficiary of Celgene&apos;s $413 million gamble in immuno-oncology, an analyst said Friday."
CELG,CELG:UW,BBG000BFCMR2,"Allergan, Celgene Offer Solid Biotech Value",2017-07-07 20:30:00 +0000,http://finance.yahoo.com/r/e77058be-dfbe-3b99-8202-ade00f74ba9a/allergan-celgene-offer-solid-biotech-value.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The two giants likely won't be home runs, but they remain stalwarts in the biotech space."
CELG,CELG:UW,BBG000BFCMR2,Is Amgen Making a Mistake?,2017-07-07 17:58:00 +0000,http://finance.yahoo.com/r/ecd2e7db-ad0a-3824-988a-a6a0cd05caf2/is-amgen-making-a-mistake-1499450322?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Yesterday, Celgene (CELG) bought the rights to an anti-cancer treatment from Beigene, making it the latest company to bet big on what's known as a PD-1 inhibitor.  Bristol-Myers Squibb (BMY) and Merck (MRK) are the leaders in this field but it's Amgen (AMGN) that's notably absent.  Thus, for companies who have decided to invest heavily in the I/O space like Celgene, Regeneron Pharmaceuticals (REGN) (and others), it makes more sense to own both components of a combination rather than give much of the value away to the PD(L)1 owner."
CELG,CELG:UW,BBG000BFCMR2,"Allergan, Celgene Offer Solid Biotech Value",2017-07-07 17:30:00 +0000,http://finance.yahoo.com/r/cb6173c0-a7ea-3616-80a8-bd1c39cbb882/allergan-celgene-offer-solid-biotech-value?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The two giants likely won't be home runs, but they remain stalwarts in the biotech space."
CELG,CELG:UW,BBG000BFCMR2,Improving Health for This Pharma ETF,2017-07-07 16:00:00 +0000,http://finance.yahoo.com/r/f30a5b9f-b239-3ada-9749-8b826068c83b/improving-health-pharma-etf-pjp?partner=YahooSA&yptr=yahoo&.tsrc=rss,This pharma ETF could be ready to become a healthcare leader.
CELG,CELG:UW,BBG000BFCMR2,3 Best Fidelity Funds to Finish 2017,2017-07-06 23:44:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f_ENSg3hF_8/3-best-fidelity-funds-to-finish-2017-cm812785,InvestorPlace Stock Market News Stock Advice amp Trading Tips The second half of 2017 may be the most difficult to forecast in years but investors can find what they need among the broad selection of Fidelity funds Source Shutterstock Whether you want to make a sector play
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG), BeiGene Team Up For PD-1 Inhibitor in China",2017-07-06 22:45:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/39s_HzG0JKw/celgene-celg-beigene-team-up-for-pd-1-inhibitor-in-china-cm812738,Celgene Corporation CELG recently entered into a strategic collaboration with China based BeiGene Ltd BGNE Per the deal Celgene will develop and commercialize BeiGene s investigational anti programmed cell death protein 1 PD 1 inhibitor BGB A317 The candidate will be used to
CELG,CELG:UW,BBG000BFCMR2,"Gainers & Losers Of July 6: VSTM, BGNE, ALRN, TXMD, OCUL...",2017-07-06 21:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GwZFFCJZQoc/gainers--losers-of-july-6-vstm-bgne-alrn-txmd-ocul-20170706-01273,"Gainers & Losers Of July 6: VSTM, BGNE, ALRN, TXMD, OCUL..."
CELG,CELG:UW,BBG000BFCMR2,"Why HSN, Herman Miller, and BeiGene Jumped Today",2017-07-06 21:44:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3b47PeAz9jw/why-hsn-herman-miller-and-beigene-jumped-today-cm812698,The stock market lost ground on Thursday with major benchmarks falling around 1 on the day Rising tensions on the geopolitical front weighed on sentiment especially because of the North Korean test launch of an intercontinental ballistic missile and the attendant threat that it poses
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG), BeiGene Team Up For PD-1 Inhibitor in China",2017-07-06 20:52:08 +0000,https://finance.yahoo.com/news/celgene-celg-beigene-team-pd-205208539.html?.tsrc=rss,"Celgene Corporation (CELG) recently entered into a strategic collaboration with China based-BeiGene, Ltd. (BGNE)."
CELG,CELG:UW,BBG000BFCMR2,Celgene Enters PD1 Market with BeiGene Deal,2017-07-06 20:42:00 +0000,http://finance.yahoo.com/r/82635255-33b9-3824-b4bf-43338eb5af8e/celgene-enters-pd1-market-with-beigene-deal.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Celgene acquired the rights to BeiGene's PD-1 checkpoint inhibitor, propelling the biotech giant forward in immuno-oncology research."
CELG,CELG:UW,BBG000BFCMR2,"Why HSN, Herman Miller, and BeiGene Jumped Today",2017-07-06 20:28:00 +0000,http://finance.yahoo.com/r/21b33f4f-dbdb-3097-bb2f-0e220f2efded/why-hsn-herman-miller-and-beigene-jumped-today.aspx?yptr=yahoo&.tsrc=rss,These stocks gained in a tough market. Find out why.
CELG,CELG:UW,BBG000BFCMR2,"Health Care Sector Update for 07/06/2017: CORI,BGNE,CELG,EGLT",2017-07-06 20:23:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gePKlnyNOdQ/health-care-sector-update-for-07062017-coribgnecelgeglt-cm812688,Top Health Care StocksTop Health Care Stocks JNJ 0 87 JNJ 0 87 PFE 0 64 PFE 0 64 ABT 1 29 ABT 1 29 MRK 1 20 MRK 1 20 AMGN 1 44 AMGN 1 44 Health care stocks were leading the U S markets lower today with the NYSE Health Care Index on a 0 9 slide this afternoon while shares of
CELG,CELG:UW,BBG000BFCMR2,"Deal May Help Celgene Rival Dow&apos;s Merck, Bristol In Cancer Drugs",2017-07-06 20:19:45 +0000,http://finance.yahoo.com/r/1c22a925-5bec-35c4-818d-e925a09b2227/deal-may-help-celgene-rival-dows-merck-bristol-in-cancer-drugs?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene could challenge Dow component Merck and Bristol, an analyst said after the biotech announced a $413 million deal giving it access to a key immuno-oncology drug."
CELG,CELG:UW,BBG000BFCMR2,Mid-Afternoon Market Update: L Brands Falls Following Disappointing Sales Report; Herman Miller Shares Surge,2017-07-06 20:08:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t5yh9ZGSqrY/mid-afternoon-market-update-l-brands-falls-following-disappointing-sales-report-herman-miller-shares-surge-cm812686,Toward the end of trading Thursday the Dow traded down 0 60 percent to 21 349 83 while the NASDAQ declined 0 70 percent to 6 107 95 The S amp P also fell dropping 0 72 percent to 2 414 94 Leading and Lagging Sectors Technology shares rose by 0 64 percent in the US market
CELG,CELG:UW,BBG000BFCMR2,Here's Why BeiGene Ltd. Rose as Much as 31.4% on Thursday,2017-07-06 19:45:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KeDN4Mkleeo/heres-why-beigene-ltd-rose-as-much-as-314-on-thursday-cm812634,What happened Shares of BeiGene Ltd NASDAQ BGNE rocketed more than 31 higher at one point Thursday morning after the 160 clinical stage biopharma announced a new collaboration with Celgene Corp NASDAQ CELG The biopharma giant acquired worldwide rights outside
CELG,CELG:UW,BBG000BFCMR2,Celgene is Tardy to This Cancer-Drug Party,2017-07-06 18:54:54 +0000,http://finance.yahoo.com/r/9fac1672-3ad1-305e-8672-bf6f221e673e/celgene-beigene-pd1-l1-deal-too-much-too-late?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&trackingId=yhoo.headline&yptr=yahoo&.tsrc=rss,Its licensing deal with a Chinese biotech pays too much for so little chance of success.
CELG,CELG:UW,BBG000BFCMR2,"Health Care Sector Update for 07/06/2017: IMGN,BGNE,CELG,EGLT",2017-07-06 18:23:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-AM9Dl9OBSE/health-care-sector-update-for-07062017-imgnbgnecelgeglt-cm812622,Top Health Care StocksTop Health Care Stocks JNJ 0 87 JNJ 0 87 PFE 0 64 PFE 0 64 ABT 1 29 ABT 1 29 MRK 1 20 MRK 1 20 AMGN 1 44 AMGN 1 44 Health care stocks were leading the U S markets lower with the NYSE Health Care Index on a 0 9 slide this afternoon while shares of health
CELG,CELG:UW,BBG000BFCMR2,Here&apos;s Why BeiGene Ltd. Rose as Much as 31.4% on Thursday,2017-07-06 18:07:00 +0000,http://finance.yahoo.com/r/c7d18b09-2251-3218-bf5b-c2174acdb0e7/heres-why-beigene-ltd-rose-as-much-as-31-thursday.aspx?yptr=yahoo&.tsrc=rss,The mid-cap Chinese biopharma announced a collaboration with Celgene that has a few interesting twists to it.
CELG,CELG:UW,BBG000BFCMR2,Mid-Day Market Update: Crude Oil Up Over 2%; Egalet Shares Plummet,2017-07-06 17:38:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/POz6cACdv_8/mid-day-market-update-crude-oil-up-over-2-egalet-shares-plummet-cm812588,Midway through trading Thursday the Dow traded down 0 47 percent to 21 376 42 while the NASDAQ declined 0 92 percent to 6 094 10 The S amp P also fell dropping 0 64 percent to 2 416 95 Leading and Lagging Sectors Technology shares rose by 0 24 percent in the US market on
CELG,CELG:UW,BBG000BFCMR2,"IYH, PFE, MDT, CELG: ETF Inflow Alert",2017-07-06 16:47:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wr6gALx2Owk/iyh-pfe-mdt-celg-etf-inflow-alert-cm812534,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Healthcare ETF Symbol IYH where we have detected an approximate 67 0 million dollar inflow that s a 3 4 increase week over week in
CELG,CELG:UW,BBG000BFCMR2,Celgene signs deal with BeiGene for tumor cancer treatment,2017-07-06 16:21:06 +0000,https://finance.yahoo.com/news/celgene-signs-deal-beigene-tumor-162106555.html?.tsrc=rss,"Celgene Corp said it would buy a  stake in BeiGene Ltd to help develop and commercialize  the China-based cancer immunotherapy developer's treatment for  solid tumor cancers, expanding its position in the field of  immuno-oncology.  BeiGene's shares rose as much as 31.4 percent to an all-time  high of $68.67 in afternoon trading on Thursday.  Celgene's  shares were marginally down."
CELG,CELG:UW,BBG000BFCMR2,Merck Falls as FDA Puts Hold on 3 Keytruda Myeloma Studies,2017-07-06 15:46:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fNDHQed2Tbg/merck-falls-as-fda-puts-hold-on-3-keytruda-myeloma-studies-cm812376,Merck amp Co Inc MRK shares were down more than 1 in after hours trading on Wednesday after the company announced that the FDA has placed a clinical hold on three combination studies of Keytruda in multiple myeloma a form of blood cancer While the KEYNOTE 183 and KEYNOTE 185 phase
CELG,CELG:UW,BBG000BFCMR2,Mid-Morning Market Update: Markets Open Lower; Liberty Interactive To Acquire HSN,2017-07-06 15:38:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tAnvuS4fQEI/mid-morning-market-update-markets-open-lower-liberty-interactive-to-acquire-hsn-cm812455,Following the market opening Thursday the Dow traded down 0 51 percent to 21 369 62 while the NASDAQ declined 0 92 percent to 6 094 38 The S amp P also fell dropping 0 63 percent to 2 417 27 Leading and Lagging Sectors Technology shares rose by 0 11 percent in the US market
CELG,CELG:UW,BBG000BFCMR2,Biotech Movers: Immuno-Oncology Pact With Celgene Sends BeiGene Shares Soaring,2017-07-06 13:29:00 +0000,http://finance.yahoo.com/r/18d26f66-5b69-31c0-b7f3-3377c5b9aa22/biotech-movers-immuno-oncology-pact-with-celgene-sends-beigene-shares-soaring.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,BeiGene and Impax Laboratories were among the biotech movers in premarket trading on July 6.
CELG,CELG:UW,BBG000BFCMR2,How Transformative Is This Licensing Deal for BeiGene?,2017-07-06 12:35:09 +0000,https://finance.yahoo.com/news/transformative-licensing-deal-beigene-123509897.html?.tsrc=rss,"This partnership should be fairly transformative for BeiGene, seeing as it can start making some actual money."
CELG,CELG:UW,BBG000BFCMR2,BeiGene stock surges 12% on Celgene cancer collaboration,2017-07-06 12:27:47 +0000,http://finance.yahoo.com/r/7b6805d5-1994-38c4-aa8f-19af7e55a40a/Story.aspx?guid=4617CA21-96B2-4703-8BD6-F2B04A270E3C&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"BeiGene Ltd. shares surged 12.6% in premarket trade Thursday on news of its cancer collaboration with Celgene Corp. . BeiGene will receive $263 million in upfront licensing fees, and is eligible for up ..."
CELG,CELG:UW,BBG000BFCMR2,BeiGene Ltd. (BGNE) Has Climbed To A New High On Celgene Deal,2017-07-06 09:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xH5s1Mf_iXs/beigene-ltd-bgne-has-climbed-to-a-new-high-on-celgene-deal-20170706-00688,BeiGene Ltd. (BGNE) Has Climbed To A New High On Celgene Deal
CELG,CELG:UW,BBG000BFCMR2,"ARRY Working Its Way, Be All Ears For Auris, BGNE Inks Deal With CELG",2017-07-06 04:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S1i7ltsXB9E/arry-working-its-way-be-all-ears-for-auris-bgne-inks-deal-with-celg-20170706-00114,"ARRY Working Its Way, Be All Ears For Auris, BGNE Inks Deal With CELG"
CELG,CELG:UW,BBG000BFCMR2,How a Conference Caused Bluebird Bio's Shares to Rocket 33% in June,2017-07-06 03:43:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g_WlrL1UtX8/how-a-conference-caused-bluebird-bios-shares-to-rocket-33-in-june-cm812177,What happened After presenting data showing a very high response rate to a clinical stage drug in early state development 160 shares in bluebird bio NASDAQ BLUE jumped 32 6 in June according to S amp P Global Market Intelligence So what The company
CELG,CELG:UW,BBG000BFCMR2,How a Conference Caused Bluebird Bio&apos;s Shares to Rocket 33% in June,2017-07-06 02:31:00 +0000,http://finance.yahoo.com/r/0810ce5e-eced-3ad4-9d50-be3820722c53/how-a-conference-caused-bluebird-bios-shares-to-ro.aspx?yptr=yahoo&.tsrc=rss,A presentation at the influential American Society of Clinical Oncology in early June fueled optimism in the clinical-stage biotech company.
CELG,CELG:UW,BBG000BFCMR2,"Celgene to buy BeiGene stake, to develop tumor cancer treatment",2017-07-06 02:05:49 +0000,https://finance.yahoo.com/news/celgene-buy-beigene-stake-develop-020549094.html?.tsrc=rss,"Biopharmaceutical company Celgene Corp  will buy a stake in BeiGene Ltd and help  develop and commercialize BeiGene's investigational treatment  for tumor cancers, the companies said on Wednesday.  Celgene will acquire 32.7 million, or 5.9 percent of  BeiGene's ordinary shares, at $4.58 each, or $59.55 per  BeiGene's American Depositary Shares (ADS), they said in a  statement."
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Enters Into Global Strategic Immuno-Oncology Collaboration with BeiGene to Advance PD-1 Inhibitor Program for Solid Tumor Cancers,2017-07-06 01:00:00 +0000,https://finance.yahoo.com/news/celgene-corporation-enters-global-strategic-010000354.html?.tsrc=rss,"Celgene Corporation and BeiGene, Ltd. entered into a strategic collaboration to develop and commercialize BeiGene’s investigational anti-programmed cell death protein 1 inhibitor, BGB-A317, for patients with solid tumor cancers in the United States, Europe, Japan and rest of world outside Asia."
CELG,CELG:UW,BBG000BFCMR2,"Celgene, BeiGene Collaborate On PD-1 Inhibitor Program For Solid Tumor Cancers",2017-07-05 22:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o18w3DrRGI4/celgene-beigene-collaborate-on-pd1-inhibitor-program-for-solid-tumor-cancers-20170705-01204,"Celgene, BeiGene Collaborate On PD-1 Inhibitor Program For Solid Tumor Cancers"
CELG,CELG:UW,BBG000BFCMR2,FDA puts hold on Merck multiple myeloma trials after deaths,2017-07-05 21:39:05 +0000,https://finance.yahoo.com/news/fda-puts-hold-merck-multiple-213905828.html?.tsrc=rss,"Merck & Co said on Wednesday the  U.S. Food and Drug Administration had placed a clinical hold on  three multiple myeloma studies testing its Keytruda in  combination with other medicines for the blood cancer after more  deaths were reported in patients receiving the Merck  immunotherapy.  The rare setback for Keytruda sent Merck shares more than 1  percent lower.  Merck has been on a roll with the medicine, jumping to the  front of the pack of companies with new immuno-oncology drugs,  particularly after Keytruda extended survival as an initial  treatment for advanced lung cancer, by far the largest oncology  market."
CELG,CELG:UW,BBG000BFCMR2,"These 6 Biotech, Drug Plays Are In Buy Range: Investing Action Plan",2017-07-05 20:12:28 +0000,http://finance.yahoo.com/r/71be4e45-6819-36e8-8405-b096d99fe3bb/these-6-biotech-drug-plays-are-in-buy-range-investing-action-plan?src=A00220&yptr=yahoo&.tsrc=rss,Here&apos;s your Investing Action Plan for Thursday: what you need to know as an investor for the coming day.
CELG,CELG:UW,BBG000BFCMR2,Bright spots in biotech,2017-07-05 17:54:00 +0000,https://finance.yahoo.com/video/bright-spots-biotech-175400830.html?.tsrc=rss,CNBC's Seema Mody reports on some highs in the biotechnology sector.
CELG,CELG:UW,BBG000BFCMR2,Celgene Stock Will Continue to Rise on MS Drug's Success: Leerink,2017-07-05 17:26:00 +0000,http://finance.yahoo.com/r/e1f5b954-f57f-36aa-b6a3-7feff3e1038d/celgene-stock-will-continue-to-rise-on-ms-drug-s-success-leerink.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Leerink analysts see Celgene continuing in an upward trend as its new multiple sclerosis drug ozanimod differentiates itself from a competitive field.
CELG,CELG:UW,BBG000BFCMR2,Celgene: What's in the Pipeline?,2017-07-05 15:50:00 +0000,http://finance.yahoo.com/r/1b02ce06-573f-3919-a64e-84f742cc3a14/celgene-whats-in-the-pipeline-1499269826?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"In the July 1 issue of Barron's, Jack Hough argued that Celgene (CELG) had more room to run despite gaining 32% since he recommended it.  His argument was based on the fact that Celgene has the pipeline in place in place to diversify away from its biggest seller, the blood-cancer treatment Revlimid.  Today, Leerink's Geoffrey Porges and Bradley Canino take a deep dive into one of those drugs, the multiple sclerosis-treatment ozanimod, which they contend is becoming ""one of the more important catalysts for Celgene’s stock this year."" They explain why: Our recent upgrade of Celgene (CELG) was based in part on our positive view of the outlook for Revlimid (lenalidomide), and in part on our positive view of the company’s late stage pipeline, most notably the prospects for the company’s two phase III new chemical entities (NCE’s) luspatercept and ozanimod."
CELG,CELG:UW,BBG000BFCMR2,Why Gilead Stock Is Back in the Game,2017-07-05 13:00:00 +0000,http://finance.yahoo.com/r/d07b66e9-6360-345e-ab2d-57f97ccdeb3b/why-gilead-stock-back-game?partner=YahooSA&yptr=yahoo&.tsrc=rss,President Trump’s softening stance on pharma has allowed biotechs like Gilead to regain some traction.
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corporation to Announce Second Quarter 2017 Results on July 27, 2017",2017-07-05 11:30:00 +0000,https://finance.yahoo.com/news/celgene-corporation-announce-second-quarter-113000055.html?.tsrc=rss,"Celgene Corporation will host a conference call and live audio webcast on Thursday, July 27, 2017 at 9 a.m. ET to discuss second quarter 2017 financial and operational results."
CELG,CELG:UW,BBG000BFCMR2,Why is Corcept's Stock Up More Than 60% So Far This Year?,2017-07-03 15:49:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/afkyr86r2fw/why-is-corcepts-stock-up-more-than-60-so-far-this-year-cm811198,Shares of Corcept Therapeutics Incorporated CORT has soared 62 5 this year so far massively outperforming the 5 6 increase registered by the Zacks classified Medical Drugs industry during this period Here we analyze the factors that led to the rally Corcept s only marketed
CELG,CELG:UW,BBG000BFCMR2,3 Charts That Show Why to Buy Gilead Sciences Stock Now,2017-07-02 16:36:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_NELil938dk/3-charts-that-show-why-to-buy-gilead-sciences-stock-now-cm810960,Probably every investor interested in biotech knows all of the challenges facing Gilead Sciences NASDAQ GILD Its once high flying stock has been beaten down over the last couple of years as sales plunged for its hepatitis C franchise However over the last month Gilead
CELG,CELG:UW,BBG000BFCMR2,3 Charts That Show Why to Buy Gilead Sciences Stock Now,2017-07-02 15:01:00 +0000,http://finance.yahoo.com/r/423781d3-3bc8-3cb8-b3e6-093cf4e9b2c1/3-charts-that-show-why-to-buy-gilead-sciences-stoc.aspx?yptr=yahoo&.tsrc=rss,Why buy Gilead Sciences stock? These charts tell the story.
CELG,CELG:UW,BBG000BFCMR2,3 Value Stocks for the 2nd Quarter,2017-07-01 17:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MJatc8mDtBU/3-value-stocks-for-the-2nd-quarter-cm810887,While true bargains are becoming harder and harder to find there s still value to be found in the markets if you are willing to turn over enough rocks So which stocks do we think could appeal to value investors today We asked that question to a team of Fools and they picked
CELG,CELG:UW,BBG000BFCMR2,3 Value Stocks for the 2nd Quarter,2017-07-01 16:02:00 +0000,http://finance.yahoo.com/r/fdd5dbba-dbde-3079-a62f-888e24ee63e6/3-value-stocks-for-the-2nd-quarter.aspx?yptr=yahoo&.tsrc=rss,"Are you looking for a bargain in today&apos;s pricey market? Here&apos;s why you might want to consider VEREIT, Cisco Systems, and Celgene."
CELG,CELG:UW,BBG000BFCMR2,[$$] Celgene Could Rally Another 20% on Drug Gains,2017-07-01 05:17:00 +0000,http://finance.yahoo.com/r/ea0484a0-c78f-3d34-8e17-7e7705f14bd0/celgene-could-rally-another-20-on-drug-gains-1498886222?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Follow Up: Altaba | Review | Preview  Investors watching for good news at  Celgene will soon have plenty of opportunities.  By 2020, Celgene sees the potential for $21 billion in yearly revenue—nearly double what it booked last year.  Earnings estimates have climbed too, keeping the valuation attractive."
CELG,CELG:UW,BBG000BFCMR2,Beauty of Weakness; Uncertainty Remains: Rev Shark's Best Blog,2017-07-01 01:00:00 +0000,http://finance.yahoo.com/r/f5670848-fd44-3921-8f28-95a972156d43/on-not-talking-about-the-market-darth-vader-meet-amazon-jim-cramer-s-best-blog.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Guest James 'Rev Shark' DePorre discusses the beauty of weakness and also mentions that uncertainty remains.
CELG,CELG:UW,BBG000BFCMR2,"Can Celgene, Bluebird Keep Their Lead As Rivals Champ At The Bit?",2017-06-30 20:16:38 +0000,http://finance.yahoo.com/r/9a0852a4-43d2-346c-be6c-bfa53450bf19/can-celgene-bluebird-keep-their-lead-as-rivals-champ-at-the-bit?src=A00220&yptr=yahoo&.tsrc=rss,Celgene and Bluebird stocks sustained downgrades Friday as rivals like Kite and Juno look likely to chip away at their lead in immuno-oncology drugs.
CELG,CELG:UW,BBG000BFCMR2,"This Analyst Is Disappointed With Performance Of Celgene's Mongersen, Ozanimod",2017-06-30 18:23:38 +0000,https://finance.yahoo.com/news/analyst-disappointed-performance-celgenes-mongersen-182338108.html?.tsrc=rss,"BTIG said in a note on Friday it is disappointed with the performance of Celgene Corporation (NASDAQ: CELG )'s mongersen and ozanimod. Mongersen is Celgene's an anti-inflammatory, anti-sense oligonucleotide, ..."
CELG,CELG:UW,BBG000BFCMR2,The Cure For Cancer? Look At Your Blood,2017-06-30 17:10:32 +0000,http://finance.yahoo.com/r/dc2e0f7e-738c-30ab-bf2a-12edd93714f9/drugmakers-make-science-fiction-reality-in-cancer?src=A00220&yptr=yahoo&.tsrc=rss,What once seemed sci-fi is becoming real in treating blood cancers: doctoring patients&apos; blood to kill tumors. The FDA is about to consider the first such drug.
CELG,CELG:UW,BBG000BFCMR2,Bluebird Bio: Too Much Good News?,2017-06-30 14:40:00 +0000,http://finance.yahoo.com/r/4f7a2953-e80e-3444-b70e-61b5c6bdcb41/bluebird-bio-too-much-good-news-1498833622?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Bluebird Bio (BLUE) has had a great run this year, soaring more than 73% since the start of 2017.  The drug maker emerged as a big winner from the American College of Clinical Oncology’s (ASCO) annual confab, which is part of the reasons why the stock has spiked 40% in the past month, and peaked above $120 a share along the way.  High hopes for bb2121, the experimental cancer drug Bluebird Bio is developing with Celgene (CELG), are a big ingredient in the stock’s performance."
CELG,CELG:UW,BBG000BFCMR2,Can Regeneron Hit $540?,2017-06-30 13:25:00 +0000,http://finance.yahoo.com/r/d84fecc2-687a-323b-9212-265bb68bbc7b/can-regeneron-hit-540-1498829120?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The broader biotech sector has pulled back since hitting a new high earlier this month. And like most of its brethren, Regeneron Pharmaceuticals (REGN) has fallen as well, though at a faster pace. Since ..."
CELG,CELG:UW,BBG000BFCMR2,The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion),2017-06-30 12:04:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GMtHptIhuGE/the-9-best-selling-prescription-drugs-in-2016-each-one-topped-6-billion-cm810320,Prescription drug costs in the U S are rising And costs are going up despite a record number of generic drugs that are on the market One primary reason behind the continued increase of prescription drug costs is the greater number of specialty drugs that have been introduced
CELG,CELG:UW,BBG000BFCMR2,The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion),2017-06-30 10:00:00 +0000,http://finance.yahoo.com/r/f27a8ac9-dc1c-3bfe-83da-0f54f2054a92/the-9-best-selling-prescription-drugs-in-2016-each.aspx?yptr=yahoo&.tsrc=rss,These prescription drugs raked in billions of dollars last year. But several of them might not be so lucrative for much longer.
CELG,CELG:UW,BBG000BFCMR2,"Celgene Falls On Downgrade, But Here Are Signs Of Orderly Pullback",2017-06-30 08:39:00 +0000,http://finance.yahoo.com/r/11dc1971-99be-3f47-a117-feb3f76d9558/celgene-falls-on-downgrade-but-here-are-signs-of-orderly-pullback?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene is sliding on a downgrade Friday, but the pullback seems to be orderly."
CELG,CELG:UW,BBG000BFCMR2,"Celgene, Gilead and Other Red-Hot Biotech Stocks Just Got Run Over",2017-06-29 18:25:00 +0000,http://finance.yahoo.com/r/e8b5cc68-dc71-3c45-972f-d36f5cfc8919/celgene-gilead-stocks-lower-as-selloff-hits-biotech.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Ouch.
CELG,CELG:UW,BBG000BFCMR2,Technology Stocks Smashed as Biotech Soars,2017-06-29 18:00:00 +0000,http://finance.yahoo.com/r/912feba1-a54c-32bd-ad29-ef1b9d840982/technology-stock-smashed-biotech-soars?partner=YahooSA&yptr=yahoo&.tsrc=rss,Money has been moving out of the technology sector and into biotech stocks since mid-June. Why?
CELG,CELG:UW,BBG000BFCMR2,Which Companies Are Now Outperforming 95% Of All Stocks?,2017-06-29 15:19:39 +0000,http://finance.yahoo.com/r/e06cbce3-8d73-3f78-8ca7-5ef78fa61798/companies-now-outperforming-95-of-all-stocks?src=A00220&yptr=yahoo&.tsrc=rss,See which stocks just got an upgrade and now have a 95 or higher IBD Composite Rating.
CELG,CELG:UW,BBG000BFCMR2,6 Top Stocks You Can Buy and Hold for the Next Decade,2017-06-29 12:04:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/54GYrqPVd-E/6-top-stocks-you-can-buy-and-hold-for-the-next-decade-cm809728,Time and again the data have shown that slow and steady wins the race when it comes to investing While dicing in and out the market and trying to time big jumps or steep drops may work from time to time it s an impossible task to perfect over the long run According to a study
CELG,CELG:UW,BBG000BFCMR2,6 Top Stocks You Can Buy and Hold for the Next Decade,2017-06-29 10:46:00 +0000,http://finance.yahoo.com/r/7bbf002b-57bd-3080-a72c-b9976289ff93/6-top-stocks-you-can-buy-and-hold-for-the-next-dec.aspx?yptr=yahoo&.tsrc=rss,These businesses with clear-cut competitive advantages should allow you to rest easy at night.
CELG,CELG:UW,BBG000BFCMR2,2 Fastest Growing Biotech Stocks,2017-06-28 21:04:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UG9yk_buRn4/2-fastest-growing-biotech-stocks-cm809607,Even though biotech has been sky rocketing over the last five years the industry s eye popping growth spurt isn t showing any signs of slowing down In fact EvaluatePharma estimates that global prescription drug sales will rise at an astounding compound annual growth rate or CAGR
CELG,CELG:UW,BBG000BFCMR2,"Notable Wednesday Option Activity: CELG, KTOS, BKFS",2017-06-28 21:03:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/giqglgq7lF8/notable-wednesday-option-activity-celg-ktos-bkfs-cm809619,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Celgene Corp Symbol CELG where a total volume of 24 058 contracts has been traded thus far today a contract volume which is representative of approximately 2 4
CELG,CELG:UW,BBG000BFCMR2,2 Fastest Growing Biotech Stocks,2017-06-28 19:44:00 +0000,http://finance.yahoo.com/r/cad7a982-1e33-37a0-9e6a-b887c86853c3/3-fastest-growing-pharma-stocks.aspx?yptr=yahoo&.tsrc=rss,"Celgene and Alexion Pharmaceuticals are biotech&apos;s brightest stars, but can they continue to outshine their peers?"
CELG,CELG:UW,BBG000BFCMR2,"Apple, Biotechs Lead Nasdaq Rebound; 5 More Leaders Are Showing Resilience",2017-06-28 18:30:44 +0000,http://finance.yahoo.com/r/388a385c-4ebf-3549-8c68-9df33ffded4d/apple-biotechs-lead-nasdaq-rebound-5-more-leaders-are-showing-resilience?src=A00220&yptr=yahoo&.tsrc=rss,"The Nasdaq composite, helped by Apple and biotechs, is leading Wednesday&apos;s rebound. Some chip stocks are showing good action too."
CELG,CELG:UW,BBG000BFCMR2,"Wednesday’s Vital Data: Nvidia Corporation (NVDA), Tesla Inc (TSLA) and Alibaba Group Holding Ltd (BABA)",2017-06-28 18:04:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oOGynsQYoqQ/wednesdays-vital-data-nvidia-corporation-nvda-tesla-inc-tsla-and-alibaba-group-holding-ltd-baba-cm809574,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are mixed this morning with the Nasdaq Composite bucking the overall uptrend due to continued weakness in the tech sector In fact the Nasdaq was initially headed for its third straight day
CELG,CELG:UW,BBG000BFCMR2,Where to find value in health-care stocks ahead of Senate...,2017-06-28 16:39:00 +0000,https://finance.yahoo.com/video/where-value-health-care-stocks-163900033.html?.tsrc=rss,CNBC's Landon Dowdy reports on the health care sector moves ahead of the Senate health-care bill vote. The “Fast Money Halftime Report” traders weigh in.
CELG,CELG:UW,BBG000BFCMR2,Agios/Celgene's Leukemia Candidate Positive in Phase I/II,2017-06-27 17:50:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q8vazVjtzDA/agioscelgenes-leukemia-candidate-positive-in-phase-iii-cm808933,Agios Pharmaceuticals Inc AGIO has announced positive efficacy and safety data from the ongoing phase I II dose escalation and expansion study on experimental candidate IDHIFA enasidenib at an oral session at the European Hematology Association EHA IDHIFA is being developed for
CELG,CELG:UW,BBG000BFCMR2,Health Care Select Sector SPDR Fund Experiences Big Inflow,2017-06-27 16:52:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ib10_en9X5U/health-care-select-sector-spdr-fund-experiences-big-inflow-cm808880,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 297 4 million dollar inflow that s a 1 7 increase week over week
CELG,CELG:UW,BBG000BFCMR2,2 Pharma Buyout Targets That May Surprise You,2017-06-27 13:52:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4X3eYqqERa8/2-pharma-buyout-targets-that-may-surprise-you-cm808514,Mergers and acquisitions can be extremely profitable for pharmaceutical investors A little over a year ago for instance Jazz Pharmaceuticals swooped in to buy Celator Pharmaceuticals 160 in a cash deal valued at 1 5 billion representing a stunning 73 windfall for Celator
CELG,CELG:UW,BBG000BFCMR2,Major Biotech Short Interest Surges,2017-06-27 12:50:11 +0000,https://finance.yahoo.com/news/major-biotech-short-interest-surges-125011849.html?.tsrc=rss,"The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased."
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock With 497% Growth, Positive Trial Results Nears Buy Zone",2017-06-26 20:17:13 +0000,http://finance.yahoo.com/r/e32db28c-ac13-3d88-a192-80537472c311/exelexis-biotech-stock-with-497-growth-positive-trial-results-nears-buy-zone-celgene-climbs?src=A00220&yptr=yahoo&.tsrc=rss,"With biotech stocks like Celgene, Bluebird Bio and Regeneron on the move, cancer treatment developer Exelixis may be poised to pop into a new buy zone."
CELG,CELG:UW,BBG000BFCMR2,"How We Earn $5,300 In Dividends From A $10,000 Investment (VZ, PSX, GILD)",2017-06-26 19:51:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ErtykEKh76c/how-we-earn-5300-in-dividends-from-a-10000-investment-vz-psx-gild-cm808344,InvestorPlace Stock Market News Stock Advice amp Trading Tips It s the most lucrative investing strategy I ve ever found It won t happen overnight but I m convinced anyone can earn a significant amount of money with this strategy Let me explain Consider your
CELG,CELG:UW,BBG000BFCMR2,Seattle Genetics: A Disappointing Study…Or Was It?,2017-06-26 18:52:00 +0000,http://finance.yahoo.com/r/6af3866f-8299-3e70-b1cc-b4d07210c8ee/seattle-genetics-a-disappointing-studyor-was-it-1498503146?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Seattle Genetics (SGEN) are moving lower today, falling more than 9% after the drug maker’s experimental lymphoma drug failed to impress.  The data from the late-stage study testing Adcetris, co-developed with Japan's Takeda Pharmaceutical, helped blood cancer patients live longer without worsening their conditions, meeting its endpoint.  Altogether, lots of uncertainty whether these data could support a robust commercial adoption."
CELG,CELG:UW,BBG000BFCMR2,Agio Pharma Sinks on Midstage Trial,2017-06-26 15:05:35 +0000,https://finance.yahoo.com/news/agio-pharma-sinks-midstage-trial-150535301.html?.tsrc=rss,Agio Pharmaceuticals saw its shares sink on Monday after the firm announced results from its midstage trial for the treatment of relapsed or refractory acute myeloid leukemia.
CELG,CELG:UW,BBG000BFCMR2,Epizyme Progressing Well on Two Lead Pipeline Candidates,2017-06-26 14:55:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sCU3DvRRyTg/epizyme-progressing-well-on-two-lead-pipeline-candidates-cm808031,We issued an updated research report on Epizyme Inc EPZM on Jun 23 2017 Currently Epizyme is a development stage biopharmaceutical company focused on bringing novel epigenetic therapies for the treatment of cancer and other diseases to market Key candidates in Epizyme s pipeline
CELG,CELG:UW,BBG000BFCMR2,"Which 2 Top ETFs Holding Amazon, Apple, Celgene Are In Buy Range?",2017-06-26 14:50:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qkFjGrhLiww/which-2-top-etfs-holding-amazon-apple-celgene-are-in-buy-range-cm808007,The U S stock market is trading near record highs but that doesn t mean it s too late to get exposure to big names like Amazon com AMZN Apple AAPL and Celgene CELG via major index ETFs Below 160 are two that are still in buy range from
CELG,CELG:UW,BBG000BFCMR2,Corcept Therapeutics Incorporated in 3 Charts,2017-06-26 13:52:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KD-1dpbut-Y/corcept-therapeutics-incorporated-in-3-charts-cm807952,Corcept Therapeutics Incorporated NASDAQ CORT is definitely on a roll The drugmaker s stock is up nearly 70 so far in 2017 Corcept s share price has has more than doubled over the past 12 months And over the last three years the company s market cap has nearly quadrupled What
CELG,CELG:UW,BBG000BFCMR2,Corcept Therapeutics Incorporated in 3 Charts,2017-06-26 12:43:00 +0000,http://finance.yahoo.com/r/3a399a59-8811-3f8c-aead-e4ff77624b12/corcept-therapeutics-incorporated-in-3-charts.aspx?yptr=yahoo&.tsrc=rss,Corcept has been one of the best-performing drug stocks this year. These charts show why the good times could continue.
CELG,CELG:UW,BBG000BFCMR2,3 Reasons to Buy Celgene Stock and Never Sell,2017-06-25 16:50:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sRUM7te6lQQ/3-reasons-to-buy-celgene-stock-and-never-sell-cm807862,Celgene NASDAQ CELG stock has been in my investment portfolio since 2013 I enjoyed a couple of great years with the biotech stock performing really well Over the past couple of years however Celgene hasn t generated high returns Despite the lackluster performance since
CELG,CELG:UW,BBG000BFCMR2,3 Reasons to Buy Celgene Stock and Never Sell,2017-06-25 15:01:00 +0000,http://finance.yahoo.com/r/07599d18-d7eb-3b52-b905-915e026799a4/3-reasons-to-buy-celgene-stock-and-never-sell.aspx?yptr=yahoo&.tsrc=rss,Here&apos;s why Celgene stock is a keeper.
CELG,CELG:UW,BBG000BFCMR2,2 Top Biotech Stocks to Buy on Sale,2017-06-24 13:50:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aB6MXa_ld6g/2-top-biotech-stocks-to-buy-on-sale-cm807744,Biotech stocks have been soaring over the last few years due to an uptick in innovation and a growing demand for healthcare services across the board As a result valuations across this high flying space have ballooned making it increasingly difficult to suss out attractive
CELG,CELG:UW,BBG000BFCMR2,2 Top Biotech Stocks to Buy on Sale,2017-06-24 12:33:00 +0000,http://finance.yahoo.com/r/2005769f-3f2b-30fe-8b03-caa77421c21d/2-top-biotech-stocks-to-buy-on-sale.aspx?yptr=yahoo&.tsrc=rss,Bargain hunters may want to check out these two top biotech stocks right now.
CELG,CELG:UW,BBG000BFCMR2,Too Late To Catch Biotech Rally As Trump Fears Subside?,2017-06-23 20:52:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0LfyNluf2BA/too-late-to-catch-biotech-rally-as-trump-fears-subside-cm807600,With names like AbbVie ABBV and Celgene CELG on a tear the past week many biotech sector 160 ETFs hit 52 week or longer highs On Friday they took a breather but retained the bulk of their big weekly gains Most biotech funds are extended from their
CELG,CELG:UW,BBG000BFCMR2,"Week In Review: Biotechs, Software Drive Nasdaq; Boeing Tops Airbus; Oil Hit",2017-06-23 20:36:19 +0000,http://finance.yahoo.com/r/2aece89e-e2cd-3876-8405-9ad0f4364cf1/week-in-review-biotechs-oracle-lift-nasdaq-oil-curbs-s-dows-boeing-jets?src=A00220&yptr=yahoo&.tsrc=rss,"Biotechs and desktop software led the market, while Boeing fared well at the Paris Air Show, oil kept falling, China cracked down on Weibo."
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks for Enterprising Investors,2017-06-23 13:54:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0WCDy7ozik4/3-biotech-stocks-for-enterprising-investors-cm807280,Biotech stocks are a natural area of exploration for aggressive investors with high expectations for their stocks After all this high growth industry is chock full of novel growth platforms some of which can be challenging to understand at times With this theme in mind we
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks for Enterprising Investors,2017-06-23 12:04:00 +0000,http://finance.yahoo.com/r/092f4252-d499-3d88-8cd4-8fc44ee3ed92/3-biotech-stocks-for-enterprising-investors.aspx?yptr=yahoo&.tsrc=rss,"Kite Pharma, Celgene, and Acadia Pharmaceuticals are three biotech stocks that should be on enterprising investors&apos; radars. Here&apos;s why."
CELG,CELG:UW,BBG000BFCMR2,Biotech Resurgence Has Bite But No FAANGs,2017-06-22 20:50:00 +0000,http://finance.yahoo.com/r/3a769344-f7d6-386a-8a7b-9eabfb12f945/biotech-resurgence-has-bite-but-no-faangs?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Move over FAANGs, when comparing the performance of the 10 Select Sector SPDR ETFs, healthcare is currently leading in the last 1-week, 6-week and 12-week performance periods. However, it appears the leadership within the healthcare sector is changing. Here's the short list with analysis."
CELG,CELG:UW,BBG000BFCMR2,This Top Biotech Stock Remains Just Within Buy Range,2017-06-22 20:30:38 +0000,http://finance.yahoo.com/r/98a0fa40-fead-32d7-b6f8-f7800e5c1b30/top-biotech-stock-just-with-buy-range-as-boom-continues?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Celgene shows improving technical performance.
CELG,CELG:UW,BBG000BFCMR2,"After Celgene, Regeneron Breakouts, This Biotech Stock May Be Next",2017-06-22 20:27:26 +0000,http://finance.yahoo.com/r/d0b07bb5-6147-3b54-bf95-33df8542698b/after-celgene-regeneron-breakouts-this-biotech-stock-may-be-next?src=A00220&yptr=yahoo&.tsrc=rss,"With biotech stocks like Celgene, Bluebird Bio and Regeneron on the move, cancer treatment developer Exelixis may be poised to pop into a new buy zone."
CELG,CELG:UW,BBG000BFCMR2,Why The Biotech Rally Could Still Tack On Another 15% Upside,2017-06-22 20:05:23 +0000,http://finance.yahoo.com/r/cd0483b6-79e9-3071-aee6-c76cdab539ad/why-the-biotech-rally-could-still-tack-on-another-15-upside?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene, Regeneron and Vertex could lead the biotech sector to 15% more upside following the second quarter, an analyst said Thursday."
CELG,CELG:UW,BBG000BFCMR2,Which Stocks Are Showing Rising Relative Strength?,2017-06-22 18:47:35 +0000,http://finance.yahoo.com/r/fa200388-9cb9-3ac3-9950-f37df6d0879f/which-stocks-are-showing-rising-relative-strength?src=A00220&yptr=yahoo&.tsrc=rss,See which stocks just got an IBD RS Rating upgrade.
CELG,CELG:UW,BBG000BFCMR2,"Stock Indexes Grip Small Gains, But This New Leader Swings Higher",2017-06-22 16:11:35 +0000,http://finance.yahoo.com/r/9df7c551-7c82-3443-bd8d-ddab5744444e/stock-indexes-grip-small-gains-but-new-leader-swings-higher?src=A00220&yptr=yahoo&.tsrc=rss,"U.S. stock indexes gripped slender gains midday Thursday, as strength in biotechs offset weakness in chip stocks."
CELG,CELG:UW,BBG000BFCMR2,Otezla Could Significantly Drive Celgene’s Revenue Growth,2017-06-22 13:06:31 +0000,http://finance.yahoo.com/r/57eedbb5-fcbe-32f8-aa78-709a50d26dfd/otezla-could-significantly-drive-celgenes-revenue-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Celgene’s (CELG) Otezla generated revenues of around $1.0 billion, a 116% year-over-year (or YoY) increase."
CELG,CELG:UW,BBG000BFCMR2,Celebrated Photographer Martin Schoeller Shines a Light on People With Psoriatic Disease Including Olympic Swimmer and Author Dara Torres as Part of Celgene’s SHOW MORE OF YOU Campaign,2017-06-22 13:00:00 +0000,https://finance.yahoo.com/news/celebrated-photographer-martin-schoeller-shines-130000712.html?.tsrc=rss,Award-winning portrait photographer Martin Schoeller along with 12-time Olympic medalist and New York Times best-selling author Dara Torres and others with psoriatic disease have come together for the SHOW MORE OF YOU campaign from Celgene Corporation and Otezla® 30 mg tablets.
CELG,CELG:UW,BBG000BFCMR2,What Analysts Recommend for Celgene in 2017,2017-06-22 11:36:28 +0000,http://finance.yahoo.com/r/6af410d9-5ad0-3308-9046-baefbd7087ea/what-analysts-recommend-for-celgene-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Celgene (CELG) has a focused and robust clinical pipeline that may help it launch new drugs in the future.
CELG,CELG:UW,BBG000BFCMR2,Futures: These 2 Big Breakouts Highlight New Market Leadership,2017-06-22 10:48:59 +0000,http://finance.yahoo.com/r/fdb36375-5029-3e80-af82-34b9bdcfc6eb/these-2-big-breakouts-highlight-new-market-leadership-sp-500-futures?src=A00220&yptr=yahoo&.tsrc=rss,"Nasdaq 100 futures edged higher Thursday morning as Oracle surged on strong earnings. On Wednesday, Celgene broke out as biotechs and business software increasingly lead the market rally."
CELG,CELG:UW,BBG000BFCMR2,Celgene Is Headed Much Higher Even After a Monster Breakout,2017-06-22 00:21:00 +0000,http://finance.yahoo.com/r/6e1575c5-660b-35d3-af36-69fcadb0e767/celgene-heading-for-all-time-high.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Biotechs are hot.
CELG,CELG:UW,BBG000BFCMR2,5 Biotech Stocks That Are Roaring Back to Life,2017-06-22 00:19:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fUGdfB4IjU4/5-biotech-stocks-that-are-roaring-back-to-life-cm806624,InvestorPlace Stock Market News Stock Advice amp Trading Tips While the broad market drifts lower in trading on Wednesday for the second day biotech stocks and pharma stocks are blasting to the upside in a rare show of strength amid a week of weakness Source Shutterstock
CELG,CELG:UW,BBG000BFCMR2,Cramer finds where the real growth is in a split market,2017-06-21 22:00:00 +0000,https://finance.yahoo.com/video/cramer-finds-where-real-growth-220000508.html?.tsrc=rss,Jim Cramer tracks the stock market's high-growth sectors and explains the battle between value and growth.
CELG,CELG:UW,BBG000BFCMR2,Finding real growth in a split market,2017-06-21 21:48:00 +0000,https://finance.yahoo.com/video/finding-real-growth-split-market-214800612.html?.tsrc=rss,Jim Cramer tracks the stock market's high-growth sectors and explains the battle between value and growth.
CELG,CELG:UW,BBG000BFCMR2,"Technician: Forget tech, keep buying health-care stocks",2017-06-21 21:08:00 +0000,https://finance.yahoo.com/video/technician-forget-tech-keep-buying-210800075.html?.tsrc=rss,"Robert Sluymer, managing director of at Fundstrat Global Advisors, talks about where to invest in the health-care sector."
CELG,CELG:UW,BBG000BFCMR2,Biotech Breakouts: Biogen Spinoff Bioverativ In Buy Zone,2017-06-21 20:11:47 +0000,http://finance.yahoo.com/r/17bbe4ed-20d2-3541-9615-008ca8ad3ace/biotech-breakouts-biogen-spin-off-bioverativ-in-buy-zone?src=A00220&yptr=yahoo&.tsrc=rss,"Bioverativ shows rising price performance, earning an upgrade to its IBD Relative Strength Rating."
CELG,CELG:UW,BBG000BFCMR2,Benzinga's Option Alert Recap From June 21,2017-06-21 20:08:49 +0000,https://finance.yahoo.com/news/benzingas-option-alert-recap-june-200849226.html?.tsrc=rss,"Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity. Here's a recap of the options alerts from Wednesday, June 21, 2017. All timestamps are in Eastern ..."
CELG,CELG:UW,BBG000BFCMR2,When &apos;New&apos; Means A Stock Hasn&apos;t Led The Market In A While,2017-06-21 19:48:58 +0000,http://finance.yahoo.com/r/e0a7069c-7fac-39fd-9f51-31600f86f9d7/sometimes-new-means-the-stock-hasnt-been-around-for-a-while?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene and Grifols are former leaders, but enough time has passed to give them a new shine."
CELG,CELG:UW,BBG000BFCMR2,Nasdaq Leads Again; Are These 3 Stocks The Next Apple In Biotech Land?,2017-06-21 19:45:55 +0000,http://finance.yahoo.com/r/1a30b82f-ca3e-3263-b98c-414001c5180b/nasdaq-leads-again-are-these-3-stocks-the-next-apple-in-biotech-land?src=A00220&yptr=yahoo&.tsrc=rss,"The Nasdaq composite on Wednesday deflected yet another pounding in crude oil futures and related companies in the stock market, moving moderately higher as the Dow Jones industrial average harbored light losses."
CELG,CELG:UW,BBG000BFCMR2,Wednesday's ETF with Unusual Volume: IBB,2017-06-21 19:20:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vIDPdo23WrA/wednesdays-etf-with-unusual-volume-ibb-cm806440,The iShares Nasdaq Biotechnology ETF IBB is seeing unusually high volume in afternoon trading Wednesday with over 2 9 million shares traded versus three month average volume of about 903 000 Shares of IBB were up about 3 2 on the day Components of that ETF with the highest volume
CELG,CELG:UW,BBG000BFCMR2,Nasdaq Rises; Is Celgene Back From A Two-Year Slump?,2017-06-21 16:03:05 +0000,http://finance.yahoo.com/r/25d4dbd2-de5d-3ae2-81a4-4f0d4b13ccf7/nasdaq-rises-is-celgene-back-from-a-two-year-slump?src=A00220&yptr=yahoo&.tsrc=rss,Biotechs helped the Nasdaq lead a rebound in U.S. equities on Wednesday. Celgene broke out.
CELG,CELG:UW,BBG000BFCMR2,Celgene Clears Buy Point As Biotech Stocks Add To Win Streak,2017-06-21 15:26:00 +0000,http://finance.yahoo.com/r/13afe2fd-d803-375e-b24c-9495575a6f6c/celgene-clears-buy-point-as-biotech-stocks-add-to-win-streak?src=A00220&yptr=yahoo&.tsrc=rss,Celgene cleared a buy point Wednesday. Analysts told IBD that generalist investors are beginning to return to the sector.
CELG,CELG:UW,BBG000BFCMR2,"Biotechs In Focus, Celgene Breaks Out; The Latest On Nike, Apple",2017-06-21 15:26:00 +0000,http://finance.yahoo.com/r/82de8a58-2a33-3ca3-8e24-11de80c0e250/biotechs-in-focus-celgene-breaks-out-the-latest-on-nike-apple?src=A00220&yptr=yahoo&.tsrc=rss,"Stock Market Today for Wednesday: CELG, AAPL, NKE, ORCL"
CELG,CELG:UW,BBG000BFCMR2,"Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More",2017-06-21 15:25:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZllTJ5jWXYA/small-cancer-biotech-space-in-focus-3-stocks-up-100-more-cm806187,The oncology space has always been keenly watched by investors interested in the pharma biotech sector Cancer is the second most common cause of death in the U S preceded only by heart disease According to a report by the American Cancer Society almost 1 7 million cancer cases are expected
CELG,CELG:UW,BBG000BFCMR2,An Overview of Celgene’s Hematology and Oncology Pipeline,2017-06-21 14:38:12 +0000,http://finance.yahoo.com/r/02ac2474-c168-3583-b2e5-853936cb7562/an-overview-of-celgenes-hematology-and-oncology-pipeline?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In December 2016, Celgene’s and Juno Therapeutics’ (JUNO) novel investigational drug, JCAR017, was given breakthrough designation by the US Food and Drug Administration (or FDA)."
CELG,CELG:UW,BBG000BFCMR2,Amgen: In Defense of A Pipeline,2017-06-21 14:35:00 +0000,http://finance.yahoo.com/r/b0c77884-5a47-3ae4-8b7a-cfad798fb9ad/amgen-in-defense-of-a-pipeline-1498055757?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Critics complain that Amgen’s pipeline is bereft of exciting possibilities.  Meanwhile, Amgen’s genetics-based R&D approach hasn’t delivered any homeruns yet, what with sputtering sales of its cholesterol drug Repatha and safety issues surrounding the experimental osteoporosis drug romosozumab."
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt",2017-06-21 13:23:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tJWlLa8XQ64/biotech-stock-roundup-clovis-soars-on-rubraca-data-seattle-hit-by-study-halt-cm806136,Clovis CLVS and Seattle Genetics SGEN were both in the news with the companies providing pipeline updates while Clovis shares soared on positive Rubraca data Seattle Genetics shares were impacted by the discontinuation of a late stage study Recap of the Week s Most Important
CELG,CELG:UW,BBG000BFCMR2,What’s in Celgene’s Immunology and Inflammation Clinical Pipeline?,2017-06-21 13:08:32 +0000,http://finance.yahoo.com/r/69cebaea-e2ba-33a3-834e-035dba840ba9/whats-in-celgenes-immunology-and-inflammation-clinical-pipeline?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Celgene has entered a strategic collaboration with Acceleron for the development of luspatercept.
CELG,CELG:UW,BBG000BFCMR2,Why Abraxane Could See Steady Growth in 2017,2017-06-21 11:37:16 +0000,http://finance.yahoo.com/r/cc3dc3b5-06c6-3fe5-bb5c-c1b2b3efae36/why-abraxane-could-see-steady-growth-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Celgene’s (CELG) Abraxane reported revenues of ~$973 million, which is ~1% year-over-year (or YoY) growth."
CELG,CELG:UW,BBG000BFCMR2,Why Pomalyst Could See Significant Revenue Growth in 2017,2017-06-20 22:05:43 +0000,http://finance.yahoo.com/r/95f53564-2f92-3041-a6c3-84b674b0f87a/why-pomalyst-could-see-significant-revenue-growth-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Celgene’s (CELG) Pomalyst crossed the $1 billion sales mark."
CELG,CELG:UW,BBG000BFCMR2,"‘Trader’s favorite’ Nvidia should be a ‘long-term investor’s favorite’ too, strategist argues",2017-06-20 21:35:39 +0000,https://finance.yahoo.com/news/trader-favorite-nvidia-long-term-213539984.html?.tsrc=rss,"Interest in chipmaker Nvidia has exploded, and one technician says the stock has room to run."
CELG,CELG:UW,BBG000BFCMR2,"‘Trader’s favorite’ Nvidia should be a ‘long-term investor’s favorite’ too, strategist argues",2017-06-20 21:35:39 +0000,http://finance.yahoo.com/r/4c29da92-c880-3d34-96e1-9be2cdfdb3dc/104541142?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104541142&yptr=yahoo&.tsrc=rss,"Interest in chipmaker Nvidia has exploded, and one technician says the stock has room to run."
CELG,CELG:UW,BBG000BFCMR2,Revlimid Could Continue to Drive Celgene’s Revenue Growth in 2017,2017-06-20 20:36:18 +0000,http://finance.yahoo.com/r/fbd25c44-6393-3d4f-b546-3c4079236b8b/revlimid-could-continue-to-drive-celgenes-revenue-growth-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Celgene’s (CELG) Revlimid generated revenues of around $6.9 billion, which reflected a ~20% year-over-year (or YOY) growth."
CELG,CELG:UW,BBG000BFCMR2,Biotech Stock With 50% Profit Margin Nears Buy Zone,2017-06-20 20:13:24 +0000,http://finance.yahoo.com/r/10091ed6-bb82-3292-bdfa-4cfdc5ef8fa1/biotech-stock-with-50-profit-margin-nears-buy-zone?src=A00220&yptr=yahoo&.tsrc=rss,"On Tuesday, Celgene got an upgrade for its IBD SmartSelect Composite Rating from 94﻿﻿ ﻿to 97."
CELG,CELG:UW,BBG000BFCMR2,"Nasdaq Falls, Dow Holds Up; Biotechs On Fire As Oil Slumps Again",2017-06-20 19:05:45 +0000,http://finance.yahoo.com/r/05b33a8a-5067-32b5-96d3-6e03a310f1b1/nasdaq-falls-dow-holds-up-biotechs-on-fire-oil-slumps-again?src=A00220&yptr=yahoo&.tsrc=rss,The Nasdaq composite followed up Monday&apos;s bullish gain in lower volume with a 0.5% decline in higher volume in late trading Tuesday.
CELG,CELG:UW,BBG000BFCMR2,How Did Celgene Perform in 1Q17?,2017-06-20 18:45:19 +0000,http://finance.yahoo.com/r/6571ed91-7b16-3242-adc0-f7aa1781ee2c/how-did-celgene-perform-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Celgene (CELG) reported revenues of ~$3.0 billion, an increase of ~18% year-over-year (or YoY)."
CELG,CELG:UW,BBG000BFCMR2,Biotech Stocks To Watch And Pharma Industry News,2017-06-20 18:39:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
CELG,CELG:UW,BBG000BFCMR2,Biotech Funds Could Break Out,2017-06-20 15:01:00 +0000,http://finance.yahoo.com/r/ee8138be-e853-3904-9d0f-2a476179ee61/biotech-funds-could-break-out-xbi-ibb?partner=YahooSA&yptr=yahoo&.tsrc=rss,Capital exiting 2017 market leaders is pouring into biotech funds. Is the sector's two-year correction coming to an end?
CELG,CELG:UW,BBG000BFCMR2,Analyzing Eli Lilly’s Collaboration with KeyBioscience AG,2017-06-20 13:06:31 +0000,http://finance.yahoo.com/r/2df4f3e9-c376-3050-aceb-602e61abba20/analyzing-eli-lillys-collaboration-with-keybioscience-ag?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On June 8, 2017, Eli Lilly (LLY) announced a strategic collaboration with KeyBioscience AG to focus on the development of dual amylin calcitonin receptor agonists (or DACRAs)."
CELG,CELG:UW,BBG000BFCMR2,Celgene Presents Interim Results from Cancer Drug Study,2017-06-19 17:20:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WhrfJzuWBKg/celgene-presents-interim-results-from-cancer-drug-study-cm805166,Celgene Corporation CELG announced encouraging results from an interim analysis of a phase IIIb study MAGNIFY on Revlimid The study evaluated Revlimid in combination with Roche Holding AG s RHHBY Rituxan R2 in patients with relapsed or refractory marginal zone lymphoma MZL The
CELG,CELG:UW,BBG000BFCMR2,Health Care Select Sector SPDR Fund Experiences Big Inflow,2017-06-19 16:19:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z6rdKqfHmTo/health-care-select-sector-spdr-fund-experiences-big-inflow-cm805089,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 170 9 million dollar inflow that s a 1 0 increase week over week
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Apple, Procter & Gamble, Celgene, PayPal and Southern",2017-06-19 15:24:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vYxV_HeOMHY/the-zacks-analyst-blog-highlights-apple-procter-gamble-celgene-paypal-and-southern-cm805027,For Immediate Release Chicago IL June 19 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog include
CELG,CELG:UW,BBG000BFCMR2,"Biogen: ""The Underperformance Stops Here""",2017-06-19 15:11:00 +0000,http://finance.yahoo.com/r/05671a65-d2e2-3e72-886c-753d7d8245b3/biogen-the-underperformance-stops-here-1497885096?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It was more than three months ago when UBS warned investors to exit Biogen (BIIB), initiating coverage on the drug maker at a Sell and predicting the shares would fall to $260 a share.  Analyst Carter Gould’s prediction came to bear.  As of Friday’s close, Biogen’s share price had fallen to just under $252, a more than 14% decline since he set his sell rating on March 8."
CELG,CELG:UW,BBG000BFCMR2,Celgene Presents Interim Results from Cancer Drug Study,2017-06-19 15:01:03 +0000,https://finance.yahoo.com/news/celgene-presents-interim-results-cancer-150103615.html?.tsrc=rss,"Celgene Corporation (CELG) announced encouraging results from an interim analysis of a phase IIIb study, MAGNIFY, on Revlimid."
CELG,CELG:UW,BBG000BFCMR2,J&J Immunotherapy Darzalex Ok'd for Expanded Combination Use,2017-06-19 14:24:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6JmUlFmh5KI/jj-immunotherapy-darzalex-okd-for-expanded-combination-use-cm804934,Johnson amp Johnson JNJ announced that its immunotherapy Darzalex has been approved for use in combination with Celgene Corporation s CELG multiple myeloma drug Pomalyst pomalidomide and dexamethasone The combination has been approved for the treatment of patients with multiple myeloma
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Apple, Procter & Gamble, Celgene, PayPal and Southern",2017-06-19 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-apple-133001859.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Apple, Procter & Gamble, Celgene, PayPal and Southern"
CELG,CELG:UW,BBG000BFCMR2,J&J Immunotherapy Darzalex Ok&apos;d for Expanded Combination Use,2017-06-19 12:43:12 +0000,https://finance.yahoo.com/news/j-j-immunotherapy-darzalex-ok-124312442.html?.tsrc=rss,"Johnson & Johnson (JNJ) announced that its immunotherapy, Darzalex has been approved for use in combination with Celgene Corporation&apos;s (CELG) multiple myeloma drug Pomalyst (pomalidomide) and dexamethasone."
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Clinical Data Evaluating Broad Range of Blood Cancers to Be Presented at EHA 2017,2017-06-19 11:30:00 +0000,https://finance.yahoo.com/news/celgene-announces-clinical-data-evaluating-113000665.html?.tsrc=rss,"Celgene Corporation today announced that data from a broad range of company-sponsored and investigator-initiated studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 22nd European Hematology Association annual meeting in Madrid, Spain, from June 22-25, 2017."
CELG,CELG:UW,BBG000BFCMR2,InPlay from Briefing.com,2017-06-19 06:51:50 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
CELG,CELG:UW,BBG000BFCMR2,"FDA Nod For Ipsen, XNCR On Watch, Results MAGNIFY CELG's R2 Regimen",2017-06-18 19:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XpfTopwKZVU/fda-nod-for-ipsen-xncr-on-watch-results-magnify-celgs-r2-regimen-20170618-00025,"FDA Nod For Ipsen, XNCR On Watch, Results MAGNIFY CELG's R2 Regimen"
CELG,CELG:UW,BBG000BFCMR2,"FDA Nod For Ipsen, XNCR On Watch, Results MAGINIFY CELG's R2 Regimen",2017-06-18 19:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q6eH-y_jV3U/fda-nod-for-ipsen-xncr-on-watch-results-maginify-celgs-r2-regimen-20170618-00024,"FDA Nod For Ipsen, XNCR On Watch, Results MAGINIFY CELG's R2 Regimen"
CELG,CELG:UW,BBG000BFCMR2,3 Top Healthcare Stocks You Haven't Thought Of,2017-06-18 14:20:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PO-KVAeTWcc/3-top-healthcare-stocks-you-havent-thought-of-cm804795,The best performing healthcare stocks typically receive little to no fanfare until after they ve already made a monstrous move upward 160 Many 160 fly under the radar before reaching a major value creating event such as a pivotal clinical or regulatory catalyst With this theme
CELG,CELG:UW,BBG000BFCMR2,3 Top Healthcare Stocks You Haven&apos;t Thought Of,2017-06-18 13:07:00 +0000,http://finance.yahoo.com/r/94f2e018-2bc2-3560-8970-12f089e2032c/3-top-healthcare-stocks-you-havent-thought-of.aspx?yptr=yahoo&.tsrc=rss,"Jounce Therapeutics, Lexicon Pharmaceuticals, and Paratek Pharmaceuticals might be three hidden gems in the healthcare sector worth checking out."
CELG,CELG:UW,BBG000BFCMR2,Updated Data from Phase IIIb MAGNIFY Study of REVLIMID (lenalidomide) and Rituximab Combination (R2) Show Clinical Activity and Responses in Relapsed/Refractory Follicular and Marginal Zone Lymphoma,2017-06-17 11:30:00 +0000,https://finance.yahoo.com/news/updated-data-phase-iiib-magnify-113000516.html?.tsrc=rss,"Celgene Corporation today announced results from an interim analysis of MAGNIFY, a phase IIIb, randomized, open-label, multicenter study of REVLIMID plus rituximab combination therapy in patients with relapsed or refractory marginal zone lymphoma ."
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Trades to Diversify Your Portfolio,2017-06-16 21:22:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/31G7gL4xXkU/3-biotech-trades-to-diversify-your-portfolio-cm804636,InvestorPlace Stock Market News Stock Advice amp Trading Tips Is biotech a buy sell or hold The answer is that depends But in this strategist s view and in paying homage to the price charts of Regeneron Pharmaceuticals Inc NASDAQ REGN Amgen Inc NASDAQ AMGN
CELG,CELG:UW,BBG000BFCMR2,"Notable Friday Option Activity: AZO, IMPV, CELG",2017-06-16 21:19:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wkm36cPgS1w/notable-friday-option-activity-azo-impv-celg-cm804596,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in AutoZone Inc Symbol AZO where a total of 3 719 contracts have traded so far representing approximately 371 900 underlying shares That amounts to about 51 8 of AZO s average
CELG,CELG:UW,BBG000BFCMR2,Celgene&apos;s Future Is Tied To One &apos;Mixer&apos; Drug — And That&apos;s OK,2017-06-16 20:47:38 +0000,http://finance.yahoo.com/r/d75c6306-9e36-3d96-9cef-bd2f24e11e88/celgenes-future-is-tied-to-one-mixer-drug-and-thats-ok?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene&apos;s Revlimid will continue to carry the biotech even after losing patent exclusivity in 2026, an analyst said Friday."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. – Value Analysis (NASDAQ:CELG) : June 16, 2017",2017-06-16 20:42:54 +0000,http://finance.yahoo.com/r/fda9b005-906e-3cb9-9abe-8e12d2be04b3/celgene-corp-value-analysis-nasdaqcelg-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Celgene Corp. a score of 78. Our analysis is based on comparing Celgene Corp. with the following peers – Amgen Inc., Gilead Sciences, Inc., Biogen Inc., OncoMed Pharmaceuticals, Inc., Eli Lilly and Company, Alexion Pharmaceuticals, Inc., Johnson & Johnson, Illumina, Inc., Novartis AG Sponsored ADR and Acceleron ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,"Nike, Kroger Downgraded; Celgene Upgraded; Lam Research Gets PT Hike",2017-06-16 20:06:29 +0000,http://finance.yahoo.com/r/b860afd3-7ba7-325d-924c-cc4cc5b9ad94/nike-kroger-downgraded-celgene-upgraded-lam-research-gets-pt-hike?src=A00220&yptr=yahoo&.tsrc=rss,"Analyst actions on Friday included downgrades for Nike and Kroger, an upgrade for Celgene and price-target hikes for Lam Research and Athenahealth."
CELG,CELG:UW,BBG000BFCMR2,"Top Analyst Reports for Apple, Procter & Gamble, and Celgene",2017-06-16 19:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6xUsk7Jy_8I/top-analyst-reports-for-apple-procter-gamble-and-celgene-cm804575,Friday June 16 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 16 major stocks including Apple AAPL Procter amp Gamble PG and Celgene CELG These research reports have been hand picked from
CELG,CELG:UW,BBG000BFCMR2,Why Celgene is Bucking Biotech Weakness Today,2017-06-16 18:50:00 +0000,http://finance.yahoo.com/r/feccaa13-c9a0-353f-aa27-d189f1d0877c/why-celgene-is-bucking-biotech-weakness-today-1497639007?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Big biotech stocks have been under pressure today, but not Celegene (CELG), which was upgraded by Leerink today.  Gilead Sciences (GILD) has fallen, while Amgen (AMGN) has decline, Biogen (BIIB) is off, and Regeneron Pharmaceuticals (REGN) has dropped.  Leerink's Geoffrey Porges and Bradley Canino explain why they upgraded Celgene to Outperform from Market Perform: We are upgrading Celgene to Outperform based on the stock’s discounted valuation, our existing price target, our above-consensus estimates, expected positive trajectory for Q2, and imminent pipeline validation events in the second half of 2017."
CELG,CELG:UW,BBG000BFCMR2,2 Incredibly Cheap Biotech Stocks,2017-06-16 17:49:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DCnN66hYRnY/2-incredibly-cheap-biotech-stocks-cm804492,Biotech stocks sport some of the richest valuations in the market today making it hard to suss out any attractive bargains within this high flying group The average forward price to earnings ratio among large cap biotechs after all presently stands at a stately 45 2 Having
CELG,CELG:UW,BBG000BFCMR2,"Top Analyst Reports for Apple, Procter & Gamble, and Celgene",2017-06-16 17:08:05 +0000,https://finance.yahoo.com/news/top-analyst-reports-apple-procter-170805279.html?.tsrc=rss,"Top Analyst Reports for Apple, Procter & Gamble, and Celgene"
CELG,CELG:UW,BBG000BFCMR2,2 Incredibly Cheap Biotech Stocks,2017-06-16 16:47:00 +0000,http://finance.yahoo.com/r/1ebc81a5-7dd2-3943-98ee-e489baa153c5/2-incredibly-cheap-biotech-stocks.aspx?yptr=yahoo&.tsrc=rss,"Amgen and Celgene are trading at sizable discounts right now, but are they bargains?"
CELG,CELG:UW,BBG000BFCMR2,3 Top-Performing Biotech Stocks This Week,2017-06-16 13:09:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TuZKrWahRDE/3-top-performing-biotech-stocks-this-week-cm804215,The market may be moving into the summer doldrums but some biotechnology stocks continue to put up impressive results This past week the best performing stocks in the industry included Kite Pharma NASDAQ KITE bluebird bio NASDAQ BLUE and Lexicon
CELG,CELG:UW,BBG000BFCMR2,"Morning Movers: Celgene Gains, Nike Drops, Valeant Rises",2017-06-16 12:30:00 +0000,http://finance.yahoo.com/r/a5985b1e-def4-39bf-a71c-64afe4228996/morning-movers-celgene-gains-nike-drops-valeant-rises-1497616254?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a higher open this morning following recent selling pressure. S&P 500 futures have risen 0.1%, while Dow Jones Industrial Average futures have advanced 0.1%. Nasdaq Composite futures ..."
CELG,CELG:UW,BBG000BFCMR2,3 Top-Performing Biotech Stocks This Week,2017-06-16 11:41:00 +0000,http://finance.yahoo.com/r/31ced567-a06e-39ac-922b-c09142ac8de8/3-top-performing-biotech-stocks-this-week.aspx?yptr=yahoo&.tsrc=rss,"Here&apos;s why shares of Kite Pharma, bluebird bio, and Lexicon Pharmaceuticals shot higher this past week."
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Reports Data on Lupus Drug in Phase II Trial,2017-06-16 00:06:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BByQyNFvC0A/celgene-celg-reports-data-on-lupus-drug-in-phase-ii-trial-cm804154,Celgene Corporation CELG announced results from the phase II trial SLE 001 at the Annual European Congress of Rheumatology EULAR 2017 in Madrid The trial evaluated investigational candidate CC 220 The data showed greater improvement with CC 220 an oral immunomodulatory compound
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Reports Data on Lupus Drug in Phase II Trial,2017-06-15 21:45:09 +0000,https://finance.yahoo.com/news/celgene-celg-reports-data-lupus-214509983.html?.tsrc=rss,"Celgene Corporation (CELG) announced results from the phase II trial, SLE-001 which evaluated lupus candidate, CC-220, at the Annual European Congress of Rheumatology (EULAR) 2017 in Madrid."
CELG,CELG:UW,BBG000BFCMR2,Could This Small Biotech Pique Interest Of Gilead And Others?,2017-06-15 19:20:00 +0000,http://finance.yahoo.com/r/32d887b7-a74e-3009-93af-7a9442c9f157/could-this-small-biotech-whet-gileads-thirst-for-an-oncology-play?src=A00220&yptr=yahoo&.tsrc=rss,A slew of biotechs and drugmakers might take a closer look at Epizyme after the small-cap biotech presented strong data in a lymphoma trial.
CELG,CELG:UW,BBG000BFCMR2,Don’t Be Scared of Biogen Inc (BIIB) Stock,2017-06-15 18:11:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cJJTbSsumKs/dont-be-scared-of-biogen-inc-biib-stock-cm804035,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biogen Inc NASDAQ BIIB stock has had a choppy few months It has been ping ponging back and forth by 15 in either direction as political rhetoric weighs on biotechs Politicians have used
CELG,CELG:UW,BBG000BFCMR2,Can Celgene Corporation Be a Value Stock?,2017-06-15 15:09:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pe91odb_0tg/can-celgene-corporation-be-a-value-stock-cm803809,Call me crazy but I don t think Celgene Corporation NASDAQ CELG is quite as expensive as it looks on the surface Sure the biotech stock is trading at a price to earnings multiple nearly twice that of the average stock in the benchmark S amp P 500 index but the oncology giant
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug",2017-06-15 14:12:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/48Ck4WkI57Y/biotech-stock-roundup-management-changes-at-biogen-alexion-gild-files-hiv-drug-cm803727,Biogen BIIB and Alexion ALXN were both in the headlines this week with the companies announcing management changes while Biogen s shares were down on the news Alexion s shares soared Meanwhile Gilead GILD continues to work on strengthening its HIV franchise with the company now seeking
CELG,CELG:UW,BBG000BFCMR2,Can Celgene Corporation Be a Value Stock?,2017-06-15 13:11:00 +0000,http://finance.yahoo.com/r/665bde5c-81c0-3043-8db9-155827907de0/can-celgene-corporation-be-a-value-stock.aspx?yptr=yahoo&.tsrc=rss,"Celgene&apos;s valuation looks sky high, but expectations are even higher. Is it time to buy?"
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug",2017-06-15 12:26:12 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-management-changes-122612497.html?.tsrc=rss,Key highlights in the biotech sector include management changes for Biogen (BIIB) and Alexion as well as a regulatory filing for Gilead&apos;s HIV regimen.
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : June 15, 2017",2017-06-15 12:14:01 +0000,http://finance.yahoo.com/r/c8249c9a-ebc0-3b0d-9191-48d568179270/celgene-corp-breached-its-50-day-moving-average-in-a-bullish-manner-celg-us-june-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Celgene Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,Acceleron (XLRN) Kidney Cancer Candidate Fails in Phase II,2017-06-14 21:09:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HiUGy6unu8Y/acceleron-xlrn-kidney-cancer-candidate-fails-in-phase-ii-cm803508,Acceleron Pharma Inc s XLRN stock had gone down earlier and then regained ground by almost 5 after the company announced disappointing top line results from a phase II DART study evaluating its pipeline candidate dalantercept in combination with Pfizer s PFE Inlyta axitinib for treatment
CELG,CELG:UW,BBG000BFCMR2,Phase 2a Safety and Efficacy Data Support Further Development of Oral CC-220 in Patients with Lupus,2017-06-14 11:30:00 +0000,https://finance.yahoo.com/news/phase-2a-safety-efficacy-data-113000621.html?.tsrc=rss,"Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation , today announced results from the phase 2a SLE-001 trial evaluating CC-220, the Company's investigational, oral immunomodulatory compound, at the Annual European Congress of Rheumatology 2017 in Madrid."
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Results From Phase 2a SLE-001 Trial Evaluating CC-220,2017-06-14 07:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yrk7ZIfGs_E/celgene-announces-results-from-phase-2a-sle001-trial-evaluating-cc220-20170614-00309,Celgene Announces Results From Phase 2a SLE-001 Trial Evaluating CC-220
CELG,CELG:UW,BBG000BFCMR2,Amgen's Multiple Myeloma Drug Receives NICE Recommendation,2017-06-13 15:32:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EirVuGMFOAU/amgens-multiple-myeloma-drug-receives-nice-recommendation-cm802675,Amgen Inc AMGN announced that Kyprolis gained recommendation from National Institute for Health and Care Excellence NICE in combination with dexamethasone for the treatment of relapsed multiple myeloma RMM in patients who have received at least one prior therapy excluding Johnson
CELG,CELG:UW,BBG000BFCMR2,Merck Stalls Enrolment in Two Myeloma Studies of Keytruda,2017-06-13 15:32:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dBb2SZtz8ks/merck-stalls-enrolment-in-two-myeloma-studies-of-keytruda-cm802663,Merck amp Co Inc MRK announced that it is pausing two late stage studies evaluating its anti PD 1 therapy Keytruda as a combination therapy for the treatment of multiple melanoma a form of blood cancer Shares were down more than 1 in after hours trading Merck s shares are up 9 2
CELG,CELG:UW,BBG000BFCMR2,Celgene's Next Blockbuster: What You Need to Know,2017-06-13 13:29:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4gdxEHORCLw/celgenes-next-blockbuster-what-you-need-to-know-cm802508,Celgene NASDAQ CELG gets no respect The company has 3 blockbuster drugs including what could be the best selling cancer drug of 2017 the best growth rate in large cap biotech and a PEG ratio below 1 And yet Celgene has so far failed to outperform the S amp P over
CELG,CELG:UW,BBG000BFCMR2,"Excitement from ASCO: TG Thereapeutics, Loxo Oncology, and Bluebird Bio",2017-06-13 13:29:00 +0000,http://finance.yahoo.com/r/780dd542-afa9-3c18-8f22-243958fa3931/industry-focus-healthcare-06-07-2017.aspx?yptr=yahoo&.tsrc=rss,"After presentations at the annual American Society of Clinical Oncology conference this week sent shares higher, investors in bluebird bio, TG Therapeutics, and Loxo Oncology are cheering."
CELG,CELG:UW,BBG000BFCMR2,Today's Research Reports on Stocks to Watch: Celgene and Teva Pharmaceutical Industries,2017-06-13 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000865.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 13, 2017 / U.S. markets dipped Monday as the Tech sector's sell-off continued for the second consecutive session. The Dow Jones Industrial Average declined 0.17 percent ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene&apos;s Next Blockbuster: What You Need to Know,2017-06-13 11:24:00 +0000,http://finance.yahoo.com/r/a394d239-7bf0-3fc3-8101-ca8a60bcafdd/celgenes-next-blockbuster-what-you-need-to-know.aspx?yptr=yahoo&.tsrc=rss,Could Celgene&apos;s newest drug finally get this company the respect it deserves?
CELG,CELG:UW,BBG000BFCMR2,[$$] Dragonfly Therapeutics Strikes Immuno-Oncology Deal With Celgene,2017-06-12 21:51:23 +0000,http://finance.yahoo.com/r/de453ae3-9847-33f1-ab71-589db9d8ae5e/dragonfly-therapeutics-strikes-immuno-oncology-deal-with-celgene-1497304281?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Dragonfly Therapeutics Inc. has secured $33 million through a collaboration with Celgene Corp. to develop immuno-oncology treatments for various blood cancers.
CELG,CELG:UW,BBG000BFCMR2,Merck to pause two late-stage studies testing Keytruda in myeloma,2017-06-12 21:18:13 +0000,https://finance.yahoo.com/news/merck-pause-two-stage-studies-211813664.html?.tsrc=rss,"Merck & Co said it paused  enrolments in two late-stage studies testing its immunotherapy  drug, Keytruda, for multiple myeloma, in combination with other  therapies, as the U.S. drugmaker looks to better understand more  reports of death in the Keytruda groups.  Merck said the action followed recommendation by an external  data monitoring committee and that patients currently enrolled  in the two studies would continue to receive the treatment.  The trials included combinations with Celgene Corp's  Pomalyst and Revlimid."
CELG,CELG:UW,BBG000BFCMR2,"Waltham-based Dragonfly inks collaboration with Celgene, bags $33M",2017-06-12 15:15:09 +0000,http://finance.yahoo.com/r/95e6643d-c32a-3675-92bc-33a0af8e7c1a/waltham-based-dragonfly-inks-collaboration-with.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Dragonfly Therapeutics, a 20-employee Waltham biotech co-founded by the head of the Koch Institute at MIT, has struck a collaboration deal with Celgene Corp. to develop drugs that mobilize the immune system to fight blood cancers.  Dragonfly said Monday it will receive $33 million upfront in the deal, plus undisclosed potential milestone payments and royalties.  New Jersey-based Celgene (CELG), meanwhile, gets an exclusive option to in-license global rights for up to four drugs targeting acute myeloid leukemia, multiple myeloma and other blood cancers."
CELG,CELG:UW,BBG000BFCMR2,Moody's: Patent invalidation creates risk for US branded drug makers,2017-06-12 14:47:05 +0000,http://finance.yahoo.com/r/83b7fb47-a35e-3885-82d7-be1ba83abbcd/viewresearchdoc.aspx?docid=PR_368089&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170612_PR_368089&yptr=yahoo&.tsrc=rss,"Announcement: Moody's: Patent invalidation creates risk for US branded drug makers. Global Credit Research- 12 Jun 2017. New York, June 12, 2017-- A number of blockbuster drugs are undergoing patent reviews ..."
CELG,CELG:UW,BBG000BFCMR2,9 Biotech Stats That Will Blow You Away,2017-06-12 14:31:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-8a3oNDm2oY/9-biotech-stats-that-will-blow-you-away-cm801994,In many ways the biotech industry could be described as Wall Street s roulette wheel The odds are certainly against your succeeding with many drug developers losing money and looking to simply get their first drug approved However for those that do succeed the returns can be
CELG,CELG:UW,BBG000BFCMR2,Short Interest Surges in Major Biotechs,2017-06-12 13:40:31 +0000,https://finance.yahoo.com/news/short-interest-surges-major-biotechs-134031686.html?.tsrc=rss,"The May 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased."
CELG,CELG:UW,BBG000BFCMR2,Seeking Alpha Interviews: Bret Jensen,2017-06-12 13:28:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XLry0Q1hdq4/seeking-alpha-interviews-bret-jensen-cm801975,By LilaMax Media ByLilaMax Media In the tenth episode of Seeking Alpha Interviews LilaMax s Jane King sits down with Bret Jensen of The Biotech Forum and The Insiders Forum to discuss the general state of the biotech sector the narrow range it s been trading in for the past five months
CELG,CELG:UW,BBG000BFCMR2,GILD Named A Top Socially Responsible Dividend Stock,2017-06-12 13:26:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w6_kg7M3jx4/gild-named-a-top-socially-responsible-dividend-stock-cm801781,Gilead Sciences Inc Symbol GILD has been named a Top Socially Responsible Dividend Stock by Dividend Channel signifying a stock with above average DividendRank statistics including a strong 3 2 yield as well as being recognized by prominent asset managers as being a
CELG,CELG:UW,BBG000BFCMR2,9 Biotech Stats That Will Blow You Away,2017-06-12 12:23:00 +0000,http://finance.yahoo.com/r/a61a1764-b4a9-30a6-85c9-e4c83e9291df/9-biotech-stats-that-will-blow-you-away.aspx?yptr=yahoo&.tsrc=rss,How much do you really know about the costs of developing a drug?
CELG,CELG:UW,BBG000BFCMR2,"Notable Friday Option Activity: MET, CELG, CAT",2017-06-09 20:28:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IS0KPAtD3p8/notable-friday-option-activity-met-celg-cat-cm801420,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in MetLife Inc Symbol MET where a total of 33 008 contracts have traded so far representing approximately 3 3 million underlying shares That amounts to about 67 4 of MET s average
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation (CELG) Stock’s Range Is Tight — Time to Profit,2017-06-09 19:29:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/drIhzrEULLQ/celgene-corporation-celg-stocks-range-is-tight-time-to-profit-cm801436,InvestorPlace Stock Market News Stock Advice amp Trading Tips Celgene Corporation s NASDAQ CELG stock price is relatively flattish in 2017 but not without its drama We saw a 15 rally followed by a 10 correction before reverting back to near the short term mean
CELG,CELG:UW,BBG000BFCMR2,The 3 Best Value Stocks You Can Buy Right Now,2017-06-09 17:45:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nrHIibn3RUA/the-3-best-value-stocks-you-can-buy-right-now-cm801313,High flying growth stocks might grab all the headlines but even the best businesses can provide inferior returns if you overpay for them This is why the world s most successful investors scour the markets for the best value stocks or those currently trading at a discount to
CELG,CELG:UW,BBG000BFCMR2,"BIB, CELG, AMGN, INCY: ETF Inflow Alert",2017-06-09 16:30:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vfFaGmpkUtI/bib-celg-amgn-incy-etf-inflow-alert-cm801286,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the ProShares Ultra Nasdaq Biotechnology Symbol BIB where we have detected an approximate 63 0 million dollar inflow that s a 17 3 increase week over week
CELG,CELG:UW,BBG000BFCMR2,The 3 Best Value Stocks You Can Buy Right Now,2017-06-09 16:17:00 +0000,http://finance.yahoo.com/r/292156be-1324-3b4c-8dce-3ab5cea4ea9d/the-3-best-value-stocks-you-can-buy-right-now.aspx?yptr=yahoo&.tsrc=rss,These large-cap value stocks belong at the top of your shopping list.
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation (CELG) Stock’s Range Is Tight — Time to Profit,2017-06-09 15:07:58 +0000,https://finance.yahoo.com/news/celgene-corporation-celg-stock-range-150758009.html?.tsrc=rss,"Celgene Corporation’s (NASDAQ:CELG) stock price is relatively flattish in 2017 but not without its drama.  Fundamentally, Celgene stock is not cheap.  Except for a couple of nervous Nelly analysts, most of those who cover it have a bullish bias on CELG stock."
CELG,CELG:UW,BBG000BFCMR2,2 Reasons Why Biogen's Shares Slumped in May,2017-06-09 12:28:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a4CVlQ_-1eU/2-reasons-why-biogens-shares-slumped-in-may-cm801005,What happened Biotech titan Biogen NASDAQ BIIB had a rough time last month as a pair of unrelated issues helped send its shares down by 8 58 according to data from S amp P Global Market Intelligence First off the biotech industry as a whole took a step back in
CELG,CELG:UW,BBG000BFCMR2,2 Reasons Why Biogen&apos;s Shares Slumped in May,2017-06-09 11:22:00 +0000,http://finance.yahoo.com/r/876cc1bc-b71e-3c5d-8370-6bf32160dffc/2-reasons-why-biogens-shares-slumped-in-may.aspx?yptr=yahoo&.tsrc=rss,A pair of unrelated issues helped send the large-cap biotech&apos;s shares down by 8.58% over the month -- only one of them company-specific.
CELG,CELG:UW,BBG000BFCMR2,"Juno Therapeutics: To Sell, Or Not To Sell…Good Question",2017-06-08 14:13:00 +0000,http://finance.yahoo.com/r/7e2b76a1-5269-37d2-be3a-a3263c8586b9/juno-therapeutics-to-sell-or-not-to-sellgood-question-1496931199?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Is it time to shed shares of Juno Therapeutics (JUNO)?  BTIG analyst Dane Leone thinks so.  The drug maker’s stock price is down 4% today to $22.75 a share after Leone cut his rating from a Neutral to a Sell with a $12 price target.
CELG,CELG:UW,BBG000BFCMR2,3 Large-Cap Stocks for June,2017-06-08 13:44:00 +0000,http://finance.yahoo.com/r/30a728ec-ff3e-3e54-bce4-d8a57b247025/3-large-cap-stocks-for-june.aspx?yptr=yahoo&.tsrc=rss,"Not only are these already very big companies, but two are at their all-time highs. We still think they&apos;re worth buying now. Keep reading to learn why that&apos;s the case."
CELG,CELG:UW,BBG000BFCMR2,"Gainers & Losers Of June 7: NH, CRUS, PTCT, ANAB, ACRX...",2017-06-08 00:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9ktmTE5eBQs/gainers--losers-of-june-7-nh-crus-ptct-anab-acrx-20170608-00005,"Gainers & Losers Of June 7: NH, CRUS, PTCT, ANAB, ACRX..."
CELG,CELG:UW,BBG000BFCMR2,Why bluebird bio Inc. Flew Higher Again Today,2017-06-07 20:53:00 +0000,http://finance.yahoo.com/r/cd68c6fc-ab95-3d8d-8f8d-dbb7fb401adb/why-bluebird-bio-inc-flew-higher-again-today.aspx?yptr=yahoo&.tsrc=rss,The biotech&apos;s post-ASCO run continues.
CELG,CELG:UW,BBG000BFCMR2,ASCO Was A Bust For Biotech,2017-06-07 16:56:00 +0000,http://finance.yahoo.com/r/178aa1da-6eb2-3749-8f4f-e84b484ddea4/asco-was-a-bust-for-biotech-1496854582?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The American Society of Clinical Oncology meeting is one of the most closely watched medical conferences of the year.  The Wall Street Journal’s “Heard on the Street” columnist Charley Grant noted today that this year’s conference, which ended Tuesday, passed “without much of a stir, at least from an investor point of view.” In short, while some individual stocks rose and fell sharply, the broader S&P Biotechnology Select Industry Index essentially hasn’t moved through Tuesday."
CELG,CELG:UW,BBG000BFCMR2,Celgene and Agios Announce Data on Idhifa for Leukemia,2017-06-07 15:29:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5XZZWfVxQeg/celgene-and-agios-announce-data-on-idhifa-for-leukemia-cm800067,Celgene Corporation CELG and partner Agios Pharmaceuticals Inc AGIO announced new efficacy and safety data from the ongoing phase I dose escalation and expansion study on experimental candidate Idhifa enasidenib at an oral session at the American Society of Clinical Oncology ASCO
CELG,CELG:UW,BBG000BFCMR2,Celgene and Agios Announce Data on Idhifa for Leukemia,2017-06-07 14:07:02 +0000,https://finance.yahoo.com/news/celgene-agios-announce-data-idhifa-140702653.html?.tsrc=rss,"Celgene Corporation (CELG) and Agios Pharmaceuticals, Inc. (AGIO) announced new efficacy and safety data on experimental candidate Idhifa (enasidenib)."
CELG,CELG:UW,BBG000BFCMR2,3 Promising Stocks to Buy Now,2017-06-07 12:22:00 +0000,http://finance.yahoo.com/r/1320692b-4a10-3dda-9a7c-46f82d06eed8/3-promising-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"Shopify, Lumentum, and bluebird bio could be on the cusp of becoming much bigger companies, according to this Motley Fool contributor."
CELG,CELG:UW,BBG000BFCMR2,"Gainers & Losers Of June 6: VTL, EGLT, AMRI, AGLE, CRVS...",2017-06-06 21:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K3VHQ4BgSNM/gainers--losers-of-june-6-vtl-eglt-amri-agle-crvs-20170606-01380,"Gainers & Losers Of June 6: VTL, EGLT, AMRI, AGLE, CRVS..."
CELG,CELG:UW,BBG000BFCMR2,Top Health Stocks to Buy Now,2017-06-06 21:18:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/co6JKKGeNcQ/top-health-stocks-to-buy-now-cm799654,What are the top health stocks to buy now There is a wide range of U S and international healthcare and medical choices to invest in Three health stocks in particular look especially intriguing
CELG,CELG:UW,BBG000BFCMR2,This Small Biotech Soared On Its Celgene-Partnered Trial,2017-06-06 20:58:35 +0000,http://finance.yahoo.com/r/907770dc-c082-3cc0-9d9f-5a249899bed1/this-small-biotech-is-breaking-out-on-its-celgene-partnered-trial?src=A00220&yptr=yahoo&.tsrc=rss,"Bluebird Bio stock rocketed to a 20-month high Tuesday, busting into a buy zone, on strong data presented Monday in a cancer trial with Celgene."
CELG,CELG:UW,BBG000BFCMR2,"3 Takeaways From Monday's ASCO Meetings: Puma Biotech, Incyte, Celgene",2017-06-06 20:34:08 +0000,https://finance.yahoo.com/news/3-takeaways-mondays-asco-meetings-203408835.html?.tsrc=rss,The American Society of Clinical Oncology’s annual meeting ended Tuesday. The event was filled with updates on clinical trials and research. Credit Suisse analyst Alethia Young released her key findings ...
CELG,CELG:UW,BBG000BFCMR2,Top Health Stocks to Buy Now,2017-06-06 19:43:00 +0000,http://finance.yahoo.com/r/ed5f3585-8556-3b0e-ac50-ecb9c764f0bb/top-health-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"Why Celgene, Intuitive Surgical, and Vertex Pharmaceuticals rank among the top health stocks to buy now."
CELG,CELG:UW,BBG000BFCMR2,Why bluebird bio Inc Flew Higher Today,2017-06-06 19:18:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UNQVOJZfTv0/why-bluebird-bio-inc-flew-higher-today-cm799599,What happened bluebird bio NASDAQ BLUE is up 11 at 12 34 p m EDT Tuesday after presenting solid early stage data for its cancer treatment codenamed bb2121 at the American Society of Clinical Oncology 160 meeting on Monday Theoretically the data should have been priced
CELG,CELG:UW,BBG000BFCMR2,"Julian Robertson Buys Adobe Systems Inc, Boston Scientific Corp, JPMorgan Chase, Sells ...",2017-06-06 18:16:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dal57z7hayw/julian-robertson-buys-adobe-systems-inc-boston-scientific-corp-jpmorgan-chase-sells-cm799584,Julian Robertson New Purchases ADBE BSX JPM NTES OZRK QCOM DIN WING FRGI TWNK Added Positions VLRS RYAAY BUD Reduced Positions COMM BAC PCLN RCL MSFT FB TTWO GOOG P BX Sold Out HFC AAPL SHPG HZNP C LB IGT GDEN MGP
CELG,CELG:UW,BBG000BFCMR2,Why bluebird bio Inc Flew Higher Today,2017-06-06 17:40:00 +0000,http://finance.yahoo.com/r/69e9e0fa-6307-381b-9bef-9556ceb46af0/why-bluebird-bio-inc-flew-higher-today.aspx?yptr=yahoo&.tsrc=rss,Solid early-stage data for its CAR-T treatment bb2121 has investors looking up.
CELG,CELG:UW,BBG000BFCMR2,InPlay from Briefing.com,2017-06-06 16:57:58 +0000,https://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
CELG,CELG:UW,BBG000BFCMR2,Updated Data from Phase 1 Trial of Oral IDHIFA® (enasidenib) Demonstrate Complete Responses and Duration of Response in Patients with Relapsed or Refractory AML and an IDH2 Mutation,2017-06-06 16:26:00 +0000,https://finance.yahoo.com/news/updated-data-phase-1-trial-162600034.html?.tsrc=rss,"Celgene Corporation and Agios Pharmaceuticals, Inc. today announced new efficacy and safety data from the ongoing Phase 1 dose-escalation and expansion study evaluating investigational oral IDHIFA® in patients with relapsed or refractory acute myeloid leukemia and an isocitrate dehydrogenase-2 mutation."
CELG,CELG:UW,BBG000BFCMR2,Why Halozyme Therapeutics Inc. Sank 16.5% in May,2017-06-06 13:14:00 +0000,http://finance.yahoo.com/r/e13fee34-7d50-35d1-b3d1-76f3e7dc76f1/why-halozyme-therapeutics-inc-sank-165-in-may.aspx?yptr=yahoo&.tsrc=rss,News that a secondary stock offering would be taking place at a discounted price caused shares of the developmental stage biotech to swoon.
CELG,CELG:UW,BBG000BFCMR2,"​Bluebird and Radius gain, while Blueprint and Tesaro fall, at ASCO cancer summit",2017-06-06 10:30:12 +0000,http://finance.yahoo.com/r/ef1ee849-2e9c-3415-93e7-50e292c95b20/bluebird-and-radius-gain-while-blueprint-and.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Some local biotechs are among the biggest stock market gainers — and losers — so far at this week's closely-watched annual conference in Chicago on cancer drug research.  The annual meeting of the American Society of Clinical Oncology, which began Friday and runs through Tuesday, has featured presentations by companies from across the globe on some of the most promising cancer treatments currently in clinical trials.  The conference comes at a time when oncology R&D is booming: according to one recent report, the number of late-stage cancer drugs has increased by 45 percent over the last decade, while the size and duration of pivotal trials has decreased."
CELG,CELG:UW,BBG000BFCMR2,"Gainers & Losers Of June 5: LOXO, CLSN, RDUS, GLYC, JUNO...",2017-06-05 22:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nkjIXwy7ShE/gainers--losers-of-june-5-loxo-clsn-rdus-glyc-juno-20170605-01326,"Gainers & Losers Of June 5: LOXO, CLSN, RDUS, GLYC, JUNO..."
CELG,CELG:UW,BBG000BFCMR2,Bluebird Bio shares pop on what CEO calls ‘very exciting’ cancer news,2017-06-05 21:28:34 +0000,https://finance.yahoo.com/news/bluebird-bio-shares-pop-ceo-212834631.html?.tsrc=rss,Bluebird Bio CEO Nick Leschly said the multiple myeloma patients in a study have had an &quot;incredible response rate.&quot;
CELG,CELG:UW,BBG000BFCMR2,Bluebird Bio shares pop on what CEO calls ‘very exciting’ cancer news,2017-06-05 21:28:34 +0000,http://finance.yahoo.com/r/fb8bed38-4686-3bf5-9b46-3f6a9fe24905/104511351?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104511351&yptr=yahoo&.tsrc=rss,"Bluebird Bio CEO Nick Leschly said the multiple myeloma patients in a study have had an ""incredible response rate."""
CELG,CELG:UW,BBG000BFCMR2,"Notes From ASCO 2017: Tesaro, Amgen, Others Report New Data",2017-06-05 17:48:02 +0000,https://finance.yahoo.com/news/notes-asco-2017-tesaro-amgen-174802731.html?.tsrc=rss,The 2017 American Society of Clinical Oncology annual meeting is taking place in Chicago from last Friday through Tuesday. There have already been several companies that have updated shareholders with ...
CELG,CELG:UW,BBG000BFCMR2,UPDATE: Bluebird Bio stock rises 7.4% on positive data from ongoing early-stage clinical trial,2017-06-05 13:46:28 +0000,http://finance.yahoo.com/r/65fb5be0-9b26-30fd-9a88-5069a8bf0106/Story.aspx?guid=EADD6A94-4142-464F-BFCD-C0BA33635355&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Bluebird Bio Inc. shares rose 7.4% in heavy morning trade Monday after the company released updated results from an ongoing early-stage clinical trial in relapsed/refractory multiple myeloma. Relapsed ...
CELG,CELG:UW,BBG000BFCMR2,Bluebird Bio stock rises 5% on positive data from ongoing early-stage clinical trial,2017-06-05 13:34:37 +0000,https://finance.yahoo.com/news/bluebird-bio-stock-rises-5-133437300.html?.tsrc=rss,Bluebird Bio Inc. shares rose as much as 5% in morning trade Monday after the company released updated results from an ongoing early-stage clinical trial in relapsed/refractory multiple myeloma. Relapsed ...
CELG,CELG:UW,BBG000BFCMR2,Celgene CEO on paying for cancer care,2017-06-05 12:34:00 +0000,https://finance.yahoo.com/video/celgene-ceo-paying-cancer-care-110800478.html?.tsrc=rss,With the focus on drug prices as sharp as ever—President Trump in January accused the pharmaceutical industry of &quot;getting away with murder&quot; on its prices—Celgene CEO Mark Alles says the U.S. must rethink the way patients pay for cancer care.
CELG,CELG:UW,BBG000BFCMR2,"Bluebird, Celgene CAR-T Keeps Multiple Myeloma Patients Relapse Free",2017-06-05 11:30:00 +0000,http://finance.yahoo.com/r/70325457-ebf0-334c-95a4-e2726b2b6edb/bluebird-celgene-car-t-keeps-multiple-myeloma-patients-relapse-free.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,100% response rate with zero relapses are the latest update from Bluebird's BB2121 study in multiple myeloma patients.
CELG,CELG:UW,BBG000BFCMR2,bluebird bio and Celgene Corporation Announce Updated Clinical Results from Ongoing First-in-Human Multicenter Study of bb2121 Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting,2017-06-05 11:30:00 +0000,https://finance.yahoo.com/news/bluebird-bio-celgene-corporation-announce-113000157.html?.tsrc=rss,"bluebird bio, Inc. , and Celgene Corporation today announced that updated results from the ongoing CRB-401 Phase 1 clinical study of bb2121, an investigational anti-BCMA CAR T cell therapy, in 18 patients with relapsed/refractory multiple myeloma will be presented at the American Society of Clinical Oncology Annual Meeting in Chicago, Illinois."
CELG,CELG:UW,BBG000BFCMR2,Bluebird Bio Inc. (BLUE) Is Climbing On Study Results,2017-06-05 09:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tBj4t21jnlY/bluebird-bio-inc-blue-is-climbing-on-study-results-20170605-00729,Bluebird Bio Inc. (BLUE) Is Climbing On Study Results
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks to Buy If You've Never Bought a Biotech Stock,2017-06-04 17:00:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0CyqCz8iXGM/3-biotech-stocks-to-buy-if-youve-never-bought-a-biotech-stock-cm798442,If you don t have biotech stocks in your investing portfolio why not For many people the answer is that they think biotech stocks are too risky Although it s true that some biotech stocks are very risky that s not the case for all of them And leaving out these stocks means that you
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks to Buy If You&apos;ve Never Bought a Biotech Stock,2017-06-04 15:41:00 +0000,http://finance.yahoo.com/r/e82e4dc5-9cf4-3977-a829-724b8edae92d/3-biotech-stocks-to-buy-if-youve-never-bought-a-bi.aspx?yptr=yahoo&.tsrc=rss,"No biotech stocks in your investing portfolio? Take a look at Celgene, Regeneron, and Vertex."
CELG,CELG:UW,BBG000BFCMR2,Celgene & Acceleron Complete Enrollment on Thalassemia Drug,2017-06-02 17:31:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K2O6Vt1uw3I/celgene-acceleron-complete-enrollment-on-thalassemia-drug-cm798072,Celgene Corporation CELG and Acceleron Pharma Inc XLRN announced that the companies have completed target enrollment in the phase III studies MEDALIST and BELIEVE on pipeline candidate luspatercept Both the companies expect to report top line results from these trials in mid 2018 We
CELG,CELG:UW,BBG000BFCMR2,Celgene & Acceleron Complete Enrollment on Thalassemia Drug,2017-06-02 15:52:03 +0000,https://finance.yahoo.com/news/celgene-acceleron-complete-enrollment-thalassemia-155203731.html?.tsrc=rss,"Celgene Corporation (CELG) and Acceleron Pharma Inc. (XLRN) announced that the companies have completed target enrollment in the phase III studies, MEDALIST and BELIEVE on pipeline candidate luspatercept."
CELG,CELG:UW,BBG000BFCMR2,5 Top Stocks to Buy in June,2017-06-02 11:31:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DsiqFpWJ6xU/5-top-stocks-to-buy-in-june-cm797800,InvestorPlace Stock Market News Stock Advice amp Trading Tips We re headed into the summer doldrums a slow time of year for stocks to buy It s understandable as long term investors have other things floating around their minds such as ball games vacations fishing and spending
CELG,CELG:UW,BBG000BFCMR2,"Notable Thursday Option Activity: TDG, DE, CELG",2017-06-01 19:32:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JrzeUJYWCoI/notable-thursday-option-activity-tdg-de-celg-cm797623,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in TransDigm Group Inc Symbol TDG where a total of 4 646 contracts have traded so far representing approximately 464 600 underlying shares That amounts to about 49 1 of TDG s
CELG,CELG:UW,BBG000BFCMR2,Jazz Pharmaceuticals' Vyxeos NDA Granted Priority Review,2017-06-01 17:32:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WUUSCLE-ocs/jazz-pharmaceuticals-vyxeos-nda-granted-priority-review-cm797548,Jazz Pharmaceuticals plc JAZZ announced that the New Drug Application NDA for its experimental leukemia candidate Vyxeos has been accepted for priority review by the FDA The specialty biopharmaceutical company is looking to get Vyxeos cytarabine and daunorubicin liposome injection
CELG,CELG:UW,BBG000BFCMR2,Celgene and Acceleron Complete Target Enrollment in the MEDALIST and BELIEVE Phase 3 Studies of Luspatercept in Myelodysplastic Syndromes and Beta-Thalassemia,2017-06-01 11:30:00 +0000,https://finance.yahoo.com/news/celgene-acceleron-complete-target-enrollment-113000791.html?.tsrc=rss,Celgene Corporation and Acceleron Pharma Inc. today announced that they have completed target enrollment in the MEDALIST and BELIEVE Phase 3 studies of luspatercept in patients with myelodysplastic syndromes and beta-thalassemia.
CELG,CELG:UW,BBG000BFCMR2,Top 3 Healthcare Stocks for 2017,2017-06-01 10:05:00 +0000,http://finance.yahoo.com/r/97824694-1af8-3e49-ba74-bce8bcb2b185/top-healthcare-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss,These 3 healthcare stocks began 2017 in an upward trend and may continue.
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Outflows: XLV, MDT, AMGN, CELG",2017-05-31 16:35:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/04gyFWxfYtU/noteworthy-etf-outflows-xlv-mdt-amgn-celg-cm796916,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 155 3 million dollar outflow that s a 1 0 decrease week over week
CELG,CELG:UW,BBG000BFCMR2,Celgene's Stock May Be Incredibly Overvalued Right Now -- Here's Why,2017-05-31 13:33:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mHlfqeeLba8/celgenes-stock-may-be-incredibly-overvalued-right-now-heres-why-cm796644,Celgene NASDAQ CELG has long garnered one of the richest valuations among large cap biotechs and for good reason The long and short of it is that Celgene has been able to post industry leading levels of revenue growth year after year thanks to its unmatched ability to churn out
CELG,CELG:UW,BBG000BFCMR2,Celgene&apos;s Stock May Be Incredibly Overvalued Right Now -- Here&apos;s Why,2017-05-31 12:06:00 +0000,http://finance.yahoo.com/r/bf6c9f14-c440-3467-851e-c72094a53932/celgenes-stock-may-be-incredibly-overvalued-right.aspx?yptr=yahoo&.tsrc=rss,Celgene&apos;s long thesis might be unraveling.
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Down 6% Since Earnings Report: Can It Rebound?,2017-05-31 09:31:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zA7GI8cLO2s/celgene-celg-down-6-since-earnings-report-can-it-rebound-cm796573,It has been about a month since the last earnings report for Celgene Corporation CELG Shares have lost about 6 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Down 6% Since Earnings Report: Can It Rebound?,2017-05-31 07:50:07 +0000,https://finance.yahoo.com/news/celgene-celg-down-6-since-075007333.html?.tsrc=rss,Celgene (CELG) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
CELG,CELG:UW,BBG000BFCMR2,3 Large-Cap Stocks for the Long Term,2017-05-31 00:32:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BvkQtI5bPe8/3-large-cap-stocks-for-the-long-term-cm796535,Why make investing harder than it needs to be Sometimes the best stocks really are large caps with a valuation of 10 billion or higher Large cap stocks might seem played out but they almost always have established business models that can stand the test of time which means you
CELG,CELG:UW,BBG000BFCMR2,3 Large-Cap Stocks for the Long Term,2017-05-30 22:40:00 +0000,http://finance.yahoo.com/r/f60354db-54ba-3b38-b214-ffff0523b012/3-large-cap-stocks-for-the-long-term.aspx?yptr=yahoo&.tsrc=rss,Sometimes bigger really is better.
CELG,CELG:UW,BBG000BFCMR2,How a Tragedy Changed How Drugs Are Sold,2017-05-30 15:34:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mvc6v8d3JHU/how-a-tragedy-changed-how-drugs-are-sold-cm796166,Thalidomide was a popular anti anxiety medicine in the 1960s until it was discovered that use of the drug in pregnant women led to extreme birth defects in their children The aftermath of the tragedy had profound impacts on healthcare policy today and is one common
CELG,CELG:UW,BBG000BFCMR2,How a Tragedy Changed How Drugs Are Sold,2017-05-30 14:13:00 +0000,http://finance.yahoo.com/r/b0e0d53a-435e-37e0-8b82-54ac58b6a77a/how-a-tragedy-changed-how-drugs-are-sold.aspx?yptr=yahoo&.tsrc=rss,"Thalidomide caused one of the greatest medical tragedies in modern history and has had a huge impact on the way drugs are researched, marketed, and sold."
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Puma Soars on Advisory Panel Vote, Priority Review for Kite Drug",2017-05-30 13:37:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4TE2mSDzGdM/biotech-stock-roundup-puma-soars-on-advisory-panel-vote-priority-review-for-kite-drug-cm795997,While Puma s PBYI shares soared on a positive recommendation from an FDA advisory panel for the company s breast cancer treatment neratinib companies like Inovio INO and BioCryst BCRX also saw their shares gaining on positive data Recap of the Week s Most Important Stories
CELG,CELG:UW,BBG000BFCMR2,Meet the Cancer Therapy that Could Become the Second Best-Selling Drug in the World by Year's End,2017-05-29 14:33:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mXn-vGo3b2U/meet-the-cancer-therapy-that-could-become-the-second-best-selling-drug-in-the-world-by-years-end-cm795870,The pharmaceutical industry is big business According to the International Trade Administration s Top Markets Report on pharmaceuticals last year the global drug market is expected to grow from about 1 trillion in sales in 2015 to 1 3 trillion by 2020 representing about 5
CELG,CELG:UW,BBG000BFCMR2,Meet the Cancer Therapy that Could Become the Second Best-Selling Drug in the World by Year&apos;s End,2017-05-29 12:21:00 +0000,http://finance.yahoo.com/r/e413a9d4-080d-3b4b-aaaa-9b1884fc8c4e/meet-the-cancer-therapy-that-could-become-the-seco.aspx?yptr=yahoo&.tsrc=rss,"Conservatively, this cancer drug is expected to generate between $8 billion and $8.3 billion in full-year sales."
CELG,CELG:UW,BBG000BFCMR2,3 Stocks the Market Is Wrong About,2017-05-28 15:31:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YuOmTSzCLAs/3-stocks-the-market-is-wrong-about-cm795765,There s an old investing truism that says the market almost always gets a company s valuation right over the long term But in the short term which can last for several years good companies can get overlooked and that can create some nice investing opportunities We asked
CELG,CELG:UW,BBG000BFCMR2,3 Stocks the Market Is Wrong About,2017-05-28 13:40:00 +0000,http://finance.yahoo.com/r/6892b312-e3b9-3131-adef-0d9f739ce5f5/3-stocks-the-market-is-wrong-about.aspx?yptr=yahoo&.tsrc=rss,Here are three out-of-favor companies that deserve much more attention from investors.
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Bristol-Myers Squibb,2017-05-28 12:30:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nh-UPvD6ifI/better-buy-celgene-corporation-vs-bristol-myers-squibb-cm795743,Investors haven t been too enamored with Celgene NASDAQ CELG and Bristol Myers Squibb NYSE BMY lately Both have super successful cancer drugs and are making plenty of money However neither stock has performed very well so far in 2017 Which of these two drug stocks is
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Bristol-Myers Squibb,2017-05-28 11:27:00 +0000,http://finance.yahoo.com/r/857c7062-f0f3-3302-a102-76e25435e570/better-buy-celgene-corporation-vs-bristol-myers-sq.aspx?yptr=yahoo&.tsrc=rss,It&apos;s Celgene versus Bristol-Myers Squibb in a head-to-head matchup. Which drug stock wins as the better pick for long-term investors?
CELG,CELG:UW,BBG000BFCMR2,3 Stocks With iRobot-Like Return Potential,2017-05-26 15:33:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i7QNdQrvTBE/3-stocks-with-irobot-like-return-potential-cm795249,Which stocks have the potential to be the next iRobot NASDAQ IRBT First let s explain what we re asking Shares of home robot maker iRobot have surged over the last year rising about 135 thanks to terrific global demand for its latest Roomba 900 series vacuums and
CELG,CELG:UW,BBG000BFCMR2,I Still Can't Believe Juno Therapeutics Spent $46.4 Million on This Failed Drug,2017-05-25 21:32:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xeXBdnKpBpU/i-still-cant-believe-juno-therapeutics-spent-464-million-on-this-failed-drug-cm794838,In March Juno Therapeutics NASDAQ JUNO announced that it was ending development of JCAR015 after five patients with acute lymphoblastic leukemia ALL died from cerebral edema brain swelling in its phase 2 clinical trial The lethal side effect made it unlikely
CELG,CELG:UW,BBG000BFCMR2,I Still Can&apos;t Believe Juno Therapeutics Spent $46.4 Million on This Failed Drug,2017-05-25 20:21:00 +0000,http://finance.yahoo.com/r/a4927e0c-f92e-376f-9cef-7c104e9e2418/i-still-cant-believe-juno-therapeutics-spent-464-m.aspx?yptr=yahoo&.tsrc=rss,A costly learning exercise.
CELG,CELG:UW,BBG000BFCMR2,"Nasdaq 100 Movers: FAST, ULTA",2017-05-25 16:34:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EKALLu-TPtA/nasdaq-100-movers-fast-ulta-cm794670,In early trading on Thursday shares of Ulta Beauty topped the list of the day s best performing components of the Nasdaq 100 index trading up 3 5 Year to date Ulta Beauty registers a 13 9 gain And the worst performing Nasdaq 100 component thus far on the day is Fastenal trading
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Raise the Stakes in Major Biotechs,2017-05-25 13:50:14 +0000,https://finance.yahoo.com/news/short-sellers-raise-stakes-major-135014512.html?.tsrc=rss,"The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed."
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Regeneron, Amgen and Celgene",2017-05-25 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-regeneron-133001322.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Regeneron, Amgen and Celgene"
CELG,CELG:UW,BBG000BFCMR2,Kyprolis Could Significantly Drive Amgen’s Revenue Growth in 2017,2017-05-25 11:36:06 +0000,http://finance.yahoo.com/r/3e5b2c83-fa36-3bee-b8ee-0a56eb2f7d4f/kyprolis-could-significantly-drive-amgens-revenue-growth-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Amgen’s (AMGN) Kyprolis has gained considerable market share in second-line multiple myeloma (or MM) indication since its launch in 2012.
CELG,CELG:UW,BBG000BFCMR2,3 Healthcare Stocks for Savvy Investors,2017-05-24 19:46:00 +0000,http://finance.yahoo.com/r/157018ea-9607-38fd-a38e-d6cc138a78d5/3-healthcare-stocks-for-savvy-investors.aspx?yptr=yahoo&.tsrc=rss,These three healthcare stocks might be great buys for savvy investors.
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data",2017-05-24 12:37:12 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-fda-nod-123712717.html?.tsrc=rss,Key highlights in the biotech sector include FDA approval for Regeneron&apos;s (REGN) Kevzara and data from Amgen and Celgene.
CELG,CELG:UW,BBG000BFCMR2,Blog Coverage: Celgene Reported Positive Late Stage Results from Trial of Ozanimod in Patients with Relapsing Multiple Sclerosis,2017-05-24 12:15:00 +0000,https://finance.yahoo.com/news/blog-coverage-celgene-reported-positive-121500565.html?.tsrc=rss,"Upcoming AWS Coverage on Regeneron Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / May 24, 2017 / Active Wall St. blog coverage looks at the headline from Celgene Corp. (NASDAQ: CELG ) ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Multiple Sclerosis Drug Meets Primary Endpoint,2017-05-23 20:06:08 +0000,https://finance.yahoo.com/news/celgene-celg-multiple-sclerosis-drug-200608487.html?.tsrc=rss,"Celgene Corporation (CELG) announced positive results from the phase III trial, RADIANCE that evaluated the efficacy and safety of experimental candidate ozanimod."
CELG,CELG:UW,BBG000BFCMR2,"Zymeworks: Early But Compelling Data, Large Biopharma Partners And A Potential June Catalyst",2017-05-23 18:09:44 +0000,https://finance.yahoo.com/news/zymeworks-early-compelling-data-large-180944755.html?.tsrc=rss,"Barclays initiated coverage of Zymeworks Inc (NYSE: ZYME ) with an Overweight rating and price target of $20. The company released first-quarter earnings last week, reporting ($1.13) EPS on the quarter ..."
CELG,CELG:UW,BBG000BFCMR2,Will Novartis&apos; MS Drug Stomp Celgene&apos;s Before It Even Hits The Market?,2017-05-22 20:15:21 +0000,http://finance.yahoo.com/r/5d4d168a-3771-3d37-a518-bdc22c66168a/will-novartis-ms-drug-stomp-celgenes-before-it-even-hits-the-market?src=A00220&yptr=yahoo&.tsrc=rss,Celgene stock dipped to a four-month low Monday after ozanimod failed to show a disability benefit over interferon in multiple sclerosis patients.
CELG,CELG:UW,BBG000BFCMR2,Celgene Becomes Oversold (CELG),2017-05-22 18:12:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2tkaIKGWgTY/celgene-becomes-oversold-celg-cm792786,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
CELG,CELG:UW,BBG000BFCMR2,CELG Makes Notable Cross Below Critical Moving Average,2017-05-22 17:13:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M2xZnWcwHHQ/celg-makes-notable-cross-below-critical-moving-average-cm792713,In trading on Monday shares of Celgene Corp Symbol CELG crossed below their 200 day moving average of 115 41 changing hands as low as 115 06 per share Celgene Corp shares are currently trading down about 1 5 on the day The chart below shows the one year performance of CELG
CELG,CELG:UW,BBG000BFCMR2,"Nasdaq 100 Movers: AMGN, WYNN",2017-05-22 16:12:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/noSVB9WTb50/nasdaq-100-movers-amgn-wynn-cm792654,In early trading on Monday shares of Wynn Resorts WYNN topped the list of the day s best performing components of the Nasdaq 100 index trading up 2 6 Year to date Wynn Resorts registers a 44 4 gain And the worst performing Nasdaq 100 component thus far on the day is Amgen
CELG,CELG:UW,BBG000BFCMR2,Celgene's multiple sclerosis drug succeeds in late-stage trial,2017-05-22 12:57:29 +0000,https://finance.yahoo.com/news/celgenes-multiple-sclerosis-drug-succeeds-125729226.html?.tsrc=rss,"Celgene Corp said its oral drug  to treat relapsing multiple sclerosis met the main goal in a  second late-stage study, bringing the U.S. biotech a step closer  to launching a potential blockbuster.  The drug, ozanimod, reduced annualized relapse rate in  patients with relapsing multiple sclerosis, compared to Biogen  Inc's Avonex, the company said on Monday.  Celgene's shares were marginally down in premarket trading."
CELG,CELG:UW,BBG000BFCMR2,Celgene Stock Rises Premarket on Positive Late-Stage Test Results for Multiple Sclerosis Treatment,2017-05-22 12:20:00 +0000,http://finance.yahoo.com/r/55a65a32-06d6-396c-8528-9c69e880932b/celgene-stock-rises-premarket-on-positive-late-stage-test-results-for-multiple-sclerosis-treatment.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The trial enrolled 1,313 RMS patients in 21 countries for two years of study."
CELG,CELG:UW,BBG000BFCMR2,Celgene reports positive results in trial of multiple sclerosis treatment,2017-05-22 12:03:06 +0000,https://finance.yahoo.com/news/celgene-reports-positive-results-trial-120306616.html?.tsrc=rss,"Celgene Corp. shares rose about 1% premarket before surrendering their gains, after the company reported positive results from a late-stage trial of a treatment for multiple sclerosis. Celgene said the ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene reports positive results in trial of multiple sclerosis treatment,2017-05-22 12:03:06 +0000,http://finance.yahoo.com/r/88ff0606-77e3-3f40-b276-0b5a66d17d75/Story.aspx?guid=11E68364-AE0E-46CA-810C-C6D844B41E4E&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Celgene Corp. shares rose about 1% premarket before surrendering their gains, after the company reported positive results from a late-stage trial of a treatment for multiple sclerosis. Celgene said the ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene's multiple sclerosis drug succeeds in late-stage trial,2017-05-22 11:54:59 +0000,https://finance.yahoo.com/news/celgenes-multiple-sclerosis-drug-succeeds-115459033.html?.tsrc=rss,"Celgene Corp said its oral drug to treat relapsing multiple sclerosis met the main goal of reducing annualized relapse rate, when compared to Biogen Inc's Avonex, in a second late-stage study. The drug, ..."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Announces Positive Results from RADIANCE, the Second Pivotal Phase III Trial of Oral Ozanimod in Patients with Relapsing Multiple Sclerosis",2017-05-22 11:30:00 +0000,https://finance.yahoo.com/news/celgene-announces-positive-results-radiance-113000161.html?.tsrc=rss,"Celgene Corporation today announced that its phase III RADIANCE trial, evaluating the efficacy and safety of ozanimod, an investigational oral, selective S1P 1 and 5 receptor modulator, in patients with relapsing multiple sclerosis , met the primary endpoint in reducing annualized relapse rate , compared to weekly interferon β-1a ."
CELG,CELG:UW,BBG000BFCMR2,Celgene: Second Phase III Trial Of Ozanimod Meets Primary Endpoint - Quick Facts,2017-05-22 07:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0X4fDh1BISk/celgene-second-phase-iii-trial-of-ozanimod-meets-primary-endpoint--quick-facts-20170522-00321,Celgene: Second Phase III Trial Of Ozanimod Meets Primary Endpoint - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,5 Leadership Lessons From Exceptionally Successful CEOs,2017-05-21 16:22:00 +0000,http://finance.yahoo.com/r/a280e724-775c-3d0f-8208-4871f67c6762/5-leadership-lessons-from-successful-ceos.aspx?yptr=yahoo&.tsrc=rss,"Important leadership ideas from the CEOs of Celgene, Cognizant, General Electric, MasterCard, and Texas Instruments."
CELG,CELG:UW,BBG000BFCMR2,Why Long-Term Investors Should Prefer Celgene Over Biogen,2017-05-21 13:03:00 +0000,http://finance.yahoo.com/r/2ff19d64-8e8c-3158-85ca-17db1ef47b08/why-long-term-investors-should-prefer-celgene-over.aspx?yptr=yahoo&.tsrc=rss,Biogen isn&apos;t a bad biotech stock pick. But Celgene is better. Here&apos;s why.
CELG,CELG:UW,BBG000BFCMR2,Why Stay Bullish On Gilead,2017-05-19 16:02:00 +0000,http://finance.yahoo.com/r/482217aa-20b1-35d8-ad6b-7095e61a0a71/why-stay-bullish-on-gilead-1495209758?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"There’s no shortage of investors who have lost confidence in Gilead Sciences (GILD). Hopes of better news were shattered by its most recent earnings report. And so far, the company has not delivered a ..."
CELG,CELG:UW,BBG000BFCMR2,Top 5 Biotech Stocks for 2017,2017-05-19 12:00:00 +0000,http://finance.yahoo.com/r/9faea74e-596a-3c50-9c59-fd8ba54d4ff6/biotech-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Biotech can be risky, but these top biotech stocks have stable track records."
CELG,CELG:UW,BBG000BFCMR2,3 Stocks To Buy When The Market's Crashing,2017-05-18 18:13:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j1Fmir-rBu0/3-stocks-to-buy-when-the-markets-crashing-cm791406,Stocks don t go up or down in a straight line So with shares flirting with new highs a drop isn t unexpected As markets fall buying shares in fast growing companies on sale could lead to market beating performance when markets return to their winning ways Three of my
CELG,CELG:UW,BBG000BFCMR2,3 Stocks To Buy When The Market&apos;s Crashing,2017-05-18 17:01:00 +0000,http://finance.yahoo.com/r/9146dca1-31c4-3cd5-927b-994275ddfee6/crashing-market-3-stocks-to-buy.aspx?yptr=yahoo&.tsrc=rss,"Picking up shares in Shopify, Lumentum, and Celgene when markets tumble could pay off big."
CELG,CELG:UW,BBG000BFCMR2,Broad Range of Clinical Data Evaluating Celgene Therapies to Be Presented at American Society of Clinical Oncology (ASCO),2017-05-17 21:41:00 +0000,https://finance.yahoo.com/news/broad-range-clinical-data-evaluating-214100832.html?.tsrc=rss,"Celgene Corporation today announced that data from a broad range of company-sponsored and investigator-initiated studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the American Society of Clinical Oncology Annual Meeting between June 2-6 in Chicago, Ill."
CELG,CELG:UW,BBG000BFCMR2,"Notable Wednesday Option Activity: MPC, EXPE, CELG",2017-05-17 21:14:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cPB-YinT9zY/notable-wednesday-option-activity-mpc-expe-celg-cm790864,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Marathon Petroleum Corp Symbol MPC where a total volume of 20 672 contracts has been traded thus far today a contract volume which is representative of approximately 2
CELG,CELG:UW,BBG000BFCMR2,"Bluebird, Kite and Juno Delivering CAR-T Cancer Study Updates to ASCO '17 Meeting",2017-05-17 21:10:00 +0000,http://finance.yahoo.com/r/5de8fd0e-5a6d-3c8b-8476-507373b08b4a/bluebird-kite-and-juno-delivering-car-t-cancer-study-updates-to-asco-17-meeting.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The drug companies engineering T-cells to recognize and kill cancer, otherwise known as chimeric antigen receptor T-cells, or CAR-Ts, will be busy at the ASCO annual meeting in June."
CELG,CELG:UW,BBG000BFCMR2,"Celgene, Agios Update Blood Cancer Drug Study Results in ASCO '17 Abstract",2017-05-17 21:02:00 +0000,http://finance.yahoo.com/r/50aaaa92-f6da-3cc2-830f-a717c0e165a0/celgene-agios-update-blood-cancer-drug-study-results-in-asco-17-abstract.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The new enasidenib data -- improved tumor response rate but shorter duration -- were made public on Wednesday night in a research abstract.
CELG,CELG:UW,BBG000BFCMR2,Celgene leukemia drug extends survival in early stage trial,2017-05-17 21:00:00 +0000,https://finance.yahoo.com/news/celgene-leukemia-drug-extends-survival-210000745.html?.tsrc=rss,"Nearly 20 percent of patients with an  aggressive form of leukemia experienced complete remission along  with prolonged survival from treatment with an experimental  Celgene Corp drug, according to data from an  early-stage study released on Wednesday.  The drug, enasidenib, delivered high overall response rates  in patients with acute myeloid leukemia (AML) whose disease had  relapsed following prior treatments.  Available data from 176 patients showed 40.3 percent  responded to the treatment, with 19.3 percent achieving complete  remission."
CELG,CELG:UW,BBG000BFCMR2,"David Rolfe Gains 3 Holdings, Sells 2 Others in 1st Quarter",2017-05-17 11:14:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EwaQ-OTpIzQ/david-rolfe-gains-3-holdings-sells-2-others-in-1st-quarter-cm790346,Wedgewood Partners David Rolfe Trades Portfolio gained three new holdings during the first quarter and sold two others His new positions are Edwards Lifesciences Corp EW Celgene Corp CELG and Boeing Co BA Wedgewood Partners David Rolfe Trades
CELG,CELG:UW,BBG000BFCMR2,Celgene's (CELG) Revlimid Looks Solid on Label Expansion,2017-05-17 00:15:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ka35GWrFUNM/celgenes-celg-revlimid-looks-solid-on-label-expansion-cm790282,We issued an updated research report on Celgene Corporation CELG on May 15 2017 Celgene is a biopharmaceutical company focused on the discovery development and commercialization of drugs targeting cancer and inflammatory diseases through next generation solutions in protein
CELG,CELG:UW,BBG000BFCMR2,"Cramer's lightning round: Buy this defense stock on fundamentals, not rumors",2017-05-16 22:48:02 +0000,http://finance.yahoo.com/r/f444e202-c209-351d-9cad-0872f92ce243/104473314?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104473314&yptr=yahoo&.tsrc=rss,"Jim Cramer rattles off his take on caller favorite stocks, including this defense play."
CELG,CELG:UW,BBG000BFCMR2,"Cramer&apos;s lightning round: Buy this defense stock on fundamentals, not rumors",2017-05-16 22:48:02 +0000,https://finance.yahoo.com/news/cramer-apos-lightning-round-buy-224802887.html?.tsrc=rss,"Jim Cramer rattles off his take on caller favorite stocks, including this defense play."
CELG,CELG:UW,BBG000BFCMR2,Celgene&apos;s (CELG) Revlimid Looks Solid on Label Expansion,2017-05-16 22:14:10 +0000,https://finance.yahoo.com/news/celgene-apos-celg-revlimid-looks-221410404.html?.tsrc=rss,"Celgene&apos;s key growth driver, Revlimid, continues to outperform on the back of market share gains and increased duration."
CELG,CELG:UW,BBG000BFCMR2,iShares Nasdaq Biotechnology Index (ETF) (IBB): The Quick Guide to IBB,2017-05-15 22:15:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l5j_FsUdnTA/ishares-nasdaq-biotechnology-index-etf-ibb-the-quick-guide-to-ibb-cm789575,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotechnology is one of the more tempting and complex areas of the broader healthcare sector investing However stock picking in this space is tricky which has made biotechnology exchange traded
CELG,CELG:UW,BBG000BFCMR2,3 Post-Earnings Biotech Buys,2017-05-14 14:00:00 +0000,http://finance.yahoo.com/r/daee86ea-60c9-309b-a7de-5673f0829cd7/3-post-earnings-biotech-buys?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"These names are now undervalued, despite solid results and good fundamentals."
CELG,CELG:UW,BBG000BFCMR2,"Redwood Investments, LLC Buys AmerisourceBergen Corp, MGM Resorts International, HD Supply ...",2017-05-12 17:24:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/twDb9ziWn9M/redwood-investments-llc-buys-amerisourcebergen-corp-mgm-resorts-international-hd-supply-cm788659,Redwood Investments LLC New Purchases ABC MGM HDS MRVL KMT OSK OSIS MTSI ABCB CRUS Added Positions JPM PI SLCA IPHI HLS BAX CBM PE KOP WDC Reduced Positions WOOF WM CTAS AAPL GD NDAQ HW BRK B CTXS SSTK Sold Out AYI
CELG,CELG:UW,BBG000BFCMR2,"Bellevue Group AG Buys Align Technology Inc, Anthem Inc, Walgreens Boots Alliance Inc, Sells ...",2017-05-12 16:24:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3WVcSrhdk5I/bellevue-group-ag-buys-align-technology-inc-anthem-inc-walgreens-boots-alliance-inc-sells-cm788614,Bellevue Group AG New Purchases ALGN WBA ABC HRC THC GNMK LIVN XRAY TSRO MDCO Added Positions ANTM AMGN CNC ISRG WMGI LLY ILMN GILD SHPG HZNP Reduced Positions SYK ZLTQ BDX ZBH MDT GMED REGN CERN HCSG JNJ Sold Out ARIA
CELG,CELG:UW,BBG000BFCMR2,4 of the Cheapest Biotech Stocks in the World,2017-05-11 16:06:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x2RV_FePCyg/4-of-the-cheapest-biotech-stocks-in-the-world-cm788001,When you think of biotech stocks cheap is probably the last word that comes to mind Most biotech stocks aren t profitable and many have no products currently on pharmacy shelves This means biotech valuations tend to be a hodgepodge of investor emotions future peak
CELG,CELG:UW,BBG000BFCMR2,Peek Under The Hood: XLV Has 10% Upside,2017-05-11 15:04:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qkWiSzTiAXk/peek-under-the-hood-xlv-has-10-upside-cm787748,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
CELG,CELG:UW,BBG000BFCMR2,ONCYF: FDA Grants Fast Track Authority,2017-05-11 13:00:00 +0000,http://finance.yahoo.com/news/oncyf-fda-grants-fast-track-130000668.html?.tsrc=rss,"By John Vandermosten, CFA OTC:ONCYF On May 8th, Oncolytics Biotech, Inc. (OTC:ONCYF) announced that the FDA had granted Fast Track status to REOLYSIN for the treatment of metastatic breast cancer.  Fast ..."
CELG,CELG:UW,BBG000BFCMR2,Today's Research Reports on Stocks to Watch: Allergan and Celgene,2017-05-11 12:00:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000515.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 11, 2017 / Botox maker Allergan suffered a loss on Wednesday, the day after the multi-national pharmaceutical company released its first quarter earnings that beat estimates. ..."
CELG,CELG:UW,BBG000BFCMR2,4 of the Cheapest Biotech Stocks in the World,2017-05-11 04:00:00 +0000,http://finance.yahoo.com/r/c2084956-a67d-3e34-b06d-4378c34488a1/4-of-the-cheapest-biotech-stocks-in-the-world.aspx?yptr=yahoo&.tsrc=rss,All four of these drug stocks have PEG ratios below 1.
CELG,CELG:UW,BBG000BFCMR2,Major Biotech Short Interest Remains Mixed,2017-05-10 14:40:19 +0000,http://finance.yahoo.com/news/major-biotech-short-interest-remains-144019480.html?.tsrc=rss,"The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed."
CELG,CELG:UW,BBG000BFCMR2,"Western Digital, Mattel, Celgene and Acceleron Pharma highlighted as Zacks Bull and Bear of the Day",2017-05-09 16:06:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4bY7vfJnlic/western-digital-mattel-celgene-and-acceleron-pharma-highlighted-as-zacks-bull-and-bear-of-the-day-cm786565,For Immediate Release Chicago IL May 09 2017 Zacks Equity Research Western Digital Corporation NASDAQ WDC Free Report as the Bull of the Day Mattel NASDAQ MAT Free Report as the Bear of the Day In addition Zacks Equity Research provides analysis on Celgene
CELG,CELG:UW,BBG000BFCMR2,"Western Digital, Mattel, Celgene and Acceleron Pharma highlighted as Zacks Bull and Bear of the Day",2017-05-09 13:30:01 +0000,http://finance.yahoo.com/news/western-digital-mattel-celgene-acceleron-133001335.html?.tsrc=rss,"Western Digital, Mattel, Celgene and Acceleron Pharma highlighted as Zacks Bull and Bear of the Day"
CELG,CELG:UW,BBG000BFCMR2,Today's Research Reports on Trending Tickers: Celgene and Kite Pharma,2017-05-09 12:00:00 +0000,http://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000583.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 9, 2017 / Celgene takes a hit for its partner Acceleron after the company posted first quarter earnings results that depressed investors. Kite Pharma on the other hand had ..."
CELG,CELG:UW,BBG000BFCMR2,Why Shares of Biopharma Giant Celgene (CELG) Tumbled Today,2017-05-08 23:00:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QD_-fnDNyak/why-shares-of-biopharma-giant-celgene-celg-tumbled-today-cm786200,On Monday shares of biopharmaceutical company Celgene Corp CELG tumbled and closed the day down 3 31 to 118 36 per share after one of its partners Acceleron Pharma XLRN reported disappointing first quarter results XLRN stock closed down 12 79 to 27 69 per share Celgene and
CELG,CELG:UW,BBG000BFCMR2,Why Acceleron Pharma Inc. Is Tumbling Today,2017-05-08 22:03:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pzTYobA2s8Y/why-acceleron-pharma-inc-is-tumbling-today-cm786195,What happened In response to reporting disappointing first quarter results shares of Acceleron Pharma NASDAQ XLRN a clinical stage biotech focused on rare diseases were down 12 as of 3 45 p m EDT So what Here s a look at the headline numbers from the quarter
CELG,CELG:UW,BBG000BFCMR2,Why Shares of Biopharma Giant Celgene (CELG) Tumbled Today,2017-05-08 21:06:09 +0000,http://finance.yahoo.com/news/why-shares-biopharma-giant-celgene-210609093.html?.tsrc=rss,"On Monday, shares of biopharmaceutical company Celgene Corp. (CELG) tumbled, and closed the day down 3.31% to $118.36 per share after one of its partners, Acceleron Pharma (XLRN), reported disappointing first-quarter results. XLRN stock closed down 12.79% to $27.69 per share."
CELG,CELG:UW,BBG000BFCMR2,​Aadi Bioscience gets $23 million funding,2017-05-08 20:50:12 +0000,http://finance.yahoo.com/r/2b4bd2dc-bab6-30f6-93df-6583e5178a6d/aadi-bioscience-gets-23-million-funding.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Aadi Bioscience Inc., a clinical stage biopharmaceutical company focused on treating diseases related to mTOR activation, said it has raised $23 million in a series A funding round. Pacific Palisades, ..."
CELG,CELG:UW,BBG000BFCMR2,How Celgene Toppled On A Small-Cap Biotech&apos;s Ragged Quarter,2017-05-08 20:14:59 +0000,http://finance.yahoo.com/r/dac5d3e0-c119-393b-9db4-8b731bbdc107/how-celgene-stock-toppled-on-a-small-cap-biotechs-ragged-q1?src=A00220&yptr=yahoo&.tsrc=rss,Celgene stock toppled Monday after cancer partner Acceleron reported first-quarter losses and sales that lagged views.
CELG,CELG:UW,BBG000BFCMR2,Why Acceleron Pharma Inc. Is Tumbling Today,2017-05-08 20:01:00 +0000,http://finance.yahoo.com/r/c82ea521-cfc1-340a-93ca-a64b2da95593/why-acceleron-pharma-inc-is-tumbling-today.aspx?yptr=yahoo&.tsrc=rss,Shares drop after the company&apos;s first-quarter earnings results came up short of expectations.
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Monday Option Activity: CELG, UAL, DIS",2017-05-08 19:01:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rwRKg0J4Gq4/noteworthy-monday-option-activity-celg-ual-dis-cm786024,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Celgene Corp Symbol CELG where a total volume of 22 919 contracts has been traded thus far today a contract volume which is representative of approximately 2 3
CELG,CELG:UW,BBG000BFCMR2,BioMarin: Is Profitability On The Horizon?,2017-05-08 18:57:00 +0000,http://finance.yahoo.com/r/cc0a47e1-94b4-33a2-b154-c473e610724a/biomarin-is-profitability-on-the-horizon-1494269871?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"When will BioMarin Pharmaceuticals (BMRN) turn a profit? The drug maker specializes in therapies for rare diseases, and already markets a handful of medications that generated revenue of $1.12 billion ..."
CELG,CELG:UW,BBG000BFCMR2,[$$] Funding Snapshot: Aadi Bioscience Raises $23 Million Series A,2017-05-08 15:42:41 +0000,http://finance.yahoo.com/r/eddbc37c-dbe7-3341-82a0-59321967f411/funding-snapshot-aadi-bioscience-raises-23-million-series-a-1494258159?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Company: Aadi Bioscience Inc.
CELG,CELG:UW,BBG000BFCMR2,InPlay from Briefing.com,2017-05-08 13:52:36 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
CELG,CELG:UW,BBG000BFCMR2,Luspatercept Phase 2 Data Presented at the 14th International Symposium on Myelodysplastic Syndromes,2017-05-06 11:00:00 +0000,http://finance.yahoo.com/news/luspatercept-phase-2-data-presented-110000262.html?.tsrc=rss,"Acceleron Pharma Inc. and Celgene Corporation , today announced preliminary Phase 2 results from the ongoing three-month base and long-term extension studies with investigational drug luspatercept in patients with lower-risk myelodysplastic syndromes at the 14th International Symposium on MDS in Valencia, Spain."
CELG,CELG:UW,BBG000BFCMR2,A Strong Case for Buying Celgene,2017-05-05 21:27:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IEc4bQNtur8/a-strong-case-for-buying-celgene-cm785279,The pharmaceutical industry can present a growth investor with a dilemma Should I settle for the slow growth of the big drug companies to get safety or should I accept the risks of smaller biotechs to get the growth Celgene NASDAQ CELG offers something in between with the best
CELG,CELG:UW,BBG000BFCMR2,Does Celgene Have Too May Eggs In One Drug Basket?,2017-05-05 20:31:39 +0000,http://finance.yahoo.com/r/d0843bd3-4d16-368b-abb7-eb439d93eda8/does-celgene-have-too-may-eggs-in-one-drug-basket?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene is facing concentration risk from cancer drug Revlimid, which accounted for 64% of sales in the first quarter."
CELG,CELG:UW,BBG000BFCMR2,"Activision, Zillow Price Targets Hiked; Celgene, Lumentum Downgraded",2017-05-05 20:04:02 +0000,http://finance.yahoo.com/r/7d0a8ec2-d02f-3ad6-85a7-e6a9a16fbeeb/activision-zillow-price-targets-hiked-celgene-lumentum-downgraded?src=A00220&yptr=yahoo&.tsrc=rss,"Activision Blizzard scored with price target hikes after posting first-quarter earnings, Zillow&apos;s price target was hiked on stronger-than-expected Q1 earnings, and Lumentum Holdings downgraded."
CELG,CELG:UW,BBG000BFCMR2,A Strong Case for Buying Celgene,2017-05-05 19:41:00 +0000,http://finance.yahoo.com/r/f2b3f8bf-b87f-384a-b65e-9990285424e5/a-strong-case-for-buying-celgene.aspx?yptr=yahoo&.tsrc=rss,High growth at a reasonable price in a large-capitalization drug stock makes this an unusually attractive pick.
CELG,CELG:UW,BBG000BFCMR2,Celgene: Too Much of a Good Thing?,2017-05-05 17:53:00 +0000,http://finance.yahoo.com/r/567794d5-ed20-3262-ba1e-e89ddc39ca02/celgene-too-much-of-a-good-thing-1494006814?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Celgene (CELG) have gained 20% during the past 12 months, outperforming both the S&P 500, which has risen 17%, and the iShares Nasdaq Biotechnology Index ETF's (IBB) 14% advance. But Celgene's ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Stock Falls Following Argus Downgrade,2017-05-05 17:27:00 +0000,http://finance.yahoo.com/r/c22c40d4-6b20-3507-9a0b-1042656845c0/celgene-stock-falls-following-argus-downgrade.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Celgene shares were down more than 2% Friday afternoon.
CELG,CELG:UW,BBG000BFCMR2,iShares Core S&P Total U.S. Stock Market ETF Experiences Big Inflow,2017-05-05 17:25:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0oE6hb2fPnY/ishares-core-sp-total-us-stock-market-etf-experiences-big-inflow-cm785071,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core S amp P Total U S Stock Market ETF Symbol ITOT where we have detected an approximate 57 3 million dollar inflow that s a 0 7 increase week
CELG,CELG:UW,BBG000BFCMR2,"Agios (AGIO) Q1 Loss Narrower than Expected, Indhifa in Focus",2017-05-05 15:27:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PGjFe-CjgWU/agios-agio-q1-loss-narrower-than-expected-indhifa-in-focus-cm785031,Agios Pharmaceuticals Inc AGIO posted first quarter 2017 loss of 1 56 per share narrower than the Zacks Consensus Estimate of a loss of 1 79 but wider than the year ago loss of 61 cents Agios s shares have underperformed the Zacks classified Medical Products industry so far
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics (JUNO) Posts Wider-than-Expected Q1 Loss,2017-05-05 15:27:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5bghWc58upA/juno-therapeutics-juno-posts-wider-than-expected-q1-loss-cm785029,Juno Therapeutics Inc JUNO reported first quarter 2017 loss of 71 cents per share including stock based compensation expenses wider than the Zacks Consensus Estimate of a loss of 66 cents The quarterly loss however narrowed from the year ago loss of 79 cents per share Shares of
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics Q1 Revenue Improves Thanks to Celgene Collaboration,2017-05-05 15:24:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9HA4OUAbqh4/juno-therapeutics-q1-revenue-improves-thanks-to-celgene-collaboration-cm784984,When Juno Therapeutics NASDAQ JUNO announced its fourth quarter and full year 2016 results in March investors were most focused on the company s discontinuation of development of a once promising lead cancer drug Juno chose to refocus on its other pipeline candidates
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics Q1 Revenue Improves Thanks to Celgene Collaboration,2017-05-05 15:02:00 +0000,http://finance.yahoo.com/r/3f253fe6-de2f-3b4e-a0cb-ad5fee1f7cfd/premium-juno-therapeutics-q1-results.aspx?yptr=yahoo&.tsrc=rss,"The clinical-stage biotech posts much higher top-line results in Q1 with an influx in cash from its big partner, Celgene."
CELG,CELG:UW,BBG000BFCMR2,Has Celgene Become Vulnerable To 'Revenue Concentration Risk'?,2017-05-05 12:46:18 +0000,http://finance.yahoo.com/news/celgene-become-vulnerable-revenue-concentration-124618860.html?.tsrc=rss,"Argus' David Toung downgraded shares of Celgene Corporation (NASDAQ: CELG ) from Buy to Hold after fully digesting the company's first-quarter earnings report. Stay Critical, Investors According to Toung, ..."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : May 5, 2017",2017-05-05 12:16:27 +0000,http://finance.yahoo.com/r/a3034e35-63a3-3d42-bb01-51c718c775ab/celgene-corp-breached-its-50-day-moving-average-in-a-bullish-manner-celg-us-may-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Celgene Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Amgen, Gilead, Celgene Q1 Earnings, Sunesis Down on Vosaroxin Update",2017-05-03 13:31:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6O0dk47b5ew/biotech-stock-roundup-amgen-gilead-celgene-q1-earnings-sunesis-down-on-vosaroxin-update-cm783260,It was all about earnings this week with companies like Amgen AMGN Celgene CELG Vertex AbbVie Alexion and Gilead GILD reporting results So far it looks like a mixed quarter for quite a few companies with earnings topping expectations while revenues fell short Recap of the Week
CELG,CELG:UW,BBG000BFCMR2,Celgene vs. Amgen: Which Stock is a Better Pick Post Q1 Earnings?,2017-05-03 12:53:12 +0000,http://finance.yahoo.com/news/celgene-vs-amgen-stock-better-125312015.html?.tsrc=rss,Here is a look at how Celgene (CELG) and Amgen (AMGN) fared in the first quarter and which one looks better-positioned for the remainder of the year.
CELG,CELG:UW,BBG000BFCMR2,3 Debt-Free Clinical-Stage Biotech Stocks That Are Swimming in Cash,2017-05-03 12:27:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-z1pkrH_AtU/3-debt-free-clinical-stage-biotech-stocks-that-are-swimming-in-cash-cm783215,Investing in biotech stocks is like playing roulette in a casino The odds are clearly against you with most discovery stage preclinical and clinical stage experimental drugs failing to meet their trial goals However if a drug or multiple drugs within a pipeline do succeed
CELG,CELG:UW,BBG000BFCMR2,5 Best Stocks for Investing in Cancer Treatments,2017-05-03 12:25:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6TLqTkX7nwY/5-best-stocks-for-investing-in-cancer-treatments-cm783238,Medical science hasn t yet won the war on cancer but it is scoring important victories in battles against many forms of the dreaded disease Advances in new treatments have made cancer a hot investing theme over the past 18 months helping to power fresh interest in biotechnology stocks
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Webcast at Upcoming Investor Conferences,2017-05-03 11:30:00 +0000,http://finance.yahoo.com/news/celgene-corporation-webcast-upcoming-investor-113000854.html?.tsrc=rss,Celgene Corporation plans to present at three upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com.
CELG,CELG:UW,BBG000BFCMR2,[$$] Four Small Biotechs See Bullish April Stock Buys,2017-05-03 09:51:00 +0000,http://finance.yahoo.com/r/48412691-f35c-31d5-b2a8-feaea1418814/four-small-biotechs-see-bullish-april-stock-buys-1493805107?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Surfing is an apt comparison with biotech investing when considering the gnarly spellings of drug developers and medicines, the importance of having good pipelines, and what a wipeout the sector was last year.  After catching waves of double-digit returns from 2012 through 2015, the S&P Biotechnology Select Industry index crashed 16% in 2016.  For the investor who is looking for individual picks rather than a sector exchange-traded fund (the SPDR S&P Biotech ETF (XBI) tracks the index while the Direxion Daily S&P Biotech Bear 1X Shares (LABS) bets against it by seeking an inverse return), some bullish buys in April of Agios Pharmaceuticals (AGIO), BioLine Rx (BLRX), Tocagen (TOCA) and OncoMed Pharmaceuticals (OMED) may be of interest."
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation: The Bear Case From a Bull,2017-05-02 13:28:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Vyb2BWDCDI/celgene-corporation-the-bear-case-from-a-bull-cm782466,I haven t been bashful in explaining how I feel about Celgene Corporation NASDAQ CELG stock Earlier this year I wrote an article asking if Celgene was simply the best biotech stock on the planet The answer was yes More recently I wrote about the one stock I d buy right
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation: The Bear Case From a Bull,2017-05-02 12:04:00 +0000,http://finance.yahoo.com/r/21657037-62b8-3fbf-be30-c2c3372a93b4/celgene-corporation-the-bear-case-from-a-bull.aspx?yptr=yahoo&.tsrc=rss,A pessimistic look at the potential for Celgene stock from someone who has been very optimistic about the biotech.
CELG,CELG:UW,BBG000BFCMR2,What's in Store for Juno Therapeutics (JUNO) in Q1 Earnings?,2017-05-01 21:28:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fBfWs8aY9o4/whats-in-store-for-juno-therapeutics-juno-in-q1-earnings-cm782309,Juno Therapeutics Inc JUNO is scheduled to report first quarter 2017 results on May 4 after the market closes Last quarter the company posted a negative earnings surprise of 4 76 Year to date Juno s shares gained 32 3 while the Zacks classified Medical Biomed Genetics
CELG,CELG:UW,BBG000BFCMR2,Celgene CEO: The value of our medicines is priced into ho...,2017-05-01 17:21:00 +0000,http://finance.yahoo.com/video/celgene-ceo-value-medicines-priced-172100805.html?.tsrc=rss,"At the Milken Institute Conference, Celgene CEO Mark Alles speaks to Brian Sullivan about the current environment for drug prices."
CELG,CELG:UW,BBG000BFCMR2,Agios Pharmaceuticals (AGIO) Q1 Earnings: What's in Store?,2017-05-01 16:31:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UEE1oOnqS3o/agios-pharmaceuticals-agio-q1-earnings-whats-in-store-cm782059,Agios Pharmaceuticals Inc AGIO is scheduled to report first quarter results on May 4 before market open Shares gained 19 1 so far this year while the Zacks classified Medical Products industry witnessed an increase of 14 3 Agios performance has been mixed with the company
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. :CELG-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017",2017-05-01 14:53:38 +0000,http://finance.yahoo.com/r/c9786894-2297-3ced-9af0-903a6f3d88f6/celgene-corp-celg-us-earnings-analysis-q1-2017-by-the-numbers-may-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Celgene Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Celgene Corp. – Amgen Inc., Biogen Inc., Eli Lilly and Company, Alexion Pharmaceuticals, Inc., Johnson & Johnson, Illumina, Inc. and Novartis AG Sponsored ADR (AMGN-US, BIIB-US, LLY-US, ALXN-US, JNJ-US, ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,"Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views",2017-05-01 05:00:00 +0000,http://finance.yahoo.com/r/be04be42-e0dc-38c3-a65c-b8c369859b9a/good-the-bad-and-the-ugly-what-troubles-me-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly."
CELG,CELG:UW,BBG000BFCMR2,[$$] Cancer pill costs soar as drug companies retain pricing power,2017-04-30 16:15:20 +0000,"http://finance.yahoo.com/r/11f9b3e1-fc6f-36e2-adc3-ba0f4ac803d6/935e6ebe-29a1-11e7-9ec8-168383da43b7,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","When Jean Allen-Yannotti was diagnosed with a type of leukaemia in November 2015, it was the latest blow in a long fight that had already seen her defeat breast and lip cancer. Her doctors prescribed a ..."
CELG,CELG:UW,BBG000BFCMR2,Edited Transcript of CELG earnings conference call or presentation 27-Apr-17 1:00pm GMT,2017-04-30 12:00:45 +0000,http://finance.yahoo.com/news/edited-transcript-celg-earnings-conference-120047778.html?.tsrc=rss,Q1 2017 Celgene Corp Earnings Call
CELG,CELG:UW,BBG000BFCMR2,3 Top Biotech Stocks to Buy Now,2017-04-29 17:26:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zMYXyaPW3zo/3-top-biotech-stocks-to-buy-now-cm781666,If you had invested 10 000 in three select biotech stocks three years ago you d now have nearly 98 000 Which three biotech stocks would have made this accomplishment possible Celgene NASDAQ CELG Jazz Pharmaceuticals NASDAQ JAZZ and Vertex Pharmaceuticals
CELG,CELG:UW,BBG000BFCMR2,3 Top Biotech Stocks to Buy Now,2017-04-29 16:03:00 +0000,http://finance.yahoo.com/r/d462df76-a929-3e0f-a1ea-b8f4cc756912/3-top-biotech-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"Biotech stocks Celgene, Jazz Pharmaceuticals, and Vertex Pharmaceuticals are hard to beat."
CELG,CELG:UW,BBG000BFCMR2,"Garrison Bradford & Associates Inc Buys Ross Stores, Emerson Electric Co, Enbridge, Sells ...",2017-04-29 14:25:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D-4ZnaqBFlI/garrison-bradford-associates-inc-buys-ross-stores-emerson-electric-co-enbridge-sells-cm781639,Garrison Bradford Associates Inc New Purchases EMR ENB UEMS Added Positions JBLU ROST NVDQ RRC AMZN IPGP MACK AMLP Reduced Positions BXMT BX AOS HCN TJX CQH UNP QCOM PSF OAK Sold Out SE MUJ HIMX New Purchases
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Earnings: Trading Price for Volume,2017-04-28 21:27:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y13uD8GJZCk/celgene-corporation-earnings-trading-price-for-volume-cm781447,Celgene NASDAQ CELG reported strong first quarter results on Thursday but with one minor issue Celgene results The raw numbers Metric Q1 2017 Q1 2016 Year Over
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Friday Option Activity: ABCO, CELG, SLB",2017-04-28 21:26:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mB__FFOZk_Q/noteworthy-friday-option-activity-abco-celg-slb-cm781457,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Advisory Board Company Symbol ABCO where a total volume of 2 009 contracts has been traded thus far today a contract volume which is representative of approximately 200
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Earnings: Trading Price for Volume,2017-04-28 20:20:00 +0000,http://finance.yahoo.com/r/99444cfd-89e9-39ad-a07f-cf5179cfc08f/celgene-corporation-earnings-trading-price-for-vol.aspx?yptr=yahoo&.tsrc=rss,"The move could pay off, but first-quarter results suffered because of it."
CELG,CELG:UW,BBG000BFCMR2,"Vertex Big Winner In Biopharma Q1 As AbbVie, AstraZeneca Dip",2017-04-28 20:09:23 +0000,http://finance.yahoo.com/r/2327e107-70a6-3b32-90a1-c45b4e6ea34e/vertex-big-winner-in-biopharma-q1-as-abbvie-astrazeneca-dip?src=A00220&yptr=yahoo&.tsrc=rss,Vertex was the big winner Friday following a slew of biotechs and drugmakers issuing first-quarter reports Thursday.
CELG,CELG:UW,BBG000BFCMR2,What's Worrying Me About Biogen,2017-04-28 19:26:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pn2WeLMrHMo/whats-worrying-me-about-biogen-cm781369,Biogen Inc NASDAQ BIIB recently reported its first quarter financial results and while the company remains the market share leader in multiple sclerosis MS treatment there are signs that its dominance could be waning An increasingly competitive market MS is a central
CELG,CELG:UW,BBG000BFCMR2,What&apos;s Worrying Me About Biogen,2017-04-28 18:20:00 +0000,http://finance.yahoo.com/r/356d311a-a849-33cc-aea6-e75a8baaf6fc/whats-worrying-me-about-biogen.aspx?yptr=yahoo&.tsrc=rss,Biogen could struggle to maintain its market-leading position in multiple sclerosis over the next two years.
CELG,CELG:UW,BBG000BFCMR2,Today's Research Reports on Stocks to Watch: EXACT Sciences and Celgene,2017-04-28 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000706.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 28, 2017 / Strong corporate earnings outweighed losses by the energy sector Thursday as U.S. crude futures slipped on growing output concerns. The Dow Jones Industrial ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene CEO: Big supporters of trying to refine ACA,2017-04-28 11:20:42 +0000,http://finance.yahoo.com/video/celgene-ceo-big-supporters-trying-112042393.html?.tsrc=rss,"Celgene CEO Mark Alles on the Republican health care plan, tax reform, the pharmaceutical company's earnings, drug pipeline and the future of the FDA."
CELG,CELG:UW,BBG000BFCMR2,Alexion Beats On First-Quarter Sales; Profits Top By 15 Cents,2017-04-27 21:45:20 +0000,http://finance.yahoo.com/r/b9816a25-99a5-3ebc-9c2f-17ebd9d06c1b/alexion-crushes-wall-streets-revenue-profits-expectations?src=A00220&yptr=yahoo&.tsrc=rss,Alexion stock popped on Thursday after the top 10 biotech crushed Wall Street&apos;s expectations for first-quarter sales and adjusted profits.
CELG,CELG:UW,BBG000BFCMR2,"AbbVie Flirts With Buy Point After Q1 Earnings, Sales Top",2017-04-27 20:48:42 +0000,http://finance.yahoo.com/r/16693180-f10d-3670-a61e-760fac0fa42e/abbvie-crushes-q1-sales-earnings-views?src=A00220&yptr=yahoo&.tsrc=rss,AbbVie reported better-than-expected earnings and revenue early Thursday. Shares of the drugmaker traded around a buy point.
CELG,CELG:UW,BBG000BFCMR2,"Celgene Dips On $95 Million Lag In Psoriasis Sales, But Earnings Top",2017-04-27 20:43:49 +0000,http://finance.yahoo.com/r/06f62447-ab83-3a1d-a287-c76290c5e3fd/celgene-earnings-top-but-biotechs-sales-miss?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene reported better-than-expected first-quarter earnings, but sales were a little light, following similar results from fellow biotech giant Amgen late Wednesday."
CELG,CELG:UW,BBG000BFCMR2,Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports,2017-04-27 20:07:00 +0000,http://finance.yahoo.com/r/b9d286e0-61b1-3c1a-abb3-a358104185de/making-sense-of-thursday-s-flood-of-biotech-and-pharma-earnings-reports.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,A guide to keep track of all the companies reporting first quarter financial results today -- making sense of what's important and disregarding what's not.
CELG,CELG:UW,BBG000BFCMR2,Three Biotechs Enter…One Biotech Gains,2017-04-27 19:51:00 +0000,http://finance.yahoo.com/r/0d3fa7ac-9ab1-34d3-8fa5-4554736e241d/three-biotechs-enterone-biotech-gains-1493322699?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Three biotech stocks--Alexion Pharmaceuticals (ALXN), Amgen (AMGN), and Celgene (CELG)--reported earnings since yesterday's close. But just one has seen its shares head higher after the announcement. That ..."
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Tops on Q1 Earnings, Sales Miss, Raises View",2017-04-27 17:31:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k30rc6ns-qs/celgene-celg-tops-on-q1-earnings-sales-miss-raises-view-cm780499,Celgene Corporatio n CELG reported first quarter 2017 earnings of 1 53 per share including share based compensation expense and tax adjustments beating the Zacks Consensus Estimate of 1 47 but up from 1 18 per share in the year ago quarter Celgene s share price movement shows
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Ionis Pharmaceuticals, Inc. vs. bluebird bio",2017-04-27 17:31:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cylZBQVTC6o/better-buy-ionis-pharmaceuticals-inc-vs-bluebird-bio-cm780433,The most promising biotechs have productive platforms and are pioneering new approaches to treating conditions difficult to address with conventional therapies Two that fit that bill are Ionis Pharmaceuticals NASDAQ IONS and bluebird bio NASDAQ BLUE Which one represents
CELG,CELG:UW,BBG000BFCMR2,Biopharma earnings bonanza,2017-04-27 16:07:00 +0000,http://finance.yahoo.com/video/biopharma-earnings-bonanza-160700524.html?.tsrc=rss,"CNBC's Meg Tirrell reports on the moves in the biotech sector following earnings from Amgen, Bristol-Myers and more. The &quot;Fast Money Halftime Report&quot; traders weigh in."
CELG,CELG:UW,BBG000BFCMR2,Celgene 1st quarter sales miss; expects psoriasis drug rebound,2017-04-27 15:44:34 +0000,http://finance.yahoo.com/news/celgene-quarterly-profit-beats-revlimid-120602141.html?.tsrc=rss,"Celgene Corp on Thursday  reported lower-than-expected first-quarter revenue with Otezla  sales well short of Wall Street estimates, but the U.S.  biotechnology company promised  the psoriasis drug was poised to  rebound.  Lower costs helped the company beat analysts' earnings  expectations by 5 cents, and Celgene raised both ends of its  full-year forecast by that amount."
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Tops on Q1 Earnings, Sales Miss, Raises View",2017-04-27 15:11:03 +0000,http://finance.yahoo.com/news/celgene-celg-tops-q1-earnings-151103437.html?.tsrc=rss,"Celgene&apos;s (CELG) first-quarter results were mixed, with the company beating on earnings but missing on sales."
CELG,CELG:UW,BBG000BFCMR2,Health Care Sector Update for 04/27/2017: CELG,2017-04-27 13:45:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7vya8Dg7cYA/health-care-sector-update-for-04272017-celg-cm780159,Top Health care stocks Top Health care stocks JNJ 0 2 JNJ 0 2 PFE flatPFE flat ABT flatABT flat MRK 3 1 MRK 3 1 AMGN 2 6 AMGN 2 6 Health care shares were mixed in early trade on Thursday Health care shares were mixed in early trade on Thursday In health care stocks
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Beats On Q1 Earnings, Misses On Sales",2017-04-27 13:29:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/im8mMHpDmJU/celgene-celg-beats-on-q1-earnings-misses-on-sales-cm780220,Summit NJ based Celgene Corporation CELG is a biopharmaceutical company focused on the discovery development and commercialization of drugs targeting cancer and inflammatory diseases Celgene s key growth driver is Revlimid The company s portfolio also includes Pomalyst Imnovid
CELG,CELG:UW,BBG000BFCMR2,Biotech Earnings Roundup: Exact Sciences Flying Higher,2017-04-27 12:51:00 +0000,http://finance.yahoo.com/r/4cb6bc0e-10a5-33c2-a9e2-dc71625c4a4a/biotech-earnings-roundup-exact-sciences-flying-higher?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Shares of Exact Sciences are flying higher after earnings; Amgen, Alkermes and Celgene are sinking lower."
CELG,CELG:UW,BBG000BFCMR2,Celgene quarterly profit beats on Revlimid demand,2017-04-27 12:50:48 +0000,http://finance.yahoo.com/news/celgene-quarterly-profit-beats-revlimid-125048220.html?.tsrc=rss,"U.S. biotechnology company Celgene Corp reported a better-than-expected profit on Thursday, helped by demand for its flagship multiple myeloma drug Revlimid. The company's net income rose to $941 million, ..."
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Beats On Q1 Earnings, Misses On Sales",2017-04-27 12:13:12 +0000,http://finance.yahoo.com/news/celgene-celg-beats-q1-earnings-121312241.html?.tsrc=rss,Celgene beat on first-quarter 2017 earnings.
CELG,CELG:UW,BBG000BFCMR2,Celgene tops 1Q profit forecasts,2017-04-27 11:44:25 +0000,http://finance.yahoo.com/news/celgene-tops-1q-profit-forecasts-114425916.html?.tsrc=rss,"The Summit, New Jersey-based company said it had profit of $1.16 per share. Earnings, adjusted for one-time gains and costs, came to $1.68 per share. The results surpassed Wall Street expectations. The ..."
CELG,CELG:UW,BBG000BFCMR2,Biogen Reports Strong Revenue Growth in 1Q17,2017-04-27 11:39:42 +0000,http://finance.yahoo.com/r/80ef9d55-040c-360e-bdf5-78e97c21b4be/biogen-reported-strong-revenue-growth-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Biogen (BIIB) reported its 1Q17 results on April 25, 2017. Its revenues were about $2.8 billion, which is a YoY (year-over-year) rise of about 3.0%."
CELG,CELG:UW,BBG000BFCMR2,Celgene quarterly profit rises 17.5 percent,2017-04-27 11:35:37 +0000,http://finance.yahoo.com/news/celgene-quarterly-profit-rises-17-113537250.html?.tsrc=rss,"U.S. biotechnology company Celgene Corp reported a 17.5 percent jump in quarterly net income on Thursday, helped by demand for its flagship multiple myeloma drug Revlimid. The company's net income rose ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Reports First Quarter 2017 Operating and Financial Results,2017-04-27 11:27:00 +0000,http://finance.yahoo.com/news/celgene-reports-first-quarter-2017-112700494.html?.tsrc=rss,"Celgene Corporation reported net product sales of $2,950 million for the first quarter of 2017, an 18 percent increase from the same period in 2016. Net product sales growth includes a 0.6 percent negative impact from currency exchange effects."
CELG,CELG:UW,BBG000BFCMR2,"Earnings Reaction History: Celgene Corporation, 54.5% Follow-Through Indicator, 2.4% Sensitive",2017-04-27 11:05:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LnPouaFR0Bk/earnings-reaction-history-celgene-corporation-545-follow-through-indicator-24-sensitive-cm780061,Expected Earnings Release 04 27 2017 PremarketExpected Earnings Release 04 27 2017 Premarket Avg Extended Hours Dollar Volume 9 547 655Avg Extended Hours Dollar Volume 9 547 655 Celgene Corporation CELG is due to issue its quarterly earnings report in the upcoming extended
CELG,CELG:UW,BBG000BFCMR2,Market Recon: The Tax Reform Is Just Ordinary Negotiation on Steroids,2017-04-27 10:35:00 +0000,http://finance.yahoo.com/r/3a691b3d-e2e6-3147-9326-c0d47e838a6d/market-recon-the-tax-reform-is-just-ordinary-negotiation-on-steroids.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Nobody shows their hand in negotiations. Why should government? This new tax plan must go to Congress.
CELG,CELG:UW,BBG000BFCMR2,Celgene Q1 17 Earnings Conference Call At 9:00 AM ET,2017-04-27 08:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sUt2zFxTBPo/celgene-q1-17-earnings-conference-call-at-900-am-et-20170427-00881,Celgene Q1 17 Earnings Conference Call At 9:00 AM ET
CELG,CELG:UW,BBG000BFCMR2,Celgene Raises 2017 Earnings Guidance - Quick Facts,2017-04-27 07:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Z0dTHqWsLc/celgene-raises-2017-earnings-guidance--quick-facts-20170427-00721,Celgene Raises 2017 Earnings Guidance - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Announces 28% Gain In Q1 Bottom Line,2017-04-27 07:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rt_YOjag6bM/celgene-corporation-announces-28-gain-in-q1-bottom-line-20170427-00683,Celgene Corporation Announces 28% Gain In Q1 Bottom Line
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Earnings Advance 28% In Q1,2017-04-27 07:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U2K5u3kPuRo/celgene-corporation-earnings-advance-28-in-q1-20170427-00684,Celgene Corporation Earnings Advance 28% In Q1
CELG,CELG:UW,BBG000BFCMR2,"Glen Harbor Capital Management LLC Buys Johnson Controls International PLC, Prologis, ...",2017-04-26 23:25:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tGTGwjrRmIQ/glen-harbor-capital-management-llc-buys-johnson-controls-international-plc-prologis-cm779978,Glen Harbor Capital Management LLC New Purchases IVV LLL XLK XLV XLF XLY XLI LCII XLP LAZ Added Positions JCI PLD UNH JPM SPG RF PRU ABT BHI DFS Reduced Positions GILD ESRX STT UTX ITW CTL DAL CTXS RTN TRV Sold Out CCI
CELG,CELG:UW,BBG000BFCMR2,"Pre-Market Earnings Report for April 27, 2017 :  CMCSA, ABBV, CELG, UNP, BMY, DOW, UPS, AMT, SPG, RTN, F, CME",2017-04-26 20:12:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p6Q_D9qSseE/pre-market-earnings-report-for-april-27-2017-cmcsa-abbv-celg-unp-bmy-dow-ups-amt-spg-rtn-f-cme-cm779833,The following companies are expected to report earnings prior to market open on 04 27 2017 Visit our Earnings Calendar for a full list of expected earnings releases Comcast Corporation CMCSA is reporting for the quarter ending March 31 2017 The cable
CELG,CELG:UW,BBG000BFCMR2,Time for Big Cap Biotech,2017-04-26 16:14:00 +0000,http://finance.yahoo.com/r/a98dc061-b9cb-3414-8a5c-1d0ab92d0e01/time-big-cap-biotech-celg-vrtx?partner=YahooSA&yptr=yahoo&.tsrc=rss,The biotech sector is gaining ground after strong first quarter earnings and could finally be headed into a major recovery.
CELG,CELG:UW,BBG000BFCMR2,Celgene exec. chair: Trump administration will listen to ...,2017-04-26 15:14:00 +0000,http://finance.yahoo.com/video/celgene-exec-chair-trump-administration-151400651.html?.tsrc=rss,"CNBC's Meg Tirrell speaks with Robert Hugin, Celgene executive chairman, about the outlook for the pharmaceutical industry under the Trump administration."
CELG,CELG:UW,BBG000BFCMR2,"Pharma Stocks Q1 Earnings Roster for Apr 27: CELG, ABBV, BMY",2017-04-26 14:08:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J5LPdt37ifM/pharma-stocks-q1-earnings-roster-for-apr-27-celg-abbv-bmy-cm779340,Things are certainly looking up as we get into the thick of the Q1 earnings season By the end of this week approximately half of the S amp P 500 Index would be reporting making the picture clearer As of Apr 21 95 S amp P 500 members accounting for 24 9 of the index s total
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug",2017-04-26 14:07:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z8kcvhvq52c/biotech-stock-roundup-biogen-gains-on-strong-q1-nash-data-on-gilead-drug-cm779308,Earnings season for the biotech sector is off to a promising start with Biogen BIIB reporting better than expected first quarter results While focus remained on Biogen s results companies like Gilead GILD were also in the news on the presentation of pipeline data Recap of the Week s
CELG,CELG:UW,BBG000BFCMR2,The 1 Stock I'd Buy Right Now,2017-04-26 14:05:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k8FYvHcFIg4/the-1-stock-id-buy-right-now-cm779302,There are more than 5 700 publicly traded companies in the U S Even more are listed on non U S stock exchanges Investors definitely have plenty of options If you could only buy one stock though which would it be It s a very tough decision because there are quite a few
CELG,CELG:UW,BBG000BFCMR2,Stocks Give an Encore Performance,2017-04-26 14:03:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U2kk5k-Jw4U/stocks-give-an-encore-performance-cm779189,It feels like the market just now found out that we re having a good earnings season It took solid reports from the likes of Caterpillar and McDonalds among others to force the realization but better late than never As a result stocks followed up yesterday s sharp rally with an
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Grow More Selective on Major Biotechs,2017-04-26 13:40:07 +0000,http://finance.yahoo.com/news/short-sellers-grow-more-selective-134007781.html?.tsrc=rss,"The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed."
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Amgen Inc. vs. Biogen,2017-04-26 13:05:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aE32V7j-Nzs/better-buy-amgen-inc-vs-biogen-cm779256,If you re looking for unusually high returns on your capital biotechnology remains a fairly safe bet even despite its monstrous run up over the past five years The growing and aging global population after all is expected to drive an ever increasing demand for the biologically
CELG,CELG:UW,BBG000BFCMR2,"Pharma Stocks Q1 Earnings Roster for Apr 27: CELG, ABBV, BMY",2017-04-26 12:04:12 +0000,http://finance.yahoo.com/news/pharma-stocks-q1-earnings-roster-120412931.html?.tsrc=rss,"Celgene, AbbVie and Bristol-Myers Squibb are expected to report earnings on Apr 27."
CELG,CELG:UW,BBG000BFCMR2,The 1 Stock I&apos;d Buy Right Now,2017-04-26 12:04:00 +0000,http://finance.yahoo.com/r/48da4947-94f2-342d-a45e-03970616a9f5/the-1-stock-id-buy-right-now.aspx?yptr=yahoo&.tsrc=rss,"In the vast ocean of stocks, big biotech Celgene is the one that looks most attractive to me at the moment."
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Amgen Inc. vs. Biogen,2017-04-26 11:20:00 +0000,http://finance.yahoo.com/r/840e080b-f8f2-3af5-beda-17f4620e575a/better-buy-amgen-inc-vs-biogen.aspx?yptr=yahoo&.tsrc=rss,Which biotech is the better stock?
CELG,CELG:UW,BBG000BFCMR2,"[$$] Aquinnah Pharmaceuticals Taps Pfizer, AbbVie for $10 Million",2017-04-26 02:07:01 +0000,http://finance.yahoo.com/r/c95183f3-79f9-3e49-b065-de8aa98679d5/aquinnah-pharmaceuticals-taps-pfizer-abbvie-for-10-million-1493172418?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,A trio of pharmaceutical companies is financing an effort by Aquinnah Pharmaceuticals Inc. to use a new approach to tackling neurological diseases that have long frustrated drugmakers.
CELG,CELG:UW,BBG000BFCMR2,Fundstrat: 3 Nasdaq names to buy,2017-04-25 21:08:00 +0000,http://finance.yahoo.com/video/fundstrat-3-nasdaq-names-buy-210800337.html?.tsrc=rss,"Robert Sluymer, Fundstrat Global Advisors, goes to the charts to discuss three names still left to buy as the Nasdaq crosses 6K."
CELG,CELG:UW,BBG000BFCMR2,Key Factors to Look Out for in Celgene's (CELG) Q1 Results,2017-04-25 14:08:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UsVLGeMUSN0/key-factors-to-look-out-for-in-celgenes-celg-q1-results-cm778639,Earnings season for the pharma and biotech sector will start in full flow this week with several major companies scheduled to report results Celgene Corporation CELG is one of the companies that will be reporting results later this week A look at the company s earnings track record
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Celgene Corporation vs. Merck & Co., Inc.",2017-04-25 13:06:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S2t_66-EBVA/better-buy-celgene-corporation-vs-merck-co-inc-cm778421,Two of the hottest cancer drugs around belong to Celgene Corporation NASDAQ CELG and Merck amp Co Inc NYSE MRK Celgene claims blockbuster blood cancer drug Revlimid while Merck s Keytruda appears to be one of the most powerful lung cancer treatments ever But which
CELG,CELG:UW,BBG000BFCMR2,Key Factors to Look Out for in Celgene&apos;s (CELG) Q1 Results,2017-04-25 12:41:12 +0000,http://finance.yahoo.com/news/key-factors-look-celgene-apos-124112948.html?.tsrc=rss,"Apart from the usual earnings and revenue numbers, investors will be focused on the performance of Celgene&apos;s (CELG) key products and its pipeline progress."
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Celgene Corporation vs. Merck & Co., Inc.",2017-04-25 11:04:00 +0000,http://finance.yahoo.com/r/4745efac-48e0-3b6c-99ef-6bfa3d3dddb4/better-buy-celgene-corporation-vs-merck-co-inc.aspx?yptr=yahoo&.tsrc=rss,Which drug stock wins in a head-to-head matchup between Celgene and Merck?
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) to Post Q1 Earnings: What's in the Cards?,2017-04-24 21:04:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1tkU1Z0huz0/celgene-celg-to-post-q1-earnings-whats-in-the-cards-cm778230,Celgene Corporation CELG is scheduled to report first quarter 2017 results on Apr 27 before the opening bell Last quarter the company reported a negative earnings surprise of 1 40 Celgene outperformed the Zacks classified Medical Biomedical and Genetics industry in the past one year
CELG,CELG:UW,BBG000BFCMR2,Celgene research leader Dr. Rupert Vessey joins Juno board,2017-04-24 21:00:13 +0000,http://finance.yahoo.com/r/891cd1c6-e6cd-31f9-96dd-006459f539ac/juno-therapeutics-board-celgene-rupert-vessey.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Juno Therapeutics Inc. has added Celgene Corp. President of Research and Early Development Dr. Rupert Vessey to the Seattle-based biotech's board.  Vessey will serve as as Celgene's designated appointee to Juno's board, replacing Dr. Tom Daniel, who retired last summer but will remain on the board as an independent director.  Juno (JUNO) inked a $1 billion collaboration with Celegene in 2015."
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) to Post Q1 Earnings: What&apos;s in the Cards?,2017-04-24 19:17:07 +0000,http://finance.yahoo.com/news/celgene-celg-post-q1-earnings-191707800.html?.tsrc=rss,"Celgene Corporation (CELG) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. – Value Analysis (NASDAQ:CELG) : April 24, 2017",2017-04-24 19:13:15 +0000,http://finance.yahoo.com/r/6f8823bd-0389-367d-8dac-e0bb9521ebc1/celgene-corp-value-analysis-nasdaqcelg-april-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Celgene Corp. a score of 78. Our analysis is based on comparing Celgene Corp. with the following peers – Amgen Inc., Gilead Sciences, Inc., Biogen Inc., OncoMed Pharmaceuticals, Inc., Eli Lilly and Company, Alexion Pharmaceuticals, Inc., Johnson & Johnson, Illumina, Inc., Novartis AG Sponsored ADR and Acceleron ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Gilead Sciences vs. Celgene,2017-04-24 19:05:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4y6STh2wa1c/better-buy-gilead-sciences-vs-celgene-cm778123,Gilead Sciences NASDAQ GILD and Celgene NASDAQ CELG are two of the most successful biopharmaceutical companies to rise out of the 1980s but since early 2015 Gilead shares have fallen 30 while Celgene shares have risen 11 For investors considering them now the question
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Gilead Sciences vs. Celgene,2017-04-24 17:02:00 +0000,http://finance.yahoo.com/r/2dc88782-694a-3c9f-9a2b-544e96208f22/better-buy-gilead-sciences-inc-vs-celgene.aspx?yptr=yahoo&.tsrc=rss,"These two biopharmaceutical stocks have been going in opposite directions, which has left one trading at a bargain valuation."
CELG,CELG:UW,BBG000BFCMR2,9 Reasons Celgene Could Be the World's Most Perfect Stock,2017-04-24 14:05:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HKY73jixTes/9-reasons-celgene-could-be-the-worlds-most-perfect-stock-cm777736,The average investor has more than 5 000 publicly traded stocks on reputable U S exchanges to choose from With that much hay in the barn finding that needle can be quite difficult But if you re looking for the world s most perfect stock perhaps your search might end with
CELG,CELG:UW,BBG000BFCMR2,9 Reasons Celgene Could Be the World&apos;s Most Perfect Stock,2017-04-24 12:21:00 +0000,http://finance.yahoo.com/r/7feadcbd-cf59-3764-b31e-0cce8363952a/9-reasons-celgene-could-be-the-worlds-most-perfect.aspx?yptr=yahoo&.tsrc=rss,Celgene may be a picture-perfect stock for long-term investors to consider buying.
CELG,CELG:UW,BBG000BFCMR2,Johnson & Johnson's Weak Pharma Revenue Could Spell Doom for Rest of Sector,2017-04-23 22:55:00 +0000,http://finance.yahoo.com/r/642e755c-6429-3613-97f6-5af507a7c9bf/johnson-amp-johnson-s-weak-pharma-revenues-could-spell-doom-for-rest-of-sector.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The New Brunswick, N.J.-based company noted that its pharma sales dipped due to weakness in the U.S. compared to other markets."
CELG,CELG:UW,BBG000BFCMR2,3 Stocks That Growth Investors Should Love,2017-04-23 17:03:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-8DunDjcPMc/3-stocks-that-growth-investors-should-love-cm777595,If you re a growth investor you love revenue growth You love earnings growth And most of all you love share price growth There are three stocks that should check off all of these boxes in the days ahead Celgene NASDAQ CELG Ionis Pharmaceuticals NASDAQ IONS
CELG,CELG:UW,BBG000BFCMR2,3 Stocks That Growth Investors Should Love,2017-04-23 15:01:00 +0000,http://finance.yahoo.com/r/2fceb37f-e2ae-3054-b3cb-31e9d6321287/3-stocks-that-growth-investors-should-love.aspx?yptr=yahoo&.tsrc=rss,"Impressive growth could be in store for biotech stocks Celgene, Ionis, and Vertex."
CELG,CELG:UW,BBG000BFCMR2,"Magee Thomson Investment Partners Llc Buys Inphi, Take-Two Interactive Software, Domino's ...",2017-04-22 16:02:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aftU5kxQidM/magee-thomson-investment-partners-llc-buys-inphi-take-two-interactive-software-dominos-cm777514,Magee Thomson Investment Partners Llc New Purchases TTWO DPZ SNES PRTK NWPX NNBR MIND LJPC LBIO ICHR Added Positions IPHI FANG FB ADXS GSUM VRNS Reduced Positions ALGN NOW ORLY EQIX MA CELG AMAT MSFT AMZN WST Sold Out MBLY
CELG,CELG:UW,BBG000BFCMR2,3 Top Stocks to Buy With Your Tax Refund,2017-04-22 13:03:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hglDFppZA6Y/3-top-stocks-to-buy-with-your-tax-refund-cm777468,Roughly 70 of U S tax filers are expected to receive a tax refund this year according to data from wallethub com More importantly the average refund check is expected to come in at just under 2 900 which is plenty of capital in which to invest So what stocks should you
CELG,CELG:UW,BBG000BFCMR2,3 Top Stocks to Buy With Your Tax Refund,2017-04-22 11:26:00 +0000,http://finance.yahoo.com/r/4727686c-2f33-34ac-ba0d-5a05152dce08/3-top-stocks-to-buy-with-your-tax-refund.aspx?yptr=yahoo&.tsrc=rss,Did you just get a refund check from Uncle Sam? Here are three stocks you should consider buying with those funds.
CELG,CELG:UW,BBG000BFCMR2,"Covenant Asset Management, LLC Buys Netflix, Citizens Financial Group, Regions Financial, Sells ...",2017-04-22 11:02:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/98H23BOZ5Go/covenant-asset-management-llc-buys-netflix-citizens-financial-group-regions-financial-sells-cm777448,Covenant Asset Management LLC New Purchases RF HII STLD AEIS MS LOPE ODFL UNH MCHP ULTA Added Positions NFLX CFG VNQ VTV DGS QCOM SF JPM EZM IJS Reduced Positions SBUX V BIIB PANW AAPL VWO BAC GILD CELG REGN Sold Out EGBN
CELG,CELG:UW,BBG000BFCMR2,"Street Watches To See If $125,000 Drug Boosts Biogen&apos;s Results",2017-04-21 20:13:54 +0000,http://finance.yahoo.com/r/ecf53783-ebba-363a-bae3-da92f0670785/will-biogens-q1-spinraza-revenue-be-a-slam-dunk-or-resounding-flop?src=A00220&yptr=yahoo&.tsrc=rss,Wall Street will be keyed in Tuesday to Biogen&apos;s earnings for a first look at whether payer pushback hindered sales of Spinraza.
CELG,CELG:UW,BBG000BFCMR2,"Notable Friday Option Activity: HAS, CELG, XOM",2017-04-21 20:04:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iEMFojUeAtA/notable-friday-option-activity-has-celg-xom-cm777287,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Hasbro Inc Symbol HAS where a total volume of 4 239 contracts has been traded thus far today a contract volume which is representative of approximately 423 900
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : April 21, 2017",2017-04-21 12:48:54 +0000,http://finance.yahoo.com/r/f4392750-ad19-37b6-96ae-1e7953737802/celgene-corp-breached-its-50-day-moving-average-in-a-bullish-manner-celg-us-april-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Celgene Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,What to expect from biotech,2017-04-20 21:53:00 +0000,http://finance.yahoo.com/video/expect-biotech-215300900.html?.tsrc=rss,CNBC's Meg Tirrell discusses what healthcare investors should expect from the biotech sector. With the &quot;Fast Money&quot; traders.
CELG,CELG:UW,BBG000BFCMR2,"​Celgene to expand in Cambridge, taking former Amgen space",2017-04-20 18:55:09 +0000,http://finance.yahoo.com/r/3c560f21-e79e-37f4-8f88-58186c7c65ac/celgene-to-expand-in-cambridge-taking-former.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Celgene Corp. is expanding its presence in Cambridge, leasing about 40,000 square feet of additional space in the Alewife neighborhood that was previously occupied by Amgen.  Amgen Inc. (AMGN) occupied the fifth floor of 200 Cambridge Park Drive between January 2015 and September 2016, when staff there moved to the company’s newly-expanded office in Kendall Square, a spokeswoman for the California drugmaker said.  Celgene (CELG), which already leases part of 200 Cambridge Park Drive, recently committed to some of Amgen’s former space, a spokesman for the New Jersey pharma giant said."
CELG,CELG:UW,BBG000BFCMR2,"Cypress Capital Management LLC (WY) Buys iShares US Preferred Stock, Exxon Mobil, Whiting ...",2017-04-20 18:02:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FUnvL30xcc0/cypress-capital-management-llc-wy-buys-ishares-us-preferred-stock-exxon-mobil-whiting-cm776581,Cypress Capital Management LLC WY WY WY New Purchases NRZ MU GDX MTZ CWST ARI ZION UCBI KBE RUSHA Added Positions PFF XOM WLL SM EEP STX SCHD OCLR HD DRD Reduced Positions NKE GILD CELG SBUX RAI SCHG STZ ALK SCHX PM
CELG,CELG:UW,BBG000BFCMR2,"Commit To Buy Celgene Corp. At $75, Earn 3.1% Using Options",2017-04-19 20:04:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jcvslCNvQlE/commit-to-buy-celgene-corp-at-75-earn-31-using-options-cm776065,Investors considering a purchase of Celgene Corp Symbol CELG stock but tentative about paying the going market price of 123 18 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Inflows: IWF, BA, CELG, DD",2017-04-19 16:02:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pyobSYQEXZ0/noteworthy-etf-inflows-iwf-ba-celg-dd-cm775824,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Growth ETF Symbol IWF where we have detected an approximate 113 2 million dollar inflow that s a 0 3 increase week over week
CELG,CELG:UW,BBG000BFCMR2,Looking for a Smart Way to Use Your Tax Refund? Buy These 3 Stocks,2017-04-19 14:04:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uo5azVwVuiM/looking-for-a-smart-way-to-use-your-tax-refund-buy-these-3-stocks-cm775719,If you re like most American taxpayers you re getting a tax refund The question is What are you going to do with the money you get back from the IRS You could spend it of course An even better idea though is to invest the money Over the long run that option should pay
CELG,CELG:UW,BBG000BFCMR2,Looking for a Smart Way to Use Your Tax Refund? Buy These 3 Stocks,2017-04-19 12:04:00 +0000,http://finance.yahoo.com/r/6f54fb59-9a5d-3c3d-9b41-81b482feb6df/looking-for-a-smart-way-to-use-your-tax-refund-buy.aspx?yptr=yahoo&.tsrc=rss,"Buying Celgene, Medical Properties Trust, and Gilead Sciences stocks would put your tax refund to work for you."
CELG,CELG:UW,BBG000BFCMR2,"Dow&apos;s Johnson & Johnson Highlights &apos;Multiple Issues&apos; For Drugs, Biotechs",2017-04-18 20:01:29 +0000,http://finance.yahoo.com/r/e18a0410-d640-39c1-8fc8-67ae861e17e0/dows-johnson-johnson-highlights-multiple-issues-for-drugs-biotechs?src=A00220&yptr=yahoo&.tsrc=rss,Drug stocks toppled to a five-month low Tuesday after Dow component Johnson & Johnson reported weak first-quarter sales.
CELG,CELG:UW,BBG000BFCMR2,Cancer biotech Zymeworks sets terms for $65 million IPO,2017-04-17 15:55:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nn7Ylrux4Zs/cancer-biotech-zymeworks-sets-terms-for-65-million-ipo-cm774634,Zymeworks an early stage biotech developing antibodies that target HER2 tumors announced terms for its IPO on Monday The Vancouver Canada based company plans to raise 65 million by offering 4 5 million shares at a price range of 13 to 16 Insiders intend to purchase 42 million worth
CELG,CELG:UW,BBG000BFCMR2,3 Cancer Drug Stocks That Could Make You Rich,2017-04-17 12:42:00 +0000,http://finance.yahoo.com/r/459e81e5-f459-3d2c-b8af-96a2ec5bb4eb/3-cancer-drug-stocks-that-could-make-you-rich.aspx?yptr=yahoo&.tsrc=rss,"Agios, Celldex, and Clovis stand out as cancer drug stocks that could generate big returns."
CELG,CELG:UW,BBG000BFCMR2,Celgene Stock History: The Biotech's Path to Gigantic Gains,2017-04-14 19:53:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PbxzOPyQGgM/celgene-stock-history-the-biotechs-path-to-gigantic-gains-cm774277,A quick analysis of Celgene Corporation NASDAQ CELG stock history reveals three distinct stages with four stock splits along the way These stages led to the company becoming what the following chart shows it to be one of the biggest biotechs in the
CELG,CELG:UW,BBG000BFCMR2,Celgene Stock History: The Biotech&apos;s Path to Gigantic Gains,2017-04-14 18:43:00 +0000,http://finance.yahoo.com/r/27da1f9a-7b60-359a-9753-64e5103ed823/celgene-stock-history-the-biotechs-path-to-giganti.aspx?yptr=yahoo&.tsrc=rss,A brief look at Celgene stock history and the company&apos;s transformation from a small chiral chemical supplier to a giant biotech.
CELG,CELG:UW,BBG000BFCMR2,Retirement Accounts Benefit From Columbia Fund's Tech Bets,2017-04-13 22:53:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2igfF-xmqwA/retirement-accounts-benefit-from-columbia-funds-tech-bets-cm774049,Just as an ace baseball pitcher mixes his throws top mutual fund managers vary their investments Managers of Columbia Large Cap Growth Fund are mingling semiconductor stocks with biotech stocks online travel agencies and a Chinese fast food chain all to good effect That s been
CELG,CELG:UW,BBG000BFCMR2,"Notable Thursday Option Activity: STLD, SAM, CELG",2017-04-13 20:55:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uoOUaUr36XA/notable-thursday-option-activity-stld-sam-celg-cm774019,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Steel Dynamics Inc Symbol STLD where a total volume of 11 395 contracts has been traded thus far today a contract volume which is representative of approximately 1 1
CELG,CELG:UW,BBG000BFCMR2,The Hot Stock: Alexion Pharmaceuticals Climbs 3.3%,2017-04-13 20:18:00 +0000,http://finance.yahoo.com/r/881789be-222a-3d9f-964e-c66f05d98bf3/the-hot-stock-alexion-pharmaceuticals-climbs-3-3?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals (ALXN), a drug maker focused on rare diseases, ended Thursday at the top of the list of the best performing stocks in the S&P 500 index.  It’s been a rough two years for Alexion.  Since mid-2015, when the stock traded above $200, shares have tumbled on worries about the durability of its main drug Soliris, political furor over high drug prices, and the abrupt departure of two top executives amid an investigation into sales practices."
CELG,CELG:UW,BBG000BFCMR2,3 Rock-Solid Stocks to Buy Before the Next Market Crash,2017-04-13 13:43:00 +0000,http://finance.yahoo.com/r/6b574569-7541-356d-ac60-361a80c00f39/3-rock-solid-stocks-to-buy-before-the-next-market.aspx?yptr=yahoo&.tsrc=rss,"If you&apos;re nervous that the market could be due for a fall, you might want to consider buying shares in Netflix, Caretrust REIT, and Celgene."
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback",2017-04-12 13:58:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BQjIj_WyhI0/biotech-stock-roundup-geron-gains-on-interim-data-oncomed-slumps-on-pipeline-setback-cm773101,Several companies including Geron GERN and OncoMed OMED provided key pipeline updates this week While Geron s shares were up this week OncoMed s shares plunged and hit a 52 week low Recap of the Week s Most Important Stories Geron Up on Interim Data Geron s shares were up 19
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Back Off Major Biotechs,2017-04-12 13:10:18 +0000,http://finance.yahoo.com/news/short-sellers-back-off-major-131018190.html?.tsrc=rss,"The March 31 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks."
CELG,CELG:UW,BBG000BFCMR2,Biotechs Catching Their Breath: Cramer's 'Off The Charts',2017-04-12 10:28:00 +0000,http://finance.yahoo.com/r/d7111dff-cb7a-3210-af21-f3b9c08b0279/biotechs-catching-their-breath-cramer-s-off-the-charts.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Some recent high-flying biotechs may be preparing for their next surge.
CELG,CELG:UW,BBG000BFCMR2,First Quarter Earnings Preview: Biotech Heavyweights,2017-04-12 10:00:00 +0000,http://finance.yahoo.com/r/e948fb33-532b-35ac-a297-8a0db0e59a70/first-quarter-earnings-preview-biotech-heavyweights?partner=YahooSA&yptr=yahoo&.tsrc=rss,"The March quarter earnings season is getting underway soon, get ahead of the game with our biotech earnings preview."
CELG,CELG:UW,BBG000BFCMR2,Cramer's charts show these biotechs ignoring their 'polit...,2017-04-11 22:53:00 +0000,http://finance.yahoo.com/video/cramers-charts-show-biotechs-ignoring-225300315.html?.tsrc=rss,Jim Cramer looks to Bob Lang's charts to reveal major biotech names that are rallying despite Washington's drug pricing controversy.
CELG,CELG:UW,BBG000BFCMR2,Cramer's charts show these biotechs ignoring their 'political red herring',2017-04-11 22:22:40 +0000,http://finance.yahoo.com/r/faf01864-d867-3fe0-b4cb-0b029e7ca50a/104398059?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104398059&yptr=yahoo&.tsrc=rss,Jim Cramer looks to Bob Lang's charts to reveal major biotech names that are rallying despite Washington's drug pricing controversy.
CELG,CELG:UW,BBG000BFCMR2,Cramer&apos;s charts show these biotechs ignoring their &apos;political red herring&apos;,2017-04-11 22:22:40 +0000,http://finance.yahoo.com/news/cramers-charts-show-biotechs-ignoring-222240369.html?.tsrc=rss,Jim Cramer looks to Bob Lang&apos;s charts to reveal major biotech names that are rallying despite Washington&apos;s drug pricing controversy.
CELG,CELG:UW,BBG000BFCMR2,"OncoMed Cancer Candidate Fails Trial, Bayer Opts Out of Deal",2017-04-11 22:05:10 +0000,http://finance.yahoo.com/news/oncomed-cancer-candidate-fails-trial-220510129.html?.tsrc=rss,"It was a bad day for OncoMed Pharmaceuticals, Inc. (OMED) as it suffered two setbacks."
CELG,CELG:UW,BBG000BFCMR2,"IWF, GOOGL, BA, CELG: Large Inflows Detected at ETF",2017-04-11 16:54:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QaIdRJAwP4o/iwf-googl-ba-celg-large-inflows-detected-at-etf-cm772765,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Growth ETF Symbol IWF where we have detected an approximate 215 7 million dollar inflow that s a 0 6 increase week over week
CELG,CELG:UW,BBG000BFCMR2,3 Stocks for the Long Haul,2017-04-11 16:49:00 +0000,http://finance.yahoo.com/r/d691a3a7-f62e-3c54-88c9-716c551b513a/3-stocks-for-the-long-haul.aspx?yptr=yahoo&.tsrc=rss,These brand-name stocks could be your ticket to healthy long-term gains.
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Amazon, Celgene, Facebook and Walgreens Boots",2017-04-11 15:58:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EPkhbnH2RIc/the-zacks-analyst-blog-highlights-amazon-celgene-facebook-and-walgreens-boots-cm772719,For Immediate Release Chicago IL April 11 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Amazon, Celgene, Facebook and Walgreens Boots",2017-04-11 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-amazon-133001009.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Amazon, Celgene, Facebook and Walgreens Boots"
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for Today: AMZN, CELG, FB, WBA",2017-04-10 21:46:09 +0000,http://finance.yahoo.com/news/top-research-reports-today-amzn-214609230.html?.tsrc=rss,"Top Research Reports for Today: AMZN, CELG, FB, WBA"
CELG,CELG:UW,BBG000BFCMR2,"Peninsula biotech tumbles as cancer trial fails, Bayer nixes drug option",2017-04-10 21:10:20 +0000,http://finance.yahoo.com/r/bcb20ccb-00ef-336a-9553-86facc1bc64e/oncomed-omed-celgene-celg-bayer-pancreatic-cancer.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"A failed mid-stage study of an experimental pancreatic cancer drug and Bayer Pharma's separate decision not to exercise its option on other cancer-fighting drugs caused the stock of OncoMed Pharmaceuticals Inc. on Monday to shed a third of its value.  The Redwood City-based drug developer (OMED) said its drug, demcizumab, failed a mid-stage study in pancreatic cancer patients.  Separately, Bayer said it would not take up OncoMed-developed cancer drugs targeting Wnt, a cancer pathway that is attractive to drug makers because it plays a role in early cell division."
CELG,CELG:UW,BBG000BFCMR2,OncoMed's pancreatic cancer drug fails mid-stage study,2017-04-10 12:23:14 +0000,http://finance.yahoo.com/news/oncomeds-pancreatic-cancer-drug-fails-122314050.html?.tsrc=rss,"OncoMed Pharmaceuticals Inc said on Monday its experimental drug, in combination with Celgene Corp's Abraxane and chemotherapy, failed a mid-stage study as an initial therapy for advanced pancreatic cancer. ..."
CELG,CELG:UW,BBG000BFCMR2,"If You Love Exelixis, You Should Check Out Juno Therapeutics",2017-04-09 16:54:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_rlIYt_IsKc/if-you-love-exelixis-you-should-check-out-juno-therapeutics-cm771849,Don t you wish you d bought Exelixis NASDAQ EXEL stock three years ago The biotech s share price is up more than 460 since then including more than 350 in just the past 12 months Exelixis 160 is without question one of the hottest biotech stocks around Juno
CELG,CELG:UW,BBG000BFCMR2,3 Big Biotech Stocks With Big-Time Catalysts,2017-04-08 21:53:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AgOOISVg1Qs/3-big-biotech-stocks-with-big-time-catalysts-cm771800,Regeneron NASDAQ REGN Amgen NASDAQ AMGN and Celgene NASDAQ CELG are three of the world s biggest biotech companies and each has compelling new drugs on deck that could 160 reshape indications and become top sellers Let s take a closer look at each Hoping for
CELG,CELG:UW,BBG000BFCMR2,3 Big Biotech Stocks With Big-Time Catalysts,2017-04-08 20:11:00 +0000,http://finance.yahoo.com/r/51da3777-8f17-3164-8f92-9dd7b7ab096c/3-big-biotech-stocks-with-big-time-catalysts.aspx?yptr=yahoo&.tsrc=rss,"If these top biotech stocks play their cards right, they could each have new top-selling drugs on their hands soon."
CELG,CELG:UW,BBG000BFCMR2,"Big Tech and Biotech Trades Highlight Insider Selling: Gap, Adobe, Celgene, Splunk and More",2017-04-08 13:35:15 +0000,http://finance.yahoo.com/news/big-tech-biotech-trades-highlight-133515437.html?.tsrc=rss,"Insiders are using their last open windows to sell shares before they are closed for the earnings reports, and the volume dropped dramatically last week."
CELG,CELG:UW,BBG000BFCMR2,"[$$] Celgene Outlook Brightens, While Gilead Faces Woes",2017-04-08 04:01:00 +0000,http://finance.yahoo.com/r/40f9de6f-19a4-3835-a5e0-8dbccd47d02f/celgene-outlook-brightens-while-gilead-sciences-faces-woes-1491625554?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Just over a year ago, we recommended two drugmakers, each reliant on a single treatment for a hefty portion of revenue (“Celgene and Gilead: Two Drugmakers With 30% Upside,” Feb. 6, 2016).  Celgene (CELG) has gained 27% since then, and Gilead Sciences (GILD) has dropped 22%.  Expect Celgene to continue climbing, but the outlook for Gilead is challenging."
CELG,CELG:UW,BBG000BFCMR2,"ETFs with exposure to Celgene Corp. : April 7, 2017",2017-04-07 20:07:37 +0000,http://finance.yahoo.com/r/46cd36cc-14e7-3a35-ba5e-40c6388a3b9e/etfs-with-exposure-to-celgene-corp-april-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celgene Corp. Here are 5 ETFs with the largest exposure to CELG-US. Comparing the performance and risk of Celgene Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
CELG,CELG:UW,BBG000BFCMR2,Would Gilead Sciences Make This Staggeringly Audacious Move?,2017-04-07 19:54:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AcdRkGG62Mc/would-gilead-sciences-make-this-staggeringly-audacious-move-cm771565,Everyone and their brother wants Gilead Sciences NASDAQ GILD to make an acquisition Gilead s CEO John Milligan has indicated a preference for buying another biotech to bolster his company s oncology portfolio However Milligan has also stated that inflammation and non
CELG,CELG:UW,BBG000BFCMR2,Would Gilead Sciences Make This Staggeringly Audacious Move?,2017-04-07 18:43:00 +0000,http://finance.yahoo.com/r/dbd9df65-04ae-3042-b9a1-cab47d5d55a7/would-gilead-sciences-make-this-staggeringly-audac.aspx?yptr=yahoo&.tsrc=rss,Many expect Gilead Sciences to buy Incyte. But what if the biotech instead went big -- really big?
CELG,CELG:UW,BBG000BFCMR2,Earnings Preview: Biotechnology Looks Healthy,2017-04-07 18:00:00 +0000,http://finance.yahoo.com/r/5881e140-0423-3a49-b1e8-ea5e2f57f01f/earnings-preview-biotechnology-looks-healthy?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Healthcare stocks are getting a modest lift on Friday, gaining 0.24% while the S&P 500 has risen 0.15%. Within that group biotechnology stocks seem to be doing relatively better. The iShares Nasdaq Biotechnology ..."
CELG,CELG:UW,BBG000BFCMR2,Why Roche's New Drug Is Bad News For Biogen,2017-04-07 17:34:00 +0000,http://finance.yahoo.com/r/6ea5bb51-5630-3f66-9a72-56237da69fb9/why-roches-new-drug-is-bad-news-for-biogen?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The market is up today, but shares of Biogen (BIIB) are down.  The biotech giant dropped 1.1% to just over $268 a share after analysts at Leerink cut their price target from $300 to $290.  Granted, shaving $10 off a $300 price target doesn’t seem like much of a shift in sentiment."
CELG,CELG:UW,BBG000BFCMR2,3 Perfect Stocks You Can Buy Now,2017-04-07 14:57:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_PF24UxQCd4/3-perfect-stocks-you-can-buy-now-cm771316,Rapid top and bottom line growth bullet proof balance sheets and innovation first management teams make Amazon com NASDAQ AMZN Facebook NASDAQ FB and Celgene Corp NASDAQ CELG incredibly intriguing stocks to buy in portfolios A forest of
CELG,CELG:UW,BBG000BFCMR2,3 Perfect Stocks You Can Buy Now,2017-04-07 13:41:00 +0000,http://finance.yahoo.com/r/31131677-fbeb-304d-8657-be00ace7320e/3-perfect-stocks-to-buy-in-portfolios.aspx?yptr=yahoo&.tsrc=rss,"Amazon, Facebook, and Celgene have sources of significant future growth that could make them perfect additions to portfolios."
CELG,CELG:UW,BBG000BFCMR2,Today's Research Reports on Top Biotech Stocks: Gilead Sciences and Celgene,2017-04-07 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-top-biotech-113000677.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 7, 2017 / The major products of both companies could suffer a drop in revenues from recent political events and competition from generic versions of their drugs. RDI Initiates ..."
CELG,CELG:UW,BBG000BFCMR2,The First CAR-T Drugs Have Left the Gate,2017-04-06 21:55:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JxFpn9xMdn4/the-first-car-t-drugs-have-left-the-gate-cm771072,For all the talk about biotechs being nimble it s a big pharma that looks like it ll be the first company to launch a chimeric antigen receptor T cell CAR T product Novartis NYSE NVS announced last week that the Food and Drug Administration accepted its application to
CELG,CELG:UW,BBG000BFCMR2,"Dow Up, Cat Leads, Celgene Firm; Will These 5 Stocks Dispel Trump Trade-War Fears?",2017-04-06 20:37:02 +0000,http://finance.yahoo.com/r/5ef2ae06-88ba-3355-ae19-4d132de3ee2d/dow-up-cat-leads-celgene-firm-will-these-5-stocks-dispel-trump-trade-war-fears?src=A00220A&yptr=yahoo&.tsrc=rss,Not all stocks may react that negatively to the possibility of a trade war between the U.S. and China. Consider these 5 leading names.
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst,2017-04-05 21:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/biWDpxO9Yx4/celgene-celg-gets-paragraph-iv-notice-letter-for-pomalyst-cm770413,Celgene Corporation CELG recently received a Paragraph IV Notice Letter advising that Teva Pharmaceutical Industries Ltd TEVA submitted an Abbreviated New Drug Application ANDA to the FDA seeking an approval to manufacture and market a generic version of Pomalyst pomalidomide 1 mg 2 mg
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst,2017-04-05 19:36:07 +0000,http://finance.yahoo.com/news/celgene-celg-gets-paragraph-iv-193607894.html?.tsrc=rss,Celgene Corporation (CELG) recently received a Paragraph IV Notice Letter advising that Teva Pharmaceutical Industries Limited (TEVA) submitted an ANDA to the FDA seeking an approval to manufacture and market a generic version of Pomalyst.
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug",2017-04-05 15:27:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/diUoDB06kec/biotech-stock-roundup-acorda-down-on-court-ruling-patent-challenge-for-celg-drug-cm770134,Quite a few companies provided patent related updates this week Meanwhile Paratek s PRTK shares soared on positive late stage data Recap of the Week s Most Important Stories Acorda Slumps on Court Ruling Acorda ACOR suffered a big setback in a patent infringement lawsuit for
CELG,CELG:UW,BBG000BFCMR2,Peek Under The Hood: BBH Has 14% Upside,2017-04-05 13:24:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZMqfUqllHww/peek-under-the-hood-bbh-has-14-upside-cm769995,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug",2017-04-05 12:59:12 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-acorda-down-125912918.html?.tsrc=rss,Court rulings and patent challenges made headlines in the biotech sector with companies like Acorda (ACOR) and Celgene (CELG) providing updates.
CELG,CELG:UW,BBG000BFCMR2,Blog Coverage Aviragen to Explore Strategic Alternatives; Cuts Headcount by 25%,2017-04-05 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-aviragen-explore-strategic-121500276.html?.tsrc=rss,"Upcoming AWS Coverage on Celgene Post-Earnings Results LONDON, UK / ACCESSWIRE / April 5, 2017 / Active Wall St. blog coverage looks at the headline from Aviragen Therapeutics, Inc. (NASDAQ: AVIR ) as ..."
CELG,CELG:UW,BBG000BFCMR2,"6:02 pm Celgene has received Paragraph IV Notice Letter advising that Teva (<a href=""/q?s=teva"" name=""teva"">TEVA</a>) USA unit submitted ANDA for generic version of POMALYST (pomalidomide)",2017-04-03 22:02:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#celg,"6:02 pm Celgene has received Paragraph IV Notice Letter advising that Teva (<a href=""/q?s=teva"" name=""teva"">TEVA</a>) USA unit submitted ANDA for generic version of POMALYST (pomalidomide)"
CELG,CELG:UW,BBG000BFCMR2,Celgene Notified of ANDA Filing for POMALYST®,2017-04-03 22:00:00 +0000,http://finance.yahoo.com/news/celgene-notified-anda-filing-pomalyst-220000358.html,"[Business Wire] - Celgene Corporation has received a Paragraph IV Notice Letter advising that Teva Pharmaceuticals USA, Inc. submitted an Abbreviated New Drug Application to the U.S."
CELG,CELG:UW,BBG000BFCMR2,Celgene Notified of ANDA Filing for POMALYST®,2017-04-03 22:00:00 +0000,http://finance.yahoo.com/news/celgene-notified-anda-filing-pomalyst-220000358.html?.tsrc=rss,"Celgene Corporation has received a Paragraph IV Notice Letter advising that Teva Pharmaceuticals USA, Inc. submitted an Abbreviated New Drug Application to the U.S."
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Monday Option Activity: TIS, LVS, CELG",2017-04-03 21:35:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gjItdEQ9RUg/noteworthy-monday-option-activity-tis-lvs-celg-cm769264,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Orchids Paper Products Co Symbol TIS where a total of 545 contracts have traded so far representing approximately 54 500 underlying shares That amounts to about 42 4 of TIS
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Trades for the Faux Doomsday Scenario,2017-04-03 20:36:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Wcb-zyXb3A/3-biotech-trades-for-the-faux-doomsday-scenario-cm769273,InvestorPlace Stock Market News Stock Advice amp Trading Tips Even under normal circumstances healthcare and biotech stocks are prone to making headlines They ve been a political punching bag for more than a year now First Hillary Clinton vowed to rein in the sector policies
CELG,CELG:UW,BBG000BFCMR2,iShares Russell 1000 Growth ETF Experiences Big Inflow,2017-04-03 16:37:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7OscVVkXiPM/ishares-russell-1000-growth-etf-experiences-big-inflow-cm769110,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Growth ETF Symbol IWF where we have detected an approximate 108 1 million dollar inflow that s a 0 3 increase week over week
CELG,CELG:UW,BBG000BFCMR2,5 Best Growth Stocks to Own as Core Holdings in Your Portfolio,2017-04-03 13:38:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QEo0Tc5Erpo/5-best-growth-stocks-to-own-as-core-holdings-in-your-portfolio-cm768904,It can be hard for growth investors to decide what stocks to buy because innovation 160 means that today s winners might not be tomorrow s winners Instead of gambling by focusing on the latest fad consider building a long term portfolio that s anchored by Apple Inc NASDAQ
CELG,CELG:UW,BBG000BFCMR2,5 Best Growth Stocks to Own as Core Holdings in Your Portfolio,2017-04-03 12:01:00 +0000,https://www.fool.com/investing/2017/04/03/5-best-growth-stocks-to-own-as-core-holdings-in-yo.aspx,5 Best Growth Stocks to Own as Core Holdings in Your Portfolio
CELG,CELG:UW,BBG000BFCMR2,5 Best Growth Stocks to Own as Core Holdings in Your Portfolio,2017-04-03 12:01:00 +0000,http://finance.yahoo.com/r/204d3d21-1536-326b-b402-ccc59cf6f895/5-best-growth-stocks-to-own-as-core-holdings-in-yo.aspx?yptr=yahoo&.tsrc=rss,"Apple, Amazon, Celgene, Facebook, and Alphabet are top-tier stocks worthy of including in long-term growth portfolios."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corporation to Announce First Quarter 2017 Results on April 27, 2017",2017-04-03 11:30:00 +0000,http://finance.yahoo.com/news/celgene-corporation-announce-first-quarter-113000290.html?.tsrc=rss,"Celgene Corporation will host a conference call and live audio webcast on Thursday, April 27, 2017 at 9 a.m. ET to discuss first quarter 2017 financial and operational results."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corporation to Announce First Quarter 2017 Results on April 27, 2017",2017-04-03 11:30:00 +0000,http://finance.yahoo.com/news/celgene-corporation-announce-first-quarter-113000290.html,"[Business Wire] - Celgene Corporation will host a conference call and live audio webcast on Thursday, April 27, 2017 at 9 a.m. ET to discuss first quarter 2017 financial and operational results."
CELG,CELG:UW,BBG000BFCMR2,3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest,2017-04-02 13:36:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xMTfLAR3uI4/3-big-healthcare-stocks-that-wall-street-predicts-will-grow-the-fastest-cm768773,Rapid earnings growth typically translates to higher stock prices But can big healthcare stocks grow earnings and presumably share prices at impressive levels 160 Wall Street thinks so Analysts ranked Vertex Pharmaceuticals NASDAQ VRTX Incyte NASDAQ INCY
CELG,CELG:UW,BBG000BFCMR2,3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest,2017-04-02 11:41:00 +0000,http://finance.yahoo.com/r/9ff0e68c-2cbc-3615-91f1-ef72b98e3e44/3-big-healthcare-stocks-that-wall-street-predicts.aspx?yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals, Incyte, and Celgene could be headed for tremendous growth if Wall Street's projections are on target."
CELG,CELG:UW,BBG000BFCMR2,3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest,2017-04-02 11:41:00 +0000,https://www.fool.com/investing/2017/04/02/3-big-healthcare-stocks-that-wall-street-predicts.aspx,3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Amgen Inc.,2017-04-01 16:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_2Y8RQ6GF3Y/better-buy-celgene-corporation-vs-amgen-inc-cm768716,Several big biotech stocks have proven to be big winners for investors in recent years Celgene NASDAQ CELG and Amgen NASDAQ AMGN definitely belong in that category In the last five years Celgene s share price has more than tripled while Amgen stock is up over 140
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Amgen Inc.,2017-04-01 15:42:00 +0000,https://www.fool.com/investing/2017/04/01/better-buy-celgene-corporation-vs-amgen-inc.aspx,Better Buy: Celgene Corporation vs. Amgen Inc.
CELG,CELG:UW,BBG000BFCMR2,My 3 Top Biotech Stocks to Buy Now,2017-03-31 18:00:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aiQs59_Kf4k/my-3-top-biotech-stocks-to-buy-now-cm768421,Celgene Corp NASDAQ CELG Ionis Pharmaceuticals NASDAQ IONS and Portola Pharmaceuticals NASDAQ PTLA may be at different stages of drug development but all three have intriguing catalysts that could make them top stocks to buy No 1 Expanding its reach
CELG,CELG:UW,BBG000BFCMR2,Will Trump's FDA Chill Innovation Or Kill 'Astronomical' Prices?,2017-03-31 16:21:20 +0000,http://www.investors.com/news/technology/will-trumps-fda-chill-innovation-or-speed-up-to-kill-astronomical-prices/?src=A00220A,Will Trump's FDA Chill Innovation Or Kill 'Astronomical' Prices?
CELG,CELG:UW,BBG000BFCMR2,My 3 Top Biotech Stocks to Buy Now,2017-03-31 16:00:00 +0000,https://www.fool.com/investing/2017/03/31/my-3-top-biotech-stocks-to-buy-now.aspx,My 3 Top Biotech Stocks to Buy Now
CELG,CELG:UW,BBG000BFCMR2,Can Vertex Keep Climbing?,2017-03-31 13:43:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/31/can-vertex-keep-climbing/?mod=yahoobarrons&ru=yahoo,Can Vertex Keep Climbing?
CELG,CELG:UW,BBG000BFCMR2,3 Stocks We Can't Wait to Buy on Sale,2017-03-31 13:02:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tncRQK86wsg/3-stocks-we-cant-wait-to-buy-on-sale-cm768128,Celgene Corp NASDAQ CELG Xilinx Inc NASDAQ XLNX and Elli Mae Inc NYSE ELLI are three top stocks that our Motley Fool contributors would love to be able to buy if share prices dip The companies operate in very different sectors but they all have something
CELG,CELG:UW,BBG000BFCMR2,3 Stocks We Can't Wait to Buy on Sale,2017-03-31 11:27:00 +0000,https://www.fool.com/investing/2017/03/31/3-stocks-we-cant-wait-to-buy-on-sale.aspx,3 Stocks We Can't Wait to Buy on Sale
CELG,CELG:UW,BBG000BFCMR2,"Here's Why Halozyme Therapeutics, Inc Is Falling",2017-03-30 17:01:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vd4vvd58B2U/heres-why-halozyme-therapeutics-inc-is-falling-cm767852,What happened After reporting that enrollment in one of its early stage clinical trials has been temporarily suspended shares of Halozyme Therapeutics NASDAQ HALO a small cap biotech focused on creating products that help other drugs work better fell by as much as
CELG,CELG:UW,BBG000BFCMR2,"Here's Why Halozyme Therapeutics, Inc Is Falling",2017-03-30 15:48:00 +0000,https://www.fool.com/investing/2017/03/30/heres-why-halozyme-therapeutics-inc-is-fallin.aspx,"Here's Why Halozyme Therapeutics, Inc Is Falling"
CELG,CELG:UW,BBG000BFCMR2,No. 5-Ranked Biotech Bolts Higher On Drug Results,2017-03-30 15:03:36 +0000,http://www.investors.com/ibd-data-stories/no-5-ranked-biotech-bolts-higher-on-drug-results/?src=A00220A,No. 5-Ranked Biotech Bolts Higher On Drug Results
CELG,CELG:UW,BBG000BFCMR2,Cramer's lightning round: This energy play should do well even with low oil prices,2017-03-29 22:51:00 +0000,http://sg.finance.yahoo.com/news/cramers-lightning-round-energy-play-225100842.html,Cramer's lightning round: This energy play should do well even with low oil prices
CELG,CELG:UW,BBG000BFCMR2,Top Biotech Stocks for Growth Investors,2017-03-29 21:59:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7P7p9wHTTUc/top-biotech-stocks-for-growth-investors-cm767490,What investor doesn t like growth The biotech industry is one area where you can find tremendous growth prospects We asked three of our healthcare specialists to name their favorite biotech growth stocks Here s why they picked Omeros Corporation NASDAQ OMER
CELG,CELG:UW,BBG000BFCMR2,Top Biotech Stocks for Growth Investors,2017-03-29 20:21:00 +0000,https://www.fool.com/investing/2017/03/29/top-biotech-stocks-for-growth-investors.aspx,Top Biotech Stocks for Growth Investors
CELG,CELG:UW,BBG000BFCMR2,These Charts Suggest Biotech Is Heading Higher,2017-03-29 12:32:00 +0000,http://www.investopedia.com/news/these-charts-suggest-biotech-heading-higher-ibb-celg/?partner=YahooSA,These Charts Suggest Biotech Is Heading Higher
CELG,CELG:UW,BBG000BFCMR2,Will These Three Drugs Continue Driving Celgene's Top-Line Growth?,2017-03-28 15:03:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tgmZhyUa1AE/will-these-three-drugs-continue-driving-celgenes-top-line-growth-cm766540,Biotech company Celgene Corporation CELG has had a good run over the last 12 months with the company s shares gaining 24 8 outperforming the S amp P 500 as well as the Zacks categorized Medical Biomedical Genetics industry which declined 3 6 during this period 160
CELG,CELG:UW,BBG000BFCMR2,Will These Three Drugs Continue Driving Celgene's Top-Line Growth?,2017-03-28 13:12:01 +0000,http://finance.yahoo.com/news/three-drugs-continue-driving-celgenes-131201799.html,Will These Three Drugs Continue Driving Celgene's Top-Line Growth?
CELG,CELG:UW,BBG000BFCMR2,3 Least Risky Biotech Stocks on the Market,2017-03-28 12:59:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qJJLEJ_9Fj4/3-least-risky-biotech-stocks-on-the-market-cm766316,Biotech stocks are notoriously risky investments But not every biotech carries as much risk as others Three biotech stocks could be the least risky of all Celgene NASDAQ CELG Ligand Pharmaceuticals NASDAQ LGND and Gilead Sciences NASDAQ GILD Here s why
CELG,CELG:UW,BBG000BFCMR2,3 Least Risky Biotech Stocks on the Market,2017-03-28 11:23:00 +0000,https://www.fool.com/investing/2017/03/28/3-least-risky-biotech-stocks-on-the-market.aspx,3 Least Risky Biotech Stocks on the Market
CELG,CELG:UW,BBG000BFCMR2,3 Top Cancer Drug Stocks to Buy in 2017,2017-03-27 22:00:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qj-329w4NDM/3-top-cancer-drug-stocks-to-buy-in-2017-cm766215,Some of the best performing biopharma stocks in recent years belong to companies developing cancer drugs and it looks as if this trend is going to continue throughout 2017 and into the foreseeable future Estimated global spending for oncology medicines is expected to grow from
CELG,CELG:UW,BBG000BFCMR2,3 Top Cancer Drug Stocks to Buy in 2017,2017-03-27 20:29:00 +0000,https://www.fool.com/investing/2017/03/27/3-top-cancer-drug-stocks-to-buy-in-2017.aspx,3 Top Cancer Drug Stocks to Buy in 2017
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Monday Option Activity: CELG, GPN, AAL",2017-03-27 19:59:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lyI5-4_UBm4/noteworthy-monday-option-activity-celg-gpn-aal-cm766136,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Celgene Corp Symbol CELG where a total volume of 17 579 contracts has been traded thus far today a contract volume which is representative of approximately 1 8
CELG,CELG:UW,BBG000BFCMR2,"ETFs with exposure to Celgene Corp. : March 27, 2017",2017-03-27 19:51:42 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-celgene-corp-march-27-2017/,"ETFs with exposure to Celgene Corp. : March 27, 2017"
CELG,CELG:UW,BBG000BFCMR2,Nasdaq Turns Positive; 3 Medicals To Watch; Will Snap Complete A Base?,2017-03-27 18:30:21 +0000,http://www.investors.com/market-trend/stock-market-today/nasdaq-turns-positive-3-medicals-to-watch-will-snap-complete-a-base/?src=A00220A,Nasdaq Turns Positive; 3 Medicals To Watch; Will Snap Complete A Base?
CELG,CELG:UW,BBG000BFCMR2,"Stock Market News for March 27, 2017",2017-03-27 15:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RxzspnObrKI/stock-market-news-for-march-27-2017-cm765881,Benchmarks closed mostly in the red on Friday after Trump administration failed to get enough support among Republicans to pass the healthcare bill Republicans pulled their bill due to shortage of votes The failure to pass the healthcare bill raised doubts over Trump s ability to push through
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Gilead Sciences,2017-03-27 15:02:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8fJokYoj62s/better-buy-celgene-corporation-vs-gilead-sciences-cm765842,Get your popcorn and settle in for a biotechnology Clash of the Titans In one corner stands Celgene Corporation NASDAQ CELG an oncology powerhouse on the rise In the other corner stands Gilead Sciences Inc NASDAQ GILD an antiviral heavyweight that may be past
CELG,CELG:UW,BBG000BFCMR2,Short Interest Pulls Back in Major Biotechs,2017-03-27 14:30:30 +0000,http://finance.yahoo.com/news/short-interest-pulls-back-major-143030456.html,Short Interest Pulls Back in Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Gilead Sciences,2017-03-27 13:46:00 +0000,https://www.fool.com/investing/2017/03/27/better-buy-celgene-corporation-vs-gilead-science-2.aspx,Better Buy: Celgene Corporation vs. Gilead Sciences
CELG,CELG:UW,BBG000BFCMR2,5 Stocks to Invest Your Tax Refund In,2017-03-27 12:00:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rGyLddHAb5A/5-stocks-to-invest-your-tax-refund-in-cm765729,IMAGE SOURCE GETTY IMAGES If you re getting a tax refund from the IRS this year you might not want to rush out and spend it on a shopping spree Instead using your tax refund to improve your financial security might be the best reward you can give yourself Wondering what to
CELG,CELG:UW,BBG000BFCMR2,5 Stocks to Invest Your Tax Refund In,2017-03-27 10:00:00 +0000,https://www.fool.com/investing/2017/03/27/5-stocks-to-invest-your-tax-refund-in.aspx,5 Stocks to Invest Your Tax Refund In
CELG,CELG:UW,BBG000BFCMR2,3 Great Stocks to Buy in a Market Pullback,2017-03-26 16:59:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x1bQ6JcMEI8/3-great-stocks-to-buy-in-a-market-pullback-cm765678,Is a stock market pullback on the way Maybe And even if not now it s inevitable that the market will take a breather at some point in the future Smart investors will be ready to take advantage of a market pullback whenever it comes and offers discount prices on great stocks
CELG,CELG:UW,BBG000BFCMR2,3 Great Stocks to Buy in a Market Pullback,2017-03-26 15:01:00 +0000,https://www.fool.com/investing/2017/03/26/3-great-stocks-to-buy-in-a-market-pullback.aspx,3 Great Stocks to Buy in a Market Pullback
CELG,CELG:UW,BBG000BFCMR2,3 of the Safest Stocks You Can Buy Right Now,2017-03-26 14:59:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/72Na3VLKqGU/3-of-the-safest-stocks-you-can-buy-right-now-cm765657,Does stock market volatility have you worried Following the worst single day performance for the Dow Jones Industrial Average and S amp P 500 since the November election and quite a big rally in all three major U S indexes over the past five months we may start witnessing
CELG,CELG:UW,BBG000BFCMR2,3 of the Safest Stocks You Can Buy Right Now,2017-03-26 13:27:00 +0000,https://www.fool.com/investing/2017/03/26/3-of-the-safest-stocks-you-can-buy-right-now.aspx,3 of the Safest Stocks You Can Buy Right Now
CELG,CELG:UW,BBG000BFCMR2,2 Asset Classes That Are Arguably Still Cheap,2017-03-24 19:00:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j8fAHRL7498/2-asset-classes-that-are-arguably-still-cheap-cm765390,With the exception of a few minor hiccups the stock market has been practically unstoppable since hitting its lows in March 2009 The broad based S amp P 500 is up by more than 250 while the Dow Jones Industrial Average has rallied about 215 from its lows With such
CELG,CELG:UW,BBG000BFCMR2,2 Asset Classes That Are Arguably Still Cheap,2017-03-24 17:13:00 +0000,https://www.fool.com/investing/2017/03/24/2-asset-classes-that-are-arguably-still-cheap.aspx,2 Asset Classes That Are Arguably Still Cheap
CELG,CELG:UW,BBG000BFCMR2,"IWF, BA, CELG, BMY: ETF Inflow Alert",2017-03-24 16:59:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SUzt-aMUWvg/iwf-ba-celg-bmy-etf-inflow-alert-cm765297,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Growth ETF Symbol IWF where we have detected an approximate 107 4 million dollar inflow that s a 0 3 increase week over week
CELG,CELG:UW,BBG000BFCMR2,"Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen",2017-03-22 16:11:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4CJPvriO7Yc/zacks-investment-ideas-feature-highlights-nasdaq-biotechnology-index-gilead-valeant-pharma-celgene-and-amgen-cm764125,For Immediate Release Chicago IL March 22 2017 Today Zacks Investment Ideas feature highlights Features Nasdaq Biotechnology Index NASDAQ IBB Free Report Gilead NASDAQ GILD Free Report Valeant Pharma NYSE VRX Free Report Celgene NASDAQ
CELG,CELG:UW,BBG000BFCMR2,"Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen",2017-03-22 13:30:01 +0000,http://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-133001627.html,"Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen"
CELG,CELG:UW,BBG000BFCMR2,A Look at Ionis Pharmaceuticals’ Spinraza,2017-03-22 11:37:25 +0000,http://marketrealist.com/2017/03/a-look-at-ionis-pharmaceuticals-spinraza/?utm_source=yahoo&utm_medium=feed,A Look at Ionis Pharmaceuticals’ Spinraza
CELG,CELG:UW,BBG000BFCMR2,3 Value Stocks Senior Citizens Could Buy Right Now,2017-03-21 23:06:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1WZpEuoBwFA/3-value-stocks-senior-citizens-could-buy-right-now-cm763842,As you get older it s generally a good rule of thumb to start lowering your portfolio s risk profile But that doesn t mean you should swap out all of your stocks for lower risk investing vehicles like CDs or bonds There are a fair number of low risk stocks after all that
CELG,CELG:UW,BBG000BFCMR2,3 Value Stocks Senior Citizens Could Buy Right Now,2017-03-21 21:52:00 +0000,https://www.fool.com/investing/2017/03/21/3-value-stocks-senior-citizens-could-buy-right-now.aspx,3 Value Stocks Senior Citizens Could Buy Right Now
CELG,CELG:UW,BBG000BFCMR2,Infinity Pharma Focuses on Cancer Drug: Competition Looms,2017-03-21 21:07:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h7FVmtEhtjk/infinity-pharma-focuses-on-cancer-drug-competition-looms-cm763747,We issued an updated research report on Infinity Pharmaceuticals Inc INFI on Mar 20 2017 Infinity s share price has increased considerably by 148 9 year to date while the Zacks classified Medical Drugs industry gained 4 7 The company is currently focused on the development of
CELG,CELG:UW,BBG000BFCMR2,Biotech Bull Making a Comeback,2017-03-21 13:08:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xc3sNhMXRBg/biotech-bull-making-a-comeback-cm763355,In October of 2015 I wrote a special report for Zacks Confidential titled Biotech Outlook Bursting Bubble or Buying Opportunity At the time the Nasdaq Biotechnology Index IBB had fallen over 25 from its peak at 400 in the 3rd quarter of 2015 Here s was my introduction It
CELG,CELG:UW,BBG000BFCMR2,Why Biotech Stock Gilead (GILD) Could Be a Value Trap,2017-03-20 16:10:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sKkKzx0FFk4/why-biotech-stock-gilead-gild-could-be-a-value-trap-cm762916,Gilead Sciences Inc GILD one of the key players in the biotech market has had a phenomenal run over the last five years with shares gaining 195 1 during this period compared to the Zacks categorized Medical Biomedical Genetics industry growth of 51 8 From a valuation
CELG,CELG:UW,BBG000BFCMR2,4 Stocks at 52-Week Highs That Are Still Worth Buying Today,2017-03-20 14:10:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/myXYiCvktDs/4-stocks-at-52-week-highs-that-are-still-worth-buying-today-cm762775,Just because a stock is trading near its 52 week high doesn t necessarily mean it s expensive We asked four of our contributors to each discuss a stock that fits that description Here s why Boeing NYSE BA Wal Mart Stores NYSE WMT Celgene NASDAQ CELG
CELG,CELG:UW,BBG000BFCMR2,Why Biotech Stock Gilead (GILD) Could Be a Value Trap,2017-03-20 14:06:02 +0000,http://finance.yahoo.com/news/why-biotech-stock-gilead-gild-140602293.html,Why Biotech Stock Gilead (GILD) Could Be a Value Trap
CELG,CELG:UW,BBG000BFCMR2,Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now,2017-03-20 13:50:10 +0000,http://finance.yahoo.com/news/jefferies-4-red-hot-biotech-135010159.html,Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now
CELG,CELG:UW,BBG000BFCMR2,Leerink Presents: Your 2017 Biopharma Catalyst Tracker,2017-03-20 13:17:03 +0000,http://finance.yahoo.com/news/leerink-presents-2017-biopharma-catalyst-131703713.html,Leerink Presents: Your 2017 Biopharma Catalyst Tracker
CELG,CELG:UW,BBG000BFCMR2,4 Stocks at 52-Week Highs That Are Still Worth Buying Today,2017-03-20 12:42:00 +0000,https://www.fool.com/investing/2017/03/20/4-stocks-at-52-week-highs-that-are-still-worth-buy.aspx,4 Stocks at 52-Week Highs That Are Still Worth Buying Today
CELG,CELG:UW,BBG000BFCMR2,8 Places to Run and Hide in a Market Crash,2017-03-17 23:06:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Im7bNAwTl20/8-places-to-run-and-hide-in-a-market-crash-cm762490,InvestorPlace Stock Market News Stock Advice amp Trading Tips The country is awash in optimism and stocks are trading at all time highs Even a rate hike by the Federal Reserve couldn t stop the bulls from running down Wall Street So why am I playing the role of Cassandra and
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. :CELG-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017",2017-03-17 12:43:56 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-celg-us-earnings-analysis-q4-2016-by-the-numbers-march-17-2017/,"Celgene Corp. :CELG-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017"
CELG,CELG:UW,BBG000BFCMR2,Biogen Inc (BIIB): Profit From the BIIB Stock Bears,2017-03-16 19:07:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zOZiOhal7JE/biogen-inc-biib-profit-from-the-biib-stock-bears-cm761877,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biogen Inc NASDAQ BIIB stock much like the rest of the biotech and healthcare industry has had a tumultuous few months First Hillary Clinton used biotechs as political scapegoats and now President Donald Trump
CELG,CELG:UW,BBG000BFCMR2,"IWF, CELG, BMY, GILD: ETF Inflow Alert",2017-03-16 16:05:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1bXK1LPIimU/iwf-celg-bmy-gild-etf-inflow-alert-cm761641,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Growth ETF Symbol IWF where we have detected an approximate 165 9 million dollar inflow that s a 0 5 increase week over week
CELG,CELG:UW,BBG000BFCMR2,[$$] Celgene Shows Savvy as Gilead Keeps Backsliding,2017-03-16 11:08:00 +0000,http://www.barrons.com/articles/celgene-shows-savvy-as-gilead-keeps-backsliding-1489662508?mod=yahoobarrons&ru=yahoo,[$$] Celgene Shows Savvy as Gilead Keeps Backsliding
CELG,CELG:UW,BBG000BFCMR2,5 Things You Probably Didn't Know About Celgene Corporation,2017-03-15 22:07:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S0peoiDmEH0/5-things-you-probably-didnt-know-about-celgene-corporation-cm761375,What comes to mind when you hear Celgene s NASDAQ CELG name mentioned Perhaps the biotech s blockbuster blood cancer drug Revlimid Or maybe its fast growing psoriasis drug Otezla Celgene has come a long way to get to its current spot as one of the largest biotechs in the
CELG,CELG:UW,BBG000BFCMR2,5 Things You Probably Didn't Know About Celgene Corporation,2017-03-15 20:43:00 +0000,https://www.fool.com/investing/2017/03/15/5-things-you-probably-didnt-know-about-celgene-cor.aspx,5 Things You Probably Didn't Know About Celgene Corporation
CELG,CELG:UW,BBG000BFCMR2,Top Biotech Hits Buy Point As CEO Cites 'Momentum' In Key Drivers,2017-03-15 20:29:06 +0000,http://www.investors.com/news/technology/shares-of-this-top-drugmaker-are-breaking-out-today-on-momentum/?src=A00220A,Top Biotech Hits Buy Point As CEO Cites 'Momentum' In Key Drivers
CELG,CELG:UW,BBG000BFCMR2,Celgene To Present At Barclays Healthcare Conference; Webcast At 10:15 AM ET,2017-03-15 09:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qmVBWMkij48/celgene-to-present-at-barclays-healthcare-conference-webcast-at-1015-am-et-20170315-00613,Celgene To Present At Barclays Healthcare Conference; Webcast At 10:15 AM ET
CELG,CELG:UW,BBG000BFCMR2,Amgen's Repatha Meets Primary Endpoint in Phase III Study,2017-03-14 17:07:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rn-sGnlzlkQ/amgens-repatha-meets-primary-endpoint-in-phase-iii-study-cm760625,Biotech major Amgen Inc AMGN announced positive data from a phase III study evaluating its PCSK9 inhibitor Repatha in patients who were receiving apheresis to help control their low density lipoprotein cholesterol LDL C Data from the study showed that Repatha subcutaneous
CELG,CELG:UW,BBG000BFCMR2,Credit Suisse's Top 10 Stocks for 2017,2017-03-14 15:08:00 +0000,https://www.thestreet.com/slideshow/14037952/1/credit-suisse-s-top-10-stocks-for-2017.html?puc=yahoo&cm_ven=YAHOO,Credit Suisse's Top 10 Stocks for 2017
CELG,CELG:UW,BBG000BFCMR2,Amgen's Repatha Meets Primary Endpoint in Phase III Study,2017-03-14 14:35:02 +0000,http://finance.yahoo.com/news/amgens-repatha-meets-primary-endpoint-143502692.html,Amgen's Repatha Meets Primary Endpoint in Phase III Study
CELG,CELG:UW,BBG000BFCMR2,Top Biotech May 'Unveil' Breakthrough Treatment — And Breakout Move,2017-03-12 18:57:42 +0000,http://www.investors.com/research/ibd-stock-analysis/biotech-stock-celgene-reports-positive-unveil-trial-results-for-otezla/?src=A00220A,Top Biotech May 'Unveil' Breakthrough Treatment — And Breakout Move
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation (CELG) Stock Is Staging a Tempting Breakout,2017-03-11 00:16:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TUhFbkblljk/celgene-corporation-celg-stock-is-staging-a-tempting-breakout-cm759488,InvestorPlace Stock Market News Stock Advice amp Trading Tips If there was ever a doubt the latest price action in Celgene Corporation NASDAQ CELG should help ease those fears and usher in more investor cheer in the coming weeks For investors sharing that vision a CELG
CELG,CELG:UW,BBG000BFCMR2,"Epizyme (EPZM) Reports Narrower Q4 Loss, Pipeline in Focus",2017-03-11 00:16:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I4sIny95Xis/epizyme-epzm-reports-narrower-q4-loss-pipeline-in-focus-cm759478,Epizyme Inc EPZM reported a loss of 60 cents per share in the fourth quarter of 2016 narrower than the Zacks Consensus Estimate of 64 cents but wider than the year ago loss of 53 cents Epizyme s share price has outperformed the Zacks classified Medical Biomedical Genetics industry
CELG,CELG:UW,BBG000BFCMR2,Alexion's sBLA for Soliris Receives FDA Acknowledgement,2017-03-11 00:14:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XC95fOoMveg/alexions-sbla-for-soliris-receives-fda-acknowledgement-cm759433,Alexion Pharmaceuticals Inc ALXN announced that the FDA on Mar 9 has accepted the supplemental Biologics License Application sBLA to expand the indication for Soliris for the potential treatment of 160 patients with refractory generalized myasthenia gravis gMG who
CELG,CELG:UW,BBG000BFCMR2,Top Stocks Billionaires Are Buying Now,2017-03-11 00:13:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DaQk5cC8pB0/top-stocks-billionaires-are-buying-now-cm759401,Keeping tabs on what iconic billionaire investors George Soros Warren Buffett and Carl Icahn are doing with their money can help you find new money making ideas What have Soros Buffett and Icahn been buying lately According to reports Celgene Corp NASDAQ CELG Apple
CELG,CELG:UW,BBG000BFCMR2,Top Stocks Billionaires Are Buying Now,2017-03-10 21:41:00 +0000,http://www.fool.com/investing/2017/03/10/top-stocks-billionaires-are-buying-now.aspx,Top Stocks Billionaires Are Buying Now
CELG,CELG:UW,BBG000BFCMR2,Under-The-Radar Biotech Tests Buy Zone; Cancer Trial Results 'Encouraging',2017-03-10 21:39:34 +0000,http://www.investors.com/research/ibd-stock-analysis/biotech-stock-corcept-encouraging-breast-cancer-trial-results-near-breakout/?src=A00220A,Under-The-Radar Biotech Tests Buy Zone; Cancer Trial Results 'Encouraging'
CELG,CELG:UW,BBG000BFCMR2,Major Biotechs See a Retreat in Short Interest,2017-03-10 15:30:22 +0000,http://finance.yahoo.com/news/major-biotechs-see-retreat-short-152922745.html,Major Biotechs See a Retreat in Short Interest
CELG,CELG:UW,BBG000BFCMR2,The 3 Drugs Powering Celgene to the Top of Your Portfolio,2017-03-10 15:15:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uw3tM9OhktA/the-3-drugs-powering-celgene-to-the-top-of-your-portfolio-cm759221,Celgene NASDAQ CELG investors have had a good year with shares of the company up a solid 18 in the past 12 months This incredibly successful biotech boasts over 100 clinical trials studying over 25 different drugs With all this going on it can be tough to keep track of what
CELG,CELG:UW,BBG000BFCMR2,The 3 Drugs Powering Celgene to the Top of Your Portfolio,2017-03-10 14:03:00 +0000,http://www.fool.com/investing/2017/03/10/the-3-drugs-powering-celgene-to-the-top-of-your-po.aspx,The 3 Drugs Powering Celgene to the Top of Your Portfolio
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for March 9, 2017",2017-03-09 23:32:11 +0000,http://finance.yahoo.com/news/top-research-reports-march-9-233211370.html,"Top Research Reports for March 9, 2017"
CELG,CELG:UW,BBG000BFCMR2,"Will Pfizer Take On Celgene, Other Rivals With Leukemia Drug?",2017-03-09 21:03:42 +0000,http://www.investors.com/news/technology/could-this-drugmaker-take-on-celgene-juno-kite-with-leukemia-drug/?src=A00220A,"Will Pfizer Take On Celgene, Other Rivals With Leukemia Drug?"
CELG,CELG:UW,BBG000BFCMR2,Celgene's Deep Pipeline Can Reassure Investors,2017-03-09 18:57:00 +0000,https://www.thestreet.com/story/14032637/1/celgene-s-deep-pipeline-can-reassure-investors.html?puc=yahoo&cm_ven=YAHOO,Celgene's Deep Pipeline Can Reassure Investors
CELG,CELG:UW,BBG000BFCMR2,"Drugs, travel, jewelry and social media in the blitz",2017-03-09 18:40:00 +0000,http://finance.yahoo.com/video/drugs-travel-jewelry-social-media-184000942.html,"Drugs, travel, jewelry and social media in the blitz"
CELG,CELG:UW,BBG000BFCMR2,Trade of the Day: Celgene Corporation (CELG) Stock Ready for Another Leg Up,2017-03-09 17:17:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oxqJTXzAzsE/trade-of-the-day-celgene-corporation-celg-stock-ready-for-another-leg-up-cm758678,InvestorPlace Stock Market News Stock Advice amp Trading Tips Celgene Corporation NASDAQ CELG This biotechnology company which develops and markets small molecule drugs for the treatment of cancers and inflammatory diseases has been a high
CELG,CELG:UW,BBG000BFCMR2,"Nasdaq 100 Movers: STX, REGN",2017-03-09 17:15:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YuKOTxqMFf0/nasdaq-100-movers-stx-regn-cm758609,In early trading on Thursday shares of Regeneron Pharmaceuticals topped the list of the day s best performing components of the Nasdaq 100 index trading up 1 6 Year to date Regeneron Pharmaceuticals registers a 5 6 gain And the worst performing Nasdaq 100 component thus far on
CELG,CELG:UW,BBG000BFCMR2,5 Reasons Celgene Will Be a Top Biotech Stock for the Next Decade,2017-03-09 15:15:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mDwK_SzMBY8/5-reasons-celgene-will-be-a-top-biotech-stock-for-the-next-decade-cm758427,What happens to Celgene NASDAQ CELG after Revlimid runs its course The big biotech projects strong growth through 2020 but much of its revenue will still come from its wildly successful blood cancer drug However the first generic competition for Revlimid will enter the U
CELG,CELG:UW,BBG000BFCMR2,Coverage initiated on Celgene by UBS,2017-03-09 15:00:43 +0000,http://finance.yahoo.com/q/ud?s=CELG,Coverage initiated on Celgene by UBS
CELG,CELG:UW,BBG000BFCMR2,5 Reasons Celgene Will Be a Top Biotech Stock for the Next Decade,2017-03-09 14:03:00 +0000,http://www.fool.com/investing/2017/03/09/5-reasons-celgene-will-be-a-top-biotech-stock-for.aspx,5 Reasons Celgene Will Be a Top Biotech Stock for the Next Decade
CELG,CELG:UW,BBG000BFCMR2,Seattle Genetics (SGEN): FDA Lifts Hold on Trial of AML Drug,2017-03-09 00:13:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TWj9nQ333CA/seattle-genetics-sgen-fda-lifts-hold-on-trial-of-aml-drug-cm758238,Seattle Genetics Inc SGEN announced that the FDA has lifted the clinical hold on two phase I trials of its candidate vadastuximab talirine SGN CD33A 33A 160 Vadastuximab talirine is an early stage candidate that is being developed for the treatment of acute myeloid leukemia AML
CELG,CELG:UW,BBG000BFCMR2,"Valeant (VRX) Issues Notes, Restructures Debt; Shares Down",2017-03-09 00:12:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2lxcIv02zR0/valeant-vrx-issues-notes-restructures-debt-shares-down-cm758221,Valeant Pharmaceuticals International Inc VRX commenced an offer to purchase cash up to 600 million of aggregate principal amount of the outstanding 6 75 senior notes due 2018 On Mar 3 the company had announced the divesture of its skincare products The company used the net proceeds
CELG,CELG:UW,BBG000BFCMR2,"Valeant (VRX) Issues Notes, Restructures Debt; Shares Down",2017-03-08 22:17:10 +0000,http://finance.yahoo.com/news/valeant-vrx-issues-notes-restructures-221710262.html,"Valeant (VRX) Issues Notes, Restructures Debt; Shares Down"
CELG,CELG:UW,BBG000BFCMR2,Seattle Genetics (SGEN): FDA Lifts Hold on Trial of AML Drug,2017-03-08 21:55:09 +0000,http://finance.yahoo.com/news/seattle-genetics-sgen-fda-lifts-215509004.html,Seattle Genetics (SGEN): FDA Lifts Hold on Trial of AML Drug
CELG,CELG:UW,BBG000BFCMR2,Eli Lilly's Taltz Shows Better Efficacy than J&J's Stelara,2017-03-08 17:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AFZYjxjILLk/eli-lillys-taltz-shows-better-efficacy-than-jjs-stelara-cm757980,Eli Lilly and Company LLY announced superior efficacy in a head to head study evaluating its marketed drug Taltz ixekizumab versus with Johnson amp Johnson s Stelara ustekinumab in patients with moderate to severe plaque The results from the IXORA S study were presented at the
CELG,CELG:UW,BBG000BFCMR2,Ionis Pharma Lipid Disorder Candidate Positive in Phase III,2017-03-08 17:16:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gs9zVqcW-BQ/ionis-pharma-lipid-disorder-candidate-positive-in-phase-iii-cm757978,Akcea Therapeutics an affiliate of Ionis Pharmaceuticals Inc IONS recently announced positive results from a pivotal phase III study evaluating its pipeline candidate volanesorsen for treatment of patients with familial chylomicronemia syndrome FCS The aforesaid study is referred to
CELG,CELG:UW,BBG000BFCMR2,3 Safe Stocks You Can Buy Right Now,2017-03-08 16:15:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/omJ2gDt-Oho/3-safe-stocks-you-can-buy-right-now-cm757850,The market is at all time highs a full 8 years into a bull market So if you re starting to get nervous you re not alone Now might be the time to bring some conservatism to ones portfolio So if you re on the hunt for stocks that won t keep you up at night our contributors
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Trump Tweet Hits Biotech Stocks, Concert Gains on Vertex Deal",2017-03-08 15:17:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XBWuHu8s6qM/biotech-stock-roundup-trump-tweet-hits-biotech-stocks-concert-gains-on-vertex-deal-cm757792,Once again a tweet kept the biotech industry on edge with President Donald Trump declaring that he is working on a new system where there will be competition in the Drug Industry and pricing for the American people will come way down The tweet triggered a 1 6 decline in the
CELG,CELG:UW,BBG000BFCMR2,Ionis Pharma Lipid Disorder Candidate Positive in Phase III,2017-03-08 14:45:02 +0000,http://finance.yahoo.com/news/ionis-pharma-lipid-disorder-candidate-144502215.html,Ionis Pharma Lipid Disorder Candidate Positive in Phase III
CELG,CELG:UW,BBG000BFCMR2,3 Safe Stocks You Can Buy Right Now,2017-03-08 14:32:00 +0000,http://www.fool.com/investing/2017/03/08/3-safe-stocks-you-can-buy-right-now.aspx,3 Safe Stocks You Can Buy Right Now
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Trump Tweet Hits Biotech Stocks, Concert Gains on Vertex Deal",2017-03-08 13:18:01 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-trump-tweet-131801487.html,"Biotech Stock Roundup: Trump Tweet Hits Biotech Stocks, Concert Gains on Vertex Deal"
CELG,CELG:UW,BBG000BFCMR2,Celgene To Present At Cowen & Co. Health Care Conference; Webcast At 8:40 AM ET,2017-03-08 07:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uvp4qJ2pMPE/celgene-to-present-at-cowen--co-health-care-conference-webcast-at-840-am-et-20170308-00357,Celgene To Present At Cowen & Co. Health Care Conference; Webcast At 8:40 AM ET
CELG,CELG:UW,BBG000BFCMR2,GlaxoSmithKline's Nucala Positive in Label Expansion Study,2017-03-07 23:13:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VpNn37c56l0/glaxosmithklines-nucala-positive-in-label-expansion-study-cm757591,GlaxoSmithKline plc 160 GSK announced that a phase IIIb study evaluating its respiratory drug Nucala mepolizumab met all its primary and secondary endpoints 160 The 160 MUSCA study showed that patients with severe asthma driven by eosinophilic inflammation when treated with the
CELG,CELG:UW,BBG000BFCMR2,"Despite Brief Jitters, Investors Still Favor Online Leaders And Infrastructure Plays",2017-03-07 21:16:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pwd5UEro99Q/despite-brief-jitters-investors-still-favor-online-leaders-and-infrastructure-plays-cm757577,U S diversified stock mutual funds extended their rally in February picking up steam while tacking on 2 68 160 on average after gaining 1 83 in January according to Lipper Inc That reflected gains by the broad stock market measured by the S amp P 500 which advanced 3 97 160
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks You Don't Have to Babysit,2017-03-07 21:14:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ttKEn3xGI2M/3-biotech-stocks-you-dont-have-to-babysit-cm757450,The biotechnology industry is typically characterized by companies with huge potential but little to no revenue This situation often leads to some gut wrenching volatility that keeps even the most cavalier investors constantly logging into their brokerage accounts But
CELG,CELG:UW,BBG000BFCMR2,GlaxoSmithKline's Nucala Positive in Label Expansion Study,2017-03-07 21:08:09 +0000,http://finance.yahoo.com/news/glaxosmithklines-nucala-positive-label-expansion-210809378.html,GlaxoSmithKline's Nucala Positive in Label Expansion Study
CELG,CELG:UW,BBG000BFCMR2,Biotech beat up?,2017-03-07 20:58:00 +0000,http://finance.yahoo.com/video/biotech-beat-205800916.html,Biotech beat up?
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks You Don't Have to Babysit,2017-03-07 20:04:00 +0000,http://www.fool.com/investing/2017/03/07/3-biotech-stocks-you-dont-have-to-babysit.aspx,3 Biotech Stocks You Don't Have to Babysit
CELG,CELG:UW,BBG000BFCMR2,Trump's Latest Drug Pricing Tweet Hits Biotech Stocks,2017-03-07 14:48:55 +0000,http://blogs.wsj.com/moneybeat/2017/03/07/trumps-latest-drug-pricing-tweet-hits-biotech-stocks/?mod=yahoo_hs,Trump's Latest Drug Pricing Tweet Hits Biotech Stocks
CELG,CELG:UW,BBG000BFCMR2,Is This the Right Time to Invest in Biotech Stocks?,2017-03-07 14:16:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XB4ddS57gBw/is-this-the-right-time-to-invest-in-biotech-stocks-cm757033,The biotech industry was once a Wall Street favorite chalking up impressive gains until 2015 when the drug pricing issue started weighing on the sector However a look at the industry s year to date YTD price performance indicates that the sector is showing signs of recovery But will the
CELG,CELG:UW,BBG000BFCMR2,"Here's Why the Best Is Yet to Come for Gilead Sciences, Inc.",2017-03-07 14:14:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o2QduOO6M-c/heres-why-the-best-is-yet-to-come-for-gilead-sciences-inc-cm757010,Sales are plunging for once high flying products Revenue and earnings are falling Its stock price has slumped Several of its most promising pipeline prospects are still years away from commercialization All of these statements are true for Gilead Sciences NASDAQ GILD But
CELG,CELG:UW,BBG000BFCMR2,"Here's Why the Best Is Yet to Come for Gilead Sciences, Inc.",2017-03-07 13:04:00 +0000,http://www.fool.com/investing/2017/03/07/heres-why-the-best-is-yet-to-come-for-gilead-scien.aspx,"Here's Why the Best Is Yet to Come for Gilead Sciences, Inc."
CELG,CELG:UW,BBG000BFCMR2,3 of the Best Stocks to Trade on the Street,2017-03-06 19:12:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hIHlMTOrYjY/3-of-the-best-stocks-to-trade-on-the-street-cm756809,InvestorPlace Stock Market News Stock Advice amp Trading Tips The steady beat of new all time highs continued for stocks last week The large cap laden S amp P 500 catapulted to the psychological 2 400 level before retreating amid mild profit taking Source Shutterstock
CELG,CELG:UW,BBG000BFCMR2,"IWB, BA, CELG, BMY: ETF Outflow Alert",2017-03-06 17:14:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U7rn5zWUsy8/iwb-ba-celg-bmy-etf-outflow-alert-cm756661,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 ETF Symbol IWB where we have detected an approximate 79 7 million dollar outflow that s a 0 4 decrease week over week from 135 000 000
CELG,CELG:UW,BBG000BFCMR2,J&J Presents Positive Phase III Data on Psoriasis Candidate,2017-03-06 16:18:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gEKwHSr-3fM/jj-presents-positive-phase-iii-data-on-psoriasis-candidate-cm756612,Johnson amp Johnson JNJ announced positive data from two phase III studies evaluating its pipeline candidate guselkumab for the treatment of moderate to severe plaque psoriasis We remind investors that guselkumab is presently under review in the U S and EU for the plaque
CELG,CELG:UW,BBG000BFCMR2,Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy,2017-03-06 15:20:23 +0000,http://finance.yahoo.com/news/red-hot-biotech-companies-highlight-152023423.html,Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy
CELG,CELG:UW,BBG000BFCMR2,J&J Presents Positive Phase III Data on Psoriasis Candidate,2017-03-06 13:41:01 +0000,http://finance.yahoo.com/news/j-j-presents-positive-phase-134101182.html,J&J Presents Positive Phase III Data on Psoriasis Candidate
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Oral OTEZLA Demonstrated Significant Improvement vs Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy,2017-03-05 17:35:44 +0000,http://finance.yahoo.com/news/celgene-announces-oral-otezla-demonstrated-173544973.html,Celgene Announces Oral OTEZLA Demonstrated Significant Improvement vs Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy
CELG,CELG:UW,BBG000BFCMR2,Oral OTEZLA® (Apremilast) Demonstrated Significant Improvement versus Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy,2017-03-05 13:55:00 +0000,http://finance.yahoo.com/news/oral-otezla-apremilast-demonstrated-significant-135500636.html,"[Business Wire] - Celgene Corporation today announced that results from its phase 4 UNVEIL trial evaluating OTEZLA® , the Company's oral, selective inhibitor of phosphodiesterase 4 , in patients with moderate plaque psoriasis with a body surface area of 5-10 percent, were presented at the American Academy of Dermatology's Annual Meeting in Orlando, Florida."
CELG,CELG:UW,BBG000BFCMR2,How to Profit from Celgene (CELG) Options,2017-03-04 15:52:39 +0000,http://ir.baystreet.ca/article.aspx?id=504&1488642759,How to Profit from Celgene (CELG) Options
CELG,CELG:UW,BBG000BFCMR2,Bad News Biotechs: What's Next for Juno and PTC Therapeutics?,2017-03-04 13:13:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A-y6j-V9_h4/bad-news-biotechs-whats-next-for-juno-and-ptc-therapeutics-cm756266,March has been a month associated with bad news Remember Julius Caesar and the ides of March At least Julius had the opportunity to enjoy a couple of good weeks before disaster struck Bad news came early in the month for Juno Therapeutics NASDAQ JUNO and PTC
CELG,CELG:UW,BBG000BFCMR2,Bad News Biotechs: What's Next for Juno and PTC Therapeutics?,2017-03-04 11:42:00 +0000,http://www.fool.com/investing/2017/03/04/bad-news-biotechs-whats-next-for-juno-and-ptc-ther.aspx,Bad News Biotechs: What's Next for Juno and PTC Therapeutics?
CELG,CELG:UW,BBG000BFCMR2,A Remarkable Approach to Profit from Celgene Options,2017-03-04 00:00:09 +0000,http://finance.yahoo.com/news/remarkable-approach-profit-celgene-options-000009462.html,A Remarkable Approach to Profit from Celgene Options
CELG,CELG:UW,BBG000BFCMR2,"Despite Brief Jitters, Investors Still Favor Online Leaders And Infrastructure Plays",2017-03-03 22:13:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ztEegVCpsP0/despite-brief-jitters-investors-still-favor-online-leaders-and-infrastructure-plays-cm756191,U S diversified stock mutual funds extended their rally in February picking up steam while tacking on 2 68 160 on average after gaining 1 83 in January according to Lipper Inc That reflected gains by the broad stock market measured by the S amp P 500 which advanced 3 97 160
CELG,CELG:UW,BBG000BFCMR2,"Notable Friday Option Activity: CCL, PRTA, CELG",2017-03-03 22:12:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9UGSLgTDljQ/notable-friday-option-activity-ccl-prta-celg-cm756181,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Carnival Corp Symbol CCL where a total of 11 707 contracts have traded so far representing approximately 1 2 million underlying shares That amounts to about 43 4 of CCL s
CELG,CELG:UW,BBG000BFCMR2,"HealthCor Management, L.P. Buys Celgene, Intuitive Surgical, Aetna, Sells Biogen, Edwards ...",2017-03-03 20:11:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i9bJOMSiWks/healthcor-management-lp-buys-celgene-intuitive-surgical-aetna-sells-biogen-edwards-cm756149,HealthCor Management L P New Purchases ISRG AET DHR WOOF UNH BMRN HAE NBIX DXCM TMO Added Positions CELG DGX LH PCRX INCY INCR HCA MEDP COLL NTRA Reduced Positions CI HOLX ZBH ALXN HLS PRAH BCR MRK CLVS Sold Out BIIB
CELG,CELG:UW,BBG000BFCMR2,Nektar Therapeutics (NKTR) Loss Wider than Expected in Q4,2017-03-03 16:13:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lTJlpRMdzL8/nektar-therapeutics-nktr-loss-wider-than-expected-in-q4-cm755933,Nektar Therapeutics NKTR reported loss of 28 cents per share in the fourth quarter of 2016 wider than the Zacks Consensus Estimate of loss of 26 cents The reported loss was however narrower than the year ago loss of 40 cents per share The company s shares gained 13 7 following the
CELG,CELG:UW,BBG000BFCMR2,Nektar Therapeutics (NKTR) Loss Wider than Expected in Q4,2017-03-03 14:32:02 +0000,http://finance.yahoo.com/news/nektar-therapeutics-nktr-loss-wider-143202285.html,Nektar Therapeutics (NKTR) Loss Wider than Expected in Q4
CELG,CELG:UW,BBG000BFCMR2,Celgene to Present New Data from Clinical Trials on Oral OTEZLA® (apremilast) at American Academy of Dermatology Congress,2017-03-03 12:00:00 +0000,http://finance.yahoo.com/news/celgene-present-data-clinical-trials-120000315.html,"[Business Wire] - Celgene Corporation today announced that findings from ongoing clinical trials of OTEZLA® , the Company's oral, selective inhibitor of phosphodiesterase 4 , conducted in patients with moderate or moderate to severe plaque psoriasis, and in adult patients with active psoriatic arthritis, will be presented at the 75th Annual Meeting of the American Academy of Dermatology in Orlando, Florida."
CELG,CELG:UW,BBG000BFCMR2,Why Juno Therapeutics Inc. Tanked on Thursday,2017-03-03 02:12:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fqq2hgeGEhM/why-juno-therapeutics-inc-tanked-on-thursday-cm755763,What happened Juno Therapeutics NASDAQ JUNO ended down 10 6 on Thursday after announcing Wednesday after the bell that the biotech was discontinuing development of its lead treatment JCAR015 So what This shouldn t have come as much of a shock to investors JCAR015 has
CELG,CELG:UW,BBG000BFCMR2,Why Juno Therapeutics Inc. Tanked on Thursday,2017-03-03 00:37:00 +0000,http://www.fool.com/investing/2017/03/02/why-juno-therapeutics-inc-tanked-on-thursday.aspx,Why Juno Therapeutics Inc. Tanked on Thursday
CELG,CELG:UW,BBG000BFCMR2,"Keryx (KERX) Q4 Loss Wider than Expected, Revenues Beat",2017-03-03 00:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J1EvPSghvFI/keryx-kerx-q4-loss-wider-than-expected-revenues-beat-cm755717,Keryx Biopharmaceuticals Inc KERX reported fourth quarter 2016 loss of 32 cents per share narrower than the year ago loss of 36 cents However the loss was wider than the Zacks Consensus Estimate of a loss of 27 cents per share Revenues came in at 9 53 million in the quarter
CELG,CELG:UW,BBG000BFCMR2,"Puma (PBYI) Q4 Loss Wider than Expected, Neratinib in Focus",2017-03-03 00:13:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SqdcaLv8OCI/puma-pbyi-q4-loss-wider-than-expected-neratinib-in-focus-cm755715,Puma Biotechnology Inc PBYI reported a fourth quarter 2016 loss of 2 04 per share including the impact of stock based compensation expenses wider than both the Zacks Consensus Estimate of a loss of 2 02 and the year ago loss of 1 90 So far this year Puma s shares
CELG,CELG:UW,BBG000BFCMR2,"Impax (IPXL) Q4 Earnings in Line, Revenues Miss Estimates",2017-03-03 00:13:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nZyy1U2ILHA/impax-ipxl-q4-earnings-in-line-revenues-miss-estimates-cm755709,Impax Laboratories Inc IPXL posted fourth quarter 2016 adjusted earnings of 16 cents per share in line with the Zacks Consensus Estimate Earnings were also down 74 2 from 62 cents in the year ago period due to lower generic product sales The company s share price fell 34 74 following
CELG,CELG:UW,BBG000BFCMR2,"Merrimack (MACK) Q4 Loss Lower than Expected, Revenues Top",2017-03-03 00:13:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JdE5jxnJ14I/merrimack-mack-q4-loss-lower-than-expected-revenues-top-cm755704,Merrimack Pharmaceuticals Inc MACK reported a loss of 21 cents per share in the fourth quarter of 2016 a penny narrower than the Zacks Consensus Estimate of a loss of 22 cents The company reported a loss of 41 cents in the year ago quarter Quarterly revenues came in at 61 2 million
CELG,CELG:UW,BBG000BFCMR2,Why Celgene's Shares Rallied Higher in February,2017-03-02 22:13:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LnZAZJvqy-U/why-celgenes-shares-rallied-higher-in-february-cm755653,What happened After reporting fourth quarter financials in late January and announcing positive phase 3 trial results for its promising multiple sclerosis drug in February shares in Celgene Corp NASDAQ CELG 160 climbed more than 5 last month according to S amp P
CELG,CELG:UW,BBG000BFCMR2,"Merrimack (MACK) Q4 Loss Lower than Expected, Revenues Top",2017-03-02 22:08:10 +0000,http://finance.yahoo.com/news/merrimack-mack-q4-loss-lower-220810036.html,"Merrimack (MACK) Q4 Loss Lower than Expected, Revenues Top"
CELG,CELG:UW,BBG000BFCMR2,Why Celgene's Shares Rallied Higher in February,2017-03-02 20:21:00 +0000,http://www.fool.com/investing/2017/03/02/why-celgenes-shares-rallied-higher-in-february.aspx,Why Celgene's Shares Rallied Higher in February
CELG,CELG:UW,BBG000BFCMR2,Geron (GERN) Q4 Loss Narrows; Focus Remains on Imetelstat,2017-03-02 17:15:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JQfoLUzm-ng/geron-gern-q4-loss-narrows-focus-remains-on-imetelstat-cm755469,Geron Corporation GERN reported a loss of 5 cents per share in the fourth quarter of 2016 flat year over year but narrower than the Zacks Consensus Estimate of a loss of 6 cents FindTheCompany Graphiq Shares rose 2 4 in after hours trading on Wednesday However
CELG,CELG:UW,BBG000BFCMR2,Biotech ETF (BBH) Hits New 52-Week High,2017-03-02 16:17:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PdvOYV0lPzw/biotech-etf-bbh-hits-new-52-week-high-cm755393,For investors seeking momentum VanEck Vectors Biotech ETF BBH is probably on radar now The fund just hit a 52 week high and is up about 27 2 from its 52 week low price of 95 77 share But are more gains in store for this ETF Let s take a quick look at the fund and the near term
CELG,CELG:UW,BBG000BFCMR2,Billionaire George Soros Bought These 2 Biotech Stocks,2017-03-02 16:15:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oGsf8eQCmQ0/billionaire-george-soros-bought-these-2-biotech-stocks-cm755386,Billionaire super investor George Soros may have stepped away from actively managing his namesake fund but the firm s quarterly activity still garners significant interest within the investing community The Soros Fund Management after all has been one of world s most active
CELG,CELG:UW,BBG000BFCMR2,Juno (JUNO) Loss Wider; End of Cancer Drug Study Hits Stock,2017-03-02 16:15:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JKmjtOczYhc/juno-juno-loss-wider-end-of-cancer-drug-study-hits-stock-cm755325,Juno Therapeutics Inc JUNO reported wider than expected loss in the fourth quarter of 2016 Shares of the company declined in after hours trading as it announced that it has decided not to move forward with the ROCKET trial or cancer candidate JCAR015 In fact in the past one year
CELG,CELG:UW,BBG000BFCMR2,Geron (GERN) Q4 Loss Narrows; Focus Remains on Imetelstat,2017-03-02 14:57:02 +0000,http://finance.yahoo.com/news/geron-gern-q4-loss-narrows-145702387.html,Geron (GERN) Q4 Loss Narrows; Focus Remains on Imetelstat
CELG,CELG:UW,BBG000BFCMR2,Billionaire George Soros Bought These 2 Biotech Stocks,2017-03-02 14:50:00 +0000,http://www.fool.com/investing/2017/03/02/billionaire-george-soros-bought-these-2-biotech-st.aspx,Billionaire George Soros Bought These 2 Biotech Stocks
CELG,CELG:UW,BBG000BFCMR2,"Zacks Industry Outlook Highlights: GlaxoSmithKline, Celgene and Exelixis",2017-03-02 14:30:02 +0000,http://finance.yahoo.com/news/zacks-industry-outlook-highlights-glaxosmithkline-143002187.html,"Zacks Industry Outlook Highlights: GlaxoSmithKline, Celgene and Exelixis"
CELG,CELG:UW,BBG000BFCMR2,"FDA Approves Odactra, JUNO Abandons Rocket, VRML Abuzz, No Tremors For NDRM",2017-03-02 05:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AeyT2lhQlYg/fda-approves-odactra-juno-abandons-rocket-vrml-abuzz-no-tremors-for-ndrm-20170302-00244,"FDA Approves Odactra, JUNO Abandons Rocket, VRML Abuzz, No Tremors For NDRM"
CELG,CELG:UW,BBG000BFCMR2,"Valeant (VRX) Tops Q4 Earnings, Shares Down on Tepid View",2017-03-02 00:13:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iTHTVBxt89w/valeant-vrx-tops-q4-earnings-shares-down-on-tepid-view-cm755148,Shares of Valeant Pharmaceuticals Inc VRX fell over 13 9 following the company s dismal guidance for 2017 concurrent with the fourth quarter 2016 earnings We note that the shares of Valeant have underperformed the Zacks classified Medical Drugs industry in the last one year The
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics' Q4 Financial Results Overshadowed by Pipeline Setback,2017-03-02 00:12:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vW_MBUCtfis/juno-therapeutics-q4-financial-results-overshadowed-by-pipeline-setback-cm755118,The last time Juno Therapeutics NASDAQ JUNO reported quarterly results it received a big boost from its partner Celgene NASDAQ CELG However Juno s stock hasn t performed so well since then The clinical stage biotech announced its fourth quarter and full
CELG,CELG:UW,BBG000BFCMR2,"Jazz Pharma (JAZZ) Q4 Earnings Beat, Sales Miss Estimates",2017-03-01 23:13:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6GGLTKTtdx8/jazz-pharma-jazz-q4-earnings-beat-sales-miss-estimates-cm755097,Jazz Pharmaceuticals Public Limited Company JAZZ reported fourth quarter 2016 earnings of 1 91 per share which beat the Zacks Consensus Estimate of 1 65 However adjused earnings of 2 31 per share including stock based compensation expense declined 4 5 from the year ago
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics' Q4 Financial Results Overshadowed by Pipeline Setback,2017-03-01 23:03:00 +0000,http://www.fool.com/investing/2017/03/01/juno-therapeutics-q4-financial-results-overshadowe.aspx,Juno Therapeutics' Q4 Financial Results Overshadowed by Pipeline Setback
CELG,CELG:UW,BBG000BFCMR2,"M&As, Pipeline Catalysts to Drive Pharma Sector",2017-03-01 20:19:08 +0000,http://finance.yahoo.com/news/m-pipeline-catalysts-drive-pharma-201908607.html,"M&As, Pipeline Catalysts to Drive Pharma Sector"
CELG,CELG:UW,BBG000BFCMR2,​Agios CEO touts path from 'a blank piece of paper' to cusp of drug approval,2017-03-01 20:15:15 +0000,http://www.bizjournals.com/boston/news/2017/03/01/agios-ceo-touts-path-from-a-blank-piece-of-paper.html?ana=yahoo,​Agios CEO touts path from 'a blank piece of paper' to cusp of drug approval
CELG,CELG:UW,BBG000BFCMR2,Kite Pharma (KITE) Posts Q4 Loss; Up on Positive Cancer Data,2017-03-01 17:14:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ErBIeRb9bI/kite-pharma-kite-posts-q4-loss-up-on-positive-cancer-data-cm754890,Kite Pharma Inc KITE reported narrower than expected loss in the fourth quarter of 2016 Despite announcing a lower than expected sales guidance for 2017 shares of the biotech company shot up almost 25 on Tuesday The reason behind it was the announcement of better than expected results
CELG,CELG:UW,BBG000BFCMR2,Regeneron Could See a Modest Rise in Net Profit Margins in 2017,2017-03-01 15:37:18 +0000,http://marketrealist.com/2017/02/regeneron-expected-witness-modest-rise-net-profit-margins-2017/?utm_source=yahoo&utm_medium=feed,Regeneron Could See a Modest Rise in Net Profit Margins in 2017
CELG,CELG:UW,BBG000BFCMR2,[$$] Cancer Test Makers Raise Nearly $1 Billion,2017-03-01 15:04:59 +0000,https://www.wsj.com/articles/cancer-test-makers-raise-nearly-1-billion-1488380695?mod=yahoo_hs,[$$] Cancer Test Makers Raise Nearly $1 Billion
CELG,CELG:UW,BBG000BFCMR2,Medicines Company (MDCO) Q4 Loss Narrower than Expected,2017-03-01 14:37:02 +0000,http://finance.yahoo.com/news/medicines-company-mdco-q4-loss-143702497.html,Medicines Company (MDCO) Q4 Loss Narrower than Expected
CELG,CELG:UW,BBG000BFCMR2,Why Is Celgene (CELG) Up 6% Since the Last Earnings Report?,2017-03-01 13:36:01 +0000,http://finance.yahoo.com/news/why-celgene-celg-6-since-133601475.html,Why Is Celgene (CELG) Up 6% Since the Last Earnings Report?
CELG,CELG:UW,BBG000BFCMR2,Carl Icahn Takes Aim at Bristol-Myers Squibb,2017-03-01 13:06:00 +0000,http://www.fool.com/investing/2017/03/01/carl-icahn-takes-aim-at-bristol-myers-squibb.aspx,Carl Icahn Takes Aim at Bristol-Myers Squibb
CELG,CELG:UW,BBG000BFCMR2,FDA Accepts New Drug Application and Grants Priority Review for Enasidenib in Relapsed or Refractory AML with an IDH2 Mutation,2017-03-01 12:30:00 +0000,http://finance.yahoo.com/news/fda-accepts-drug-application-grants-123000983.html,[Business Wire] - Celgene Corporation and Agios Pharmaceuticals today announced that the U.S. Food and Drug Administration has accepted Celgene’s New Drug Application for enasidenib for the treatment of patients with relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase 2 mutation.
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals",2017-03-01 12:24:12 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-kite-soars-122412088.html,"Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals"
CELG,CELG:UW,BBG000BFCMR2,Celgene: FDA Grants Priority Review For Enasidenib - Quick Facts,2017-03-01 07:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/86RcQRoowfo/celgene-fda-grants-priority-review-for-enasidenib--quick-facts-20170301-00540,Celgene: FDA Grants Priority Review For Enasidenib - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,Why Gilead’s Valuation Is Low Compared to Peers,2017-02-28 22:54:16 +0000,http://marketrealist.com/2017/02/why-gileads-valuation-is-low-compared-to-peers-2/?utm_source=yahoo&utm_medium=feed,Why Gilead’s Valuation Is Low Compared to Peers
CELG,CELG:UW,BBG000BFCMR2,"Horizon (HZNP) Misses on Earnings in Q4, View Disappoints",2017-02-28 18:51:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LvyFtQJ2qVM/horizon-hznp-misses-on-earnings-in-q4-view-disappoints-cm754297,Horizon Pharma plc HZNP reported fourth quarter 2016 earnings of 50 cents per share including the impact of share based compensation expense and tax adjustments down from 55 cents in the year ago quarter Reported earnings also missed the Zacks Consensus Estimate of 52 cents Sales in
CELG,CELG:UW,BBG000BFCMR2,"Endo (ENDP) Beats on Q4 Earnings, Revenues; Guides Low",2017-02-28 18:50:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1OSAmTex0LM/endo-endp-beats-on-q4-earnings-revenues-guides-low-cm754295,Endo International plc s ENDP fourth quarter 2016 earnings of 1 77 per share beat the Zacks Consensus Estimate of 1 63 Reported earnings were also above the year ago figure of 1 36 Revenues came in at 1 24 billion in fourth quarter of 2016 up 15 6 year over year Revenues were also
CELG,CELG:UW,BBG000BFCMR2,"Theravance (TBPH) Q4 Loss Wider than Expected, Revenues Beat",2017-02-28 16:52:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PC-fOPpynBM/theravance-tbph-q4-loss-wider-than-expected-revenues-beat-cm754226,Theravance Biopharma Inc TBPH reported fourth quarter 2016 loss of 1 36 per share much wider than both the Zacks Consensus Estimate of a loss of 1 07 and the year ago loss of 1 23 The Theravance stock underperformed the Zacks classified Medical Drugs industry year to date
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Hike Their Bets in Major Biotechs,2017-02-28 15:15:44 +0000,http://finance.yahoo.com/news/short-sellers-hike-bets-major-151544999.html,Short Sellers Hike Their Bets in Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,Smart Investors Are Already Buying These Stocks for Retirement,2017-02-28 14:27:38 +0000,http://www.fool.com/investing/2017/02/28/smart-investors-are-already-buying-these-stocks-fo.aspx,Smart Investors Are Already Buying These Stocks for Retirement
CELG,CELG:UW,BBG000BFCMR2,Perrigo to Sell Tysabri Royalties; Issues Tepid 2017 View,2017-02-28 14:24:02 +0000,http://finance.yahoo.com/news/perrigo-sell-tysabri-royalties-issues-142402083.html,Perrigo to Sell Tysabri Royalties; Issues Tepid 2017 View
CELG,CELG:UW,BBG000BFCMR2,3 Ways to Play This Biotech Stocks Dip,2017-02-27 20:49:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zm7E-IF5yU4/3-ways-to-play-this-biotech-stocks-dip-cm753796,InvestorPlace Stock Market News Stock Advice amp Trading Tips The bid for world domination continues for Nasdaq Composite this week Sure the entire U S market is on fire since the November election But it s the tech heavy Nasdaq that s leading the charge these days And as we ll
CELG,CELG:UW,BBG000BFCMR2,Achillion (ACHN) Reports Narrower-Than-Expected Q4 Loss,2017-02-27 13:23:01 +0000,http://finance.yahoo.com/news/achillion-achn-reports-narrower-expected-132301493.html,Achillion (ACHN) Reports Narrower-Than-Expected Q4 Loss
CELG,CELG:UW,BBG000BFCMR2,Why Vertex Expects Its Profit Margin to Rise in 2017,2017-02-27 12:37:39 +0000,http://marketrealist.com/2017/02/vertex-pharmaceuticals-expected-witness-rise-profit-margin-2017/?utm_source=yahoo&utm_medium=feed,Why Vertex Expects Its Profit Margin to Rise in 2017
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Webcast at Upcoming Investor Conferences,2017-02-27 12:30:00 +0000,http://finance.yahoo.com/news/celgene-corporation-webcast-upcoming-investor-123000572.html,[Business Wire] - Celgene Corporation plans to present at two upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com.
CELG,CELG:UW,BBG000BFCMR2,"Emergent (EBS) Beats Earnings, Revenue Estimates in Q4",2017-02-24 22:51:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DOBWQxerG3k/emergent-ebs-beats-earnings-revenue-estimates-in-q4-cm753104,Emergent BioSolutions Inc EBS reported earnings of 74 cents per share in the fourth quarter of 2016 which surpassed the Zacks Consensus Estimate of 60 cents However the reported figure decreased from 77 cents earned in the year ago period The Emergent stock underperformed the
CELG,CELG:UW,BBG000BFCMR2,"Intercept (ICPT) Q4 Loss Wider than Expected, Revenues Beat",2017-02-24 22:51:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UP_ug5KF3q0/intercept-icpt-q4-loss-wider-than-expected-revenues-beat-cm753091,Intercept Pharmaceuticals Inc ICPT posted a loss of 4 84 per share in the fourth quarter of 2016 wider than the Zacks Consensus Estimate of a loss of 3 58 and the year ago loss of 3 62 Quarterly revenues came in at 13 8 million up significantly from 0 4 million in the year ago
CELG,CELG:UW,BBG000BFCMR2,"Notable Friday Option Activity: CELG, AMGN, LMT",2017-02-24 20:50:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f4au65pbdhs/notable-friday-option-activity-celg-amgn-lmt-cm753003,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Celgene Corp Symbol CELG where a total volume of 16 950 contracts has been traded thus far today a contract volume which is representative of approximately 1 7
CELG,CELG:UW,BBG000BFCMR2,"Emergent (EBS) Beats Earnings, Revenue Estimates in Q4",2017-02-24 20:25:08 +0000,http://finance.yahoo.com/news/emergent-ebs-beats-earnings-revenue-202508824.html,"Emergent (EBS) Beats Earnings, Revenue Estimates in Q4"
CELG,CELG:UW,BBG000BFCMR2,"Is There More Than Meets the Eye on Celgene’s President, COO Retirement?",2017-02-24 18:45:06 +0000,http://finance.yahoo.com/news/more-meets-eye-celgene-president-184506155.html,"Is There More Than Meets the Eye on Celgene’s President, COO Retirement?"
CELG,CELG:UW,BBG000BFCMR2,BioMarin (BMRN) Q4 Loss Narrower than Expected; Sales Beat,2017-02-24 16:53:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FR48qT6gNNM/biomarin-bmrn-q4-loss-narrower-than-expected-sales-beat-cm752785,BioMarin Pharmaceutical Inc BMRN reported a loss of 37 cents per share in the fourth quarter of 2016 including stock based compensation expense narrower than the year ago loss of 57 cents as well as the Zacks Consensus Estimate of a loss of 39 cents per share Total revenue came in at
CELG,CELG:UW,BBG000BFCMR2,3 Incredibly Cheap Biotech Stocks,2017-02-24 15:57:33 +0000,http://www.fool.com/investing/2017/02/24/3-incredibly-cheap-biotech-stocks.aspx,3 Incredibly Cheap Biotech Stocks
CELG,CELG:UW,BBG000BFCMR2,3 Incredibly Cheap Biotech Stocks,2017-02-24 14:52:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YaV0B9Yegzs/3-incredibly-cheap-biotech-stocks-cm752599,There are stocks that are cheap for a good reason and those that are cheap only for a season Stocks that are cheap for a reason could be value traps low priced and likely to stay that way Stocks that are cheap for a season on the other hand could make patient investors a lot of
CELG,CELG:UW,BBG000BFCMR2,REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma after Autologous Stem Cell Transplantation,2017-02-24 10:43:00 +0000,http://uk.finance.yahoo.com/news/revlimid-lenalidomide-approved-european-commission-104300068.html,REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma after Autologous Stem Cell Transplantation
CELG,CELG:UW,BBG000BFCMR2,"CELGENE CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers",2017-02-23 22:36:24 +0000,http://biz.yahoo.com/e/170223/celg8-k.html,"CELGENE CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers"
CELG,CELG:UW,BBG000BFCMR2,"Celgene Announces Retirement of President and Chief Operating Officer, Jacqualyn Fouse, Ph.D. and Promotion of Scott Smith to President and Chief Operating Officer",2017-02-23 21:30:00 +0000,http://finance.yahoo.com/news/celgene-announces-retirement-president-chief-213000683.html,"[Business Wire] - Celgene Corporation today announced that President and Chief Operating Officer Jacqualyn Fouse, Ph.D., has decided to retire from Celgene effective June 30, 2017."
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Revlimid Secures Label Expansion,2017-02-23 19:20:00 +0000,http://www.investopedia.com/news/celgenes-revlimid-secures-label-expansion-celg/?partner=YahooSA,Celgene’s Revlimid Secures Label Expansion
CELG,CELG:UW,BBG000BFCMR2,"Notable ETF Outflow Detected - SSO, MDT, BA, CELG",2017-02-23 17:51:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2j8-yl8Wt5M/notable-etf-outflow-detected-sso-mdt-ba-celg-cm752151,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the ProShares Ultra S amp P500 Symbol SSO where we have detected an approximate 21 2 million dollar outflow that s a 1 2 decrease week over week from 20 650
CELG,CELG:UW,BBG000BFCMR2,The Math Shows JKE Can Go To $145,2017-02-23 15:51:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j0yEbSIQaG4/the-math-shows-jke-can-go-to-145-cm752022,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
CELG,CELG:UW,BBG000BFCMR2,Here's Why Celgene's Latest Drug Is So Exciting,2017-02-23 14:52:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xwj1XiTO7bc/heres-why-celgenes-latest-drug-is-so-exciting-cm751796,Celgene NASDAQ CELG recently reported that its multiple sclerosis drug ozanimod successfully met its endpoints in reducing multiple sclerosis MS relapses and assuming a second trial pans out similarly that s got the biotech targeting a filing for FDA approval by the end of
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics (JUNO) Q4 Earnings: What's in the Cards?,2017-02-23 14:50:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/75Y4PGTBy-M/juno-therapeutics-juno-q4-earnings-whats-in-the-cards-cm751912,Juno Therapeutics Inc JUNO is set to report fourth quarter 2016 results on Mar 1 after the market closes Juno s shares have outperformed the Zacks classified Medical Biomedical and Genetics industry year to date Shares of the company gained 22 3 so far this year while the
CELG,CELG:UW,BBG000BFCMR2,Here's Why Celgene's Latest Drug Is So Exciting,2017-02-23 13:02:10 +0000,http://www.fool.com/investing/2017/02/23/heres-why-celgenes-latest-drug-is-so-exciting.aspx,Here's Why Celgene's Latest Drug Is So Exciting
CELG,CELG:UW,BBG000BFCMR2,FDA Expands Indication for REVLIMID® (lenalidomide) as a Maintenance Treatment for Patients with Multiple Myeloma Following Autologous Hematopoietic Stem Cell Transplant (auto-HSCT),2017-02-22 21:02:00 +0000,http://finance.yahoo.com/news/fda-expands-indication-revlimid-lenalidomide-210200119.html,[Business Wire] - Celgene Corporation today announced that the U.S. Food and Drug Administration has expanded the existing indication for REVLIMID 10 mg capsules to include use for patients with multiple myeloma as maintenance therapy following autologous hematopoietic stem cell transplant .
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising",2017-02-22 14:11:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lvmQma1GC9s/biotech-stock-roundup-alexion-reports-4q-results-celgene-ms-drug-looks-promising-cm751060,Key updates in the biotech sector include a mixed quarter from Alexion ALXN and promising data on Celgene s CELG investigational multiple sclerosis MS treatment Recap of the Week s Most Important Stories Mixed Results from Alexion Alexion s fourth quarter results were mixed
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising",2017-02-22 11:43:11 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-alexion-reports-114311834.html,"Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising"
CELG,CELG:UW,BBG000BFCMR2,3 Great Stocks to Buy Instead of NVIDIA Corporation,2017-02-22 02:07:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6PI3hBU6n7k/3-great-stocks-to-buy-instead-of-nvidia-corporation-cm750995,NVIDIA Corporation NASDAQ NVDA investors have done incredibly well over the past year riding the company s hugely successful 2016 to 315 gains in its stock price And while the company s shares still trade at a pricey but not crazy valuation it s certainly gotten more
CELG,CELG:UW,BBG000BFCMR2,3 Great Stocks to Buy Instead of NVIDIA Corporation,2017-02-22 00:01:00 +0000,http://www.fool.com/investing/2017/02/21/3-great-stocks-to-buy-instead-of-nvidia-corporatio.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Great Stocks to Buy Instead of NVIDIA Corporation
CELG,CELG:UW,BBG000BFCMR2,Blog Coverage Celgene's Multiple Sclerosis Drug Reported Positive Phase-III Results,2017-02-21 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-celgenes-multiple-sclerosis-131500877.html,"[Accesswire] - Upcoming AWS Coverage on BioMarin Pharmaceutical Post-Earnings Results LONDON, UK / ACCESSWIRE / February 21, 2017 / Active Wall St. blog coverage looks at the headline from Celgene Corp. (NASDAQ: CELG ..."
CELG,CELG:UW,BBG000BFCMR2,[$$] US exporters line up behind tax code overhaul,2017-02-21 11:00:14 +0000,"http://www.ft.com/cms/s/1b8176e6-f7f3-11e6-9516-2d969e0d3b65,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - The heads of GE, Boeing and other corporate heavyweights have warned that the US may not have another opportunity to revamp its tax code for 30 years if it misses out on a chance to do it now amid uproar ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene MS Drug Reports Positive Phase 3 Data,2017-02-20 15:30:00 +0000,http://www.investopedia.com/news/celgene-ms-drug-reports-positive-phase-3-data-celg/?partner=YahooSA,Celgene MS Drug Reports Positive Phase 3 Data
CELG,CELG:UW,BBG000BFCMR2,3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter,2017-02-20 14:54:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mBuvdy6qDvo/3-top-drug-stocks-that-can-be-purchased-on-the-cheap-this-winter-cm750193,Drug stocks have been a volatile group since the beginning of 2016 with many selling off and still more than a year later struggling to recover what they lost Meanwhile the broad based S amp P 500 has moved substantially higher It s not hard to understand why investors view
CELG,CELG:UW,BBG000BFCMR2,"Forget Alexion, Buy these 4 Biotech Stocks Instead",2017-02-20 14:53:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wCRPpf18LR0/forget-alexion-buy-these-4-biotech-stocks-instead-cm750186,New Haven CT based Alexion Pharmaceuticals Inc s ALXN fourth quarter results were mixed with the company reporting in line earnings while revenues were just shy of expectations Alexion s guidance for 2017 also fell short of expectations Although flagship drug Soliris will continue
CELG,CELG:UW,BBG000BFCMR2,3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter,2017-02-20 13:24:10 +0000,http://www.fool.com/investing/2017/02/20/3-top-drug-stocks-that-can-be-purchased-on-the-che.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter
CELG,CELG:UW,BBG000BFCMR2,"Forget Alexion, Buy these 4 Biotech Stocks Instead",2017-02-20 12:52:12 +0000,http://finance.yahoo.com/news/forget-alexion-buy-4-biotech-125212478.html,"Forget Alexion, Buy these 4 Biotech Stocks Instead"
CELG,CELG:UW,BBG000BFCMR2,Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?,2017-02-19 17:51:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eRsxZf19eeg/could-celgene-have-another-billion-dollar-blockbuster-on-its-hands-cm750114,A new and highly anticipated study by Celgene Corp NASDAQ CELG shows that its promising multiple sclerosis drug could soon reshape the 19 billion multiple sclerosis market On Friday management reported that ozanimod met its primary endpoint for reducing MS relapses better
CELG,CELG:UW,BBG000BFCMR2,Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?,2017-02-19 16:41:05 +0000,http://www.fool.com/investing/2017/02/19/could-celgene-have-another-billion-dollar-blockbus.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?
CELG,CELG:UW,BBG000BFCMR2,"Fortaleza Asset Management Inc Buys MGM Resorts International, Northrop Grumman, Salesforce. ...",2017-02-18 10:51:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6nrzZTEIC10/fortaleza-asset-management-inc-buys-mgm-resorts-international-northrop-grumman-salesforce-cm749981,Fortaleza Asset Management Inc New Purchases MGM NOC CRM GWR MCHP SCCO STMP CIEN IPAR HTLD Added Positions CTXS VEEV SPLK JBHT OZRK CAVM YELP HCSG ULTA MTSI Reduced Positions GOOGL HON HD FB AMZN ABMD LRCX GPK MCD AMGN
CELG,CELG:UW,BBG000BFCMR2,"Celgene MS Drug Wins In Trial; Will Safety Top Novartis, Biogen?",2017-02-17 21:15:10 +0000,http://www.investors.com/news/technology/celgene-ms-drug-wins-in-trial-will-safety-top-novartis-biogen/,"Celgene MS Drug Wins In Trial; Will Safety Top Novartis, Biogen?"
CELG,CELG:UW,BBG000BFCMR2,"Stocks Quietly Mixed In Afternoon; Skyworks Breaks Out, Celgene Bases",2017-02-17 18:30:04 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-quietly-mixed-in-afternoon-skyworks-breaks-out-celgene-bases/,"Stocks Quietly Mixed In Afternoon; Skyworks Breaks Out, Celgene Bases"
CELG,CELG:UW,BBG000BFCMR2,Agios Pharma (AGIO) Q4 Loss Narrower than Expected; Stock Up,2017-02-17 16:55:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DeoHfP8NzkI/agios-pharma-agio-q4-loss-narrower-than-expected-stock-up-cm749689,Agios Pharmaceuticals Inc AGIO posted fourth quarter 2016 loss of 1 34 per share narrower than the Zacks Consensus Estimate of a loss of 1 55 but wider than the year ago loss of 1 08 Shares gained more than 8 on Feb 16 2017 following the earnings results In fact Agios s
CELG,CELG:UW,BBG000BFCMR2,Agios Pharma (AGIO) Q4 Loss Narrower than Expected; Stock Up,2017-02-17 14:27:02 +0000,http://finance.yahoo.com/news/agios-pharma-agio-q4-loss-142702400.html,Agios Pharma (AGIO) Q4 Loss Narrower than Expected; Stock Up
CELG,CELG:UW,BBG000BFCMR2,Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial,2017-02-17 13:39:00 +0000,https://www.thestreet.com/story/14006548/1/celgene-multiple-sclerosis-pill-succeeds-in-first-late-stage-clinical-trial.html?puc=yahoo&cm_ven=YAHOO,Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial
CELG,CELG:UW,BBG000BFCMR2,"CELGENE CORP /DE/ Files SEC form 8-K, Other Events",2017-02-17 13:14:23 +0000,http://biz.yahoo.com/e/170217/celg8-k.html,"CELGENE CORP /DE/ Files SEC form 8-K, Other Events"
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Positive Results from Phase III SUNBEAM Trial of Oral Ozanimod in Patients with Relapsing Multiple Sclerosis,2017-02-17 12:30:00 +0000,http://finance.yahoo.com/news/celgene-announces-positive-results-phase-123000513.html,"[Business Wire] - Celgene Corporation today announced that its phase III SUNBEAM trial, evaluating the efficacy and safety of ozanimod, an investigational oral, selective S1P 1 and 5 receptor modulator, in patients with relapsing multiple sclerosis , met the primary endpoint in reducing annualized relapse rate , compared to weekly interferon β-1a ."
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Results From Phase III SUNBEAM Trial,2017-02-17 07:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RHI_K6f_Ts8/celgene-announces-results-from-phase-iii-sunbeam-trial-20170217-00341,Celgene Announces Results From Phase III SUNBEAM Trial
CELG,CELG:UW,BBG000BFCMR2,"Rosenblum Silverman Sutton S F Inc  Buys AECOM, American International Group, PayPal Holdings, ...",2017-02-16 19:53:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7HYtZKxr-1s/rosenblum-silverman-sutton-s-f-inc-buys-aecom-american-international-group-paypal-holdings-cm749154,Rosenblum Silverman Sutton S F Inc New Purchases ACM AIG CE ACRS GTT TSRO Added Positions PYPL BAC WBA AMZN CNK UTX TSLA CRM MS JPM Reduced Positions BABA JCP BMY NVDA NKE MBLY GILD FUN CELG HD Sold Out FLTX BETR ZBRA SKX
CELG,CELG:UW,BBG000BFCMR2,3 Biotechs With Tremendously Promising Pipelines,2017-02-16 19:39:43 +0000,http://www.fool.com/investing/2017/02/15/3-biotechs-with-tremendously-promising-pipelines.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotechs With Tremendously Promising Pipelines
CELG,CELG:UW,BBG000BFCMR2,Agios (AGIO) Q4 Loss Narrower than Expected; Revenues Up Y/Y,2017-02-16 13:53:01 +0000,http://finance.yahoo.com/news/agios-agio-q4-loss-narrower-135301369.html,Agios (AGIO) Q4 Loss Narrower than Expected; Revenues Up Y/Y
CELG,CELG:UW,BBG000BFCMR2,Cramer fires back at naysayers: Here's your proof that th...,2017-02-15 23:35:00 +0000,http://finance.yahoo.com/video/cramer-fires-back-naysayers-heres-233500301.html,Cramer fires back at naysayers: Here's your proof that th...
CELG,CELG:UW,BBG000BFCMR2,Proof the rally is real,2017-02-15 22:59:00 +0000,http://finance.yahoo.com/video/proof-rally-real-225900454.html,Proof the rally is real
CELG,CELG:UW,BBG000BFCMR2,3 Biotechs With Tremendously Promising Pipelines,2017-02-15 22:55:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ItTAfMVDYlQ/3-biotechs-with-tremendously-promising-pipelines-cm748613,Research and development is the lifeblood of biotech companies The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher That s been the case for Celgene NASDAQ CELG Ionis Pharmaceuticals NASDAQ IONS and
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Wednesday Option Activity: AET, CELG, DVN",2017-02-15 19:54:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wVg6V7rrZWs/noteworthy-wednesday-option-activity-aet-celg-dvn-cm748478,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Aetna Inc Symbol AET where a total of 18 542 contracts have traded so far representing approximately 1 9 million underlying shares That amounts to about 47 5 of AET s average
CELG,CELG:UW,BBG000BFCMR2,CELGENE CORP /DE/ Financials,2017-02-15 18:04:12 +0000,http://finance.yahoo.com/q/is?s=celg,CELGENE CORP /DE/ Financials
CELG,CELG:UW,BBG000BFCMR2,Want to Get In on Biotech? Check Out These 3 Stocks,2017-02-15 16:57:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mIxlOnhZiXA/want-to-get-in-on-biotech-check-out-these-3-stocks-cm748353,For beginning investors the biotech industry can appear somewhat scary Most biotech stocks aren t profitable meaning they re arguably influenced by emotions and clinical trial data more so than any other industry However biotech stocks can also offer significant
CELG,CELG:UW,BBG000BFCMR2,Celgene Could Have One More Powerful Move Higher,2017-02-15 15:56:00 +0000,https://www.thestreet.com/story/14002646/1/celgene-is-set-to-surge.html?puc=yahoo&cm_ven=YAHOO,Celgene Could Have One More Powerful Move Higher
CELG,CELG:UW,BBG000BFCMR2,Amgen Looking to Broaden Leukemia Drug Blincyto's Label,2017-02-15 14:57:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VbtQs5TluLA/amgen-looking-to-broaden-leukemia-drug-blincytos-label-cm748167,Biotech major Amgen Inc AMGN announced that it has submitted a supplemental biologics license application sBLA to the FDA for its leukemia immunotherapy Blincyto So far this year Amgen s shares are up 14 9 better than a 4 5 increase registered by the Zacks classified Biomed
CELG,CELG:UW,BBG000BFCMR2,Want to Get In on Biotech? Check Out These 3 Stocks,2017-02-15 14:48:10 +0000,http://www.fool.com/investing/2017/02/15/want-to-get-in-on-biotech-check-out-these-3-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Want to Get In on Biotech? Check Out These 3 Stocks
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Presents HIV Data",2017-02-15 14:21:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w_c5VRf-ydo/biotech-stock-roundup-regenerons-praluent-to-remain-on-market-for-now-gild-presents-hiv-data-cm748087,Regeneron REGN got a bit of a boost with the company and its partner being allowed to continue marketing their PCSK9 inhibitor Praluent pending their appeal in a patent infringement lawsuit Meanwhile Gilead GILD which saw its shares being punished for a not so rosy outlook for
CELG,CELG:UW,BBG000BFCMR2,Some of biotech's biggest names have acquired this Md. company,2017-02-14 20:10:20 +0000,http://www.bizjournals.com/washington/news/2017/02/14/roivant-sciences.html?ana=yahoo,Some of biotech's biggest names have acquired this Md. company
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics, Exelixis and Akebia Therapeutics",2017-02-14 16:21:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/08J0bT5Z2kI/the-zacks-analyst-blog-highlights-gilead-sciences-celgene-fate-therapeutics-exelixis-and-akebia-therapeutics-cm747617,For Immediate Release Chicago IL February 14 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,3 Top Biotech Stocks to Buy on Sale,2017-02-14 15:28:02 +0000,http://www.fool.com/investing/2017/02/13/3-top-biotech-stocks-to-buy-on-sale.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Biotech Stocks to Buy on Sale
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics, Exelixis and Akebia Therapeutics",2017-02-14 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-gilead-143002852.html,"The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics, Exelixis and Akebia Therapeutics"
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : February 14, 2017",2017-02-14 13:33:57 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-breached-its-50-day-moving-average-in-a-bullish-manner-celg-us-february-14-2017/,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : February 14, 2017"
CELG,CELG:UW,BBG000BFCMR2,Key Presenters At Leerink's Healthcare Conference,2017-02-13 20:52:10 +0000,http://finance.yahoo.com/news/key-presenters-leerinks-healthcare-conference-205210539.html,Key Presenters At Leerink's Healthcare Conference
CELG,CELG:UW,BBG000BFCMR2,Regeneron: It's All Riding On Dupixent,2017-02-13 19:25:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/13/regeneron-its-all-riding-on-dupixent/?mod=yahoobarrons&ru=yahoo,Regeneron: It's All Riding On Dupixent
CELG,CELG:UW,BBG000BFCMR2,How one stock changed my life,2017-02-13 16:31:03 +0000,http://finance.yahoo.com/news/the-stock-that-changed-my-life-163103969.html,How one stock changed my life
CELG,CELG:UW,BBG000BFCMR2,"Forget Gilead, Buy These 5 Biotech Stocks Instead",2017-02-13 16:22:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aPXypYElVcA/forget-gilead-buy-these-5-biotech-stocks-instead-cm747021,Biotech major Gilead Sciences Inc GILD reported better than expected results for the fourth quarter of 2016 however shares were down 8 6 immediately after the company reported results Overall Gilead s shares are down 9 3 ever since 4Q results were announced Moreover over
CELG,CELG:UW,BBG000BFCMR2,"Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More",2017-02-13 16:22:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pLLVWmpV-n4/drug-stocks-earnings-slated-for-feb-14-incy-prta-more-cm747016,The year 2017 seems to have started on a positive note for investors in the U S Approximately 71 6 of the companies or 358 members in the S amp P 500 Index have reported results so far Per the Earnings Trends an impressive 69 of the companies reported in the index have beaten
CELG,CELG:UW,BBG000BFCMR2,3 Top Biotech Stocks to Buy on Sale,2017-02-13 16:21:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nDMezJnJnyQ/3-top-biotech-stocks-to-buy-on-sale-cm747015,How can you know if a biotech stock is a bargain It s not an exact science but one of the best ways to identify biotech bargains is to evaluate companies growth prospects compared with their current stock price and earnings The price to earnings ratio can point out stocks that
CELG,CELG:UW,BBG000BFCMR2,"Forget Gilead, Buy These 5 Biotech Stocks Instead",2017-02-13 14:14:02 +0000,http://finance.yahoo.com/news/forget-gilead-buy-5-biotech-141402577.html,"Forget Gilead, Buy These 5 Biotech Stocks Instead"
CELG,CELG:UW,BBG000BFCMR2,"Capital Guardian Asset Management, LLC Buys CSX, Ingersoll-Rand PLC, BorgWarner, Sells Under ...",2017-02-11 14:17:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6rHqoW4uSNU/capital-guardian-asset-management-llc-buys-csx-ingersoll-rand-plc-borgwarner-sells-under-cm746674,Capital Guardian Asset Management LLC New Purchases IR BWA GM QCOM TIF RL CHK INFO UAA APO Added Positions CSX JBHT DOW APA DD MU WDC AAPL AGN MSFT Reduced Positions MMM LMT UNP LVS AMGN LGND TJX AOS EXPD PFE Sold Out UA
CELG,CELG:UW,BBG000BFCMR2,"Edgewood Management Llc Buys Allergan PLC, Illumina, Cognizant Technology Solutions, Sells ...",2017-02-11 12:17:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nvERH-4HWrM/edgewood-management-llc-buys-allergan-plc-illumina-cognizant-technology-solutions-sells-cm746653,Edgewood Management Llc New Purchases AGN MAR CB IVW IWF MUB TRIP VUG Added Positions ILMN CTSH NFLX V FB CME EQIX SPY NVDA NKE Reduced Positions GILD GOOG GOOGL AMT INFO DVY MMM CRM PG REGN Sold Out ADBE BMRN BABA SPLK
CELG,CELG:UW,BBG000BFCMR2,Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017,2017-02-10 23:18:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i0Wb7IAm9cw/heres-why-ma-has-tesaros-stock-soaring-40-in-2017-cm746593,Hope that a big drugmaker will bid to buy Tesaro NASDAQ TSRO has sent this company s shares skyrocketing 40 this year That s impressive but there could be room to run higher Why Because Tesaro could be about to land its second FDA approval and this next approval could be
CELG,CELG:UW,BBG000BFCMR2,Is Biogen a Risky Stock?,2017-02-10 21:14:18 +0000,http://www.fool.com/investing/2017/02/10/is-biogen-a-risky-stock.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Biogen a Risky Stock?
CELG,CELG:UW,BBG000BFCMR2,3 Stocks We'd Buy and Hold for the Next 20 Years,2017-02-10 19:49:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xvz2-WP8iLw/3-stocks-wed-buy-and-hold-for-the-next-20-years-cm746406,Stocks that can stand the test of time and produce market beating returns along the way don t exactly fall out of the sky Our contributors though think that the biotech Celgene NASDAQ CELG the healthcare giant Johnson amp Johnson NYSE JNJ and the medical device
CELG,CELG:UW,BBG000BFCMR2,"Birchview Capital, LP Buys Veracyte, Vanda Pharmaceuticals, Aevi Genomic Medicine, Sells Kura ...",2017-02-10 18:17:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mpw_M0BYqT0/birchview-capital-lp-buys-veracyte-vanda-pharmaceuticals-aevi-genomic-medicine-sells-kura-cm746436,Birchview Capital LP New Purchases VNDA GNMX Added Positions VCYT CELGZ OPK Sold Out KURA ICPT New Purchases VNDA GNMX New Purchases VNDA GNMX Added Positions VCYT CELGZ OPK Added Positions
CELG,CELG:UW,BBG000BFCMR2,3 Stocks We'd Buy and Hold for the Next 20 Years,2017-02-10 17:01:12 +0000,http://www.fool.com/investing/2017/02/10/3-stocks-wed-buy-and-hold-for-the-next-20-years.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks We'd Buy and Hold for the Next 20 Years
CELG,CELG:UW,BBG000BFCMR2,Is Biogen a Risky Stock?,2017-02-10 16:20:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DnPiXoHJ-BU/is-biogen-a-risky-stock-cm746269,Following the spinoff of two of its fastest growing drugs Biogen Inc NASDAQ BIIB is more focused on neurological disease than it s been in years However the company could face a stiff new challenger in multiple sclerosis soon and the best drug in its research pipeline is
CELG,CELG:UW,BBG000BFCMR2,Biotech ETFs Powered by Q4 Earnings,2017-02-10 15:22:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OJuFssEKJO8/biotech-etfs-powered-by-q4-earnings-cm746320,The biotech industry which was shunned by investors last year made a strong comeback following Trump s victory in anticipation of softer regulation Though Trump spooked the industry by saying that drugmakers are getting away with murder and pledging to initiate a bidding process for
CELG,CELG:UW,BBG000BFCMR2,Major Biotechs Scare Off Loads of Short Sellers,2017-02-10 14:55:35 +0000,http://finance.yahoo.com/news/major-biotechs-scare-off-loads-145535906.html,Major Biotechs Scare Off Loads of Short Sellers
CELG,CELG:UW,BBG000BFCMR2,Biotech ETFs Powered by Q4 Earnings,2017-02-10 13:38:01 +0000,http://finance.yahoo.com/news/biotech-etfs-powered-q4-earnings-133801922.html,Biotech ETFs Powered by Q4 Earnings
CELG,CELG:UW,BBG000BFCMR2,"CELGENE CORP /DE/ Files SEC form 10-K, Annual Report",2017-02-10 11:03:13 +0000,http://biz.yahoo.com/e/170210/celg10-k.html,"CELGENE CORP /DE/ Files SEC form 10-K, Annual Report"
CELG,CELG:UW,BBG000BFCMR2,Why bluebird bio Stock Surged 20.7% Higher in January,2017-02-09 22:19:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PDhmsSYca-s/why-bluebird-bio-stock-surged-207-higher-in-january-cm745858,What happened After updating investors on its wide ranging gene therapy research program at a key industry conference early in the month 160 shares of bluebird bio NASDAQ BLUE surged 20 7 higher in January 160 according to S amp P Global Market Intelligence So
CELG,CELG:UW,BBG000BFCMR2,Why bluebird bio Stock Surged 20.7% Higher in January,2017-02-09 20:21:05 +0000,http://www.fool.com/investing/2017/02/09/why-bluebird-bio-stock-surged-207-higher-in-januar.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why bluebird bio Stock Surged 20.7% Higher in January
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Celgene, Cellectis S.A., Exelixis, Exact Sciences and Sunesis Pharmaceuticals",2017-02-08 16:23:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZiWCvzzfUmo/the-zacks-analyst-blog-highlights-celgene-cellectis-sa-exelixis-exact-sciences-and-sunesis-pharmaceuticals-cm744838,For Immediate Release Chicago IL February 08 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Celgene, Exelixis, Ligand Pharmaceuticals and RedHill Biopharma",2017-02-08 16:23:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F_jkw37SB0Q/the-zacks-analyst-blog-highlights-celgene-exelixis-ligand-pharmaceuticals-and-redhill-biopharma-cm744841,For Immediate Release Chicago IL February 08 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Celgene, Cellectis S.A., Exelixis, Exact Sciences and Sunesis Pharmaceuticals",2017-02-08 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-celgene-143002432.html,"The Zacks Analyst Blog Highlights: Celgene, Cellectis S.A., Exelixis, Exact Sciences and Sunesis Pharmaceuticals"
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Celgene, Exelixis, Ligand Pharmaceuticals and RedHill Biopharma",2017-02-08 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-celgene-143002999.html,"The Zacks Analyst Blog Highlights: Celgene, Exelixis, Ligand Pharmaceuticals and RedHill Biopharma"
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Amgen Inc. vs. Celgene,2017-02-08 14:19:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qt9q31NLZqQ/better-buy-amgen-inc-vs-celgene-cm744678,Amgen NASDAQ AMGN and Celgene NASDAQ CELG are without question two of the most successful biotechs in the world So far in 2017 Amgen has enjoyed greater success Shares of the big biotech jumped after the company announced great results for cholesterol drug Repatha in
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Amgen Inc. vs. Celgene,2017-02-08 13:23:58 +0000,http://www.fool.com/investing/2017/02/08/better-buy-amgen-inc-vs-celgene.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Amgen Inc. vs. Celgene
CELG,CELG:UW,BBG000BFCMR2,5 Great Biotech Stocks to Buy Now,2017-02-07 20:26:08 +0000,http://finance.yahoo.com/news/5-great-biotech-stocks-buy-202608361.html,5 Great Biotech Stocks to Buy Now
CELG,CELG:UW,BBG000BFCMR2,"IVV, HON, CELG, UNP: ETF Outflow Alert",2017-02-07 17:17:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/neJQqrL2se8/ivv-hon-celg-unp-etf-outflow-alert-cm744245,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core S amp P 500 ETF Symbol IVV where we have detected an approximate 161 2 million dollar outflow that s a 0 2 decrease week over week
CELG,CELG:UW,BBG000BFCMR2,"Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More",2017-02-07 16:23:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pPEt0dlJZec/drug-stock-q4-earnings-to-watch-on-feb-8-agn-gsk-more-cm744195,We are in the thick of the Q4 reporting cycle with quarterly numbers of several companies already on board Growth is likely to be the highest in two years Total earnings may even set a new quarterly record Approximately 275 S amp P 500 members representing 55 of the index s total
CELG,CELG:UW,BBG000BFCMR2,"Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More",2017-02-07 14:06:02 +0000,http://finance.yahoo.com/news/drug-stock-q4-earnings-watch-140602999.html,"Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More"
CELG,CELG:UW,BBG000BFCMR2,4 Drug Stocks that are Broker Favorites,2017-02-07 12:41:12 +0000,http://finance.yahoo.com/news/4-drug-stocks-broker-favorites-124112242.html,4 Drug Stocks that are Broker Favorites
CELG,CELG:UW,BBG000BFCMR2,"Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More",2017-02-06 13:45:01 +0000,http://finance.yahoo.com/news/drug-stocks-reporting-earnings-feb-134501581.html,"Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More"
CELG,CELG:UW,BBG000BFCMR2,3 Stocks That Could Make You Rich,2017-02-06 12:45:25 +0000,http://www.fool.com/investing/2017/02/05/3-stocks-that-could-make-you-rich.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks That Could Make You Rich
CELG,CELG:UW,BBG000BFCMR2,3 Stocks That Could Make You Rich,2017-02-05 14:17:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qs_8l5Rugkc/3-stocks-that-could-make-you-rich-cm743341,Trying to get rich quick is a fantastic way to lose money but there are a few great healthcare stocks that could help you accumulate wealth over the long run For risk averse investors looking for fast growing dividend income CVS Health NYSE CVS is poised to boost
CELG,CELG:UW,BBG000BFCMR2,Celgene Subsidiary Invests in Jounce Therapeutics,2017-02-03 17:30:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rZh2H79wdqw/celgene-subsidiary-invests-in-jounce-therapeutics-cm743000,Celgene Switzerland SA a subsidiary of Celgene Corp CELG and 10 owner of Jounce Therapeutics Inc JNCE purchased 625 000 shares ofthe company on Feb 2 according a filing with the SEC Celgene Switzerland SA a subsidiary ofCelgene Corp Celgene Corp CELG and 10
CELG,CELG:UW,BBG000BFCMR2,"ETFs with exposure to Celgene Corp. : February 3, 2017",2017-02-03 15:32:24 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-celgene-corp-february-3-2017/,"ETFs with exposure to Celgene Corp. : February 3, 2017"
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Webcast at Upcoming Investor Conference,2017-02-03 12:30:00 +0000,http://finance.yahoo.com/news/celgene-corporation-webcast-upcoming-investor-123000212.html,[Business Wire] - Celgene Corporation plans to present at an upcoming investor conference where Celgene management will provide an overview of the Company. The conference will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com.
CELG,CELG:UW,BBG000BFCMR2,Biogen: What Now?,2017-02-02 22:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/02/biogen-what-now/?mod=yahoobarrons&ru=yahoo,Biogen: What Now?
CELG,CELG:UW,BBG000BFCMR2,Celgene Subsidiary Invests in Jounce Therapeutics,2017-02-02 21:23:34 +0000,http://finance.yahoo.com/news/celgene-subsidiary-invests-jounce-therapeutics-212334377.html,Celgene Subsidiary Invests in Jounce Therapeutics
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines",2017-02-02 16:37:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ufuJh1kzAuU/the-zacks-analyst-blog-highlights-johnson-johnson-paypal-thermo-fisher-celgene-and-american-airlines-cm742242,For Immediate Release Chicago IL February 02 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,What Could Make Biogen Crash?,2017-02-02 14:35:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qua6mrkFBeQ/what-could-make-biogen-crash-cm742007,Although Biogen Inc NASDAQ BIIB is one of the globe s biggest biotechs and it has the balance sheet to prove it it could face a big threat soon from an unexpected competitor Celgene Corp NASDAQ CELG Celgene is best known for its cancer drugs but it s in the
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines",2017-02-02 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-johnson-143002154.html,"The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines"
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data",2017-02-02 13:34:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iTZggseE-VE/biotech-stock-roundup-celgene-biogen-abbv-post-q4-results-catabasis-falls-on-dmd-data-cm741986,Major biotech stocks like Celgene CELG Biogen BIIB and AbbVie ABBV reported fourth quarter results last week Meanwhile Catabasis CATB shares plunged on data from an ongoing study on its lead pipeline candidate Recap of the Week s Most Important Stories A Look at
CELG,CELG:UW,BBG000BFCMR2,What Could Make Biogen Crash?,2017-02-02 13:02:11 +0000,http://www.fool.com/investing/2017/02/02/what-could-make-biogen-crash.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Could Make Biogen Crash?
CELG,CELG:UW,BBG000BFCMR2,Understanding Celgene’s Operational Performance Projections for 2017,2017-02-02 12:35:48 +0000,http://marketrealist.com/2017/01/celgene-projects-solid-operational-performance-2017/?utm_source=yahoo&utm_medium=feed,Understanding Celgene’s Operational Performance Projections for 2017
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : February 2, 2017",2017-02-02 12:27:59 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-breached-its-50-day-moving-average-in-a-bullish-manner-celg-us-february-2-2017/,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : February 2, 2017"
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data",2017-02-02 11:27:11 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-celgene-biogen-112711812.html,"Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data"
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for February 1, 2017",2017-02-01 22:30:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OjkJ3RxlO6w/top-research-reports-for-february-1-2017-cm741884,Wednesday February 1 2017 Today s Research Daily features new research reports on 12 major stocks including Johnson amp Johnson JNJ PayPal PYPL and Thermo Fisher TMO Johnson amp Johnson have gained 8 5 over the last year widely outperforming the large cap pharma space
CELG,CELG:UW,BBG000BFCMR2,Roche CEO Shrugs Off Trump's Drug Stance; 2016 Sales Narrowly Miss,2017-02-01 21:12:31 +0000,http://www.investors.com/news/technology/roche-ceo-shrugs-off-trumps-drug-stance-2016-sales-narrowly-miss/,Roche CEO Shrugs Off Trump's Drug Stance; 2016 Sales Narrowly Miss
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for February 1, 2017",2017-02-01 20:17:08 +0000,http://finance.yahoo.com/news/top-research-reports-february-1-201708645.html,"Top Research Reports for February 1, 2017"
CELG,CELG:UW,BBG000BFCMR2,"Garrison Bradford & Associates Inc Buys Welltower, Everest Re Group, Himax Technologies, ...",2017-02-01 18:30:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2lm23wSXmOg/garrison-bradford-associates-inc-buys-welltower-everest-re-group-himax-technologies-cm741720,Garrison Bradford Associates Inc New Purchases RE HIMX Added Positions HCN UNH ACAD BX AL Reduced Positions NVDQ EPD BASFY NVGS PGF FSP SAVE IPGP JBLU OHRP Sold Out WNR New Purchases RE HIMX New Purchases RE
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals",2017-02-01 16:35:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WJiBKnPfQLo/the-zacks-analyst-blog-highlights-synergy-pharmaceuticals-amgen-valeant-pharmaceuticals-international-celgene-and-lexicon-pharmaceuticals-cm741587,For Immediate Release Chicago IL February 01 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Big Plans for Otezla in 2017,2017-02-01 15:36:01 +0000,http://marketrealist.com/2017/01/celgene-aims-expand-addressable-market-size-otezla-2017/?utm_source=yahoo&utm_medium=feed,Celgene’s Big Plans for Otezla in 2017
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals",2017-02-01 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-synergy-143002700.html,"The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals"
CELG,CELG:UW,BBG000BFCMR2,Why Celgene’s Otezla Is Expected to See Strong Demand Trends in 2017,2017-02-01 14:06:27 +0000,http://marketrealist.com/2017/01/otezla-expected-witness-strong-demand-trends-2017/?utm_source=yahoo&utm_medium=feed,Why Celgene’s Otezla Is Expected to See Strong Demand Trends in 2017
CELG,CELG:UW,BBG000BFCMR2,Behind Celgene’s Blockbuster Revenue Hit in 4Q16,2017-02-01 12:36:34 +0000,http://marketrealist.com/2017/01/blockbuster-therapy-otezla-contributed-significantly-celgenes-revenue-growth-4q16/?utm_source=yahoo&utm_medium=feed,Behind Celgene’s Blockbuster Revenue Hit in 4Q16
CELG,CELG:UW,BBG000BFCMR2,Drug Stocks Rally on Trump Meet with Pharma Bigwigs,2017-02-01 12:14:12 +0000,http://finance.yahoo.com/news/drug-stocks-rally-trump-meet-121412868.html,Drug Stocks Rally on Trump Meet with Pharma Bigwigs
CELG,CELG:UW,BBG000BFCMR2,Fmr. Onyx CEO: Responsibility to find and research cures ...,2017-01-31 21:17:00 +0000,http://finance.yahoo.com/video/fmr-onyx-ceo-responsibility-research-211700370.html,Fmr. Onyx CEO: Responsibility to find and research cures ...
CELG,CELG:UW,BBG000BFCMR2,"Trump pushes drugmakers for lower prices, more U.S. production",2017-01-31 20:27:32 +0000,http://sg.finance.yahoo.com/news/trump-meet-novartis-ceo-other-121249594.html,"Trump pushes drugmakers for lower prices, more U.S. production"
CELG,CELG:UW,BBG000BFCMR2,[$$] Pharma stocks rally on Trump pledge to speed drug approvals,2017-01-31 18:38:52 +0000,"http://www.ft.com/cms/s/9bb59bd4-e7d7-11e6-893c-082c54a7f539,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[$$] Pharma stocks rally on Trump pledge to speed drug approvals
CELG,CELG:UW,BBG000BFCMR2,Unusual activity: Bulls bet on Celgene & Potash,2017-01-31 17:34:00 +0000,http://finance.yahoo.com/video/unusual-activity-bulls-bet-celgene-173400024.html,Unusual activity: Bulls bet on Celgene & Potash
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Abraxane Sees Stable Demand in 4Q16,2017-01-31 15:37:02 +0000,http://marketrealist.com/2017/01/abraxane-witnesses-stable-demand-4q16/?utm_source=yahoo&utm_medium=feed,Celgene’s Abraxane Sees Stable Demand in 4Q16
CELG,CELG:UW,BBG000BFCMR2,"Trump, at Biopharma Meeting, Pledges to 'Streamline' FDA, Cut Regulations but Wants Lower Prices",2017-01-31 15:37:00 +0000,https://www.thestreet.com/story/13972858/1/trump-in-biopharma-meeting-pledges-to-streamline-fda-cut-regulations-but-wants-lower-prices.html?puc=yahoo&cm_ven=YAHOO,"Trump, at Biopharma Meeting, Pledges to 'Streamline' FDA, Cut Regulations but Wants Lower Prices"
CELG,CELG:UW,BBG000BFCMR2,4 Top Biotech Stocks With Big Upcoming Catalysts,2017-01-31 15:15:10 +0000,http://finance.yahoo.com/news/4-top-biotech-stocks-big-151510658.html,4 Top Biotech Stocks With Big Upcoming Catalysts
CELG,CELG:UW,BBG000BFCMR2,Inside Celgene’s Pomalyst: A Solid Growth Trend in 4Q16,2017-01-31 14:07:39 +0000,http://marketrealist.com/2017/01/pomalyst-witnessed-solid-growth-trend-4q16/?utm_source=yahoo&utm_medium=feed,Inside Celgene’s Pomalyst: A Solid Growth Trend in 4Q16
CELG,CELG:UW,BBG000BFCMR2,Trump Calls For Increased Competition To Reduce Drug Prices,2017-01-31 13:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yqw5STKRvP0/trump-calls-for-increased-competition-to-reduce-drug-prices-20170131-01172,Trump Calls For Increased Competition To Reduce Drug Prices
CELG,CELG:UW,BBG000BFCMR2,4 FDA Decisions to Watch Out for in Feb 2017,2017-01-31 13:33:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fs_oSg_FQn8/4-fda-decisions-to-watch-out-for-in-feb-2017-cm740607,Last year there was a notable dip in FDA novel drug approvals with the agency giving its nod to 22 treatments well below the 45 approvals in 2015 and 41 in 2014 So far in 2017 only one drug has gained approval Synergy Pharmaceuticals Inc s SGYP Trulance for the treatment of
CELG,CELG:UW,BBG000BFCMR2,Inside Celgene’s Revlimid: Strong Patient Demand in 4Q16,2017-01-31 12:38:06 +0000,http://marketrealist.com/2017/01/revlimid-continued-witness-strong-patient-demand-4q16/?utm_source=yahoo&utm_medium=feed,Inside Celgene’s Revlimid: Strong Patient Demand in 4Q16
CELG,CELG:UW,BBG000BFCMR2,7 Top Stocks to Buy in February,2017-01-31 12:30:08 +0000,http://www.fool.com/investing/2017/01/31/7-top-stocks-to-buy-in-february.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,7 Top Stocks to Buy in February
CELG,CELG:UW,BBG000BFCMR2,4 FDA Decisions to Watch Out for in Feb 2017,2017-01-31 11:43:11 +0000,http://finance.yahoo.com/news/4-fda-decisions-watch-feb-114311066.html,4 FDA Decisions to Watch Out for in Feb 2017
CELG,CELG:UW,BBG000BFCMR2,Understanding Celgene’s Robust Profit Margin Rise in 4Q16,2017-01-30 21:05:48 +0000,http://marketrealist.com/2017/01/celgene-witnessed-robust-rise-profit-margins-4q16/?utm_source=yahoo&utm_medium=feed,Understanding Celgene’s Robust Profit Margin Rise in 4Q16
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Financial Performance in 2016: Strong Growth in Volumes,2017-01-30 19:36:03 +0000,http://marketrealist.com/2017/01/strong-growth-volumes-driven-celgenes-financial-performance-2016/?utm_source=yahoo&utm_medium=feed,Celgene’s Financial Performance in 2016: Strong Growth in Volumes
CELG,CELG:UW,BBG000BFCMR2,Celgene Reported Robust Revenue Growth in 4Q16,2017-01-30 17:54:01 +0000,http://marketrealist.com/2017/01/celgene-reported-robust-revenue-growth-4q16/?utm_source=yahoo&utm_medium=feed,Celgene Reported Robust Revenue Growth in 4Q16
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Gets Favorable CHMP Opinion for Revlimid,2017-01-30 17:33:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0hjSmlomAag/celgene-celg-gets-favorable-chmp-opinion-for-revlimid-cm740237,Celgene Corporation CELG announced that the European Medicines Agency s EMA Committee for Medicinal Products for Human Use CHMP has rendered a positive opinion for oncology drug Revlimid as monotherapy for the maintenance treatment of adult patients with newly diagnosed multiple myeloma
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Gets Favorable CHMP Opinion for Revlimid,2017-01-30 15:20:03 +0000,http://finance.yahoo.com/news/celgene-celg-gets-favorable-chmp-152003352.html,Celgene (CELG) Gets Favorable CHMP Opinion for Revlimid
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. :CELG-US: Earnings Analysis: 2016 By the Numbers : January 30, 2017",2017-01-30 14:40:05 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-celg-us-earnings-analysis-2016-by-the-numbers-january-30-2017/,"Celgene Corp. :CELG-US: Earnings Analysis: 2016 By the Numbers : January 30, 2017"
CELG,CELG:UW,BBG000BFCMR2,3 Top Pharmaceutical Stocks to Buy in February,2017-01-30 14:34:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qA2js-qHwrs/3-top-pharmaceutical-stocks-to-buy-in-february-cm740000,Any time is a good time to buy the stock of a well run company with great prospects An even better time to buy that kind of stock though is when there s a potential upcoming catalyst Three top pharmaceutical stocks check off all these boxes Celgene NASDAQ CELG
CELG,CELG:UW,BBG000BFCMR2,Drug Stocks Reporting Q4 Earnings on Jan 31: LLY and PFE,2017-01-30 13:33:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8OwP6JmTR8U/drug-stocks-reporting-q4-earnings-on-jan-31-lly-and-pfe-cm739957,As the Q4 earnings season picks up pace we believe this quarter is witnessing the highest growth momentum in the last eight quarters As of Jan 27 2017 170 S amp P 500 members accounting for 33 9 of the index s total market capitalization have reported results according to the
CELG,CELG:UW,BBG000BFCMR2,3 Top Pharmaceutical Stocks to Buy in February,2017-01-30 13:22:06 +0000,http://www.fool.com/investing/2017/01/30/3-top-pharmaceutical-stocks-to-buy-in-february.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Pharmaceutical Stocks to Buy in February
CELG,CELG:UW,BBG000BFCMR2,How Big Is the Opportunity for Celgene's Otezla Overseas?,2017-01-28 18:31:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tl9qLYQsVGI/how-big-is-the-opportunity-for-celgenes-otezla-overseas-cm739813,Celgene Corp NASDAQ CELG hit a biotech home run with Otezla a fast growing drug that s used to treat psoriatic arthritis and psoriasis Since winning approval for use in psoriasis in September 2014 Otezla has steadily been chipping away at U S market share in the
CELG,CELG:UW,BBG000BFCMR2,How Big Is the Opportunity for Celgene's Otezla Overseas?,2017-01-28 17:01:09 +0000,http://www.fool.com/investing/2017/01/28/how-big-is-the-opportunity-for-celgenes-otezla-ove.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,How Big Is the Opportunity for Celgene's Otezla Overseas?
CELG,CELG:UW,BBG000BFCMR2,"Premier Asset Managment LLC Buys Time Warner Inc, Boeing Co, Lowe's Companies Inc, Sells Lennar ...",2017-01-28 15:30:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PgPXNTxCeaw/premier-asset-managment-llc-buys-time-warner-inc-boeing-co-lowes-companies-inc-sells-lennar-cm739783,Premier Asset Managment LLC New Purchases TWX BA CBOE UL TEVA EAT DUK BMO KO GPS Added Positions LOW CAA CSCO NXPI BCE BRK B WBA MRK QQQ TOT Reduced Positions MBLY ISRG PCLN GILD FB AAPL CAVM CELG ICE UAL Sold Out LEN
CELG,CELG:UW,BBG000BFCMR2,3 Most Unbelievably Undervalued Biotech Stocks,2017-01-28 13:28:39 +0000,http://www.fool.com/investing/2017/01/27/3-most-unbelievably-undervalued-biotech-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Most Unbelievably Undervalued Biotech Stocks
CELG,CELG:UW,BBG000BFCMR2,"Notable Friday Option Activity: MXIM, CELG, AIG",2017-01-27 21:32:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/diN8Lp9nHvc/notable-friday-option-activity-mxim-celg-aig-cm739602,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Maxim Integrated Products Inc Symbol MXIM where a total of 9 377 contracts have traded so far representing approximately 937 700 underlying shares That amounts to about 42
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Continues Its Double-Digit Growth,2017-01-27 19:31:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f8QTrOOVy8E/celgene-corporation-continues-its-double-digit-growth-cm739524,Celgene s NASDAQ CELG earnings release on Thursday didn t come with many surprises since the company announced preliminary fourth quarter results earlier this month as it usually does at the annual J P Morgan Healthcare Conference Unlike some companies that only release
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation (CELG) To Acquire Autoimmune Firm Delinia For $775 Million,2017-01-27 18:44:31 +0000,http://www.insidermonkey.com/blog/celgene-corporation-celg-to-acquire-autoimmune-firm-delinia-for-775-million-526971/,Celgene Corporation (CELG) To Acquire Autoimmune Firm Delinia For $775 Million
CELG,CELG:UW,BBG000BFCMR2,"Morgan Dempsey Capital Management Llc Buys Target Corp, Cisco Systems Inc, Reynolds American ...",2017-01-27 18:30:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QqLSbB09bNU/morgan-dempsey-capital-management-llc-buys-target-corp-cisco-systems-inc-reynolds-american-cm739525,Morgan Dempsey Capital Management Llc Added Positions BMY DUK LLY NEE VZ Reduced Positions PRLB CTSH AAPL VIPS BIDU ILMN ISRG CELG GOOGL GILD Added Positions BMY DUK LLY NEE VZ Added Positions BMY
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Continues Its Double-Digit Growth,2017-01-27 18:28:19 +0000,http://www.fool.com/investing/2017/01/27/celgene-corporation-continues-its-double-digit-gro.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Celgene Corporation Continues Its Double-Digit Growth
CELG,CELG:UW,BBG000BFCMR2,"IVW, CELG, AVGO, ACN: ETF Outflow Alert",2017-01-27 17:32:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fv3XWa8O0nA/ivw-celg-avgo-acn-etf-outflow-alert-cm739445,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Growth ETF Symbol IVW where we have detected an approximate 113 6 million dollar outflow that s a 0 7 decrease week over week
CELG,CELG:UW,BBG000BFCMR2,3 Most Unbelievably Undervalued Biotech Stocks,2017-01-27 14:34:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5_INDldUJy4/3-most-unbelievably-undervalued-biotech-stocks-cm739169,Finding undervalued biotech stocks isn t as easy as it might seem Many biotechs don t have a product on the market so any attempt at valuation involves a lot of guesswork about pipeline prospects And many biotechs that do have products on the market command high premiums
CELG,CELG:UW,BBG000BFCMR2,Blog Coverage Celgene Acquires Delinia; Set to Expand Inflammation and Immunology Portfolio,2017-01-27 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-celgene-acquires-delinia-131500797.html,"[Accesswire] - Upcoming AWS Coverage on Vertex Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / January 27, 2017 / Active Wall St. blog coverage looks at the headline from Celgene Corp. (NASDAQ: CELG ) ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Receives Positive CHMP Opinion to Expand REVLIMID® (Lenalidomide) Indication as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma (MM) after Autologous Stem Cell Transplantation,2017-01-27 12:17:00 +0000,http://uk.finance.yahoo.com/news/celgene-receives-positive-chmp-opinion-121700355.html,Celgene Receives Positive CHMP Opinion to Expand REVLIMID® (Lenalidomide) Indication as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma (MM) after Autologous Stem Cell Transplantation
CELG,CELG:UW,BBG000BFCMR2,​Cambridge’s Jounce raises hopes as first Mass. biotech of 2017 to go public,2017-01-27 11:15:06 +0000,http://www.bizjournals.com/boston/news/2017/01/27/cambridge-s-jounce-raises-hopes-as-first-mass.html?ana=yahoo,​Cambridge’s Jounce raises hopes as first Mass. biotech of 2017 to go public
CELG,CELG:UW,BBG000BFCMR2,Celgene Gets Positive CHMP Opinion To Expand REVLIMID,2017-01-27 07:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gELiM6XQ6hs/celgene-gets-positive-chmp-opinion-to-expand-revlimid-20170127-00276,Celgene Gets Positive CHMP Opinion To Expand REVLIMID
CELG,CELG:UW,BBG000BFCMR2,Gilead Sciences Expected to Witness Drop in Revenues in 2017,2017-01-27 06:24:02 +0000,http://marketrealist.com/2017/01/gilead-sciences-expected-witness-drop-revenues-2017/?utm_source=yahoo&utm_medium=feed,Gilead Sciences Expected to Witness Drop in Revenues in 2017
CELG,CELG:UW,BBG000BFCMR2,Jounce Therapeutics prices upsized IPO at $16 to advance cancer immunotherapies with Celgene,2017-01-27 05:31:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IavSLNVT9i8/jounce-therapeutics-prices-upsized-ipo-at-16-to-advance-cancer-immunotherapies-with-celgene-cm739108,Jounce Therapeutics an early stage biotech developing T cell immuno oncology therapies with Celgene raised 104 million by offering 6 5 million shares at 16 above the range of 13 to 15 Jounce Therapeutics plans to list on the Nasdaq under the symbol JNCE J P Morgan and Cowen amp
CELG,CELG:UW,BBG000BFCMR2,Edited Transcript of CELG earnings conference call or presentation 26-Jan-17 2:00pm GMT,2017-01-27 01:12:58 +0000,http://finance.yahoo.com/news/edited-transcript-celg-earnings-conference-011258050.html,Edited Transcript of CELG earnings conference call or presentation 26-Jan-17 2:00pm GMT
CELG,CELG:UW,BBG000BFCMR2,Celgene's Fastest-Growing Drugs,2017-01-26 23:33:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d_WyjeOyVxM/celgenes-fastest-growing-drugs-cm739031,Celgene Corp NASDAQ CELG is best known for Revlimid a widely prescribed multiple myeloma therapy that saw sales jump 20 last year to 7 billion That s impressive growth for a drug that s already a megablockbuster but Revlimid isn t the company s fastest growing medicine
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Misses on Earnings & Revenues, Keeps View",2017-01-26 22:32:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m687rmYEWCk/celgene-celg-misses-on-earnings-revenues-keeps-view-cm739034,Celgene Corporation CELG reported fourth quarter 2016 earnings of 1 41 per share including share based compensation expense and tax adjustments missing the Zacks Consensus Estimate of 1 43 but up from 1 02 per share in the year ago quarter Celgene s share price movement shows that
CELG,CELG:UW,BBG000BFCMR2,[$$] Celgene To Acquire Biotech Startup Delinia For Up to $775 Million,2017-01-26 22:15:41 +0000,http://www.wsj.com/articles/celgene-to-pay-up-to-775-million-to-buy-biotech-startup-delinia-1485439414?mod=yahoo_hs,[$$] Celgene To Acquire Biotech Startup Delinia For Up to $775 Million
CELG,CELG:UW,BBG000BFCMR2,Celgene Aims To Hurdle Revlimid Patent Loss By Growing EPS Annually,2017-01-26 22:06:52 +0000,http://www.investors.com/news/technology/celgene-aims-to-hurdle-revlimid-patent-loss-by-growing-eps-annually/,Celgene Aims To Hurdle Revlimid Patent Loss By Growing EPS Annually
CELG,CELG:UW,BBG000BFCMR2,Celgene's Fastest-Growing Drugs,2017-01-26 21:41:05 +0000,http://www.fool.com/investing/2017/01/26/celgenes-fastest-growing-drugs.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Celgene's Fastest-Growing Drugs
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Misses on Earnings & Revenues, Keeps View",2017-01-26 20:29:08 +0000,http://finance.yahoo.com/news/celgene-celg-misses-earnings-revenues-202908028.html,"Celgene (CELG) Misses on Earnings & Revenues, Keeps View"
CELG,CELG:UW,BBG000BFCMR2,Biotech ETFs: Is It Time To Buy?,2017-01-26 18:21:00 +0000,http://blogs.barrons.com/focusonfunds/2017/01/26/biotech-etfs-is-it-time-to-buy/?mod=yahoobarrons&ru=yahoo,Biotech ETFs: Is It Time To Buy?
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Misses On Q4 Earnings & Revenues,2017-01-26 17:32:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KPDZdDxuRpI/celgene-celg-misses-on-q4-earnings-revenues-cm738755,Summit NJ based Celgene Corporation CELG is a biopharmaceutical company focused on the discovery development and commercialization of drugs targeting cancer and inflammatory diseases Celgene s key growth driver is Revlimid The company s portfolio also includes Pomalyst Imnovid
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Celgene and Bristol-Myers Squibb",2017-01-26 16:35:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rvepgBebphE/the-zacks-analyst-blog-highlights-johnson-johnson-biogen-celgene-and-bristol-myers-squibb-cm738687,For Immediate Release Chicago IL January 26 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,Why Celgene is Tumbling,2017-01-26 16:01:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/26/why-celgene-is-tumbling/?mod=yahoobarrons&ru=yahoo,Why Celgene is Tumbling
CELG,CELG:UW,BBG000BFCMR2,"Celgene's 2% share decline may be due to disappointing 2020 guidance, analyst says",2017-01-26 15:38:13 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=4937EED7-E116-442A-9063-F417DAA347B4&siteid=yhoof2,"Celgene's 2% share decline may be due to disappointing 2020 guidance, analyst says"
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Back Off Major Biotechs,2017-01-26 15:35:57 +0000,http://finance.yahoo.com/news/short-sellers-back-off-major-153557632.html,Short Sellers Back Off Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Misses On Q4 Earnings & Revenues,2017-01-26 15:32:03 +0000,http://finance.yahoo.com/news/celgene-celg-misses-q4-earnings-153203331.html,Celgene (CELG) Misses On Q4 Earnings & Revenues
CELG,CELG:UW,BBG000BFCMR2,"Magee Thomson Investment Partners Llc Buys Charles Schwab Corp, Zions Bancorp, Flex Ltd, Sells ...",2017-01-26 15:30:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HCHI1ydO12A/magee-thomson-investment-partners-llc-buys-charles-schwab-corp-zions-bancorp-flex-ltd-sells-cm738659,Magee Thomson Investment Partners Llc Charles Schwab New Purchases SCHW ZION FLEX FANG ANET FLXN EMES REI QTNA NPTN Added Positions GKOS VMC MSFT AMOT USCR TRVN TIS SUPN SQNS RDHL Reduced Positions AYI AMZN NOW FB MTSI MBLY
CELG,CELG:UW,BBG000BFCMR2,Celgene Shares Sink Despite 36% Earnings Growth,2017-01-26 15:26:00 +0000,https://www.thestreet.com/story/13967995/1/celgene-q1-earnings-and-2017-guidance-land-in-line-with-consensus.html?puc=yahoo&cm_ven=YAHOO,Celgene Shares Sink Despite 36% Earnings Growth
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Celgene and Bristol-Myers Squibb",2017-01-26 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-johnson-143002915.html,"The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Celgene and Bristol-Myers Squibb"
CELG,CELG:UW,BBG000BFCMR2,"3 Top Biotech Stocks You Can Still Buy With the Dow at 20,000",2017-01-26 13:33:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xNt5nIWD3i0/3-top-biotech-stocks-you-can-still-buy-with-the-dow-at-20000-cm738478,The Dow Jones Industrial Index is crossing over the 20 000 mark and while that s only a number it may have you wondering if there are any stocks that you can still buy No one knows where the stock market will go in the short term but long term investors might want to buy 160
CELG,CELG:UW,BBG000BFCMR2,[$$] Celgene Revenue Rises on Revlimid Strength,2017-01-26 13:12:58 +0000,http://www.wsj.com/articles/celgene-revenue-rises-on-revlimid-strength-1485436376?mod=yahoo_hs,[$$] Celgene Revenue Rises on Revlimid Strength
CELG,CELG:UW,BBG000BFCMR2,Celgene beats 4Q profit forecasts,2017-01-26 12:50:12 +0000,http://sg.finance.yahoo.com/news/celgene-beats-4q-profit-forecasts-125012635.html,Celgene beats 4Q profit forecasts
CELG,CELG:UW,BBG000BFCMR2,"CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit",2017-01-26 12:37:35 +0000,http://biz.yahoo.com/e/170126/celg8-k.html,"CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit"
CELG,CELG:UW,BBG000BFCMR2,Celgene Reports Fourth Quarter and Full-Year 2016 Operating and Financial Results,2017-01-26 12:30:00 +0000,http://finance.yahoo.com/news/celgene-reports-fourth-quarter-full-123000550.html,"[Business Wire] - Celgene Corporation reported operating results for the fourth quarter and full-year of 2016. For the fourth quarter of 2016, net product sales were $2,977 million, an increase of 17 percent, year-over-year."
CELG,CELG:UW,BBG000BFCMR2,Q4 2016 Celgene Corp Earnings Release - Before Market Open,2017-01-26 12:07:07 +0000,http://biz.yahoo.com/research/earncal/20170126.html?t=celg,Q4 2016 Celgene Corp Earnings Release - Before Market Open
CELG,CELG:UW,BBG000BFCMR2,Delinia Delivers An Exciting Autoimmune Therapy To Celgene,2017-01-26 12:04:00 +0000,http://www.forbes.com/sites/brucebooth/2017/01/26/delinia-delivers-an-exciting-autoimmune-therapy-to-celgene/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Delinia Delivers An Exciting Autoimmune Therapy To Celgene
CELG,CELG:UW,BBG000BFCMR2,"3 Top Biotech Stocks You Can Still Buy With the Dow at 20,000",2017-01-26 12:01:06 +0000,http://www.fool.com/investing/2017/01/26/3-top-biotech-stocks-you-can-still-buy-with-the-do.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"3 Top Biotech Stocks You Can Still Buy With the Dow at 20,000"
CELG,CELG:UW,BBG000BFCMR2,"Celgene to Acquire Delinia, Inc.",2017-01-26 12:00:00 +0000,http://finance.yahoo.com/news/celgene-acquire-delinia-inc-120000484.html,"[Business Wire] - Celgene Corporation and Delinia, Inc. , a privately held biotechnology company developing novel therapeutics for autoimmune diseases, today announced that they have entered into an agreement for the acquisition of Delinia by Celgene."
CELG,CELG:UW,BBG000BFCMR2,"Earnings Reaction History: Celgene Corporation, 54.5% Follow-Through Indicator, 2.4% Sensitive",2017-01-26 11:31:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GZcrOD4sqXc/earnings-reaction-history-celgene-corporation-545-follow-through-indicator-24-sensitive-cm738447,Expected Earnings Release 01 26 2017 PremarketExpected Earnings Release 01 26 2017 Premarket Avg Extended Hours Dollar Volume 8 902 085Avg Extended Hours Dollar Volume 8 902 085 Celgene Corporation CELG is due to issue its quarterly earnings report in the upcoming extended
CELG,CELG:UW,BBG000BFCMR2,Celgene Q4 16 Earnings Conference Call At 9:00 AM ET,2017-01-26 08:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sY4TcxxMHoA/celgene-q4-16-earnings-conference-call-at-900-am-et-20170126-00596,Celgene Q4 16 Earnings Conference Call At 9:00 AM ET
CELG,CELG:UW,BBG000BFCMR2,Celgene Issues Guidance; Announces Acquisition Of Delinia - Quick Facts,2017-01-26 07:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IR2WTbgTRGM/celgene-issues-guidance-announces-acquisition-of-delinia--quick-facts-20170126-00514,Celgene Issues Guidance; Announces Acquisition Of Delinia - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Announces 34% Increase In Q4 Bottom Line,2017-01-26 07:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NGc9HjnX8Vc/celgene-corporation-announces-34-increase-in-q4-bottom-line-20170126-00490,Celgene Corporation Announces 34% Increase In Q4 Bottom Line
CELG,CELG:UW,BBG000BFCMR2,Biotech Stocks Facing FDA Decision In February,2017-01-26 04:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dqQ5wiKja1s/biotech-stocks-facing-fda-decision-in-february-20170126-00181,Biotech Stocks Facing FDA Decision In February
CELG,CELG:UW,BBG000BFCMR2,3 Top Biotech Stocks to Buy Now,2017-01-25 23:32:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I1ZEnRE-pnE/3-top-biotech-stocks-to-buy-now-cm738370,Don t fret about political uncertainties now is a great time to buy biotech stocks Three big biotechs in particular look to be solid picks Here s why AbbVie NYSE ABBV Celgene NASDAQ CELG and Gilead Sciences NASDAQ GILD are three top biotech stocks you can
CELG,CELG:UW,BBG000BFCMR2,3 Top Biotech Stocks to Buy Now,2017-01-25 22:58:07 +0000,http://www.fool.com/investing/2017/01/25/3-top-biotech-stocks-to-buy-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Biotech Stocks to Buy Now
CELG,CELG:UW,BBG000BFCMR2,"Ford, Alphabet, Microsoft, Starbucks, Biotechs: Investing Action Plan",2017-01-25 21:31:46 +0000,http://www.investors.com/research/investing-action-plan/ford-alphabet-microsoft-starbucks-biotechs-investing-action-plan/,"Ford, Alphabet, Microsoft, Starbucks, Biotechs: Investing Action Plan"
CELG,CELG:UW,BBG000BFCMR2,"Pre-Market Earnings Report for January 26, 2017 :  CMCSA, CELG, BMY, DOW, BIIB, CAT, F, RTN, NOC, PX, AEP, LUV",2017-01-25 21:20:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8eFr0qivFZo/pre-market-earnings-report-for-january-26-2017-cmcsa-celg-bmy-dow-biib-cat-f-rtn-noc-px-aep-luv-cm738325,The following companies are expected to report earnings prior to market open on 01 26 2017 Visit our Earnings Calendar for a full list of expected earnings releases Comcast Corporation CMCSA is reporting for the quarter ending December 31 2016 The cable
CELG,CELG:UW,BBG000BFCMR2,5 Stocks to Watch Before the Market Opens Tomorrow,2017-01-25 20:47:34 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-before-the-market-opens-tomorrow-204745719.html,5 Stocks to Watch Before the Market Opens Tomorrow
CELG,CELG:UW,BBG000BFCMR2,Is This Johnson & Johnson's Next Billion-Dollar Blockbuster?,2017-01-25 20:32:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UZW7511Frfc/is-this-johnson-johnsons-next-billion-dollar-blockbuster-cm738270,Johnson amp Johnson NYSE JNJ reported its fourth quarter financials this week and one of the bright spots in the quarter was ramping demand for Darzalex the company s new multiple myeloma therapy Will Darzalex be the next Johnson amp Johnson drug to eclipse the billion
CELG,CELG:UW,BBG000BFCMR2,Is This Johnson & Johnson's Next Billion-Dollar Blockbuster?,2017-01-25 19:02:05 +0000,http://www.fool.com/investing/2017/01/25/is-this-johnson-johnsons-next-billion-dollar-block.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is This Johnson & Johnson's Next Billion-Dollar Blockbuster?
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation (CELG) Eyes Expansion In 2017,2017-01-25 18:30:24 +0000,http://www.insidermonkey.com/blog/celgene-corporation-celg-eyes-expansion-in-2017-524300/,Celgene Corporation (CELG) Eyes Expansion In 2017
CELG,CELG:UW,BBG000BFCMR2,Bristol-Myers Squibb May Report Strong Revenue Performance for 2017,2017-01-25 16:51:15 +0000,http://marketrealist.com/2017/01/bristol-myers-squibb-may-report-strong-revenue-performance-2017/?utm_source=yahoo&utm_medium=feed,Bristol-Myers Squibb May Report Strong Revenue Performance for 2017
CELG,CELG:UW,BBG000BFCMR2,"Drug Stock Earnings to Watch on Jan 26: BIIB, CELG & BMY",2017-01-25 16:37:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iKm14iqHKm8/drug-stock-earnings-to-watch-on-jan-26-biib-celg-bmy-cm738039,Investors around the world are seeing a ray of hope as the fourth quarter earnings season kicked off on an encouraging note Both earnings and sales growth in Q4 are tracking above other recent periods and on track to reach the highest level in the last eight quarters With Q4
CELG,CELG:UW,BBG000BFCMR2,What to Expect From Major Health Care Stocks Reporting This Week,2017-01-25 16:25:15 +0000,http://finance.yahoo.com/news/expect-major-health-care-stocks-162515341.html,What to Expect From Major Health Care Stocks Reporting This Week
CELG,CELG:UW,BBG000BFCMR2,Celgene to File NDA for Ozanimod as Multiple Sclerosis Therapy,2017-01-25 15:36:06 +0000,http://marketrealist.com/2017/01/celgene-plans-file-new-drug-application-ozanimod-multiple-sclerosis-therapy-2017/?utm_source=yahoo&utm_medium=feed,Celgene to File NDA for Ozanimod as Multiple Sclerosis Therapy
CELG,CELG:UW,BBG000BFCMR2,"Drug Stock Earnings to Watch on Jan 26: BIIB, CELG & BMY",2017-01-25 14:08:02 +0000,http://finance.yahoo.com/news/drug-stock-earnings-watch-jan-140802252.html,"Drug Stock Earnings to Watch on Jan 26: BIIB, CELG & BMY"
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Otezla Expected to Post Strong Revenue in 2017,2017-01-25 14:06:14 +0000,http://marketrealist.com/2017/01/otezla-expected-post-strong-revenue-numbers-2017/?utm_source=yahoo&utm_medium=feed,Celgene’s Otezla Expected to Post Strong Revenue in 2017
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Synergy Drug Gets FDA Nod, AbbVie, GILD HCV Drugs under EU Review",2017-01-25 13:32:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K9TilylyjZM/biotech-stock-roundup-synergy-drug-gets-fda-nod-abbvie-gild-hcv-drugs-under-eu-review-cm737784,There were quite a few updates on the regulatory front this week with Synergy SGYP gaining FDA approval for its constipation drug while both Gilead GILD and AbbVie ABBV got accelerated assessment for their HCV drugs in the EU Recap of the Week s Most Important Stories AbbVie
CELG,CELG:UW,BBG000BFCMR2,Could Celgene Grow beyond 2020 with CC-122?,2017-01-25 12:36:36 +0000,http://marketrealist.com/2017/01/novel-celmod-agent-cc-122-expected-drive-celgenes-growth-beyond-2020/?utm_source=yahoo&utm_medium=feed,Could Celgene Grow beyond 2020 with CC-122?
CELG,CELG:UW,BBG000BFCMR2,Inside Amgen’s Oncology Segment: Multiple Investigational Therapies in 2017,2017-01-24 22:05:45 +0000,http://marketrealist.com/2017/01/amgen-continues-explore-multiple-investigational-therapies-oncology-segment-2017/?utm_source=yahoo&utm_medium=feed,Inside Amgen’s Oncology Segment: Multiple Investigational Therapies in 2017
CELG,CELG:UW,BBG000BFCMR2,Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary,2017-01-24 20:03:30 +0000,http://finance.yahoo.com/news/eaton-vance-worldwide-health-sciences-200156909.html,Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary
CELG,CELG:UW,BBG000BFCMR2,Celgene Is Advancing Research in Myeloid Disease Segment,2017-01-24 15:37:34 +0000,http://marketrealist.com/2017/01/celgene-advancing-research-programs-myeloid-diseases-segment-2017/?utm_source=yahoo&utm_medium=feed,Celgene Is Advancing Research in Myeloid Disease Segment
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks to Buy and Hold Stress-Free,2017-01-24 14:33:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rWCo-eIhwHo/3-biotech-stocks-to-buy-and-hold-stress-free-cm737168,Image source Getty Images Although the industry tracking iShares Nasdaq Biotechnology ETF 160 is littered with volatile stocks that led it 18 8 lower last year it does contain a handful of companies suitable even for nervous investors Investing in the industry can seem like
CELG,CELG:UW,BBG000BFCMR2,Celgene Targets Anemia Opportunity with Luspatercept,2017-01-24 14:06:35 +0000,http://marketrealist.com/2017/01/celgene-targets-anemia-opportunity-investigational-drug-luspatercept/?utm_source=yahoo&utm_medium=feed,Celgene Targets Anemia Opportunity with Luspatercept
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks to Buy and Hold Stress-Free,2017-01-24 13:13:00 +0000,http://www.fool.com/investing/2017/01/24/3-biotech-stocks-to-buy-and-hold-stress-free.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotech Stocks to Buy and Hold Stress-Free
CELG,CELG:UW,BBG000BFCMR2,Celgene to Target Unmet Demand in Myeloid Disease Segment,2017-01-24 12:37:45 +0000,http://marketrealist.com/2017/01/celgene-plans-target-unmet-demand-myeloid-diseases-segment-future-years/?utm_source=yahoo&utm_medium=feed,Celgene to Target Unmet Demand in Myeloid Disease Segment
CELG,CELG:UW,BBG000BFCMR2,Celgene's Hugin: Drug Prices Should Be Fair,2017-01-23 22:16:08 +0000,http://finance.yahoo.com/video/celgenes-hugin-drug-prices-fair-221608052.html,Celgene's Hugin: Drug Prices Should Be Fair
CELG,CELG:UW,BBG000BFCMR2,Celgene Expected to Still Dominate Multiple Myeloma Space,2017-01-23 21:05:43 +0000,http://marketrealist.com/2017/01/celgene-expected-continue-dominate-multiple-myeloma-space-2017/?utm_source=yahoo&utm_medium=feed,Celgene Expected to Still Dominate Multiple Myeloma Space
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Hugin: We Should Charge a Fair Price,2017-01-23 20:12:09 +0000,http://finance.yahoo.com/video/celgene-hugin-charge-fair-price-201209962.html,Celgene’s Hugin: We Should Charge a Fair Price
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Revlimid Expected to Post Strong Revenue in 2017,2017-01-23 19:35:51 +0000,http://marketrealist.com/2017/01/revlimid-expected-post-strong-revenue-numbers-2017/?utm_source=yahoo&utm_medium=feed,Celgene’s Revlimid Expected to Post Strong Revenue in 2017
CELG,CELG:UW,BBG000BFCMR2,Top Biotech Stocks to Buy in 2017,2017-01-23 19:16:31 +0000,http://www.fool.com/investing/2017/01/22/top-biotech-stocks-to-buy-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Top Biotech Stocks to Buy in 2017
CELG,CELG:UW,BBG000BFCMR2,[video]5 Reasons Celgene Should Buy Biogen,2017-01-23 18:30:00 +0000,https://www.thestreet.com/story/13962383/1/5-reasons-celgene-should-buy-biogen.html?puc=yahoo&cm_ven=YAHOO,[video]5 Reasons Celgene Should Buy Biogen
CELG,CELG:UW,BBG000BFCMR2,Celgene Estimates Robust Revenue in 2017,2017-01-23 17:40:38 +0000,http://marketrealist.com/2017/01/celgene-estimates-robust-revenue-performance-2017/?utm_source=yahoo&utm_medium=feed,Celgene Estimates Robust Revenue in 2017
CELG,CELG:UW,BBG000BFCMR2,5 Stupendously Expensive Cancer Drugs,2017-01-23 16:27:28 +0000,http://www.fool.com/investing/2017/01/23/5-stupendously-expensive-cancer-drugs.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Stupendously Expensive Cancer Drugs
CELG,CELG:UW,BBG000BFCMR2,5 Reasons Celgene Should Buy Biogen,2017-01-23 16:18:00 +0000,http://realmoney.thestreet.com/articles/01/23/2017/5-reasons-celgene-should-buy-biogen?puc=yahoo&cm_ven=YAHOO,5 Reasons Celgene Should Buy Biogen
CELG,CELG:UW,BBG000BFCMR2,Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017,2017-01-23 14:55:41 +0000,http://finance.yahoo.com/news/jefferies-cheap-biotech-pharma-stocks-145541778.html,Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017
CELG,CELG:UW,BBG000BFCMR2,Prima Biomed Initiates Randomized Study for Breast Cancer,2017-01-23 14:40:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8dU9xNPpnU4/prima-biomed-initiates-randomized-study-for-breast-cancer-cm736644,Prima Biomed Ltd PBMD announced that it has dosed the first patient in the enlarged randomized phase of the phase IIb study AIPAC Active Immunotherapy PAClitaxel on its most advanced pipeline candidate IMP321 based on the LAG 3 immune control mechanism for the treatment of
CELG,CELG:UW,BBG000BFCMR2,Prima Biomed Initiates Randomized Study for Breast Cancer,2017-01-23 13:28:01 +0000,http://finance.yahoo.com/news/prima-biomed-initiates-randomized-study-132801163.html,Prima Biomed Initiates Randomized Study for Breast Cancer
CELG,CELG:UW,BBG000BFCMR2,Top Biotech Stocks to Buy in 2017,2017-01-23 12:53:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bfUvky1en4o/top-biotech-stocks-to-buy-in-2017-cm736463,The past 18 months haven t been very pleasant for biotech investors The SPDR S amp P Biotech ETF NYSEMKT XBI has fallen nearly 30 from its all time highs set back in the summer of 2015 Many individual biotech stocks have performed far worse One bright side to all of
CELG,CELG:UW,BBG000BFCMR2,"Biotech School: When Cellceutix CEO Rants About 'Criminal' Short, Smart Investors See Red Flags",2017-01-23 11:00:00 +0000,https://www.thestreet.com/story/13960573/1/biotech-school-when-cellceutix-ceo-rants-about-criminal-short-smart-investors-see-red-flags.html?puc=yahoo&cm_ven=YAHOO,"Biotech School: When Cellceutix CEO Rants About 'Criminal' Short, Smart Investors See Red Flags"
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Q4 Earnings: Will the Stock Pull a Surprise?,2017-01-20 15:42:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JzyJ_JWgrrs/celgene-celg-q4-earnings-will-the-stock-pull-a-surprise-cm735907,Celgene Corporation CELG is scheduled to report fourth quarter 2016 results on Jan 26 before the opening bell Last quarter the company reported a positive earnings surprise of 6 11 Notably shares of Celgene have outperformed the Zacks classified Medical Biomedical and Genetics industry
CELG,CELG:UW,BBG000BFCMR2,Celgene Could Skyrocket by 22% With Ease,2017-01-20 14:40:00 +0000,https://www.thestreet.com/story/13960202/1/celgene-could-jump-22.html?puc=yahoo&cm_ven=YAHOO,Celgene Could Skyrocket by 22% With Ease
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Q4 Earnings: Will the Stock Pull a Surprise?,2017-01-20 13:45:01 +0000,http://finance.yahoo.com/news/celgene-celg-q4-earnings-stock-134501406.html,Celgene (CELG) Q4 Earnings: Will the Stock Pull a Surprise?
CELG,CELG:UW,BBG000BFCMR2,Blog Coverage PharmAthene and Altimmune Announced a Merger; Set to Establish Immunotherapeutic Collaboration,2017-01-20 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-pharmathene-altimmune-announced-131500842.html,"[Accesswire] - Upcoming AWS Coverage on Celgene LONDON, UK / ACCESSWIRE / January 20, 2017 / Active Wall St. blog coverage looks at the headline from PharmAthene, Inc. (NYSE: PIP ) and Altimmune, Inc., a privately-held ..."
CELG,CELG:UW,BBG000BFCMR2,"Skylands Capital, LLC Buys Coherent Inc, Arch Coal Inc, GATX Corp, Sells Norfolk Southern Corp, ...",2017-01-20 12:36:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Um-GF4Xr7u8/skylands-capital-llc-buys-coherent-inc-arch-coal-inc-gatx-corp-sells-norfolk-southern-corp-cm735809,Skylands Capital LLC For the details of Power Corp of Canada s stock buys and sells go to http www gurufocus com StockBuy php GuruName Power Corp of Canada For the details of Power Corp of Canada s stock buys and sells go
CELG,CELG:UW,BBG000BFCMR2,"Morgens Waterfall Vintiadis & Co Inc Buys SPDR S&P Regional Banking, UnitedHealth Group ...",2017-01-20 12:36:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ze4LhPv2y-Q/morgens-waterfall-vintiadis-co-inc-buys-spdr-sp-regional-banking-unitedhealth-group-cm735808,Morgens Waterfall Vintiadis Co Inc New Purchases KRE UNH IBM TTWO EA DXJ CZR SMTC TSLA YELP Added Positions CELG CHK Reduced Positions FB V DHR AMAT AMD HAL MGM APC NVDA SLB Sold Out AMZN ATVI INTC TWTR XLNX LVS
CELG,CELG:UW,BBG000BFCMR2,"Notable ETF Outflow Detected - IVW, CELG, ACN, AVGO",2017-01-19 17:50:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hUPT4lKsS9g/notable-etf-outflow-detected-ivw-celg-acn-avgo-cm735510,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Growth ETF Symbol IVW where we have detected an approximate 180 7 million dollar outflow that s a 1 2 decrease week over week
CELG,CELG:UW,BBG000BFCMR2,"Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen",2017-01-18 21:33:27 +0000,http://www.investors.com/news/technology/gilead-2017-outlook-hamstrung-on-hep-c-but-rbc-bullish-on-amgen-biogen/,"Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen"
CELG,CELG:UW,BBG000BFCMR2,"Commit To Buy Celgene Corp. At $55, Earn 3.5% Using Options",2017-01-18 18:38:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9PbYI7lNzhI/commit-to-buy-celgene-corp-at-55-earn-35-using-options-cm734943,Investors considering a purchase of Celgene Corp Symbol CELG shares but cautious about paying the going market price of 114 53 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. – Value Analysis (NASDAQ:CELG) : January 18, 2017",2017-01-18 18:28:19 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-value-analysis-nasdaqcelg-january-18-2017/,"Celgene Corp. – Value Analysis (NASDAQ:CELG) : January 18, 2017"
CELG,CELG:UW,BBG000BFCMR2,4 Top Biotech Mutual Funds for 2017,2017-01-18 17:39:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hLjcNBqzg0c/4-top-biotech-mutual-funds-for-2017-cm734897,Biotechnology shares have welcomed this year in style marking a striking reversal from last year s dismal performance Part of the rebound in biotech can be attributed to the January effect Bargain hunting investors parked money into biotech firms which are trading at a discount to their
CELG,CELG:UW,BBG000BFCMR2,Orphan Drugs Among 2015's Top 10 Best-Selling Medications,2017-01-18 15:40:29 +0000,http://finance.yahoo.com/news/orphan-drugs-among-2015s-top-154029638.html,Orphan Drugs Among 2015's Top 10 Best-Selling Medications
CELG,CELG:UW,BBG000BFCMR2,Analysts Predict 14% Gains Ahead For The Holdings of XLV,2017-01-18 14:38:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UaBYB8XgqUU/analysts-predict-14-gains-ahead-for-the-holdings-of-xlv-cm734608,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
CELG,CELG:UW,BBG000BFCMR2,Health Care Sector Fell amid Donald Trump’s Comments,2017-01-18 13:47:07 +0000,http://marketrealist.com/2017/01/health-care-sector-declined-amid-comments-donald-trump/?utm_source=yahoo&utm_medium=feed,Health Care Sector Fell amid Donald Trump’s Comments
CELG,CELG:UW,BBG000BFCMR2,Is Donald Trump Celgene's Biggest Risk in 2017?,2017-01-18 00:37:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V1jLxQMrEVk/is-donald-trump-celgenes-biggest-risk-in-2017-cm734528,If biotech investors were hoping that the election of Donald Trump as the next president of the United States would mean an end to the risk of drug price controls they might be mistaken During a press conference last week Trump called out drug companies for getting away with
CELG,CELG:UW,BBG000BFCMR2,Is Donald Trump Celgene's Biggest Risk in 2017?,2017-01-17 22:41:05 +0000,http://www.fool.com/investing/2017/01/17/is-donald-trump-celgenes-biggest-risk-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Donald Trump Celgene's Biggest Risk in 2017?
CELG,CELG:UW,BBG000BFCMR2,"Nasdaq 100 Movers: INCY, DLTR",2017-01-17 16:37:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-RfoOdvBjnY/nasdaq-100-movers-incy-dltr-cm734201,In early trading on Tuesday shares of Dollar Tree DLTR topped the list of the day s best performing components of the Nasdaq 100 index trading up 3 6 Year to date Dollar Tree registers a 3 6 gain And the worst performing Nasdaq 100 component thus far on the day is Incyte
CELG,CELG:UW,BBG000BFCMR2,"ETFs with exposure to Celgene Corp. : January 17, 2017",2017-01-17 16:13:32 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-celgene-corp-january-17-2017/,"ETFs with exposure to Celgene Corp. : January 17, 2017"
CELG,CELG:UW,BBG000BFCMR2,Medidata Solutions Clinical Cloud Gets Picked by Celgene,2017-01-17 14:40:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sc-kXbPQxmM/medidata-solutions-clinical-cloud-gets-picked-by-celgene-cm734180,Headquartered in New York Medidata Solutions Inc MDSO recently announced that Celgene Corporation CELG has adopted Medidata Clinical Cloud for using its suite of strategic monitoring tools and data analytics solutions Over the past one year Medidata Solutions registered a return
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Amgen Inc. vs. Celgene Corporation,2017-01-17 13:37:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tYjry3l9aq0/better-buy-amgen-inc-vs-celgene-corporation-cm734053,While 2016 wasn t the best year for Amgen NASDAQ AMGN and Celgene NASDAQ CELG both big biotech stocks have been tremendous winners over the last several years for investors This year could be shaping up to be a strong one for Amgen and Celgene But which of these
CELG,CELG:UW,BBG000BFCMR2,Medidata Solutions Clinical Cloud Gets Picked by Celgene,2017-01-17 13:12:01 +0000,http://finance.yahoo.com/news/medidata-solutions-clinical-cloud-gets-131201987.html,Medidata Solutions Clinical Cloud Gets Picked by Celgene
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Amgen Inc. vs. Celgene Corporation,2017-01-17 12:10:38 +0000,http://www.fool.com/investing/2017/01/17/better-buy-amgen-inc-vs-celgene-corporation.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Amgen Inc. vs. Celgene Corporation
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : January 16, 2017",2017-01-16 12:43:18 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-breached-its-50-day-moving-average-in-a-bullish-manner-celg-us-january-16-2017/,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : January 16, 2017"
CELG,CELG:UW,BBG000BFCMR2,Donald Trump Just Leveled Drug Companies With These 4 Words,2017-01-14 14:37:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NwaB9QOHwHA/donald-trump-just-leveled-drug-companies-with-these-4-words-cm733619,Image source Getty Images Chances are that if you ve filled a prescription recently you probably don t need a lecture about how rapidly rising drug prices are weighing on consumers pocketbooks According to HR Consultancy Segal specialty drug prices rose nearly 19 in 2016
CELG,CELG:UW,BBG000BFCMR2,Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference,2017-01-13 21:16:00 +0000,http://www.investors.com/news/technology/trumps-disastrous-pharma-view-doesnt-rattle-healthcare-conference/,Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference
CELG,CELG:UW,BBG000BFCMR2,Why investor is selling Celgene calls,2017-01-13 12:45:26 +0000,http://finance.yahoo.com/news/why-investor-selling-celgene-calls-124526808.html,Why investor is selling Celgene calls
CELG,CELG:UW,BBG000BFCMR2,"Notable Thursday Option Activity: MNK, CELG, DE",2017-01-12 20:57:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LJOOUILlJ8o/notable-thursday-option-activity-mnk-celg-de-cm732960,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Mallinckrodt plc Symbol MNK where a total volume of 10 012 contracts has been traded thus far today a contract volume which is representative of approximately 1 0
CELG,CELG:UW,BBG000BFCMR2,Energous Corp Shines Brightly as the Next Fortune-Building Company (WATT),2017-01-12 16:01:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lI6DOiBivEM/energous-corp-shines-brightly-as-the-next-fortune-building-company-watt-cm732815,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The student threw his hands up in frustration Professor he said I just don t get it He slumped in his chair totally defeated I understood the feeling I had spent more than
CELG,CELG:UW,BBG000BFCMR2,Biotech Short Sellers Run for Cover,2017-01-12 14:35:19 +0000,http://finance.yahoo.com/news/biotech-short-sellers-run-cover-143519393.html,Biotech Short Sellers Run for Cover
CELG,CELG:UW,BBG000BFCMR2,Analyst: Government wouldn't want to kill goose that lays...,2017-01-11 18:47:00 +0000,http://finance.yahoo.com/video/analyst-government-wouldnt-want-kill-184700528.html,Analyst: Government wouldn't want to kill goose that lays...
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short",2017-01-11 15:59:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p5QQEtaGVTI/biotech-stock-roundup-ariad-to-be-acquired-for-52b-vertex-outlook-falls-short-cm732170,The big news in the biotech sector this week is the acquisition agreement under which Japanese firm Takeda will be acquiring cancer focused ARIAD ARIA for a whopping 5 2 billion Several other licensing deals and agreements were announced this week as well Recap of the Week s Most
CELG,CELG:UW,BBG000BFCMR2,Celgene 2016 Net $5.94 A Share On $11.2B In Sales,2017-01-11 15:50:00 +0000,http://www.investopedia.com/news/celgene-2016-net-594share-112b-sales-celg/?partner=YahooSA,Celgene 2016 Net $5.94 A Share On $11.2B In Sales
CELG,CELG:UW,BBG000BFCMR2,Trade of the Day: Celgene Corporation (CELG) Stock Keeps Growing,2017-01-11 14:56:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0kaCccGxkEA/trade-of-the-day-celgene-corporation-celg-stock-keeps-growing-cm732082,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Celgene Corporation NASDAQ CELG This biotechnology company which develops and markets small molecule drugs for the treatment of cancers and inflammatory diseases
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short",2017-01-11 14:13:02 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-ariad-acquired-141302797.html,"Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short"
CELG,CELG:UW,BBG000BFCMR2,Celgene CEO: We're in a miraculous time for cancer,2017-01-11 12:17:14 +0000,http://finance.yahoo.com/video/celgene-ceo-were-miraculous-time-121714553.html,Celgene CEO: We're in a miraculous time for cancer
CELG,CELG:UW,BBG000BFCMR2,"Trump Press Conference, Celgene, GW Pharma Lead Investing Action Plan",2017-01-10 22:53:24 +0000,http://www.investors.com/research/investing-action-plan/trump-press-conference-celgene-gw-pharma-lead-investing-action-plan/,"Trump Press Conference, Celgene, GW Pharma Lead Investing Action Plan"
CELG,CELG:UW,BBG000BFCMR2,What's Next For Celgene,2017-01-10 22:52:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mFbOk2zsbRM/whats-next-for-celgene-cm731893,Celgene Corp s NASDAQ CELG management took to the stage at the annual JP Morgan healthcare conference to outline to industry watchers its plans for the future The presentation included updates to its financial guidance and a peek into management s plans for its drug
CELG,CELG:UW,BBG000BFCMR2,Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation,2017-01-10 21:51:30 +0000,http://www.investors.com/news/technology/celgene-ceo-drug-pricing-debate-hinges-on-incentives-for-innovation/,Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation
CELG,CELG:UW,BBG000BFCMR2,What's Next For Celgene,2017-01-10 21:21:06 +0000,http://www.fool.com/investing/2017/01/10/whats-next-for-celgene.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What's Next For Celgene
CELG,CELG:UW,BBG000BFCMR2,Why Agios Pharmaceuticals Sank 34.4% in 2016,2017-01-10 20:51:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ljj26ugoWfI/why-agios-pharmaceuticals-sank-344-in-2016-cm731846,Image source Getty Images What happened Investors in Agios Pharmaceuticals NASDAQ AGIO a company focused on metabolic disorders had a wild ride in 2016 The company s stock traded erratically all year long based on the headlines of the day but it ultimately lost more
CELG,CELG:UW,BBG000BFCMR2,Why Agios Pharmaceuticals Sank 34.4% in 2016,2017-01-10 19:23:07 +0000,http://www.fool.com/investing/2017/01/10/why-agios-pharmaceuticals-sank-344-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Agios Pharmaceuticals Sank 34.4% in 2016
CELG,CELG:UW,BBG000BFCMR2,"Celgene Issues Preliminary 2016 Results, Lifts 2017 View",2017-01-10 15:54:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oqqLfuknU8c/celgene-issues-preliminary-2016-results-lifts-2017-view-cm731582,Celgene Corporation CELG announced preliminary 2016 results and upped the guidance for 2017 while maintaining its outlook for 2020 at the J P Morgan Healthcare Conference The company also provided a business update at the conference Celgene s share price movement shows that the stock
CELG,CELG:UW,BBG000BFCMR2,Celgene Set to Buy Swiss Biotech Anokion for $45M,2017-01-10 15:25:00 +0000,http://www.investopedia.com/news/celgene-preps-45m-takeover-anokion-celg/?partner=YahooSA,Celgene Set to Buy Swiss Biotech Anokion for $45M
CELG,CELG:UW,BBG000BFCMR2,"Celgene Issues Preliminary 2016 Results, Lifts 2017 View",2017-01-10 13:55:01 +0000,http://finance.yahoo.com/news/celgene-issues-preliminary-2016-results-135501244.html,"Celgene Issues Preliminary 2016 Results, Lifts 2017 View"
CELG,CELG:UW,BBG000BFCMR2,Jefferies Has 5 Top Biotech Stocks to Buy for 2017,2017-01-10 13:35:34 +0000,http://finance.yahoo.com/news/jefferies-5-top-biotech-stocks-133534894.html,Jefferies Has 5 Top Biotech Stocks to Buy for 2017
CELG,CELG:UW,BBG000BFCMR2,Here's a Biotech IPO You'll Want to Watch,2017-01-10 13:23:50 +0000,http://www.fool.com/investing/2017/01/09/heres-a-biotech-ipo-youll-want-to-watch.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's a Biotech IPO You'll Want to Watch
CELG,CELG:UW,BBG000BFCMR2,So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction,2017-01-09 22:41:00 +0000,https://www.thestreet.com/story/13947393/1/dow-retreats-from-20-000-as-crude-settles-at-three-week-low-nasdaq-hits-new-record.html?puc=yahoo&cm_ven=YAHOO,So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction
CELG,CELG:UW,BBG000BFCMR2,"The Monday Sights, Sounds and Biotech Buzz from the J.P. Morgan Healthcare Conference",2017-01-09 20:55:00 +0000,https://www.thestreet.com/story/13947469/1/the-monday-sights-sounds-and-biotech-buzz-from-the-j-p-morgan-healthcare-conference.html?puc=yahoo&cm_ven=YAHOO,"The Monday Sights, Sounds and Biotech Buzz from the J.P. Morgan Healthcare Conference"
CELG,CELG:UW,BBG000BFCMR2,Is Celgene Simply the Best Biotech Stock on the Planet?,2017-01-09 20:49:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R6wqV7oA4bo/is-celgene-simply-the-best-biotech-stock-on-the-planet-cm731272,A mic drop at the end of Celgene NASDAQ CELG CEO Mark Alles presentation at the 160 35th Annual J P Morgan NYSE JPM Healthcare Conference might have been appropriate Celgene traditionally kicks off the conference and did so again this year Alles briefly described
CELG,CELG:UW,BBG000BFCMR2,Is Celgene Simply the Best Biotech Stock on the Planet?,2017-01-09 19:24:22 +0000,http://www.fool.com/investing/2017/01/09/is-celgene-simply-the-best-biotech-stock-on-the-pl.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Celgene Simply the Best Biotech Stock on the Planet?
CELG,CELG:UW,BBG000BFCMR2,"Celgene raises 2017 revenue, profit forecast; maintains 2020 view",2017-01-09 18:28:03 +0000,http://finance.yahoo.com/news/celgene-raises-2017-revenue-profit-164404505.html,"[Reuters] - Celgene Corp on Monday raised its 2017 revenue and profit forecasts on the strength of its flagship Revlimid multiple myeloma drug and increased expectations for other treatments for cancer and psoriasis. The U.S. biotech company reiterated its 2020 forecast for sales exceeding $21 billion as Chief Executive Officer Mark Alles kicked off the annual JP Morgan Healthcare Conference in San Francisco. Following the official presentation, Chief Operating Officer Jackie Fouse said the 2020 forecast was largely based on increasing sales of its existing product portfolio."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Sees Much Higher Profits, but Wall Street Still Yawns",2017-01-09 17:55:00 +0000,https://www.thestreet.com/story/13947025/1/celgene-raises-2017-guidance-shares-fall-anyway.html?puc=yahoo&cm_ven=YAHOO,"Celgene Sees Much Higher Profits, but Wall Street Still Yawns"
CELG,CELG:UW,BBG000BFCMR2,"[video]Celgene Ups Revenue and Profit Projections for 2017, but Stock Falls",2017-01-09 17:52:00 +0000,http://www.thestreet.com/video/13947112/celgene-ups-revenue-and-profit-projections-for-2017-but-stock-falls.html?puc=yahoov&cm_ven=YAHOOV,"[video]Celgene Ups Revenue and Profit Projections for 2017, but Stock Falls"
CELG,CELG:UW,BBG000BFCMR2,Celgene CEO: Would love to meet with President-elect Trum...,2017-01-09 17:36:00 +0000,http://finance.yahoo.com/video/celgene-ceo-love-meet-president-173600221.html,Celgene CEO: Would love to meet with President-elect Trum...
CELG,CELG:UW,BBG000BFCMR2,[$$] Celgene Anticipates Slowing Sales Growth for Main Drug Revlimid,2017-01-09 17:02:28 +0000,http://www.wsj.com/articles/celgene-anticipates-slowing-sales-growth-for-main-drug-revlimid-1483981344?mod=yahoo_hs,[$$] Celgene Anticipates Slowing Sales Growth for Main Drug Revlimid
CELG,CELG:UW,BBG000BFCMR2,Start the New Year off Right with 3 Best Biotech Stocks,2017-01-09 16:11:34 +0000,http://www.fool.com/investing/2017/01/08/start-the-new-year-off-right-with-3-best-biotech-s.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Start the New Year off Right with 3 Best Biotech Stocks
CELG,CELG:UW,BBG000BFCMR2,"Celgene raises 2017 revenue, profit forecasts",2017-01-09 16:09:59 +0000,http://finance.yahoo.com/news/celgene-raises-2017-revenue-profit-160959031.html,"[Reuters] - Celgene Corp raised its 2017 revenue and profit forecasts, as the company benefits from new patient market share gains for its flagship multiple myeloma drug, Revlimid. The Summit, New Jersey-based company ..."
CELG,CELG:UW,BBG000BFCMR2,"CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit",2017-01-09 15:51:53 +0000,http://biz.yahoo.com/e/170109/celg8-k.html,"CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit"
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Announces Preliminary 2016 Unaudited Results and 2017 Financial Guidance,2017-01-09 15:45:00 +0000,http://finance.yahoo.com/news/celgene-corporation-announces-preliminary-2016-154500656.html,[Business Wire] - Celgene Corporation today provided a business update as well as its preliminary 2016 unaudited results and financial guidance for 2017 at the 35th Annual J.P. Morgan Healthcare Conference.
CELG,CELG:UW,BBG000BFCMR2,Here's a Biotech IPO You'll Want to Watch,2017-01-09 14:52:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dRTxG2awj9A/heres-a-biotech-ipo-youll-want-to-watch-cm730931,You might be too busy to pay much attention to every tiny biotech that goes public There s one initial public offering IPO coming up though that I think you ll want to keep your eyes on Jounce Therapeutics filed a few days ago for an IPO in 2017 Any company that Celgene
CELG,CELG:UW,BBG000BFCMR2,Celgene To Present At J.P. Morgan Healthcare Conference; Webcast At 10:30 AM ET,2017-01-09 09:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TvFSQh3mhZA/celgene-to-present-at-jp-morgan-healthcare-conference-webcast-at-1030-am-et-20170109-00635,Celgene To Present At J.P. Morgan Healthcare Conference; Webcast At 10:30 AM ET
CELG,CELG:UW,BBG000BFCMR2,Start the New Year off Right with 3 Best Biotech Stocks,2017-01-08 17:49:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H8BiRk_zAyw/start-the-new-year-off-right-with-3-best-biotech-stocks-cm730824,Many Americans start off each new year by heading to the gym That s a great idea but the enthusiasm soon fades away and the crowded gyms of January turn into the wide open spaces of February Here s another way to start the new year off right that has more staying power Buy
CELG,CELG:UW,BBG000BFCMR2,Top Stocks to Buy in 2017,2017-01-08 17:12:08 +0000,http://www.fool.com/investing/2017/01/07/top-stocks-to-buy-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Top Stocks to Buy in 2017
CELG,CELG:UW,BBG000BFCMR2,Top Stocks to Buy in 2017,2017-01-07 18:49:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l9_gd_tgDL0/top-stocks-to-buy-in-2017-cm730742,Obamacare uncertainty and pushback on drug prices sent shockwaves through the healthcare sector in 2016 Will 2017 be a better year for investors Washington s passage of the 21st Century Cures Act potential insurance reform and key data on game changing drugs could make or break
CELG,CELG:UW,BBG000BFCMR2,Cramer's game plan: Banks will be in hog heaven next week,2017-01-06 23:16:23 +0000,http://www.cnbc.com/id/104204457?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104204457,Cramer's game plan: Banks will be in hog heaven next week
CELG,CELG:UW,BBG000BFCMR2,Rally will fade away into second half: Analyst,2017-01-06 19:10:00 +0000,http://finance.yahoo.com/video/rally-fade-away-second-half-191000344.html,Rally will fade away into second half: Analyst
CELG,CELG:UW,BBG000BFCMR2,"Why Halozyme Therapeutics, Inc Fell 40.6% in 2016",2017-01-06 16:25:56 +0000,http://www.fool.com/investing/2017/01/06/why-halozyme-therapeutics-inc-fell-406-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Halozyme Therapeutics, Inc Fell 40.6% in 2016"
CELG,CELG:UW,BBG000BFCMR2,"Healthcare Stocks to Buy for 2017: Less Risky, More Risky, and Most Risky",2017-01-06 15:55:40 +0000,http://www.fool.com/investing/2017/01/05/healthcare-stocks-to-buy-for-2017-less-risky-more.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Healthcare Stocks to Buy for 2017: Less Risky, More Risky, and Most Risky"
CELG,CELG:UW,BBG000BFCMR2,"Bristol-Myers, J&J Ink Immunotherapy Research Collaboration",2017-01-06 14:40:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WFlI3XUuJQs/bristol-myers-jj-ink-immunotherapy-research-collaboration-cm730346,Bristol Myers Squibb Company BMY announced a new clinical research collaboration with Johnson amp Johnson s JNJ Janssen Biotech Inc under which its immuno oncology drug Opdivo will be evaluated in combination with the latter s Darzalex in phase Ib phase II studies for multiple myeloma
CELG,CELG:UW,BBG000BFCMR2,Halozyme (HALO) Up on Positive Phase II Data on PEGPH20,2017-01-06 14:40:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/938soG4ZPVM/halozyme-halo-up-on-positive-phase-ii-data-on-pegph20-cm730339,Shares of Halozyme Therapeutics Inc HALO surged almost 18 after the company announced top line data from the phase II HALO 202 study on PEGPH20 for the treatment of stage IV metastatic pancreatic cancer patients A look at Halozyme s share price movement in 2016 shows that the
CELG,CELG:UW,BBG000BFCMR2,Halozyme (HALO) Up on Positive Phase II Data on PEGPH20,2017-01-06 13:19:01 +0000,http://finance.yahoo.com/news/halozyme-halo-positive-phase-ii-131901986.html,Halozyme (HALO) Up on Positive Phase II Data on PEGPH20
CELG,CELG:UW,BBG000BFCMR2,"Bristol-Myers, J&J Ink Immunotherapy Research Collaboration",2017-01-06 13:17:01 +0000,http://finance.yahoo.com/news/bristol-myers-j-j-ink-131701835.html,"Bristol-Myers, J&J Ink Immunotherapy Research Collaboration"
CELG,CELG:UW,BBG000BFCMR2,"CELGENE CORP /DE/ Files SEC form 8-K, Other Events",2017-01-05 22:13:12 +0000,http://biz.yahoo.com/e/170105/celg8-k.html,"CELGENE CORP /DE/ Files SEC form 8-K, Other Events"
CELG,CELG:UW,BBG000BFCMR2,"Top Biotech Picks: ""The Strong Will Survive And Thrive""",2017-01-05 19:44:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/05/top-biotech-picks-the-strong-will-survive-and-thrive/?mod=yahoobarrons&ru=yahoo,"Top Biotech Picks: ""The Strong Will Survive And Thrive"""
CELG,CELG:UW,BBG000BFCMR2,"Healthcare Stocks to Buy for 2017: Less Risky, More Risky, and Most Risky",2017-01-05 17:40:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H6SI_10g1ME/healthcare-stocks-to-buy-for-2017-less-risky-more-risky-and-most-risky-cm729944,What do UnitedHealth Group NYSE UNH CVS Health NYSE CVS Celgene Corp NASDAQ CELG Regeneron Pharmaceuticals NASDAQ REGN GW Pharmaceuticals plc NASDAQ GWPH and Cara Therapeutics NASDAQ CARA all have in common They make Motley Fool
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Outflows: IYH, CELG, BIIB, AET",2017-01-05 17:37:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/icxUke8jXv8/noteworthy-etf-outflows-iyh-celg-biib-aet-cm729874,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Healthcare ETF Symbol IYH where we have detected an approximate 73 5 million dollar outflow that s a 4 0 decrease week over week from 12 600
CELG,CELG:UW,BBG000BFCMR2,Six Happenings You Won't Want to miss when 'Frisco Takes Center Stage in Healthcare,2017-01-05 15:30:00 +0000,https://www.thestreet.com/story/13942819/1/six-happenings-you-won-t-want-to-miss-when-frisco-takes-center-stage-in-healthcare.html?puc=yahoo&cm_ven=YAHOO,Six Happenings You Won't Want to miss when 'Frisco Takes Center Stage in Healthcare
CELG,CELG:UW,BBG000BFCMR2,What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017,2017-01-05 11:21:00 +0000,https://www.thestreet.com/story/13942459/1/what-biotech-investors-can-expect-from-the-j-p-morgan-healthcare-conference-2017.html?puc=yahoo&cm_ven=YAHOO,What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017
CELG,CELG:UW,BBG000BFCMR2,Buy health care despite Obamacare battle?,2017-01-04 22:19:00 +0000,http://finance.yahoo.com/video/buy-health-care-despite-obamacare-221900214.html,Buy health care despite Obamacare battle?
CELG,CELG:UW,BBG000BFCMR2,Did Biogen Just Throw in the Towel to Celgene?,2017-01-04 16:55:26 +0000,http://www.fool.com/investing/2017/01/04/did-biogen-just-throw-in-the-towel-to-celgene.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Did Biogen Just Throw in the Towel to Celgene?
CELG,CELG:UW,BBG000BFCMR2,The investing insanity of trying to find the next Amazon,2017-01-04 15:39:34 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=851F7C76-D28F-11E6-ACB9-174D52089D58&siteid=yhoof2,The investing insanity of trying to find the next Amazon
CELG,CELG:UW,BBG000BFCMR2,Did Biogen Just Throw in the Towel to Celgene?,2017-01-04 14:39:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eUaAJovuKYw/did-biogen-just-throw-in-the-towel-to-celgene-cm729112,Image source kb3training com Specialty medicines are only used by 1 2 of the U S population but they re downright costly In fact in 2015 specialty drugs represented 37 of nationwide drug spend and this figure is expected to reach 50 by 2018 With inflammatory conditions
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corporation to Announce Fourth Quarter and Full-Year 2016 Results on January 26, 2017",2017-01-04 13:33:20 +0000,http://www.publicnow.com/view/5F9A88F60267A2A7802447B0488B3D3C261842BD,"[at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) will host a conference call and live audio webcast on Thursday, January 26, 2017 at 9 a.m. ET to discuss fourth quarter and full-year 2016 ..."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corporation to Announce Fourth Quarter and Full-Year 2016 Results on January 26, 2017",2017-01-04 12:30:00 +0000,http://finance.yahoo.com/news/celgene-corporation-announce-fourth-quarter-123000743.html,"[Business Wire] - Celgene Corporation will host a conference call and live audio webcast on Thursday, January 26, 2017 at 9 a.m. ET to discuss fourth quarter and full-year 2016 financial and operational results."
CELG,CELG:UW,BBG000BFCMR2,Cramer says Congress could be the culprit to end the stock market rally in 2017,2017-01-03 23:13:15 +0000,http://www.cnbc.com/id/104196947?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104196947,Cramer says Congress could be the culprit to end the stock market rally in 2017
CELG,CELG:UW,BBG000BFCMR2,A startup trying to get the human body to fight cancer just filed for an IPO,2017-01-03 15:56:01 +0000,http://finance.yahoo.com/news/startup-trying-human-body-fight-155601184.html,A startup trying to get the human body to fight cancer just filed for an IPO
CELG,CELG:UW,BBG000BFCMR2,Is It Worth Following Celgene Corporation (CELG) Into Jounce At IPO?,2017-01-03 15:44:06 +0000,http://www.insidermonkey.com/blog/is-it-worth-following-celgene-corporation-celg-into-jounce-at-ipo-514310/,Is It Worth Following Celgene Corporation (CELG) Into Jounce At IPO?
CELG,CELG:UW,BBG000BFCMR2,Blog Coverage Cytori Announced Stock Purchase Agreement of Up to $20 Million,2017-01-03 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-cytori-announced-stock-131500213.html,"[Accesswire] - Upcoming AWS Coverage on Celgene LONDON, UK / ACCESSWIRE / January 3, 2017 / Active Wall St. blog coverage looks at the headline from Cytori Therapeutics, Inc. (NASDAQ: CYTX) as the Company announced on ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Present at the 35th Annual J.P. Morgan Healthcare Conference,2017-01-03 12:43:07 +0000,http://www.publicnow.com/view/518D1AB9CAE06D761BD1E0FD135CC09EF8501637,"[at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- During the 35 Annual J.P. Morgan Healthcare Conference on January 9, 2017 at 10:30 a.m. ET, Celgene Corporation (NASDAQ:CELG) will present a business update on the Company ..."
CELG,CELG:UW,BBG000BFCMR2,Gilead Sciences’ Valuation Compared to Its Peers,2016-12-30 21:16:51 +0000,http://marketrealist.com/2016/12/gilead-sciences-valuation-compared-to-its-peers/?utm_source=yahoo&utm_medium=feed,Gilead Sciences’ Valuation Compared to Its Peers
CELG,CELG:UW,BBG000BFCMR2,Cambridge immunotherapy firm Jounce plots $75M IPO,2016-12-30 18:35:05 +0000,http://www.bizjournals.com/boston/news/2016/12/30/cambridge-immunotherapy-firm-jounce-plots-75m-ipo.html?ana=yahoo,Cambridge immunotherapy firm Jounce plots $75M IPO
CELG,CELG:UW,BBG000BFCMR2,Prima (PBMD) Reports Favorable Initial Melanoma Study Data,2016-12-30 17:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EfoI0QestWc/prima-pbmd-reports-favorable-initial-melanoma-study-data-cm727960,Prima Biomed Ltd PBMD announced interim data from a phase I study of the TACTI mel T wo ACT ive I mmunotherapeutics in mel anoma program on its most advanced pipeline candidate IMP321 based on the LAG 3 immune control mechanism for the treatment of patients with unresectable
CELG,CELG:UW,BBG000BFCMR2,Prima (PBMD) Reports Favorable Initial Melanoma Study Data,2016-12-30 14:37:02 +0000,http://finance.yahoo.com/news/prima-pbmd-reports-favorable-initial-143702798.html,[Zacks] - Prima (PBMD) announced interim data from the TACTI-mel program on IMP321 for the treatment of patients with unresectable or metastatic melanoma.
CELG,CELG:UW,BBG000BFCMR2,Orkambi Is Still Strong Revenue Driver for Vertex Pharmaceuticals,2016-12-29 20:05:28 +0000,http://marketrealist.com/2016/12/orkambi-continues-strong-revenue-driver-vertex-pharmaceuticals-2016/?utm_source=yahoo&utm_medium=feed,Orkambi Is Still Strong Revenue Driver for Vertex Pharmaceuticals
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Celgene, 21st Century Fox, Prudential, Amazon and Exelon",2016-12-29 17:01:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dkgEAkqWeNk/the-zacks-analyst-blog-highlights-celgene-21st-century-fox-prudential-amazon-and-exelon-cm727482,For Immediate Release Chicago IL December 29 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Celgene, 21st Century Fox, Prudential, Amazon and Exelon",2016-12-29 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-celgene-143002571.html,"[Zacks] - The Zacks Analyst Blog Highlights: Celgene, 21st Century Fox, Prudential, Amazon and Exelon"
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for December 28, 2016",2016-12-29 06:56:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q99Pra0_v2g/top-research-reports-for-december-28-2016-cm727236,Wednesday December 28 2016 Today s Research Daily features new research reports on 16 major stocks including Celgene CELG 21st Century Fox FOXA and Prudential PRU Shares of Celgene has lost 0 7 year to date outperforming the Zacks Medical Biomedical and Genetics sector which
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for December 28, 2016",2016-12-28 23:04:11 +0000,http://finance.yahoo.com/news/top-research-reports-december-28-230411757.html,"[Zacks] - Top Research Reports for December 28, 2016"
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, Incyte, Eli Lilly, Regeneron Pharmaceuticals and Ophthotech",2016-12-28 17:02:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LHXNZZdyNGs/the-zacks-analyst-blog-highlights-alexion-pharmaceuticals-celgene-incyte-eli-lilly-regeneron-pharmaceuticals-and-ophthotech-cm726995,For Immediate Release Chicago IL December 28 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Inflows: IWF, MA, BMY, CELG",2016-12-28 16:59:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NiS-DhVFSw8/noteworthy-etf-inflows-iwf-ma-bmy-celg-cm726962,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Growth ETF Symbol IWF where we have detected an approximate 196 7 million dollar inflow that s a 0 6 increase week over week
CELG,CELG:UW,BBG000BFCMR2,"Celgene Winding Up for 2017 Breakout (CELG, IBB)",2016-12-28 15:55:00 +0000,http://www.investopedia.com/stock-analysis/cotd/122816/celgene-winding-2017-breakout-celg-ibb-celg-ibb-xbi.aspx?partner=YahooSA,"Celgene Winding Up for 2017 Breakout (CELG, IBB)"
CELG,CELG:UW,BBG000BFCMR2,Biotech Short Interest Sinks,2016-12-28 15:10:48 +0000,http://finance.yahoo.com/news/biotech-short-interest-sinks-151048968.html,Biotech Short Interest Sinks
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold",2016-12-28 15:02:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Jkz0UVgKkE/biotech-stock-roundup-fda-nod-for-biogenionis-drug-seattle-genetics-hit-by-clinical-hold-cm726791,Biogen BIIB and Ionis IONS got an early Christmas gift with the FDA approving their spinal muscular atrophy SMA treatment Spinraza three months within the filing of the regulatory application Meanwhile Seattle Genetics SGEN has been hit by clinical holds on several early stage
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, Incyte, Eli Lilly, Regeneron Pharmaceuticals and Ophthotech",2016-12-28 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-alexion-143002668.html,"The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, Incyte, Eli Lilly, Regeneron Pharmaceuticals and Ophthotech"
CELG,CELG:UW,BBG000BFCMR2,What’s Behind Amgen’s Discounted Valuation?,2016-12-28 12:36:25 +0000,http://marketrealist.com/2016/12/whats-behind-amgens-discounted-valuation/?utm_source=yahoo&utm_medium=feed,What’s Behind Amgen’s Discounted Valuation?
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold",2016-12-28 12:32:12 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-fda-nod-123212945.html,"Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold"
CELG,CELG:UW,BBG000BFCMR2,Time for biotech to boom ... or bust?,2016-12-27 19:45:00 +0000,http://finance.yahoo.com/video/time-biotech-boom-bust-194500895.html,Time for biotech to boom ... or bust?
CELG,CELG:UW,BBG000BFCMR2,"Forget Alexion (ALXN), Buy These 3 Biotech Stocks Instead",2016-12-27 16:02:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c7vFwp3s2r4/forget-alexion-alxn-buy-these-3-biotech-stocks-instead-cm726406,New Haven CT based Alexion Pharmaceuticals Inc ALXN has had a tough year with shares falling 33 3 year to date YTD The company which is known for its focus on developing treatments for rare disorders has underperformed the Zacks categorized Medical Biomed Genetics industry which
CELG,CELG:UW,BBG000BFCMR2,"Forget Alexion (ALXN), Buy These 3 Biotech Stocks Instead",2016-12-27 13:53:01 +0000,http://finance.yahoo.com/news/forget-alexion-alxn-buy-3-135301037.html,"Forget Alexion (ALXN), Buy These 3 Biotech Stocks Instead"
CELG,CELG:UW,BBG000BFCMR2,Stocks Trade Quietly Ahead Of Long Weekend; Biotechs Lead,2016-12-23 20:07:15 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-trade-quietly-ahead-of-long-weekend-biotechs-lead/,Stocks Trade Quietly Ahead Of Long Weekend; Biotechs Lead
CELG,CELG:UW,BBG000BFCMR2,"Lockheed On Trump's Naughty List? Celgene Rises, Deutsche Holds Tight",2016-12-23 19:34:54 +0000,http://finance.yahoo.com/video/lockheed-trumps-naughty-list-celgene-193454141.html,"Lockheed On Trump's Naughty List? Celgene Rises, Deutsche Holds Tight"
CELG,CELG:UW,BBG000BFCMR2,Celgene's Otezla Gains Positive Recommendation from NICE,2016-12-23 16:01:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jWlIyloIFsY/celgenes-otezla-gains-positive-recommendation-from-nice-cm725655,Celgene Corporation CELG announced that the National Institute for Health and Care Excellence NICE has issued a final appraisal determination recommending the use of its oral phosphodiesterase 4 Otezla 160 NICE has recommended Otezla for the treatment of adults with active
CELG,CELG:UW,BBG000BFCMR2,"Celgene, Evotec Target Unmet Demand in Neurodegenerative Segment",2016-12-23 14:06:22 +0000,http://marketrealist.com/2016/12/celgene-evotec-target-unmet-demand-neurodegenerative-segment/?utm_source=yahoo&utm_medium=feed,"Celgene, Evotec Target Unmet Demand in Neurodegenerative Segment"
CELG,CELG:UW,BBG000BFCMR2,Celgene's Otezla Gains Positive Recommendation from NICE,2016-12-23 13:45:01 +0000,http://finance.yahoo.com/news/celgenes-otezla-gains-positive-recommendation-134501026.html,Celgene's Otezla Gains Positive Recommendation from NICE
CELG,CELG:UW,BBG000BFCMR2,"Otezla Penetrates the Psoriasis, Psoriatic Arthritis Segments",2016-12-23 12:36:29 +0000,http://marketrealist.com/2016/12/otezla-continues-penetrate-psoriasis-psoriatic-arthritis-segments-2016/?utm_source=yahoo&utm_medium=feed,"Otezla Penetrates the Psoriasis, Psoriatic Arthritis Segments"
CELG,CELG:UW,BBG000BFCMR2,What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016,2016-12-22 16:20:00 +0000,https://www.thestreet.com/story/13935497/1/what-adam-feuerstein-got-right-and-wrong-about-biotech-stock-in-2016.html?puc=yahoo&cm_ven=YAHOO,What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
CELG,CELG:UW,BBG000BFCMR2,9 Stocks Ray Dalio Continues to Buy,2016-12-22 16:07:20 +0000,http://finance.yahoo.com/news/9-stocks-ray-dalio-continues-160720346.html,9 Stocks Ray Dalio Continues to Buy
CELG,CELG:UW,BBG000BFCMR2,This Drug May Become a Long-Term Growth Driver for Celgene,2016-12-22 15:38:39 +0000,http://marketrealist.com/2016/12/ag-221-may-become-long-term-growth-driver-celgene-future-years/?utm_source=yahoo&utm_medium=feed,This Drug May Become a Long-Term Growth Driver for Celgene
CELG,CELG:UW,BBG000BFCMR2,Abraxane Is Still Witnessing Robust Demand in Solid Tumor Segment,2016-12-22 14:07:13 +0000,http://marketrealist.com/2016/12/abraxane-continues-witness-robust-demand-solid-tumour-segment/?utm_source=yahoo&utm_medium=feed,Abraxane Is Still Witnessing Robust Demand in Solid Tumor Segment
CELG,CELG:UW,BBG000BFCMR2,Health Care Sector Impacted Markets on December 21,2016-12-22 14:04:19 +0000,http://marketrealist.com/2016/12/health-care-sector-weigh-markets-december-21/?utm_source=yahoo&utm_medium=feed,Health Care Sector Impacted Markets on December 21
CELG,CELG:UW,BBG000BFCMR2,RBC Likes Large Cap Biotech Leaders for 2017,2016-12-22 13:25:48 +0000,http://247wallst.com/healthcare-business/2016/12/22/rbc-likes-large-cap-biotech-leaders-for-2017/,RBC Likes Large Cap Biotech Leaders for 2017
CELG,CELG:UW,BBG000BFCMR2,5 Steps To Buying Biotech Stocks,2016-12-22 13:06:21 +0000,http://www.fool.com/investing/2016/12/21/5-steps-to-buying-biotech-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Steps To Buying Biotech Stocks
CELG,CELG:UW,BBG000BFCMR2,Pomalyst Still Dominates the Third-Line Multiple Myeloma Segment,2016-12-22 12:36:59 +0000,http://marketrealist.com/2016/12/pomalyst-continues-dominate-third-line-multiple-myeloma-segment-2016/?utm_source=yahoo&utm_medium=feed,Pomalyst Still Dominates the Third-Line Multiple Myeloma Segment
CELG,CELG:UW,BBG000BFCMR2,Oral OTEZLA®▼ (Apremilast) Receives Positive Nice Recommendation for Adults with Psoriatic Arthritis,2016-12-22 09:32:07 +0000,http://www.publicnow.com/view/A659972E82E6D7D07A5509596350CB5E4FFDC0BC,"[at noodls] - First-in-class oral treatment for psoriatic arthritis made available via the National Health Service (NHS) STOCKLEY PARK, England--(BUSINESS WIRE)-- Celgene announced today that the National Institute ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene: NICE Issues Positive Recommendation For OTEZLA - Quick Facts,2016-12-22 04:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/loxn_F1ztz8/celgene-nice-issues-positive-recommendation-for-otezla--quick-facts-20161222-00073,Celgene: NICE Issues Positive Recommendation For OTEZLA - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,Revlimid Continues to Be a Key Growth Driver for Celgene in 2016,2016-12-21 23:05:43 +0000,http://marketrealist.com/2016/12/revlimid-continues-key-growth-driver-celgene-2016/?utm_source=yahoo&utm_medium=feed,Revlimid Continues to Be a Key Growth Driver for Celgene in 2016
CELG,CELG:UW,BBG000BFCMR2,Celgene Expects Strong Revenue Growth in 2016,2016-12-21 21:17:49 +0000,http://marketrealist.com/2016/12/celgene-expects-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Celgene Expects Strong Revenue Growth in 2016
CELG,CELG:UW,BBG000BFCMR2,Juno Gets Breakthrough Therapy Status for Lymphoma Drug,2016-12-21 17:59:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aEaGC5UOAmc/juno-gets-breakthrough-therapy-status-for-lymphoma-drug-cm724683,Juno Therapeutics Inc JUNO and partner Celgene Corporation CELG announced that the FDA has granted Breakthrough Therapy designation to their investigational candidate JCAR017 for the treatment of relapsed refractory r r aggressive large B cell non Hodgkin lymphoma NHL
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Otezla Approved in Japan for Two Indications,2016-12-21 16:01:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HHTvF_w7Qps/celgene-celg-otezla-approved-in-japan-for-two-indications-cm724517,Celgene Corporation CELG received encouraging news with the Japanese Ministry of Health Labor and Welfare granting full marketing authorization to its oral phosphodiesterase 4 PDE4 Otezla Otezla has been approved for the treatment of adults with plaque psoriasis with an inadequate
CELG,CELG:UW,BBG000BFCMR2,"3 Stocks to Buy If the Dow Hits 20,000",2016-12-21 15:59:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GIIKxK-CXJM/3-stocks-to-buy-if-the-dow-hits-20000-cm724481,The Dow Jones Industrial Average has 20 000 in its sights and if the exchange eclipses that lofty level it could send shares soaring even higher Is your portfolio positioned for upside Read on to see why I think Celgene Corp NASDAQ CELG ExxonMobil Corporation
CELG,CELG:UW,BBG000BFCMR2,Juno Gets Breakthrough Therapy Status for Lymphoma Drug,2016-12-21 15:40:03 +0000,http://finance.yahoo.com/news/juno-gets-breakthrough-therapy-status-154003126.html,Juno Gets Breakthrough Therapy Status for Lymphoma Drug
CELG,CELG:UW,BBG000BFCMR2,5 Steps To Buying Biotech Stocks,2016-12-21 14:58:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PhgbFj4OlDY/5-steps-to-buying-biotech-stocks-cm724431,Image source Getty Images Biotech investing is risky Very risky Historically only 10 of drugs in clinical trials make it to market and with steep odds like that it s easy to understand why biotech stocks are more prone to significant pops and drops than stocks in
CELG,CELG:UW,BBG000BFCMR2,"3 Stocks to Buy If the Dow Hits 20,000",2016-12-21 14:41:07 +0000,http://www.fool.com/investing/2016/12/21/3-stocks-to-buy-if-the-dow-hits-20000.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"3 Stocks to Buy If the Dow Hits 20,000"
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Otezla Approved in Japan for Two Indications,2016-12-21 13:42:01 +0000,http://finance.yahoo.com/news/celgene-celg-otezla-approved-japan-134201359.html,Celgene (CELG) Otezla Approved in Japan for Two Indications
CELG,CELG:UW,BBG000BFCMR2,"Regeneron Likely To Jump On Amgen LDL-Buster, But Expectations Too High",2016-12-20 21:32:30 +0000,http://www.investors.com/news/technology/regeneron-likely-to-jump-on-amgen-ldl-buster-but-expectations-too-high/,"Regeneron Likely To Jump On Amgen LDL-Buster, But Expectations Too High"
CELG,CELG:UW,BBG000BFCMR2,Amgen: You're Not the One,2016-12-20 19:48:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/20/amgen-youre-not-the-one/?mod=yahoobarrons&ru=yahoo,Amgen: You're Not the One
CELG,CELG:UW,BBG000BFCMR2,Biotech Stocks: There Go the Generalists,2016-12-20 18:28:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/20/biotech-stocks-there-go-the-generalists/?mod=yahoobarrons&ru=yahoo,Biotech Stocks: There Go the Generalists
CELG,CELG:UW,BBG000BFCMR2,iShares Russell 3000 ETF Experiences Big Inflow,2016-12-20 17:59:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BD71iO34hho/ishares-russell-3000-etf-experiences-big-inflow-cm724074,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 3000 ETF Symbol IWV where we have detected an approximate 404 7 million dollar inflow that s a 6 0 increase week over week in outstanding
CELG,CELG:UW,BBG000BFCMR2,Reasons To Own Regeneron In 2017; CS Sees 30% Upside,2016-12-20 17:59:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/20/reasons-to-own-regeneron-in-2017-cs-sees-30-upside/?mod=yahoobarrons&ru=yahoo,Reasons To Own Regeneron In 2017; CS Sees 30% Upside
CELG,CELG:UW,BBG000BFCMR2,"Celgene Added To CS Focus List; ""The Best House In The Biotech Neighborhood""",2016-12-20 17:36:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/20/celgene-added-to-cs-focus-list-the-best-house-in-the-biotech-neighborhood/?mod=yahoobarrons&ru=yahoo,"Celgene Added To CS Focus List; ""The Best House In The Biotech Neighborhood"""
CELG,CELG:UW,BBG000BFCMR2,3 Incredibly Cheap Biotech Stocks,2016-12-20 16:51:18 +0000,http://www.fool.com/investing/2016/12/20/3-incredibly-cheap-biotech-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Incredibly Cheap Biotech Stocks
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics' and Celgene Corporation's Investigational Drug JCAR017 Granted Breakthrough Therapy Designation from FDA and Priority Medicines Eligibility from EMA for Relapsed/Refractory Diffuse Large B-cell Lymphoma,2016-12-20 15:12:13 +0000,http://www.publicnow.com/view/281F7164B5395E88D84627AC51712B4999A0E52B,"[at noodls] - -- Early results recently announced with JCAR017 in non-Hodgkin lymphoma and pediatric acute lymphoblastic leukemia -- Pivotal DLBCL trial expected to begin in 2017 SEATTLE & SUMMIT, N.J.--(BUSINESS WIRE)-- ..."
CELG,CELG:UW,BBG000BFCMR2,3 Incredibly Cheap Biotech Stocks,2016-12-20 14:58:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1ISynuyV0RI/3-incredibly-cheap-biotech-stocks-cm723783,If you re looking for cheap biotech stocks to buy going into the new year you re in luck Shares of Celgene NASDAQ CELG Incyte NASDAQ INCY and Ionis Pharmaceuticals NASDAQ IONS are far less expensive than they appear on the surface Image
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics’ and Celgene Corporation’s Investigational Drug JCAR017 Granted Breakthrough Therapy Designation from FDA and Priority Medicines Eligibility from EMA for Relapsed/Refractory Diffuse Large B-cell Lymphoma,2016-12-20 14:22:09 +0000,http://www.publicnow.com/view/31A41C749F7845BEF79E77748FE01B983B6B1099,"[at noodls] - -- Early results recently announced with JCAR017 in non-Hodgkin lymphoma and pediatric acute lymphoblastic leukemia -- Pivotal DLBCL trial expected to begin in 2017 SEATTLE & SUMMIT, N.J.--(BUSINESS WIRE)--Dec. ..."
CELG,CELG:UW,BBG000BFCMR2,"Top Analyst Upgrades and Downgrades: Amgen, American Express, American Water Works, Celgene, Square and More",2016-12-20 13:55:15 +0000,http://247wallst.com/investing/2016/12/20/top-analyst-upgrades-and-downgrades-amgen-american-express-american-water-works-celgene-square-and-more/,"Top Analyst Upgrades and Downgrades: Amgen, American Express, American Water Works, Celgene, Square and More"
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Johnson & Johnson,2016-12-20 12:50:53 +0000,http://www.fool.com/investing/2016/12/19/better-buy-celgene-corporation-vs-johnson-johnson.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Celgene Corporation vs. Johnson & Johnson
CELG,CELG:UW,BBG000BFCMR2,"Oral PDE-4 Inhibitor, OTEZLA®, Approved for the Treatment of Plaque Psoriasis and Psoriatic Arthritis in Japan",2016-12-20 12:42:07 +0000,http://www.publicnow.com/view/3844F6194C58B9C453425732A4CE535DE8A090E5,"[at noodls] - The first oral treatment in 25 years for patients in Japan with these diseases SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced that OTEZLA (apremilast), Celgene's oral ..."
CELG,CELG:UW,BBG000BFCMR2,"Juno Therapeutics, Celgene Get Breakthrough Therapy Designation From FDA",2016-12-20 10:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jHkjC1cS9qQ/juno-therapeutics-celgene-get-breakthrough-therapy-designation-from-fda-20161220-00558,"Juno Therapeutics, Celgene Get Breakthrough Therapy Designation From FDA"
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Johnson & Johnson,2016-12-19 22:57:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/57nrRQMmeEk/better-buy-celgene-corporation-vs-johnson-johnson-cm723620,Celgene NASDAQ CELG stepped onto Johnson amp Johnson s NYSE JNJ turf in 2014 with its launch of Otezla The drug competes head to head with J amp J s Stelara in the psoriasis and psoriatic arthritis markets That s a fight that Johnson amp Johnson is still winning
CELG,CELG:UW,BBG000BFCMR2,3 Small Biotech Stocks That Big Biotechs Like,2016-12-19 20:09:24 +0000,http://www.fool.com/investing/2016/12/18/3-small-biotech-stocks-that-big-biotechs-like.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Small Biotech Stocks That Big Biotechs Like
CELG,CELG:UW,BBG000BFCMR2,"Agios Stops Development of PKR Activator AG-519, Stock Falls",2016-12-19 16:00:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D-gzJNMFbrw/agios-stops-development-of-pkr-activator-ag-519-stock-falls-cm723207,Agios Pharmaceuticals Inc s AGIO shares tumbled 19 4 after the company announced that it is has decided to discontinue the development of one of its pyruvate kinase R PKR activator AG 519 The decision was taken after the verbal notification of a clinical hold by the FDA which led
CELG,CELG:UW,BBG000BFCMR2,Great News: Clinical Trial Success Rates Are Up for the First Time in More Than a Decade,2016-12-19 14:51:10 +0000,http://www.fool.com/investing/2016/12/19/great-news-clinical-trial-success-rates-are-up-for.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Great News: Clinical Trial Success Rates Are Up for the First Time in More Than a Decade
CELG,CELG:UW,BBG000BFCMR2,3 Small Biotech Stocks That Big Biotechs Like,2016-12-18 21:56:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tjGNwPZcnwM/3-small-biotech-stocks-that-big-biotechs-like-cm723018,Sometimes little dogs get to run with the big dogs That s the case for three small biotechs Cytokinetics NASDAQ CYTK bluebird bio NASDAQ BLUE and Galapagos NASDAQ GLPG Here s why big biotechs Amgen NASDAQ AMGN Celgene NASDAQ CELG and
CELG,CELG:UW,BBG000BFCMR2,Is Billionaire Julian Robertson Struggling With Large-Cap Stocks?,2016-12-16 23:29:21 +0000,http://www.insidermonkey.com/blog/is-billionaire-julian-robertson-struggling-with-large-cap-stocks-511427/,Is Billionaire Julian Robertson Struggling With Large-Cap Stocks?
CELG,CELG:UW,BBG000BFCMR2,Webcast/Conference call regarding strategic collaboration with Celgene,2016-12-16 10:28:10 +0000,http://www.publicnow.com/view/50CF57785DC1D5266AF144BE7B4E619FFC618AB2,"[at noodls] - Hamburg, Germany, 16 December 2016: Evotec invites you to join a brief conference call. The conference will be held in English. ... This is an abstract of the original noodl. To continue reading this document, ..."
CELG,CELG:UW,BBG000BFCMR2,Conference call regarding strategic collaboration with Celgene,2016-12-16 09:38:05 +0000,http://www.publicnow.com/view/3FCDD27D256359655550BB71737AFCD056A4175E,"[at noodls] - Hamburg, Germany, 16 December 2016: Evotec invites you to join a brief conference call. The conference will be held in English. ... This is an abstract of the original noodl. To continue reading this document, ..."
CELG,CELG:UW,BBG000BFCMR2,3 Biggest Risks for Celgene Corporation,2016-12-15 22:57:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QhdjBxoJAEE/3-biggest-risks-for-celgene-corporation-cm722198,There are few stocks that I am as bullish about as Celgene NASDAQ CELG The biotech has enjoyed strong earnings growth thanks to dominance of its blood cancer treatment Revlimid and the tremendous success of autoimmune disease drug Otezla However like any other company
CELG,CELG:UW,BBG000BFCMR2,3 Biggest Risks for Celgene Corporation,2016-12-15 22:37:33 +0000,http://www.fool.com/investing/2016/12/15/3-biggest-risks-for-celgene-corporation.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biggest Risks for Celgene Corporation
CELG,CELG:UW,BBG000BFCMR2,"Evotec, Celgene Enter Drug Discovery Collaboration",2016-12-15 21:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BvgprrfzVls/evotec-celgene-enter-drug-discovery-collaboration-20161215-01245,"Evotec, Celgene Enter Drug Discovery Collaboration"
CELG,CELG:UW,BBG000BFCMR2,Biotech ETF holds gains,2016-12-14 20:54:00 +0000,http://finance.yahoo.com/video/biotech-etf-holds-gains-205400431.html,Biotech ETF holds gains
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Celgene, Regeneron Pharmaceuticals, Ophthotech and Exelixis",2016-12-14 17:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NhU-h4RWqmw/the-zacks-analyst-blog-highlights-celgene-regeneron-pharmaceuticals-ophthotech-and-exelixis-cm721403,For Immediate Release Chicago IL December 14 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Celgene, Regeneron Pharmaceuticals, Ophthotech and Exelixis",2016-12-14 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-celgene-143002936.html,"The Zacks Analyst Blog Highlights: Celgene, Regeneron Pharmaceuticals, Ophthotech and Exelixis"
CELG,CELG:UW,BBG000BFCMR2,3 Great Stocks to Beat the Biotech Blues,2016-12-13 14:59:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FvOeEBkdu7U/3-great-stocks-to-beat-the-biotech-blues-cm720567,There is no doubt that 2016 has been a pretty tumultuous year for biotech stocks with the sector facing a lot of flak for rising drug prices The sector has been under pressure for more than a year now though shares did rally post elections in November Immediately after election results
CELG,CELG:UW,BBG000BFCMR2,3 Great Stocks to Beat the Biotech Blues,2016-12-13 13:09:01 +0000,http://finance.yahoo.com/news/3-great-stocks-beat-biotech-130901414.html,3 Great Stocks to Beat the Biotech Blues
CELG,CELG:UW,BBG000BFCMR2,"CELGENE CORP /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year",2016-12-12 22:02:25 +0000,http://biz.yahoo.com/e/161212/celg8-k.html,"CELGENE CORP /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year"
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Buybacks With the Biggest Bang for the Buck,2016-12-12 19:05:38 +0000,http://www.fool.com/investing/2016/12/12/3-biotech-buybacks-with-the-biggest-bang-for-the-b.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotech Buybacks With the Biggest Bang for the Buck
CELG,CELG:UW,BBG000BFCMR2,Help Wanted: Large-Cap Biotech CEOs Capable of Soothing Raw Nerves of Health Care Investors in 2017,2016-12-12 18:54:00 +0000,https://www.thestreet.com/story/13922604/1/help-wanted-large-cap-biotech-ceos-capable-of-soothing-raw-nerves-of-healthcare-investors-in-2017.html?puc=yahoo&cm_ven=YAHOO,Help Wanted: Large-Cap Biotech CEOs Capable of Soothing Raw Nerves of Health Care Investors in 2017
CELG,CELG:UW,BBG000BFCMR2,Celgene Takes a Turn for the Better,2016-12-12 18:42:00 +0000,http://realmoney.thestreet.com/articles/12/12/2016/celgene-takes-turn-better?puc=yahoo&cm_ven=YAHOO,Celgene Takes a Turn for the Better
CELG,CELG:UW,BBG000BFCMR2,Corcept Korlym Positive in Phase I/II Breast Cancer Study,2016-12-12 16:58:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4q8YaJiRM0U/corcept-korlym-positive-in-phase-iii-breast-cancer-study-cm720125,Corcept Therapeutics Incorporated CORT announced encouraging efficacy data from a phase I II study on Korlym mifepristone in patients suffering from metastatic triple negative breast cancer TNBC Data were presented at the San Antonio Breast Cancer Symposium Corcept s year to date
CELG,CELG:UW,BBG000BFCMR2,3 Drugs Heading to the FDA Soon,2016-12-12 14:59:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4ggZtEWLFqc/3-drugs-heading-to-the-fda-soon-cm719977,It s incredibly difficult to usher a drug successfully through scientifically controlled clinical trials to the FDA but when drug developers pull it off the payoff for investors can be huge At least that s what investors in Flexion Therapeutics NASDAQ FLXN Kite
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Buybacks With the Biggest Bang for the Buck,2016-12-12 14:59:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dCFhlI4MabY/3-biotech-buybacks-with-the-biggest-bang-for-the-buck-cm719974,The best investment for some biotechs in 2016 was in themselves Many biopharmaceutical companies bought back significant numbers of shares this year But which of these biotech buybacks holds the potential to provide the biggest bang for the buck for investors Here s why
CELG,CELG:UW,BBG000BFCMR2,Biotech Short Interest Remains Mixed,2016-12-12 14:10:59 +0000,http://finance.yahoo.com/news/biotech-short-interest-remains-mixed-141059205.html,Biotech Short Interest Remains Mixed
CELG,CELG:UW,BBG000BFCMR2,3 Drugs Heading to the FDA Soon,2016-12-12 13:21:14 +0000,http://www.fool.com/investing/2016/12/12/3-drugs-heading-to-the-fda-soon.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Drugs Heading to the FDA Soon
CELG,CELG:UW,BBG000BFCMR2,The Best Healthcare Stocks for 2017,2016-12-11 12:34:34 +0000,http://www.fool.com/investing/2016/12/10/the-best-healthcare-stocks-for-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Best Healthcare Stocks for 2017
CELG,CELG:UW,BBG000BFCMR2,Is Celgene a Buffett Stock?,2016-12-10 14:21:45 +0000,http://www.fool.com/investing/2016/12/09/is-celgene-a-buffett-stock.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Celgene a Buffett Stock?
CELG,CELG:UW,BBG000BFCMR2,The Best Healthcare Stocks for 2017,2016-12-10 13:56:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2IJvoQU3ZHg/the-best-healthcare-stocks-for-2017-cm719711,Although 2016 hasn t been the greatest year for healthcare stocks in general another year is around the corner and with it come new opportunities Here s why Celgene NASDAQ CELG Ligand Pharmaceuticals NASDAQ LGND and UnitedHealth Group NYSE UNH stand out as
CELG,CELG:UW,BBG000BFCMR2,"Stock Market News for December 09, 2016",2016-12-09 17:58:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0VQEkg8IiPs/stock-market-news-for-december-09-2016-cm719409,Markets finished at record highs again on Thursday following ECB s announcement about trimming bond buying volume and the continuing Trump induced rally Meanwhile decline in initial claims also added to the optimism Moreover strong gains in financials and rebound in healthcare sector
CELG,CELG:UW,BBG000BFCMR2,"Stocks Hold at Records as Health Care Jumps, Crude Surges",2016-12-09 16:39:00 +0000,https://www.thestreet.com/story/13920861/1/stocks-hold-at-records-as-health-care-jumps-crude-surges.html?puc=yahoo&cm_ven=YAHOO,"Stocks Hold at Records as Health Care Jumps, Crude Surges"
CELG,CELG:UW,BBG000BFCMR2,Is Celgene a Buffett Stock?,2016-12-09 15:59:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vpWJRtPHb9g/is-celgene-a-buffett-stock-cm719260,As of the end of September Berkshire Hathaway NYSE BRK A NYSE BRK B held more than 68 billion in cash on its balance sheet Remarkably this figure is actually up since the start of the year even though Berkshire recently acquired Precision Castparts for 37 2 billion
CELG,CELG:UW,BBG000BFCMR2,Should You Buy Drug Stocks on Their Post-Election Drop?,2016-12-09 15:19:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hMGviIAT390/should-you-buy-drug-stocks-on-their-post-election-drop-cm719282,"We have seen a strong rally in stocks since the U.S Presidential election, based on the assumption that, as a businessperson, the President elect will usher in a business-friendly era. The general feeling seems to be that some of the things said on the campaign trail, things like restricting trade, deporting millions"
CELG,CELG:UW,BBG000BFCMR2,The 3 Best Biotech Stocks for 2017,2016-12-09 00:34:12 +0000,http://www.fool.com/investing/2016/12/08/the-3-best-biotech-stocks-for-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The 3 Best Biotech Stocks for 2017
CELG,CELG:UW,BBG000BFCMR2,The 3 Best Biotech Stocks for 2017,2016-12-08 22:57:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w92Ey8DhjdY/the-3-best-biotech-stocks-for-2017-cm718946,Trying to pick the best biotech stocks for 2017 defined as those with the best returns is a bit of a crapshoot The biotech stocks that ultimately produce the best returns are likely to be the ones that investors had little confidence in You can certainly find winners among
CELG,CELG:UW,BBG000BFCMR2,Biogen Inc (BIIB) Stock Trade Showcases the ‘Art of the Steal’,2016-12-08 17:59:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vMp7VC2va6I/biogen-inc-biib-stock-trade-showcases-the-art-of-the-steal-cm718768,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It has been nearly a month and for Biogen Inc NASDAQ BIIB and the biotech sector it has been a period of Trump amp Dump Now it s time to take advantage of value
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corporation (CELG) Presents Encouraging Phase 2 tnAcity Clinical Trial Results, Decides Not To Pursue Phase 3",2016-12-08 17:05:47 +0000,http://www.insidermonkey.com/blog/celgene-corporation-celg-presents-encouraging-phase-2-tnacity-clinical-trial-results-decides-not-to-pursue-phase-3-502400/,"Celgene Corporation (CELG) Presents Encouraging Phase 2 tnAcity Clinical Trial Results, Decides Not To Pursue Phase 3"
CELG,CELG:UW,BBG000BFCMR2,"Sleepy Morning, But Picking Up? Airlines, Biotechs In Motion",2016-12-08 17:03:29 +0000,http://finance.yahoo.com/video/sleepy-morning-picking-airlines-biotechs-170329198.html,"Sleepy Morning, But Picking Up? Airlines, Biotechs In Motion"
CELG,CELG:UW,BBG000BFCMR2,"Stock Market News for December 08, 2016",2016-12-08 16:57:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uIHL9Elek24/stock-market-news-for-december-08-2016-cm718651,The Trump induced rally continued to boost major benchmarks to finish at all time record highs on Wednesday offsetting the decline in healthcare stocks Though Trump s comment about putting a brake on drug prices led the healthcare sector to end with losses substantial broad based gains later
CELG,CELG:UW,BBG000BFCMR2,"Why Celgene Corporation (CELG), Nu Skin Enterprises, Inc. (NUS) and Pioneer Energy Services Corp (PES) Are 3 of Today’s Worst Stocks",2016-12-08 01:55:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JWWOhDcsVWY/why-celgene-corporation-celg-nu-skin-enterprises-inc-nus-and-pioneer-energy-services-corp-pes-are-3-of-todays-worst-stocks-cm718399,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Despite the slow start to the effort once the bulls got going later in the session they didn t look back The S amp P 500 ended the day at 2 241 35 up 1 32 That close was an all
CELG,CELG:UW,BBG000BFCMR2,Trump Warns Investors &quot;I'm Going To Bring Down Drug Prices&quot;,2016-12-07 23:57:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fBuuciNiDss/trump-warns-investors-im-going-to-bring-down-drug-prices-cm718362,Time magazine s Person of the Year President elect Donald Trump just dropped a bomb on biotech and pharmaceutical industry CEO s and investors During an interview with Time Trump suggested that it s a bad bet to bank on him as being friendly to drug companies at least in
CELG,CELG:UW,BBG000BFCMR2,"Following ASH Conference, Vetr Upgrades Celgene",2016-12-07 23:29:41 +0000,http://finance.yahoo.com/news/following-ash-conference-vetr-upgrades-232941923.html,"Following ASH Conference, Vetr Upgrades Celgene"
CELG,CELG:UW,BBG000BFCMR2,Why You Should Let Celgene Corporation Invest Your Money,2016-12-07 22:58:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SYy5mJ8y19A/why-you-should-let-celgene-corporation-invest-your-money-cm718334,How would you like to have an investment manager who quadrupled your initial investment over the last 10 years That s the return that Celgene Corporation NASDAQ CELG achieved But Celgene is a biotech not an investment manager right Actually it s both The company has
CELG,CELG:UW,BBG000BFCMR2,"Trump Warns Investors ""I'm Going To Bring Down Drug Prices""",2016-12-07 22:02:07 +0000,http://www.fool.com/investing/2016/12/07/trump-warns-investors-im-going-to-bring-down-drug.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Trump Warns Investors ""I'm Going To Bring Down Drug Prices"""
CELG,CELG:UW,BBG000BFCMR2,"S&P 500, Dow Notch All-Time Highs; Dave & Buster's Soars 19%",2016-12-07 21:07:23 +0000,http://www.investors.com/market-trend/stock-market-today/s-dave-busters-soars-19/,"S&P 500, Dow Notch All-Time Highs; Dave & Buster's Soars 19%"
CELG,CELG:UW,BBG000BFCMR2,"Wednesday Sector Laggards: Healthcare, Energy",2016-12-07 20:55:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IfN8zIAfmbE/wednesday-sector-laggards-healthcare-energy-cm718256,In afternoon trading on Wednesday Healthcare stocks are the worst performing sector showing a 0 7 loss Within the sector Celgene Corp Symbol CELG and Endo International plc Symbol ENDP are two of the day s laggards showing a loss of 4 8 and 4 7 respectively Among healthcare
CELG,CELG:UW,BBG000BFCMR2,"Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally",2016-12-07 19:46:00 +0000,https://www.thestreet.com/story/13917873/1/dow-looks-again-at-a-record-as-wall-street-shakes-off-biotech-slump.html?puc=yahoo&cm_ven=YAHOO,"Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally"
CELG,CELG:UW,BBG000BFCMR2,"Stock Indexes Extend Gains, But Big R&D Biotechs Dive",2016-12-07 19:04:22 +0000,http://www.investors.com/market-trend/stock-market-today/stock-indexes-rise-but-big-rd-biomeds-dive/,"Stock Indexes Extend Gains, But Big R&D Biotechs Dive"
CELG,CELG:UW,BBG000BFCMR2,Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares,2016-12-07 17:40:08 +0000,http://247wallst.com/healthcare-business/2016/12/07/trumps-drug-price-comments-weigh-on-biotech-and-pharma-etfs-and-shares/,Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares
CELG,CELG:UW,BBG000BFCMR2,3 Top Healthcare Stocks,2016-12-07 16:19:03 +0000,http://www.fool.com/investing/2016/12/06/3-top-healthcare-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Healthcare Stocks
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus",2016-12-07 16:00:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hCwvJS9FNHo/biotech-stock-roundup-actelion-remains-in-ma-spotlight-ash-data-in-focus-cm717971,Several companies like Celgene Read more Acceleron Celgene Present Myelodysplastic Syndromes Data Alexion Read more Alexion Presents Data from Ultra Rare Blood Disorder Study Juno and Kite KITE were present at the annual meeting of the American Society of Hematology ASH with data
CELG,CELG:UW,BBG000BFCMR2,Drug Stocks Tumble After Trump Vows to Pressure Prices,2016-12-07 15:36:58 +0000,http://blogs.wsj.com/moneybeat/2016/12/07/drug-stocks-tumble-after-trump-vows-to-pressure-drug-prices/?mod=yahoo_hs,Drug Stocks Tumble After Trump Vows to Pressure Prices
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus",2016-12-07 13:49:01 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-actelion-remains-134901750.html,"Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus"
CELG,CELG:UW,BBG000BFCMR2,[$$] Gormley's Take: Keeping Options Open Can Pay Off in a Buyout,2016-12-07 12:30:04 +0000,http://www.wsj.com/articles/gormleys-take-keeping-options-open-can-pay-off-in-a-buyout-1481113800?mod=yahoo_hs,[$$] Gormley's Take: Keeping Options Open Can Pay Off in a Buyout
CELG,CELG:UW,BBG000BFCMR2,tnAcity Data Presented at SABCS Evaluates the Investigational Use of ABRAXANE® as First-Line Treatment of Metastatic Triple Negative Breast Cancer,2016-12-07 12:30:00 +0000,http://finance.yahoo.com/news/tnacity-data-presented-sabcs-evaluates-123000819.html,"[Business Wire] - Celgene Corporation today announced that the results of its randomized phase II tnAcity trial of ABRAXANE® for injectable suspension will be presented at the 2016 San Antonio Breast Cancer Symposium December 6-10, 2016."
CELG,CELG:UW,BBG000BFCMR2,Celgene Pins Future on Decoding Successful Cancer Treatment,2016-12-07 10:00:23 +0000,http://www.bloomberg.com/news/articles/2016-12-07/drugmaker-pins-future-on-decoding-successful-cancer-treatment?cmpid=yhoo.headline,Celgene Pins Future on Decoding Successful Cancer Treatment
CELG,CELG:UW,BBG000BFCMR2,Health-Care Selloff Pressures Stocks,2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/caxnNEG9O0U/healthcare-selloff-pressures-stocks-20161207-00671,Health-Care Selloff Pressures Stocks
CELG,CELG:UW,BBG000BFCMR2,Health-Care Stocks Slide,2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OlvSh3TkZxQ/healthcare-stocks-slide-20161207-00658,Health-Care Stocks Slide
CELG,CELG:UW,BBG000BFCMR2,U.S. Stocks Post Biggest One-Day Rally Since Election,2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0dOM0SIYWFE/us-stocks-post-biggest-oneday-rally-since-election-20161207-01039,U.S. Stocks Post Biggest One-Day Rally Since Election
CELG,CELG:UW,BBG000BFCMR2,"Dow, S&P 500 Set New Highs",2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GOO97GRIBR8/dow-sp-500-set-new-highs-20161207-01024,"Dow, S&P 500 Set New Highs"
CELG,CELG:UW,BBG000BFCMR2,"Dow, S&P 500 on Track to Set New Highs",2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9QjODalEmps/dow-sp-500-on-track-to-set-new-highs-20161207-00861,"Dow, S&P 500 on Track to Set New Highs"
CELG,CELG:UW,BBG000BFCMR2,Stocks Pressured by Health-Care Selloff,2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HBGrOMK7b7Q/stocks-pressured-by-healthcare-selloff-20161207-00707,Stocks Pressured by Health-Care Selloff
CELG,CELG:UW,BBG000BFCMR2,"Stocks Rise, Despite Slide in Health-Care Shares",2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tE1fCvC9lBc/stocks-rise-despite-slide-in-healthcare-shares-20161207-00786,"Stocks Rise, Despite Slide in Health-Care Shares"
CELG,CELG:UW,BBG000BFCMR2,Juno Reports Positive Phase I Study Data on Lymphoma Drug,2016-12-06 22:57:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ELi2jgUgcd0/juno-reports-positive-phase-i-study-data-on-lymphoma-drug-cm717693,Juno Therapeutics Inc JUNO announced encouraging preliminary clinical data from a phase I study TRANSCEND on its lead pipeline candidate JCAR017 for the treatment of patients with relapsed or refractory r r aggressive non Hodgkin lymphoma NHL Results were presented at the 58th
CELG,CELG:UW,BBG000BFCMR2,3 Top Healthcare Stocks,2016-12-06 21:27:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PzkFGUyg87I/3-top-healthcare-stocks-cm717617,The populations in U S and developed nations around the globe are getting older and their healthcare costs are getting bigger Whether you re looking for dazzling growth or stability Celgene NASDAQ CELG Ionis Pharmacuticals NASDAQ IONS and Johnson amp
CELG,CELG:UW,BBG000BFCMR2,Stock Exchange: Model Picks Teach Us To Manage Risk,2016-12-06 21:25:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xxUTh9FtZG0/stock-exchange-model-picks-teach-us-to-manage-risk-cm717556,By Jeff Miller ByJeff Miller Individual investors are intensely focused on the concept of risk And why shouldn t they be Finding an appropriate level of downside risk is paramount However too few give equal weight to the potential upside risk in their decisions Permabears
CELG,CELG:UW,BBG000BFCMR2,Juno Reports Positive Phase I Study Data on Lymphoma Drug,2016-12-06 21:01:09 +0000,http://finance.yahoo.com/news/juno-reports-positive-phase-study-210109748.html,Juno Reports Positive Phase I Study Data on Lymphoma Drug
CELG,CELG:UW,BBG000BFCMR2,Phase III Studies Present Additional Evidence for REVLIMID® (lenalidomide) as Maintenance Therapy in Multiple Myeloma,2016-12-06 21:00:00 +0000,http://finance.yahoo.com/news/phase-iii-studies-present-additional-210000198.html,"[Business Wire] - Celgene Corporation , today announced results from two studies evaluating the investigational use of REVLIMID® maintenance therapy in patients with multiple myeloma."
CELG,CELG:UW,BBG000BFCMR2,ABOUND Data Presented at the World Conference on Lung Cancer Further Explores Safety and Efficacy of ABRAXANE® for Challenging Patient Populations,2016-12-06 08:00:00 +0000,http://uk.finance.yahoo.com/news/abound-data-presented-world-conference-080000893.html,ABOUND Data Presented at the World Conference on Lung Cancer Further Explores Safety and Efficacy of ABRAXANE® for Challenging Patient Populations
CELG,CELG:UW,BBG000BFCMR2,"Combined Analysis of Oral Epigenetic Therapy, CC-486, Demonstrated Hematologic Responses in Patients Who Received Prior Epigenetic Hypo-Methylating Agents (HMA)",2016-12-06 00:30:00 +0000,http://finance.yahoo.com/news/combined-analysis-oral-epigenetic-therapy-003000410.html,"[Business Wire] - Abstract #905 -- Celgene Corporation , today announced results from an analysis of three phase I/II studies evaluating CC-486 in patients with myelodysplastic syndromes , chronic myelomonocytic leukemia and acute myeloid leukemia who had received prior hypomethylating agents were presented today at the 58th American Society of Hematology Annual Meeting in San Diego, Calif."
CELG,CELG:UW,BBG000BFCMR2,Acceleron and Celgene Announce Updated Results from Phase 2 Studies of Luspatercept in Beta-Thalassemia Presented at the 58th Annual Meeting of the American Society of Hematology,2016-12-05 22:45:00 +0000,http://finance.yahoo.com/news/acceleron-celgene-announce-updated-results-224500348.html,"[Business Wire] - Acceleron Pharma Inc. and Celgene Corporation today announced Phase 2 results from an open-label three-month base study and the ongoing long-term safety extension study with luspatercept in patients with beta-thalassemia during an oral presentation at the 58th Annual Meeting of the American Society of Hematology in San Diego, California."
CELG,CELG:UW,BBG000BFCMR2,"Celgene, Acceleron Launch Blood Disorder Study (CELG)",2016-12-05 18:48:00 +0000,http://www.investopedia.com/news/celgene-acceleron-target-blood-disorder-celg-xlrn/?partner=YahooSA,"Celgene, Acceleron Launch Blood Disorder Study (CELG)"
CELG,CELG:UW,BBG000BFCMR2,Celgene Buys Blood Cancer Specialist Acetylon (CELG),2016-12-05 16:20:00 +0000,http://www.investopedia.com/news/celgene-buys-blood-cancer-drug-maker-acetylon-celg/?partner=YahooSA,Celgene Buys Blood Cancer Specialist Acetylon (CELG)
CELG,CELG:UW,BBG000BFCMR2,Celgene CEO: Excited by opportunities corporate tax refor...,2016-12-05 16:16:00 +0000,http://finance.yahoo.com/video/celgene-ceo-excited-opportunities-corporate-161600631.html,Celgene CEO: Excited by opportunities corporate tax refor...
CELG,CELG:UW,BBG000BFCMR2,"Acceleron, Celgene Present Myelodysplastic Syndromes Data",2016-12-05 15:42:03 +0000,http://finance.yahoo.com/news/acceleron-celgene-present-myelodysplastic-syndromes-154203377.html,"Acceleron, Celgene Present Myelodysplastic Syndromes Data"
CELG,CELG:UW,BBG000BFCMR2,Acceleron Pharma Inc Conference Call to Review Data Presented at American Society of Hematology Annual Meeting scheduled for 9:00 am ET today,2016-12-05 14:00:00 +0000,http://biz.yahoo.com/cc/1/155031.html,Acceleron Pharma Inc Conference Call to Review Data Presented at American Society of Hematology Annual Meeting scheduled for 9:00 am ET today
CELG,CELG:UW,BBG000BFCMR2,Why Celgene Shares Jumped 13.9% In November,2016-12-05 13:03:20 +0000,http://www.fool.com/investing/2016/12/05/why-celgene-shares-jumped-139-in-november.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Celgene Shares Jumped 13.9% In November
CELG,CELG:UW,BBG000BFCMR2,Acceleron and Celgene Announce Preliminary Results from an Investigator Initiated Phase 2 Study of Sotatercept in Myelofibrosis at the 58th Annual Meeting of the American Society of Hematology,2016-12-05 12:00:00 +0000,http://finance.yahoo.com/news/acceleron-celgene-announce-preliminary-results-120000648.html,"[Business Wire] - Acceleron Pharma Inc. and Celgene Corporation , today announced preliminary results from an ongoing investigator initiated Phase 2 study with investigational drug sotatercept in patients with myelofibrosis at the 58th Annual Meeting of the American Society of Hematology in San Diego, California."
CELG,CELG:UW,BBG000BFCMR2,"Acceleron, Celgene Announce Preliminary Results From Sotatercept Phase 2 Study",2016-12-05 07:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6wb7XBAyKNY/acceleron-celgene-announce-preliminary-results-from-sotatercept-phase-2-study-20161205-00241,"Acceleron, Celgene Announce Preliminary Results From Sotatercept Phase 2 Study"
CELG,CELG:UW,BBG000BFCMR2,"ALNY In Motion, Shire Finds New Use For Old Drug, TFX Snaps Up VASC",2016-12-05 00:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GPggaNQCUwk/alny-in-motion-shire-finds-new-use-for-old-drug-tfx-snaps-up-vasc-20161205-00008,"ALNY In Motion, Shire Finds New Use For Old Drug, TFX Snaps Up VASC"
CELG,CELG:UW,BBG000BFCMR2,"Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment",2016-12-04 18:13:00 +0000,https://www.thestreet.com/story/13913178/1/acceleron-celgene-seek-to-replace-entrenched-anti-anemia-drugs-in-mds-treatment.html?puc=yahoo&cm_ven=YAHOO,"Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment"
CELG,CELG:UW,BBG000BFCMR2,Acceleron and Celgene Announce Updated Results from Ongoing Phase 2 Studies of Luspatercept in Myelodysplastic Syndromes at the 58th Annual Meeting of the American Society of Hematology,2016-12-04 17:00:00 +0000,http://finance.yahoo.com/news/acceleron-celgene-announce-updated-results-170000896.html,"[Business Wire] - Acceleron Pharma Inc. and Celgene Corporation , today announced preliminary Phase 2 results from the ongoing three-month base and long-term extension studies with investigational drug luspatercept in patients with lower risk myelodysplastic syndromes at the 58th Annual Meeting of the American Society of Hematology in San Diego, California."
CELG,CELG:UW,BBG000BFCMR2,Celgene buys part of Boston cancer drug firm,2016-12-04 16:35:08 +0000,http://www.bizjournals.com/boston/news/2016/12/04/celgene-buys-part-of-boston-cancer-drug-firm.html?ana=yahoo,Celgene buys part of Boston cancer drug firm
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corporation, Dana-Farber Cancer Institute and University of Arkansas for Medical Sciences Establish the Myeloma Genome Project",2016-12-03 23:30:00 +0000,http://finance.yahoo.com/news/celgene-corporation-dana-farber-cancer-233000568.html,"[Business Wire] - Celgene Corporation , Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences today announced the creation of the Myeloma Genome Project, a collaborative initiative aimed at compiling the largest dataset of high-quality genomic and clinical data to identify distinct molecular disease segments within multiple myeloma to advance diagnosis, prognosis and treatment of multiple ..."
CELG,CELG:UW,BBG000BFCMR2,Why bluebird bio Shares Rallied 24.7% In November,2016-12-03 12:41:07 +0000,http://www.fool.com/investing/2016/12/03/why-bluebird-bio-shares-rallied-247-in-november.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why bluebird bio Shares Rallied 24.7% In November
CELG,CELG:UW,BBG000BFCMR2,Adventures in CAR-T Racing: Crashes and Curves Edition,2016-12-02 16:20:01 +0000,http://www.fool.com/investing/2016/12/02/adventures-in-car-t-racing-crashes-and-curves-edit.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Adventures in CAR-T Racing: Crashes and Curves Edition
CELG,CELG:UW,BBG000BFCMR2,A Potentially Astounding Advance in Multiple Myeloma,2016-12-01 22:36:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pRzb5ADoEtg/a-potentially-astounding-advance-in-multiple-myeloma-cm716665,Multiple myeloma is a B cell cancer caused by malignant plasma cells It s a tough to treat cancer with many patients undergoing multiple treatments over time Eventually patients whose disease returns despite receiving multiple prior treatments are left with few treatment
CELG,CELG:UW,BBG000BFCMR2,Bluebird Rockets On Myeloma Drug; Celgene Gets Boost,2016-12-01 22:00:03 +0000,http://www.investors.com/news/technology/bluebird-rockets-on-most-potent-myeloma-drug-celgene-gets-boost/,Bluebird Rockets On Myeloma Drug; Celgene Gets Boost
CELG,CELG:UW,BBG000BFCMR2,A Potentially Astounding Advance in Multiple Myeloma,2016-12-01 20:40:00 +0000,http://www.fool.com/investing/2016/12/01/a-potentially-astounding-advance-in-multiple-myelo.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,A Potentially Astounding Advance in Multiple Myeloma
CELG,CELG:UW,BBG000BFCMR2,Here's Why Bluebird Bio (BLUE) is Rallying Today,2016-12-01 20:33:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WZ65Qvreclk/heres-why-bluebird-bio-blue-is-rallying-today-cm716578,On Thursday shares of biotech company Bluebird Bio Inc BLUE are rallying up over 17 in midday trading after positive results came in for its experimental anti BCMA CAR chimeric antigen receptor T cell product candidate 160 bb2121 in an early stage study for relapsed refractory
CELG,CELG:UW,BBG000BFCMR2,Here's Why Bluebird Bio (BLUE) is Rallying Today,2016-12-01 18:58:06 +0000,http://finance.yahoo.com/news/heres-why-bluebird-bio-blue-185806350.html,Here's Why Bluebird Bio (BLUE) is Rallying Today
CELG,CELG:UW,BBG000BFCMR2,Bluebird Bio Flies; Blood Cancer Drug Impresses In Small Trial,2016-12-01 18:43:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/01/bluebird-bio-flies-blood-cancer-drug-impresses-in-small-trial/?mod=yahoobarrons&ru=yahoo,Bluebird Bio Flies; Blood Cancer Drug Impresses In Small Trial
CELG,CELG:UW,BBG000BFCMR2,Celgene Invests More In Data Analytics Software (CELG),2016-12-01 18:26:00 +0000,http://www.investopedia.com/news/celgene-boosts-investment-gns-healthcare-celg/?partner=YahooSA,Celgene Invests More In Data Analytics Software (CELG)
CELG,CELG:UW,BBG000BFCMR2,Here’s What’s So Important About The bluebird bio Inc (BLUE) Data,2016-12-01 16:42:45 +0000,http://www.insidermonkey.com/blog/heres-whats-so-important-about-the-bluebird-bio-inc-blue-data-495840/,Here’s What’s So Important About The bluebird bio Inc (BLUE) Data
CELG,CELG:UW,BBG000BFCMR2,"Why bluebird bio, Inc. Stock Is Soaring Today",2016-12-01 15:19:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N7uv8SWFoD8/why-bluebird-bio-inc-stock-is-soaring-today-cm716236,Image source Getty Images What happened Shares of the clinical stage biotech bluebird bio Inc NASDAQ BLUE rose by more than 24 in pre market trading today as a result of its experimental anti BCMA CAR T chimeric antigen receptor T cell 160 cell
CELG,CELG:UW,BBG000BFCMR2,Bluebird bio stock gains on impressive early cancer trial results,2016-12-01 15:05:08 +0000,http://www.bizjournals.com/boston/news/2016/12/01/bluebird-bio-stock-gains-on-impressive-early.html?ana=yahoo,Bluebird bio stock gains on impressive early cancer trial results
CELG,CELG:UW,BBG000BFCMR2,"Bluebird Bio, Celgene Multiple Myeloma Therapy Strong In 9-Patient Study",2016-12-01 14:40:07 +0000,http://www.investors.com/news/technology/bluebird-bio-celgene-multiple-myeloma-therapy-strong-in-9-patient-study/,"Bluebird Bio, Celgene Multiple Myeloma Therapy Strong In 9-Patient Study"
CELG,CELG:UW,BBG000BFCMR2,Is Celgene Corporation (CELG) Worthy of Your Portfolio?,2016-12-01 14:30:03 +0000,http://www.insidermonkey.com/blog/is-celgene-corporation-celg-worthy-of-your-portfolio-489862/,"[at Insider Monkey] - Is Celgene Corporation (NASDAQ:CELG) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy league graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of […]"
CELG,CELG:UW,BBG000BFCMR2,"Why bluebird bio, Inc. Stock Is Soaring Today",2016-12-01 14:11:00 +0000,http://www.fool.com/investing/2016/12/01/why-bluebird-bio-inc-stock-is-soaring-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why bluebird bio, Inc. Stock Is Soaring Today"
CELG,CELG:UW,BBG000BFCMR2,"Celgene, Kite, Spark Look To Sidestep Lilly Alzheimer's Flop",2016-11-30 21:15:50 +0000,http://www.investors.com/news/technology/celgene-kite-spark-look-to-sidestep-lilly-alzheimers-flop-at-ash/,"Celgene, Kite, Spark Look To Sidestep Lilly Alzheimer's Flop"
CELG,CELG:UW,BBG000BFCMR2,3 Biotechs With Save-the-Date Catalysts on Tap,2016-11-30 17:34:00 +0000,http://www.fool.com/investing/2016/11/29/3-biotechs-with-save-the-date-catalysts-on-tap.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotechs With Save-the-Date Catalysts on Tap
CELG,CELG:UW,BBG000BFCMR2,"NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted as Zacks Bull and Bear of the Day",2016-11-30 16:59:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hYLlfJM21c4/nvidia-sothebys-holdings-celgene-regeneron-pharmaceuticals-and-sanofi-highlighted-as-zacks-bull-and-bear-of-the-day-cm715770,For Immediate Release Chicago IL November 30 2016 Zacks Equity Research highlights NVIDIA NASDAQ NVDA Free Report as the Bull of the Day and Sotheby s Holdings NYSE BID Free Report as the Bear of the Day In addition Zacks Equity Research provides analysis on
CELG,CELG:UW,BBG000BFCMR2,"NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted as Zacks Bull and Bear of the Day",2016-11-30 14:30:02 +0000,http://finance.yahoo.com/news/nvidia-sothebys-holdings-celgene-regeneron-143002420.html,"NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted as Zacks Bull and Bear of the Day"
CELG,CELG:UW,BBG000BFCMR2,Winners & losers from repealing Obamacare,2016-11-29 21:15:00 +0000,http://finance.yahoo.com/video/winners-losers-repealing-obamacare-211500280.html,Winners & losers from repealing Obamacare
CELG,CELG:UW,BBG000BFCMR2,Celgene vs. Regeneron: Which Stock is a Better Pick?,2016-11-29 16:58:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bTKRO7_m-dg/celgene-vs-regeneron-which-stock-is-a-better-pick-cm715163,It sure has been a tough year for biotech stocks but all that seems to have changed with the election results Companies like Celgene Corporation CELG and Regeneron Pharmaceuticals Inc REGN two key players in the industry have seen a surge in their share prices post election and
CELG,CELG:UW,BBG000BFCMR2,Celgene vs. Regeneron: Which Stock is a Better Pick?,2016-11-29 14:28:02 +0000,http://finance.yahoo.com/news/celgene-vs-regeneron-stock-better-142802306.html,Celgene vs. Regeneron: Which Stock is a Better Pick?
CELG,CELG:UW,BBG000BFCMR2,"Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More",2016-11-29 14:05:06 +0000,http://247wallst.com/investing/2016/11/29/top-analyst-upgrades-and-downgrades-ak-steel-celgene-darden-delphi-automotive-johnson-johnson-us-steel-and-more/,"Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More"
CELG,CELG:UW,BBG000BFCMR2,Humira Has Been a Key Growth Driver for AbbVie in 2016,2016-11-28 15:05:43 +0000,http://marketrealist.com/2016/11/humira-continues-key-growth-driver-abbvie-2016/?utm_source=yahoo&utm_medium=feed,Humira Has Been a Key Growth Driver for AbbVie in 2016
CELG,CELG:UW,BBG000BFCMR2,Gilead Sciences’s HCV Fall Was Partially Offset by HIV Business,2016-11-28 15:05:38 +0000,http://marketrealist.com/2016/11/gilead-sciencess-hcv-fall-was-partially-offset-by-hiv-business/?utm_source=yahoo&utm_medium=feed,Gilead Sciences’s HCV Fall Was Partially Offset by HIV Business
CELG,CELG:UW,BBG000BFCMR2,Celgene Stock Split: Is the Biotech Ready to Split Again?,2016-11-28 14:33:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C8dnWGHmg6c/celgene-stock-split-is-the-biotech-ready-to-split-again-cm714468,The biotechnology industry has been a huge growth engine for the stock market in recent years and Celgene NASDAQ CELG stands as one of the biggest players in the biotech industry The company behind treatments such as blood cancer drug Revlimid and psoriasis fighter Otezla has
CELG,CELG:UW,BBG000BFCMR2,Celgene Stock Split: Is the Biotech Ready to Split Again?,2016-11-28 13:43:05 +0000,http://www.fool.com/investing/2016/11/28/celgene-stock-split-is-the-biotech-ready-to-split.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Celgene Stock Split: Is the Biotech Ready to Split Again?
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Grow More Aggressive on Major Biotechs,2016-11-28 12:35:16 +0000,http://finance.yahoo.com/news/short-sellers-grow-more-aggressive-123516310.html,Short Sellers Grow More Aggressive on Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Merck & Co.,2016-11-25 15:07:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p5AsZWxDzCo/better-buy-celgene-corporation-vs-merck-co-cm713858,Over the past month Celgene NASDAQ CELG shares notched a gain of more than 20 while Merck amp Co NYSE MRK stock has risen about 17 year to date Both drugmakers have exciting futures in the oncology space With worldwide cancer medicine spending projected to rise
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Merck & Co.,2016-11-25 13:15:38 +0000,http://www.fool.com/investing/2016/11/25/better-buy-celgene-corporation-vs-merck-co.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Celgene Corporation vs. Merck & Co.
CELG,CELG:UW,BBG000BFCMR2,"Should You Light Up An Investment In Reynolds American, Inc. (RAI)?",2016-11-24 18:54:34 +0000,http://www.insidermonkey.com/blog/should-you-light-up-an-investment-in-reynolds-american-inc-rai-491007/,"Should You Light Up An Investment In Reynolds American, Inc. (RAI)?"
CELG,CELG:UW,BBG000BFCMR2,"More and More Hedge Funds Are Buying QUALCOMM, Inc. (QCOM)",2016-11-23 22:26:23 +0000,http://www.insidermonkey.com/blog/more-and-more-hedge-funds-are-buying-qualcomm-inc-qcom-489834/,"More and More Hedge Funds Are Buying QUALCOMM, Inc. (QCOM)"
CELG,CELG:UW,BBG000BFCMR2,What Happened in Biotech in 2016?,2016-11-23 21:44:34 +0000,http://www.fool.com/investing/2016/11/22/what-happened-in-biotech-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Happened in Biotech in 2016?
CELG,CELG:UW,BBG000BFCMR2,3 Biotechs That Don't Pay Dividends -- but Could,2016-11-23 20:14:40 +0000,http://www.fool.com/investing/2016/11/22/3-biotechs-that-dont-pay-dividends-but-could.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotechs That Don't Pay Dividends -- but Could
CELG,CELG:UW,BBG000BFCMR2,"Notable ETF Outflow Detected - TQQQ, INTC, KHC, CELG",2016-11-23 17:06:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-R6TOSocvBk/notable-etf-outflow-detected-tqqq-intc-khc-celg-cm713334,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the ProShares UltraPro QQQ Symbol TQQQ where we have detected an approximate 32 0 million dollar outflow that s a 2 8 decrease week over week from 9 000 000
CELG,CELG:UW,BBG000BFCMR2,3 Beaten-Down Biotech Stocks You Can Buy Right Now,2016-11-23 13:28:32 +0000,http://www.fool.com/investing/2016/11/22/3-beaten-down-biotech-stocks-you-can-buy-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Beaten-Down Biotech Stocks You Can Buy Right Now
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola",2016-11-23 13:05:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eaUft2HOB78/biotech-stock-roundup-acorda-stops-ampyra-pswd-development-crl-for-spectrums-qapzola-cm713105,With elections over and third quarter earnings season drawing to a close focus is back on pipeline and regulatory updates This week Acorda ACOR announced that it won t be continuing with the development of Ampyra for post stroke walking difficulties PSWD Meanwhile Spectrum SPPI got
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola",2016-11-23 11:31:11 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-acorda-stops-113111066.html,"Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola"
CELG,CELG:UW,BBG000BFCMR2,What Happened in Biotech in 2016?,2016-11-22 23:19:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jc0QNGC1rY8/what-happened-in-biotech-in-2016-cm713018,Image source Getty Images It s been a rollercoaster of a year for the biotech industry with the decline that started in the middle of last year continuing into this year a recovery from those lows after a few gyrations a pre election decline on fears of price controls and
CELG,CELG:UW,BBG000BFCMR2,3 Biotechs That Don't Pay Dividends -- but Could,2016-11-22 21:19:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/82jlcx1t41w/3-biotechs-that-dont-pay-dividends-but-could-cm712939,Biotech stocks aren t generally known for their dividends There are a few exceptions but as a rule most biotechs either don t have the ability to reward shareholders with dividends or they need the cash to fuel additional growth However some biotechs could easily pay dividends if
CELG,CELG:UW,BBG000BFCMR2,Why some of tech's biggest billionaires are searching for fountain of youth,2016-11-22 18:08:07 +0000,http://www.cnbc.com/id/104122009?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104122009,Why some of tech's biggest billionaires are searching for fountain of youth
CELG,CELG:UW,BBG000BFCMR2,Inside Bristol’s Key to Success: Multiple Labels for Opdivo,2016-11-22 15:04:21 +0000,http://marketrealist.com/2016/11/inside-bristols-key-to-success-multiple-labels-for-opdivo/?utm_source=yahoo&utm_medium=feed,Inside Bristol’s Key to Success: Multiple Labels for Opdivo
CELG,CELG:UW,BBG000BFCMR2,Will This Franchise Lead Celgene To Over $20 Billion in Revenue?,2016-11-22 14:19:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Tok8-UWNZU/will-this-franchise-lead-celgene-to-over-20-billion-in-revenue-cm712493,Celgene NASDAQ CELG has done what many biotechs can only dream of establish itself as a major player in oncology with one of the best selling drugs in the industry 160 This drug Revlimid anchors the company s hematology business with over 6 billion in revenue and
CELG,CELG:UW,BBG000BFCMR2,Will This Franchise Lead Celgene To Over $20 Billion in Revenue?,2016-11-22 13:28:15 +0000,http://www.fool.com/investing/2016/11/22/will-this-franchise-lead-celgene-to-over-20-billio.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Will This Franchise Lead Celgene To Over $20 Billion in Revenue?
CELG,CELG:UW,BBG000BFCMR2,Nearly 350 Abstracts Evaluating Celgene Therapies to Be Presented at American Society of Hematology Annual Meeting (ASH),2016-11-22 12:30:00 +0000,http://finance.yahoo.com/news/nearly-350-abstracts-evaluating-celgene-123000397.html,"[Business Wire] - Celgene Corporation today announced that data from nearly 350 abstracts, including more than 150 oral presentations, evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 58th American Society of Hematology Annual Meeting between Dec."
CELG,CELG:UW,BBG000BFCMR2,Cramer: Trump Rally is a FANG + FANG Affair,2016-11-22 00:01:00 +0000,http://realmoney.thestreet.com/articles/11/21/2016/cramer-trump-rally-fang-fang-affair?puc=yahoo&cm_ven=YAHOO,Cramer: Trump Rally is a FANG + FANG Affair
CELG,CELG:UW,BBG000BFCMR2,3 Irrefutable Reasons to Sell Johnson & Johnson Stock,2016-11-21 23:18:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NMG5S6a9sGM/3-irrefutable-reasons-to-sell-johnson-johnson-stock-cm712362,Johnson amp Johnson NYSE JNJ has arguably been one of the best stocks to own for years The company claims multiple successful brands from Aveeno to Zytiga But as much as I like J amp J investors might want to consider selling the stock Here are three irrefutable reasons
CELG,CELG:UW,BBG000BFCMR2,3 Irrefutable Reasons to Sell Johnson & Johnson Stock,2016-11-21 21:33:27 +0000,http://www.fool.com/investing/2016/11/21/3-irrefutable-reasons-to-sell-johnson-johnson-stoc.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Irrefutable Reasons to Sell Johnson & Johnson Stock
CELG,CELG:UW,BBG000BFCMR2,"Amgen, Biogen, Celgene Eye M&A In Trump's 'Pro-Biotech' World",2016-11-21 21:07:25 +0000,http://www.investors.com/news/technology/amgen-biogen-celgene-eye-ma-in-trumps-pro-biotech-world/,"Amgen, Biogen, Celgene Eye M&A In Trump's 'Pro-Biotech' World"
CELG,CELG:UW,BBG000BFCMR2,Agios Presents Data from Dose Expansion Study of AG-120,2016-11-21 15:52:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pnlu8hHVlXE/agios-presents-data-from-dose-expansion-study-of-ag-120-cm711888,Agios Pharmaceuticals Inc AGIO announced first data from a phase I study on AG 120 an oral first in class IDH1 mutant inhibitor which is being evaluated as a single agent for the treatment of isocitrate dehydrogenase 1 IDH1 mutant positive glioma and chondrosarcoma The study is part
CELG,CELG:UW,BBG000BFCMR2,Agios Presents Data from Dose Expansion Study of AG-120,2016-11-21 14:00:02 +0000,http://finance.yahoo.com/news/agios-presents-data-dose-expansion-140002372.html,Agios Presents Data from Dose Expansion Study of AG-120
CELG,CELG:UW,BBG000BFCMR2,Celgene Buys Brain Cancer Drug from Triphase (CELG),2016-11-21 12:55:00 +0000,http://www.investopedia.com/news/celgene-acquires-brain-cancer-drug-celg/?partner=YahooSA,Celgene Buys Brain Cancer Drug from Triphase (CELG)
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Webcast an Analyst and Investor Event from the American Society of Hematology Meeting in December,2016-11-21 12:40:08 +0000,http://www.publicnow.com/view/35FA19A6D211FC20B1774609E1EE08706D0DCCC9,"[at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) plans to webcast an analyst and investor event being held at the American Society of Hematology (ASH) meeting in San Diego on December ..."
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Bristol-Myers Squibb,2016-11-19 17:05:52 +0000,http://www.fool.com/investing/2016/11/18/better-buy-celgene-corporation-vs-bristol-myers-sq.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Celgene Corporation vs. Bristol-Myers Squibb
CELG,CELG:UW,BBG000BFCMR2,3 Beaten-Down Biotech Stocks to Buy for Huge Gains,2016-11-18 21:50:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0juU5e11Db4/3-beaten-down-biotech-stocks-to-buy-for-huge-gains-cm710891,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips In addition to financial stocks the healthcare sector and biotech stocks breathed a collective sigh of relief following the election of Donald Trump as President It is widely believed that a secular trend
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Juno Therapeutics vs. bluebird bio,2016-11-18 21:23:31 +0000,http://www.fool.com/investing/2016/11/17/better-buy-juno-therapeutics-vs-bluebird-bio.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Juno Therapeutics vs. bluebird bio
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Celgene Corporation vs. Bristol-Myers Squibb,2016-11-18 18:51:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-wA2EsLYRd8/better-buy-celgene-corporation-vs-bristol-myers-squibb-cm711370,Celgene NASDAQ CELG and Bristol Myers Squibb NYSE BMY have gained plenty of attention recently as great healthcare value plays My colleague Sean Williams included both stocks in his list of four top drug stocks that can be purchased on the cheap this fall David
CELG,CELG:UW,BBG000BFCMR2,How's Life For The Other Half Of The Big Cap 20?,2016-11-18 17:55:34 +0000,http://www.investors.com/stock-lists/ibd-big-cap-20/hows-life-for-the-other-half-of-the-big-cap-20/,How's Life For The Other Half Of The Big Cap 20?
CELG,CELG:UW,BBG000BFCMR2,7 Top Stocks to Buy With Trump As President,2016-11-18 15:51:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fg8oGy5KIqc/7-top-stocks-to-buy-with-trump-as-president-cm711204,Image source Disney ABC Television Group via Flickr It s official The craziest election we ve probably ever seen on American soil is history and Donald Trump a man with no prior political or military background is about to become the 45th president of the United States
CELG,CELG:UW,BBG000BFCMR2,7 Top Stocks to Buy With Trump As President,2016-11-18 14:24:08 +0000,http://www.fool.com/investing/2016/11/18/7-top-stocks-to-buy-with-trump-as-president.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,7 Top Stocks to Buy With Trump As President
CELG,CELG:UW,BBG000BFCMR2,Cramer: Why Are These Stocks Doing Well?,2016-11-18 00:17:00 +0000,http://realmoney.thestreet.com/articles/11/17/2016/cramer-why-are-these-stocks-doing-well?puc=yahoo&cm_ven=YAHOO,Cramer: Why Are These Stocks Doing Well?
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Juno Therapeutics vs. bluebird bio,2016-11-17 22:50:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vGyfin9O4qY/better-buy-juno-therapeutics-vs-bluebird-bio-cm710879,Image source Getty Images This round of our ongoing Better Buy series pits two up and coming biotechs Juno Therapeutics NASDAQ JUNO and bluebird bio NASDAQ BLUE against each other Platforms in the making Both Juno Therapeutics and Bluebird are developing
CELG,CELG:UW,BBG000BFCMR2,Celgene Rally Is No Flash in the Pan; More Gains to Come,2016-11-17 18:03:00 +0000,http://realmoney.thestreet.com/articles/11/17/2016/celgene-rally-no-flash-pan-more-gains-come?puc=yahoo&cm_ven=YAHOO,Celgene Rally Is No Flash in the Pan; More Gains to Come
CELG,CELG:UW,BBG000BFCMR2,3 Compelling Reasons to Buy Celgene Corporation Stock Right Now,2016-11-17 16:04:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P27Nz3RBrVw/3-compelling-reasons-to-buy-celgene-corporation-stock-right-now-cm710581,If I didn t already own shares of Celgene NASDAQ CELG it would probably be the top stock on my list to buy There are plenty of reasons why buying this biotech stock makes sense including sustained growth of its blockbuster blood cancer drug But Celgene isn t just
CELG,CELG:UW,BBG000BFCMR2,3 Compelling Reasons to Buy Celgene Corporation Stock Right Now,2016-11-17 14:49:06 +0000,http://www.fool.com/investing/2016/11/17/3-compelling-reasons-to-buy-celgene-corporation-st.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Compelling Reasons to Buy Celgene Corporation Stock Right Now
CELG,CELG:UW,BBG000BFCMR2,"The Art Of Portfolio Management: Fewer Stocks, The Best Way To A Big Return",2016-11-15 21:19:09 +0000,http://www.investors.com/how-to-invest/investors-corner/the-art-of-portfolio-management-fewer-stocks-the-best-way-to-a-big-return/,"The Art Of Portfolio Management: Fewer Stocks, The Best Way To A Big Return"
CELG,CELG:UW,BBG000BFCMR2,Xtandi Is Expected to Witness Strong Growth Trends Going Forward,2016-11-15 15:04:47 +0000,http://marketrealist.com/2016/11/xtandi-expected-witness-strong-growth-trends-future-years/?utm_source=yahoo&utm_medium=feed,Xtandi Is Expected to Witness Strong Growth Trends Going Forward
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Biogen Inc. vs. Celgene Corporation,2016-11-15 13:28:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IhaX6gHLg9s/better-buy-biogen-inc-vs-celgene-corporation-cm709146,This year might have started off poorly for biotech stocks but things have certainly changed after the surprising election results Two of the biggest biotechs around Biogen NASDAQ BIIB and Celgene NASDAQ CELG are now enjoying nice runs Which of these two stocks is
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Biogen Inc. vs. Celgene Corporation,2016-11-15 12:40:15 +0000,http://www.fool.com/investing/2016/11/15/better-buy-biogen-inc-vs-celgene-corporation.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Biogen Inc. vs. Celgene Corporation
CELG,CELG:UW,BBG000BFCMR2,Celgene To Present At Stifel Nicolaus Weisel Conference; Webcast At 8:45 AM ET,2016-11-15 07:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eFsB41iYwOg/celgene-to-present-at-stifel-nicolaus-weisel-conference-webcast-at-845-am-et-20161115-00373,Celgene To Present At Stifel Nicolaus Weisel Conference; Webcast At 8:45 AM ET
CELG,CELG:UW,BBG000BFCMR2,Data on Early Onset of Efficacy for Oral OTEZLA® (apremilast) in Active Psoriatic Arthritis Presented at American College of Rheumatology,2016-11-14 12:30:00 +0000,http://finance.yahoo.com/news/data-early-onset-efficacy-oral-123000302.html,"[Business Wire] - Celgene Corporation today announced findings from the ACTIVE phase 3b clinical trial of OTEZLA® , the Company's oral, selective inhibitor of phosphodiesterase 4 , at the 2016 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting in Washington, D.C."
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics On a Roll in Q3 with Celgene's Cash and Lift of Clinical Hold,2016-11-12 18:26:50 +0000,http://www.fool.com/investing/2016/11/11/juno-therapeutics-on-a-roll-in-q3-with-celgenes-ca.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Juno Therapeutics On a Roll in Q3 with Celgene's Cash and Lift of Clinical Hold
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks You MUST Buy for Donald Trump’s Presidency,2016-11-11 20:29:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XGKLDkkun44/3-biotech-stocks-you-must-buy-for-donald-trumps-presidency-cm707294,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The biotech industry has been dealt a Trump card Wednesday Now it s your turn to vote and go long in a much more hospitable environment in these three large cap biotech stocks Source Pixelbay
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics On a Roll in Q3 with Celgene's Cash and Lift of Clinical Hold,2016-11-11 20:28:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9gIrlIpjoMY/juno-therapeutics-on-a-roll-in-q3-with-celgenes-cash-and-lift-of-clinical-hold-cm708052,Juno Therapeutics NASDAQ JUNO announced its third quarter earnings results on Wednesday after the market closed Shares of the biotech were already soaring in response to the outcome of the U S elections That uptrend continued after Juno provided an update on its third
CELG,CELG:UW,BBG000BFCMR2,Juno Therapeutics (JUNO) Q3 Loss Narrower than Expected,2016-11-11 15:16:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z-EY87SM77g/juno-therapeutics-juno-q3-loss-narrower-than-expected-cm707707,Juno Therapeutics Inc JUNO reported a loss of 58 cents per share including stock based compensation expense in the third quarter of 2016 narrower than the Zacks Consensus Estimate loss of 64 cents However quarterly loss widened from the year ago figure of 53 cents The company
CELG,CELG:UW,BBG000BFCMR2,"Drug Stocks' Q3 Earnings to Watch on Nov 14: ARGS, AST",2016-11-11 14:16:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8zvFArW39Zc/drug-stocks-q3-earnings-to-watch-on-nov-14-args-ast-cm707722,With 89 of the S amp P 500 members having already reported their results the Q3 reporting cycle is soon to wrap up Though earnings and revenue growth for the reported index members is still low an improvement over other recent periods is palpable In fact it is being said that the
CELG,CELG:UW,BBG000BFCMR2,Can The Uptrend Continue for Celgene (CELG)?,2016-11-10 21:15:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5HEbOJPW_as/can-the-uptrend-continue-for-celgene-celg-cm707244,Investors certainly have to be happy with Celgene Corporation CELG and its short term performance After all the stock has jumped by 20 in the past 4 weeks and it is also above its 20 Day Simple Moving Average as well This is certainly a good trend but investors are probably
CELG,CELG:UW,BBG000BFCMR2,3 Reasons to Sell Biogen,2016-11-10 17:03:30 +0000,http://www.fool.com/investing/2016/11/10/3-reasons-to-sell-biogen.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons to Sell Biogen
CELG,CELG:UW,BBG000BFCMR2,Can The Uptrend Continue for Celgene (CELG)?,2016-11-10 16:23:04 +0000,http://finance.yahoo.com/news/uptrend-continue-celgene-celg-162304477.html,Can The Uptrend Continue for Celgene (CELG)?
CELG,CELG:UW,BBG000BFCMR2,Drug Stocks Surge on Trump Win: 5 Stocks to Buy Now,2016-11-10 15:56:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e8xd6YkfwdM/drug-stocks-surge-on-trump-win-5-stocks-to-buy-now-cm707089,The Presidential election is finally over and the stock market has reacted favorably to Donald Trump s surprise win with the S amp P 500 rising 1 1 the Dow Jones Industrial Average surging 1 4 and the NASDAQ gaining 1 1 Finance energy pharma biotech financial services
CELG,CELG:UW,BBG000BFCMR2,5 Top Biotech Stocks to Buy on Trump Victory,2016-11-10 14:57:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8lUDtamTPqM/5-top-biotech-stocks-to-buy-on-trump-victory-cm706999,Tougher action on drug pricing by Democrat Hillary Clinton had clouded the outlook for biotech stocks this year But the startling win of Republican Donald Trump dissipated the fears Also biotech stocks recovered from a sharp sell off witnessed over the past one year Trump s plan to
CELG,CELG:UW,BBG000BFCMR2,Drug Stocks Surge on Trump Win: 5 Stocks to Buy Now,2016-11-10 13:31:01 +0000,http://finance.yahoo.com/news/drug-stocks-surge-trump-win-133101328.html,Drug Stocks Surge on Trump Win: 5 Stocks to Buy Now
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Grow More Selective on Major Biotechs,2016-11-10 12:20:09 +0000,http://finance.yahoo.com/news/short-sellers-grow-more-selective-122009544.html,Short Sellers Grow More Selective on Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,"Jim Cramer's Top Takeaways: Chipotle, Merck, Pfizer",2016-11-10 11:00:00 +0000,https://www.thestreet.com/story/13753587/1/jim-cramer-s-top-takeaways-chipotle-merck-pfizer.html?puc=yahoo&cm_ven=YAHOO,"Jim Cramer's Top Takeaways: Chipotle, Merck, Pfizer"
CELG,CELG:UW,BBG000BFCMR2,Cramer turns bullish on drug stocks with Trump in the White House,2016-11-09 23:30:06 +0000,http://www.cnbc.com/id/104094621?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104094621,Cramer turns bullish on drug stocks with Trump in the White House
CELG,CELG:UW,BBG000BFCMR2,Why These Biotechs Are Soaring Today,2016-11-09 22:54:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZJGGZxGdoIE/why-these-biotechs-are-soaring-today-cm706827,Image source Getty Images What happened Juno Therapeutics NASDAQ JUNO Vertex Pharmaceuticals NASDAQ VRTX BioMarin Pharmaceutical NASDAQ BMRN and Celgene NASDAQ CELG were all up at least 10 as of 2 58 p m after Donald Trump won the U
CELG,CELG:UW,BBG000BFCMR2,"Biotech, Drug Stocks Fly On Clinton Loss, But 'Trump Uncertainty'",2016-11-09 21:33:40 +0000,http://www.investors.com/research/ibd-industry-themes/biotechs-drugs-fly-on-clinton-defeat-but-trump-uncertainty-lingers/,"Biotech, Drug Stocks Fly On Clinton Loss, But 'Trump Uncertainty'"
CELG,CELG:UW,BBG000BFCMR2,Why These Biotechs Are Soaring Today,2016-11-09 21:10:59 +0000,http://www.fool.com/investing/2016/11/09/why-these-biotechs-are-soaring-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why These Biotechs Are Soaring Today
CELG,CELG:UW,BBG000BFCMR2,"Pharma, biotech shares soar as Trump win calms pricing talk",2016-11-09 19:41:13 +0000,http://sg.finance.yahoo.com/news/trump-win-boosts-drug-stocks-134606929.html,"Pharma, biotech shares soar as Trump win calms pricing talk"
CELG,CELG:UW,BBG000BFCMR2,How a Donald Trump Presidency Could Affect Biotech Stocks,2016-11-09 18:54:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ch66dk87DsQ/how-a-donald-trump-presidency-could-affect-biotech-stocks-cm706631,Image source 160 Flickr user Jamelle Bouie Hillary Clinton has not been a friend to biotechnology stocks on the campaign trail and as as result investors have sold off biotech stocks in anticipation of her winning the Presidency Now that Donald Trump has successfully upset
CELG,CELG:UW,BBG000BFCMR2,Biotech: Is Today's Trump Rally Just the Beginning?,2016-11-09 18:18:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/09/biotech-is-todays-trump-rally-just-the-beginning/?mod=yahoobarrons&ru=yahoo,Biotech: Is Today's Trump Rally Just the Beginning?
CELG,CELG:UW,BBG000BFCMR2,S&P 500 Analyst Moves: CELG,2016-11-09 17:53:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NIyokXGSLkA/sp-500-analyst-moves-celg-cm706532,The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S amp P 500 index Celgene Corp CELG is now the 15 analyst pick moving up by 6 spots This rank is formed by averaging the analyst opinions for each component from each
CELG,CELG:UW,BBG000BFCMR2,How a Donald Trump Presidency Could Affect Biotech Stocks,2016-11-09 17:21:07 +0000,http://www.fool.com/investing/2016/11/09/how-a-donald-trump-presidency-could-affect-biotech.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,How a Donald Trump Presidency Could Affect Biotech Stocks
CELG,CELG:UW,BBG000BFCMR2,How Did Regeneron Perform in 3Q16?,2016-11-09 15:48:00 +0000,http://marketrealist.com/2016/11/how-did-regeneron-perform-in-3q16/?utm_source=yahoo&utm_medium=feed,How Did Regeneron Perform in 3Q16?
CELG,CELG:UW,BBG000BFCMR2,The Market Offers Some Opportunities but They're Disappearing Fast,2016-11-09 15:19:00 +0000,http://realmoney.thestreet.com/articles/11/09/2016/market-offers-some-opportunities-theyre-disappearing-fast?puc=yahoo&cm_ven=YAHOO,The Market Offers Some Opportunities but They're Disappearing Fast
CELG,CELG:UW,BBG000BFCMR2,When Is The PEG Ratio Superior To The P/E Ratio? (Part 2),2016-11-09 14:52:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yBcvpsWxs8k/when-is-the-peg-ratio-superior-to-the-pe-ratio-part-2-cm702956,By Chuck Carnevale ByChuck Carnevale Introduction IntroductionIntroduction Financial metrics such as P E ratios price to cash flow ratios PEG ratios price to sales ratios price to book value and many others should be thought of as tools in the investor s toolbox They can all
CELG,CELG:UW,BBG000BFCMR2,Drug & Biotech Stocks Leap After Hillary Clinton''s Election Defeat,2016-11-09 09:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uFQavD9grdA/drug--biotech-stocks-leap-after-hillary-clintons-election-defeat-20161109-00724,Drug & Biotech Stocks Leap After Hillary Clinton''s Election Defeat
CELG,CELG:UW,BBG000BFCMR2,Pharma Stocks Gain on U.S. Election Result,2016-11-09 08:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f1S-IrJZIDQ/pharma-stocks-gain-on-us-election-result-20161109-00570,Pharma Stocks Gain on U.S. Election Result
CELG,CELG:UW,BBG000BFCMR2,3 Stocks Set to Thrive in Pharma's New Price-Conscious World,2016-11-09 00:19:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UzXqjV9yn0E/3-stocks-set-to-thrive-in-pharmas-new-price-conscious-world-cm706017,Image source Getty Images With both presidential nominees pushing for 160 drug price reform investors need to start protecting themselves There s no need to dump all your pharma holdings you may want to pull away from those that lean on eye popping price increases on old drugs
CELG,CELG:UW,BBG000BFCMR2,Biotech ETFs Slumping on Q3 Results,2016-11-09 00:07:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IFQ3FMbTTLY/biotech-etfs-slumping-on-q3-results-cm706018,The biotech sector has faced rough trading since the beginning of 2016 continuing the volatile trend from the second half of 2015 Media and political focus on the high prices of drugs and increasing competition have made things difficult for the sector Democratic presidential candidate
CELG,CELG:UW,BBG000BFCMR2,3 Stocks Set to Thrive in Pharma's New Price-Conscious World,2016-11-08 21:50:03 +0000,http://www.fool.com/investing/2016/11/08/3-stocks-set-to-thrive-in-pharmas-new-price-consci.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks Set to Thrive in Pharma's New Price-Conscious World
CELG,CELG:UW,BBG000BFCMR2,Biogen's Growth Is Far Weaker Than You May Think,2016-11-08 21:39:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vUfNSpTN7LA/biogens-growth-is-far-weaker-than-you-may-think-cm705856,Image source Getty Images Over the past year Biogen s NASDAQ BIIB stock has essentially traded sideways due to the increasingly competitive landscape facing its flagship multiple sclerosis treatment franchise which includes key drugs like Tecfidera and Avonex The biotech s
CELG,CELG:UW,BBG000BFCMR2,"Can Small-Cap Biotech Take On Gilead, Celgene, Biogen In Alzheimer's?",2016-11-08 21:24:30 +0000,http://www.investors.com/news/technology/can-this-small-cap-biotech-take-on-gilead-celgene-biogen-in-alzheimers/,"Can Small-Cap Biotech Take On Gilead, Celgene, Biogen In Alzheimer's?"
CELG,CELG:UW,BBG000BFCMR2,Biotechs Climb For Third Straight Day; Which Leaders Are Buyable?,2016-11-08 21:03:18 +0000,http://www.investors.com/news/technology/biotechs-climb-for-third-straight-day-which-leaders-are-buyable/,Biotechs Climb For Third Straight Day; Which Leaders Are Buyable?
CELG,CELG:UW,BBG000BFCMR2,Biotech ETFs Slumping on Q3 Results,2016-11-08 20:26:08 +0000,http://finance.yahoo.com/news/biotech-etfs-slumping-q3-results-202608322.html,Biotech ETFs Slumping on Q3 Results
CELG,CELG:UW,BBG000BFCMR2,iShares Global Healthcare ETF Experiences Big Outflow,2016-11-08 19:36:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SzAQiKICFpQ/ishares-global-healthcare-etf-experiences-big-outflow-cm705689,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Global Healthcare ETF Symbol IXJ where we have detected an approximate 136 9 million dollar outflow that s a 9 5 decrease week over week
CELG,CELG:UW,BBG000BFCMR2,Is Juno Therapeutics a Bargain or a Value Trap?,2016-11-08 18:59:00 +0000,http://www.fool.com/investing/2016/11/07/is-juno-therapeutics-a-bargain-or-a-value-trap.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Juno Therapeutics a Bargain or a Value Trap?
CELG,CELG:UW,BBG000BFCMR2,Gilead Sciences' Next Challenge to Incyte's Myelofibrosis Drug Dominance,2016-11-08 18:47:00 +0000,https://www.thestreet.com/story/13885447/1/gilead-sciences-next-challenge-to-incyte-s-myelofibrosis-drug-dominance.html?puc=yahoo&cm_ven=YAHOO,Gilead Sciences' Next Challenge to Incyte's Myelofibrosis Drug Dominance
CELG,CELG:UW,BBG000BFCMR2,Biogen's Growth Is Far Weaker Than You May Think,2016-11-08 17:37:35 +0000,http://www.fool.com/investing/2016/11/08/biogens-growth-is-far-weaker-than-you-may-think.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Biogen's Growth Is Far Weaker Than You May Think
CELG,CELG:UW,BBG000BFCMR2,Celgene Is a High Quality Company Selling at a Discount,2016-11-08 16:00:00 +0000,http://realmoney.thestreet.com/articles/11/08/2016/celgene-high-quality-company-selling-discount?puc=yahoo&cm_ven=YAHOO,Celgene Is a High Quality Company Selling at a Discount
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : November 8, 2016",2016-11-08 13:00:19 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-breached-its-50-day-moving-average-in-a-bullish-manner-celg-us-november-8-2016/,"Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : November 8, 2016"
CELG,CELG:UW,BBG000BFCMR2,Celgene To Present At Credit Suisse Conference; Webcast At 11:30 AM ET,2016-11-08 10:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hSbUG_IhKX8/celgene-to-present-at-credit-suisse-conference-webcast-at-1130-am-et-20161108-00783,Celgene To Present At Credit Suisse Conference; Webcast At 11:30 AM ET
CELG,CELG:UW,BBG000BFCMR2,"Zacks Industry Outlook Highlights: Bristol-Myers, Biogen, Merck, Celgene and ARIAD Pharmaceuticals",2016-11-08 00:56:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G2GYMALdCpQ/zacks-industry-outlook-highlights-bristol-myers-biogen-merck-celgene-and-ariad-pharmaceuticals-cm705007,For Immediate Release Chicago IL November 07 2016 Today Zacks Equity Research discusses the Pharmaceuticals Part 2 including Bristol Myers NYSE BMY Free Report Biogen NASDAQ BIIB Free Report Merck amp Co Inc NYSE MRK Free Report
CELG,CELG:UW,BBG000BFCMR2,Cramer: The market doesn't love Hillary Clinton — here's where money is flowing,2016-11-07 23:15:05 +0000,http://www.cnbc.com/id/104060464?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104060464,Cramer: The market doesn't love Hillary Clinton — here's where money is flowing
CELG,CELG:UW,BBG000BFCMR2,2 Reasons Why the iShares NASDAQ Biotechnology Index (ETF) Tumbled 11% in October,2016-11-07 19:55:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ttbyiRkvzAw/2-reasons-why-the-ishares-nasdaq-biotechnology-index-etf-tumbled-11-in-october-cm705200,Image source Getty Images What happened Shares of the iShares NASDAQ Biotechnology Index NASDAQ IBB a comprehensive and widely followed electronic traded fund ETF that tracks the performance of the largest biotech companies tumbled 11 in October according to data
CELG,CELG:UW,BBG000BFCMR2,Is Juno Therapeutics a Bargain or a Value Trap?,2016-11-07 19:53:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/27Yn1uKBC5U/is-juno-therapeutics-a-bargain-or-a-value-trap-cm705173,Image source Getty Images What happened Shares of the clinical stage biotech Juno Therapeutics NASDAQ JUNO tumbled by more than 18 in October 160 according to data from S amp P Global Market Intelligence JUNO data by
CELG,CELG:UW,BBG000BFCMR2,"Zacks Industry Outlook Highlights: Bristol-Myers, Biogen, Merck, Celgene and ARIAD Pharmaceuticals",2016-11-07 14:30:02 +0000,http://finance.yahoo.com/news/zacks-industry-outlook-highlights-bristol-143002199.html,"Zacks Industry Outlook Highlights: Bristol-Myers, Biogen, Merck, Celgene and ARIAD Pharmaceuticals"
CELG,CELG:UW,BBG000BFCMR2,3 Best Biotech Stocks of the 21st Century (So Far),2016-11-07 04:52:07 +0000,http://www.fool.com/investing/2016/11/06/3-best-biotech-stocks-of-the-21st-century-so-far.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Best Biotech Stocks of the 21st Century (So Far)
CELG,CELG:UW,BBG000BFCMR2,"MorphoSys AG Posts 9-month Loss, Adj. Revenues Up 5%; Confirms 2016 Guidance",2016-11-07 01:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i8NwMvUrpdo/morphosys-ag-posts-9month-loss-adj-revenues-up-5-confirms-2016-guidance-20161107-00374,"MorphoSys AG Posts 9-month Loss, Adj. Revenues Up 5%; Confirms 2016 Guidance"
CELG,CELG:UW,BBG000BFCMR2,3 Top Healthcare Stocks to Own If Donald Trump Becomes President,2016-11-06 21:47:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sbwXM8KB3SI/3-top-healthcare-stocks-to-own-if-donald-trump-becomes-president-cm704609,Just a few days ago FiveThirtyEight baseball columnist Rob Arthur wrote that the Chicago Cubs had a smaller chance of winning the World Series than Donald Trump had for winning the presidency Now the Cubs are champions And Trump has a reasonably good shot at winning also What
CELG,CELG:UW,BBG000BFCMR2,3 Best Biotech Stocks of the 21st Century (So Far),2016-11-06 18:52:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UQLz8fuKv0Y/3-best-biotech-stocks-of-the-21st-century-so-far-cm704596,Many biotech stocks have generated incredible returns in recent years but which are the best biotech stocks of the 21st century This will exclude companies that haven t traded publicly since the turn of the century or have market caps below 250 million which weeds out many biotechs
CELG,CELG:UW,BBG000BFCMR2,Friday Wasn't Bad; Amazon-Induced Woes: Best of Kass,2016-11-05 01:00:00 +0000,https://www.thestreet.com/story/13882286/1/friday-wasn-t-bad-amazon-induced-woes-best-of-kass.html?puc=yahoo&cm_ven=YAHOO,Friday Wasn't Bad; Amazon-Induced Woes: Best of Kass
CELG,CELG:UW,BBG000BFCMR2,Tracking ETF Losers Can Be Valuable To Your Investment Strategy,2016-11-04 22:48:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FQUV0eX6cRo/tracking-etf-losers-can-be-valuable-to-your-investment-strategy-cm704436,What are ETF investors fretting about these days A whole lot but mostly over 160 the stubborn fact that there are few bargains to be had across the broad U S stock market and broad fixed income market I have been confronted in almost every client conversation I have with
CELG,CELG:UW,BBG000BFCMR2,Franklin DynaTech's Matthew Moberg Wins With Stocks Of Innovators,2016-11-04 22:48:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DEXMHo2ApOo/franklin-dynatechs-matthew-moberg-wins-with-stocks-of-innovators-cm704433,Leading tech stocks tumbled last week as mutual funds sold shares in the likes of Facebook Apple Amazon and Google But the manager of 3 billion Franklin DynaTech Fund an IBD Best Mutual Fund 2016 Award winner isn t panicking Judging by DynaTech s FKDNX lowly
CELG,CELG:UW,BBG000BFCMR2,Digging Into Four Large Caps,2016-11-04 22:46:00 +0000,https://www.thestreet.com/story/13881439/1/digging-into-four-large-caps.html?puc=yahoo&cm_ven=YAHOO,Digging Into Four Large Caps
CELG,CELG:UW,BBG000BFCMR2,Franklin DynaTech's Matthew Moberg Wins With Stocks Of Innovators,2016-11-04 21:25:23 +0000,http://www.investors.com/etfs-and-funds/mutual-funds/franklin-dynatechs-matthew-moberg-wins-with-stocks-of-innovators/,Franklin DynaTech's Matthew Moberg Wins With Stocks Of Innovators
CELG,CELG:UW,BBG000BFCMR2,When Is The PEG Ratio Superior To The P/E Ratio? Part 2,2016-11-04 20:02:00 +0000,http://www.insidermonkey.com/blog/when-is-the-peg-ratio-superior-to-the-pe-ratio-part-2-484997/,When Is The PEG Ratio Superior To The P/E Ratio? Part 2
CELG,CELG:UW,BBG000BFCMR2,Why Celgene Corp Is a Better Buy Than Gilead Sciences,2016-11-04 19:54:06 +0000,http://www.fool.com/investing/2016/11/03/why-celgene-corp-is-a-better-buy-than-gilead-scien.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Celgene Corp Is a Better Buy Than Gilead Sciences
CELG,CELG:UW,BBG000BFCMR2,11 improving health-care companies whose stocks are loved by analysts,2016-11-04 18:17:59 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=B5AB84B4-9BA5-11E6-A1F3-C7B5B4B04643&siteid=yhoof2,11 improving health-care companies whose stocks are loved by analysts
CELG,CELG:UW,BBG000BFCMR2,Time To Buy Healthcare Stocks,2016-11-04 00:06:00 +0000,http://www.forbes.com/sites/bryanrich/2016/11/03/time-to-buy-healthcare-stocks/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Time To Buy Healthcare Stocks
CELG,CELG:UW,BBG000BFCMR2,Why Celgene Corp Is a Better Buy Than Gilead Sciences,2016-11-03 21:08:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tsknLK6xbUg/why-celgene-corp-is-a-better-buy-than-gilead-sciences-cm703624,Image source Getty Images Over the past five years there have perhaps been no large cap biotech companies that have been as successful as Celgene Corp NASDAQ CELG and Gilead Sciences NASDAQ GILD New drug launches have resulted in sales and profit surging higher at
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Dow Chemical, Celgene, Ford, BB&T and Sony",2016-11-03 18:08:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q0kO52eoe-A/the-zacks-analyst-blog-highlights-dow-chemical-celgene-ford-bbt-and-sony-cm703476,For Immediate Release Chicago IL November 03 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,How calls are playing Celgene upside,2016-11-03 16:14:10 +0000,http://finance.yahoo.com/news/celgene-calls-betting-gains-161410793.html,How calls are playing Celgene upside
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Dow Chemical, Celgene, Ford, BB&T and Sony",2016-11-03 16:01:04 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-dow-160104504.html,"The Zacks Analyst Blog Highlights: Dow Chemical, Celgene, Ford, BB&T and Sony"
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Ziopharm Oncology, Inc. vs. Juno Therapeutics",2016-11-03 15:54:30 +0000,http://www.fool.com/investing/2016/11/03/better-buy-ziopharm-oncology-inc-vs-juno-therapeut.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Ziopharm Oncology, Inc. vs. Juno Therapeutics"
CELG,CELG:UW,BBG000BFCMR2,Will Juno Therapeutics (JUNO) Disappoint in Q3 Earnings?,2016-11-03 14:10:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v_398me66Yw/will-juno-therapeutics-juno-disappoint-in-q3-earnings-cm703257,Juno Therapeutics Inc JUNO will be reporting third quarter 2016 results on Nov 9 after the market closes Last quarter the company posted a negative earnings surprise of 27 5 The company started trading in Dec 2014 So far it has had a poor track record with the company
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stock Roundup: Amgen Down on Enbrel Sales, Regeneron's Sarilumab Faces Delay",2016-11-03 14:09:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IvrO7ewrYvE/biotech-stock-roundup-amgen-down-on-enbrel-sales-regenerons-sarilumab-faces-delay-cm703242,Third quarter earnings season is in full flow with several major biotech companies including Gilead GILD and Amgen AMGN reporting results Meanwhile companies like TESARO TSRO and Regeneron REGN provided regulatory updates while TESARO submitted a regulatory application for its
CELG,CELG:UW,BBG000BFCMR2,Agios (AGIO) Posts Wider-than-Expected Loss in Q3,2016-11-03 13:15:01 +0000,http://finance.yahoo.com/news/agios-agio-posts-wider-expected-131501397.html,Agios (AGIO) Posts Wider-than-Expected Loss in Q3
CELG,CELG:UW,BBG000BFCMR2,Four Large Cap Stocks That Appear Ready to Rebound,2016-11-02 20:48:00 +0000,http://www.thestreet.com/video/13877631/four-large-cap-stocks-that-appear-ready-to-rebound.html?puc=yahoov&cm_ven=YAHOOV,Four Large Cap Stocks That Appear Ready to Rebound
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for Celgene, Ford & Dow Chemical",2016-11-02 20:08:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4ICJA9Z7Neg/top-research-reports-for-celgene-ford-dow-chemical-cm702777,Tuesday November 2 2016 Today s Research Daily features new research reports on 16 major stocks including Dow Chemical DOW Celgene CELG and Ford F Dow Chemical shares have lagged the basic materials sector this year but have performed largely in line with the S amp P 500
CELG,CELG:UW,BBG000BFCMR2,2 Bullish Biotech Trades to Take Your Mind off the Election (BIIB CELG),2016-11-02 17:08:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mmYJol4ltYc/2-bullish-biotech-trades-to-take-your-mind-off-the-election-biib-celg-cm702607,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips If the market is always right it may finally be time for a different sort of bullish pairs trade in Biogen Inc NASDAQ BIIB and Celgene Corporation NASDAQ
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for Celgene, Ford & Dow Chemical",2016-11-02 16:55:04 +0000,http://finance.yahoo.com/news/top-research-reports-celgene-ford-165504468.html,"Top Research Reports for Celgene, Ford & Dow Chemical"
CELG,CELG:UW,BBG000BFCMR2,"Corcept (CORT) Beats on Q3 Earnings, Lifts Sales Guidance",2016-11-02 13:16:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B-jeXkaeGNc/corcept-cort-beats-on-q3-earnings-lifts-sales-guidance-cm702305,Corcept Therapeutics Incorporated s CORT adjusted third quarter 2016 earnings including stock based compensation expense of 2 cents per share beating the Zacks Consensus Estimate of a penny Excluding stock based compensation expenses adjusted earnings amounted to 4 cents per
CELG,CELG:UW,BBG000BFCMR2,Celgene and IBM Watson Health Forge Collaboration Designed to Transform Patient Safety Monitoring,2016-11-01 21:20:17 +0000,http://www.publicnow.com/view/139A16027737998D87ED75321E679EA1C3B6F9D1,"[at noodls] - SUMMIT, N.J.and CAMBRIDGE, Mass., Nov. 1, 2016/PRNewswire/ -- Celgene Corporation (NASDAQ: CELG) and IBM Watson Health (NYSE: IBM) today announced a collaboration to co-develop IBM Watson for Patient Safety, ..."
CELG,CELG:UW,BBG000BFCMR2,"Celgene, IBM Team on Drug Monitoring (CELG, IBM)",2016-11-01 20:20:00 +0000,http://www.investopedia.com/news/celgene-ibm-partner-drug-safety-celg-ibm/?partner=YahooSA,[at Investopedia] - Celgene agreed to use IBM's Watson Health platform to identify potential side effects in experimental drugs.
CELG,CELG:UW,BBG000BFCMR2,"Notable ETF Outflow Detected - IYH, CELG, ESRX, AET",2016-11-01 16:14:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fdbze6D2Juk/notable-etf-outflow-detected-iyh-celg-esrx-aet-cm701736,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Healthcare ETF Symbol IYH where we have detected an approximate 21 2 million dollar outflow that s a 1 2 decrease week over week from 12 400
CELG,CELG:UW,BBG000BFCMR2,"ETF’s with exposure to Celgene Corp. : November 1, 2016",2016-11-01 15:52:45 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-celgene-corp-november-1-2016/,"ETF’s with exposure to Celgene Corp. : November 1, 2016"
CELG,CELG:UW,BBG000BFCMR2,2 Beaten-Up Biotech Blue Chip Stocks on Sale Today,2016-10-31 22:15:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zw5RRK3rZhw/2-beaten-up-biotech-blue-chip-stocks-on-sale-today-cm701411,Image source 160 thebluediamondgallery This has been an overall rough year for biotech stocks With the iShares Biotechnology Nasdaq ETF 160 down more than 20 YTD investors have learned more than ever that betting on biotech is always a risky business However as is often
CELG,CELG:UW,BBG000BFCMR2,Agios (AGIO): Will the Stock Disappoint in Q3 Earnings?,2016-10-31 22:14:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-NwyXzVMUvI/agios-agio-will-the-stock-disappoint-in-q3-earnings-cm701398,Agios Pharmaceuticals Inc AGIO is scheduled to report third quarter 2016 results on Nov 3 before the opening bell Agios performance has been far from encouraging with company missing estimates thrice in the trailing four quarters Overall Agios has recorded an average negative
CELG,CELG:UW,BBG000BFCMR2,2 Beaten-Up Biotech Blue Chip Stocks on Sale Today,2016-10-31 20:34:21 +0000,http://www.fool.com/investing/2016/10/31/2-beaten-up-biotech-blue-chip-stocks-on-sale-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,2 Beaten-Up Biotech Blue Chip Stocks on Sale Today
CELG,CELG:UW,BBG000BFCMR2,Agios (AGIO): Will the Stock Disappoint in Q3 Earnings?,2016-10-31 20:34:08 +0000,http://finance.yahoo.com/news/agios-agio-stock-disappoint-q3-203408402.html,Agios (AGIO): Will the Stock Disappoint in Q3 Earnings?
CELG,CELG:UW,BBG000BFCMR2,Analysts’ Recommendations for Amgen and Its Peers in 2016,2016-10-31 15:09:07 +0000,http://marketrealist.com/2016/10/analyst-recommendations-amgen-peers-2016/?utm_source=yahoo&utm_medium=feed,Analysts’ Recommendations for Amgen and Its Peers in 2016
CELG,CELG:UW,BBG000BFCMR2,Celgene Boldly Targeting $6 Billion (or More) in New Business,2016-10-31 14:04:18 +0000,http://www.fool.com/investing/2016/10/31/celgene-boldly-targeting-6-billion-or-more-in-new.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Celgene Boldly Targeting $6 Billion (or More) in New Business
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. :CELG-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016",2016-10-31 13:46:56 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-celg-us-earnings-analysis-q3-2016-by-the-numbers-october-31-2016/,"Celgene Corp. :CELG-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016"
CELG,CELG:UW,BBG000BFCMR2,Celgene Boldly Targeting $6 Billion (or More) in New Business,2016-10-31 13:16:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HIyMEzAx4tE/celgene-boldly-targeting-6-billion-or-more-in-new-business-cm700857,Doing one thing well is hard enough especially in biotech where the field is littered with the bodies of companies that couldn t get a single drug successfully through trials let alone enough to become a franchise And yet Celgene NASDAQ CELG which has already built
CELG,CELG:UW,BBG000BFCMR2,2 Reasons Celgene Corporation's Future Just Got Brighter,2016-10-29 16:17:46 +0000,http://www.fool.com/investing/2016/10/28/2-reasons-celgene-corporations-future-just-got-bri.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,2 Reasons Celgene Corporation's Future Just Got Brighter
CELG,CELG:UW,BBG000BFCMR2,Biogen Quietly Abandons a Key Next-Gen Multiple Sclerosis Drug,2016-10-29 13:38:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CTI7Vic5EMk/biogen-quietly-abandons-a-key-next-gen-multiple-sclerosis-drug-cm700675,Biogen Inc NASDAQ BIIB 160 controls over 30 of market share in the 19 billion and growing multiple sclerosis drug market but a recent decision to abandon development of MT 1303 calls into question whether or not Biogen can maintain its dominance in the indication over
CELG,CELG:UW,BBG000BFCMR2,Biogen Quietly Abandons a Key Next-Gen Multiple Sclerosis Drug,2016-10-29 10:41:08 +0000,http://www.fool.com/investing/2016/10/29/biogen-quietly-abandons-a-key-next-gen-multiple-sc.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Biogen Quietly Abandons a Key Next-Gen Multiple Sclerosis Drug
CELG,CELG:UW,BBG000BFCMR2,5 Things Amgen Inc.'s Management Wants You to Know,2016-10-28 22:32:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xFiZCBNF3ek/5-things-amgen-incs-management-wants-you-to-know-cm700591,Amgen Inc NASDAQ AMGN reported its third quarter results after the market closed on Thursday Those results looked good overall but the numbers only tell about the past To find out about the biotech s future listen carefully to what management has to say Here are five
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Is Firing on All Cylinders,2016-10-28 21:33:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kg88Ut0mrc4/celgene-corporation-is-firing-on-all-cylinders-cm700560,Image source Getty Images Celgene NASDAQ CELG reported a solid quarter on Thursday raising its 2016 guidance for the third consecutive quarter Celgene results The raw numbers Metric Q3 2016
CELG,CELG:UW,BBG000BFCMR2,5 Things Amgen Inc.'s Management Wants You to Know,2016-10-28 21:02:40 +0000,http://www.fool.com/investing/2016/10/28/5-things-amgen-inc-management-wants-you-to-know.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Things Amgen Inc.'s Management Wants You to Know
CELG,CELG:UW,BBG000BFCMR2,Celgene 3Q Earnings Beat Street Estimates (CELG),2016-10-28 20:40:00 +0000,http://www.investopedia.com/news/celgene-3q-net-171m-or-21-cents-share-celg/?partner=YahooSA,Celgene 3Q Earnings Beat Street Estimates (CELG)
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Is Firing on All Cylinders,2016-10-28 20:05:43 +0000,http://www.fool.com/investing/2016/10/28/celgene-corporation-is-firing-on-all-cylinders.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Celgene Corporation Is Firing on All Cylinders
CELG,CELG:UW,BBG000BFCMR2,2 Reasons Celgene Corporation's Future Just Got Brighter,2016-10-28 17:33:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AroJGtPJaMg/2-reasons-celgene-corporations-future-just-got-brighter-cm700415,Image source Getty Images The rearview mirror looks pretty good for Celgene Corporation NASDAQ CELG Blockbuster blood cancer drug Revlimid has powered the biotech to tremendous success Celgene s stock is up 340 over the past 10 years Unfortunately the present isn t
CELG,CELG:UW,BBG000BFCMR2,"Stock Market News for October 28, 2016",2016-10-28 14:10:02 +0000,http://finance.yahoo.com/news/stock-market-news-october-28-141002223.html,"Stock Market News for October 28, 2016"
CELG,CELG:UW,BBG000BFCMR2,Celgene May Be Ready to Lap Bristol,2016-10-28 12:00:16 +0000,http://www.bloomberg.com/gadfly/articles/2016-10-28/celgene-earnings-lapping-bristol-myers-squibb?cmpid=yhoo.headline,Celgene May Be Ready to Lap Bristol
CELG,CELG:UW,BBG000BFCMR2,Edited Transcript of CELG earnings conference call or presentation 27-Oct-16 1:00pm GMT,2016-10-28 04:26:41 +0000,http://finance.yahoo.com/news/edited-transcript-celg-earnings-conference-042641730.html,Edited Transcript of CELG earnings conference call or presentation 27-Oct-16 1:00pm GMT
CELG,CELG:UW,BBG000BFCMR2,"Why Celgene Corporation (CELG), Centurylink Inc (CTL) and Qualcomm, Inc. (QCOM) Are 3 of Today’s Best Stocks",2016-10-27 23:42:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m0osADCdJGo/why-celgene-corporation-celg-centurylink-inc-ctl-and-qualcomm-inc-qcom-are-3-of-todays-best-stocks-cm699901,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Global bonds continued faltering Thursday a scenario that pressured U S equities but the dollar rose With the greenback approaching its best levels of the year that could be a
CELG,CELG:UW,BBG000BFCMR2,"Bristol-Myers, Celgene Stocks Rocket After Sweeping Q3 Expectations",2016-10-27 20:56:03 +0000,http://www.investors.com/news/technology/bristol-myers-celgene-stocks-rocket-after-sweeping-q3-expectations/,"Bristol-Myers, Celgene Stocks Rocket After Sweeping Q3 Expectations"
CELG,CELG:UW,BBG000BFCMR2,Celgene Delivers a Blockbuster Quarter,2016-10-27 20:43:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q0Dbfdrffhk/celgene-delivers-a-blockbuster-quarter-cm699739,Multiple myeloma powerhouse Celgene Corp NASDAQ CELG rode sales growth for its first and second line multiple myeloma drug Revlimid to a record setting quarter in Q3 The company s results outpaced industry watchers predictions on both the top and bottom lines allowing
CELG,CELG:UW,BBG000BFCMR2,Alexion Crushes Q3 Expectations; Stock Bounds On Drug Trial Plans,2016-10-27 20:19:18 +0000,http://www.investors.com/news/technology/alexion-crushes-q3-expectations-stock-bounds-on-drug-trial-plans/,Alexion Crushes Q3 Expectations; Stock Bounds On Drug Trial Plans
CELG,CELG:UW,BBG000BFCMR2,"US STOCKS-Stocks dip as earnings pour in, consumer discretionary lags",2016-10-27 20:14:21 +0000,http://uk.finance.yahoo.com/news/us-stocks-stocks-dip-earnings-201421181.html,"US STOCKS-Stocks dip as earnings pour in, consumer discretionary lags"
CELG,CELG:UW,BBG000BFCMR2,Celgene Delivers a Blockbuster Quarter,2016-10-27 19:22:05 +0000,http://www.fool.com/investing/2016/10/27/celgene-delivers-a-blockbuster-quarter.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Celgene Delivers a Blockbuster Quarter
CELG,CELG:UW,BBG000BFCMR2,"US STOCKS-Stocks flat as earnings roll in, Comcast drags Nasdaq",2016-10-27 18:47:18 +0000,http://uk.finance.yahoo.com/news/us-stocks-stocks-flat-earnings-184718302.html,"US STOCKS-Stocks flat as earnings roll in, Comcast drags Nasdaq"
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Beats on Q3 Earnings, Raises '16 Outlook",2016-10-27 17:42:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NShLezeq-80/celgene-celg-beats-on-q3-earnings-raises-16-outlook-cm699542,Celgene Corporation CELG reported third quarter 2016 earnings of 1 39 per share including share based compensation expense and tax adjustments beating the Zacks Consensus Estimate of 1 31 and surging almost 28 from the year ago period Excluding share based compensation expense Celgene
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Shares Cross Above 200 DMA,2016-10-27 16:43:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CFLCPx369Mk/celgene-celg-shares-cross-above-200-dma-cm699584,In trading on Thursday shares of Celgene Corp Symbol CELG crossed above their 200 day moving average of 104 39 changing hands as high as 105 29 per share Celgene Corp shares are currently trading up about 6 3 on the day The chart below shows the one year performance of CELG
CELG,CELG:UW,BBG000BFCMR2,Stock Indexes Hesitate; Celgene Leaps On Q3 Results,2016-10-27 16:04:03 +0000,http://www.investors.com/market-trend/stock-market-today/stock-indexes-hesitate-celgene-leaps-on-q3-results/,Stock Indexes Hesitate; Celgene Leaps On Q3 Results
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Tops Q3 Earnings and Revenue Estimates,2016-10-27 15:45:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hb94_ZeTaA0/celgene-celg-tops-q3-earnings-and-revenue-estimates-cm699365,Summit NJ based Celgene Corporation CELG is a biopharmaceutical company focused on the discovery development and commercialization of drugs targeting cancer and inflammatory diseases Celgene s key growth driver is Revlimid The company s portfolio also includes Pomalyst Imnovid
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Beats on Q3 Earnings, Raises '16 Outlook",2016-10-27 15:45:03 +0000,http://finance.yahoo.com/news/celgene-celg-beats-q3-earnings-154503140.html,"Celgene (CELG) Beats on Q3 Earnings, Raises '16 Outlook"
CELG,CELG:UW,BBG000BFCMR2,The Good (Celgene) and Bad (Biogen) Ways to Deliver Drug Revenue Growth,2016-10-27 15:23:00 +0000,https://www.thestreet.com/story/13870174/1/the-good-celgene-and-bad-biogen-ways-to-deliver-drug-revenue-growth.html?puc=yahoo&cm_ven=YAHOO,The Good (Celgene) and Bad (Biogen) Ways to Deliver Drug Revenue Growth
CELG,CELG:UW,BBG000BFCMR2,U.S. stocks turn lower as defensive sectors sell off,2016-10-27 15:10:13 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=45018DB8-9C12-11E6-A1F3-C7B5B4B04643&siteid=yhoof2,U.S. stocks turn lower as defensive sectors sell off
CELG,CELG:UW,BBG000BFCMR2,"Celgene (CELG) Stock Jumps on Q3 Beat, Guidance",2016-10-27 14:46:00 +0000,https://www.thestreet.com/story/13870075/1/celgene-celg-stock-jumps-on-q3-beat-guidance.html?puc=yahoo&cm_ven=YAHOO,"Celgene (CELG) Stock Jumps on Q3 Beat, Guidance"
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Tops Q3 Earnings and Revenue Estimates,2016-10-27 13:31:01 +0000,http://finance.yahoo.com/news/celgene-celg-tops-q3-earnings-133101052.html,Celgene (CELG) Tops Q3 Earnings and Revenue Estimates
CELG,CELG:UW,BBG000BFCMR2,Morning Movers: Celgene Soars on Earnings; Bristol-Myers Jumps,2016-10-27 13:17:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/27/morning-movers-celgene-soars-on-earnings-bristol-myers-jumps/?mod=yahoobarrons&ru=yahoo,Morning Movers: Celgene Soars on Earnings; Bristol-Myers Jumps
CELG,CELG:UW,BBG000BFCMR2,[$$] Celgene Beats Estimates and Raises Guidance,2016-10-27 12:59:22 +0000,http://www.wsj.com/articles/celgene-beats-estimates-and-raises-guidance-1477573160?mod=yahoo_hs,[$$] Celgene Beats Estimates and Raises Guidance
CELG,CELG:UW,BBG000BFCMR2,"Revlimid sales spark Celgene quarterly beat, forecast raise",2016-10-27 12:41:03 +0000,http://finance.yahoo.com/news/celgenes-revlimid-shines-revenue-beats-120251051.html,"Revlimid sales spark Celgene quarterly beat, forecast raise"
CELG,CELG:UW,BBG000BFCMR2,5 Stocks to Watch After the Market Closes Today,2016-10-27 12:30:09 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-after-the-market-closes-today-123012474.html,5 Stocks to Watch After the Market Closes Today
CELG,CELG:UW,BBG000BFCMR2,Celgene tops Street 3Q forecasts,2016-10-27 11:47:54 +0000,http://sg.finance.yahoo.com/news/celgene-tops-street-3q-forecasts-114754436.html,Celgene tops Street 3Q forecasts
CELG,CELG:UW,BBG000BFCMR2,"CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit",2016-10-27 11:39:04 +0000,http://biz.yahoo.com/e/161027/celg8-k.html,"CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit"
CELG,CELG:UW,BBG000BFCMR2,Celgene quarterly revenue rises 28 percent as Revlimid shines,2016-10-27 11:38:15 +0000,http://finance.yahoo.com/news/celgene-quarterly-revenue-rises-28-113815561.html,Celgene quarterly revenue rises 28 percent as Revlimid shines
CELG,CELG:UW,BBG000BFCMR2,Celgene Reports Third Quarter 2016 Operating and Financial Results,2016-10-27 11:30:00 +0000,http://finance.yahoo.com/news/celgene-reports-third-quarter-2016-113000421.html,"[Business Wire] - Celgene Corporation reported net product sales of $2,969 million for the third quarter of 2016, a 28 percent increase from the same period in 2015. Net product sales growth includes a 1 percent negative impact from currency exchange effects."
CELG,CELG:UW,BBG000BFCMR2,5 Things You Must Know Before the Market Opens Thursday,2016-10-27 11:14:00 +0000,https://www.thestreet.com/story/13867145/1/5-things-you-must-know-before-the-market-opens-thursday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Thursday
CELG,CELG:UW,BBG000BFCMR2,Q3 2016 Celgene Corp Earnings Release - Before Market Open,2016-10-27 11:07:05 +0000,http://biz.yahoo.com/research/earncal/20161027.html?t=celg,Q3 2016 Celgene Corp Earnings Release - Before Market Open
CELG,CELG:UW,BBG000BFCMR2,Celgene Corp. (CELG) Is Climbing After Q3 Earnings Surpassed Expectations,2016-10-27 10:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C-xwG7nDo88/celgene-corp-celg-is-climbing-after-q3-earnings-surpassed-expectations-20161027-01010,Celgene Corp. (CELG) Is Climbing After Q3 Earnings Surpassed Expectations
CELG,CELG:UW,BBG000BFCMR2,Celgene Beats Estimates and Raises Guidance,2016-10-27 09:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kPtZmrRsxsU/celgene-beats-estimates-and-raises-guidance-20161027-00937,Celgene Beats Estimates and Raises Guidance
CELG,CELG:UW,BBG000BFCMR2,Celgene Q3 16 Earnings Conference Call At 9:00 AM ET,2016-10-27 08:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xlW3rYFDisU/celgene-q3-16-earnings-conference-call-at-900-am-et-20161027-00666,Celgene Q3 16 Earnings Conference Call At 9:00 AM ET
CELG,CELG:UW,BBG000BFCMR2,Celgene Updates 2016 Guidance And 2017 Targets - Quick Facts,2016-10-27 08:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zhTbIRLjslY/celgene-updates-2016-guidance-and-2017-targets--quick-facts-20161027-00646,Celgene Updates 2016 Guidance And 2017 Targets - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Reveals 25% Rise In Q3 Bottom Line,2016-10-27 07:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dndf0dkT0iQ/celgene-corporation-reveals-25-rise-in-q3-bottom-line-20161027-00511,Celgene Corporation Reveals 25% Rise In Q3 Bottom Line
CELG,CELG:UW,BBG000BFCMR2,Novartis' Is Challenging Biogen on Biogen's Own Turf,2016-10-26 22:51:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jjqu7yamiUA/novartis-is-challenging-biogen-on-biogens-own-turf-cm698999,Biogen Inc NASDAQ BIIB may be the Goliath in the 17 billion and growing market for multiple sclerosis MS treatment but it s Novartis NYSE NVS Gilenya not Biogen s Tecfidera that s growing more quickly this year Image source Novartis Some
CELG,CELG:UW,BBG000BFCMR2,5 Stocks to Watch Before the Market Opens Tomorrow,2016-10-26 20:30:13 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-before-the-market-opens-tomorrow-003008317.html,5 Stocks to Watch Before the Market Opens Tomorrow
CELG,CELG:UW,BBG000BFCMR2,"Pre-Market Earnings Report for October 27, 2016 :  MO, BMY, CELG, UPS, CL, DOW, TMO, EPD, COP, AMT, F, RTN",2016-10-26 20:19:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xj4Z5ZRKIRM/pre-market-earnings-report-for-october-27-2016-mo-bmy-celg-ups-cl-dow-tmo-epd-cop-amt-f-rtn-cm698924,The following companies are expected to report earnings prior to market open on 10 27 2016 Visit our Earnings Calendar for a full list of expected earnings releases Altria Group MO is reporting for the quarter ending September 30 2016 The tobacco company
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Stock Higher Ahead of Q3 Earnings Report,2016-10-26 17:19:00 +0000,https://www.thestreet.com/story/13868224/1/celgene-celg-stock-higher-ahead-of-q3-earnings-report.html?puc=yahoo&cm_ven=YAHOO,Celgene (CELG) Stock Higher Ahead of Q3 Earnings Report
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Celldex Therapeutics, Inc. vs. bluebird bio, Inc.",2016-10-26 15:15:18 +0000,http://www.fool.com/investing/2016/10/25/better-buy-celldex-therapeutics-inc-vs-bluebird-bi.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Celldex Therapeutics, Inc. vs. bluebird bio, Inc."
CELG,CELG:UW,BBG000BFCMR2,"Drug Stock Q3 Earnings Roster for Oct 27: AMGN, BMY & More",2016-10-26 13:50:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oh1yETFMaVw/drug-stock-q3-earnings-roster-for-oct-27-amgn-bmy-more-cm698462,The Q3 earnings season has so far seen encouraging reports with 116 S amp P 500 companies having already released results as of Oct 21 Of the total 80 2 surpassed earnings estimates while 62 9 trumped revenue expectations The Q3 earnings cycle is on track to be the first quarter to
CELG,CELG:UW,BBG000BFCMR2,"Drug Stock Q3 Earnings Roster for Oct 27: AMGN, BMY & More",2016-10-26 12:45:12 +0000,http://finance.yahoo.com/news/drug-stock-q3-earnings-roster-124512439.html,"Drug Stock Q3 Earnings Roster for Oct 27: AMGN, BMY & More"
CELG,CELG:UW,BBG000BFCMR2,4 Top Drug Stocks That Can Be Purchased on the Cheap This Fall,2016-10-26 12:27:59 +0000,http://www.fool.com/investing/2016/10/25/4-top-drug-stocks-that-can-be-purchased-on-the-che.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Top Drug Stocks That Can Be Purchased on the Cheap This Fall
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Can’t Make Up Their Minds on Major Biotechs,2016-10-26 11:15:00 +0000,http://247wallst.com/healthcare-business/2016/10/26/short-sellers-cant-make-up-their-minds-on-major-biotechs/,Short Sellers Can’t Make Up Their Minds on Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Merck & Co. Inc. vs. AbbVie Inc.,2016-10-25 21:51:43 +0000,http://www.fool.com/investing/2016/10/25/better-buy-merck-co-inc-vs-abbvie-inc.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Merck & Co. Inc. vs. AbbVie Inc.
CELG,CELG:UW,BBG000BFCMR2,4 Top Drug Stocks That Can Be Purchased on the Cheap This Fall,2016-10-25 14:25:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F3nBd9-FyfI/4-top-drug-stocks-that-can-be-purchased-on-the-cheap-this-fall-cm697683,Some great drug stocks could be hiding in plain view Image source Getty Images U S stocks have been taken for a wild ride in 2016 but at least most long term investors can relish the fact that despite the volatility the broader market indexes are all higher year to date The
CELG,CELG:UW,BBG000BFCMR2,The 1 Stock You've Been Overlooking for Your Roth IRA,2016-10-25 12:24:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KOjZkbKOpU4/the-1-stock-youve-been-overlooking-for-your-roth-ira-cm697625,Roth IRAs have the potential to make you rich while keeping Uncle Sam from getting his mitts on any of your profits The tax free retirement account is therefore best for stocks with the most potential for capital appreciation Below you ll find out why Visa NYSE V
CELG,CELG:UW,BBG000BFCMR2,The 1 Stock You've Been Overlooking for Your Roth IRA,2016-10-25 10:41:00 +0000,http://www.fool.com/retirement/2016/10/25/the-1-stock-youve-been-overlooking-for-your-roth-i.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,The 1 Stock You've Been Overlooking for Your Roth IRA
CELG,CELG:UW,BBG000BFCMR2,Celgene Sinking Ahead of Earnings,2016-10-25 10:20:00 +0000,https://www.thestreet.com/story/13864795/1/celgene-sinking-ahead-of-earnings.html?puc=yahoo&cm_ven=YAHOO,Celgene Sinking Ahead of Earnings
CELG,CELG:UW,BBG000BFCMR2,These Stocks Have Been Fueling the Invesco American Franchise Fund,2016-10-24 21:04:33 +0000,http://marketrealist.com/2016/10/stocks-fueling-invesco-american-franchise-fund/?utm_source=yahoo&utm_medium=feed,These Stocks Have Been Fueling the Invesco American Franchise Fund
CELG,CELG:UW,BBG000BFCMR2,iShares Nasdaq Biotechnology ETF Experiences Big Outflow,2016-10-24 16:23:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kkJxe-sEMuo/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-cm697146,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Nasdaq Biotechnology ETF Symbol IBB where we have detected an approximate 414 3 million dollar outflow that s a 5 5 decrease week over week
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Webcast at Upcoming Investor Conferences in November,2016-10-24 11:51:06 +0000,http://www.publicnow.com/view/71D01B833020C7B1C82E81EAC097B02C0CE9BBA8,"[at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences in November where Celgene management will provide an overview of the Company. The ..."
CELG,CELG:UW,BBG000BFCMR2,Top Health Care Earnings Coming Next Week,2016-10-23 14:35:30 +0000,http://247wallst.com/healthcare-business/2016/10/23/top-health-care-earnings-coming-next-week/,Top Health Care Earnings Coming Next Week
CELG,CELG:UW,BBG000BFCMR2,Best And Worst Biotech ETFs Of 2016 Tell A Tale About This Industry,2016-10-21 14:00:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oYmB58AyONI/best-and-worst-biotech-etfs-of-2016-tell-a-tale-about-this-industry-cm696324,An election year has added to the pressures that hit biotechnology stocks hard but a look under the hood of two sibling biotech ETFs is revealing 160 It shows the more speculative companies in 160 this extremely heterogeneous industry caused 160 much of the hurt
CELG,CELG:UW,BBG000BFCMR2,41 Billion Reasons Why Gilead Sciences Might Need New Management,2016-10-20 19:52:32 +0000,http://www.fool.com/investing/2016/10/19/41-billion-reasons-why-gilead-sciences-might-need.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,41 Billion Reasons Why Gilead Sciences Might Need New Management
CELG,CELG:UW,BBG000BFCMR2,"Commit To Purchase Celgene Corp. At $75, Earn 5.9% Using Options",2016-10-20 17:26:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EYVwH6EN9BM/commit-to-purchase-celgene-corp-at-75-earn-59-using-options-cm696071,Investors eyeing a purchase of Celgene Corp Symbol CELG shares but cautious about paying the going market price of 100 14 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January 2018
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Q3 Earnings: What's in Store for the Stock?,2016-10-20 15:29:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aSbcsZF3ltU/celgene-celg-q3-earnings-whats-in-store-for-the-stock-cm695954,Celgene Corporation CELG is scheduled to report third quarter 2016 results on Oct 27 before the opening bell Celgene s track record has been decent with the company beating earnings estimates on three occasions over the trailing four quarters Overall the company has delivered an
CELG,CELG:UW,BBG000BFCMR2,Celgene Otezla Psoriasis Drug Wins NICE Nod (CELG),2016-10-20 14:15:00 +0000,http://www.investopedia.com/news/celgenes-otezla-gets-nice-ok-psoriasis-celg/?partner=YahooSA,Celgene Otezla Psoriasis Drug Wins NICE Nod (CELG)
CELG,CELG:UW,BBG000BFCMR2,Biotech Stocks: Do Earnings Even Matter Anymore?,2016-10-20 13:58:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/20/biotech-stocks-do-earnings-even-matter-anymore/?mod=yahoobarrons&ru=yahoo,Biotech Stocks: Do Earnings Even Matter Anymore?
CELG,CELG:UW,BBG000BFCMR2,Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains,2016-10-20 13:55:36 +0000,http://247wallst.com/healthcare-business/2016/10/20/mega-cap-biotechs-cheapest-in-years-4-to-buy-for-2017-gains/,Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains
CELG,CELG:UW,BBG000BFCMR2,Celgene (CELG) Q3 Earnings: What's in Store for the Stock?,2016-10-20 13:48:01 +0000,http://finance.yahoo.com/news/celgene-celg-q3-earnings-whats-134801169.html,Celgene (CELG) Q3 Earnings: What's in Store for the Stock?
CELG,CELG:UW,BBG000BFCMR2,Oral OTEZLA® ▼ (Apremilast) Receives Positive Nice Recommendation for Adults with Chronic Plaque Psoriasis,2016-10-20 08:00:00 +0000,http://uk.finance.yahoo.com/news/oral-otezla-apremilast-receives-positive-080000186.html,Oral OTEZLA® ▼ (Apremilast) Receives Positive Nice Recommendation for Adults with Chronic Plaque Psoriasis
CELG,CELG:UW,BBG000BFCMR2,"Celgene: NICE OKs Oral OTEZLA For Chronic Plaque Psoriasis In England, Wales",2016-10-20 04:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IIhT4_kAB74/celgene-nice-oks-oral-otezla-for-chronic-plaque-psoriasis-in-england-wales-20161020-00111,"Celgene: NICE OKs Oral OTEZLA For Chronic Plaque Psoriasis In England, Wales"
CELG,CELG:UW,BBG000BFCMR2,[$$] Crispr Therapeutics Ends Barely Higher in IPO,2016-10-19 22:17:17 +0000,http://www.wsj.com/articles/crispr-therapeutics-ends-barely-higher-in-ipo-1476915433?mod=yahoo_hs,[$$] Crispr Therapeutics Ends Barely Higher in IPO
CELG,CELG:UW,BBG000BFCMR2,Celgene Explores App to Collect Study Data (CELG),2016-10-19 15:12:00 +0000,http://www.investopedia.com/news/celgene-develop-iphone-app-study-celg/?partner=YahooSA,Celgene Explores App to Collect Study Data (CELG)
CELG,CELG:UW,BBG000BFCMR2,Like Growth? Then You'll Love These 5 Stocks,2016-10-19 14:47:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w7d9MvxVqZM/like-growth-then-youll-love-these-5-stocks-cm695239,Image source Getty Images Fast growing stocks that can deliver consistent top line growth are tough to come by so we asked five of our best contributors what their favorite growth stock picks are right now After hunting within their respective universes the five settled on these
CELG,CELG:UW,BBG000BFCMR2,Like Growth? Then You'll Love These 5 Stocks,2016-10-19 13:20:07 +0000,http://www.fool.com/investing/2016/10/19/like-growth-then-youll-love-these-5-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Like Growth? Then You'll Love These 5 Stocks
CELG,CELG:UW,BBG000BFCMR2,"Celgene Skips the Placebo, Fails Drug Development 101",2016-10-19 11:28:00 +0000,https://www.thestreet.com/story/13858404/1/celgene-skips-the-placebo-fails-drug-development-101.html?puc=yahoo&cm_ven=YAHOO,"Celgene Skips the Placebo, Fails Drug Development 101"
CELG,CELG:UW,BBG000BFCMR2,Celgene Ozanimod Treats Ulcerative Colitis (CELG),2016-10-18 15:39:00 +0000,http://www.investopedia.com/news/celgene-uc-drug-ozanimod-shows-good-results-celg/?partner=YahooSA,Celgene Ozanimod Treats Ulcerative Colitis (CELG)
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Ionis Pharmaceuticals, Inc. vs. Celgene",2016-10-18 13:55:33 +0000,http://www.fool.com/investing/2016/10/17/better-buy-ionis-pharmaceuticals-inc-vs-celgene.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Ionis Pharmaceuticals, Inc. vs. Celgene"
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation and Sage Bionetworks Announce Technology Collaboration to Develop Observational Study Using the Apple ResearchKit Framework,2016-10-18 11:43:04 +0000,http://www.publicnow.com/view/554852A3DABD5EFB21FB66F1F3F081A5935DD2E8,"[at noodls] - Observational study to examine the burden of chronic anemia in myelodysplastic syndromes and beta-thalassemia SUMMIT, N.J. & SEATTLE--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) and Sage Bionetworks ..."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Pitted Against Gilead, Biogen In Crohn's Drug Battle",2016-10-17 20:03:12 +0000,http://www.investors.com/news/technology/celgene-pitted-against-gilead-biogen-in-crohns-drug-battle/,"Celgene Pitted Against Gilead, Biogen In Crohn's Drug Battle"
CELG,CELG:UW,BBG000BFCMR2,Celgene to Present Phase Ib Data on Crohn's Disease Drug,2016-10-17 15:44:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YdgsWIca7oI/celgene-to-present-phase-ib-data-on-crohns-disease-drug-cm694152,Celgene Corporation s CELG wholly owned subsidiary Celgene International Sàrl announced encouraging data from a phase Ib study on its pipeline candidate GED 0301 mongersen Data will be presented at the United European Gastroenterology Week The randomized double blind multi
CELG,CELG:UW,BBG000BFCMR2,"Better Buy: Ionis Pharmaceuticals, Inc. vs. Celgene",2016-10-17 15:43:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kgd1xG4qDKE/better-buy-ionis-pharmaceuticals-inc-vs-celgene-cm694144,Image source Getty Images Both Ionis Pharmaceuticals NASDAQ IONS and Celgene NASDAQ CELG have seen better days While both stocks soared over the past several years 2016 hasn t been so hot Shares of Ionis are down around 50 so far this year and Celgene s stock
CELG,CELG:UW,BBG000BFCMR2,A Moment of Truth Is Approaching on Celgene,2016-10-17 15:31:00 +0000,http://realmoney.thestreet.com/articles/10/17/2016/moment-truth-approaching-celgene?puc=yahoo&cm_ven=YAHOO,A Moment of Truth Is Approaching on Celgene
CELG,CELG:UW,BBG000BFCMR2,Celgene to Present Phase Ib Data on Crohn's Disease Drug,2016-10-17 13:24:01 +0000,http://finance.yahoo.com/news/celgene-present-phase-ib-data-132401704.html,Celgene to Present Phase Ib Data on Crohn's Disease Drug
CELG,CELG:UW,BBG000BFCMR2,"CELGENE CORP /DE/ Files SEC form 8-K, Other Events",2016-10-17 13:01:31 +0000,http://biz.yahoo.com/e/161017/celg8-k.html,"CELGENE CORP /DE/ Files SEC form 8-K, Other Events"
CELG,CELG:UW,BBG000BFCMR2,Oral Ozanimod Efficacy and Safety Results from Phase 2 TOUCHSTONE Extension Trial in Patients with Ulcerative Colitis to Be Presented at UEGW and ACG,2016-10-17 12:13:03 +0000,http://www.publicnow.com/view/A740AB11E84264923195258761C01AC97CF0F6FF,[at noodls] - Open-label extension of TOUCHSTONE study of ozanimod showed continued symptom improvement through week 44 of the extension Safety and tolerability were consistent with previous studies of ozanimod VIENNA--(BUSINESS ...
CELG,CELG:UW,BBG000BFCMR2,Oral Ozanimod Efficacy and Safety Results from Phase 2 TOUCHSTONE Extension Trial in Patients with Ulcerative Colitis to Be Presented at UEGW and ACG,2016-10-17 12:00:00 +0000,http://uk.finance.yahoo.com/news/oral-ozanimod-efficacy-safety-results-120000369.html,Oral Ozanimod Efficacy and Safety Results from Phase 2 TOUCHSTONE Extension Trial in Patients with Ulcerative Colitis to Be Presented at UEGW and ACG
CELG,CELG:UW,BBG000BFCMR2,Celgene Crohn's Pill Data Unspectacular but Perhaps Good Enough,2016-10-17 10:46:00 +0000,https://www.thestreet.com/story/13854781/1/celgene-crohn-s-pill-data-unspectacular-but-perhaps-good-enough.html?puc=yahoo&cm_ven=YAHOO,Celgene Crohn's Pill Data Unspectacular but Perhaps Good Enough
CELG,CELG:UW,BBG000BFCMR2,Celgene Crohn’s Drug Benefit Supported by Image Data in Trial,2016-10-17 02:04:51 +0000,http://www.bloomberg.com/news/articles/2016-10-17/celgene-crohn-s-drug-benefit-supported-by-image-data-in-trial?cmpid=yhoo.headline,Celgene Crohn’s Drug Benefit Supported by Image Data in Trial
CELG,CELG:UW,BBG000BFCMR2,Oral GED-0301 Phase 1b Results Show Clinical Remission and Endoscopic Response at Week 12 in Patients with Active Crohn’s Disease,2016-10-16 23:11:00 +0000,http://uk.finance.yahoo.com/news/oral-ged-0301-phase-1b-231100227.html,Oral GED-0301 Phase 1b Results Show Clinical Remission and Endoscopic Response at Week 12 in Patients with Active Crohn’s Disease
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Oral GED-0301 Phase 1b Results On Crohn''s Disease,2016-10-16 23:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/unsar8Gsz-E/celgene-announces-oral-ged0301-phase-1b-results-on-crohns-disease-20161016-00032,Celgene Announces Oral GED-0301 Phase 1b Results On Crohn''s Disease
CELG,CELG:UW,BBG000BFCMR2,3 Stocks We're Never Selling,2016-10-14 23:41:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5XDzpwER7Ic/3-stocks-were-never-selling-cm693734,Image source Celgene Here at the Motley Fool we re convinced the best way to predictably create wealth is to buy shares of solid businesses and hold them over the long term and the longer the better But where should you look to find these great businesses To help get
CELG,CELG:UW,BBG000BFCMR2,3 Stocks We're Never Selling,2016-10-14 21:40:00 +0000,http://www.fool.com/investing/2016/10/14/3-stocks-were-never-selling.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Stocks We're Never Selling
CELG,CELG:UW,BBG000BFCMR2,Celgene/Agios Ink Deals with Abbott to Identify IDH Mutations,2016-10-13 16:45:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q06uK9NTKF4/celgeneagios-ink-deals-with-abbott-to-identify-idh-mutations-cm692955,Celgene Corporation CELG and Agios Pharmaceuticals Inc AGIO announced that they have entered into collaboration agreements with Abbott Laboratories ABT to develop and commercialize diagnostic tests to identify isocitrate dehydrogenase IDH mutations in patients with acute myeloid
CELG,CELG:UW,BBG000BFCMR2,Abbott Develops AML Tests With Celgene and Agios,2016-10-13 16:05:02 +0000,http://finance.yahoo.com/news/abbott-develops-aml-tests-celgene-160502670.html,Abbott Develops AML Tests With Celgene and Agios
CELG,CELG:UW,BBG000BFCMR2,It's Not Easy Being Green: 3 Solid Names That Stand Out,2016-10-13 15:00:00 +0000,http://realmoney.thestreet.com/articles/10/13/2016/its-not-easy-being-green-3-solid-names-stand-out?puc=yahoo&cm_ven=YAHOO,It's Not Easy Being Green: 3 Solid Names That Stand Out
CELG,CELG:UW,BBG000BFCMR2,Celgene/Agios Ink Deals with Abbott to Identify IDH Mutations,2016-10-13 14:10:02 +0000,http://finance.yahoo.com/news/celgene-agios-ink-deals-abbott-141002276.html,Celgene/Agios Ink Deals with Abbott to Identify IDH Mutations
CELG,CELG:UW,BBG000BFCMR2,Blog Coverage Celgene and Agios Team up with Abbott,2016-10-13 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-celgene-agios-team-131500511.html,"[Accesswire] - LONDON, UK / ACCESSWIRE / October 13, 2016 / Active Wall St. blog coverage looks at the headline from Celgene Corp. (NASDAQ: CELG ) and Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ) announced on October ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene to Present New Data on Investigational Compounds at UEGW and ACG Congresses,2016-10-13 12:20:04 +0000,http://www.publicnow.com/view/0D114800F4F774E9683D949A2F123CD530C74EE5,[at noodls] - Exploratory phase 1b study interim data assessing the effects of oral GED-0301 (mongersen) on both endoscopic and clinical outcomes at 12 weeks in patients with active Crohn's disease TOUCHSTONE extension ...
CELG,CELG:UW,BBG000BFCMR2,Celgene Otezla Arthritis Drug Wins NICE Nod (CELG),2016-10-12 20:10:00 +0000,http://www.investopedia.com/news/celgenes-otezla-drug-secures-nice-backing-celg/?partner=YahooSA,Celgene Otezla Arthritis Drug Wins NICE Nod (CELG)
CELG,CELG:UW,BBG000BFCMR2,"Celgene, Agios, Abbott Team For Test (CELG, AGIO)",2016-10-12 16:40:00 +0000,http://www.investopedia.com/news/celgene-and-agios-partner-abbott-celg-agio/?partner=YahooSA,"Celgene, Agios, Abbott Team For Test (CELG, AGIO)"
CELG,CELG:UW,BBG000BFCMR2,Trading the biotech sell-off,2016-10-12 16:15:00 +0000,http://finance.yahoo.com/video/trading-biotech-sell-off-161500602.html,Trading the biotech sell-off
CELG,CELG:UW,BBG000BFCMR2,"Here’s Why Stanley Black & Decker, Celgene Corporation, and Three Other Stocks Are Trending Today",2016-10-12 14:41:57 +0000,http://www.insidermonkey.com/blog/heres-why-stanley-black-decker-celgene-corporation-and-three-other-stocks-are-trending-today-480807/,"Here’s Why Stanley Black & Decker, Celgene Corporation, and Three Other Stocks Are Trending Today"
CELG,CELG:UW,BBG000BFCMR2,Top Biotech Plays Highlight Jefferies Growth Stocks to Buy,2016-10-12 13:55:50 +0000,http://247wallst.com/healthcare-business/2016/10/12/top-biotech-plays-highlight-jefferies-growth-stocks-to-buy/,Top Biotech Plays Highlight Jefferies Growth Stocks to Buy
CELG,CELG:UW,BBG000BFCMR2,Celgene and Agios Announce Collaborations with Abbott for Diagnostic Identification of IDH Mutations in AML,2016-10-12 11:53:10 +0000,http://www.publicnow.com/view/99A11E8E335F0EB7571182EDDAA5F7A140B3FBFB,[at noodls] - Companion diagnostic technology to be utilized with enasidenib (AG-221/CC-90007) and AG-120 development programs for relapsed/refractory acute myeloid leukemia (AML) Approximately 20% of AML patients have ...
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Have Mixed Views on Major Biotechs,2016-10-12 11:10:47 +0000,http://247wallst.com/healthcare-business/2016/10/12/short-sellers-have-mixed-views-on-major-biotechs/,Short Sellers Have Mixed Views on Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,Celgene & Agios To Collaborate With Abbott To Identify IDH Mutations In AML,2016-10-12 07:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WBulaAOoqoc/celgene--agios-to-collaborate-with-abbott-to-identify-idh-mutations-in-aml-20161012-00231,Celgene & Agios To Collaborate With Abbott To Identify IDH Mutations In AML
CELG,CELG:UW,BBG000BFCMR2,"Cramer: Sing It, Martha -- Nowhere to Run to in This Market, Nowhere to Hide",2016-10-11 23:01:00 +0000,http://realmoney.thestreet.com/articles/10/11/2016/cramer-sing-it-martha-nowhere-run-market-nowhere-hide?puc=yahoo&cm_ven=YAHOO,"[at TheStreet] - On days like this, the money just keeps sloshing around."
CELG,CELG:UW,BBG000BFCMR2,3 Top Biotech Stocks to Buy Right Now,2016-10-11 20:21:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VXk2-HnZmAY/3-top-biotech-stocks-to-buy-right-now-cm691445,IMAGE SOURCE GETTY IMAGES Looking for great biotech stocks to buy You have plenty of options Biotech stocks in general have performed great over the past few years and are bouncing back from a slump that began in the second half of 2015 The good news is that you can make
CELG,CELG:UW,BBG000BFCMR2,6 S&P 500 Stocks to Own for the Next 10 Years,2016-10-11 13:17:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B4lWPxNOTOc/6-sp-500-stocks-to-own-for-the-next-10-years-cm691461,When it comes to stocks we like playing the long game picking solid companies sticking with them through tough times and hanging on for years even a decade or more Investing for the long haul can smooth out the risks of buying individual stocks which may tumble or stay depressed
CELG,CELG:UW,BBG000BFCMR2,3 Top Biotech Stocks to Buy Right Now,2016-10-11 12:21:31 +0000,http://www.fool.com/investing/2016/10/11/3-top-biotech-stocks-to-buy-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Biotech Stocks to Buy Right Now
CELG,CELG:UW,BBG000BFCMR2,What Do Analysts Have to Say about Bristol-Myers Squibb?,2016-10-11 12:04:43 +0000,http://marketrealist.com/2016/10/what-do-analysts-have-to-say-about-bristol-myers-squibb/?utm_source=yahoo&utm_medium=feed,What Do Analysts Have to Say about Bristol-Myers Squibb?
CELG,CELG:UW,BBG000BFCMR2,"Notable ETF Inflow Detected - VUG, BMY, AGN, CELG",2016-10-10 16:18:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JSGyh8XBM6Q/notable-etf-inflow-detected-vug-bmy-agn-celg-cm691056,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Growth ETF Symbol VUG where we have detected an approximate 80 8 million dollar inflow that s a 0 4 increase week over week in outstanding units
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Biogen vs. Celgene,2016-10-10 15:29:44 +0000,http://www.fool.com/investing/2016/10/10/better-buy-biogen-vs-celgene.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Biogen vs. Celgene
CELG,CELG:UW,BBG000BFCMR2,Kite Pharma Starts ZUMA-6 Combo Trial on Lymphoma Drug,2016-10-10 15:21:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fZsNzfAhNjo/kite-pharma-starts-zuma-6-combo-trial-on-lymphoma-drug-cm691012,Kite Pharma Inc KITE announced the initiation of ZUMA 6 a phase Ib II combination study on its lead pipeline candidate KTE C19 in combination Genentech s Tecentriq atezolizumab 160 for the treatment of chemorefractory diffuse large B cell lymphoma DLBCL Note that Kite has
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Amazon, Celgene, Chubb, Delta and Merck",2016-10-10 15:21:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qyUSU2e8bqE/the-zacks-analyst-blog-highlights-amazon-celgene-chubb-delta-and-merck-cm691001,For Immediate Release Chicago IL October 10 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
CELG,CELG:UW,BBG000BFCMR2,What’s The Deal Between MetaStat Inc. (MTST) And Celgene Corporation (CELG)?,2016-10-10 15:21:18 +0000,http://www.insidermonkey.com/blog/whats-the-deal-between-metastat-inc-mtst-and-celgene-corporation-celg-480018/,What’s The Deal Between MetaStat Inc. (MTST) And Celgene Corporation (CELG)?
CELG,CELG:UW,BBG000BFCMR2,Better Buy: Biogen vs. Celgene,2016-10-10 14:21:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X1rK2Bhiq_Q/better-buy-biogen-vs-celgene-cm690962,Image source Flickr Fresh off a strong Q2 earnings beat and riding high on takeout rumors the past 3 months have been good to Biogen NASDAQ BIIB investors with shares up 27 since July The same however cannot be said for Celgene NASDAQ CELG up a measly 3
CELG,CELG:UW,BBG000BFCMR2,"The Zacks Analyst Blog Highlights: Amazon, Celgene, Chubb, Delta and Merck",2016-10-10 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-amazon-133001856.html,"The Zacks Analyst Blog Highlights: Amazon, Celgene, Chubb, Delta and Merck"
CELG,CELG:UW,BBG000BFCMR2,6 Best S&P 500 Stocks to Own for the Next 10 Years,2016-10-10 13:10:01 +0000,http://portal.kiplinger.com/slideshow/investing/T052-S003-6-s-p-500-stocks-to-own-for-the-next-10-years/index.html?rid=SYN-yahoo&rpageid=15517,6 Best S&P 500 Stocks to Own for the Next 10 Years
CELG,CELG:UW,BBG000BFCMR2,The Big Reason You Shouldn't Give Up on Big-Cap Biotech,2016-10-09 16:13:59 +0000,http://www.fool.com/investing/2016/10/08/the-big-reason-you-shouldnt-give-up-on-big-cap-bio.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Big Reason You Shouldn't Give Up on Big-Cap Biotech
CELG,CELG:UW,BBG000BFCMR2,The Big Reason You Shouldn't Give Up on Big-Cap Biotech,2016-10-08 17:43:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KnMQdI3srDo/the-big-reason-you-shouldnt-give-up-on-big-cap-biotech-cm690712,Image source ccPixs com via Flickr Pushback against rising drug prices has caused the iShares Nasdaq Biotechnology ETF NASDAQ IBB to lose 16 of its value this year Yet while headwinds remain that could slow top line growth across the industry selling top tier
CELG,CELG:UW,BBG000BFCMR2,Bristol-Myers Squibb’s Premium Valuation,2016-10-07 22:04:18 +0000,http://marketrealist.com/2016/10/bristol-myers-squibbs-premium-valuation/?utm_source=yahoo&utm_medium=feed,Bristol-Myers Squibb’s Premium Valuation
CELG,CELG:UW,BBG000BFCMR2,Why Gilead’s Valuation Is Low Compared to Peers,2016-10-07 19:52:51 +0000,http://marketrealist.com/2016/10/why-gileads-valuation-is-low-compared-to-peers/?utm_source=yahoo&utm_medium=feed,Why Gilead’s Valuation Is Low Compared to Peers
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for Amazon, Celgene & Chubb",2016-10-07 19:43:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pTNLV5tZ6Zs/top-research-reports-for-amazon-celgene-chubb-cm690500,Friday October 7 2016 Today s Research Daily features new research reports on 16 major stocks including Amazon AMZN Celgene CELG and Chubb CB Shares of Strong Buy rated Amazon have been strong performers lately they are up more than 25 year to date with analysts steadily
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Outcomes To Be Revealed at ESMO (CELG),2016-10-07 19:05:00 +0000,http://www.investopedia.com/news/celgene-releasing-new-findings-drugs-celg/?partner=YahooSA,Celgene’s Outcomes To Be Revealed at ESMO (CELG)
CELG,CELG:UW,BBG000BFCMR2,"Top Research Reports for Amazon, Celgene & Chubb",2016-10-07 16:27:04 +0000,http://finance.yahoo.com/news/top-research-reports-amazon-celgene-162704419.html,"Top Research Reports for Amazon, Celgene & Chubb"
CELG,CELG:UW,BBG000BFCMR2,Will Biogen Join Gilead in the Disappointment Club?,2016-10-07 15:51:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/07/will-biogen-join-gilead-in-the-disappointment-club/?mod=yahoobarrons&ru=yahoo,Will Biogen Join Gilead in the Disappointment Club?
CELG,CELG:UW,BBG000BFCMR2,Health Care Sector Update for 10/07/2016: CELG,2016-10-07 13:44:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b8iNJ2VzjHc/health-care-sector-update-for-10072016-celg-cm690232,Top Health care stocks Top Health care stocks JNJ 0 2 JNJ 0 2 PFE 0 2 PFE 0 2 ABT flatABT flat MRK 0 1 MRK 0 1 AMGN flatAMGN flat Health care shares were mainly higher in pre market trade Friday Health care shares were mainly higher in pre market trade Friday In health
CELG,CELG:UW,BBG000BFCMR2,Data Presented at ESMO 2016 Adds to Understanding of Abraxane® as a Therapy for Patients with Historically Challenging Solid Tumors,2016-10-07 11:50:00 +0000,http://finance.yahoo.com/news/data-presented-esmo-2016-adds-115000112.html,"[Business Wire] - Celgene Corporation today announced results from multiple sponsored and independent studies will be presented during the European Society of Medical Oncology 2016 Annual Meeting evaluating the use of ABRAXANE® as a foundational treatment, either alone or in combination with novel agents and novel regimens, for patients with traditionally challenging cancers, including metastatic pancreatic cancer , ..."
CELG,CELG:UW,BBG000BFCMR2,3 Health Stocks to Own for the Next 10 Years,2016-10-06 17:20:05 +0000,http://portal.kiplinger.com/slideshow/investing/T052-S003-3-health-stocks-to-own-for-the-next-10-years/index.html?rid=SYN-yahoo&rpageid=15518,3 Health Stocks to Own for the Next 10 Years
CELG,CELG:UW,BBG000BFCMR2,Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now,2016-10-06 13:50:39 +0000,http://247wallst.com/healthcare-business/2016/10/06/big-pharma-and-top-biotechs-highlight-jefferies-stocks-to-buy-now/,Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now
CELG,CELG:UW,BBG000BFCMR2,4 Top Growth Stocks Priced at a Bargain This Fall,2016-10-06 12:45:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sPBpRyYQuCE/4-top-growth-stocks-priced-at-a-bargain-this-fall-cm689575,Image source Getty Images This year didn t exactly begin on the right foot and yet at the beginning of October the S amp P 500 sits a healthy 6 higher on a year to date basis For buy and hold investors the trading action this year has vindicated the strategy of
CELG,CELG:UW,BBG000BFCMR2,4 Top Growth Stocks Priced at a Bargain This Fall,2016-10-06 11:24:07 +0000,http://www.fool.com/retirement/2016/10/06/4-top-growth-stocks-priced-at-a-bargain-this-fall.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Top Growth Stocks Priced at a Bargain This Fall
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Acceptance of Late Breaking GED-0301 CD-001 Abstract at the United European Gastroenterology Week (UEGW) Meeting,2016-10-04 11:58:07 +0000,http://www.publicnow.com/view/1E94234C056B4239191C32C343537EA5D5C157F2,"[at noodls] - Celgene to hold an analyst call on October 18, 2016 at 9 a.m. ET SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced that the data from a randomized, double-blind, multicenter, ..."
CELG,CELG:UW,BBG000BFCMR2,Instant Analysis: Celgene Pays $600 Million for Swiss Biotech,2016-10-04 11:41:44 +0000,http://www.fool.com/investing/2016/10/03/instant-analysis-celgene-pays-600-million-for-swis.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Instant Analysis: Celgene Pays $600 Million for Swiss Biotech
CELG,CELG:UW,BBG000BFCMR2,Instant Analysis: Celgene Pays $600 Million for Swiss Biotech,2016-10-03 15:47:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/il_IclZX57Y/instant-analysis-celgene-pays-600-million-for-swiss-biotech-cm687804,IMAGE SOURCE CELGENE What happened Celgene NASDAQ CELG 160 is at it again The acquisitive company agreed to pay 600 million for Switzerland based EngMab Privately held EngMab is a biotech that concentrates its efforts on T cell bispecific antibodies TCBs As
CELG,CELG:UW,BBG000BFCMR2,Gilead: Will New HIV Drugs Overshadow Hep C Worries?,2016-10-03 15:03:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/03/gilead-will-new-hiv-drugs-overshadow-hep-c-worries/?mod=yahoobarrons&ru=yahoo,Gilead: Will New HIV Drugs Overshadow Hep C Worries?
CELG,CELG:UW,BBG000BFCMR2,Gilead Sciences' Pain Is Celgene's Gain,2016-10-03 13:46:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jK8HqTiPS2U/gilead-sciences-pain-is-celgenes-gain-cm687618,Image source Getty Images Failure is never fun Gilead Sciences NASDAQ GILD announced its first pipeline setback of 2016 in January The big biotech shut down its phase 2 study of simtuzumab in treating 160 idiopathic pulmonary fibrosis after the drug didn t prove
CELG,CELG:UW,BBG000BFCMR2,Gilead Sciences' Pain Is Celgene's Gain,2016-10-03 12:57:59 +0000,http://www.fool.com/investing/2016/10/03/gilead-sciences-pain-is-celgenes-gain.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Gilead Sciences' Pain Is Celgene's Gain
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corporation to Announce Third Quarter 2016 Results on October 27, 2016",2016-10-03 11:46:04 +0000,http://www.publicnow.com/view/64CFBC8466AC6A56B29F223BD7E3C11C80D5000C,"[at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) will host a conference call and live audio webcast on Thursday, October 27, 2016 at 9 a.m. ET to discuss third quarter 2016 financial and ..."
CELG,CELG:UW,BBG000BFCMR2,Is Celgene the Smartest Buyer in Biotech?,2016-10-02 00:13:39 +0000,http://www.fool.com/investing/2016/09/30/is-celgene-the-smartest-buyer-in-biotech.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Celgene the Smartest Buyer in Biotech?
CELG,CELG:UW,BBG000BFCMR2,Celgene Is Building an Autoimmune Empire -- and No One Is Talking About It,2016-10-01 13:21:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B0AjWCOU0XA/celgene-is-building-an-autoimmune-empire-and-no-one-is-talking-about-it-cm687448,Image source 160 PublicDomainPictures net When it comes to Celgene NASDAQ CELG investors focus has revolved around its megablockbuster Revlimid franchise and for good reason Revlimid an oral treatment for blood cancer indicated for use in first and second line
CELG,CELG:UW,BBG000BFCMR2,Is Celgene the Smartest Buyer in Biotech?,2016-10-01 01:21:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8zdnk8Aiqdw/is-celgene-the-smartest-buyer-in-biotech-cm687412,Image source Getty Images Celgene NASDAQ CELG is well known for its superstar drugs including 160 blood cancer drug Revlimid which hit 5 8 billion in sales last year and could well reach 10 billion in 2020 160 But what fewer investors realize is how the company
CELG,CELG:UW,BBG000BFCMR2,Could Growing HIV Franchise Drive Gilead Sciences’ Valuation?,2016-09-30 22:03:44 +0000,http://marketrealist.com/2016/09/could-growing-hiv-franchise-drive-gilead-sciences-valuation/?utm_source=yahoo&utm_medium=feed,Could Growing HIV Franchise Drive Gilead Sciences’ Valuation?
CELG,CELG:UW,BBG000BFCMR2,Celgene's Trio Of New Drugs Could Tack On $3 Billion-Plus: RBC,2016-09-30 20:30:47 +0000,http://www.investors.com/news/technology/celgenes-trio-of-new-drugs-could-tack-on-3-billion-plus-rbc/,Celgene's Trio Of New Drugs Could Tack On $3 Billion-Plus: RBC
CELG,CELG:UW,BBG000BFCMR2,Cempra Gets More Good News,2016-09-30 19:04:52 +0000,http://finance.yahoo.com/tumblr/blog-cempra-gets-more-good-news-190457155.html,Cempra Gets More Good News
CELG,CELG:UW,BBG000BFCMR2,"Amgen, Biogen, Gilead Could Spike VA Pricing To Skirt California Measure",2016-09-29 20:26:08 +0000,http://www.investors.com/news/technology/amgen-biogen-gilead-could-spike-va-pricing-to-skirt-california-measure/,"Amgen, Biogen, Gilead Could Spike VA Pricing To Skirt California Measure"
CELG,CELG:UW,BBG000BFCMR2,"IVW, CELG, NKE, AVGO: ETF Inflow Alert",2016-09-29 16:23:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PJBV6mqswfQ/ivw-celg-nke-avgo-etf-inflow-alert-cm686606,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Growth ETF Symbol IVW where we have detected an approximate 48 8 million dollar inflow that s a 0 4 increase week over week in
CELG,CELG:UW,BBG000BFCMR2,Will Celgene Depose Biogen to Become Top Dog In Multiple Sclerosis?,2016-09-28 16:22:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hjoTupSpWlQ/will-celgene-depose-biogen-to-become-top-dog-in-multiple-sclerosis-cm685978,Image source 160 https www pexels com photo black and white people bar men 4417 In July 2015 Celgene NASDAQ CELG made headlines with its 7 2 billion acquisition of Receptos mainly in order to get its hands on Receptos lead autoimmune candidate ozanimod
CELG,CELG:UW,BBG000BFCMR2,Will Celgene Depose Biogen to Become Top Dog In Multiple Sclerosis?,2016-09-28 15:01:00 +0000,http://www.fool.com/investing/2016/09/28/will-celgene-depose-biogen-to-become-top-dog-in-mu.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Will Celgene Depose Biogen to Become Top Dog In Multiple Sclerosis?
CELG,CELG:UW,BBG000BFCMR2,Oral OTEZLA® (apremilast) Long-Term Safety Data Presented at EADV Congress in Both Psoriasis and Psoriatic Arthritis,2016-09-28 06:00:00 +0000,http://finance.yahoo.com/news/oral-otezla-apremilast-long-term-060000591.html,"[Business Wire] - Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation , today announced that long-term safety findings from ongoing clinical trials of apremilast, the Company's oral, selective inhibitor of phosphodiesterase 4 , were presented at the European Academy of Dermatology and Venereology Annual Congress in Vienna, Austria."
CELG,CELG:UW,BBG000BFCMR2,"Celgene Presents OTEZLA Long-Term Safety Data In Psoriasis,Psoriatic Arthritis",2016-09-28 02:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y0XJVrXUKQQ/celgene-presents-otezla-longterm-safety-data-in-psoriasispsoriatic-arthritis-20160928-00059,"Celgene Presents OTEZLA Long-Term Safety Data In Psoriasis,Psoriatic Arthritis"
CELG,CELG:UW,BBG000BFCMR2,Julian Robertson: Biotech Stocks Are Cheap,2016-09-28 01:07:33 +0000,http://finance.yahoo.com/video/julian-robertson-biotech-stocks-cheap-010733693.html,Julian Robertson: Biotech Stocks Are Cheap
CELG,CELG:UW,BBG000BFCMR2,Amgen: The Blame Game,2016-09-27 14:44:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/27/amgen-the-blame-game/?mod=yahoobarrons&ru=yahoo,Amgen: The Blame Game
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. – Value Analysis (NASDAQ:CELG) : September 27, 2016",2016-09-27 14:42:09 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-value-analysis-nasdaqcelg-september-27-2016/,"Celgene Corp. – Value Analysis (NASDAQ:CELG) : September 27, 2016"
CELG,CELG:UW,BBG000BFCMR2,The 3 Best-Run Companies in the Healthcare Sector,2016-09-27 14:22:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/__5OQiDk2Ng/the-3-best-run-companies-in-the-healthcare-sector-cm685217,Image source Getty Images The healthcare sector is massive and poised for long term growth but it s also becoming increasingly more competitive One way investors can increase their odds of success is by putting money to work in companies that have a world class management team
CELG,CELG:UW,BBG000BFCMR2,The 3 Best-Run Companies in the Healthcare Sector,2016-09-27 13:03:00 +0000,http://www.fool.com/investing/2016/09/27/the-3-best-run-companies-in-the-healthcare-sector.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The 3 Best-Run Companies in the Healthcare Sector
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Increase Bets in Major Biotechs,2016-09-27 11:50:26 +0000,http://247wallst.com/healthcare-business/2016/09/27/short-sellers-increase-bets-in-major-biotechs-5/,Short Sellers Increase Bets in Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,Amgen Multiple Myeloma Drug Kyprolis Fails to Help Newly Diagnosed Patients,2016-09-27 10:27:00 +0000,https://www.thestreet.com/story/13752698/1/amgen-multiple-myeloma-drug-kyprolis-fails-to-help-newly-diagnosed-patients.html?puc=yahoo&cm_ven=YAHOO,Amgen Multiple Myeloma Drug Kyprolis Fails to Help Newly Diagnosed Patients
CELG,CELG:UW,BBG000BFCMR2,3 Top Biotech Stocks to Buy on Sale,2016-09-26 20:25:44 +0000,http://www.fool.com/investing/2016/09/26/3-top-biotech-stocks-to-buy-on-sale.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Biotech Stocks to Buy on Sale
CELG,CELG:UW,BBG000BFCMR2,What’s the Upside Potential for Gilead?,2016-09-26 15:04:51 +0000,http://marketrealist.com/2016/09/whats-the-upside-potential-for-gilead/?utm_source=yahoo&utm_medium=feed,What’s the Upside Potential for Gilead?
CELG,CELG:UW,BBG000BFCMR2,3 Top Biotech Stocks to Buy on Sale,2016-09-26 14:24:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9snXci0A7dY/3-top-biotech-stocks-to-buy-on-sale-cm684420,Image source Getty Images Investors looking for growth opportunities often like what they find in the biotech sector Unfortunately biotech stocks frequently come with valuations that are either sky high or highly speculative The good news though is that there are some
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bearish Manner : CELG-US : September 26, 2016",2016-09-26 12:51:41 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-breached-its-50-day-moving-average-in-a-bearish-manner-celg-us-september-26-2016/,"Celgene Corp. breached its 50 day moving average in a Bearish Manner : CELG-US : September 26, 2016"
CELG,CELG:UW,BBG000BFCMR2,The Factors behind Gilead’s Discounted Valuation,2016-09-23 15:10:03 +0000,http://marketrealist.com/2016/09/the-factors-behind-gileads-discounted-valuation/?utm_source=yahoo&utm_medium=feed,The Factors behind Gilead’s Discounted Valuation
CELG,CELG:UW,BBG000BFCMR2,3 Health Stocks to Own for the Next 10 Years,2016-09-23 13:20:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vNrxTGDw3_c/3-health-stocks-to-own-for-the-next-10-years-cm683614,When it comes to stocks we like playing the long game picking solid companies sticking with them through tough times and hanging on for years even a decade or more Investing for the long haul can smooth out the risks of buying individual stocks which may tumble or stay depressed
CELG,CELG:UW,BBG000BFCMR2,Allergan's Vitae Buy Could Spark More Interest in Kadmon,2016-09-23 10:25:00 +0000,https://www.thestreet.com/story/13746516/1/allergan-s-vitae-buy-could-spark-more-interest-in-kadmon.html?puc=yahoo&cm_ven=YAHOO,Allergan's Vitae Buy Could Spark More Interest in Kadmon
CELG,CELG:UW,BBG000BFCMR2,"HC Wainwright Initiates OncoMed Pharmaceuticals With Buy Rating, $20 Target",2016-09-22 14:45:33 +0000,http://finance.yahoo.com/news/hc-wainwright-initiates-oncomed-pharmaceuticals-144533278.html,"HC Wainwright Initiates OncoMed Pharmaceuticals With Buy Rating, $20 Target"
CELG,CELG:UW,BBG000BFCMR2,The Most Exciting Drug in Celgene's Pipeline,2016-09-21 21:21:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E0P62i6efko/the-most-exciting-drug-in-celgenes-pipeline-cm682863,Image source Pixabay Seeing as it contributes more than 60 of total revenue it is no surprise that 6 billion blood cancer drug Revlimid has captured the attention of Celgene NASDAQ CELG investors With four of the seven approved drugs in Celgene s product lineup treating
CELG,CELG:UW,BBG000BFCMR2,The Most Exciting Drug in Celgene's Pipeline,2016-09-21 19:46:54 +0000,http://www.fool.com/investing/2016/09/21/the-most-exciting-drug-in-celgenes-pipeline.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Most Exciting Drug in Celgene's Pipeline
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Outflows: TQQQ, KHC, WBA, CELG",2016-09-21 16:22:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xWRpTnoAIkI/noteworthy-etf-outflows-tqqq-khc-wba-celg-cm682690,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the ProShares UltraPro QQQ Symbol TQQQ where we have detected an approximate 61 8 million dollar outflow that s a 6 2 decrease week over week from 8 000 000
CELG,CELG:UW,BBG000BFCMR2,Ionis’s Orphan Drug in Third Phase of Clinical Trials,2016-09-21 15:05:26 +0000,http://marketrealist.com/2016/09/ioniss-orphan-drug-in-third-phase-of-clinical-trials/?utm_source=yahoo&utm_medium=feed,Ionis’s Orphan Drug in Third Phase of Clinical Trials
CELG,CELG:UW,BBG000BFCMR2,Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB) Is Turning Things Around,2016-09-21 14:22:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7IIqsxX6-Zk/trade-of-the-day-ishares-nasdaq-biotechnology-index-etf-ibb-is-turning-things-around-cm682508,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips iShares Nasdaq Biotechnology Index ETF NASDAQ IBB This exchange traded fund ETF tracks the NASDAQ Biotechnology Index It invests 90 of its assets in stocks of
CELG,CELG:UW,BBG000BFCMR2,Biotech ETF At Best Level Since January; Are You Braced For Bumps?,2016-09-20 22:20:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wZc1kAUU_Vs/biotech-etf-at-best-level-since-january-are-you-braced-for-bumps-cm681987,Major index ETFs finished flat 160 Tuesday as investors shrugged off weak housing data and awaited the Federal Reserve s decision on interest rates Biotechnology 160 exchange traded funds rose and 160 health care led advancing S amp P 500 sectors Shares of Sarepta
CELG,CELG:UW,BBG000BFCMR2,Bristol-Myers Squibb’s Role in the Multiple Myeloma Market,2016-09-20 15:04:17 +0000,http://marketrealist.com/2016/09/competitive-pressures-relapsed-refractory-multiple-myeloma-market-may-affect-emplicitis-sales/?utm_source=yahoo&utm_medium=feed,Bristol-Myers Squibb’s Role in the Multiple Myeloma Market
CELG,CELG:UW,BBG000BFCMR2,Trade of the Day: Celgene Corporation (CELG) Looking Healthy Again,2016-09-20 14:21:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C6O8w_6suUc/trade-of-the-day-celgene-corporation-celg-looking-healthy-again-cm681847,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Celgene Corporation NASDAQ CELG This biotechnology company develops and markets small molecule drugs for the treatment of cancers and inflammatory diseases It granted
CELG,CELG:UW,BBG000BFCMR2,Celgene Presents Efficacy & Safety Phase II Ozanimod Data,2016-09-20 13:23:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GkHgucx0BRw/celgene-presents-efficacy-safety-phase-ii-ozanimod-data-cm681727,Celgene Corporation s CELG wholly owned subsidiary Celgene International Sàrl announced data from the 96 week blinded extension period for a total of up to 120 weeks of exposure on treatment of the phase II study RADIANCE on an experimental oral selective S1P 1 and 5 receptor
CELG,CELG:UW,BBG000BFCMR2,Celgene Presents Efficacy & Safety Phase II Ozanimod Data,2016-09-20 10:53:10 +0000,http://finance.yahoo.com/news/celgene-presents-efficacy-safety-phase-105310657.html,Celgene Presents Efficacy & Safety Phase II Ozanimod Data
CELG,CELG:UW,BBG000BFCMR2,How To Predict The Next Sarepta (FDA Approval Stock) And Win Big,2016-09-19 22:56:00 +0000,http://www.forbes.com/sites/bryanrich/2016/09/19/how-to-predict-the-next-sarepta-fda-approval-stock-and-win-big/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,How To Predict The Next Sarepta (FDA Approval Stock) And Win Big
CELG,CELG:UW,BBG000BFCMR2,3 Top Stocks on Sale This Fall,2016-09-19 14:23:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6hHG1R04NhI/3-top-stocks-on-sale-this-fall-cm681206,Image source Getty Images The leaves have begun changing color all across the country the weather is just a little bit cooler Fall is in the air and so is stock market volatility There are a number of questions left to be answered this fall that could have a direct impact on
CELG,CELG:UW,BBG000BFCMR2,3 Top Stocks on Sale This Fall,2016-09-19 12:41:06 +0000,http://www.fool.com/investing/2016/09/19/3-top-stocks-on-sale-this-fall.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Stocks on Sale This Fall
CELG,CELG:UW,BBG000BFCMR2,RBC Says These 4 Top Biotechs Could Have Big Upside Potential,2016-09-19 12:25:17 +0000,http://247wallst.com/healthcare-business/2016/09/19/rbc-says-these-4-top-biotechs-could-have-big-upside-potential/,RBC Says These 4 Top Biotechs Could Have Big Upside Potential
CELG,CELG:UW,BBG000BFCMR2,Vertex: Did Management Deliver Investors a Backhanded Slap?,2016-09-16 16:49:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/16/vertex-did-management-deliver-investors-a-backhanded-slap/?mod=yahoobarrons&ru=yahoo,Vertex: Did Management Deliver Investors a Backhanded Slap?
CELG,CELG:UW,BBG000BFCMR2,Oral Ozanimod Efficacy and Safety Results at 2 Years from Phase 2 RADIANCE Trial of Patients with Relapsing Multiple Sclerosis Presented at 32nd ECTRIMS,2016-09-16 14:48:09 +0000,http://www.publicnow.com/view/852AF4F36C06D9496D03B1BFA2EF1693D47758D6,[at noodls] - Ozanimod demonstrated continued efficacy over 96 weeks on MRI and clinical measures of multiple sclerosis disease activity No new safety or tolerability issues were identified during the ongoing blinded ...
CELG,CELG:UW,BBG000BFCMR2,5 Reasons Celgene Is a Buy,2016-09-15 16:17:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gcXu4WItcfg/5-reasons-celgene-is-a-buy-cm680038,Image source Celgene While the past few months have been good to Celgene NASDAQ CELG investors shares are still down about 11 year to date dramatically underperforming the broader market CELG data by YCharts In spite of this
CELG,CELG:UW,BBG000BFCMR2,Celgene Outspends Big Pharmas in Deals (CELG),2016-09-15 15:50:00 +0000,http://www.investopedia.com/news/celgene-outspends-big-pharmas-deals-celg/?partner=YahooSA,Celgene Outspends Big Pharmas in Deals (CELG)
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Big Bet May Pay Off (CELG),2016-09-15 15:31:00 +0000,http://www.investopedia.com/news/celgenes-big-bet-may-pay-celg/?partner=YahooSA,Celgene’s Big Bet May Pay Off (CELG)
CELG,CELG:UW,BBG000BFCMR2,5 Reasons Celgene Is a Buy,2016-09-15 14:44:17 +0000,http://www.fool.com/investing/2016/09/15/5-reasons-celgene-is-a-buy.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Reasons Celgene Is a Buy
CELG,CELG:UW,BBG000BFCMR2,Biotechs Help Nasdaq To Small Gain; Apple's Rise Fails To Spur Dow,2016-09-14 20:16:40 +0000,http://www.investors.com/market-trend/stock-market-today/biotechs-help-nasdaq-to-small-gain-apples-rise-fails-to-spur-dow/,Biotechs Help Nasdaq To Small Gain; Apple's Rise Fails To Spur Dow
CELG,CELG:UW,BBG000BFCMR2,Celgene's Crohn's Disease Drug Positive in Phase Ib Study,2016-09-13 15:49:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4BgFqL3q_aU/celgenes-crohns-disease-drug-positive-in-phase-ib-study-cm678786,Celgene Corporation CELG announced positive interim top line results from a phase Ib trial on its investigational pipeline candidate GED 0301 mongersen The candidate is being developed for the treatment of patients suffering from Crohn s disease chronic inflammatory condition
CELG,CELG:UW,BBG000BFCMR2,Celgene's Crohn's Disease Drug Positive in Phase Ib Study,2016-09-13 13:37:01 +0000,http://finance.yahoo.com/news/celgenes-crohns-disease-drug-positive-133701236.html,Celgene's Crohn's Disease Drug Positive in Phase Ib Study
CELG,CELG:UW,BBG000BFCMR2,First-Ever Psoriatic Arthritis Awareness Day Aims to Educate on Importance of Early Diagnosis and Treatment,2016-09-13 11:48:07 +0000,http://www.publicnow.com/view/30F210968485EC5147B795E1D727A54F93FCBDD2,"[at noodls] - Celgene Unites With National Psoriasis Foundation to Elevate Awareness of Psoriatic Arthritis (PsA) and Rally Support for Patient Community SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: ..."
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Run for Cover From Major Biotechs,2016-09-13 11:05:22 +0000,http://247wallst.com/healthcare-business/2016/09/13/short-sellers-run-for-cover-from-major-biotechs-9/,Short Sellers Run for Cover From Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift",2016-09-13 03:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9erYE7-344M/rprx-on-track-across-the-pond-cerc-gets-funded-data-gives-fomx-a-facelift-20160913-00097,"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift"
CELG,CELG:UW,BBG000BFCMR2,"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift",2016-09-13 03:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-EPzd1eDAnQ/rprx-on-track-across-the-pond-cerc-gets-funded-data-gives-fomx-a-facelift-20160913-00098,"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift"
CELG,CELG:UW,BBG000BFCMR2,Traders pick biotech stocks as sector sees best day in months,2016-09-12 22:45:36 +0000,http://www.cnbc.com/id/103934092?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103934092,Traders pick biotech stocks as sector sees best day in months
CELG,CELG:UW,BBG000BFCMR2,Buying biotech: 5 trades in pharma,2016-09-12 21:00:00 +0000,http://finance.yahoo.com/video/buying-biotech-5-trades-pharma-210000476.html,Buying biotech: 5 trades in pharma
CELG,CELG:UW,BBG000BFCMR2,Biotech: Four Catalysts for Four Stocks,2016-09-12 19:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/12/biotech-four-catalysts-for-four-stocks/?mod=yahoobarrons&ru=yahoo,Biotech: Four Catalysts for Four Stocks
CELG,CELG:UW,BBG000BFCMR2,Response to Bloomberg Article on Celgene Payment: David Steensma,2016-09-12 19:24:33 +0000,http://www.bloomberg.com/news/articles/2016-09-12/response-to-bloomberg-article-on-celgene-payment-david-steensma?cmpid=yhoo.headline,Response to Bloomberg Article on Celgene Payment: David Steensma
CELG,CELG:UW,BBG000BFCMR2,"IYH, BMY, AGN, CELG: Large Outflows Detected at ETF",2016-09-12 16:32:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CLtDXwDt-so/iyh-bmy-agn-celg-large-outflows-detected-at-etf-cm678026,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Healthcare ETF Symbol IYH where we have detected an approximate 29 7 million dollar outflow that s a 1 5 decrease week over week from 13 250
CELG,CELG:UW,BBG000BFCMR2,Two Things You Must Understand About Biotech Investing,2016-09-12 15:59:44 +0000,http://www.fool.com/investing/2016/09/11/two-things-you-must-understand-about-biotech-inves.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Two Things You Must Understand About Biotech Investing
CELG,CELG:UW,BBG000BFCMR2,Celgene Data Offer A Rorschach Test To Wall Street,2016-09-12 15:48:00 +0000,http://www.forbes.com/sites/matthewherper/2016/09/12/celgene-data-offer-a-rorschach-test-to-wall-street/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Celgene Data Offer A Rorschach Test To Wall Street
CELG,CELG:UW,BBG000BFCMR2,Look Under The Hood: IVV Has 11% Upside,2016-09-12 14:31:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tuk31qifyPI/look-under-the-hood-ivv-has-11-upside-cm677843,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
CELG,CELG:UW,BBG000BFCMR2,Celgene To Present At Morgan Stanley Conference; Webcast At 2:50 PM ET,2016-09-12 13:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5wLcpXk0sSc/celgene-to-present-at-morgan-stanley-conference-webcast-at-250-pm-et-20160912-00868,Celgene To Present At Morgan Stanley Conference; Webcast At 2:50 PM ET
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Interim Topline Data from Trial of Investigational Oral GED-0301 in Patients with Active Crohn's Disease,2016-09-12 11:58:04 +0000,http://www.publicnow.com/view/1EC91CDCB6E3AA5681B16FAD2DA7895E11CDC56E,"[at noodls] - Data show endoscopic improvement and clinical response and remission at week 12 Safety and tolerability consistent with previous studies Results expected to be presented at upcoming medical meetings SUMMIT, ..."
CELG,CELG:UW,BBG000BFCMR2,"CELGENE CORP /DE/ Files SEC form 8-K, Other Events",2016-09-12 11:50:12 +0000,http://biz.yahoo.com/e/160912/celg8-k.html,"CELGENE CORP /DE/ Files SEC form 8-K, Other Events"
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Interim Topline Data from Trial of Investigational Oral GED-0301 in Patients with Active Crohn’s Disease,2016-09-12 11:30:00 +0000,http://finance.yahoo.com/news/celgene-announces-interim-topline-data-113000993.html,"[Business Wire] - Celgene Corporation today announced interim topline data from a randomized, double-blind, multicenter, exploratory phase 1b study evaluating the effects of oral GED-0301 on both endoscopic and clinical outcomes in patients with active Crohn’s disease."
CELG,CELG:UW,BBG000BFCMR2,Celgene Reports Interim Topline Data From GED-0301 Trial - Quick Facts,2016-09-12 07:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7A30W9Acvhk/celgene-reports-interim-topline-data-from-ged0301-trial--quick-facts-20160912-00286,Celgene Reports Interim Topline Data From GED-0301 Trial - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,Two Things You Must Understand About Biotech Investing,2016-09-11 16:30:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2HKTCcBLieM/two-things-you-must-understand-about-biotech-investing-cm677459,A multibillion dollar market for drugs that work similarly to branded biologics is emerging and investors might not want to miss out on the opportunity Over 100 billion in brand name sales of biologic drugs will lose patent protection over the next five to 10 years and
CELG,CELG:UW,BBG000BFCMR2,4 Key BioPharma Movers in the Past Week,2016-09-11 14:35:07 +0000,http://247wallst.com/healthcare-business/2016/09/11/4-key-biopharma-movers-in-the-past-week/,4 Key BioPharma Movers in the Past Week
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation (CELG) – Two Ways to Trade CELG Stock,2016-09-09 20:34:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B3CCvQXhQa8/celgene-corporation-celg-two-ways-to-trade-celg-stock-cm676892,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotechnology stocks such as 160 Celgene Corporation 160 NASDAQ CELG have shown a good amount of grit over the last month and a half or so despite a number of
CELG,CELG:UW,BBG000BFCMR2,Why Celgene Corporation (CELG) Can Finish 2016 in the Black,2016-09-09 20:33:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y1Wv4zir4Ng/why-celgene-corporation-celg-can-finish-2016-in-the-black-cm677078,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotech stocks never fully recovered from last summer s correction after Hillary Clinton fired shots on her Twitter Inc NYSE TWTR account about drug pricing With
CELG,CELG:UW,BBG000BFCMR2,Market Watches to See if Biogen Will Meet Its Raised Guidance,2016-09-09 19:04:10 +0000,http://marketrealist.com/2016/09/market-watches-to-see-if-biogen-will-meet-its-raised-guidance/?utm_source=yahoo&utm_medium=feed,Market Watches to See if Biogen Will Meet Its Raised Guidance
CELG,CELG:UW,BBG000BFCMR2,Analysts Look for Celgene to Offer Striking Returns in 2016,2016-09-09 15:04:18 +0000,http://marketrealist.com/2016/09/analysts-look-for-celgene-to-offer-striking-returns-in-2016/?utm_source=yahoo&utm_medium=feed,Analysts Look for Celgene to Offer Striking Returns in 2016
CELG,CELG:UW,BBG000BFCMR2,"3 Reasons bluebird bio, Inc. Stock Dipped 13.7% in August",2016-09-09 14:24:51 +0000,http://www.fool.com/investing/2016/09/09/3-reasons-bluebird-bio-inc-stock-dipped-137-in-aug.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"3 Reasons bluebird bio, Inc. Stock Dipped 13.7% in August"
CELG,CELG:UW,BBG000BFCMR2,Global Expansion to Fuel Revenue for Otezla,2016-09-09 14:04:28 +0000,http://marketrealist.com/2016/09/global-expansion-to-fuel-revenue-for-otezla/?utm_source=yahoo&utm_medium=feed,Global Expansion to Fuel Revenue for Otezla
CELG,CELG:UW,BBG000BFCMR2,The Biotech ETF With The Unusual Investment Strategy,2016-09-09 13:48:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LzdJHyilsgk/the-biotech-etf-with-the-unusual-investment-strategy-cm676816,"With most of the investable universe covered by an ETF in some form or another, fund providers are targeting increasingly narrow spaces for new product launches.     Management style tactics are also veering from the norm, as evidenced by the boom in smart beta products. While many of the ETFs are perfectly"
CELG,CELG:UW,BBG000BFCMR2,10 Must-Know Biotech Stock Events to Close Out 2016,2016-09-09 13:14:00 +0000,https://www.thestreet.com/story/13699729/1/10-must-know-biotech-stock-events-to-close-out-2016.html?puc=yahoo&cm_ven=YAHOO,10 Must-Know Biotech Stock Events to Close Out 2016
CELG,CELG:UW,BBG000BFCMR2,When Will the Generic Version of Abraxane Be Available?,2016-09-09 12:04:31 +0000,http://marketrealist.com/2016/09/when-will-the-generic-version-of-abraxane-be-available/?utm_source=yahoo&utm_medium=feed,When Will the Generic Version of Abraxane Be Available?
CELG,CELG:UW,BBG000BFCMR2,Biogen: Be Like Celgene?,2016-09-08 18:53:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/08/biogen-be-like-celgene/?mod=yahoobarrons&ru=yahoo,Biogen: Be Like Celgene?
CELG,CELG:UW,BBG000BFCMR2,"Agios' (AGIO) Partner Celgene to File for Enasidenib, Stock Up",2016-09-08 15:21:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oIyyaYJvjew/agios-agio-partner-celgene-to-file-for-enasidenib-stock-up-cm676183,Agios Pharmaceuticals Inc s AGIO shares were up almost 26 after the company revealed in an 8 K filing that its collaboration partner Celgene Corporation CELG will submit a new drug application NDA for enasidenib AG 221 for the treatment of patients with relapsed and or refractory
CELG,CELG:UW,BBG000BFCMR2,Celgene Carves Out More Share of This Cancer Treatment Market,2016-09-08 15:04:46 +0000,http://marketrealist.com/2016/09/celgene-carves-out-more-share-of-this-cancer-treatment-market/?utm_source=yahoo&utm_medium=feed,Celgene Carves Out More Share of This Cancer Treatment Market
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation (Nasdaq: CELG) to Ring The Nasdaq Stock Market Closing Bell,2016-09-08 14:09:03 +0000,http://www.publicnow.com/view/32135191A1B8D3626B2415910E31E08B5748F4DA,"[at noodls] - ADVISORY, Sept. 08, 2016 (GLOBE NEWSWIRE) -- What: Celgene Corporation (Nasdaq:CELG), an integrated global biopharmaceutical company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, ..."
CELG,CELG:UW,BBG000BFCMR2,What Are the Possible Threats to Revlimid?,2016-09-08 14:04:47 +0000,http://marketrealist.com/2016/09/what-are-the-possible-threats-to-revlimid/?utm_source=yahoo&utm_medium=feed,What Are the Possible Threats to Revlimid?
CELG,CELG:UW,BBG000BFCMR2,Blog Coverage Celgene Partner of Agios Pharma Plans NDA to Get FDA Approval for Blood Cancer Drug AG 221,2016-09-08 13:16:40 +0000,http://news.investornetwork.com/2016/09/08/blog-coverage-celgene-partner-of-agios-pharma-plans-nda-to-get-fda-approval-for-blood-cancer-drug-ag-221/?1=1&1473340600,Blog Coverage Celgene Partner of Agios Pharma Plans NDA to Get FDA Approval for Blood Cancer Drug AG 221
CELG,CELG:UW,BBG000BFCMR2,"Agios' (AGIO) Partner Celgene to File for Enasidenib, Stock Up",2016-09-08 13:09:01 +0000,http://finance.yahoo.com/news/agios-agio-partner-celgene-file-130901714.html,"Agios' (AGIO) Partner Celgene to File for Enasidenib, Stock Up"
CELG,CELG:UW,BBG000BFCMR2,How Can Revlimid Eventually Lead the Lymphoma Space?,2016-09-08 12:04:50 +0000,http://marketrealist.com/2016/09/how-can-revlimid-eventually-lead-the-lymphoma-space/?utm_source=yahoo&utm_medium=feed,How Can Revlimid Eventually Lead the Lymphoma Space?
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy Wednesday Option Activity: FRAN, CELG, GS",2016-09-07 21:17:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rOAUZetOu2g/noteworthy-wednesday-option-activity-fran-celg-gs-cm675874,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Francesca s Holdings Corp Symbol FRAN where a total of 3 514 contracts have traded so far representing approximately 351 400 underlying shares That amounts to about 54 4 of FRAN
CELG,CELG:UW,BBG000BFCMR2,Close Update: Stocks Retreat on Bullish Job Data and Hawkish Fed Speak,2016-09-07 20:57:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2lrqtXnOdWw/close-update-stocks-retreat-on-bullish-job-data-and-hawkish-fed-speak-cm675906,Stocks closed fractionally lower Wednesday as Wall Street faltered on record high job openings and remarks from two members of the Fed that advocated for a September rate hike Gains in the technology and telecom sector helped mitigate selling pressure on the Nasdaq Composite as it closed at
CELG,CELG:UW,BBG000BFCMR2,Agios Stock Soars As Partner Celgene Preps Drug Filing,2016-09-07 20:40:24 +0000,http://www.investors.com/news/technology/agios-stock-soars-as-partner-celgene-preps-drug-filing/,Agios Stock Soars As Partner Celgene Preps Drug Filing
CELG,CELG:UW,BBG000BFCMR2,Why Agios Pharmaceuticals Inc Stock Skyrocketed Today,2016-09-07 19:18:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zAwWC4raKnQ/why-agios-pharmaceuticals-inc-stock-skyrocketed-today-cm675812,Image source Getty Images What happened Agios Pharmaceuticals NASDAQ AGIO is up 23 at 1 03 p m ET after announcing that its partner Celgene NASDAQ CELG plans to submit an application to the Food and Drug Administration for enasidenib by the end of the year
CELG,CELG:UW,BBG000BFCMR2,Celgene Shows Spending Pays,2016-09-07 19:11:16 +0000,http://www.bloomberg.com/gadfly/articles/2016-09-07/celgene-ag-221-news-shows-spending-pays?cmpid=yhoo.headline,Celgene Shows Spending Pays
CELG,CELG:UW,BBG000BFCMR2,This Celgene Cancer Treatment Could Lead the Industry by 2021,2016-09-07 19:04:05 +0000,http://marketrealist.com/2016/09/this-celgene-cancer-treatment-could-lead-the-industry-by-2021/?utm_source=yahoo&utm_medium=feed,This Celgene Cancer Treatment Could Lead the Industry by 2021
CELG,CELG:UW,BBG000BFCMR2,Celgene’s Enterprise Value to Earnings in Line with Peers,2016-09-07 18:04:08 +0000,http://marketrealist.com/2016/09/celgenes-enterprise-value-to-earnings-in-line-with-peers/?utm_source=yahoo&utm_medium=feed,Celgene’s Enterprise Value to Earnings in Line with Peers
CELG,CELG:UW,BBG000BFCMR2,Why Agios Pharmaceuticals Inc Stock Skyrocketed Today,2016-09-07 17:45:47 +0000,http://www.fool.com/investing/2016/09/07/why-agios-pharmaceuticals-inc-stock-skyrocketed-to.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Agios Pharmaceuticals Inc Stock Skyrocketed Today
CELG,CELG:UW,BBG000BFCMR2,Midday Update: Wall Street Braces for Beige Book,2016-09-07 17:17:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cnFZzkHkCKQ/midday-update-wall-street-braces-for-beige-book-cm675745,Wall Street remained defensive Wednesday as investors braced for further clarity on the outcome to this month s Federal Open Market Committee meeting from the Beige Book anecdotal report on regional economic activity Hawkish comments from Federal Reserve Presidents Esther George and Jeffrey
CELG,CELG:UW,BBG000BFCMR2,Mid-Day Market Update: Sprouts Farmers Market Drops Following Guidance Cut; Cogentix Medical Shares Surge,2016-09-07 17:17:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3oMQ1_BNLyI/mid-day-market-update-sprouts-farmers-market-drops-following-guidance-cut-cogentix-medical-shares-surge-cm675748,Midway through trading Wednesday the Dow traded down 0 26 percent to 18 489 80 while the NASDAQ declined 0 05 percent to 5 273 07 The S amp P also fell dropping 0 21 percent to 2 181 94 Leading and Lagging Sectors On Wednesday energy shares surged by 0 20 percent Meanwhile
CELG,CELG:UW,BBG000BFCMR2,Did Agios Just Speed Up Its Business Plan by 2 Years?,2016-09-07 16:10:10 +0000,http://247wallst.com/healthcare-business/2016/09/07/did-agios-just-speed-up-its-business-plan-by-2-years/,Did Agios Just Speed Up Its Business Plan by 2 Years?
CELG,CELG:UW,BBG000BFCMR2,Mid-Morning Market Update: Markets Mostly Flat; HD Supply Misses Q2 Views,2016-09-07 15:47:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jVRZ-N1qKh4/mid-morning-market-update-markets-mostly-flat-hd-supply-misses-q2-views-cm675692,Following the market opening Wednesday the Dow traded down 0 07 percent to 18 525 45 while the NASDAQ gained 0 10 percent to 5 280 95 The S amp P also fell dropping 0 03 percent to 2 185 77 Leading and Lagging Sectors Wednesday morning energy shares surged by 0 43
CELG,CELG:UW,BBG000BFCMR2,Understanding Celgene’s Premium PE Valuation,2016-09-07 15:41:18 +0000,http://marketrealist.com/2016/09/understanding-celgenes-premium-pe-valuation/?utm_source=yahoo&utm_medium=feed,Understanding Celgene’s Premium PE Valuation
CELG,CELG:UW,BBG000BFCMR2,Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene,2016-09-07 12:10:00 +0000,https://www.thestreet.com/story/13696016/1/agios-blood-cancer-drug-heading-to-early-fda-filing-by-partner-celgene.html?puc=yahoo&cm_ven=YAHOO,Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene
CELG,CELG:UW,BBG000BFCMR2,Celgene To Present At Citi 11th Biotech Conference; Webcast At 12:00 PM ET,2016-09-07 11:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kufhl5NGpy0/celgene-to-present-at-citi-11th-biotech-conference-webcast-at-1200-pm-et-20160907-00858,Celgene To Present At Citi 11th Biotech Conference; Webcast At 12:00 PM ET
CELG,CELG:UW,BBG000BFCMR2,"With Solid Growth And Strong Pipeline, Argus Is Positive On Celgene's Long-Term Prospects",2016-09-06 19:55:16 +0000,http://finance.yahoo.com/news/solid-growth-strong-pipeline-argus-195516391.html,"With Solid Growth And Strong Pipeline, Argus Is Positive On Celgene's Long-Term Prospects"
CELG,CELG:UW,BBG000BFCMR2,Next Up for Celgene's Crohn's Pill: A Snapshot Inside Patients' Colons (Updated),2016-09-05 23:18:00 +0000,https://www.thestreet.com/story/13639414/1/next-up-for-celgene-s-crohn-s-pill-a-snapshot-inside-patients-colons.html?puc=yahoo&cm_ven=YAHOO,Next Up for Celgene's Crohn's Pill: A Snapshot Inside Patients' Colons (Updated)
CELG,CELG:UW,BBG000BFCMR2,Time to look at biotechs?,2016-09-02 17:03:00 +0000,http://finance.yahoo.com/video/time-look-biotechs-170300197.html,Time to look at biotechs?
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Outflows: IYH, BMY, AGN, CELG",2016-09-02 16:18:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nNDWzM9usNk/noteworthy-etf-outflows-iyh-bmy-agn-celg-cm674090,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Healthcare ETF Symbol IYH where we have detected an approximate 60 3 million dollar outflow that s a 2 9 decrease week over week from 13 650
CELG,CELG:UW,BBG000BFCMR2,Notable Two Hundred Day Moving Average Cross - CELG,2016-09-01 17:10:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qX3a6V27QHM/notable-two-hundred-day-moving-average-cross-celg-cm673562,In trading on Thursday shares of Celgene Corp Symbol CELG crossed below their 200 day moving average of 106 06 changing hands as low as 105 38 per share Celgene Corp shares are currently trading off about 0 5 on the day The chart below shows the one year performance of CELG
CELG,CELG:UW,BBG000BFCMR2,"For Biotech ETFs, It’s All About U.S. Presidential Politics",2016-09-01 16:00:33 +0000,http://finance.yahoo.com/news/biotech-etfs-u-presidential-politics-160033935.html,"For Biotech ETFs, It’s All About U.S. Presidential Politics"
CELG,CELG:UW,BBG000BFCMR2,[$$] Novartis Carts Itself Off,2016-09-01 15:10:00 +0000,http://www.barrons.com/articles/novartis-carts-itself-off-1472742605?mod=yahoobarrons&ru=yahoo,[$$] Novartis Carts Itself Off
CELG,CELG:UW,BBG000BFCMR2,"Celgene To Surge By Double-Digits After Big Tumble, Vetr Crowd Says",2016-08-31 18:10:23 +0000,http://finance.yahoo.com/news/celgene-surge-double-digits-big-181023246.html,"Celgene To Surge By Double-Digits After Big Tumble, Vetr Crowd Says"
CELG,CELG:UW,BBG000BFCMR2,Celgene's Deep Pullback Reaches Key Support,2016-08-31 17:43:00 +0000,https://www.thestreet.com/story/13690823/1/celgene-s-deep-pullback-reaches-key-support.html?puc=yahoo&cm_ven=YAHOO,Celgene's Deep Pullback Reaches Key Support
CELG,CELG:UW,BBG000BFCMR2,"Novartis Disbands Cell Therapy Unit; What's Ahead For Kite, Juno?",2016-08-31 17:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/31/novartis-disbands-cell-therapy-unit-whats-ahead-for-kite-juno/?mod=yahoobarrons&ru=yahoo,"Novartis Disbands Cell Therapy Unit; What's Ahead For Kite, Juno?"
CELG,CELG:UW,BBG000BFCMR2,Biotech: In Unfamiliar Territory?,2016-08-31 14:24:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/31/biotech-in-unfamiliar-territory/?mod=yahoobarrons&ru=yahoo,Biotech: In Unfamiliar Territory?
CELG,CELG:UW,BBG000BFCMR2,United Therapeutics Makes Novel Technologies a Priority,2016-08-31 14:05:03 +0000,http://marketrealist.com/2016/08/united-therapeutics-explores-novel-technologies-strengthening-drug-pipeline-2016/?utm_source=yahoo&utm_medium=feed,United Therapeutics Makes Novel Technologies a Priority
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corp. breached its 50 day moving average in a Bearish Manner : CELG-US : August 31, 2016",2016-08-31 12:23:59 +0000,http://www.capitalcube.com/blog/index.php/celgene-corp-breached-its-50-day-moving-average-in-a-bearish-manner-celg-us-august-31-2016/,"Celgene Corp. breached its 50 day moving average in a Bearish Manner : CELG-US : August 31, 2016"
CELG,CELG:UW,BBG000BFCMR2,These 3 Billionaires Dumped Johnson & Johnson Stock. Should You?,2016-08-31 11:34:56 +0000,http://www.fool.com/investing/2016/08/30/these-3-billionaires-dumped-johnson-johnson-should.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 3 Billionaires Dumped Johnson & Johnson Stock. Should You?
CELG,CELG:UW,BBG000BFCMR2,These 3 Billionaires Dumped Johnson & Johnson Stock. Should You?,2016-08-30 13:14:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1FbV7oJEBls/these-3-billionaires-dumped-johnson-johnson-stock-should-you-cm672021,"Image source  Getty Images.  While I don't believe in blindly following billionaires into or out of specific equities, the fact that these so called ""super investors"" can have a sizable impact on the"
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Webcast at Upcoming Investor Conferences and R&D Deep Dive in September,2016-08-29 11:53:03 +0000,http://www.publicnow.com/view/A8C835D719997A232E035CD9BBDFB11CEDEF8000,"[at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences and at an R&D deep dive in September where Celgene management will provide an overview ..."
CELG,CELG:UW,BBG000BFCMR2,3 Great Stocks for Your 401(k),2016-08-27 14:28:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jxn7EULNgME/3-great-stocks-for-your-401k-cm671197,Image source  Getty Images.  The 401(k) is quite possibly the most powerful tool for employees today to grow wealth for when they retire. One of the biggest advantages is that you defer any
CELG,CELG:UW,BBG000BFCMR2,3 Great Stocks for Your 401(k),2016-08-27 13:05:00 +0000,http://www.fool.com/investing/2016/08/27/3-great-stocks-for-your-401k.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Great Stocks for Your 401(k)
CELG,CELG:UW,BBG000BFCMR2,What Do Analysts Think about BioMarin’s Return Potential?,2016-08-26 15:06:30 +0000,http://marketrealist.com/2016/08/analysts-think-biomarins-return-potential/?utm_source=yahoo&utm_medium=feed,What Do Analysts Think about BioMarin’s Return Potential?
CELG,CELG:UW,BBG000BFCMR2,Wall Street Breakfast: Pfizer To Buy Medivation For $14B,2016-08-26 13:47:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aSLS1ocr8GQ/wall-street-breakfast-pfizer-to-buy-medivation-for-14b-cm668864,"By Wall Street Breakfast Pfizer has agreed to acquire Medivation ( MDVN ) for $14B, with Pfizer ( PFE ) beating out rivals Celgene ( CELG ), Gilead ( GILD ), Sanofi ( SNY ), Merck (MRK) and AstraZeneca"
CELG,CELG:UW,BBG000BFCMR2,Franklin fund manager loads up on banks as profits rise,2016-08-26 12:55:42 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=982410F0-6ACC-11E6-933B-8BAFB8E4E1DA&siteid=yhoof2,Franklin fund manager loads up on banks as profits rise
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stocks: Oops, She Did It Again",2016-08-25 13:38:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/25/biotech-stocks-oops-she-did-it-again/?mod=yahoobarrons&ru=yahoo,"Biotech Stocks: Oops, She Did It Again"
CELG,CELG:UW,BBG000BFCMR2,Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?,2016-08-25 13:04:31 +0000,http://marketrealist.com/2016/08/teva-pharmaceutical-expected-strengthen-specialty-pipeline-3q16/?utm_source=yahoo&utm_medium=feed,Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Increase Bets in Major Biotechs,2016-08-25 12:40:13 +0000,http://247wallst.com/healthcare-business/2016/08/25/short-sellers-increase-bets-in-major-biotechs-4/,Short Sellers Increase Bets in Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,"Dear Pfizer, Stop Overpaying for Acquisitions!",2016-08-24 21:45:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GOUg-HeNGsg/dear-pfizer-stop-overpaying-for-acquisitions-cm669797,"Image source  Getty Images.  If you've ever taken the time to sit down and listen to one of Pfizer 's(NYSE  PFE) quarterly conference calls or investor day updates, you'll catch many of"
CELG,CELG:UW,BBG000BFCMR2,"Dear Pfizer, Stop Overpaying for Acquisitions!",2016-08-24 19:41:00 +0000,http://www.fool.com/investing/2016/08/24/dear-pfizer-stop-overpaying-for-acquisitions.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Dear Pfizer, Stop Overpaying for Acquisitions!"
CELG,CELG:UW,BBG000BFCMR2,Imbruvica Continues to Report Better-than-Expected Sales in 2016,2016-08-24 15:04:05 +0000,http://marketrealist.com/2016/08/imbruvica-continues-report-better-expected-sales-2016/?utm_source=yahoo&utm_medium=feed,Imbruvica Continues to Report Better-than-Expected Sales in 2016
CELG,CELG:UW,BBG000BFCMR2,Mylan price hike happy?,2016-08-23 21:41:00 +0000,http://finance.yahoo.com/video/mylan-price-hike-happy-214100198.html,Mylan price hike happy?
CELG,CELG:UW,BBG000BFCMR2,What Are Analysts’ Recommendations for AbbVie in 2016?,2016-08-23 18:04:05 +0000,http://marketrealist.com/2016/08/analyst-recommendations-abbvie-2016-2/?utm_source=yahoo&utm_medium=feed,What Are Analysts’ Recommendations for AbbVie in 2016?
CELG,CELG:UW,BBG000BFCMR2,[$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions,2016-08-23 04:09:26 +0000,http://www.wsj.com/articles/pfizers-medivation-deal-latest-in-long-line-of-similar-acquisitions-1471882973?ru=yahoo?mod=yahoo_itp,[$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions
CELG,CELG:UW,BBG000BFCMR2,Medivation Scores Premium in Sale to Pfizer,2016-08-22 18:05:00 +0000,https://www.thestreet.com/story/13681748/1/medivation-scores-premium-in-sale-to-pfizer.html?puc=yahoo&cm_ven=YAHOO,Medivation Scores Premium in Sale to Pfizer
CELG,CELG:UW,BBG000BFCMR2,ETFs in Focus on Pfizer's Medivation Acquisition,2016-08-22 17:42:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eFjK215lNmY/etfs-in-focus-on-pfizers-medivation-acquisition-cm668570,"The biotech giant, Pfizer Inc. PFE and Xtandi manufacturer, Medivation, Inc. MDVN entered into a definitive merger agreement under which Pfizer will acquire Medivation for $81.50 per share in cash or a total enterprise value of about"
CELG,CELG:UW,BBG000BFCMR2,Stocks Fluctuate as Wall Street Is Cautious Ahead of Yellen Speech,2016-08-22 17:18:00 +0000,https://www.thestreet.com/story/13681613/1/stocks-fall-back-into-red-on-crude-selloff.html?puc=yahoo&cm_ven=YAHOO,Stocks Fluctuate as Wall Street Is Cautious Ahead of Yellen Speech
CELG,CELG:UW,BBG000BFCMR2,Here's Why a Gilead Stock Split Is Unlikely,2016-08-22 17:11:00 +0000,http://www.fool.com/investing/2016/08/22/heres-why-a-gilead-stock-split-is-unlikely.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why a Gilead Stock Split Is Unlikely
CELG,CELG:UW,BBG000BFCMR2,[$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions,2016-08-22 16:22:57 +0000,http://www.wsj.com/articles/pfizers-medivation-deal-latest-in-long-line-of-similar-acquisitions-1471882973?mod=yahoo_hs,[$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
CELG,CELG:UW,BBG000BFCMR2,Biotech stocks rally as investors bet on the next big tie-up,2016-08-22 15:57:44 +0000,http://www.cnbc.com/id/103884606?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103884606,Biotech stocks rally as investors bet on the next big tie-up
CELG,CELG:UW,BBG000BFCMR2,"ETF’s with exposure to Celgene Corp. : August 22, 2016",2016-08-22 15:13:26 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-celgene-corp-august-22-2016/,"ETF’s with exposure to Celgene Corp. : August 22, 2016"
CELG,CELG:UW,BBG000BFCMR2,Pfizer buys Medivation $14 billion cash,2016-08-22 14:06:00 +0000,http://finance.yahoo.com/video/pfizer-buys-medivation-14-billion-140600586.html,Pfizer buys Medivation $14 billion cash
CELG,CELG:UW,BBG000BFCMR2,3 Top Stocks You Can Buy on Sale,2016-08-22 11:56:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/33MIES3B378/3-top-stocks-you-can-buy-on-sale-cm668213,"Image source  Getty Images.  The S&P 500 is currently trading for more than 25 times trailing earnings, which is quite expensive from a historical standard. That doesn't mean it's destined to fall drastically"
CELG,CELG:UW,BBG000BFCMR2,"From Nightmare Drug to Celgene Blockbuster, Thalidomide Is Back",2016-08-22 09:00:00 +0000,http://www.bloomberg.com/news/articles/2016-08-22/from-nightmare-drug-to-celgene-blockbuster-thalidomide-is-back?cmpid=yhoo.headline,"From Nightmare Drug to Celgene Blockbuster, Thalidomide Is Back"
CELG,CELG:UW,BBG000BFCMR2,Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation,2016-08-22 01:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9dklLZSptco/pfizer-reportedly-nears-14-bln-deal-to-acquire-medivation-20160822-00012,Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation
CELG,CELG:UW,BBG000BFCMR2,3 Top Stocks You Can Buy on Sale,2016-08-21 20:43:00 +0000,http://www.fool.com/investing/2016/08/21/3-top-stocks-you-can-buy-on-sale-2.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Stocks You Can Buy on Sale
CELG,CELG:UW,BBG000BFCMR2,3 Reasons Medivation Is the Juiciest Target in Biotech,2016-08-21 15:41:00 +0000,http://www.fool.com/investing/2016/08/21/3-reasons-medivation-is-the-juiciest-target-in-bio.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons Medivation Is the Juiciest Target in Biotech
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Outflows: TQQQ, GILD, QCOM, CELG",2016-08-19 16:39:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5ZyeKFpLONQ/noteworthy-etf-outflows-tqqq-gild-qcom-celg-cm667776,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the ProShares UltraPro QQQ (Symbol TQQQ) where we have detected an approximate $31.1 million dollar outflow that's"
CELG,CELG:UW,BBG000BFCMR2,"Biotech Stocks: Trouble Ahead, Trouble Behind?",2016-08-19 16:39:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/19/biotech-stocks-trouble-ahead-trouble-behind/?mod=yahoobarrons&ru=yahoo,"Biotech Stocks: Trouble Ahead, Trouble Behind?"
CELG,CELG:UW,BBG000BFCMR2,CELG Expects This Investigational Drug to Be a Key Growth Driver,2016-08-19 13:04:08 +0000,http://marketrealist.com/2016/08/investigational-crohns-disease-drug-ged-0301-expected-become-key-growth-driver-celgene/?utm_source=yahoo&utm_medium=feed,CELG Expects This Investigational Drug to Be a Key Growth Driver
CELG,CELG:UW,BBG000BFCMR2,"Gilead May Be Better Off Splitting Itself in Two, Analysts Say",2016-08-18 18:08:00 +0000,https://www.thestreet.com/story/13679512/1/gilead-may-be-better-off-splitting-itself-in-two-analysts-say.html?puc=yahoo&cm_ven=YAHOO,"Gilead May Be Better Off Splitting Itself in Two, Analysts Say"
CELG,CELG:UW,BBG000BFCMR2,How Much Medivation Can Really Fetch in a Buyout,2016-08-18 16:50:49 +0000,http://247wallst.com/healthcare-business/2016/08/18/how-much-medivation-can-really-fetch-in-a-buyout/,How Much Medivation Can Really Fetch in a Buyout
CELG,CELG:UW,BBG000BFCMR2,"Despite Competitive Pressures, CELG Leads in Hematologic Oncology",2016-08-18 15:04:07 +0000,http://marketrealist.com/2016/08/despite-competitive-pressures-celgene-continues-leader-hematologic-oncology-segment/?utm_source=yahoo&utm_medium=feed,"Despite Competitive Pressures, CELG Leads in Hematologic Oncology"
CELG,CELG:UW,BBG000BFCMR2,Ozanimod May Prove to Be a Strong Growth Driver for Celgene,2016-08-18 13:04:26 +0000,http://marketrealist.com/2016/08/ozanimod-may-prove-strong-growth-driver-celgene-future-years/?utm_source=yahoo&utm_medium=feed,Ozanimod May Prove to Be a Strong Growth Driver for Celgene
CELG,CELG:UW,BBG000BFCMR2,Another Endorsement for Biotech ETFs,2016-08-17 21:56:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hYQcDdHfypE/another-endorsement-for-biotech-etfs-cm666016,"The iShares Nasdaq Biotechnology ETF (NasdaqGS  IBB ) , which tracks the Nasdaq Biotechnology Index, and rival biotechnology exchange traded funds, seem to have put the woes experienced earlier this year behind them and recently have"
CELG,CELG:UW,BBG000BFCMR2,CELG’s Otezla Continues Dominating US Inflammation and Immunology,2016-08-17 15:04:21 +0000,http://marketrealist.com/2016/08/celgenes-otezla-continues-dominate-inflammation-immunology-segment-u-s/?utm_source=yahoo&utm_medium=feed,CELG’s Otezla Continues Dominating US Inflammation and Immunology
CELG,CELG:UW,BBG000BFCMR2,Olympic Swimmer and Author Dara Torres Teams Up With Celgene to Launch SHOW MORE OF YOU Psoriasis Campaign,2016-08-17 13:21:03 +0000,http://www.publicnow.com/view/4293A30EC797993EE1B844448334702B1FBF3F5F,"[at noodls] - New Campaign Aims to Inspire People With Psoriasis to Show More of Their True Selves SUMMIT, N.J.--(BUSINESS WIRE)-- Twelve-time Olympic medalist, best-selling author, host of a cable sports TV show, and ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Continues to Develop Its Hematologic Oncology Pipeline,2016-08-17 13:04:27 +0000,http://marketrealist.com/2016/08/celgene-continues-develop-hematology-oncology-pipeline-2016/?utm_source=yahoo&utm_medium=feed,Celgene Continues to Develop Its Hematologic Oncology Pipeline
CELG,CELG:UW,BBG000BFCMR2,Olympic Swimmer and Author Dara Torres Teams Up With Celgene to Launch SHOW MORE OF YOU Psoriasis Campaign,2016-08-17 13:01:00 +0000,http://finance.yahoo.com/news/olympic-swimmer-author-dara-torres-130100103.html,"[Business Wire] - Twelve-time Olympic medalist, best-selling author, host of a cable sports TV show, and mom Dara Torres dives into a very important conversation this summer as she teams up with Celgene Corporation and Otezla® to launch the SHOW MORE OF YOU campaign."
CELG,CELG:UW,BBG000BFCMR2,"With new president and focus on big investors, Cellceutix aims for the Nasdaq",2016-08-17 11:00:11 +0000,http://www.bizjournals.com/boston/blog/bioflash/2016/08/with-new-president-and-focus-on-big-investors.html?ana=yahoo,"With new president and focus on big investors, Cellceutix aims for the Nasdaq"
CELG,CELG:UW,BBG000BFCMR2,4 Top Biotech Stocks That Can Be Purchased on the Cheap This Summer,2016-08-16 18:54:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MyXXrmZlDag/4-top-biotech-stocks-that-can-be-purchased-on-the-cheap-this-summer-cm665738,"Image source  Getty Images.  U.S stocks have been taken for a wild ride in 2016, but at least most long term investors can relish the fact that despite the volatility, the broader market"
CELG,CELG:UW,BBG000BFCMR2,Abraxane Still Leads the US Metastatic Pancreatic Cancer Segment,2016-08-16 15:04:37 +0000,http://marketrealist.com/2016/08/abraxane-continues-leader-metastatic-pancreatic-cancer-segment-u-s/?utm_source=yahoo&utm_medium=feed,Abraxane Still Leads the US Metastatic Pancreatic Cancer Segment
CELG,CELG:UW,BBG000BFCMR2,Pomalyst Continues to Witness Strong Global Demand in 2016,2016-08-16 13:04:58 +0000,http://marketrealist.com/2016/08/pomalyst-continues-witness-strong-demand-globally-2016/?utm_source=yahoo&utm_medium=feed,Pomalyst Continues to Witness Strong Global Demand in 2016
CELG,CELG:UW,BBG000BFCMR2,4 Top Biotech Stocks That Can Be Purchased on the Cheap This Summer,2016-08-16 12:18:00 +0000,http://www.fool.com/investing/2016/08/16/4-top-biotech-stocks-that-can-be-purchased-on-the.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Top Biotech Stocks That Can Be Purchased on the Cheap This Summer
CELG,CELG:UW,BBG000BFCMR2,Revlimid Is Expected to Become a Major Lymphoma Drug by 2020,2016-08-15 15:05:00 +0000,http://marketrealist.com/2016/08/revlimid-expected-become-major-lymphoma-drug-2020/?utm_source=yahoo&utm_medium=feed,Revlimid Is Expected to Become a Major Lymphoma Drug by 2020
CELG,CELG:UW,BBG000BFCMR2,Top Biotechs Are Among Jefferies Growth Stock Favorites,2016-08-15 14:20:29 +0000,http://247wallst.com/investing/2016/08/15/top-biotechs-are-among-jefferies-growth-stock-favorites/,Top Biotechs Are Among Jefferies Growth Stock Favorites
CELG,CELG:UW,BBG000BFCMR2,7 Battered Biotech Stocks to Buy,2016-08-15 13:35:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gy9ryP6mR8o/7-battered-biotech-stocks-to-buy-cm665200,"Sometimes bad news is good news. A pummeling of biotechnology stocks over the past year means that gutsy investors can get in on a formerly high flying sector at discounted prices. From its peak in July 2015,"
CELG,CELG:UW,BBG000BFCMR2,Strong Growth in Demand Could Boost Revlimid’s Sales in 2016,2016-08-15 13:06:06 +0000,http://marketrealist.com/2016/08/strong-growth-demand-expected-boost-revlimids-sales-2016/?utm_source=yahoo&utm_medium=feed,Strong Growth in Demand Could Boost Revlimid’s Sales in 2016
CELG,CELG:UW,BBG000BFCMR2,"Dr. Jerome Zeldis, M.D., Ph.D., former Chief Medical Officer of Celgene, to Join Sorrento as Chief Medical Officer and President of Clinical Development",2016-08-15 13:00:00 +0000,http://finance.yahoo.com/news/dr-jerome-zeldis-m-d-130000130.html,"[PR Newswire] - SAN DIEGO, Aug. 15, 2016 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; ""Sorrento""), an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer, ..."
CELG,CELG:UW,BBG000BFCMR2,Analysts’ Recommendations for Celgene and Its Peers in 2016,2016-08-12 17:09:29 +0000,http://marketrealist.com/2016/08/analyst-recommendations-celgene-peers-2016/?utm_source=yahoo&utm_medium=feed,Analysts’ Recommendations for Celgene and Its Peers in 2016
CELG,CELG:UW,BBG000BFCMR2,How Do Celgene’s Valuation Multiples Compare to Its Peers’?,2016-08-12 17:09:01 +0000,http://marketrealist.com/2016/08/celgenes-valuation-multiples-compare-peers/?utm_source=yahoo&utm_medium=feed,How Do Celgene’s Valuation Multiples Compare to Its Peers’?
CELG,CELG:UW,BBG000BFCMR2,Should Gilead Split in Two?,2016-08-12 17:03:00 +0000,https://www.thestreet.com/story/13674067/1/should-gilead-split-in-two.html?puc=yahoo&cm_ven=YAHOO,Should Gilead Split in Two?
CELG,CELG:UW,BBG000BFCMR2,"Gilead Draws Buyers as Prospect of Business Divide Rises, Jim Cramer Says",2016-08-12 10:30:00 +0000,http://realmoney.thestreet.com/articles/08/12/2016/gilead-draws-buyers-prospect-business-divide-rises-jim-cramer-says?puc=yahoo&cm_ven=YAHOO,"Gilead Draws Buyers as Prospect of Business Divide Rises, Jim Cramer Says"
CELG,CELG:UW,BBG000BFCMR2,Analysts: Gilead Should Divide Itself and Conquer,2016-08-12 10:30:00 +0000,http://realmoney.thestreet.com/articles/08/12/2016/analysts-gilead-should-divide-itself-and-conquer?puc=yahoo&cm_ven=YAHOO,Analysts: Gilead Should Divide Itself and Conquer
CELG,CELG:UW,BBG000BFCMR2,Valeant sinks on criminal probe,2016-08-11 16:28:00 +0000,http://finance.yahoo.com/video/valeant-sinks-criminal-probe-162800408.html,Valeant sinks on criminal probe
CELG,CELG:UW,BBG000BFCMR2,The 1 Stock You've Been Overlooking for Your Roth IRA,2016-08-11 13:52:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X-PdaRIztwo/the-1-stock-youve-been-overlooking-for-your-roth-ira-cm663892,"Image source  Getty Images.  Americans have a veritable bounty of retirement tools to choose from, but arguably none is better than the Roth IRA .  A Roth IRA is a tax advantaged"
CELG,CELG:UW,BBG000BFCMR2,The 1 Stock You've Been Overlooking for Your Roth IRA,2016-08-11 12:24:00 +0000,http://www.fool.com/investing/2016/08/11/the-1-stock-youve-been-overlooking-for-your-roth-i.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The 1 Stock You've Been Overlooking for Your Roth IRA
CELG,CELG:UW,BBG000BFCMR2,"Gilead Sciences, Inc.: A Breakdown Looms for GILD Stock",2016-08-10 20:51:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bBZnDYLYaKc/gilead-sciences-inc-a-breakdown-looms-for-gild-stock-cm663675,"Biotech stocks are on the mend with breakouts multiplying across the sector. But not all drug plays are being bid up. Chief among the scorned is Gilead Sciences, Inc. (NASDAQ"
CELG,CELG:UW,BBG000BFCMR2,Short Sellers Run for Cover From Major Biotechs,2016-08-10 12:50:48 +0000,http://247wallst.com/healthcare-business/2016/08/10/short-sellers-run-for-cover-from-major-biotechs-8/,Short Sellers Run for Cover From Major Biotechs
CELG,CELG:UW,BBG000BFCMR2,bluebird bio Inc. Earnings: Waiting for Data,2016-08-09 21:56:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x1gAc2WHc5E/bluebird-bio-inc-earnings-waiting-for-data-cm662873,"Image source  Getty Images.  Last week bluebird bio Inc. (NASDAQ  BLUE) released its second quarter earnings report. As is common, the biotech's management held no conference call  since its revenue only"
CELG,CELG:UW,BBG000BFCMR2,"Stock Market News for August 09, 2016",2016-08-09 16:38:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZG-8sKAiAGM/stock-market-news-for-august-09-2016-cm662605,"Despite strong crude rally, major benchmarks closed in the red on Monday on the back of declines in healthcare stocks. Declines in healthcare giants like Bristol Myers and Merck offset gains in energy stocks on the back of rising"
CELG,CELG:UW,BBG000BFCMR2,BIOTECH: Cancer-focused startup gets $37M stake,2016-08-08 21:10:11 +0000,http://www.bizjournals.com/bizwomen/news/latest-news/2016/08/biotech-cancer-focused-startup-gets-37m-stake.html?ana=yahoo,BIOTECH: Cancer-focused startup gets $37M stake
CELG,CELG:UW,BBG000BFCMR2,This big biotech boosts its deep Bay Area cancer-fighting portfolio,2016-08-08 18:55:12 +0000,http://www.bizjournals.com/sanfrancisco/blog/biotech/2016/08/celgene-celg-cleave-biosciences-flexus-sean-parker.html?ana=yahoo,This big biotech boosts its deep Bay Area cancer-fighting portfolio
CELG,CELG:UW,BBG000BFCMR2,A Trio of Catalysts Sends Celgene Corporation 14% Higher in July,2016-08-08 17:18:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bc_NDi7lrTU/a-trio-of-catalysts-sends-celgene-corporation-14-higher-in-july-cm661954,"Image source  Getty Images.  What  Shares of Celgene Corporation (NASDAQ  CELG) , a biotech blue chip company primarily focused on oncology, immunology, and inflammatory drug research, surged 14% in July ,"
CELG,CELG:UW,BBG000BFCMR2,"Noteworthy ETF Outflows: OEF, GILD, AGN, CELG",2016-08-08 16:12:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xcp1-rs6D9I/noteworthy-etf-outflows-oef-gild-agn-celg-cm661850,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the iShares S&P 100 ETF (Symbol OEF) where we have detected an approximate $28.9 million dollar outflow"
CELG,CELG:UW,BBG000BFCMR2,3 Biotech Stocks to Buy in August,2016-08-07 04:16:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Flagezwb7Ns/3-biotech-stocks-to-buy-in-august-cm661488,"Image source  Getty Images.  It's been an awful year to be a biotech shareholder. The market cap weighted iShares Nasdaq Biotechnology ETF has bounced off some scary low points recently, but it's still"
CELG,CELG:UW,BBG000BFCMR2,"Agios (AGIO) Q2 Loss Wider than Expected, Pipeline in Focus",2016-08-05 19:27:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GANM0bud1sI/agios-agio-q2-loss-wider-than-expected-pipeline-in-focus-cm661286,"Agios Pharmaceuticals, Inc.AGIO reported a second quarter 2016 loss of $1.47 per share, much wider than the Zacks Consensus Estimate of a loss of $1.28 and the year ago loss of 85 cents. Agios Pharmaceuticals Inc. (AGIO) Street EPS"
CELG,CELG:UW,BBG000BFCMR2,"Agios (AGIO) Q2 Loss Wider than Expected, Pipeline in Focus",2016-08-05 15:10:03 +0000,http://finance.yahoo.com/news/agios-agio-q2-loss-wider-151003502.html,"Agios (AGIO) Q2 Loss Wider than Expected, Pipeline in Focus"
CELG,CELG:UW,BBG000BFCMR2,"Juno (JUNO) Q2 Loss Wider-than-Expected, Focus on Pipeline",2016-08-05 12:56:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8uLnKdhU2go/juno-juno-q2-loss-wider-than-expected-focus-on-pipeline-cm660954,"Juno Therapeutics Inc.JUNO reported a loss of 67 cents per share (including stock based compensation expense) in the second quarter of 2016, wider than the Zacks Consensus Estimate of a loss of 51 cents per share and the year"
CELG,CELG:UW,BBG000BFCMR2,"Celgene Upgraded; Alibaba Price Target Bullish; Square, EA Targets Hiked",2016-08-04 20:23:16 +0000,http://www.investors.com/news/celgene-a-buy-price-targets-raised-on-square-ea-tableau/,"Celgene Upgraded; Alibaba Price Target Bullish; Square, EA Targets Hiked"
CELG,CELG:UW,BBG000BFCMR2,Buy Celgene: Analyst,2016-08-04 20:12:36 +0000,http://www.cnbc.com/id/103846516?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103846516,Buy Celgene: Analyst
CELG,CELG:UW,BBG000BFCMR2,"ETF’s with exposure to Celgene Corp. : August 4, 2016",2016-08-04 18:45:46 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-celgene-corp-august-4-2016/,"ETF’s with exposure to Celgene Corp. : August 4, 2016"
CELG,CELG:UW,BBG000BFCMR2,S&P 500 Analyst Moves: CELG,2016-08-04 17:55:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zd13Nb-sJYs/sp-500-analyst-moves-celg-cm660563,"The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Celgene Corp. ( CELG ) is now the #29 analyst pick, moving up by 1 spot. This rank"
CELG,CELG:UW,BBG000BFCMR2,Call of the day: Scotts Miracle-Gro & Celgene,2016-08-04 16:37:00 +0000,http://finance.yahoo.com/video/call-day-scotts-miracle-gro-163700118.html,Call of the day: Scotts Miracle-Gro & Celgene
CELG,CELG:UW,BBG000BFCMR2,Merrill Lynch Says the Time to Put Money Into Biotech Is Now,2016-08-04 14:40:14 +0000,http://247wallst.com/healthcare-business/2016/08/04/merrill-lynch-says-the-time-to-put-money-into-biotech-is-now/,Merrill Lynch Says the Time to Put Money Into Biotech Is Now
CELG,CELG:UW,BBG000BFCMR2,"Top Analyst Upgrades and Downgrades: Apollo Global, ADM, Celgene, Total, Whole Foods, Targa Resources and More",2016-08-04 12:55:09 +0000,http://247wallst.com/investing/2016/08/04/top-analyst-upgrades-and-downgrades-apollo-global-adm-celgene-total-whole-foods-targa-resources-and-more/,"Top Analyst Upgrades and Downgrades: Apollo Global, ADM, Celgene, Total, Whole Foods, Targa Resources and More"
CELG,CELG:UW,BBG000BFCMR2,"Notable Wednesday Option Activity: SRNE, CELG, RDUS",2016-08-03 16:52:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CHrzT1SeHlw/notable-wednesday-option-activity-srne-celg-rdus-cm659706,"Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Sorrento Therapeutics Inc (Symbol SRNE), where a total volume of 966 contracts has been traded thus far today, a contract volume"
CELG,CELG:UW,BBG000BFCMR2,Time to buy biotech?,2016-08-03 16:30:00 +0000,http://finance.yahoo.com/video/time-buy-biotech-163000035.html,Time to buy biotech?
CELG,CELG:UW,BBG000BFCMR2,2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?,2016-08-02 21:51:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BdzkqjF1tP8/2-biotech-funds-leading-nascent-bull-market-which-is-right-for-you-cm659159,"For proof of a more risk on mood among stock market investors, look no further than the resurgence of growth oriented funds and biotech ETFs in the past month.  As the broad, volatile biotech sector recovers from a drubbing"
CELG,CELG:UW,BBG000BFCMR2,Will Agios (AGIO) Disappoint Estimates in Q2 Earnings?,2016-08-02 17:52:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cBlwTZRDtoM/will-agios-agio-disappoint-estimates-in-q2-earnings-cm659007,"Agios Pharmaceuticals, Inc.AGIO is scheduled to report second quarter 2016 results on Aug 4, before the opening bell. Last quarter, the company had posted a positive surprise of 11.59%. Let's see how things are shaping up for this announcement."
CELG,CELG:UW,BBG000BFCMR2,Juno (JUNO) Q2 Earnings: Will the Stock Disappoint?,2016-08-02 12:57:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zHbARuM0OIY/juno-juno-q2-earnings-will-the-stock-disappoint-cm658584,"Juno Therapeutics Inc.JUNO will be reporting second quarter 2016 results on Aug 4, after the market closes . Juno, which started trading from Dec 2014, had delivered a negative earnings surprise of 17.91% in the last quarter. Let's see"
CELG,CELG:UW,BBG000BFCMR2,MorphoSys Posts Loss In H1; Confirms 2016 Guidance - Quick Facts,2016-08-01 01:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c5yB4pr3mNk/morphosys-posts-loss-in-h1-confirms-2016-guidance--quick-facts-20160801-00017,MorphoSys Posts Loss In H1; Confirms 2016 Guidance - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,Sanofi Profit Down as Diabetes Drug Sales Slip,2016-07-29 02:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cCgdaPdSaT4/sanofi-profit-down-as-diabetes-drug-sales-slip-20160729-00076,Sanofi Profit Down as Diabetes Drug Sales Slip
CELG,CELG:UW,BBG000BFCMR2,Celgene Lifts Guidance as Revlimid Sales Rise -- Update,2016-07-28 14:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nrsNKXUlcK0/celgene-lifts-guidance-as-revlimid-sales-rise--update-20160728-01403,Celgene Lifts Guidance as Revlimid Sales Rise -- Update
CELG,CELG:UW,BBG000BFCMR2,Celgene beats Street 2Q forecasts,2016-07-28 11:58:38 +0000,http://sg.finance.yahoo.com/news/celgene-beats-street-2q-forecasts-115838700.html,Celgene beats Street 2Q forecasts
CELG,CELG:UW,BBG000BFCMR2,Celgene Reports Second Quarter 2016 Operating and Financial Results,2016-07-28 11:38:05 +0000,http://www.publicnow.com/view/592CAC7233B9A2A413364350342B84A9C93AB50C,"[at noodls] - - Net Product Sales $2.74B in Q2:16: Increased 22% Y/Y - REVLIMID Net Product Sales $1.7B in Q2:16; Increased 18% Y/Y - 2016 Guidance Updated: REVLIMID and Total Net Product Sales; EPS SUMMIT, N.J.--(BUSINESS ..."
CELG,CELG:UW,BBG000BFCMR2,U.S. Hot Stocks: Hot Stocks to Watch,2016-07-28 09:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0rtxEsVfnRE/us-hot-stocks-hot-stocks-to-watch-20160728-01028,U.S. Hot Stocks: Hot Stocks to Watch
CELG,CELG:UW,BBG000BFCMR2,Celgene Lifts Guidance as Revlimid Sales Rise,2016-07-28 08:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o43okHQ6IHw/celgene-lifts-guidance-as-revlimid-sales-rise-20160728-00885,Celgene Lifts Guidance as Revlimid Sales Rise
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation Announces 13% Gain In Q2 Bottom Line,2016-07-28 07:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Um6jNjgjRzc/celgene-corporation-announces-13-gain-in-q2-bottom-line-20160728-00583,Celgene Corporation Announces 13% Gain In Q2 Bottom Line
CELG,CELG:UW,BBG000BFCMR2,Celgene and LYSARC Provide Update on the Phase III ‘REMARC' Study of REVLIMID® Maintenance Treatment in Patients with Diffuse Large B-Cell Lymphoma Responding to First-Line R-CHOP Therapy,2016-07-25 20:48:02 +0000,http://www.publicnow.com/view/E9AD81954EB6E476195CFC0B84A65C0BF8B7383B,"[at noodls] - SUMMIT, N.J. & LYON, France--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) and the Lymphoma Study Association (LYSA) today announced that the Lymphoma Academic Research Organisation (LYSARC) reported ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Drug Misses Secondary Endpoint in One of Its Lymphoma Trials,2016-07-25 19:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M0DwkDCcZHo/celgene-drug-misses-secondary-endpoint-in-one-of-its-lymphoma-trials-20160725-01203,Celgene Drug Misses Secondary Endpoint in One of Its Lymphoma Trials
CELG,CELG:UW,BBG000BFCMR2,"Celgene To Receive Options To Jointly Develop, Commercialize Jounce's JTX-2011",2016-07-19 07:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9aLRfBMztIc/celgene-to-receive-options-to-jointly-develop-commercialize-jounces-jtx2011-20160719-00238,"Celgene To Receive Options To Jointly Develop, Commercialize Jounce's JTX-2011"
CELG,CELG:UW,BBG000BFCMR2,REVLIMID® (Lenalidomide) Approved by the European Commission for the Treatment of Relapsed/Refractory Patients with Mantle Cell Lymphoma,2016-07-15 06:18:06 +0000,http://www.publicnow.com/view/B43A76CE430AF9BDAB8A157CFDC0286367673367,"[at noodls] - Approved indication for REVLIMID (lenalidomide) offers a new option for European patients with relapsed/refractory MCL, one of the poorest prognoses among all lymphomas Approval gives Celgene its first ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene: European Commission Approves REVLIMID - Quick Facts,2016-07-15 02:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z7lKRgSTWAo/celgene-european-commission-approves-revlimid--quick-facts-20160715-00027,Celgene: European Commission Approves REVLIMID - Quick Facts
CELG,CELG:UW,BBG000BFCMR2,Juno to Resume Clinical Trial of Anticancer Treatment,2016-07-12 18:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mkP4Sh3j3Xw/juno-to-resume-clinical-trial-of-anticancer-treatment-20160712-01278,Juno to Resume Clinical Trial of Anticancer Treatment
CELG,CELG:UW,BBG000BFCMR2,Juno Shares Plunge as Drug Trial Placed on Hold After Patient Deaths,2016-07-07 17:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9tUHt486t8A/juno-shares-plunge-as-drug-trial-placed-on-hold-after-patient-deaths-20160707-01069,Juno Shares Plunge as Drug Trial Placed on Hold After Patient Deaths
CELG,CELG:UW,BBG000BFCMR2,"U.S. Stocks Rise, Led by Riskier Sectors",2016-07-06 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lP_IRnpBsCM/us-stocks-rise-led-by-riskier-sectors-20160706-00921,"U.S. Stocks Rise, Led by Riskier Sectors"
CELG,CELG:UW,BBG000BFCMR2,Biotech Medivation Opens Door to Takeover Talks -- WSJ,2016-07-06 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p7rgeNLGMLo/biotech-medivation-opens-door-to-takeover-talks--wsj-20160706-00048,Biotech Medivation Opens Door to Takeover Talks -- WSJ
CELG,CELG:UW,BBG000BFCMR2,"Sanofi, Medivation Start Takeover Talks -- 2nd Update",2016-07-05 18:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oWLoKnBrb_0/sanofi-medivation-start-takeover-talks--2nd-update-20160705-01034,"Sanofi, Medivation Start Takeover Talks -- 2nd Update"
CELG,CELG:UW,BBG000BFCMR2,Medivation Opens Door to Takeover Talks With Sanofi,2016-07-05 17:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3xjgcN4-6NQ/medivation-opens-door-to-takeover-talks-with-sanofi-20160705-01035,Medivation Opens Door to Takeover Talks With Sanofi
CELG,CELG:UW,BBG000BFCMR2,"Celgene Corporation to Announce Second Quarter 2016 Results on July 28, 2016",2016-07-01 11:41:02 +0000,http://www.publicnow.com/view/5D2D3E1634639B88B39B69558877264A5D5B6EAA,"[at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) will host a conference call and live audio webcast on Thursday, July 28, 2016 at 9 a.m. ET to discuss second quarter 2016 financial and ..."
CELG,CELG:UW,BBG000BFCMR2,Four NCI Cancer Centers Announce Landmark Research Consortium and Collaborations with Celgene,2016-06-22 11:39:08 +0000,http://www.publicnow.com/view/0000EB5F280F8EBDA6E7A97493C527B1FF0F0CEE,"[at noodls] - Pioneering Public-Private Cancer Initiative with Unified Leadership Committed to Changing the Course of Cancer Care NEW YORK--(BUSINESS WIRE)-- Today, The Abramson Cancer Center at the University of Pennsylvania, ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Additional $3 Billion Share Repurchase Authorization,2016-06-15 11:49:09 +0000,http://www.publicnow.com/view/EBCDBCDFAD32730A0A27CD8640D418D7D069CFA6,"[at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced that during its June meeting the Company's Board of Directors authorized the repurchase of up to an additional $3.0 billion ..."
CELG,CELG:UW,BBG000BFCMR2,Acceleron and Celgene Announce Updated Results from an Ongoing Phase 2 Study of Luspatercept in Myelodysplastic Syndromes at the 21st Congress of the European Hematology Association,2016-06-10 13:59:09 +0000,http://www.publicnow.com/view/756598CD63F28CD64B306751BE7318123F5F9971,[at noodls] - - Preliminary results show that treatment with investigational drug luspatercept results in clinically meaningful increases in hemoglobin and durable transfusion independence in patients with lower risk ...
CELG,CELG:UW,BBG000BFCMR2,Acceleron and Celgene Announce Updated Results from an Ongoing Phase 2 Study of Luspatercept in Beta-Thalassemia Presented at the 21st Congress of the European Hematology Association,2016-06-10 13:59:09 +0000,http://www.publicnow.com/view/FF940D9BD662B138574D314A68119E9C9D6A11E2,"[at noodls] - - Longer term data with investigational drug luspatercept show sustained increases in hemoglobin levels, reduced transfusion burden, and improved patient reported quality of life measures in patients with ..."
CELG,CELG:UW,BBG000BFCMR2,Study Reveals Racial Disparities in Multiple Myeloma Treatment Patterns,2016-06-07 20:28:02 +0000,http://www.publicnow.com/view/69FD2B0A8B014B4A254DF3984C5C52CDB37FFC41,"[at noodls] - Analysis shows gaps in treatment initiation and access between Caucasians and African Americans following multiple myeloma diagnosis SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Webcast at Upcoming Investor Conferences,2016-05-20 11:43:05 +0000,http://www.publicnow.com/view/4E810A1C87BF79E187B17956C9E73305989204A9,"[at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) plans to present at three upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2016,2016-05-18 22:12:02 +0000,http://www.publicnow.com/view/E2211C800ECFA752AC2ED698D05B9059D7CD8165,"[at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced more than 65 presentations reporting on investigational studies in blood and solid tumor cancers will be presented during ..."
CELG,CELG:UW,BBG000BFCMR2,Agios and Celgene Establish New Collaboration in Metabolic Immuno-Oncology and Amend Certain Rights from 2010 Agreement,2016-05-17 22:42:10 +0000,http://www.publicnow.com/view/145E31774AAF01F97D547D88461E31BAE2670E64,[at noodls] - - New Collaboration Builds on Agios Research Platform and Leverages Celgene Capabilities; Agios to Receive $200 Million Upfront Payment - - AG-120 Rights Outside the United States Transferred to Agios ...
CELG,CELG:UW,BBG000BFCMR2,"Celgene Launches Fictional Film, Millefeuille, to Shed New Light on Complex Psoriasis Challenges",2016-05-17 19:22:04 +0000,http://www.publicnow.com/view/90CAF391D59081212CA9BE946AB1DF41C3AEC2AE,"[at noodls] - Celgene launches fictional film, Millefeuille, to shed new light on complex psoriasis challenges Published on Celgene Newsroom (http://celgene.newshq.businesswire.com) on 5/17/16 2:43 am EDT Celgene launches ..."
CELG,CELG:UW,BBG000BFCMR2,Celgene Reports First Quarter 2016 Operating and Financial Results,2016-04-28 11:57:32 +0000,http://www.publicnow.com/view/12C5C14EE12AAF56FEA49334DD7D219D1B5A5475,[at noodls] - - Strong Operating Momentum Drives Q1 Results - 2016 Guidance: Raising Lower-End of Ranges for Net Product Sales and Adjusted Diluted EPS - 2017 Financial Targets Updated; 2020 Financial Targets On-Track ...
CELG,CELG:UW,BBG000BFCMR2,Celgene beats 1Q profit forecasts,2016-04-28 11:47:39 +0000,http://sg.finance.yahoo.com/news/celgene-beats-1q-profit-forecasts-114739851.html,Celgene beats 1Q profit forecasts
CELG,CELG:UW,BBG000BFCMR2,Celgene and Juno Announce Celgene Exercised Option to Develop and Commercialize CD19-directed Product Candidates,2016-04-11 14:41:11 +0000,http://www.publicnow.com/view/0A0E41E92EA9A94091FC92243C2831C1F5DDC981,"[at noodls] - http://www.businesswire.com/news/home/20160411005739/en/ Juno currently has three CD19-directed product candidates in clinical development, including JCAR015, JCAR017, and JCAR014. JCAR015 is in a Phase ..."
CELG,CELG:UW,BBG000BFCMR2,Drug distribution becomes weapon to block competition,2016-03-03 15:38:35 +0000,http://sg.finance.yahoo.com/news/drug-distribution-becomes-weapon-block-150848729.html,Drug distribution becomes weapon to block competition
CELG,CELG:UW,BBG000BFCMR2,Celgene misses 4Q profit forecasts,2016-01-28 13:11:36 +0000,http://sg.finance.yahoo.com/news/celgene-misses-4q-profit-forecasts-131136246.html,Celgene misses 4Q profit forecasts
CELG,CELG:UW,BBG000BFCMR2,"US STOCKS-On Wall Street, oil proffers modest Santa Claus rally",2015-12-23 21:24:17 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-street-oil-212417089.html,"US STOCKS-On Wall Street, oil proffers modest Santa Claus rally"
CELG,CELG:UW,BBG000BFCMR2,Celgene settles U.S. patent litigation for top seller Revlimid,2015-12-22 22:59:21 +0000,http://sg.finance.yahoo.com/news/celgene-allow-sale-generic-revlimid-220258194.html,Celgene settles U.S. patent litigation for top seller Revlimid
CELG,CELG:UW,BBG000BFCMR2,AstraZeneca chases Acerta to secure next cancer drug winner,2015-12-14 14:00:42 +0000,http://sg.finance.yahoo.com/news/astrazeneca-confirms-talks-cancer-drug-081935545.html,AstraZeneca chases Acerta to secure next cancer drug winner
CELG,CELG:UW,BBG000BFCMR2,Celgene reports 3Q loss,2015-11-05 12:46:10 +0000,http://sg.finance.yahoo.com/news/celgene-reports-3q-loss-124610835.html,Celgene reports 3Q loss
CELG,CELG:UW,BBG000BFCMR2,Celgene Corporation to Webcast Upcoming Investor Conferences in September,2015-08-26 12:30:00 +0000,http://uk.finance.yahoo.com/news/celgene-corporation-webcast-upcoming-investor-123000779.html,Celgene Corporation to Webcast Upcoming Investor Conferences in September
CELG,CELG:UW,BBG000BFCMR2,July is now fifth busiest high-grade month on record,2015-07-31 16:09:40 +0000,http://uk.finance.yahoo.com/news/july-now-fifth-busiest-high-160940262.html,July is now fifth busiest high-grade month on record
CELG,CELG:UW,BBG000BFCMR2,Wall Street lauds Celgene's $7.2 billion Receptos buy,2015-07-15 17:14:22 +0000,http://sg.finance.yahoo.com/news/wall-street-lauds-celgenes-7-171422186.html,Wall Street lauds Celgene's $7.2 billion Receptos buy
CELG,CELG:UW,BBG000BFCMR2,US STOCKS-Wall St higher; financial stocks lead,2015-07-15 17:09:18 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-higher-170918384.html,US STOCKS-Wall St higher; financial stocks lead
CELG,CELG:UW,BBG000BFCMR2,US STOCKS-Wall St up as Fed says on track to raise rates in 2015,2015-07-15 15:34:46 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-fed-153446612.html,US STOCKS-Wall St up as Fed says on track to raise rates in 2015
CELG,CELG:UW,BBG000BFCMR2,Celgene will buy drug developer Receptos for $7.32 billion,2015-07-14 22:20:39 +0000,http://sg.finance.yahoo.com/news/celgene-buy-drug-developer-receptos-213012647.html,Celgene will buy drug developer Receptos for $7.32 billion
CELG,CELG:UW,BBG000BFCMR2,Celgene to buy Receptos for $7.2 billion,2015-07-14 22:13:01 +0000,http://sg.finance.yahoo.com/news/celgene-buy-receptos-7-2-221301046.html,Celgene to buy Receptos for $7.2 billion
CELG,CELG:UW,BBG000BFCMR2,"Celgene, Juno map out cancer treatment collaboration",2015-06-30 13:45:22 +0000,http://sg.finance.yahoo.com/news/celgene-juno-map-cancer-treatment-134522926.html,"Celgene, Juno map out cancer treatment collaboration"
CELG,CELG:UW,BBG000BFCMR2,Global cancer drug spending hits $100 billion in 2014 - IMS Health,2015-05-05 06:48:00 +0000,http://sg.finance.yahoo.com/news/global-cancer-drug-spending-hits-040552760.html,Global cancer drug spending hits $100 billion in 2014 - IMS Health
CELG,CELG:UW,BBG000BFCMR2,Celgene sales highlight Revlimid dependence ahead of patent ruling,2015-04-30 19:57:58 +0000,http://uk.finance.yahoo.com/news/celgene-sales-highlight-revlimid-dependence-195758570.html,Celgene sales highlight Revlimid dependence ahead of patent ruling
CELG,CELG:UW,BBG000BFCMR2,Wall Street falls on mixed economic data; Apple weighs,2015-04-30 17:42:55 +0000,http://sg.finance.yahoo.com/news/wall-street-falls-mixed-economic-174255673.html,Wall Street falls on mixed economic data; Apple weighs
CELG,CELG:UW,BBG000BFCMR2,US STOCKS-Wall St falls on mixed economic data; Apple weighs,2015-04-30 17:28:58 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-falls-172858355.html,US STOCKS-Wall St falls on mixed economic data; Apple weighs
CELG,CELG:UW,BBG000BFCMR2,"Wall Street opens lower as Apple, Celgene weigh",2015-04-30 14:53:48 +0000,http://sg.finance.yahoo.com/news/wall-street-opens-lower-apple-145348550.html,"Wall Street opens lower as Apple, Celgene weigh"
CELG,CELG:UW,BBG000BFCMR2,"US STOCKS-Wall St opens lower as Apple, Celgene weigh",2015-04-30 14:39:19 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-opens-143919717.html,"US STOCKS-Wall St opens lower as Apple, Celgene weigh"
CELG,CELG:UW,BBG000BFCMR2,Celgene tops 1Q profit forecasts,2015-04-30 11:51:53 +0000,http://sg.finance.yahoo.com/news/celgene-tops-1q-profit-forecasts-115153050.html,Celgene tops 1Q profit forecasts
CELG,CELG:UW,BBG000BFCMR2,Midday Glance: Biotechnology companies,2015-04-29 18:53:41 +0000,http://sg.finance.yahoo.com/news/midday-glance-biotechnology-companies-172130913--finance.html,Midday Glance: Biotechnology companies
CELG,CELG:UW,BBG000BFCMR2,Early Glance: Biotechnology companies,2015-04-29 14:45:33 +0000,http://sg.finance.yahoo.com/news/early-glance-biotechnology-companies-142627063--finance.html,Early Glance: Biotechnology companies
CELG,CELG:UW,BBG000BFCMR2,Investors seek protection against healthcare stock decline,2015-04-24 19:13:25 +0000,http://sg.finance.yahoo.com/news/investors-seek-protection-against-healthcare-191325937.html,Investors seek protection against healthcare stock decline
CELG,CELG:UW,BBG000BFCMR2,"AstraZeneca insists Celgene deal about strategy, not cash",2015-04-24 14:09:35 +0000,http://sg.finance.yahoo.com/news/astrazeneca-insists-celgene-deal-strategy-104649996.html,"AstraZeneca insists Celgene deal about strategy, not cash"
CELG,CELG:UW,BBG000BFCMR2,"AstraZeneca insists Celgene deal about strategy, not cash",2015-04-24 14:07:10 +0000,http://uk.finance.yahoo.com/news/astrazeneca-insists-celgene-deal-strategy-104324392.html,"AstraZeneca insists Celgene deal about strategy, not cash"
CELG,CELG:UW,BBG000BFCMR2,AstraZeneca looks beyond Nexium hit with new cancer deals,2015-04-24 08:27:29 +0000,http://sg.finance.yahoo.com/news/astrazeneca-hit-copycat-nexium-strong-062234109.html,AstraZeneca looks beyond Nexium hit with new cancer deals
CELG,CELG:UW,BBG000BFCMR2,AstraZeneca looks beyond Nexium hit with new cancer deals,2015-04-24 08:23:12 +0000,http://uk.finance.yahoo.com/news/astrazeneca-looks-beyond-nexium-hit-065135561.html,AstraZeneca looks beyond Nexium hit with new cancer deals
CELG,CELG:UW,BBG000BFCMR2,"Europe gives green light to AbbVie hepatitis C medicine, others",2014-11-21 12:20:25 +0000,http://uk.finance.yahoo.com/news/europe-gives-green-light-abbvie-122025634.html,"Europe gives green light to AbbVie hepatitis C medicine, others"
